data_1o0l_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1o0l _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 CA-C-O 121.26 0.442 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -166.0 1.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.883 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -39.45 82.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.393 0.139 . . . . 0.0 111.158 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.417 ' O ' HG11 ' A' ' 14' ' ' VAL . 13.1 ttp180 -62.2 -38.01 87.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.84 66.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.686 HD22 ' HE1' ' A' ' 46' ' ' MET . 1.6 tp -72.4 -42.28 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.494 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 9.7 p -66.49 -36.07 76.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 109.969 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.23 -22.96 60.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.322 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -73.16 -66.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.644 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -53.44 -50.66 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.798 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.582 HG11 HD13 ' A' ' 22' ' ' LEU . 96.4 t -67.64 -42.31 86.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.429 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.48 -52.29 52.2 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.211 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -55.57 -45.33 77.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.148 0.579 . . . . 0.0 111.223 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -48.37 66.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -63.38 -45.31 91.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.578 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.732 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -62.17 -26.98 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.026 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -85.99 -23.97 26.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.57 66.12 1.12 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.9 -72.17 0.29 Allowed Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.833 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.2 t80 -91.2 52.96 2.22 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.163 0.506 . . . . 0.0 110.332 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.15 -31.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.668 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -35.35 79.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.392 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.77 57.39 2.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.659 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -60.18 128.26 35.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.617 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 165.6 -60.91 0.24 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.278 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.466 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 32.1 Cg_exo -58.8 -52.51 5.12 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 121.96 1.773 . . . . 0.0 111.024 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -92.57 42.48 2.68 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.51 -18.32 31.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 110.313 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.55 147.5 17.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.622 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -93.94 -158.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.964 2.443 . . . . 0.0 113.135 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -83.3 96.77 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.31 -24.44 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.737 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 20.6 m-20 -79.5 163.25 59.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.105 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.427 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 25.3 Cg_endo -78.0 50.39 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.42 2.746 . . . . 0.0 112.102 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.656 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.49 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.345 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.645 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.3 m170 -59.23 -60.48 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.09 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.561 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.4 -24.88 61.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.045 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -73.82 -50.71 19.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.92 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.686 ' HE1' HD22 ' A' ' 13' ' ' LEU . 3.8 ttm -66.74 -37.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.43 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.98 84.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.542 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.62 -27.69 51.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.348 0.595 . . . . 0.0 110.678 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB1' ' HZ ' ' A' ' 147' ' ' PHE . . . -68.98 -62.65 1.29 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.563 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.644 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.94 -45.85 41.1 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.72 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.34 -50.11 72.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.054 0.455 . . . . 0.0 111.697 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -46.37 84.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.198 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -68.73 -36.33 78.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.274 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.21 -32.5 71.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.302 0.572 . . . . 0.0 109.547 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -83.12 -25.76 31.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.414 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -91.47 -29.43 17.02 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.21 96.86 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 110.992 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt-85 -72.54 -3.69 26.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.601 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.453 HH12 HG13 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -132.2 87.89 2.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.761 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.05 -61.02 1.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.658 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 6.9 m-85 -79.67 0.44 30.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.471 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 p -73.42 -53.99 9.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.33 -24.27 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.919 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.746 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -63.15 -44.77 94.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.862 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.65 51.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.898 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 63' ' ' ASP . . . -51.66 -44.28 62.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.201 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.476 HE22 HD13 ' A' ' 106' ' ' LEU . 19.7 mt-30 -69.2 -51.24 39.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.716 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -86.17 20.22 2.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.097 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.74 -40.88 32.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 71' ' ' THR . 1.5 p -90.88 -60.83 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.466 ' H ' HG12 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -172.7 145.7 1.41 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.11 -158.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.075 2.516 . . . . 0.0 112.623 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.99 -71.07 2.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.77 50.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.54 0.686 . . . . 0.0 111.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.484 ' HB2' ' HH2' ' A' ' 125' ' ' TRP . . . -102.61 -20.51 14.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.646 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.677 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -65.13 -38.06 89.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 26.1 mp0 -67.43 -42.05 83.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -64.06 -45.57 88.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 5.7 t80 -62.39 -51.86 65.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.712 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -58.33 -32.62 68.68 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 22.8 mm-40 -64.15 -56.74 12.67 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.417 ' O ' HD12 ' A' ' 86' ' ' LEU . 12.3 m -63.84 -31.88 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.315 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.0 m -65.56 -43.41 89.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.356 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.621 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -66.96 -36.67 82.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.244 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.46 -26.25 64.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.894 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.714 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -79.81 -30.91 40.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.087 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -95.96 1.48 52.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -50.15 21.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.747 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.14 61.71 0.15 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.844 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.13 58.67 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.004 -1.093 . . . . 0.0 114.129 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.581 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.5 Cg_endo -81.08 41.89 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.43 2.087 . . . . 0.0 111.741 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.769 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.2 t-20 -64.47 162.89 14.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -56.05 -26.28 48.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.698 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.02 94.14 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.714 ' HG3' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -87.54 -27.23 22.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.952 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.793 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.05 -30.88 49.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.388 0.614 . . . . 0.0 110.149 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 53' ' ' PHE . 13.3 t -63.18 -55.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.66 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.56 -28.66 69.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.322 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 99' ' ' PHE . 8.1 m-85 -57.46 -57.62 11.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 109.956 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.622 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 13.6 m-85 -74.88 -37.68 62.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.2 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.74 -37.5 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.157 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -57.15 -52.33 65.72 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.697 0.284 . . . . 0.0 111.202 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.605 ' HA3' ' HE2' ' A' ' 126' ' ' MET . . . -74.41 -40.85 38.89 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.225 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.29 89.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.189 0.495 . . . . 0.0 111.016 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.416 ' C ' HD23 ' A' ' 64' ' ' LEU . . . -71.36 -41.04 70.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.746 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.7 -48.74 80.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.584 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.689 ' HB3' HD21 ' A' ' 22' ' ' LEU . 67.0 m -59.66 -42.26 92.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.316 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.433 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -54.89 -55.96 24.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 0.0 110.855 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.4 -17.87 64.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -77.88 -32.97 52.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.583 HG23 HG21 ' A' ' 119' ' ' VAL . 35.0 t -75.21 -22.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.658 0.742 . . . . 0.0 109.356 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -4.89 59.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.609 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.444 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.2 tttt -132.06 -162.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.585 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.18 55.19 3.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.539 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.52 43.64 2.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.023 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.7 mp0 -60.54 -55.32 46.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.962 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.4 Cg_exo -64.72 -26.84 60.43 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.956 1.771 . . . . 0.0 112.198 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.6 mm? -65.72 -28.11 68.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.313 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.583 HG21 HG23 ' A' ' 111' ' ' VAL . 79.3 t -59.23 -50.69 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.956 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.87 -32.58 84.36 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.838 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 7.9 mm100 -64.63 -52.88 55.09 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' LEU . 44.8 t -58.3 -33.49 47.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.958 0.408 . . . . 0.0 110.115 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.21 -46.92 81.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.427 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.684 ' HA ' HG13 ' A' ' 127' ' ' VAL . 19.0 pt-20 -72.31 -39.43 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.064 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.677 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.9 m0 -57.8 -38.7 75.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.483 0.658 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.605 ' HE2' ' HA3' ' A' ' 103' ' ' GLY . 4.7 ttm -71.96 -56.07 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.69 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.684 HG13 ' HA ' ' A' ' 124' ' ' GLU . 4.2 p -61.19 -33.21 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.424 ' N ' HG12 ' A' ' 127' ' ' VAL . 31.0 mt-10 -73.09 -45.79 55.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.6 t80 -59.88 -37.39 79.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.704 0.764 . . . . 0.0 109.894 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 1.015 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.51 -54.98 8.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.822 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.17 -32.6 70.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -82.43 -35.11 27.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.87 -43.5 1.22 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 1.015 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.51 -48.49 81.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.595 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.8 -38.92 57.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.603 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.15 -50.02 73.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.796 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.769 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.8 t90 -58.17 -49.28 77.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 109.525 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.639 HG13 ' HE3' ' A' ' 137' ' ' TRP . 11.3 mt -58.08 -47.14 87.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.152 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -61.12 -40.0 92.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -30.54 43.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -60.03 3.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.947 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.3 -11.07 0.02 OUTLIER Glycine 0 C--N 1.319 -0.367 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.32 169.16 41.89 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.612 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 138' ' ' ILE . 96.0 m95 -62.2 -29.03 70.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.51 78.66 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.578 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.81 -44.06 94.4 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.629 ' HD1' ' CD2' ' A' ' 147' ' ' PHE . 9.2 t80 -64.83 -34.21 77.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.579 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.821 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -70.55 -25.55 63.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.37 -32.66 20.84 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.454 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -57.95 -51.49 69.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.643 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' A' ' 151' ' ' TYR . 1.4 m-85 -130.32 30.23 4.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.85 -133.13 8.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.927 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -68.59 -45.45 71.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.548 ' O ' HD21 ' A' ' 156' ' ' LEU . . . -93.68 48.78 2.3 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.12 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.23 73.26 8.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.12 0.486 . . . . 0.0 110.734 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -65.77 160.05 23.85 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.575 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -57.01 -32.18 65.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.281 -178.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.609 ' HB2' HD11 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -69.62 -39.41 77.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.651 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.528 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -68.38 -36.31 78.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.402 ' HA ' ' HE2' ' A' ' 151' ' ' TYR . 61.9 mtt180 -67.56 -50.57 57.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -64.47 -27.32 68.91 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.019 0.438 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -63.34 -47.52 81.81 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.47 178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.445 HH11 ' HE2' ' A' ' 147' ' ' PHE . 11.0 ttp180 -63.4 -39.2 93.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.19 -49.12 70.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.888 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.54 -27.23 73.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.585 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -70.11 -56.63 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.464 -0.368 . . . . 0.0 111.532 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.835 ' HA ' HG23 ' A' ' 170' ' ' VAL . 9.8 p-90 -60.34 -27.87 67.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.453 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.73 74.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.688 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -24.09 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.835 HG23 ' HA ' ' A' ' 167' ' ' TRP . 28.7 m -96.38 -41.15 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.588 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -75.35 -27.4 59.17 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.411 -0.805 . . . . 0.0 111.079 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 1.4 m -81.51 -29.92 33.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.414 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.927 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.2 p -71.57 -28.24 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 110.398 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.927 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -114.44 33.91 5.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.209 0.528 . . . . 0.0 109.628 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.3 t -81.52 -4.72 56.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.242 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -89.39 6.13 83.52 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.647 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 29.29 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.453 HG13 HH12 ' A' ' 59' ' ' ARG . 0.7 OUTLIER -87.23 50.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.054 0.454 . . . . 0.0 110.731 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.14 -1.85 53.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 10.4 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.233 0.259 0 CA-C-O 121.047 0.353 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -72.49 -174.12 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.095 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -37.8 52.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.292 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' HG12 ' A' ' 14' ' ' VAL . 23.8 ttp180 -64.13 -38.67 91.89 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.49 -35.25 68.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.593 HD23 ' HE3' ' A' ' 46' ' ' MET . 3.0 tp -71.66 -43.19 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 11' ' ' ARG . 4.3 p -65.85 -33.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.971 0.415 . . . . 0.0 110.159 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.15 -24.77 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.456 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.36 -63.16 1.39 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -55.54 -51.77 65.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.619 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.62 -38.94 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.789 0.328 . . . . 0.0 110.281 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.63 -51.78 55.3 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.477 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.67 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 73.3 t80 -61.38 -42.27 98.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 0.0 110.847 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -62.61 -46.81 86.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.447 ' N ' HD13 ' A' ' 22' ' ' LEU . 8.1 mp -68.24 -44.72 75.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.726 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.6 -29.14 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.2 pt20 -85.84 -22.94 27.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.84 65.75 1.11 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.26 -70.45 0.31 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.965 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -89.83 51.14 2.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.213 0.53 . . . . 0.0 110.155 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.88 -28.24 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.545 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.63 -29.26 64.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.94 57.87 1.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.726 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.51 112.5 3.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.855 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 178.57 -58.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.403 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -57.86 -48.95 14.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.227 1.951 . . . . 0.0 111.992 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.16 32.69 5.96 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.709 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.3 -20.63 29.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.908 0.385 . . . . 0.0 110.109 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.86 145.6 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -97.55 -159.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.199 2.599 . . . . 0.0 113.647 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -81.59 84.41 6.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.05 1.19 7.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.034 0.445 . . . . 0.0 111.273 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 40.6 m-20 -104.98 163.0 18.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.58 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 37.6 Cg_endo -80.12 47.03 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.443 2.762 . . . . 0.0 111.85 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -175.07 -31.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.755 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.3 m170 -58.0 -58.82 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.342 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 4.0 tt0 -58.18 -25.02 61.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.27 -50.31 16.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.266 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.593 ' HE3' HD23 ' A' ' 13' ' ' LEU . 3.2 ttm -66.89 -37.6 84.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.33 -42.01 23.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.324 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.745 ' HB3' HG22 ' A' ' 97' ' ' VAL . . . -59.16 -54.89 41.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.523 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.6 -50.58 41.93 Favored Glycine 0 C--O 1.22 -0.726 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.294 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.36 -50.05 68.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -48.48 80.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.591 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -71.28 -33.46 69.77 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.212 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.76 -25.34 67.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.55 0.691 . . . . 0.0 109.327 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -84.82 -37.32 20.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.327 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -92.92 -61.22 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.073 0.463 . . . . 0.0 112.165 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.9 69.7 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.402 0.681 . . . . 0.0 111.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -77.82 -16.97 57.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -81.39 46.43 0.94 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.36 . . . . 0.0 111.476 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 t -120.98 -6.45 9.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.649 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.8 m-85 -92.98 -26.31 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -39.3 93.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.538 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.55 -24.99 66.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.706 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -66.16 -41.29 90.57 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -76.67 -46.65 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.26 -43.03 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.544 HE22 HD13 ' A' ' 106' ' ' LEU . 25.0 mt-30 -67.57 -59.32 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.938 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.494 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.35 16.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.62 -26.8 45.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 0.0 110.529 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 71' ' ' THR . 3.4 p -93.01 -60.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.449 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.554 ' H ' HG11 ' A' ' 70' ' ' VAL . 8.6 t -174.69 146.96 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.817 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.58 178.12 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.651 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 101.91 -76.62 0.35 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.947 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.81 48.96 0.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.176 0.512 . . . . 0.0 111.77 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.37 -24.01 16.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 5.9 pt20 -60.66 -42.0 96.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.845 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.24 87.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.719 0.295 . . . . 0.0 110.54 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -62.83 -42.2 99.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.07 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.12 -51.62 65.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.282 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 p -55.86 -32.93 64.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.383 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.472 HE21 ' HB3' ' A' ' 81' ' ' GLN . 0.8 OUTLIER -60.18 -65.0 0.75 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.118 0.485 . . . . 0.0 110.611 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.817 HG13 ' HG ' ' A' ' 180' ' ' LEU . 13.4 m -58.45 -32.2 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.594 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 82' ' ' VAL . 40.9 m -65.79 -43.6 88.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 0.0 110.106 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -71.28 -33.73 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 174' ' ' LEU . 14.3 mt-10 -71.46 -29.82 65.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.338 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -81.37 -34.82 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.909 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -87.65 -8.64 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.099 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -44.22 -45.15 8.34 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.408 ' H ' HD21 ' A' ' 174' ' ' LEU . . . -170.66 63.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.218 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.491 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.8 55.83 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.792 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.7 Cg_endo -80.47 38.38 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.116 1.877 . . . . 0.0 111.569 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.831 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.4 t-20 -68.3 162.76 24.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.089 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.478 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 25.8 m95 -53.53 -26.98 23.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.71 -42.3 98.69 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.687 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.9 mtp180 -86.72 -22.47 26.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.82 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.829 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.31 -31.69 54.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 110.25 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.831 HG12 ' HB2' ' A' ' 53' ' ' PHE . 9.5 t -61.62 -56.84 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -27.56 69.36 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.618 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.829 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.3 m-85 -57.07 -55.82 29.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.054 0.454 . . . . 0.0 109.942 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.622 ' HE1' HD21 ' A' ' 130' ' ' LEU . 12.5 m-85 -75.96 -38.68 57.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.938 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.8 t -60.85 -37.66 77.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.599 ' HE2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -55.74 -50.5 70.2 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.77 0.319 . . . . 0.0 111.219 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.21 -38.44 34.41 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.056 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.5 96.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.081 0.44 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -68.74 -38.27 80.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.706 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.13 -45.19 95.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.186 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.86 -42.51 97.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.43 31.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 110.843 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.97 -16.12 63.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 m -77.98 -33.83 51.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 t -77.08 -20.85 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.708 0.766 . . . . 0.0 109.019 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -82.09 -2.33 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.235 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.459 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 12.3 mtmt -138.27 -155.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.459 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 21.0 mt-10 -99.16 53.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.698 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.817 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -127.66 44.87 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.556 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 8.7 mt-10 -54.08 -56.2 28.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 22.0 Cg_exo -66.54 -32.13 40.02 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.018 1.812 . . . . 0.0 112.954 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.651 HD23 ' H ' ' A' ' 73' ' ' GLY . 3.9 mp -59.57 -31.93 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.11 -53.74 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.42 86.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.084 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.586 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 4.5 mm100 -65.09 -50.81 64.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.555 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 91.8 t -57.87 -35.07 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -63.02 -47.07 84.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.687 ' HA ' HG11 ' A' ' 127' ' ' VAL . 16.9 pt-20 -71.49 -39.04 71.12 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.008 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 35.7 m0 -58.1 -38.08 75.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 109.128 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.575 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.6 ttm -73.1 -55.6 6.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.67 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.687 HG11 ' HA ' ' A' ' 124' ' ' GLU . 4.7 p -60.3 -33.34 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.12 -50.89 36.04 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.598 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 129' ' ' TYR . 9.5 t80 -58.2 -33.59 69.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.465 0.65 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.824 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.89 -52.51 9.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.116 -178.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -34.76 76.57 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 m -81.72 -39.21 24.57 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -43.32 2.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.824 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.9 mm? -61.61 -44.08 97.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.295 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.62 61.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.62 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.69 -53.7 30.84 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.831 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.1 t90 -56.68 -46.69 81.01 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.647 HG21 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.29 -49.05 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.418 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -64.07 -34.97 79.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -80.97 -13.28 59.02 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -43.38 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.851 0.358 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.9 -26.86 0.11 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.647 ' HA2' HG21 ' A' ' 138' ' ' ILE . . . 102.99 171.29 26.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.061 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.469 ' CZ2' HD11 ' A' ' 138' ' ' ILE . 98.0 m95 -58.78 -29.47 66.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.87 79.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.821 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.478 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.29 -41.01 97.08 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.507 ' HE1' HH21 ' A' ' 163' ' ' ARG . 9.7 t80 -66.01 -35.27 80.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.499 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.945 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -67.02 -29.1 68.83 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.127 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -26.72 24.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.186 0.517 . . . . 0.0 109.976 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 8.6 mt -71.2 -40.98 70.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.773 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.505 ' HD1' ' HA ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -130.65 31.79 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.153 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.29 -133.18 7.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.527 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.14 -43.27 17.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.162 0.506 . . . . 0.0 110.302 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.71 52.27 4.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.454 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.31 73.62 10.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.154 0.502 . . . . 0.0 110.077 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.756 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -62.79 169.97 2.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.425 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.47 -33.93 66.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.403 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.756 ' HB2' HD12 ' A' ' 156' ' ' LEU . 23.1 mt-10 -72.15 -45.22 61.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.69 0.281 . . . . 0.0 110.524 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 150' ' ' LEU . . . -61.97 -42.68 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -62.48 -50.7 70.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.795 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.62 -35.4 80.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 2.9 mt -67.94 -29.89 69.07 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.361 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.507 HH21 ' HE1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.22 -48.27 62.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.554 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.534 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.4 OUTLIER -67.43 -44.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.587 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.87 -25.32 73.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.989 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -69.13 -51.22 40.56 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.571 0.224 . . . . 0.0 111.379 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.956 ' HA ' HG23 ' A' ' 170' ' ' VAL . 19.5 p-90 -71.98 -21.23 61.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.239 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.71 82.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.309 0.576 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.4 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -86.26 -32.84 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.572 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.956 HG23 ' HA ' ' A' ' 167' ' ' TRP . 29.5 m -86.99 -31.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -73.13 -32.97 65.26 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.938 -0.477 . . . . 0.0 110.413 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.862 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.6 OUTLIER -85.63 -27.6 25.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.095 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 1.01 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.5 p -71.0 -26.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 0.0 110.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 1.01 ' HG ' HG11 ' A' ' 173' ' ' VAL . 1.1 mt -120.46 39.54 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.298 0.571 . . . . 0.0 110.388 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.862 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.3 OUTLIER -62.42 -29.93 70.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.794 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.67 40.88 2.99 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.496 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -105.0 10.56 34.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 109.896 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.86 57.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.438 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -85.47 -4.7 59.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.694 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.817 ' HG ' HG13 ' A' ' 82' ' ' VAL . 9.2 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 CA--C 1.529 0.258 0 CA-C-O 120.932 0.305 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -162.85 0.56 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -36.88 71.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.997 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -37.84 87.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.79 -35.62 62.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.297 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD22 ' HE1' ' A' ' 46' ' ' MET . 6.2 tp -73.69 -40.47 63.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.333 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.695 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 6.7 p -65.19 -37.71 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 110.06 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -24.65 59.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -60.33 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.605 ' HE2' ' CE1' ' A' ' 17' ' ' PHE . 3.1 t80 -59.12 -56.04 27.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.684 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.508 HG12 HD13 ' A' ' 22' ' ' LEU . 95.9 t -64.32 -38.99 83.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.82 -52.22 53.72 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 20' ' ' TYR . 41.2 t80 -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.696 0.284 . . . . 0.0 110.869 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.93 -42.03 97.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.782 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.508 HD13 HG12 ' A' ' 18' ' ' VAL . 7.5 mp -71.21 -45.17 63.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.855 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.648 HH11 ' HB2' ' A' ' 31' ' ' ALA . 26.5 ttp85 -65.56 -15.56 62.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.659 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.36 -36.07 24.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -153.6 78.43 1.14 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 111.836 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.95 -68.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.444 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.605 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 1.6 t80 -91.85 56.52 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.165 0.507 . . . . 0.0 110.01 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 29' ' ' CYS . 8.7 p -78.56 -32.36 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.87 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' HG13 ' A' ' 28' ' ' VAL . 34.7 m -70.54 -33.31 71.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.09 56.25 3.26 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.399 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.648 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -68.21 112.26 5.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.416 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.23 -51.73 0.12 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 119.88 -1.153 . . . . 0.0 113.849 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 38.4 Cg_exo -63.47 -43.71 16.74 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.093 1.862 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.95 32.36 7.54 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.107 -0.952 . . . . 0.0 112.659 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.87 -14.26 39.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.242 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.0 142.18 15.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.781 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.39 -154.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.033 2.489 . . . . 0.0 113.242 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -85.23 80.15 9.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.628 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.51 16.31 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.809 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 13.1 m-20 -126.57 157.81 69.64 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.513 ' C ' HG23 ' A' ' 148' ' ' THR . 2.9 Cg_exo -71.36 36.58 0.3 Allowed 'Trans proline' 0 N--CA 1.474 0.34 0 C-N-CA 124.251 3.3 . . . . 0.0 113.12 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -167.81 -27.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.2 m170 -59.66 -55.25 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.959 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.488 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -63.1 -22.42 66.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.942 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -76.76 -48.73 17.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.994 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.549 ' HE1' ' CZ3' ' A' ' 144' ' ' TRP . 1.0 OUTLIER -68.98 -32.91 72.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.368 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -43.02 96.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.843 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.13 50.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 110.174 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -62.64 -62.19 1.91 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.278 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.682 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.15 -48.34 32.33 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.834 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.96 -45.5 82.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.124 0.462 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.9 96.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.644 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -76.93 -28.19 55.17 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.097 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.98 -23.09 66.52 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 m -94.85 -39.19 10.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.101 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -84.81 -57.71 3.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -82.83 73.6 9.85 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.986 0.514 . . . . 0.0 111.383 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -76.5 -10.28 59.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.522 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 54.43 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -57.43 1.84 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.052 0.453 . . . . 0.0 111.875 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.611 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 70.5 m-85 -55.17 -31.74 61.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -39.04 87.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.8 m-20 -70.69 -20.56 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 110.267 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.907 HD11 ' HA ' ' A' ' 61' ' ' PHE . 25.0 mt -70.13 -41.43 73.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.99 -43.97 61.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.09 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.84 -43.63 73.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.69 HE22 HD13 ' A' ' 106' ' ' LEU . 26.9 mt-30 -63.22 -58.07 8.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.448 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HG ' ' HE3' ' A' ' 115' ' ' MET . 0.5 OUTLIER -80.43 8.02 8.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.561 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 11.9 t60 -79.0 -23.06 44.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -63.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 t -172.88 144.47 1.22 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.182 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.563 ' HG3' ' HE2' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.85 171.71 16.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.88 2.387 . . . . 0.0 111.598 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.623 ' H ' HD22 ' A' ' 118' ' ' LEU . . . 97.54 -60.8 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.342 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 19.19 0.13 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -75.9 -22.37 56.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.606 0.241 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.628 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -62.06 -39.5 92.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.612 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 3.9 mt-30 -67.62 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HB3' HD22 ' A' ' 180' ' ' LEU . 0.7 OUTLIER -59.86 -45.12 93.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.813 0.34 . . . . 0.0 110.154 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 79' ' ' PHE . 21.2 t80 -62.35 -51.74 66.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.928 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -59.24 -33.81 71.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 74.4 mm-40 -63.56 -50.67 68.59 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.126 0.489 . . . . 0.0 109.991 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.678 HG21 HD21 ' A' ' 180' ' ' LEU . 65.5 t -63.7 -37.34 79.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.461 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 m -61.64 -46.73 88.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.756 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.641 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.37 -39.45 93.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 110.243 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.476 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.0 mm-40 -67.91 -28.68 67.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.28 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.496 HD23 HH11 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -76.61 -38.57 54.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -82.29 -8.79 59.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -38.58 12.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.807 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.4 57.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.131 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 91' ' ' PRO . . . 173.7 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.498 -1.334 . . . . 0.0 115.098 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HA ' ' HE2' ' A' ' 99' ' ' PHE . 9.4 Cg_endo -82.35 23.89 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.454 2.102 . . . . 0.0 111.249 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.792 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 m-20 -63.94 158.0 23.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.078 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.655 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 5.8 m95 -50.35 -24.97 3.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.23 -49.94 66.95 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.467 -0.873 . . . . 0.0 110.955 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.759 ' HD2' HD13 ' A' ' 174' ' ' LEU . 8.4 mtt180 -86.66 -18.67 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.052 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.67 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.13 -31.51 63.38 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.471 0.653 . . . . 0.0 110.259 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' A' ' 53' ' ' PHE . 28.8 t -60.99 -52.63 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.49 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.64 69.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.312 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.67 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.31 -55.11 39.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.695 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 m-85 -76.65 -38.26 54.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.06 -35.69 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.613 ' HE1' ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -52.75 -60.76 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 111.551 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.23 -34.54 69.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.143 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.288 0.544 . . . . 0.0 110.517 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.703 ' HB2' HD12 ' A' ' 64' ' ' LEU . . . -68.05 -39.94 82.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.69 HD13 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -60.59 -44.92 95.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.663 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.443 ' O ' HG21 ' A' ' 111' ' ' VAL . 95.7 m -66.51 -40.73 89.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.203 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.436 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -55.68 -54.6 42.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.82 -15.46 62.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.1 m -78.31 -33.07 49.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 107' ' ' CYS . 47.3 t -75.45 -31.67 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.347 0.594 . . . . 0.0 109.556 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -77.12 0.7 20.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.208 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.68 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -132.53 -151.45 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.813 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 1.3 mt-10 -108.69 51.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.83 0.348 . . . . 0.0 111.353 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -146.87 42.24 1.13 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.69 -45.84 97.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.344 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -58.13 -16.98 29.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.279 1.986 . . . . 0.0 113.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.623 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.4 OUTLIER -82.42 -22.51 35.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.606 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -56.02 -54.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.243 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.43 77.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.438 -0.886 . . . . 0.0 111.968 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.5 mm-40 -67.34 -50.92 58.0 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.575 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 30.5 t -57.84 -33.86 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 0.0 109.767 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.33 -46.8 78.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.293 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.9 pt-20 -73.55 -35.12 65.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.021 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.628 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.5 m0 -58.92 -40.71 85.37 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.5 ttm -72.45 -52.79 14.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.849 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -62.01 -32.22 53.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -68.02 -52.64 33.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.994 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.641 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 6.4 t80 -56.6 -34.72 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 110.81 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 1.03 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.45 -53.37 8.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.454 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.6 -32.01 72.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.1 m -86.75 -43.61 12.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -44.5 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 1.03 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -59.97 -42.27 93.76 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.348 0.522 . . . . 0.0 111.632 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.32 -31.1 53.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -53.4 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.792 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 57.9 t90 -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.522 HG21 ' HA2' ' A' ' 143' ' ' GLY . 3.5 mt -57.07 -46.86 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.959 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -67.55 -29.28 68.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -94.52 -2.06 52.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -126.37 48.62 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 111.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.78 -67.41 0.92 Allowed Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.554 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 138' ' ' ILE . . . 124.79 177.23 14.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.974 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.549 ' CZ3' ' HE1' ' A' ' 46' ' ' MET . 96.5 m95 -60.93 -28.84 69.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.07 69.67 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.794 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.655 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -68.6 -38.96 81.05 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.427 ' HZ ' ' CB ' ' A' ' 49' ' ' ALA . 7.7 t80 -63.14 -41.44 99.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.363 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.743 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -64.22 -30.85 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.01 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 -16.22 35.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.761 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.93 -45.15 24.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.736 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 30.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -99.85 -119.86 4.38 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -74.22 -51.07 16.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -94.13 64.53 1.68 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.204 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.62 71.78 10.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.315 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -64.24 158.16 23.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.88 -31.71 50.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.141 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.751 ' HB2' HD11 ' A' ' 156' ' ' LEU . 6.9 mm-40 -68.19 -48.92 63.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.497 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.469 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -64.15 -36.31 83.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.417 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -59.86 -56.1 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.928 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 158' ' ' GLU . 19.5 ptt180 -69.44 -29.1 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -63.82 -39.93 95.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.335 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.809 HH22 ' HA ' ' A' ' 49' ' ' ALA . 4.0 ttp180 -70.06 -38.72 75.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.324 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.547 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.5 OUTLIER -62.85 -46.06 89.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.237 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.33 75.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.195 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.67 -56.69 8.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.972 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.857 ' HA ' HG21 ' A' ' 170' ' ' VAL . 21.4 p-90 -67.73 -21.44 65.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.412 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.8 52.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.215 0.322 . . . . 0.0 110.766 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 m -88.02 -26.91 22.35 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.857 HG21 ' HA ' ' A' ' 167' ' ' TRP . 35.1 m -80.03 -24.64 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.017 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.668 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 13.0 ttp85 -81.09 -23.06 38.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 175' ' ' THR . 0.7 OUTLIER -90.19 -35.54 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.162 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.862 HG12 ' HG ' ' A' ' 174' ' ' LEU . 7.1 p -62.77 -30.15 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.163 0.506 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.862 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -118.54 40.13 3.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.992 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.69 -25.84 67.66 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.34 9.34 55.12 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.712 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -72.43 -7.64 50.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.011 0.405 . . . . 0.0 111.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.37 66.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.027 0.441 . . . . 0.0 110.513 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.45 12.65 34.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.236 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.678 HD21 HG21 ' A' ' 82' ' ' VAL . 7.9 mt . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.114 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.529 0.274 0 CA-C-O 121.051 0.355 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.34 -157.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -41.45 72.75 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.922 0.489 . . . . 0.0 112.279 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -61.12 -37.78 83.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.13 -35.76 61.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.178 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.589 ' HB2' HD11 ' A' ' 42' ' ' LEU . 4.6 tp -73.63 -42.24 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.477 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.538 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 8.0 p -64.6 -36.11 76.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.42 60.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.318 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -65.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.94 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.665 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.2 t80 -55.13 -54.77 39.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 22' ' ' LEU . 59.9 t -67.61 -38.34 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -62.75 -55.39 27.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.91 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.686 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 t80 -60.1 -42.64 95.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.783 0.433 . . . . 0.0 110.852 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.86 -44.8 95.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.259 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 HG11 ' A' ' 18' ' ' VAL . 7.6 mp -71.13 -44.26 65.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.757 HH11 ' HB1' ' A' ' 31' ' ' ALA . 16.6 ttp85 -67.64 -13.01 61.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 2.5 mt-30 -84.36 -37.44 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.229 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -154.56 83.4 1.11 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.45 -69.13 0.35 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.664 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.594 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.3 t80 -98.68 54.79 1.04 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.236 0.541 . . . . 0.0 110.201 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -78.67 -27.12 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.179 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -39.16 80.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.87 57.34 4.64 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.169 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.757 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -65.98 110.97 3.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.413 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.5 -53.54 0.09 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.878 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.432 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 24.8 Cg_exo -65.12 -48.72 3.3 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.016 1.81 . . . . 0.0 111.27 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.03 31.46 6.26 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.301 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.33 -19.81 35.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 0.0 109.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.51 132.84 11.25 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.33 -147.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.617 2.211 . . . . 0.0 113.882 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -75.31 76.3 2.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.73 31.84 5.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.793 0.33 . . . . 0.0 111.291 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 12.7 m-20 -142.04 163.29 41.05 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.74 48.46 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.247 2.631 . . . . 0.0 112.331 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.924 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.2 m170 -59.35 -56.47 21.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.944 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.03 -24.65 64.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.906 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.97 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -75.31 -51.49 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.23 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.607 ' HE3' ' CZ3' ' A' ' 144' ' ' TRP . 5.2 ttm -68.92 -39.36 79.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.673 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -61.95 -35.53 78.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.785 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.45 -43.76 18.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.518 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' HG23 ' A' ' 97' ' ' VAL . . . -58.57 -54.32 48.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.601 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.2 -47.8 54.65 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.667 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.01 -48.51 81.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 110.898 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 56' ' ' ARG . 4.1 tp10 -60.03 -48.74 80.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.926 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.87 -35.24 76.66 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.927 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.98 -28.0 68.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.65 0.738 . . . . 0.0 109.409 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.1 m -85.81 -32.16 21.92 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.397 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 52' ' ' GLU . 7.6 mtt180 -88.73 -21.21 23.97 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -85.16 95.9 9.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.375 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -60.67 -32.94 72.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.482 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.547 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -108.62 94.64 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.126 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.41 -70.94 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.666 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 48.9 m-85 -78.51 -7.3 57.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -46.99 58.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 59' ' ' ARG . 2.5 m-20 -68.71 -18.32 64.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.199 0.524 . . . . 0.0 110.472 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 61' ' ' PHE . 31.8 mt -72.78 -40.41 65.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.45 -45.88 51.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.17 68.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.709 HE22 HD11 ' A' ' 106' ' ' LEU . 22.9 mt-30 -64.06 -54.77 28.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.041 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.497 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.09 16.06 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 -177.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -26.53 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 0.0 110.691 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -68.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.668 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t -165.92 145.72 5.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.501 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.655 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 8.2 Cg_exo -72.11 176.1 8.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.964 2.443 . . . . 0.0 111.974 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.675 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 90.64 -60.09 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -77.07 52.85 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 0.0 110.967 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.85 -25.52 10.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.709 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.3 pt20 -62.72 -35.36 79.5 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.856 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 24.4 mp0 -67.35 -45.14 77.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -63.56 -44.19 94.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.892 0.377 . . . . 0.0 110.086 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' HG13 ' A' ' 82' ' ' VAL . 10.9 t80 -62.26 -49.27 76.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.789 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 p -59.68 -32.95 70.96 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.849 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.3 mm-40 -64.82 -54.95 23.09 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 79' ' ' PHE . 7.4 p -61.58 -35.3 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.914 0.387 . . . . 0.0 110.406 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.4 m -66.99 -43.1 83.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.83 -44.52 92.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.232 0.539 . . . . 0.0 110.015 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 40.1 mt-10 -69.7 -18.21 63.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.782 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 95' ' ' ARG . 1.1 mp -83.88 -39.74 19.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.146 0.498 . . . . 0.0 109.913 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.63 -4.86 58.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -44.33 -43.32 7.42 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.876 0.735 . . . . 0.0 111.666 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.48 57.34 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.93 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.0 56.85 0.03 OUTLIER Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.775 -1.203 . . . . 0.0 114.655 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.1 Cg_endo -80.5 39.8 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.326 2.017 . . . . 0.0 111.646 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.806 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 11.5 t-20 -65.56 158.93 25.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.414 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.698 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.4 m95 -54.97 -27.44 43.82 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.321 0.388 . . . . 0.0 110.297 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.584 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.75 -39.56 97.59 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.3 -24.64 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.551 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -55.26 -30.62 60.43 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 49' ' ' ALA . 9.4 t -63.07 -53.34 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.374 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -64.63 -28.09 69.38 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.282 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.596 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 4.5 m-85 -56.83 -56.82 16.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.131 0.491 . . . . 0.0 109.928 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 8.0 m-85 -76.1 -36.33 58.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.838 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 1.7 t -60.15 -38.05 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.644 ' HE1' ' CE2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -58.13 -47.47 83.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.68 0.276 . . . . 0.0 111.061 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 126' ' ' MET . . . -77.6 -40.0 23.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.905 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.51 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.072 0.436 . . . . 0.0 110.608 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -68.43 -41.38 80.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.709 HD11 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -58.75 -47.5 84.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 63.3 m -60.93 -41.45 96.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.23 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.58 -55.79 25.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.53 -18.18 64.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.604 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -77.94 -27.99 49.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.77 -23.03 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -78.97 -15.26 58.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.9 -169.25 2.0 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.02 60.99 6.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.655 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -135.66 32.19 3.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.005 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 5.9 mp0 -54.86 -51.96 74.7 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.194 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 35.3 Cg_exo -61.14 -27.45 84.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.92 1.747 . . . . 0.0 112.433 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.675 HD23 ' H ' ' A' ' 73' ' ' GLY . 2.6 mp -71.44 -26.67 62.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.52 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.14 -53.6 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.687 0.279 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.71 83.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.79 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 117' ' ' PRO . 28.4 mt-30 -63.36 -53.68 48.73 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 118' ' ' LEU . 48.2 t -57.54 -33.9 45.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.05 0.452 . . . . 0.0 110.156 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.5 -46.48 82.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.553 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.539 ' HA ' HG11 ' A' ' 127' ' ' VAL . 21.2 pt-20 -74.09 -37.72 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.906 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.709 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.3 m0 -56.79 -37.43 71.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.9 ttm -72.36 -57.91 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.888 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -61.36 -30.36 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.975 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.459 ' N ' HG13 ' A' ' 127' ' ' VAL . 10.6 mm-40 -68.8 -50.55 49.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.148 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 129' ' ' TYR . 3.6 t80 -62.26 -31.18 71.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 111.107 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.3 -54.04 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.481 -178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.02 -35.85 77.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.892 0.377 . . . . 0.0 111.876 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.1 m -78.18 -36.21 47.75 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -43.8 1.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.912 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.2 mm? -58.27 -46.51 85.88 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.394 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.82 -35.82 45.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.19 -52.05 51.86 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.806 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.5 t90 -58.13 -47.65 82.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.482 HG23 ' HH2' ' A' ' 93' ' ' TRP . 9.2 mt -56.94 -48.1 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.755 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -63.31 -32.98 74.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 m -81.88 -18.38 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 t -84.24 -55.03 4.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 111.544 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.46 -17.32 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.63 171.58 29.18 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.615 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.607 ' CZ3' ' HE3' ' A' ' 46' ' ' MET . 95.4 m95 -59.51 -28.0 66.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.95 0.405 . . . . 0.0 109.99 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.59 78.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.788 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HG3' HD11 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -63.58 -41.58 98.36 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.635 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 14.8 t80 -66.46 -34.07 77.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.49 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.97 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.06 -29.18 70.05 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.804 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.13 -26.07 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.188 0.518 . . . . 0.0 110.043 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.494 HD11 ' HG3' ' A' ' 146' ' ' GLU . 3.5 mt -73.96 -39.14 63.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.628 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 151' ' ' TYR . 26.7 m-85 -126.83 29.24 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.666 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.16 -140.49 5.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.557 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -54.76 12.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.075 -0.563 . . . . 0.0 111.414 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -81.25 53.59 4.66 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.72 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.94 72.02 10.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.0 109.71 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.09 165.47 3.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.627 -179.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.99 -33.66 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.327 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 15.8 mm-40 -71.17 -45.57 63.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.951 0.405 . . . . 0.0 110.305 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.677 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -59.96 -47.1 87.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.777 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -63.72 -43.37 96.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.11 -22.37 61.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.277 0.56 . . . . 0.0 110.57 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 -47.05 17.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -62.42 -46.52 88.22 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.419 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.648 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.19 -44.3 95.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.07 -10.22 72.97 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.757 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.28 -58.05 2.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.861 -0.169 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.799 ' HA ' HG22 ' A' ' 170' ' ' VAL . 17.3 p-90 -61.37 -24.91 66.81 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 123.163 0.289 . . . . 0.0 111.311 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.34 84.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.407 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.9 OUTLIER -88.02 -28.02 21.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.799 HG22 ' HA ' ' A' ' 167' ' ' TRP . 3.2 m -91.16 -42.71 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.632 ' HD3' ' CE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -70.31 -24.83 63.08 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.534 -0.729 . . . . 0.0 111.007 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.813 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.2 OUTLIER -93.21 -9.96 37.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.913 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.777 HG12 ' HG ' ' A' ' 174' ' ' LEU . 3.6 p -85.62 -23.22 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 0.0 109.373 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.777 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -120.35 40.33 3.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.802 178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.813 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -69.52 -22.37 63.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.104 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.45 9.8 53.23 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.937 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . . . -76.82 7.41 4.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.095 0.448 . . . . 0.0 111.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.12 65.18 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.357 0.598 . . . . 0.0 111.09 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.32 13.87 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.212 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.455 HD11 ' N ' ' A' ' 180' ' ' LEU . 6.9 mp . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.721 -178.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo . . . . . 0 CA--C 1.529 0.269 0 CA-C-O 121.37 0.488 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -85.58 -167.45 1.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.461 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -37.6 65.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.544 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.07 -37.04 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.734 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.72 62.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.849 0.357 . . . . 0.0 110.097 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 42' ' ' LEU . 10.5 tp -70.32 -42.15 72.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.608 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 4.8 p -65.9 -35.39 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.939 0.4 . . . . 0.0 110.061 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -74.31 -20.48 60.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.659 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.06 -63.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.72 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 3.1 t80 -55.35 -51.28 67.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.579 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -70.14 -41.14 78.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 110.365 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.38 -54.25 38.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.576 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.734 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 58.3 t80 -60.64 -42.91 97.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.537 0.335 . . . . 0.0 110.979 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.2 -49.09 77.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.57 HD22 HG11 ' A' ' 119' ' ' VAL . 7.8 mp -65.78 -48.78 70.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.604 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.614 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 6.1 ttp180 -62.6 -20.34 64.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.446 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.3 mt-30 -85.39 -32.58 22.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.311 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -148.52 75.86 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.849 0.356 . . . . 0.0 111.856 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.37 -69.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.624 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.616 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.7 t80 -92.21 51.15 1.74 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 29' ' ' CYS . 12.4 p -78.19 -26.52 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.404 ' N ' HG11 ' A' ' 28' ' ' VAL . 4.1 t -76.09 -16.01 59.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.412 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.39 49.28 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.332 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -63.67 114.36 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.08 -48.23 0.05 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.692 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.588 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 6.1 Cg_exo -77.03 -48.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.201 1.934 . . . . 0.0 111.867 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -83.77 22.76 7.39 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.557 -0.747 . . . . 0.0 114.229 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.03 -32.69 59.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.37 0.585 . . . . 0.0 109.86 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.61 111.95 4.23 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 84.1 Cg_endo -84.54 -139.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.563 2.175 . . . . 0.0 114.264 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.701 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -70.03 80.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.821 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.58 -0.41 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.495 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 8.0 m-20 -110.82 161.11 26.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.447 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -77.08 45.61 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.529 2.819 . . . . 0.0 112.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -173.93 -27.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.331 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.701 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.4 m170 -62.89 -51.26 67.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.559 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.505 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -64.01 -21.68 66.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.27 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.721 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.97 -52.32 11.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.846 ' HE2' ' HZ3' ' A' ' 144' ' ' TRP . 0.0 OUTLIER -64.86 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.297 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -60.27 -40.33 89.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.206 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.94 -28.44 43.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 110.192 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.629 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -67.71 -60.47 2.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.407 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.41 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -48.91 -49.01 29.96 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.46 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.96 -53.0 58.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 111.764 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG3' ' HE ' ' A' ' 56' ' ' ARG . 8.2 tt0 -63.16 -45.66 90.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.656 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.502 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.75 -30.99 66.19 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.549 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -65.13 -30.9 71.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -86.14 -19.16 30.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.342 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HE ' ' HG3' ' A' ' 52' ' ' GLU . 16.1 mtt-85 -98.09 -49.25 4.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.187 0.518 . . . . 0.0 112.209 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.2 90.13 7.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.236 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -67.48 -21.97 65.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.166 0.508 . . . . 0.0 110.881 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -88.67 66.53 8.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 -14.43 8.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.013 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.59 ' HE2' ' CE1' ' A' ' 61' ' ' PHE . 7.9 m-85 -114.52 -0.06 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.28 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -51.84 23.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.257 0.551 . . . . 0.0 111.088 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -57.04 -33.82 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.806 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.849 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 7.5 mp -56.93 -43.25 81.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.49 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -81.47 -42.77 19.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.63 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 63' ' ' ASP . . . -48.09 -46.33 33.69 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.639 0.587 . . . . 0.0 111.799 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' NE2' ' HG ' ' A' ' 180' ' ' LEU . 65.0 mt-30 -80.65 -47.71 13.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -90.28 20.89 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -80.2 -38.13 31.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.222 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 p -90.56 -62.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.66 152.77 19.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 2.9 Cg_endo -79.66 178.17 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.847 2.365 . . . . 0.0 111.497 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.17 -56.52 4.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.759 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.44 34.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.129 0.49 . . . . 0.0 111.61 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -94.93 -24.66 16.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.66 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.643 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -58.45 -47.15 84.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.953 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.26 -45.0 88.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.034 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.826 ' HB3' HD11 ' A' ' 180' ' ' LEU . 11.0 mtt180 -64.91 -40.82 95.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.21 -48.04 69.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.459 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -59.11 -28.64 66.72 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -68.14 -60.43 2.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.799 0.333 . . . . 0.0 110.29 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 177' ' ' ALA . 10.6 p -54.52 -36.05 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.594 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.468 ' N ' HG13 ' A' ' 82' ' ' VAL . 2.4 p -68.81 -41.85 78.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.767 0.318 . . . . 0.0 110.475 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.593 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -69.83 -38.6 76.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.55 -26.34 64.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.54 -33.09 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.176 0.512 . . . . 0.0 110.392 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -85.35 -10.07 56.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -41.3 -48.73 3.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.507 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.78 54.38 0.23 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.185 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.7 57.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 119.376 -1.392 . . . . 0.0 114.683 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 41.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.072 1.848 . . . . 0.0 111.377 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.813 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -70.65 163.14 27.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.069 -178.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.648 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.3 m95 -53.59 -27.54 27.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.37 97.88 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.745 HH11 ' HB2' ' A' ' 174' ' ' LEU . 5.0 mtp180 -87.46 -19.99 27.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.579 -0.31 . . . . 0.0 111.353 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.789 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -54.97 -31.87 61.04 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 110.326 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.8 t -61.52 -54.01 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.89 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.42 70.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.272 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 99' ' ' PHE . 6.0 m-85 -56.72 -55.18 37.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.374 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 6.8 m-85 -76.93 -37.91 54.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.179 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.29 -37.99 78.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -54.13 -51.54 63.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.696 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.24 -37.54 36.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.996 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.68 95.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.126 0.463 . . . . 0.0 110.745 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 64' ' ' LEU . . . -69.96 -43.85 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.849 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -59.65 -42.34 92.56 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.279 0.561 . . . . 0.0 110.832 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.498 ' HB3' HD22 ' A' ' 22' ' ' LEU . 95.8 m -63.74 -44.99 91.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.047 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.2 76.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.572 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HA ' HD22 ' A' ' 112' ' ' ASN . 1.0 OUTLIER -76.8 -17.75 58.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.8 m -82.63 -26.43 32.23 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.715 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.06 -38.27 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.837 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 109' ' ' GLU . 21.1 p30 -82.48 1.79 35.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.742 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -120.69 -172.65 2.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.267 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.95 46.92 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.243 0.544 . . . . 0.0 111.202 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.742 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -142.22 37.15 1.54 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.199 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.3 OUTLIER -56.13 -50.12 89.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.045 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 42.8 Cg_exo -57.77 -25.94 71.09 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.163 1.909 . . . . 0.0 112.841 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 122' ' ' VAL . 1.4 mm? -69.05 -25.47 64.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.57 HG11 HD22 ' A' ' 22' ' ' LEU . 43.1 t -57.42 -45.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.96 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.34 -34.75 86.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.712 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -66.0 -50.25 64.92 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 118' ' ' LEU . 29.0 t -58.17 -32.61 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.164 0.507 . . . . 0.0 109.78 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.0 -45.86 80.03 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.429 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.794 ' HA ' HG13 ' A' ' 127' ' ' VAL . 14.4 pt-20 -74.51 -36.53 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.643 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 43.3 m0 -57.4 -39.4 76.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.1 ttm -73.74 -54.96 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.784 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.794 HG13 ' HA ' ' A' ' 124' ' ' GLU . 4.3 p -61.58 -33.03 55.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -46.73 66.0 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.304 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 21.0 t80 -61.6 -36.45 80.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.564 0.697 . . . . 0.0 110.336 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.928 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.65 -54.14 15.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.254 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.59 -37.27 80.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -74.72 -36.28 62.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -130.59 -41.36 1.2 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.928 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -60.89 -49.02 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.334 0.515 . . . . 0.0 111.813 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.73 60.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.292 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.4 -55.7 19.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.192 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.813 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 42.5 t90 -53.68 -48.48 69.45 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.126 0.488 . . . . 0.0 109.797 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.608 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.2 mt -56.27 -48.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.724 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -64.53 -36.34 83.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 p -80.82 -14.93 57.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.927 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -55.65 3.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.87 -10.91 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.577 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.28 169.28 44.21 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.698 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.846 ' HZ3' ' HE2' ' A' ' 46' ' ' MET . 96.4 m95 -60.52 -30.52 69.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.84 73.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.106 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.99 -41.31 95.53 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.533 ' HE1' HH11 ' A' ' 163' ' ' ARG . 6.9 t80 -64.93 -40.83 95.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.601 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.721 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.24 -26.23 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 110.947 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.23 -29.02 22.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.439 . . . . 0.0 110.306 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.67 -51.84 65.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.338 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.511 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -132.43 32.93 3.87 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.26 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.84 -129.61 6.75 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.864 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -51.61 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.249 0.547 . . . . 0.0 110.642 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.542 ' O ' HD22 ' A' ' 156' ' ' LEU . . . -93.13 55.89 2.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.394 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.78 73.84 7.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 110.042 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.54 161.04 15.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.776 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 3.2 mt-10 -59.21 -30.37 68.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.061 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' ' 156' ' ' LEU . 9.1 mm-40 -72.88 -36.26 67.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.487 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -70.32 -34.79 73.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.013 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.776 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 25.3 mtt-85 -63.09 -55.24 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.386 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.448 ' HD3' ' OE1' ' A' ' 158' ' ' GLU . 2.9 ptm180 -65.0 -25.15 67.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -68.47 -43.42 77.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.93 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.629 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.4 ttp180 -70.95 -34.52 71.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.521 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.515 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER -69.49 -45.6 68.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.172 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.19 -22.14 77.32 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 18.8 t-20 -64.13 -66.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.406 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.717 ' HA ' HG22 ' A' ' 170' ' ' VAL . 26.7 p-90 -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.931 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.47 75.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.99 -29.46 20.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 167' ' ' TRP . 8.4 m -92.13 -35.64 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -70.23 -34.36 72.78 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.925 -0.484 . . . . 0.0 110.595 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.95 -13.39 50.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.905 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.926 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -86.22 -23.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 109.893 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.926 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -121.07 34.29 5.26 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.012 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -18.1 65.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.823 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.69 -4.58 76.38 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.185 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.496 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.94 -5.12 23.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.02 65.54 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 110.994 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.28 -10.11 58.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.826 HD11 ' HB3' ' A' ' 78' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.752 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.463 -0.279 0 CA-C-O 120.832 0.263 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.18 -162.27 0.33 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.219 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -47.64 64.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.416 ' O ' HG12 ' A' ' 14' ' ' VAL . 15.4 ttp180 -59.07 -37.74 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.491 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.14 -36.6 61.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.989 0.424 . . . . 0.0 109.966 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 HD13 ' A' ' 42' ' ' LEU . 2.1 tp -70.44 -42.37 71.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.249 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.603 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 5.9 p -63.57 -37.38 79.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.06 0.457 . . . . 0.0 109.775 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.03 -23.87 61.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.88 -63.42 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.255 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.62 -50.06 66.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 22' ' ' LEU . 74.5 t -69.06 -41.14 81.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.107 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.585 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.17 -49.2 81.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 20' ' ' TYR . 65.2 t80 -62.32 -47.17 85.45 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.594 0.358 . . . . 0.0 111.475 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -40.9 96.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.285 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.598 HD23 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -72.15 -46.9 54.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.808 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -63.5 -17.06 62.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.804 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -80.87 -36.2 31.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.71 78.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.101 0.476 . . . . 0.0 112.082 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.35 -63.12 0.41 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.449 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 1.4 t80 -90.59 50.5 1.83 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.199 0.523 . . . . 0.0 109.915 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.3 -34.16 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.161 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -22.83 63.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.666 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.29 49.83 0.85 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.614 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.79 126.81 29.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.51 ' HA2' ' HG3' ' A' ' 35' ' ' GLU . . . 168.36 -54.23 0.22 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.736 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.585 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 17.4 Cg_exo -68.83 -49.22 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.312 2.008 . . . . 0.0 112.21 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -90.1 31.53 5.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.521 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HG3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 mm-40 -79.14 -43.05 24.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.608 . . . . 0.0 109.758 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.92 147.17 33.18 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.892 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.7 Cg_endo -98.41 -151.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.196 2.598 . . . . 0.0 113.579 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -80.7 87.33 5.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.52 -14.09 5.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.4 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 47.7 m-20 -94.41 158.74 35.18 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.076 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -75.17 50.7 2.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.721 2.947 . . . . 0.0 111.816 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.567 HD13 HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -178.97 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.345 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.6 m170 -60.58 -56.57 19.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.119 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.74 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -59.37 -24.73 63.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.041 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.923 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -77.81 -51.48 10.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.547 ' HE1' ' HZ3' ' A' ' 144' ' ' TRP . 3.6 ttm -64.72 -41.75 95.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -62.83 -31.55 72.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.665 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.16 -44.68 19.43 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.737 0.304 . . . . 0.0 110.468 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 97' ' ' VAL . . . -58.73 -54.19 49.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.09 -49.18 50.63 Favored Glycine 0 C--O 1.213 -1.165 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.238 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -56.4 -51.61 67.72 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.841 0.456 . . . . 0.0 111.627 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -48.25 82.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.634 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 6.4 m-85 -69.97 -32.83 71.26 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.391 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.02 -27.05 68.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.706 0.765 . . . . 0.0 109.029 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -79.65 -31.94 41.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.617 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -89.84 -54.01 4.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.187 0.517 . . . . 0.0 111.376 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.639 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -85.36 68.81 10.6 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.555 0.742 . . . . 0.0 111.099 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -74.47 -26.19 59.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.955 0.407 . . . . 0.0 111.912 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -82.11 61.82 5.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.26 -31.14 4.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 111.516 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.601 ' HE2' ' CE1' ' A' ' 61' ' ' PHE . 50.2 m-85 -72.78 -17.0 61.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.163 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.804 0.335 . . . . 0.0 111.499 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -71.97 -23.44 61.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -67.02 -41.82 85.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.85 -48.74 35.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.156 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.16 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.458 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.792 HE22 HD12 ' A' ' 106' ' ' LEU . 25.3 mt-30 -65.92 -58.5 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.304 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 14.1 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 30.2 t60 -79.24 -27.25 42.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.862 0.363 . . . . 0.0 110.495 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.85 -70.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.675 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -163.64 150.83 10.57 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.908 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.591 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 4.1 Cg_exo -80.49 175.8 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.052 2.502 . . . . 0.0 112.404 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.599 ' H ' HD22 ' A' ' 118' ' ' LEU . . . 93.33 -65.11 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.852 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.39 46.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.316 0.579 . . . . 0.0 111.907 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.91 -18.41 14.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.433 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.669 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.3 pt20 -64.15 -38.54 91.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.695 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 10.2 mp0 -69.44 -36.05 76.27 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.865 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 1.5 ttt180 -67.15 -47.19 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.62 -48.94 78.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 p -60.2 -33.55 72.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 89.9 mm-40 -63.3 -57.37 10.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 110.812 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.57 HG22 ' N ' ' A' ' 83' ' ' SER . 4.1 m -62.73 -33.06 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.366 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' HG22 ' A' ' 82' ' ' VAL . 64.8 m -65.78 -43.41 88.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.724 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.511 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.58 -37.27 87.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.98 -30.35 63.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.628 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.922 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -75.05 -35.33 61.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.806 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 91' ' ' PRO . 33.7 t80 -89.51 -13.27 37.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.567 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -33.55 -61.01 0.34 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.506 1.123 . . . . 0.0 113.891 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.2 62.81 0.49 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.163 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.79 70.53 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.944 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.493 ' HG3' ' CD1' ' A' ' 87' ' ' PHE . 6.8 Cg_endo -75.87 46.95 1.82 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 111.505 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.743 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -66.29 165.23 14.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.149 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 26.9 m95 -55.33 -28.36 53.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.402 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.4 89.8 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.746 HH11 ' HB ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -85.85 -28.4 24.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.317 178.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.821 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.39 -30.9 61.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.301 0.572 . . . . 0.0 110.57 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' A' ' 53' ' ' PHE . 4.7 t -66.49 -56.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.818 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.34 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.119 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.821 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.8 m-85 -56.35 -58.19 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 110.473 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 9.6 m-85 -75.07 -35.45 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.228 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.79 -39.05 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.611 ' HE1' ' CE2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -56.38 -51.86 66.74 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.7 0.286 . . . . 0.0 111.286 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.58 -41.11 44.95 Favored Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.285 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.54 88.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.347 0.573 . . . . 0.0 110.905 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -71.34 -40.95 70.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.792 HD12 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -59.32 -46.85 87.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.465 179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.598 ' HB3' HD23 ' A' ' 22' ' ' LEU . 68.9 m -62.17 -41.63 98.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -55.5 -54.94 37.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.14 66.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.578 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.1 m -76.74 -31.61 57.22 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 119' ' ' VAL . 14.1 t -79.06 -23.34 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.451 0.643 . . . . 0.0 109.295 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -84.06 -5.03 59.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.189 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -125.72 -152.44 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.295 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -108.19 50.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.205 0.526 . . . . 0.0 110.106 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.591 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -130.32 56.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.445 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.524 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.5 mp0 -62.38 -52.71 64.11 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.2 Cg_exo -65.41 -25.44 56.13 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.356 2.037 . . . . 0.0 113.112 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.599 HD22 ' H ' ' A' ' 73' ' ' GLY . 4.5 mp -67.5 -30.68 70.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.425 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 111' ' ' VAL . 91.6 t -57.61 -55.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.186 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.89 85.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.061 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.5 mt-30 -65.18 -51.42 61.2 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' CZ3' ' A' ' 125' ' ' TRP . 86.2 t -57.05 -35.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 109.867 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.16 -47.52 82.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 21.8 pt-20 -72.8 -37.1 67.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.085 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.669 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 42.8 m0 -58.89 -39.41 81.34 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.4 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 9.8 ttm -72.6 -53.94 10.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.852 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 128' ' ' GLU . 2.2 p -61.97 -33.16 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.592 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.51 ' N ' HG12 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -67.26 -51.02 58.08 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.077 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 129' ' ' TYR . 23.9 t80 -58.36 -35.69 72.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.542 0.687 . . . . 0.0 110.742 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.944 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.29 -56.05 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.559 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.75 -24.04 67.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.0 m -82.2 -43.13 18.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.93 -37.29 2.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.944 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -61.41 -48.17 82.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.229 0.468 . . . . 0.0 111.377 -178.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -37.54 62.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.257 0.348 . . . . 0.0 110.952 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.99 -53.53 52.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.413 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 59.4 t90 -57.31 -48.99 77.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.529 HG13 ' HE3' ' A' ' 137' ' ' TRP . 26.6 mt -57.77 -47.46 85.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.812 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -68.05 -26.93 66.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 m -96.23 -3.48 44.12 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.75 -53.16 3.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 111.724 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.97 -13.09 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.76 166.24 42.04 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.547 ' HZ3' ' HE1' ' A' ' 46' ' ' MET . 92.9 m95 -59.36 -30.24 68.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.5 81.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.1 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -42.95 99.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 147' ' ' PHE . 17.0 t80 -66.17 -34.14 77.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.504 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.923 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.57 -26.38 67.09 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.723 0.297 . . . . 0.0 110.836 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.79 -47.1 12.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.582 HD22 ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -54.09 -42.67 69.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.35 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -119.19 24.91 10.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.41 -135.89 4.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.647 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.64 -45.33 59.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.189 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -82.0 52.43 4.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.608 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.11 70.18 10.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.054 0.454 . . . . 0.0 110.381 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.89 158.92 23.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.902 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.1 tp10 -57.01 -33.86 67.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.072 0.463 . . . . 0.0 110.82 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.12 -38.3 82.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -75.62 -37.31 59.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 110.613 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.4 mtm180 -58.56 -53.36 59.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 7.8 ptm180 -69.11 -23.54 64.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.595 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.3 mt -71.95 -41.87 67.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.364 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.582 ' HB3' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -70.57 -35.86 73.29 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.111 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.95 -43.76 64.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.797 178.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.29 -20.27 74.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.904 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 170' ' ' VAL . 8.3 t-20 -65.3 -63.9 0.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.684 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.725 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 28.1 p-90 -64.72 -22.91 67.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.777 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.15 57.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 0.0 110.591 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -16.43 33.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.746 ' HB ' HH11 ' A' ' 95' ' ' ARG . 29.9 m -101.79 -35.75 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 174' ' ' LEU . 3.0 ttp180 -78.16 -27.84 48.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 122.229 -0.294 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 m -82.8 -15.07 53.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.86 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.08 -9.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.922 HD21 ' HG ' ' A' ' 86' ' ' LEU . 81.5 mt -79.74 -8.59 59.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.75 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 p -57.01 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.42 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 178' ' ' VAL . . . 141.0 -24.02 2.58 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.441 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -76.39 13.84 0.87 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.98 0.419 . . . . 0.0 111.154 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 176' ' ' GLY . 1.2 t -84.25 68.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' H ' HG11 ' A' ' 82' ' ' VAL . . . -99.73 0.92 42.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.022 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 8.9 mt . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.456 -0.711 0 CA-C-O 120.895 0.289 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.64 -160.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.674 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.19 -45.95 44.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.501 ' HA ' HG11 ' A' ' 14' ' ' VAL . 13.3 ptm180 -61.8 -33.29 73.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.569 0.223 . . . . 0.0 111.281 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.51 -34.03 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.536 HD21 ' HE3' ' A' ' 46' ' ' MET . 2.5 tp -73.33 -41.7 63.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 11' ' ' ARG . 9.9 p -66.05 -36.24 76.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 14' ' ' VAL . . . -73.75 -23.55 59.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.7 -66.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.65 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 3.4 t80 -54.73 -50.71 67.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.922 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 22' ' ' LEU . 74.1 t -67.34 -42.53 87.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.255 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.563 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.27 -52.55 52.01 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.2 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.677 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.5 t80 -55.82 -46.18 78.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.992 0.517 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -66.24 -41.31 90.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 107' ' ' CYS . 8.2 mp -70.16 -47.37 61.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.118 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.694 HH11 ' HB2' ' A' ' 31' ' ' ALA . 27.1 ttp85 -64.17 -18.83 64.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.541 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -78.86 -34.63 44.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -156.31 77.7 0.93 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 111.667 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.22 -70.12 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.732 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -87.31 52.31 2.47 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.144 0.497 . . . . 0.0 110.352 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.35 -34.09 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.078 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -39.62 93.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.06 57.48 2.11 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.449 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -64.71 130.97 45.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.309 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.42 -51.61 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.665 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.563 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 36.6 Cg_exo -62.05 -46.45 13.03 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.82 1.68 . . . . 0.0 111.446 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.48 38.01 3.32 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.194 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -89.01 -23.11 22.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.111 0.481 . . . . 0.0 109.965 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.86 142.2 15.95 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -93.5 -155.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.772 2.315 . . . . 0.0 113.71 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -79.18 83.16 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.333 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.82 33.44 3.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 111.087 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.8 m-20 -139.91 165.79 28.42 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.063 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 60.5 Cg_endo -81.54 49.39 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.266 2.644 . . . . 0.0 111.8 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB2' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.68 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.85 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.0 m170 -60.47 -57.52 12.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.608 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 3.8 mt-30 -59.32 -25.99 64.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.751 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.07 -52.59 10.66 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.184 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.536 ' HE3' HD21 ' A' ' 13' ' ' LEU . 7.0 ttm -66.53 -38.53 87.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.88 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.92 -38.29 85.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.885 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 -42.25 29.19 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.415 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.943 ' HB1' HG21 ' A' ' 97' ' ' VAL . . . -58.28 -56.73 18.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.593 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.96 -48.06 46.6 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.643 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.01 -47.6 84.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.056 0.428 . . . . 0.0 110.994 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -45.67 91.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -71.34 -34.91 70.95 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -24.43 67.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.532 0.682 . . . . 0.0 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -95.45 -18.59 20.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -98.67 -38.37 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.848 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.99 104.03 15.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.528 0.68 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 58' ' ' ARG . 9.9 mtt180 -87.81 -0.19 56.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.501 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -125.48 58.07 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.863 0.363 . . . . 0.0 111.18 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.536 HG22 ' HD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -120.38 0.55 10.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.936 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.69 ' HA ' HD21 ' A' ' 64' ' ' LEU . 10.9 m-85 -118.65 -28.75 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.716 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -31.56 72.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.653 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.8 -20.06 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -71.25 -40.5 70.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.28 -43.62 50.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.59 -43.01 71.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.886 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.828 HE22 HD11 ' A' ' 106' ' ' LEU . 26.9 mt-30 -64.66 -56.92 10.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.005 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.85 12.25 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 3.4 t-80 -77.7 -24.86 49.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.05 0.452 . . . . 0.0 109.96 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -91.49 -76.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.102 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -160.65 145.47 10.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.608 ' HG3' ' HE2' ' A' ' 115' ' ' MET . 9.5 Cg_exo -71.46 174.88 10.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.825 2.35 . . . . 0.0 111.722 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.697 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 85.84 -57.81 4.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.249 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.14 50.83 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 111.346 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.6 -25.05 9.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.679 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -64.79 -32.78 74.63 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.307 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -72.38 -35.0 68.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.06 0.457 . . . . 0.0 109.885 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.424 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 11.7 mtt-85 -70.19 -44.53 68.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 3.3 t80 -62.41 -48.61 78.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.567 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -57.92 -34.55 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.248 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -59.75 -63.03 1.45 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 110.501 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 79' ' ' PHE . 10.8 m -59.31 -31.85 47.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.775 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -66.51 -41.96 88.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 109.982 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -38.71 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.857 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 72.0 mt-10 -70.27 -31.99 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' O ' HD11 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -78.74 -35.69 44.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.955 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.613 ' HD1' ' CD2' ' A' ' 87' ' ' PHE . 40.8 t80 -88.83 -4.19 58.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -45.55 -43.2 11.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.03 -179.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.88 63.09 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.498 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.06 54.36 0.02 OUTLIER Glycine 0 CA--C 1.524 0.595 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.752 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.676 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 28.0 Cg_endo -80.65 42.07 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.964 1.776 . . . . 0.0 111.785 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.773 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -69.36 161.12 30.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.407 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 14.2 m95 -54.33 -26.89 32.3 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -40.69 96.99 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.592 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.0 mmp_? -87.49 -22.22 25.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.281 . . . . 0.0 110.786 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.817 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -55.5 -31.38 61.98 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.407 0.622 . . . . 0.0 110.151 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.943 HG21 ' HB1' ' A' ' 49' ' ' ALA . 6.9 t -61.43 -53.97 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.678 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.59 -29.0 70.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.315 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 6.4 m-85 -56.87 -56.56 20.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.016 0.436 . . . . 0.0 110.078 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.552 ' HE1' HD21 ' A' ' 130' ' ' LEU . 8.1 m-85 -76.52 -36.53 57.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.362 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 101' ' ' VAL . 3.6 t -61.8 -36.44 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -56.31 -55.71 30.09 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 111.321 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.3 59.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.367 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.64 99.1 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.344 0.572 . . . . 0.0 110.709 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.8 -40.61 75.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.828 HD11 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -57.12 -47.14 81.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.442 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 22' ' ' LEU . 87.9 m -61.98 -44.64 96.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.787 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -57.6 -34.43 69.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.417 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.617 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -82.73 -23.41 34.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -27.95 40.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.951 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 107' ' ' CYS . 53.8 t -69.8 -37.03 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.617 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 12.6 p30 -84.82 1.68 45.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -121.42 -152.79 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.483 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 6.1 mt-10 -108.68 47.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.608 ' HE2' ' HG3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -136.81 39.13 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.447 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -57.82 -51.0 84.97 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.109 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.7 Cg_exo -63.92 -12.01 29.86 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.169 1.913 . . . . 0.0 112.908 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.697 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.7 mp -85.05 -24.05 28.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.012 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.41 -54.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.93 72.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.129 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.553 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 74.5 mt-30 -67.84 -53.47 26.53 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.531 HG23 ' CZ3' ' A' ' 125' ' ' TRP . 54.8 t -56.02 -34.81 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 0.0 109.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.47 -46.49 85.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.47 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.573 ' HA ' HG11 ' A' ' 127' ' ' VAL . 16.6 pt-20 -73.69 -38.01 65.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.952 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.679 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.8 m0 -58.39 -38.95 78.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.713 0.768 . . . . 0.0 109.091 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.2 ttp -72.58 -55.2 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.988 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 124' ' ' GLU . 2.3 p -62.89 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.554 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 2.9 tt0 -67.78 -53.32 28.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.155 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -59.36 -33.28 70.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.377 0.608 . . . . 0.0 110.746 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.35 -56.43 5.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.153 -178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.52 -29.05 68.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 m -84.62 -36.53 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -125.51 -44.88 1.82 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.951 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -59.12 -46.9 87.13 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.37 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.77 65.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.263 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.44 -48.36 73.02 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.196 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.773 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.6 t90 -58.31 -50.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.581 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -56.19 -48.91 78.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.405 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -60.73 -34.17 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.754 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 m -86.3 -16.15 38.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.15 -58.81 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.94 -5.3 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.65 48.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.955 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -62.48 -26.48 68.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.2 -35.99 82.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.443 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.52 -44.02 95.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.609 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 12.9 t80 -64.86 -36.43 84.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.684 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.796 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 m -66.34 -27.18 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.201 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.34 25.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.684 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -42.65 66.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.622 ' HE2' ' CE1' ' A' ' 151' ' ' TYR . 12.6 m-85 -118.65 25.43 10.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.931 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -109.48 -143.09 9.89 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.12 -22.4 28.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.263 0.554 . . . . 0.0 110.567 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -95.14 33.26 5.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.615 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.56 70.62 4.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.666 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -63.5 170.55 3.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.163 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.18 -35.84 60.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.241 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.896 ' HB2' HD11 ' A' ' 156' ' ' LEU . 40.2 mt-10 -68.12 -40.27 82.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.759 0.314 . . . . 0.0 110.706 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.66 76.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -60.28 -56.62 19.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.229 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.3 -23.81 65.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -70.75 -47.92 57.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.229 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -66.94 -36.76 82.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.309 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.428 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 1.7 mt-10 -70.26 -44.21 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.298 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.84 75.1 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.7 t-20 -59.94 -66.13 0.57 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.577 -0.812 . . . . 0.0 111.111 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.631 ' HA ' HG22 ' A' ' 170' ' ' VAL . 32.2 p-90 -61.56 -27.8 68.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.342 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.38 -41.32 69.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 110.79 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -30.1 20.27 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 92' ' ' ASN . 2.7 m -92.18 -36.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -66.22 -29.47 69.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.927 0.394 . . . . 0.0 110.596 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -15.16 29.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.848 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.916 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.4 p -86.11 -25.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.557 . . . . 0.0 110.365 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.916 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.9 OUTLIER -120.66 32.95 5.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.016 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.71 70.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.409 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.35 48.23 3.77 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.277 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -111.36 15.53 21.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.489 0.661 . . . . 0.0 109.272 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.17 67.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.271 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.8 10.4 41.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.914 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 19.1 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.683 -179.996 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 6.6 Cg_exo . . . . . 0 CA--C 1.531 0.331 0 CA-C-O 120.833 0.264 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.3 -151.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -45.09 72.58 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.267 0.627 . . . . 0.0 112.682 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -36.25 79.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.727 0.298 . . . . 0.0 111.133 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . . . -76.55 -35.68 58.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 110.057 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.69 -40.21 66.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.695 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 7.0 p -65.69 -39.2 84.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.074 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.29 60.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.504 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -59.31 2.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.185 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.655 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.3 t80 -57.13 -53.91 52.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.749 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.672 HG12 HD11 ' A' ' 22' ' ' LEU . 96.6 t -66.62 -40.18 85.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.36 -51.3 59.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.011 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 73.4 t80 -63.2 -41.7 99.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.711 0.291 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.63 -40.77 97.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.649 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.724 HD23 ' HB3' ' A' ' 107' ' ' CYS . 7.4 mp -73.36 -42.7 61.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 8.2 ttp85 -65.69 -15.52 62.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.272 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.03 -35.29 25.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.04 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -158.16 79.4 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.553 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.58 -70.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.665 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -88.84 58.98 4.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.13 0.49 . . . . 0.0 110.537 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.48 -29.82 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.036 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -42.87 78.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.577 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.35 59.37 3.79 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.076 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.6 127.34 32.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.26 -54.51 0.36 Allowed Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.793 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 45.0 Cg_exo -58.53 -42.92 49.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.026 1.818 . . . . 0.0 111.407 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.771 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.94 37.65 3.65 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.478 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.84 -6.91 53.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.139 0.495 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.28 144.9 15.84 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.78 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 88.2 Cg_endo -96.06 -150.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.995 2.463 . . . . 0.0 113.118 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -88.59 86.48 7.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.62 1.93 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 55.0 m-20 -107.03 160.4 26.48 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -78.27 41.12 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.23 2.62 . . . . 0.0 111.991 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.44 -28.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.932 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.7 m170 -59.02 -56.5 21.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.848 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.67 -27.06 67.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -71.99 -49.58 36.0 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.615 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 0.9 OUTLIER -67.8 -31.57 71.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -40.99 97.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.45 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -23.27 43.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 109.851 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.703 ' HB3' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.27 -63.88 1.0 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.099 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.655 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.35 -48.41 41.08 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.864 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -42.65 79.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.089 0.471 . . . . 0.0 111.262 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -62.88 -44.32 96.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.666 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.64 -29.33 59.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.919 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.18 -24.09 66.57 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -40.48 10.15 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.634 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -88.96 -54.36 4.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 2.1 t80 -85.3 68.64 10.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.75 0.42 . . . . 0.0 111.324 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -75.93 -22.99 55.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.358 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.19 37.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.035 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -120.79 -5.01 9.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' A' ' 61' ' ' PHE . 4.9 m-85 -93.6 -31.05 14.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.891 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.18 67.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.831 0.348 . . . . 0.0 111.425 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 2.0 m-20 -77.79 -18.02 56.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.892 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.833 HD23 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -72.83 -39.63 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.36 -46.0 35.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.979 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.87 -42.87 63.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.955 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.689 HE22 HD13 ' A' ' 106' ' ' LEU . 25.2 mt-30 -67.8 -61.61 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.656 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -79.61 13.33 2.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 47.0 t60 -79.13 -26.45 42.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.46 ' C ' ' HG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -90.54 -74.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.998 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.46 ' HG1' ' C ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -159.84 142.77 10.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.075 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.8 Cg_exo -75.6 -175.34 2.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.009 2.473 . . . . 0.0 112.069 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 89.74 -65.81 2.94 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.027 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.24 41.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.833 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB2' ' HH2' ' A' ' 125' ' ' TRP . . . -97.11 -21.17 17.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.659 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -63.83 -37.97 89.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.589 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 4.4 mm100 -68.95 -35.22 76.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.32 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.49 -48.15 61.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.14 0.495 . . . . 0.0 109.769 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 7.1 t80 -61.53 -47.62 84.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -58.66 -34.98 71.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.429 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 73.4 mm-40 -60.23 -56.63 19.25 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.177 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 ' CE2' ' A' ' 102' ' ' PHE . 12.3 t -59.0 -37.86 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.081 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.2 m -62.47 -46.37 88.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.543 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.8 OUTLIER -69.46 -36.32 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.533 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 33.4 mm-40 -67.53 -32.87 73.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.872 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -77.17 -36.73 54.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.23 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.641 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 55.2 t80 -85.21 -5.61 59.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -53.79 -37.09 63.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.563 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.46 59.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.813 -1.184 . . . . 0.0 113.384 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.578 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 167.27 49.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.605 -1.284 . . . . 0.0 115.17 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -80.7 38.98 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 119.913 1.856 . . . . 0.0 111.715 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.754 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -70.15 162.61 27.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.529 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 15.1 m95 -53.22 -27.86 24.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.03 -43.49 97.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.436 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -85.65 -23.15 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.675 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.766 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.35 -30.85 61.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 110.036 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 53' ' ' PHE . 41.2 t -60.93 -56.3 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.41 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.93 -28.44 70.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.406 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.608 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 5.7 m-85 -56.45 -51.84 66.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.201 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.638 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 5.8 m-85 -81.53 -35.05 30.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 101' ' ' VAL . 15.2 t -63.75 -34.53 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.758 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -54.23 -59.08 5.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 111.496 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -69.78 -35.91 74.02 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.226 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.19 90.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.2 0.5 . . . . 0.0 110.602 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.812 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.19 -39.1 82.59 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.691 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.7 -45.3 94.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.724 ' HB3' HD23 ' A' ' 22' ' ' LEU . 82.5 m -64.14 -41.69 97.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.86 -53.7 52.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.293 . . . . 0.0 111.041 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.5 -19.95 65.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.661 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -78.71 -33.78 46.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.594 0.235 . . . . 0.0 110.716 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 107' ' ' CYS . 32.1 t -74.52 -25.88 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.481 0.658 . . . . 0.0 109.669 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.55 1.42 45.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.147 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 109' ' ' GLU . 42.7 mttt -133.93 -169.78 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.78 57.84 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 110.025 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.465 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.54 46.44 2.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.716 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.4 mp0 -62.47 -54.25 50.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 26.3 Cg_exo -63.58 -20.19 68.95 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.077 1.852 . . . . 0.0 112.864 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.5 mp -71.98 -29.49 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.62 -51.25 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.03 -31.5 80.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.603 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 5.8 mm100 -68.06 -49.82 59.01 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 118' ' ' LEU . 42.0 t -58.72 -33.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -63.33 -46.49 86.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 12.2 pt-20 -71.55 -40.44 69.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.702 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.659 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 32.3 m0 -57.99 -39.98 79.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.555 0.693 . . . . 0.0 109.337 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.4 ttp -73.56 -53.0 11.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.956 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 128' ' ' GLU . 2.9 p -63.66 -31.87 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 127' ' ' VAL . 3.1 mt-10 -69.92 -50.52 41.29 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.068 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 129' ' ' TYR . 7.0 t80 -58.92 -33.15 70.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 110.983 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.978 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.15 -52.27 9.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.89 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -35.32 79.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 m -81.15 -39.22 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.72 -41.33 2.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.978 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -63.36 -47.09 83.59 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.545 -178.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.58 -34.53 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.275 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.4 -50.0 67.16 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.219 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.754 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 45.6 t90 -59.08 -49.05 79.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.58 HG13 ' HE3' ' A' ' 137' ' ' TRP . 14.8 mt -56.92 -48.41 81.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.074 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -65.59 -30.52 71.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.2 m -83.55 -30.37 27.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -57.69 4.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.83 -10.86 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.559 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.3 170.24 40.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.626 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.615 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 94.7 m95 -62.84 -30.77 71.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.75 72.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.204 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.432 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -65.44 -41.12 93.82 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.616 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 8.2 t80 -65.85 -39.04 90.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.514 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.506 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.78 -25.73 67.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.024 0.44 . . . . 0.0 110.815 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.4 -28.04 23.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.083 0.468 . . . . 0.0 109.849 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.15 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.27 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -134.3 30.26 3.58 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.62 -111.03 3.56 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 119.84 -1.172 . . . . 0.0 112.862 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.6 -67.27 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.041 0.448 . . . . 0.0 110.973 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.94 69.88 1.86 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.553 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.54 71.38 9.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 110.343 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.1 165.04 14.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.039 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.417 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -58.91 -36.27 74.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.1 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.563 ' HB2' HD13 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -68.63 -38.96 80.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.344 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -69.98 -40.14 75.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -68.04 -49.55 60.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD2' ' OE1' ' A' ' 157' ' ' GLU . 9.7 ptm180 -62.3 -28.57 69.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 110.385 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -67.42 -42.32 83.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.833 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.6 HH22 ' HA ' ' A' ' 49' ' ' ALA . 5.2 ttp180 -67.08 -44.04 81.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.23 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.622 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.11 -47.29 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.41 -23.63 75.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.739 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.613 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 2.9 t-20 -74.43 -54.53 7.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.532 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.855 ' HA ' HG21 ' A' ' 170' ' ' VAL . 11.7 p-90 -64.25 -24.29 67.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.055 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -51.36 -52.97 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.215 0.322 . . . . 0.0 110.811 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -27.72 22.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 167' ' ' TRP . 25.0 m -80.02 -25.98 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.273 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -83.13 -15.11 52.04 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.673 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.8 OUTLIER -96.22 -39.16 9.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.96 HG11 ' HG ' ' A' ' 174' ' ' LEU . 13.2 p -59.39 -33.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.403 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.96 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -115.7 44.5 1.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.634 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.673 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.16 -43.08 92.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.294 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.21 41.42 1.32 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.724 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -100.77 -4.24 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.264 0.554 . . . . 0.0 109.878 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.41 67.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.397 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.35 8.2 45.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.446 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.583 HD13 ' HE2' ' A' ' 102' ' ' PHE . 8.7 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.532 0.382 0 CA-C-O 121.047 0.353 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -156.65 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.42 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.22 72.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -42.8 99.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.15 -35.03 66.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.546 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.6 tp -72.91 -42.18 63.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.486 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 15' ' ' ALA . 7.8 p -66.47 -37.42 79.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.572 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -72.0 -21.05 61.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 43' ' ' HIS . 1.2 t70 -77.81 -68.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 t80 -52.3 -50.33 62.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.206 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.789 HG12 HD12 ' A' ' 22' ' ' LEU . 19.3 t -75.93 -39.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.935 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 15' ' ' ALA . . . -61.22 -53.69 42.53 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.527 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.729 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 85.9 t80 -60.8 -45.47 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.029 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -61.04 -47.73 85.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.789 HD12 HG12 ' A' ' 18' ' ' VAL . 8.3 mp -67.93 -47.85 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 29.6 ttp85 -58.75 -30.95 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.554 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.63 -12.03 49.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -156.47 63.09 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.46 -71.21 0.33 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.73 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 1.3 t80 -82.2 56.62 3.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.15 0.5 . . . . 0.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 t -78.31 -32.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 m -66.27 -35.38 80.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.774 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.23 51.62 2.46 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.639 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 116.16 9.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.746 0.308 . . . . 0.0 110.668 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.22 -51.05 0.13 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.599 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.7 -48.46 2.12 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.187 1.925 . . . . 0.0 111.667 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -89.47 27.48 7.76 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.94 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.25 -58.54 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.604 0.716 . . . . 0.0 109.388 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.94 139.22 30.91 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.699 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -90.53 -133.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.722 2.281 . . . . 0.0 113.567 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 44' ' ' GLN . . . -83.63 92.02 7.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.452 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.84 10.63 5.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.489 0.661 . . . . 0.0 109.576 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.8 m-20 -121.11 160.51 44.95 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.365 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' C ' HG21 ' A' ' 148' ' ' THR . 58.3 Cg_endo -81.36 37.03 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.246 2.631 . . . . 0.0 112.4 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -165.61 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.414 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 16' ' ' ASP . 2.5 m170 -56.21 -56.98 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 9.1 tt0 -57.67 -23.4 51.23 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.557 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.91 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -82.52 -49.62 9.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.559 ' HE3' ' CZ3' ' A' ' 144' ' ' TRP . 4.5 ttm -66.42 -42.14 88.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -30.74 71.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.498 0.19 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.87 33.57 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.564 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . . . -59.51 -55.76 30.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.097 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.426 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.98 -44.75 41.57 Favored Glycine 0 C--O 1.217 -0.93 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.613 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.01 -54.14 50.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.453 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -43.43 97.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.965 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.894 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.87 -30.24 62.53 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.495 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.97 -30.35 71.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.78 0.8 . . . . 0.0 108.864 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.1 m -79.54 -33.69 41.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.297 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 56' ' ' ARG . 19.0 mtt180 -89.56 -52.12 5.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.174 0.512 . . . . 0.0 111.716 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.27 64.13 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.303 0.641 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -18.29 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.768 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.59 58.43 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -51.07 2.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 111.746 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.789 ' HA ' HD13 ' A' ' 64' ' ' LEU . 5.1 m-85 -62.17 -19.73 63.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -38.79 66.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.835 0.35 . . . . 0.0 111.311 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.783 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 3.3 m-20 -67.03 -28.41 68.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.491 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' HA ' ' A' ' 61' ' ' PHE . 20.1 mt -61.19 -43.63 98.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.338 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.8 -40.49 47.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.02 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.5 ' HB3' ' HA ' ' A' ' 63' ' ' ASP . . . -51.59 -45.52 63.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.699 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.724 HE22 HD13 ' A' ' 106' ' ' LEU . 36.9 mt-30 -67.64 -54.73 17.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.255 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -84.38 17.52 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.9 t60 -78.17 -30.28 49.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.602 HG11 ' H ' ' A' ' 71' ' ' THR . 2.4 p -91.5 -65.25 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.602 ' H ' HG11 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -162.3 145.95 9.15 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 122.138 0.175 . . . . 0.0 110.708 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' ' 68' ' ' LEU . 2.9 Cg_exo -76.45 172.18 16.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.818 2.345 . . . . 0.0 111.355 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.92 -60.99 1.13 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.625 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.17 50.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.418 0.628 . . . . 0.0 110.93 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.76 -22.12 13.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.32 -39.94 94.91 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.509 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.82 -47.71 82.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.998 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -47.66 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.81 -50.02 75.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.774 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' THR . . . . . 0.406 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 18.5 p -60.61 -30.01 69.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -68.01 -53.11 28.34 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.002 0.43 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.603 HG11 HD12 ' A' ' 180' ' ' LEU . 34.2 m -65.77 -32.3 57.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.089 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 80' ' ' THR . 1.3 p -69.13 -39.94 78.59 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.892 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -46.5 82.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.239 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -68.87 -25.03 64.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -79.82 -26.15 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.501 . . . . 0.0 109.952 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -97.37 -4.24 38.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.395 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -39.04 -50.47 1.81 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.542 0.737 . . . . 0.0 112.378 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.3 48.99 0.16 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.901 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.12 56.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.221 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.6 Cg_endo -77.8 45.78 1.87 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.21 1.94 . . . . 0.0 111.817 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.796 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.8 162.92 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.598 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.616 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 17.6 m95 -54.01 -28.85 40.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.639 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.86 -40.78 98.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.204 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 171' ' ' ARG . 6.9 mmt180 -86.35 -21.56 27.16 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.812 -0.228 . . . . 0.0 110.551 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.774 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -57.66 -30.62 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.346 0.593 . . . . 0.0 110.132 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.894 HG13 ' HB2' ' A' ' 53' ' ' PHE . 7.5 t -62.9 -55.16 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -61.61 -29.06 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.053 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.774 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 3.6 m-85 -56.42 -54.21 48.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.082 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.624 ' HE1' ' CE2' ' A' ' 100' ' ' PHE . 6.6 m-85 -79.03 -36.33 41.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.02 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 t -59.99 -38.45 76.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -57.41 -50.0 74.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.71 0.291 . . . . 0.0 111.613 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.615 ' HA3' ' HE2' ' A' ' 126' ' ' MET . . . -76.68 -37.65 34.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.261 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.63 98.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.245 0.523 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.447 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -69.22 -38.88 78.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.724 HD13 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -60.31 -44.9 95.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.494 ' HB3' HD22 ' A' ' 22' ' ' LEU . 86.6 m -64.06 -41.01 97.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.172 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.25 -54.7 40.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -17.72 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.516 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -77.97 -31.0 50.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 107' ' ' CYS . 15.6 t -80.95 -13.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.905 0.859 . . . . 0.0 109.163 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -85.02 0.07 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -144.64 -170.38 3.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.519 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.84 55.59 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 110.034 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.469 ' HE3' ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -129.85 29.69 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.513 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.503 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -53.51 -51.07 79.29 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 116' ' ' GLU . 19.1 Cg_endo -59.84 -23.19 71.39 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.238 1.959 . . . . 0.0 113.243 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 mm? -76.04 -26.68 56.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.591 0.234 . . . . 0.0 110.777 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.25 -54.3 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.193 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.29 71.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.446 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 mm100 -69.45 -49.77 51.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.532 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 46.1 t -58.52 -35.16 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.15 -50.38 73.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.359 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 10.7 pt-20 -69.27 -39.78 78.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.681 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.9 m0 -57.3 -40.93 78.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.391 0.615 . . . . 0.0 109.524 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.615 ' HE2' ' HA3' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -76.04 -44.53 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.376 -178.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.523 ' N ' ' HG2' ' A' ' 126' ' ' MET . 5.0 p -71.45 -31.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.741 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 127' ' ' VAL . 4.0 mm-40 -69.57 -48.14 61.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.09 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 13.7 t80 -59.34 -35.16 73.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.692 . . . . 0.0 110.473 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.926 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.39 -53.19 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.908 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -62.36 -28.78 70.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.9 m -85.1 -36.11 21.37 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -128.14 -40.77 1.64 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.926 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.67 -45.83 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.129 0.422 . . . . 0.0 111.325 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.04 61.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.356 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -65.71 -53.96 33.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.796 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 47.8 t90 -57.12 -47.31 81.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.463 HG13 ' HE3' ' A' ' 137' ' ' TRP . 8.3 mt -57.02 -49.18 80.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -65.1 -32.71 74.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.97 -4.41 58.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -99.31 -50.71 4.03 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.871 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . 0.443 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -176.35 -19.97 0.02 OUTLIER Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.81 168.36 35.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.559 ' CZ3' ' HE3' ' A' ' 46' ' ' MET . 89.3 m95 -60.14 -31.15 69.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.3 75.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.012 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.443 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.8 tt0 -65.74 -38.15 88.34 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.35 -38.94 81.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.747 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.91 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -61.91 -33.84 74.96 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.686 0.279 . . . . 0.0 111.401 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.78 32.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.813 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.408 HD23 ' HG3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -61.74 -44.65 96.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.084 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 151' ' ' TYR . 1.5 m-85 -111.27 16.45 20.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -108.24 -137.88 8.34 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.9 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -29.66 26.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 111.217 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.468 ' O ' HD22 ' A' ' 156' ' ' LEU . . . -83.84 37.9 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.092 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.13 68.81 9.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.46 176.78 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.206 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -53.54 -38.42 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.814 ' HB2' HD11 ' A' ' 156' ' ' LEU . 17.0 mt-10 -68.47 -46.56 69.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.91 73.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -56.78 9.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.009 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -65.36 -34.1 77.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.351 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.0 OUTLIER -67.86 -31.47 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.652 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HG3' HD23 ' A' ' 150' ' ' LEU . 6.2 mtp180 -70.14 -51.59 30.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 168' ' ' ALA . 12.8 mt-10 -67.57 -38.63 84.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.36 76.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.122 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.6 t-20 -69.4 -71.39 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.545 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 164' ' ' GLU . 35.8 p-90 -58.36 -25.4 61.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.854 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 164' ' ' GLU . . . -54.56 -63.14 1.25 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 110.883 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.75 -23.4 24.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 8.3 t -77.99 -39.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 111.682 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.57 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 16.2 ttp180 -74.15 -24.1 59.36 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.091 -0.381 . . . . 0.0 110.699 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.766 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.8 OUTLIER -84.24 -27.75 27.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.659 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.858 HG13 ' HG ' ' A' ' 174' ' ' LEU . 0.7 OUTLIER -68.27 -22.98 27.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.983 0.421 . . . . 0.0 110.497 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.858 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.4 OUTLIER -120.38 38.49 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.634 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.766 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.37 -23.24 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.297 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 6.86 67.91 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.465 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.669 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -80.08 7.03 9.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.83 65.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.27 0.557 . . . . 0.0 110.713 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.44 ' H ' HG13 ' A' ' 82' ' ' VAL . . . -102.48 13.67 33.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.19 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.846 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.974 0.322 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.83 -172.04 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.81 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -28.04 50.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 111.929 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.78 -39.98 88.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 110.093 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -34.3 62.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.654 HD12 HD11 ' A' ' 42' ' ' LEU . 2.1 tp -72.82 -41.58 64.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.525 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.2 p -64.98 -36.96 79.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.71 62.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -66.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.619 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 4.0 t80 -54.21 -52.07 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.07 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.8 t -65.5 -42.02 92.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.462 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.97 -51.83 56.09 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.18 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' A' ' 20' ' ' TYR . 42.8 t80 -58.32 -45.45 88.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.009 0.524 . . . . 0.0 111.292 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -64.52 -47.87 77.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.301 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 18' ' ' VAL . 8.6 mp -65.23 -46.71 79.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 12.6 ttp85 -62.84 -20.42 65.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.87 -31.16 23.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.798 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.32 71.97 1.14 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.163 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.16 -69.83 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.756 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.625 ' HD1' ' CD2' ' A' ' 27' ' ' TYR . 1.5 t80 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.114 0.483 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.42 -33.94 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -37.9 89.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.29 52.42 1.37 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.716 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -65.47 141.7 58.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.51 -45.71 0.53 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.111 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 11.5 Cg_exo -73.37 -47.62 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.138 1.892 . . . . 0.0 111.869 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.776 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.95 27.22 7.54 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.216 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 19.9 mm-40 -80.57 -41.96 23.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.504 0.652 . . . . 0.0 109.403 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.3 142.66 46.2 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.006 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -93.49 -166.27 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.784 2.323 . . . . 0.0 113.806 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -83.22 85.51 7.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.392 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.04 -23.44 4.96 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 4.2 m-20 -79.32 160.28 70.79 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.472 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 27.8 Cg_endo -77.61 50.16 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.279 2.653 . . . . 0.0 111.568 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD11 HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -178.96 -31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.287 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.8 m170 -60.42 -59.58 5.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.963 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.809 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -57.54 -27.1 62.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.732 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -71.88 -52.78 15.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.584 ' HE2' HD21 ' A' ' 13' ' ' LEU . 2.9 ttm -65.58 -38.3 89.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.639 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -38.63 80.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.402 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.67 45.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.22 0.533 . . . . 0.0 110.107 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.786 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -63.73 -63.21 1.23 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.424 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.48 -47.41 36.25 Favored Glycine 0 C--O 1.215 -1.038 0 O-C-N 124.137 0.898 . . . . 0.0 112.502 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -51.74 -51.62 54.84 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.855 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.06 -46.9 79.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.837 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -68.88 -35.7 77.19 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.74 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.27 -32.77 73.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 109.468 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -85.35 -18.24 34.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.606 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.06 -65.62 1.03 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.097 0.475 . . . . 0.0 111.861 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.8 67.63 8.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.243 0.617 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.4 OUTLIER -80.26 -8.95 59.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.952 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 40.9 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -120.35 0.06 10.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 30.3 m-85 -89.65 -17.11 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.172 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -41.05 93.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.7 m-20 -63.18 -27.2 69.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.821 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.922 HD21 ' HB3' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -63.74 -42.55 97.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.722 0.773 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.51 -44.05 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.409 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -42.24 63.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.441 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.673 HE22 HD11 ' A' ' 106' ' ' LEU . 21.0 mt-30 -73.01 -52.44 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.326 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.34 19.91 3.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t60 -79.34 -35.3 41.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.234 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.508 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.42 -68.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.275 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.7 145.66 8.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.416 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.523 ' HB2' HD11 ' A' ' 118' ' ' LEU . 96.6 Cg_endo -80.45 -178.01 4.16 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.623 2.215 . . . . 0.0 112.185 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.652 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.28 -71.3 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.879 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.68 44.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.97 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.15 -19.25 18.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.947 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.642 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.3 pt20 -63.78 -36.22 83.17 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.728 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -70.43 -38.73 74.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.398 . . . . 0.0 110.164 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -68.13 -44.47 76.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.946 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.45 -45.84 91.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.92 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -60.2 -33.5 72.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.195 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -61.63 -60.14 4.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.759 0.314 . . . . 0.0 111.109 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 177' ' ' ALA . 2.8 p -58.61 -36.57 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -65.59 -41.97 92.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.091 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -43.3 81.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 177' ' ' ALA . 74.9 mm-40 -70.21 -21.21 63.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -84.42 -34.88 23.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 110.291 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -85.43 -7.64 58.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.484 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.48 -50.54 2.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.019 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.3 56.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.861 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.31 51.28 0.05 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.599 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -80.44 40.81 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.149 1.9 . . . . 0.0 111.842 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.808 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.9 OUTLIER -70.35 166.12 20.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.684 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.566 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 30.6 m95 -53.19 -30.32 36.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.437 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.49 99.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.283 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -87.12 -25.76 23.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.839 -0.181 . . . . 0.0 110.931 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.773 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.74 -31.86 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.45 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG11 ' HB2' ' A' ' 53' ' ' PHE . 16.4 t -62.65 -56.12 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.6 -28.38 69.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' A' ' 99' ' ' PHE . 2.9 m-85 -55.73 -54.59 42.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.198 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.525 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.2 m-85 -78.27 -35.13 48.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.223 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 t -62.66 -36.36 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.563 ' HE2' HD11 ' A' ' 180' ' ' LEU . 0.5 OUTLIER -55.2 -55.68 28.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.466 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.89 56.1 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.41 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.135 0.468 . . . . 0.0 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.922 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -71.07 -39.33 72.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.712 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.0 -49.92 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.58 ' O ' HG22 ' A' ' 111' ' ' VAL . 79.8 m -60.17 -40.13 88.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.097 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.53 30.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.1 -15.96 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 119' ' ' VAL . 66.8 m -77.88 -29.02 50.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.586 HG23 HG23 ' A' ' 119' ' ' VAL . 16.9 t -82.1 -17.01 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.685 0.755 . . . . 0.0 109.057 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -79.69 -8.57 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.892 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -166.16 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.511 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.25 67.64 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.02 0.438 . . . . 0.0 110.036 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.95 37.23 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.223 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.573 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 3.3 mp0 -57.9 -51.7 79.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 34.1 Cg_exo -58.53 -30.73 92.69 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.044 1.829 . . . . 0.0 112.32 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.652 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -71.35 -30.95 66.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.586 HG23 HG23 ' A' ' 111' ' ' VAL . 73.4 t -57.68 -52.02 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.77 -31.73 79.18 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.503 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.9 mm-40 -66.05 -50.7 63.24 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.531 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 96.3 t -56.56 -36.46 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.02 -48.32 80.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.488 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 13.1 pt-20 -72.46 -36.42 68.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.195 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.642 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.7 m0 -58.16 -39.77 79.71 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.8 ttp -72.89 -53.4 11.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.581 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.4 p -60.45 -32.54 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.783 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -67.12 -54.7 18.9 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.061 0.458 . . . . 0.0 110.24 179.221 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 129' ' ' TYR . 2.5 t80 -58.78 -30.2 67.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.896 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.38 -52.9 8.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.526 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.29 77.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.8 m -80.83 -33.86 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 -46.31 1.95 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.896 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.31 -42.1 90.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.645 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.28 64.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.05 -51.17 60.62 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.808 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 69.8 t90 -57.81 -47.5 82.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.582 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -58.23 -47.53 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.555 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -63.52 -25.59 68.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 111.567 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -100.37 -5.64 26.96 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -122.17 44.76 2.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.722 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.33 -65.97 0.89 Allowed Glycine 0 CA--C 1.506 -0.484 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.25 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.582 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 123.59 173.45 13.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.906 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -56.04 -36.75 68.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.04 77.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.566 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.52 -43.01 98.41 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.516 ' HZ ' ' CB ' ' A' ' 49' ' ' ALA . 13.7 t80 -67.48 -31.63 71.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.699 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.654 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -69.47 -25.0 63.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.155 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.57 -34.4 19.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -56.21 -51.81 66.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.929 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.7 m-85 -130.35 31.76 4.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -98.52 -134.85 8.58 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.177 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.26 -53.42 44.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 110.334 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.483 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.61 64.06 1.87 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.708 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.24 73.3 7.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.391 0.615 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -59.22 153.39 18.53 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.114 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 2.6 mm-40 -56.66 -27.64 59.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.099 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -73.37 -42.39 62.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 110.643 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 150' ' ' LEU . . . -66.89 -37.56 84.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.271 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 160' ' ' ARG . 25.4 mtm-85 -65.64 -52.81 48.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.24 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 17.8 ptt180 -63.65 -31.36 72.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -65.74 -39.33 90.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.786 HH22 ' HA ' ' A' ' 49' ' ' ALA . 2.5 ttp180 -68.13 -43.65 77.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 29.2 mt-10 -62.44 -47.38 84.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.398 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.8 -23.76 75.66 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.953 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -74.04 -52.25 13.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.773 ' HA ' HG23 ' A' ' 170' ' ' VAL . 11.9 p-90 -65.28 -24.3 67.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.855 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.23 77.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.341 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -31.26 20.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.773 HG23 ' HA ' ' A' ' 167' ' ' TRP . 27.4 m -89.51 -37.04 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -68.77 -30.91 69.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.804 -0.56 . . . . 0.0 110.939 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.29 -37.47 21.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.663 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.662 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -66.35 -27.08 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.952 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.662 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.7 OUTLIER -115.8 32.94 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.323 0.582 . . . . 0.0 109.875 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.8 -9.99 59.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.107 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.55 15.03 62.4 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.703 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' HG21 ' A' ' 82' ' ' VAL . . . -88.38 6.53 36.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.569 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.61 71.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.531 0.682 . . . . 0.0 109.979 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.44 8.08 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.483 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.656 0.265 . . . . 0.0 110.849 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 CA--C 1.53 0.305 0 N-CA-C 112.953 0.328 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 -160.25 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -43.19 66.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -61.18 -38.23 85.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.292 . . . . 0.0 111.213 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.72 -34.91 60.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.1 0.476 . . . . 0.0 110.137 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.764 HD23 ' HE1' ' A' ' 46' ' ' MET . 4.6 tp -72.28 -42.86 65.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 15' ' ' ALA . 8.3 p -65.98 -35.8 75.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.574 ' N ' HG13 ' A' ' 14' ' ' VAL . . . -71.99 -24.21 61.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.333 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -66.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 4.5 t80 -55.08 -53.78 51.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.968 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 22' ' ' LEU . 58.4 t -67.16 -37.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.221 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.68 -51.79 53.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.059 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 1.1 t80 -63.32 -47.06 83.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.44 0.296 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 1.9 tmtm? -57.84 -37.3 73.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 111.222 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -78.44 -47.34 17.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.533 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.741 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -59.35 -27.16 65.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.853 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 14.0 pt20 -85.65 -11.09 54.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.16 -56.19 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.53 -57.43 0.66 Allowed Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.665 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -78.32 46.06 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 122.782 0.433 . . . . 0.0 111.101 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 29' ' ' CYS . 7.6 p -78.1 -31.95 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.001 0.429 . . . . 0.0 110.222 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.417 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -68.03 -39.04 83.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.39 0.614 . . . . 0.0 109.356 178.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.61 58.43 3.75 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.575 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.26 109.76 1.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.474 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -172.56 -57.46 0.05 OUTLIER Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 35.8 Cg_exo -62.33 -50.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.235 1.956 . . . . 0.0 111.482 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -85.94 27.23 5.55 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.404 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -77.4 -31.15 53.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.079 0.466 . . . . 0.0 109.891 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.43 124.82 8.05 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 92.7 Cg_endo -87.5 -150.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.591 2.194 . . . . 0.0 113.657 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -78.22 82.81 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.78 26.82 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.439 . . . . 0.0 110.627 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 9.7 m-20 -135.76 161.63 61.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.098 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 47.1 Cg_endo -78.83 50.78 3.57 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.274 2.649 . . . . 0.0 112.279 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER 179.82 -32.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.579 179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.7 m170 -60.02 -56.49 21.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.508 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 2.5 mt-30 -61.27 -25.19 66.93 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.637 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -72.82 -50.45 24.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.966 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.764 ' HE1' HD23 ' A' ' 13' ' ' LEU . 3.6 ttm -66.88 -37.37 84.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.667 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -60.93 -40.66 94.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.53 -29.38 56.72 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 110.054 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -66.19 -62.15 1.64 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.39 -45.97 28.77 Favored Glycine 0 C--O 1.216 -0.981 0 O-C-N 124.224 0.953 . . . . 0.0 112.572 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.6 -53.82 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.51 -45.87 81.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.513 ' HZ ' ' HD2' ' A' ' 171' ' ' ARG . 0.5 OUTLIER -65.16 -38.56 90.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.27 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.65 -36.53 78.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.621 . . . . 0.0 109.967 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -83.2 -12.78 56.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.352 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.88 -24.88 12.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -86.78 92.22 8.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.49 -31.32 70.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.421 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -119.65 79.11 1.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -120.81 -7.59 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.664 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.88 -29.62 4.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -32.84 71.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -71.58 -20.59 61.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.925 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.784 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -71.06 -41.06 71.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -74.34 -42.26 59.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.46 -43.31 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.785 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.592 HE22 HD11 ' A' ' 106' ' ' LEU . 28.1 mt-30 -63.42 -52.78 60.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.464 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.21 7.43 22.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 4.2 t60 -78.85 -23.27 45.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -68.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.391 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -164.67 143.12 5.55 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.1 Cg_exo -81.05 -175.96 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.412 2.741 . . . . 0.0 111.897 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 80.9 -62.3 4.44 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.82 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.83 28.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.472 . . . . 0.0 111.897 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -81.4 -23.43 37.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.662 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -59.91 -40.83 90.16 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.927 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.28 -49.07 77.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.115 0.259 . . . . 0.0 110.757 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -59.76 -43.56 94.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.966 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.81 -52.26 64.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.646 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.59 -33.6 66.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -61.92 -51.66 67.23 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.306 0.574 . . . . 0.0 109.988 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 177' ' ' ALA . 31.2 t -64.51 -35.82 75.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.711 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.998 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.617 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.84 -34.21 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.377 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 174' ' ' LEU . 3.5 mm-40 -65.99 -30.41 70.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.53 . . . . 0.0 109.948 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.38 -36.92 45.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.643 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 41.6 t80 -86.21 -2.03 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -36.9 61.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.475 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.8 59.69 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.898 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.513 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.31 53.36 0.02 OUTLIER Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.835 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.2 Cg_endo -81.37 36.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.325 2.017 . . . . 0.0 111.551 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -68.47 163.9 22.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.907 -178.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.42 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 14.6 m95 -53.67 -27.73 29.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.53 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.32 98.48 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER -86.61 -23.83 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.69 -0.255 . . . . 0.0 110.918 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -54.25 -32.07 55.13 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.381 0.61 . . . . 0.0 110.488 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 53' ' ' PHE . 6.1 t -61.95 -54.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.571 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . . . -62.11 -30.69 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.247 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.1 m-85 -55.5 -51.82 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.602 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 8.1 m-85 -82.48 -32.72 28.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.412 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 101' ' ' VAL . 3.5 t -64.95 -34.0 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.813 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -52.33 -60.05 3.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.63 61.42 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.206 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.21 83.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.157 0.479 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.92 -42.49 63.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.784 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.03 -51.85 67.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.603 179.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.645 ' HB3' HD21 ' A' ' 22' ' ' LEU . 87.1 m -60.55 -43.8 96.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.22 67.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.811 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.7 tt0 -78.63 -25.63 45.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB2' HG21 ' A' ' 119' ' ' VAL . 50.6 m -78.25 -37.02 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.676 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.9 t -66.51 -32.96 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.207 -0.308 . . . . 0.0 111.523 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.576 HD21 ' HA ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -79.3 -30.99 43.15 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.411 -0.516 . . . . 0.0 112.253 -178.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.15 113.99 2.74 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 115' ' ' MET . 23.0 mt-10 65.35 143.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 7.5 mtm 76.86 126.47 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.771 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 1.7 tt0 -120.53 -58.11 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.425 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.34 -29.23 88.4 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.218 1.946 . . . . 0.0 113.09 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 122' ' ' VAL . 1.2 mm? -60.0 -31.65 70.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.597 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 111' ' ' VAL . 89.3 t -60.86 -51.22 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.85 -30.48 72.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -64.83 -52.57 56.0 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.534 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 89.0 t -55.6 -37.55 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.025 0.44 . . . . 0.0 109.915 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -61.69 -47.04 87.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.643 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 23.2 pt-20 -74.1 -35.88 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.662 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.0 m0 -56.24 -37.98 70.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.602 ' HE3' ' HA ' ' A' ' 100' ' ' PHE . 1.2 mtp -73.34 -56.45 5.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 128' ' ' GLU . 1.4 p -60.64 -32.83 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.502 ' N ' HG13 ' A' ' 127' ' ' VAL . 3.7 mt-10 -69.7 -47.6 62.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.185 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.5 t80 -61.45 -36.14 79.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.545 0.688 . . . . 0.0 110.421 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.47 -55.57 7.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.196 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.95 -32.75 72.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.1 m -78.68 -40.78 32.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -41.05 1.88 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -60.53 -48.3 82.39 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.337 0.517 . . . . 0.0 111.709 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -35.9 41.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.238 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.75 -51.92 65.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.373 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.764 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.0 t90 -58.65 -47.58 83.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.597 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.7 mt -57.44 -48.05 83.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.389 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -68.97 -26.45 65.04 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.666 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -92.04 -9.08 44.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.13 -53.8 3.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.91 -15.64 0.02 OUTLIER Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.423 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.63 168.75 36.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.518 ' CZ2' HD12 ' A' ' 138' ' ' ILE . 94.6 m95 -63.46 -30.26 71.41 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.58 75.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.741 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.42 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -64.27 -42.8 96.28 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' A' ' 147' ' ' PHE . 11.1 t80 -66.2 -33.93 76.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.631 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.52 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -68.25 -27.07 66.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.706 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.78 -26.5 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.123 0.487 . . . . 0.0 109.936 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.64 -50.78 65.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.39 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.539 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.5 m-85 -133.05 33.24 3.67 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.991 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -102.05 -137.28 9.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.98 -39.31 79.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.166 0.507 . . . . 0.0 110.716 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.548 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -102.47 53.98 0.75 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.766 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.88 76.13 3.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.331 0.586 . . . . 0.0 110.288 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -64.37 162.59 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.24 -32.98 64.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.242 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.733 ' HB2' HD12 ' A' ' 156' ' ' LEU . 45.8 mt-10 -74.06 -35.31 64.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.716 0.294 . . . . 0.0 111.291 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.621 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -71.04 -39.18 72.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 mtm-85 -62.18 -56.36 19.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.735 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.43 -33.13 73.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -64.18 -42.64 96.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.648 HH22 ' HA ' ' A' ' 49' ' ' ALA . 3.2 ttp180 -68.2 -41.19 81.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.994 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.706 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -64.92 -40.99 95.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.43 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.75 -31.22 67.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.963 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 t-20 -67.03 -55.65 13.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.214 -0.493 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.867 ' HA ' HG23 ' A' ' 170' ' ' VAL . 12.0 p-90 -61.98 -28.94 69.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.193 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.54 -42.88 79.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 110.75 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' SER . . . . . 0.573 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.86 -30.56 20.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' A' ' 167' ' ' TRP . 35.3 m -87.03 -29.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.513 ' HD2' ' HZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -77.12 -34.72 56.63 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.804 -0.56 . . . . 0.0 110.153 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 -8.78 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.045 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.573 ' CG1' ' HG ' ' A' ' 174' ' ' LEU . 2.9 p -85.19 -26.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.26 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.573 ' HG ' ' CG1' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -121.35 43.22 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.139 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -22.61 62.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.765 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.82 8.48 49.72 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.339 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.487 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -78.17 -0.29 27.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.7 69.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.344 0.592 . . . . 0.0 110.546 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -103.56 16.11 27.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.12 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.484 HD22 HG23 ' A' ' 82' ' ' VAL . 35.4 mt . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.805 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 CA--C 1.527 0.16 0 CA-C-O 121.177 0.407 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.63 -167.17 1.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.578 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.55 75.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -62.5 -39.47 93.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.679 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.43 69.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.007 0.432 . . . . 0.0 110.018 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.424 HD11 ' SD ' ' A' ' 46' ' ' MET . 4.3 tp -70.66 -43.14 69.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.692 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 9.9 p -66.84 -34.9 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.011 0.434 . . . . 0.0 110.009 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.19 60.94 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.448 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -66.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.917 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.645 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.1 t80 -55.08 -50.73 68.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 22' ' ' LEU . 44.2 t -72.59 -39.01 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.665 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.8 -55.92 25.7 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.271 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.69 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 13.0 t80 -56.45 -44.77 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.856 0.462 . . . . 0.0 110.798 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.42 -45.58 90.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.525 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 107' ' ' CYS . 7.3 mp -68.7 -43.3 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 24.3 ttp85 -66.76 -15.31 63.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.597 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -84.14 -38.61 20.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.71 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.04 79.9 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.765 0.317 . . . . 0.0 111.841 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.14 -66.33 0.38 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.911 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -96.68 55.57 1.41 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.306 0.574 . . . . 0.0 110.333 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 29' ' ' CYS . 7.8 p -79.04 -27.75 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.977 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.445 ' N ' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -68.9 -41.07 78.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 58.69 4.02 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.772 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.26 118.13 10.22 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.81 -54.16 0.16 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.348 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.8 Cg_exo -60.55 -46.94 15.26 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 121.936 1.757 . . . . 0.0 111.021 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -97.93 36.76 3.77 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.218 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -18.24 43.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.26 140.78 16.34 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 83.2 Cg_endo -94.58 -141.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.98 2.454 . . . . 0.0 113.283 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -76.29 86.96 3.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.359 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.69 20.8 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.067 0.461 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.481 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 3.8 m-20 -131.69 161.67 60.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.938 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 56.8 Cg_endo -81.31 45.51 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.253 2.635 . . . . 0.0 111.964 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.27 -30.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.13 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.481 ' CG ' ' HB2' ' A' ' 40' ' ' ASP . 3.8 m170 -57.84 -57.13 14.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.819 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' CA ' ' HB2' ' A' ' 38' ' ' ALA . 25.1 tt0 -58.58 -26.81 64.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -74.45 -50.71 17.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.381 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 13' ' ' LEU . 3.7 ttm -67.11 -41.72 85.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.613 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -62.87 -33.76 75.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.759 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.23 -41.87 27.26 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.234 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB2' HG23 ' A' ' 97' ' ' VAL . . . -60.59 -55.66 30.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.649 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.658 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.3 -46.55 57.23 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.742 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.64 -49.0 79.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 111.502 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -65.17 -46.29 81.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.38 0.61 . . . . 0.0 110.257 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.621 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 45.7 t80 -63.34 -40.46 97.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.635 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.25 -33.03 70.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.341 0.591 . . . . 0.0 109.973 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 m -78.02 -24.8 47.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.278 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -98.71 -18.86 17.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.26 93.74 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.926 0.393 . . . . 0.0 111.409 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -61.22 -46.64 89.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.25 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.818 HH21 HG11 ' A' ' 178' ' ' VAL . 3.2 mtm-85 -91.17 86.71 6.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.106 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -113.22 -57.08 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.001 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.608 ' HE1' ' CE2' ' A' ' 61' ' ' PHE . 7.8 m-85 -90.96 0.98 57.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 59' ' ' ARG . 2.1 p -70.17 -56.49 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 111.33 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -63.92 -23.52 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.169 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.76 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.8 mp -64.69 -43.24 94.17 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.86 -41.6 29.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.503 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -36.47 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.879 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.726 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 23.5 mt-30 -75.32 -58.86 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.033 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -76.6 9.17 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -177.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.577 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.8 t60 -79.01 -18.42 53.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.957 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.34 -77.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -160.1 144.57 10.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.306 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 5.4 Cg_exo -74.84 162.96 36.54 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.811 2.341 . . . . 0.0 112.04 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.732 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 103.48 -64.06 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.643 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.57 42.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.259 0.552 . . . . 0.0 111.867 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.59 -23.23 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.685 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.9 pt20 -60.86 -41.89 96.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 1.1 mt-30 -63.45 -39.68 95.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.76 0.314 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.726 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 56.0 mtt-85 -68.24 -43.56 77.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.986 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.501 ' O ' HG12 ' A' ' 82' ' ' VAL . 8.4 t80 -62.98 -47.96 80.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -58.45 -31.28 67.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.332 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.0 mm100 -63.77 -65.43 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.646 HG13 HD22 ' A' ' 180' ' ' LEU . 4.8 p -54.93 -36.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.3 m -65.81 -46.62 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.821 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.654 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.1 -37.73 86.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.163 0.506 . . . . 0.0 109.862 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 4.9 mt-10 -68.55 -25.92 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.557 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.458 HD12 ' NH2' ' A' ' 95' ' ' ARG . 1.8 mp -78.96 -38.31 37.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.549 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -84.9 -6.54 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.386 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mt-30 -47.06 -43.16 19.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.309 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.16 56.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.529 -1.32 . . . . 0.0 113.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.45 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 158.43 57.66 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.643 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 19.1 Cg_endo -78.77 42.18 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.127 1.885 . . . . 0.0 111.54 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.76 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 4.1 t-20 -66.48 161.31 23.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.508 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.5 m95 -55.44 -27.17 46.36 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.53 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HD3' ' HG2' ' A' ' 171' ' ' ARG . 2.3 tpt180 -86.61 -22.96 25.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.76 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -31.45 63.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 109.945 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.477 HG13 ' CB ' ' A' ' 53' ' ' PHE . 4.2 t -62.55 -50.3 80.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.307 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.44 -32.49 73.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.588 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 9.6 m-85 -55.01 -53.89 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.267 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 8.8 m-85 -78.55 -37.58 42.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.24 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.16 -37.67 74.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.349 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.1 -51.19 68.77 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.91 -39.19 33.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.055 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.26 -42.57 86.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.122 0.461 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.471 ' C ' HD23 ' A' ' 64' ' ' LEU . . . -71.91 -43.78 64.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.76 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.3 -48.18 77.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.614 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.616 ' HB3' HD22 ' A' ' 22' ' ' LEU . 54.7 m -61.08 -43.34 99.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.678 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.64 -36.92 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 111.114 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.641 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 3.5 tt0 -81.35 -25.08 36.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.538 ' HB2' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -79.03 -28.95 43.31 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.051 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 119' ' ' VAL . 59.7 t -70.4 -36.39 66.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.641 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.4 p30 -84.35 0.83 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -124.89 -170.78 2.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.226 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -89.52 55.35 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.37 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.46 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.32 36.87 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.066 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.9 mp0 -56.13 -53.79 59.73 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.21 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.43 -26.96 83.94 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.05 1.833 . . . . 0.0 112.614 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.732 HD23 ' H ' ' A' ' 73' ' ' GLY . 1.4 mp -70.64 -25.82 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.585 HG21 HG22 ' A' ' 111' ' ' VAL . 85.2 t -59.62 -52.74 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.041 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.67 87.87 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.728 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 6.5 mm100 -62.61 -53.97 46.66 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.566 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 92.7 t -56.46 -37.12 49.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.941 0.401 . . . . 0.0 110.166 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -61.84 -47.45 84.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.807 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.862 ' HA ' HG11 ' A' ' 127' ' ' VAL . 9.7 pt-20 -74.81 -35.63 62.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.035 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.685 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.4 m0 -57.55 -37.55 73.28 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 27.6 ttm -74.9 -53.35 9.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.601 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.862 HG11 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -61.93 -33.31 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.51 -48.41 55.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.207 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 24.4 t80 -57.81 -37.96 74.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.28 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.94 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.91 -53.34 13.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.086 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.33 -29.29 69.79 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 m -84.62 -37.15 21.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -126.08 -43.39 1.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.94 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.6 mm? -59.67 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.081 0.401 . . . . 0.0 111.678 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.47 -36.62 55.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 123.237 0.336 . . . . 0.0 111.199 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -63.13 -52.63 61.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.76 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 63.1 t90 -57.78 -48.27 80.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.247 0.546 . . . . 0.0 109.545 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.545 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.6 mt -57.77 -46.64 86.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.322 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -65.83 -31.12 71.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.695 0.283 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -85.29 -24.84 27.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -56.37 4.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.17 -10.05 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.43 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.69 167.18 40.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.958 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.43 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 97.6 m95 -60.9 -26.46 67.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.25 -32.53 73.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.756 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.442 ' HG3' HD11 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -65.4 -40.68 93.73 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.614 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 11.0 t80 -65.84 -36.58 83.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.405 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.685 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -64.32 -31.52 72.76 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.192 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.65 -19.01 31.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.357 0.599 . . . . 0.0 110.105 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 146' ' ' GLU . 9.1 mt -79.92 -40.65 27.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.146 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 151' ' ' TYR . 1.6 m-85 -125.53 28.95 6.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -118.86 -146.7 8.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.668 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -32.77 61.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.76 40.31 2.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.106 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.13 77.17 8.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.691 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -62.37 162.02 10.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.857 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.88 -31.3 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.691 ' HB2' HD11 ' A' ' 156' ' ' LEU . 17.9 mt-10 -72.15 -42.37 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -66.14 -39.59 89.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.54 -52.07 66.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -71.11 -21.73 62.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -75.27 -48.52 22.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.451 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -65.32 -43.61 90.46 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.66 -42.81 90.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.456 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.19 -28.93 72.29 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.473 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -66.53 -56.07 12.54 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.252 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.897 ' HA ' HG23 ' A' ' 170' ' ' VAL . 13.6 p-90 -63.04 -26.12 68.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.016 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.023 0.44 . . . . 0.0 110.325 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.6 m -87.13 -32.2 20.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 167' ' ' TRP . 19.0 m -88.66 -33.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.653 ' HG2' ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -73.85 -29.74 62.29 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.656 -0.653 . . . . 0.0 110.541 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.588 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 1.8 m -85.33 -33.87 21.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.673 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.903 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.7 p -65.89 -31.29 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.903 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -110.66 33.12 4.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.087 0.47 . . . . 0.0 110.395 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.588 ' OG1' ' HA ' ' A' ' 172' ' ' THR . 8.4 m -67.68 -32.82 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.124 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.83 50.31 3.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.085 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.595 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -118.01 13.24 13.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.818 HG11 HH21 ' A' ' 59' ' ' ARG . 2.1 t -83.34 61.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.573 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.93 56.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.391 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.646 HD22 HG13 ' A' ' 82' ' ' VAL . 3.3 mt . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--O 1.232 0.216 0 CA-C-O 121.081 0.367 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -170.89 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.917 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -37.15 68.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.819 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.05 -35.71 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.722 0.296 . . . . 0.0 110.563 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.2 -36.47 58.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.683 ' HB2' HD11 ' A' ' 42' ' ' LEU . 8.0 tp -70.3 -41.78 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.987 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 15' ' ' ALA . 3.9 p -66.27 -34.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' HG11 ' A' ' 14' ' ' VAL . . . -74.08 -20.84 60.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.453 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -64.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.625 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.9 t80 -56.21 -52.66 63.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.38 -37.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.227 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.22 -52.59 48.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.253 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.624 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 0.6 OUTLIER -62.29 -44.58 96.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 2.7 mmtt -62.36 -41.46 98.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.571 HD22 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -73.28 -43.86 60.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.688 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -57.56 -33.85 68.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.558 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 24' ' ' GLN . 1.1 pt20 -86.61 -8.61 57.34 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -121.19 -58.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.92 -48.24 0.5 Allowed Glycine 0 C--O 1.23 -0.149 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.854 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 2.4 t80 -81.44 49.44 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.21 0.528 . . . . 0.0 110.963 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.44 -27.55 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -42.6 72.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 58.98 3.8 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.029 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.688 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -62.1 115.64 4.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 179.55 -53.88 0.09 OUTLIER Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.356 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.55 -50.19 7.35 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.836 1.69 . . . . 0.0 111.19 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.06 30.29 5.18 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.438 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -65.69 -38.59 89.66 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.067 0.434 . . . . 0.0 110.981 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . -110.69 132.96 11.27 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.9 Cg_endo -89.31 -143.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.505 2.137 . . . . 0.0 113.785 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.934 ' HB2' ' HA ' ' A' ' 44' ' ' GLN . . . -67.42 106.92 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.022 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.59 -33.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 0.0 111.406 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.2 m-20 -79.2 163.49 59.47 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.373 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 29.6 Cg_endo -77.83 48.7 2.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.378 2.718 . . . . 0.0 111.549 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.998 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.55 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.3 m170 -62.29 -58.21 8.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.85 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.934 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.97 -28.18 66.07 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.349 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -69.08 -55.03 11.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.77 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.734 ' HE2' ' HZ3' ' A' ' 144' ' ' TRP . 2.7 tpp -67.4 -36.7 81.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.807 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD3' ' HB1' ' A' ' 38' ' ' ALA . 3.8 ttp180 -61.92 -37.57 85.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.891 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.6 23.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HB3' HG11 ' A' ' 97' ' ' VAL . . . -59.26 -53.74 54.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.414 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.84 -48.51 44.48 Favored Glycine 0 C--O 1.215 -1.08 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.25 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.13 -49.6 75.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.87 -44.08 97.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.606 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -73.06 -33.42 65.65 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.986 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.47 -26.65 68.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.0 109.267 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 m -88.61 -25.61 22.35 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.556 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -99.83 -55.25 2.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 111.952 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.57 73.43 10.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.92 0.488 . . . . 0.0 110.567 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 58' ' ' ARG . 3.1 mpt_? -73.82 -18.49 60.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.011 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -79.35 58.55 2.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.45 . . . . 0.0 111.259 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.07 -48.95 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 86.0 m-85 -64.17 -28.28 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.197 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -34.29 76.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -74.54 -18.47 60.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.964 0.411 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.937 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -73.01 -39.05 66.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.16 -48.02 25.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.28 -43.64 61.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.902 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.699 HE22 HD11 ' A' ' 106' ' ' LEU . 24.8 mt-30 -69.54 -58.12 4.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.702 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -82.02 16.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -78.17 -33.78 50.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 71' ' ' THR . 2.2 p -92.26 -67.9 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.342 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.695 ' H ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -163.43 154.95 14.68 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 73' ' ' GLY . 98.3 Cg_endo -89.36 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.935 2.423 . . . . 0.0 112.108 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 72' ' ' PRO . . . 81.25 -78.73 1.89 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.41 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.94 47.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.357 0.599 . . . . 0.0 112.209 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.29 -18.21 22.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.262 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.654 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.8 pt20 -61.86 -38.35 87.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.6 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.44 88.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.533 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB3' HD22 ' A' ' 180' ' ' LEU . 17.5 mtt180 -67.22 -45.8 75.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.0 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 8.3 t80 -60.17 -49.76 76.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 p -57.6 -34.56 69.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -60.55 -57.74 11.44 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 177' ' ' ALA . 31.3 t -58.65 -38.44 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.877 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -65.73 -46.08 80.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.566 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.48 -36.82 81.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.789 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 24.8 mt-10 -72.98 -23.57 60.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.395 . . . . 0.0 110.582 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.2 tp -81.74 -37.69 26.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.659 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.633 ' HD2' ' CD1' ' A' ' 87' ' ' PHE . 45.3 t80 -83.93 -8.23 59.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -42.01 14.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.095 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.19 48.38 0.13 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.723 -1.227 . . . . 0.0 113.13 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.408 ' N ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.12 53.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.442 -1.361 . . . . 0.0 114.747 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.2 Cg_endo -80.09 41.36 1.11 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.12 1.88 . . . . 0.0 111.441 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.774 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.34 163.95 23.97 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.618 -178.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.5 m95 -54.2 -29.05 44.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.61 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.22 -37.74 95.37 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.68 -24.89 23.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.703 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.783 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -54.96 -31.52 60.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' A' ' 53' ' ' PHE . 10.7 t -62.89 -52.95 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.472 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.18 72.27 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.331 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.783 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.2 m-85 -56.55 -54.6 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.037 0.446 . . . . 0.0 110.231 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.67 ' HE1' ' CE2' ' A' ' 100' ' ' PHE . 15.3 m-85 -74.94 -39.48 61.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.002 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.42 HG23 ' HE1' ' A' ' 17' ' ' PHE . 2.7 t -61.39 -36.76 75.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.254 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -53.18 -59.77 4.13 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.821 0.343 . . . . 0.0 111.562 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.57 -38.67 78.89 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.28 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.8 94.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.192 0.496 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.707 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -70.33 -41.24 73.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.42 -47.37 84.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.403 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.571 ' HB3' HD22 ' A' ' 22' ' ' LEU . 60.6 m -65.18 -45.39 85.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.206 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.464 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -55.1 -40.05 70.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.772 0.32 . . . . 0.0 111.601 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.59 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -85.05 -8.77 58.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.683 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -89.92 -29.03 18.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.791 0.329 . . . . 0.0 110.16 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.65 -32.42 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 14.5 p30 -85.32 0.96 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 0.0 111.151 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -125.72 -170.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.395 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.21 53.24 2.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.029 0.443 . . . . 0.0 110.633 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.425 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.16 46.44 2.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.408 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.737 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 15.5 mp0 -64.17 -56.19 25.8 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.424 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.1 Cg_exo -64.31 -26.52 63.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.051 1.834 . . . . 0.0 112.614 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 122' ' ' VAL . 12.4 tp -66.4 -29.11 69.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.3 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.24 -52.54 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.284 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.42 -32.27 83.59 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.296 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 19.1 mm100 -65.95 -52.33 50.71 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.531 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 48.6 t -58.28 -35.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.009 0.433 . . . . 0.0 109.91 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.19 -47.02 86.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.26 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.69 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.0 pt-20 -72.69 -39.63 66.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.934 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.654 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 38.9 m0 -55.75 -37.81 68.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.3 ttm -74.11 -53.67 9.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.638 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.6 p -62.81 -34.07 63.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.491 ' N ' HG11 ' A' ' 127' ' ' VAL . 6.3 mt-10 -69.62 -46.3 66.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.476 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.566 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 10.0 t80 -61.51 -35.1 76.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.582 0.706 . . . . 0.0 110.123 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.983 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.93 -56.6 5.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.132 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.84 -31.76 72.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.8 m -82.9 -36.86 24.96 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.86 -42.5 1.9 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.983 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -60.85 -46.31 91.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.371 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.21 54.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.444 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.08 -54.95 22.14 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.774 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.7 t90 -56.66 -48.3 77.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.523 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -57.36 -47.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.569 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.27 -30.11 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -89.09 -9.02 52.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.52 -57.07 2.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.0 111.609 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.97 -13.3 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.6 168.4 39.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.117 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.734 ' HZ3' ' HE2' ' A' ' 46' ' ' MET . 96.9 m95 -61.75 -29.47 70.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.43 80.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.14 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -47.49 81.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.612 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 15.7 t80 -63.27 -38.25 90.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.078 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.834 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 7.5 m -65.98 -27.24 68.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 111.282 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.73 -34.92 27.08 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -66.15 -39.95 90.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.615 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -116.47 20.39 14.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -107.13 -140.33 9.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.444 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.21 -34.67 23.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.16 42.23 2.98 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.022 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.23 68.19 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.985 0.422 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.942 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.89 173.23 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.272 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.84 -39.3 38.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.942 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.6 mm-40 -63.56 -52.3 61.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.78 88.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.517 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -59.65 -57.1 14.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -67.8 -29.24 68.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.684 0.278 . . . . 0.0 111.581 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 4.3 tp -69.02 -46.68 67.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.68 ' HB3' HD21 ' A' ' 150' ' ' LEU . 1.8 ptt180 -68.87 -37.2 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.357 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.56 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 3.9 mt-10 -70.67 -43.2 69.58 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.141 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.7 -14.17 72.37 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.3 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.612 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 15.4 t-20 -73.25 -65.46 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.017 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.6 ' HE3' ' HD3' ' A' ' 171' ' ' ARG . 48.0 p-90 -61.54 -24.7 66.81 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.576 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.35 -64.11 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.116 0.26 . . . . 0.0 110.734 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -21.46 25.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 2.1 t -81.01 -36.32 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.6 ' HD3' ' HE3' ' A' ' 167' ' ' TRP . 0.9 OUTLIER -82.87 -13.35 56.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.516 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.848 ' HA ' HG22 ' A' ' 175' ' ' THR . 1.1 p -88.49 -31.62 18.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.76 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.946 HG11 ' HG ' ' A' ' 174' ' ' LEU . 5.7 p -67.07 -24.51 32.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.476 0.655 . . . . 0.0 110.136 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.946 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.81 42.91 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.231 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.848 HG22 ' HA ' ' A' ' 172' ' ' THR . 0.6 OUTLIER -69.28 -43.23 74.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.912 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.62 27.19 1.89 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.565 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -89.69 2.07 55.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.225 0.513 . . . . 0.0 111.046 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . 0.429 ' H ' HG22 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -80.02 68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.925 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.03 9.65 32.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.785 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.552 HD21 HG21 ' A' ' 82' ' ' VAL . 12.4 mt . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.914 0.388 . . . . 0.0 110.509 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.53 0.321 0 CA-C-O 121.285 0.452 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.11 -164.48 1.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.617 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -37.93 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.204 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -62.1 -35.4 78.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.93 -36.13 49.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.0 109.886 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.653 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.4 tp -70.44 -43.28 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -65.87 -35.35 74.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 11' ' ' ARG . . . -72.23 -22.59 61.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.7 -64.24 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 4.8 t80 -54.95 -52.71 62.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.829 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 22' ' ' LEU . 46.5 t -72.29 -40.0 64.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.32 -54.3 37.39 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.847 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.748 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 48.9 t80 -62.8 -39.69 95.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 0.186 . . . . 0.0 111.271 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.46 -42.99 98.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.645 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -70.42 -44.79 67.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.618 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.807 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -62.47 -20.69 64.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.058 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.632 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.93 -35.38 26.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.47 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -151.08 76.25 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.96 0.409 . . . . 0.0 112.025 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.67 -70.43 0.3 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.123 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -90.26 56.43 3.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.389 0.614 . . . . 0.0 109.537 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.21 -34.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.757 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -41.65 72.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.386 0.612 . . . . 0.0 109.605 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.45 56.71 4.9 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.913 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.807 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.83 120.99 13.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.484 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 172.31 -58.36 0.16 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.173 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.4 Cg_exo -60.35 -48.45 11.6 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.785 1.657 . . . . 0.0 111.014 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.748 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.91 40.04 2.71 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.898 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 10.1 pt-20 -93.76 -8.09 41.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.77 164.49 12.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.724 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -99.31 -164.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.606 2.871 . . . . 0.0 113.191 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.657 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -89.01 73.11 8.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.931 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.11 34.01 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.099 0.476 . . . . 0.0 111.589 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.509 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 5.4 m-20 -130.11 161.1 62.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -70.76 28.77 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.912 3.075 . . . . 0.0 113.055 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -166.78 -23.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.0 m170 -55.52 -64.78 0.74 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -58.4 -23.9 58.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.536 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -74.37 -46.5 40.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.462 ' HE2' ' CD1' ' A' ' 100' ' ' PHE . 15.2 ttm -72.25 -39.78 68.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -60.81 -36.14 78.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.569 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -31.34 42.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 109.98 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.644 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -65.19 -56.7 11.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.552 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.62 -48.47 42.95 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.61 -46.45 80.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.479 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -46.23 91.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.935 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.61 -31.78 65.43 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.871 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.86 -24.9 67.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.651 0.738 . . . . 0.0 109.211 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -89.38 -36.54 15.43 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.913 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -84.44 -64.43 1.16 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.93 72.01 8.98 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.843 0.857 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -82.8 -0.03 45.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.04 23.82 4.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.245 -0.284 . . . . 0.0 111.361 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.53 -1.24 30.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HA ' HD21 ' A' ' 64' ' ' LEU . 10.4 m-85 -92.6 -19.77 21.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.63 80.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.755 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 3.2 m-20 -62.76 -22.86 66.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.102 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -68.69 -39.62 80.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -79.56 -44.72 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.141 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 180' ' ' LEU . . . -51.3 -42.66 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.386 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.637 HE22 HD12 ' A' ' 106' ' ' LEU . 27.2 mt-30 -73.16 -53.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -83.26 14.74 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 82.6 t60 -77.98 -32.64 51.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.266 0.555 . . . . 0.0 109.631 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.76 -73.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.195 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.35 153.74 16.91 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.512 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.647 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 6.6 Cg_endo -86.64 -167.27 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.199 2.599 . . . . 0.0 111.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.78 -63.41 4.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.998 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.99 24.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.088 0.471 . . . . 0.0 111.85 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -80.23 -23.32 40.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.622 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.593 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 1.8 pt20 -62.01 -43.42 98.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.618 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -62.15 -42.43 99.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HB3' HD23 ' A' ' 180' ' ' LEU . 6.9 mtt180 -63.23 -44.98 93.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.88 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 9.1 t80 -62.84 -50.78 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.496 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 p -56.1 -33.68 65.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.419 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.464 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.3 mm100 -60.27 -66.58 0.5 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 180' ' ' LEU . 12.0 m -56.52 -32.73 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.681 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.1 m -65.85 -43.82 87.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.353 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.565 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.8 -37.02 73.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 109.694 179.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -29.05 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.884 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.522 HD21 ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -80.84 -31.79 35.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.309 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 91' ' ' PRO . 37.3 t80 -93.27 1.89 56.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -24.99 36.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.256 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 60.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.344 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.421 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.25 59.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.607 -1.282 . . . . 0.0 114.648 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -82.78 39.06 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.275 1.983 . . . . 0.0 111.642 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.797 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 t-20 -66.86 164.36 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.606 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -54.49 -27.15 35.84 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.235 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.34 -38.62 95.2 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.633 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.7 mmp_? -87.53 -26.61 23.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.974 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.828 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.61 -31.57 57.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.421 0.629 . . . . 0.0 109.969 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.935 HG13 ' HB2' ' A' ' 53' ' ' PHE . 22.0 t -62.09 -55.87 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.82 -29.22 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.47 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' A' ' 99' ' ' PHE . 4.4 m-85 -55.79 -54.65 41.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.095 0.474 . . . . 0.0 110.191 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.5 m-85 -77.83 -35.54 51.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -60.73 -39.86 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.529 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.4 m-85 -55.11 -51.11 67.43 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.23 -38.77 38.53 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.138 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.33 99.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.131 0.465 . . . . 0.0 110.927 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' A' ' 64' ' ' LEU . . . -70.36 -37.91 74.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.637 HD12 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.29 -44.48 97.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.156 179.151 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.634 ' HB3' HD23 ' A' ' 22' ' ' LEU . 94.8 m -63.92 -45.79 87.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.284 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.413 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -52.06 -47.96 64.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.726 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -77.34 -12.25 59.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.806 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -88.53 -24.96 22.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.941 0.401 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 107' ' ' CYS . 57.4 t -75.64 -35.77 32.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.601 HD22 ' HA ' ' A' ' 109' ' ' GLU . 22.8 p30 -81.44 0.56 37.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.408 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.48 -167.51 1.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -91.27 62.66 4.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.471 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.647 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -141.66 37.75 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.946 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.627 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.3 mp0 -55.84 -55.86 36.47 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.307 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.7 Cg_exo -65.02 -18.55 62.37 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.082 1.855 . . . . 0.0 112.341 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' A' ' 72' ' ' PRO . 2.2 mm? -74.77 -35.22 62.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.91 -57.72 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.491 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.51 79.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.965 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.498 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 5.5 mm-40 -66.35 -49.78 65.75 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.587 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 59.8 t -57.35 -36.12 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.24 -45.61 92.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.786 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.4 pt-20 -76.2 -36.86 58.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.114 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.593 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 39.4 m0 -56.69 -38.62 72.51 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.6 ttm -72.85 -54.94 7.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.685 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.5 p -60.97 -32.49 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.435 ' N ' HG11 ' A' ' 127' ' ' VAL . 43.2 mt-10 -67.9 -50.41 56.38 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.306 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 13.3 t80 -58.74 -35.21 72.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.642 0.734 . . . . 0.0 110.284 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 1.027 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.93 -48.5 30.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.956 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.04 -42.22 84.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 m -80.78 -40.57 24.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -42.1 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 1.027 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -63.2 -46.71 85.77 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.418 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.85 55.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.613 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.66 -53.06 30.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.571 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.797 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 55.6 t90 -55.3 -47.51 75.46 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.263 0.554 . . . . 0.0 109.567 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 4.3 mt -57.85 -49.17 81.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.402 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -60.62 -39.69 89.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m -78.0 -26.89 48.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -56.04 5.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.28 -15.75 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.655 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 92.32 170.85 41.1 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.183 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.493 ' CZ2' HD12 ' A' ' 138' ' ' ILE . 98.2 m95 -61.82 -26.09 67.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.24 -33.91 77.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.449 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -66.74 -38.71 87.18 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.414 ' HZ ' ' CB ' ' A' ' 49' ' ' ALA . 6.5 t80 -65.79 -38.88 90.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.659 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.81 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -67.46 -27.69 67.24 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.8 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.96 -18.06 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.094 0.474 . . . . 0.0 110.349 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.5 HD11 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -75.78 -49.42 18.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.673 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.45 31.51 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -93.3 -113.85 2.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.359 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.43 -62.94 1.43 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.14 0.495 . . . . 0.0 109.691 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.462 ' O ' HD22 ' A' ' 156' ' ' LEU . . . -83.7 64.11 4.34 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.348 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.74 74.99 7.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -60.54 153.81 22.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.153 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.623 ' HA ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -57.99 -27.36 63.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.753 -179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.596 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 1.2 mm-40 -73.83 -32.43 63.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.422 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -78.33 -41.56 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.623 ' HG2' ' HA ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -66.61 -37.89 85.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.579 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.596 ' HD2' ' OE1' ' A' ' 158' ' ' GLU . 9.8 ptp85 -72.65 -29.11 63.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.088 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -38.3 81.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.716 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.644 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.3 ttp180 -65.89 -41.9 90.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.571 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -61.62 -48.25 81.76 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.346 0.404 . . . . 0.0 110.295 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.13 -28.52 73.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.408 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.06 -58.66 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.253 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.81 ' HA ' HG21 ' A' ' 170' ' ' VAL . 14.2 p-90 -62.08 -27.42 68.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.416 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.17 76.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.446 . . . . 0.0 110.344 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.21 -28.73 20.98 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 167' ' ' TRP . 8.1 m -95.3 -36.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.618 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -81.34 -15.71 54.54 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.46 -0.775 . . . . 0.0 111.138 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 m -96.08 -17.04 21.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.156 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 1.037 HG12 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -81.2 -26.5 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.529 0.68 . . . . 0.0 109.521 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 1.037 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -120.88 39.54 3.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.692 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -30.49 71.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.15 1.93 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.541 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -99.42 6.54 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.56 60.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.99 -11.14 60.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.277 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 121.049 0.354 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -163.32 0.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.652 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.53 -38.59 69.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.959 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.481 ' HA ' HG13 ' A' ' 14' ' ' VAL . 28.3 ttp180 -63.12 -35.47 80.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.294 . . . . 0.0 110.729 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.99 60.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.208 0.528 . . . . 0.0 109.756 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.582 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -71.91 -42.73 66.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.056 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.4 p -65.11 -36.0 76.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.131 0.491 . . . . 0.0 109.703 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.25 -21.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.375 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 -63.95 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.903 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.652 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.4 t80 -54.45 -54.04 46.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.51 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.75 -39.55 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.717 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -59.47 -54.71 35.5 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.246 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.673 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 34.5 t80 -61.86 -43.21 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.563 0.345 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 12.7 mmtt -61.13 -40.27 93.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -79.16 -46.65 17.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.078 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 39.6 ttp85 -63.75 -17.25 62.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.397 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -85.02 -24.05 28.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.971 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -160.1 76.14 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.81 -68.78 0.37 Allowed Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.271 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 2.0 t80 -84.85 52.08 2.32 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.008 0.523 . . . . 0.0 109.785 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.63 -40.05 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.59 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -40.42 96.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.409 0.623 . . . . 0.0 109.626 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.25 52.06 4.04 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.043 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.69 124.49 22.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.526 ' CA ' ' HG3' ' A' ' 35' ' ' GLU . . . 176.92 -54.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.603 -1.284 . . . . 0.0 113.637 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.717 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 13.0 Cg_exo -72.26 -49.88 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.406 2.071 . . . . 0.0 112.284 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -86.04 28.12 5.22 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.774 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HG3' ' CA ' ' A' ' 32' ' ' GLY . 3.1 mt-10 -88.04 -26.22 22.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.387 0.613 . . . . 0.0 110.241 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.3 147.86 23.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.301 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -94.79 -155.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.062 2.508 . . . . 0.0 112.833 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -88.82 85.94 6.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.524 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.29 21.93 5.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 110.333 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 1.5 m-20 -125.58 159.35 61.1 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.29 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.41 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 61.2 Cg_endo -81.32 47.2 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 111.576 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.582 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -177.94 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.515 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m170 -57.25 -62.11 2.0 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.735 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 44.4 tt0 -55.8 -30.84 62.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.588 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -70.56 -51.49 28.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.999 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.1 ttm -67.9 -41.83 82.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -61.77 -35.18 77.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.89 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.46 -41.31 27.84 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.614 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . . . -59.49 -54.25 48.74 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.491 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.72 -47.24 58.76 Favored Glycine 0 C--O 1.219 -0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.441 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.43 -46.83 87.63 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -45.2 93.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.743 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.433 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -72.57 -33.0 66.46 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.143 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.87 -26.7 68.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 109.706 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -87.43 -29.21 21.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.479 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -91.68 -46.34 7.97 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.69 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.16 86.68 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.19 0.596 . . . . 0.0 110.207 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -68.52 -23.45 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -86.06 65.97 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.72 -38.12 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.507 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.59 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 42.1 m-85 -91.15 -3.4 57.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 -47.47 55.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.313 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -59.84 -32.11 70.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.469 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.816 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 4.8 mp -56.84 -44.89 82.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.589 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -80.46 -42.2 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 69' ' ' HIS . . . -50.6 -41.82 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.643 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.8 mt-30 -79.31 -53.47 6.91 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.505 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -82.37 13.1 3.79 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.653 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.6 -25.87 41.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.458 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -71.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.04 151.66 16.52 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.387 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.79 -177.52 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.065 2.51 . . . . 0.0 111.599 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.27 -71.5 2.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.972 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 45.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.226 0.536 . . . . 0.0 112.026 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.17 -21.1 16.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -63.77 -40.25 96.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.795 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 18.2 mp0 -63.79 -44.4 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.176 0.297 . . . . 0.0 111.104 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.643 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 42.8 mtt180 -65.52 -38.21 89.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.04 0.448 . . . . 0.0 110.033 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 79' ' ' PHE . 5.0 t80 -66.17 -51.25 59.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.421 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -56.66 -35.39 68.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 38.4 mm-40 -59.88 -54.66 43.56 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.518 HG21 ' N ' ' A' ' 83' ' ' SER . 9.9 m -66.89 -32.15 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.097 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.518 ' N ' HG21 ' A' ' 82' ' ' VAL . 29.9 m -66.2 -46.8 76.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.755 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.571 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -67.2 -35.62 79.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 110.323 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.49 -27.03 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.259 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -80.39 -28.15 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.694 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -95.24 -6.4 41.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.07 -50.18 6.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.429 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.56 66.35 0.22 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.4 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.406 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 150.48 62.05 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.677 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.5 Cg_endo -81.74 41.66 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.49 2.127 . . . . 0.0 111.582 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.784 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.2 t-20 -66.71 164.3 17.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -53.88 -29.15 40.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -64.84 -36.05 92.64 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.704 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.3 mmp_? -87.23 -27.18 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.447 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.928 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -55.93 -30.55 61.83 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.941 179.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 53' ' ' PHE . 18.0 t -63.84 -55.04 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.525 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.22 -29.74 70.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.928 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 7.8 m-85 -57.01 -59.87 4.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.094 0.474 . . . . 0.0 110.354 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.551 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 8.1 m-85 -72.88 -37.91 67.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.348 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.16 -38.76 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.303 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -59.27 -46.17 89.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.379 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.97 -40.32 17.3 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.064 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.92 96.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 64' ' ' LEU . . . -68.06 -42.37 80.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.816 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -57.99 -45.45 86.77 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.645 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.619 ' HB3' HD23 ' A' ' 22' ' ' LEU . 88.6 m -59.55 -41.73 90.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.458 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -59.33 -36.74 76.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.968 0.413 . . . . 0.0 110.825 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.573 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -78.27 -24.25 46.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.767 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -24.62 41.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.953 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 107' ' ' CYS . 50.6 t -72.07 -37.57 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.976 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.7 p30 -85.78 -0.06 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.335 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -123.66 -173.53 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.903 0.382 . . . . 0.0 110.935 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.8 53.31 2.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.81 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.505 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.23 48.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.484 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.509 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -60.24 -54.99 49.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.52 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 16.9 Cg_exo -68.71 -12.81 35.6 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.147 1.898 . . . . 0.0 112.96 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 115' ' ' MET . 1.5 mp -78.77 -27.97 44.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.183 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.56 -57.44 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 111.365 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.21 -29.65 71.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.265 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.4 mm-40 -67.68 -52.67 35.13 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 118' ' ' LEU . 63.8 t -56.34 -34.57 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -62.62 -47.89 81.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.342 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HA ' HG11 ' A' ' 127' ' ' VAL . 21.3 pt-20 -74.48 -37.49 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.84 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.681 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.5 m0 -54.68 -36.75 64.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.551 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 1.6 mtm -73.95 -57.57 3.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.518 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 128' ' ' GLU . 1.5 p -60.36 -32.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.488 ' N ' HG13 ' A' ' 127' ' ' VAL . 4.4 mm-40 -71.25 -47.35 57.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.038 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.571 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.7 t80 -59.72 -37.21 78.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.708 0.765 . . . . 0.0 110.161 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.982 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.89 -52.74 15.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.85 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -58.73 -35.2 72.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.789 0.328 . . . . 0.0 111.784 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.5 m -79.54 -43.25 23.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -123.64 -38.13 2.56 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.982 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -64.04 -49.1 73.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.358 0.526 . . . . 0.0 111.571 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.28 -33.32 52.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.111 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.31 -56.26 17.95 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.784 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.6 t90 -56.59 -46.59 80.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.126 0.488 . . . . 0.0 109.863 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.552 HG13 ' HE3' ' A' ' 137' ' ' TRP . 15.1 mt -58.88 -47.02 90.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.251 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -68.06 -31.66 71.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.64 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.2 m -90.14 -4.83 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.68 -51.67 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.62 -10.66 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.475 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.84 166.55 42.66 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.101 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -60.93 -27.79 68.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.18 86.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.814 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HG3' HD11 ' A' ' 150' ' ' LEU . 1.2 tt0 -62.76 -41.83 99.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.58 -34.68 78.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.517 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.588 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -67.04 -28.15 67.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.53 -27.41 25.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.376 0.608 . . . . 0.0 109.811 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.525 HD11 ' HG3' ' A' ' 146' ' ' GLU . 2.2 mt -74.24 -38.68 63.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.353 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.559 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 6.2 m-85 -122.29 26.67 8.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -117.9 -141.3 6.75 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.914 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -41.79 36.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.299 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.49 41.55 2.94 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.479 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.24 72.85 10.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 110.268 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -66.83 170.09 7.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.006 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . 0.7 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 5.6 mm-40 -52.97 -37.93 61.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.746 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.772 ' HB2' HD12 ' A' ' 156' ' ' LEU . 3.9 mp0 -63.64 -47.63 80.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.437 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -65.34 -37.05 85.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.7 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 77.5 mtt180 -58.18 -58.53 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 3.6 ptt180 -67.4 -28.77 68.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -67.22 -49.77 63.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.489 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -64.79 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.142 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.56 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 5.5 mt-10 -69.08 -47.01 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.632 0.253 . . . . 0.0 110.442 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.84 -24.51 72.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.169 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.04 -60.86 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.977 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.812 ' HA ' HG21 ' A' ' 170' ' ' VAL . 14.3 p-90 -61.72 -26.32 67.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.742 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.94 93.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.241 0.543 . . . . 0.0 110.228 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 m -86.87 -24.44 24.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.834 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 167' ' ' TRP . 5.3 m -97.07 -38.93 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -73.83 -26.18 60.46 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.625 -0.672 . . . . 0.0 111.396 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.672 ' HA ' HG21 ' A' ' 175' ' ' THR . 1.5 m -86.28 -25.71 25.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.43 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.875 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -73.7 -22.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.367 0.604 . . . . 0.0 109.763 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.875 ' HG ' HG11 ' A' ' 173' ' ' VAL . 2.9 mt -120.33 40.42 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.178 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.672 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -62.77 -22.27 66.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.806 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.36 9.46 61.33 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.714 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.59 28.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.875 0.338 . . . . 0.0 111.744 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.11 69.8 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.1 -9.41 59.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.055 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.49 ' HG ' ' HG3' ' A' ' 67' ' ' GLN . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 121.0 0.429 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.462 -0.36 0 CA-C-O 121.123 0.384 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.33 -173.95 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.57 -33.83 66.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -66.36 -33.37 75.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.393 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.83 -47.47 18.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 42' ' ' LEU . 1.2 tp -59.4 -41.26 89.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.682 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -65.64 -42.55 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.284 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 14' ' ' VAL . . . -69.07 -29.73 67.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.987 0.422 . . . . 0.0 110.379 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.38 -57.28 4.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.101 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.63 -52.32 65.91 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.443 ' O ' HD13 ' A' ' 22' ' ' LEU . 60.6 t -63.49 -42.68 97.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.2 -46.12 94.81 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.013 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.769 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 63.5 t80 -64.38 -42.43 96.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.979 0.419 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.27 -41.34 94.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.542 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.1 mp -71.7 -43.49 65.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.773 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.677 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -62.99 -20.04 64.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.113 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -78.93 -42.42 27.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.927 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -153.95 79.93 1.13 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.964 0.411 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.25 -65.79 0.32 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.88 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.604 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.35 60.3 1.16 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.296 0.57 . . . . 0.0 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 29' ' ' CYS . 1.9 p -79.6 -24.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.633 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.87 -40.97 60.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.608 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 59.83 4.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.357 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.677 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -69.96 116.01 9.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.474 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.509 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 173.71 -57.7 0.14 Allowed Glycine 0 C--O 1.226 -0.405 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.501 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.658 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 52.0 Cg_exo -57.46 -46.04 30.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.337 2.024 . . . . 0.0 111.698 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.769 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.79 31.13 7.52 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.574 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -80.97 -23.75 38.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 109.879 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.44 135.67 13.01 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.534 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 86.3 Cg_endo -89.31 -138.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.965 2.443 . . . . 0.0 113.121 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 44' ' ' GLN . . . -96.75 94.33 7.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.0 21.67 2.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.943 0.402 . . . . 0.0 110.846 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 6.2 m-20 -132.83 159.73 71.42 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.761 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 57.4 Cg_endo -79.96 51.87 4.07 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 111.685 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.16 -33.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.058 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -58.95 -59.82 4.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.907 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 29.9 tt0 -58.21 -29.1 65.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.693 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.83 -51.44 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.308 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 13' ' ' LEU . 4.0 ttm -64.98 -36.58 84.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.524 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -38.26 87.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.688 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.9 31.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.76 0.314 . . . . 0.0 110.322 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 97' ' ' VAL . . . -59.05 -57.39 13.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.369 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.64 -47.21 37.82 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.598 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.05 -48.94 79.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.016 0.408 . . . . 0.0 111.22 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -43.25 92.97 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.187 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.834 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.46 -38.6 68.2 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.624 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.88 -22.59 62.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.739 0.781 . . . . 0.0 109.725 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -94.91 -37.23 11.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.672 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -84.96 -26.36 27.21 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -86.83 98.78 11.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.161 0.505 . . . . 0.0 110.717 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -64.18 -34.09 77.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.662 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 93.61 4.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.125 0.488 . . . . 0.0 110.289 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' THR . . . . . 0.405 HG21 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.1 -59.16 1.81 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.477 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.648 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 23.7 m-85 -87.79 -10.51 50.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -41.4 88.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.948 0.404 . . . . 0.0 111.518 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.9 m-20 -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.076 0.465 . . . . 0.0 110.663 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.99 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -75.99 -40.04 54.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -73.7 -45.54 51.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.747 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.84 63.5 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.711 HE22 HD13 ' A' ' 106' ' ' LEU . 27.6 mt-30 -68.79 -56.43 8.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -88.25 16.66 5.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.572 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.63 -24.82 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.025 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.68 -64.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.578 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -170.02 150.88 3.82 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 1.9 Cg_endo -81.83 -165.19 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.03 2.487 . . . . 0.0 112.083 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 84.24 -70.73 3.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.018 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.92 39.81 0.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.059 0.457 . . . . 0.0 112.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -94.59 -23.24 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.087 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.671 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.3 pt20 -62.81 -39.2 93.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -63.07 -44.63 95.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.747 0.308 . . . . 0.0 110.304 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -63.34 -43.39 97.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.984 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.2 t80 -62.77 -50.94 69.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.362 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.77 -33.1 66.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -62.1 -64.23 1.0 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.489 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.481 HG12 ' CD2' ' A' ' 180' ' ' LEU . 13.6 m -58.61 -32.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -66.02 -43.15 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.31 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.57 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -69.45 -36.36 76.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.244 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 3.2 mm-40 -70.33 -29.68 66.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.067 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.606 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -76.47 -34.99 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.623 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 47.7 t80 -88.42 -5.51 58.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.655 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -45.62 -46.61 14.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.118 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.23 62.64 0.12 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.758 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.522 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 163.46 53.6 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.6 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 39.37 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.183 1.922 . . . . 0.0 111.555 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.687 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.4 t-20 -67.04 162.9 21.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.401 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 23.1 m95 -55.98 -27.48 52.96 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.299 0.375 . . . . 0.0 111.177 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.31 92.41 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.606 ' HG3' HD23 ' A' ' 86' ' ' LEU . 1.3 tpt180 -86.29 -26.63 24.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.291 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.781 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -30.17 61.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.309 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 53' ' ' PHE . 7.4 t -62.89 -52.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.38 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.64 69.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.398 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 9.1 m-85 -57.75 -57.01 14.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.215 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.815 ' HE1' HD22 ' A' ' 130' ' ' LEU . 10.9 m-85 -74.97 -39.9 61.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.941 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.9 -38.85 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.441 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.565 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -57.15 -51.1 70.65 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.639 0.257 . . . . 0.0 111.211 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.21 -38.15 40.41 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.266 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.11 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.174 0.487 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.825 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -68.57 -38.91 81.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.763 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.09 -43.31 91.81 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.128 179.016 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.587 ' HB3' HD21 ' A' ' 22' ' ' LEU . 90.0 m -65.51 -42.92 91.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.74 77.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HA ' HD22 ' A' ' 112' ' ' ASN . 0.3 OUTLIER -80.7 -9.54 59.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.81 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.2 m -91.16 -23.28 20.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.926 0.393 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.426 HG22 HG23 ' A' ' 119' ' ' VAL . 71.9 t -74.44 -34.35 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.641 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.478 HD22 ' HA ' ' A' ' 109' ' ' GLU . 24.1 p30 -85.3 0.81 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.302 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.85 -174.81 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -82.99 62.31 6.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 0.0 110.522 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.593 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -135.29 45.55 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.479 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.658 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.6 mt-10 -52.12 -59.38 8.51 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.609 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.658 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 7.4 Cg_exo -74.26 -22.09 16.95 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.134 1.889 . . . . 0.0 112.627 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.535 ' O ' HG22 ' A' ' 122' ' ' VAL . 3.0 mm? -64.57 -37.47 87.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.302 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.426 HG23 HG22 ' A' ' 111' ' ' VAL . 90.4 t -57.22 -54.55 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.56 -32.37 83.98 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.95 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.574 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.6 mt-30 -65.59 -52.22 53.74 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.554 HG23 ' CZ3' ' A' ' 125' ' ' TRP . 82.8 t -56.16 -35.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.29 -47.34 82.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.365 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.793 ' HA ' HG11 ' A' ' 127' ' ' VAL . 18.2 pt-20 -72.58 -38.19 67.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.671 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.9 m0 -58.1 -40.58 81.52 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 6.2 ttm -73.22 -51.28 18.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.793 HG11 ' HA ' ' A' ' 124' ' ' GLU . 3.9 p -63.23 -34.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 127' ' ' VAL . 33.7 mt-10 -73.35 -39.5 65.14 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.677 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.646 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 12.6 t80 -66.6 -34.53 78.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.647 0.736 . . . . 0.0 110.129 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.46 -53.0 8.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.828 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -31.6 71.55 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.6 m -85.46 -37.92 19.2 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -119.75 -43.66 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -61.49 -46.57 89.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.377 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.09 62.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.47 -50.3 70.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.687 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 51.9 t90 -59.28 -46.82 87.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.493 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.6 mt -57.34 -48.44 82.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.995 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -65.04 -32.06 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.2 m -82.43 -17.48 45.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.0 t -85.45 -54.74 4.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.845 0.355 . . . . 0.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -177.37 -19.31 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.41 170.93 29.35 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.468 ' HZ3' ' HE1' ' A' ' 46' ' ' MET . 96.1 m95 -59.41 -30.23 68.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.526 ' HA ' ' HG1' ' A' ' 148' ' ' THR . . . -62.08 -37.31 84.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -41.55 98.57 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.488 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.5 t80 -64.88 -38.23 90.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.485 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -63.1 -28.12 69.86 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.19 -26.75 26.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.668 . . . . 0.0 109.71 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -75.46 -39.88 58.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.45 28.11 7.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.972 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -119.2 -141.44 6.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.239 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.52 -40.0 44.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.862 0.363 . . . . 0.0 111.42 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.92 46.13 3.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.157 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.57 72.32 10.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 110.631 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -65.28 168.54 6.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.84 -34.77 63.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' A' ' 156' ' ' LEU . 1.1 mm-40 -73.17 -32.72 65.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 111.187 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 150' ' ' LEU . . . -74.6 -42.83 57.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.911 0.386 . . . . 0.0 111.386 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -66.68 -39.54 88.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.219 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -72.01 -28.53 63.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.896 0.379 . . . . 0.0 110.581 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.68 -47.07 33.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.683 ' HB3' HD23 ' A' ' 150' ' ' LEU . 1.1 ptt180 -64.27 -37.57 87.96 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.7 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 2.4 tt0 -68.24 -45.81 72.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.93 0.395 . . . . 0.0 110.109 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.91 -25.82 75.05 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.552 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.1 -58.86 4.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.656 0.265 . . . . 0.0 111.102 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.854 ' HA ' HG21 ' A' ' 170' ' ' VAL . 17.3 p-90 -61.71 -27.52 68.76 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.067 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -43.9 74.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.84 -33.61 19.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.854 HG21 ' HA ' ' A' ' 167' ' ' TRP . 17.0 m -85.05 -26.14 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -79.07 -30.46 43.97 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.759 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -89.21 -27.98 20.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.448 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.948 HG12 ' HG ' ' A' ' 174' ' ' LEU . 4.2 p -66.34 -27.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.161 0.505 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.948 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.24 44.35 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.0 110.242 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.759 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.42 -29.05 69.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.901 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.97 9.93 43.18 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.397 0.519 . . . . 0.0 114.397 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.33 11.12 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.134 0.467 . . . . 0.0 111.719 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.94 70.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.242 0.544 . . . . 0.0 110.372 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -104.19 13.55 32.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.087 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.481 ' CD2' HG12 ' A' ' 82' ' ' VAL . 18.4 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.154 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.462 -0.324 0 CA-C-O 121.131 0.388 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.48 -168.35 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -38.27 60.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -62.35 -38.85 91.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.09 62.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.0 109.977 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.567 HD23 ' HE2' ' A' ' 46' ' ' MET . 1.5 tp -72.32 -42.07 65.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.138 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.687 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 7.9 p -65.87 -36.0 76.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -23.66 60.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -65.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.02 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.619 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 4.1 t80 -53.41 -51.57 62.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.933 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 22' ' ' LEU . 97.4 t -69.5 -43.67 80.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.42 -50.86 62.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.23 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 20' ' ' TYR . 4.6 t80 -58.23 -49.66 76.3 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.976 0.51 . . . . 0.0 111.33 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 1.2 tmtm? -62.41 -35.98 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.546 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 107' ' ' CYS . 8.0 mp -76.33 -48.36 20.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 3.2 ttp180 -63.92 -18.4 64.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -84.63 -14.25 49.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -146.26 -52.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.97 -68.77 1.22 Allowed Glycine 0 C--O 1.229 -0.167 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.741 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.1 t80 -82.61 53.15 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.529 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.94 -30.54 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -42.51 77.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.35 59.24 4.86 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.834 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.21 117.9 7.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.632 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.418 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 175.57 -49.38 0.12 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.725 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 21.1 Cg_exo -67.15 -50.0 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 121.894 1.729 . . . . 0.0 111.548 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.14 34.0 4.8 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.84 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 14.6 pt-20 -88.76 -13.48 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.44 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.98 144.27 17.54 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.847 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -92.87 -175.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.832 2.355 . . . . 0.0 113.137 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -82.49 80.95 8.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.065 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.39 -11.55 7.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.41 . . . . 0.0 111.949 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.1 m-20 -86.45 160.35 51.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 30.2 Cg_endo -77.96 50.12 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.263 2.642 . . . . 0.0 111.423 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.53 -31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.783 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.664 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -58.67 -61.28 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.94 -25.01 63.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.917 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -74.99 -50.23 17.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.61 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.567 ' HE2' HD23 ' A' ' 13' ' ' LEU . 6.3 ttm -67.15 -41.93 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -33.23 73.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.059 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.63 -40.05 26.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.284 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 97' ' ' VAL . . . -59.81 -54.93 40.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . 0.417 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.46 -46.21 45.62 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.112 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.44 -56.16 24.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.122 0.486 . . . . 0.0 111.423 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -44.4 90.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -72.45 -34.84 68.06 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.611 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.41 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 6.4 tt0 -62.9 -28.06 69.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.755 0.788 . . . . 0.0 109.556 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 m -83.47 -31.12 26.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.455 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -92.3 -45.23 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 87.38 7.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.149 0.579 . . . . 0.0 111.077 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -81.19 -15.47 55.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -90.38 61.47 5.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.116 0.484 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.55 -55.82 1.91 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.277 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.899 ' HA ' HD22 ' A' ' 64' ' ' LEU . 58.5 m-85 -66.16 -18.89 65.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.403 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -44.12 86.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.683 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -68.09 -26.89 66.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.899 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.96 -45.29 28.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.337 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.94 -43.08 63.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.654 HE22 HD11 ' A' ' 106' ' ' LEU . 23.8 mt-30 -69.75 -54.36 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.474 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.44 18.99 3.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.537 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 2.1 t-160 -78.46 -38.66 40.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 71' ' ' THR . 2.9 p -92.01 -63.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.155 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.545 ' H ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.6 149.19 10.66 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 122.371 -0.206 . . . . 0.0 110.742 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HB2' HD12 ' A' ' 118' ' ' LEU . 86.5 Cg_endo -85.32 -163.19 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.896 2.397 . . . . 0.0 112.203 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.52 -72.77 2.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.45 47.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.719 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -94.66 -21.98 18.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.1 pt20 -62.11 -38.03 87.38 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.878 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.91 -39.06 90.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.701 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -68.5 -43.78 76.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -63.39 -50.2 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.756 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -57.69 -34.12 69.09 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -63.93 -61.09 2.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.746 HG13 ' HG ' ' A' ' 180' ' ' LEU . 16.2 m -58.57 -31.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 82' ' ' VAL . 49.0 m -66.8 -43.95 82.52 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.463 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -68.93 -31.48 70.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 109.738 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 74.5 mt-10 -73.09 -31.24 64.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.35 -36.26 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.611 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.667 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 64.8 t80 -86.67 -8.02 57.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.608 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -42.54 -48.77 5.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.622 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.39 58.25 0.2 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.225 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.433 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 161.43 57.14 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.705 -1.235 . . . . 0.0 114.726 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.1 Cg_endo -79.43 44.94 1.81 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.085 1.856 . . . . 0.0 111.4 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.819 ' HB2' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -69.29 164.98 21.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.673 -178.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.0 m95 -56.22 -29.64 61.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.35 -37.3 94.31 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.566 ' HG3' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -86.13 -26.53 25.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.63 179.058 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.688 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.37 -30.7 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.435 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 53' ' ' PHE . 6.2 t -64.17 -54.57 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.504 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.24 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.237 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.688 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -57.54 -56.87 16.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.98 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.647 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 7.4 m-85 -75.85 -36.96 59.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.34 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.75 -36.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.64 ' HD2' ' CD1' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -56.75 -53.97 51.7 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 111.363 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.11 -36.89 44.56 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.362 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.93 99.73 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.254 0.527 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -70.36 -40.91 73.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.793 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.71 -51.19 69.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.062 179.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.702 ' HB3' HD22 ' A' ' 22' ' ' LEU . 93.7 m -57.02 -47.06 81.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.619 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.491 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -54.24 -37.74 64.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.612 ' HA ' HD22 ' A' ' 112' ' ' ASN . 1.9 mt-10 -83.98 -25.37 30.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -79.07 -24.01 43.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.919 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 119' ' ' VAL . 89.5 t -71.16 -35.19 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.966 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.612 HD22 ' HA ' ' A' ' 109' ' ' GLU . 15.6 p30 -84.41 1.09 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.401 . . . . 0.0 110.765 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -119.67 -168.29 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.668 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.86 58.43 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.086 0.47 . . . . 0.0 110.562 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.417 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.91 47.01 2.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.392 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.598 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 6.9 mt-10 -57.33 -55.62 42.46 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.7 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.8 Cg_exo -63.17 -31.6 74.85 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.958 1.772 . . . . 0.0 112.584 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 72' ' ' PRO . 1.6 mp -60.16 -34.33 73.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.79 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 111' ' ' VAL . 92.6 t -57.2 -52.27 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 111.368 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.04 85.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.208 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.66 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.2 mm100 -67.0 -47.0 72.81 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.501 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 91.9 t -59.82 -35.55 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.27 -46.35 89.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.412 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 19.3 pt-20 -71.5 -40.47 70.16 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.824 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.4 m0 -57.3 -40.42 77.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.419 0.628 . . . . 0.0 109.371 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 ttp -71.07 -53.62 14.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.641 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 5.6 p -62.46 -38.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.469 ' N ' HG11 ' A' ' 127' ' ' VAL . 1.2 mm-40 -63.54 -46.49 85.72 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 14.6 t80 -62.47 -33.42 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.479 0.657 . . . . 0.0 110.597 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.96 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.93 -58.76 3.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.174 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 6.2 pt-20 -64.95 -20.75 66.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -89.32 -32.05 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 -42.91 0.99 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.96 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.77 -47.38 85.93 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.268 -178.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . 0.402 ' O ' ' HD2' ' A' ' 139' ' ' HIS . . . -51.93 -39.97 60.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.544 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.01 -47.12 87.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.744 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.775 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 56.5 t90 -60.47 -50.18 74.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.624 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.8 mt -57.11 -47.47 83.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.266 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 135' ' ' ALA . 43.3 m-70 -62.97 -34.25 77.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -90.9 -9.85 44.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -91.35 -45.09 8.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.62 -15.09 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.55 165.78 39.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.397 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.522 ' CZ2' HD11 ' A' ' 138' ' ' ILE . 95.4 m95 -60.53 -29.62 69.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.93 82.42 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.005 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.02 -41.85 98.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.639 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 17.9 t80 -67.93 -33.41 74.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.627 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.917 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -66.6 -26.54 67.15 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.055 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.89 -36.89 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -63.56 -41.15 98.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.004 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 2.4 m-85 -122.83 26.77 8.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.83 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -127.46 -138.55 4.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.493 -1.336 . . . . 0.0 114.043 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -62.46 1.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -0.721 . . . . 0.0 112.347 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.481 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -79.42 54.0 4.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.341 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.34 69.12 10.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.782 HD13 ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.22 167.01 13.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.297 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -51.6 -35.83 43.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.371 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.782 ' HB2' HD13 ' A' ' 156' ' ' LEU . 4.2 mm-40 -65.48 -48.07 73.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.926 0.393 . . . . 0.0 110.308 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 150' ' ' LEU . . . -62.8 -34.54 77.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.731 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -59.55 -57.2 14.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -70.4 -27.66 64.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 35.3 tp -66.69 -47.29 72.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.287 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.695 ' HB3' HD23 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -69.88 -33.15 71.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.297 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.402 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.29 -43.7 66.62 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.103 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.11 -26.37 74.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.722 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.518 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 7.2 t-20 -59.9 -61.03 2.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.265 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.402 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 32.4 p-90 -69.48 -22.82 63.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.84 -58.72 5.26 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.994 0.184 . . . . 0.0 110.745 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.6 m -88.93 -24.04 22.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -81.62 -28.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.406 ' HA ' HH11 ' A' ' 95' ' ' ARG . 1.3 ttt180 -82.16 -22.34 36.13 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.847 -0.533 . . . . 0.0 109.614 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -83.61 -43.01 16.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.85 HG13 ' HG ' ' A' ' 174' ' ' LEU . 14.4 p -57.89 -37.0 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.12 0.486 . . . . 0.0 110.861 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.85 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -110.61 36.26 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.208 0.527 . . . . 0.0 110.16 178.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.9 t -77.66 -9.71 59.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 7.27 80.55 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.732 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.431 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -79.97 25.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.26 51.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.913 0.387 . . . . 0.0 110.514 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.81 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.746 ' HG ' HG13 ' A' ' 82' ' ' VAL . 15.8 mt . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 120.816 0.341 . . . . 0.0 110.29 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 C--O 1.233 0.261 0 CA-C-O 120.806 0.252 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.31 -176.58 5.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -32.19 67.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -68.23 -32.66 73.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.396 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.26 -43.59 32.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.01 -43.55 98.59 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.339 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 127' ' ' VAL . 4.4 p -66.14 -37.65 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.512 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.9 70.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 110.422 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -70.28 -52.55 22.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.045 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 17' ' ' PHE . 4.7 t80 -58.1 -52.99 63.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.65 HG13 HD13 ' A' ' 22' ' ' LEU . 72.1 t -64.15 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.75 -51.81 56.8 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.745 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.733 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.9 t80 -61.98 -38.84 90.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.638 0.375 . . . . 0.0 110.926 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 7.4 mmtt -66.35 -43.56 85.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -75.94 -46.35 30.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.584 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -62.22 -21.19 64.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -85.74 -24.03 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.326 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.36 75.34 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 111.456 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.34 -74.62 0.26 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.645 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 2.0 t80 -85.74 58.14 4.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.957 0.408 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.39 -33.87 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.182 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.72 -14.15 61.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.182 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -109.8 40.27 2.61 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -60.27 130.48 46.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.93 -48.43 0.19 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.819 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 3.2 Cg_exo -84.11 -48.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -78.38 22.57 3.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.989 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -79.84 -26.75 40.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.72 0.76 . . . . 0.0 109.46 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.43 132.44 11.14 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.356 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -89.05 -148.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.985 2.457 . . . . 0.0 113.275 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.614 ' CB ' ' HA ' ' A' ' 44' ' ' GLN . . . -86.33 97.79 10.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.7 -34.78 1.01 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.466 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.7 m-20 -78.97 160.43 71.4 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.686 0.279 . . . . 0.0 111.617 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 25.6 Cg_endo -74.43 51.75 2.65 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.525 2.816 . . . . 0.0 112.44 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 144' ' ' TRP . 0.2 OUTLIER 179.59 -34.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.881 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -59.64 -58.0 10.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.089 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -59.72 -28.0 66.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.693 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -69.88 -49.66 50.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.419 ' HE2' ' CZ3' ' A' ' 144' ' ' TRP . 0.5 OUTLIER -63.55 -31.02 72.06 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.976 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -62.6 -42.37 99.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.413 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.3 -23.62 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.84 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.32 -64.88 0.81 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.301 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.31 -46.18 35.51 Favored Glycine 0 C--O 1.216 -1.013 0 O-C-N 124.107 0.879 . . . . 0.0 112.397 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -51.64 -51.87 52.28 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.382 0.61 . . . . 0.0 111.425 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.45 -45.69 93.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.047 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.8 OUTLIER -75.53 -33.74 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.922 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 4.2 tt0 -63.46 -26.85 68.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.2 m -88.58 -41.84 12.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.485 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -87.27 -64.43 1.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 112.205 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.614 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 5.2 t80 -80.41 61.26 4.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.121 0.486 . . . . 0.0 111.338 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -85.24 0.38 52.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -89.11 18.21 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -104.38 -0.07 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.614 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 80.3 m-85 -84.89 -23.25 29.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.112 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -35.61 81.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.979 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 1.4 m-20 -62.0 -33.49 74.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.299 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.695 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -58.84 -41.76 87.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.529 0.681 . . . . 0.0 109.325 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -80.39 -40.56 26.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.579 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.13 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.522 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.736 HE22 HD13 ' A' ' 106' ' ' LEU . 35.2 mt-30 -76.52 -49.16 17.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.28 6.35 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -176.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.1 t60 -82.64 -31.99 28.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.872 0.368 . . . . 0.0 110.66 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.486 HG23 HG22 ' A' ' 71' ' ' THR . 2.3 p -91.76 -54.77 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.486 HG22 HG23 ' A' ' 70' ' ' VAL . 5.0 t -171.97 144.51 1.5 Allowed Pre-proline 0 C--O 1.237 0.437 0 CA-C-O 120.91 0.386 . . . . 0.0 111.007 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 3.6 Cg_endo -84.36 -171.81 1.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.258 2.639 . . . . 0.0 111.258 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.404 ' H ' HD11 ' A' ' 118' ' ' LEU . . . 82.27 -67.4 3.7 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.74 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 48.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.385 0.612 . . . . 0.0 111.674 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.7 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . . . -104.39 -17.16 14.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.663 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.27 -35.69 81.66 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.251 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -67.58 -39.63 84.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.891 0.377 . . . . 0.0 110.428 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . 0.7 ' HD2' ' HA ' ' A' ' 75' ' ' ALA . 23.1 mtt180 -68.59 -45.87 70.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.646 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 6.8 t80 -61.34 -47.84 84.06 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.906 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -58.28 -33.75 69.77 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.09 -64.07 1.08 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.721 HG11 HD11 ' A' ' 180' ' ' LEU . 9.1 p -57.87 -34.58 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -68.21 -45.63 72.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -71.36 -38.02 71.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.851 0.358 . . . . 0.0 110.519 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 177' ' ' ALA . 0.2 OUTLIER -70.19 -19.38 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.269 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -85.28 -39.47 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.833 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HB2' ' HE2' ' A' ' 129' ' ' TYR . 32.9 t80 -79.24 -7.67 58.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.243 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -48.59 -35.97 14.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.431 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.51 62.46 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.834 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.562 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 164.05 51.35 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.541 -1.314 . . . . 0.0 115.04 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.3 Cg_endo -81.37 37.01 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 119.762 1.781 . . . . 0.0 111.542 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.795 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.2 t-20 -68.04 164.87 19.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.903 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.588 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 26.0 m95 -53.97 -28.2 36.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.458 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -41.14 97.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.117 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.447 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -86.09 -23.67 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.654 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.871 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -56.21 -31.59 63.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.479 0.657 . . . . 0.0 109.852 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 53' ' ' PHE . 38.7 t -61.26 -54.15 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.391 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.33 69.45 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.351 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.668 ' HE1' ' CE2' ' A' ' 99' ' ' PHE . 5.7 m-85 -56.17 -57.27 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 110.509 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.61 ' HD1' ' CD2' ' A' ' 100' ' ' PHE . 40.9 m-85 -74.56 -38.74 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.4 -40.16 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.793 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 1.616 ' HE2' ' CE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -54.79 -52.68 61.88 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . 0.655 ' HA3' ' HE3' ' A' ' 126' ' ' MET . . . -74.21 -38.11 47.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.078 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.11 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.12 0.46 . . . . 0.0 110.756 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.12 85.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.736 HD13 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -59.97 -42.41 94.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.456 179.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.704 ' HB3' HD23 ' A' ' 22' ' ' LEU . 95.0 m -69.19 -39.37 78.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.455 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -58.77 -38.75 79.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.395 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.532 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -84.67 -15.0 46.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.479 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -82.81 -24.64 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.354 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 107' ' ' CYS . 91.4 t -69.23 -33.22 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.318 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 21.6 p30 -84.99 1.06 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -126.94 -173.26 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.435 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -84.61 56.37 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.703 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.578 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -135.06 43.31 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.529 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.8 mt-10 -57.33 -53.55 64.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.396 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 17.3 Cg_exo -67.7 -27.52 38.12 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.072 1.848 . . . . 0.0 112.636 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 75' ' ' ALA . 1.3 tp -62.78 -35.66 80.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.74 -51.28 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.56 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.34 -33.52 87.46 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.4 mm100 -67.18 -50.35 61.33 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.456 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 45.1 t -58.68 -33.71 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -63.04 -46.58 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.263 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.846 ' HA ' HG13 ' A' ' 127' ' ' VAL . 15.4 pt-20 -74.03 -39.31 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.663 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.2 m0 -56.41 -37.88 70.76 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' MET . . . . . 0.655 ' HE3' ' HA3' ' A' ' 103' ' ' GLY . 8.9 ttm -73.61 -55.43 6.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.506 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.846 HG13 ' HA ' ' A' ' 124' ' ' GLU . 9.8 p -60.32 -36.19 67.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 127' ' ' VAL . 4.5 mt-10 -67.54 -48.76 66.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' A' ' 129' ' ' TYR . 8.7 t80 -59.01 -34.72 72.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.63 0.729 . . . . 0.0 110.148 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.955 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -73.07 -56.93 4.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.573 -179.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -77.43 -38.52 49.37 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -42.61 2.04 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.955 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.82 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.321 0.509 . . . . 0.0 111.676 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.94 61.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -49.52 67.21 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.795 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.0 t90 -57.96 -48.08 81.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 HD12 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -56.65 -49.55 77.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.944 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.65 -39.51 73.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.1 m -86.79 -11.27 51.5 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.2 -22.02 16.4 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.35 -24.99 0.97 Allowed Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.499 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 95.86 169.55 35.26 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.011 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.55 ' HZ3' HD12 ' A' ' 96' ' ' LEU . 96.2 m95 -60.06 -29.4 68.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' HG1' ' A' ' 148' ' ' THR . . . -61.75 -35.87 79.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.571 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.46 -42.0 96.2 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 5.9 t80 -61.95 -39.47 92.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.318 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.74 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -66.07 -27.16 67.87 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 110.75 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -15.31 41.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 0.0 109.856 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -79.03 -48.87 13.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.22 179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 1.5 m-85 -138.99 30.75 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -95.09 -132.17 6.75 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.189 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.48 -31.42 70.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.43 ' O ' HD21 ' A' ' 156' ' ' LEU . . . -115.5 65.85 0.3 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 151' ' ' TYR . . . -83.77 76.33 10.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.207 0.527 . . . . 0.0 110.481 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.651 ' HG ' ' HB2' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -60.7 153.59 23.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.324 -179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.66 -28.03 53.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.308 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.46 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -74.75 -42.14 58.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 110.801 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.651 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . . . -68.79 -34.66 75.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.242 0.544 . . . . 0.0 110.541 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 8.3 mtm-85 -63.97 -50.45 68.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.074 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -68.9 -30.11 68.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.569 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -64.77 -37.38 87.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.254 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -69.48 -42.21 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.555 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 3.4 tt0 -65.46 -44.62 86.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.403 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 -22.45 75.63 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.632 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 t-20 -74.66 -52.96 10.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.0 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.865 ' HA ' HG21 ' A' ' 170' ' ' VAL . 14.7 p-90 -66.97 -23.8 65.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.274 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.07 77.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.15 0.5 . . . . 0.0 110.382 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 -32.59 19.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.516 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 167' ' ' TRP . 34.3 m -86.12 -25.57 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.412 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.4 ttp180 -80.84 -25.38 37.76 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.588 -0.695 . . . . 0.0 109.938 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.485 ' HA ' HG21 ' A' ' 175' ' ' THR . 2.2 m -90.09 -28.6 18.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.763 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.813 HG11 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -65.32 -29.05 46.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.388 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.813 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -120.07 46.15 2.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.185 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -64.99 -42.33 94.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.94 25.18 1.53 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.499 0.56 . . . . 0.0 114.499 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . . . -88.96 -2.21 58.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.323 0.561 . . . . 0.0 110.457 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.36 66.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.805 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.03 12.03 37.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.433 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.979 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 5.6 mp . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.656 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 CA--C 1.527 0.173 0 CA-C-O 121.176 0.407 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 10' ' ' THR . 1.5 m-20 -84.75 -159.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' THR . . . . . 0.461 ' H ' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -56.47 -35.04 67.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.15 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -63.58 -39.59 94.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.689 0.28 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -32.95 57.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.814 0.34 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 42' ' ' LEU . 7.4 tp -74.74 -42.22 58.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.427 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.37 -37.93 80.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.834 0.349 . . . . 0.0 110.23 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.72 60.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.75 0.31 . . . . 0.0 110.588 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.082 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.609 ' HD1' ' CD2' ' A' ' 17' ' ' PHE . 6.7 t80 -56.63 -50.11 73.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -66.83 -42.18 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.47 -52.75 49.23 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.888 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.799 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 23.6 t80 -57.19 -46.55 82.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.073 0.549 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.52 -45.46 90.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 111.059 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 22' ' ' LEU . 7.7 mp -66.85 -47.24 72.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 23.7 ttp85 -60.77 -25.81 66.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.3 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.94 -21.79 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.952 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -157.43 72.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.759 0.314 . . . . 0.0 111.654 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.68 -75.99 0.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.599 ' HD2' ' CD1' ' A' ' 27' ' ' TYR . 1.2 t80 -84.37 56.13 3.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.05 -28.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.087 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.36 -15.16 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.478 0.656 . . . . 0.0 109.962 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -111.85 53.9 0.57 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.963 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB3' ' OE2' ' A' ' 35' ' ' GLU . . . -63.49 144.59 56.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.204 -0.498 . . . . 0.0 110.408 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.4 ' CA ' ' HG2' ' A' ' 35' ' ' GLU . . . 142.77 -57.25 0.56 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.979 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.7 -45.36 17.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.579 2.186 . . . . 0.0 112.403 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.799 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.43 39.44 2.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.743 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.428 ' OE2' ' HB3' ' A' ' 31' ' ' ALA . 74.4 mm-40 -79.31 -59.92 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.349 0.574 . . . . 0.0 109.95 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.05 128.96 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.3 Cg_endo -88.28 -132.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.835 2.357 . . . . 0.0 113.476 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.514 ' H ' ' HB2' ' A' ' 37' ' ' PRO . . . -73.79 92.4 2.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.493 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.93 39.9 1.04 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -156.41 164.9 19.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.654 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.39 49.63 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.135 2.557 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.8 -27.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.485 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -62.55 -56.03 21.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.929 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -63.98 -23.81 67.48 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.044 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -67.63 -54.1 22.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.493 ' HB2' ' HE3' ' A' ' 46' ' ' MET . 3.8 tpp -70.13 -30.07 67.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.338 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -39.87 95.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.572 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.22 -28.52 47.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 109.685 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.739 ' HB3' ' HZ ' ' A' ' 147' ' ' PHE . . . -68.5 -61.08 1.99 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.643 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.12 -45.9 42.72 Favored Glycine 0 C--O 1.215 -1.081 0 O-C-N 124.108 0.88 . . . . 0.0 112.292 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.28 -52.75 51.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.588 0.355 . . . . 0.0 111.884 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -44.0 95.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.404 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.838 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -72.56 -35.0 67.87 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.25 -27.15 68.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.323 0.583 . . . . 0.0 109.518 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -88.01 -39.24 14.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -90.37 -57.23 2.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 1.4 t80 -81.4 69.21 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -72.89 0.59 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.592 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.88 51.69 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 110.198 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.0 0.15 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.412 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 0.867 ' HA ' HD23 ' A' ' 64' ' ' LEU . 36.6 m-85 -110.51 -25.91 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 0.0 111.592 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -41.11 97.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.74 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.434 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 3.3 m-20 -68.99 -18.95 64.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.748 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.867 HD23 ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -66.87 -45.41 78.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.668 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -75.67 -47.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 63' ' ' ASP . . . -47.77 -41.63 23.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.18 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.543 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 27.9 mt-30 -71.83 -65.65 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -78.49 14.48 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.668 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 1.6 p-80 -79.15 -20.56 48.23 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.533 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.87 -72.69 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.825 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -157.15 135.64 7.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 21.2 Cg_exo -66.44 170.14 12.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.115 2.543 . . . . 0.0 112.378 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.72 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 92.18 -58.49 2.76 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.67 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.55 50.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.43 0.634 . . . . 0.0 110.848 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HB2' ' HH2' ' A' ' 125' ' ' TRP . . . -110.67 -25.08 10.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.739 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.626 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -63.03 -42.1 99.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.848 -179.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.95 -44.71 95.33 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.383 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -61.7 -42.68 99.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.246 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.624 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 9.0 t80 -62.47 -51.0 69.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.469 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -59.07 -32.2 69.57 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.725 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -61.07 -60.52 3.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.72 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 180' ' ' LEU . 16.7 m -60.29 -32.53 51.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.6 m -65.61 -42.42 91.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.16 -40.44 86.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 178.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.459 ' O ' HD22 ' A' ' 174' ' ' LEU . 87.4 mt-10 -67.13 -31.79 72.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.486 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -76.01 -36.59 59.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.45 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -85.83 -5.81 59.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -34.46 25.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.018 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.83 62.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.352 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.472 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.88 56.64 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.544 -1.313 . . . . 0.0 115.014 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 11.8 Cg_endo -82.13 29.37 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.396 2.064 . . . . 0.0 111.194 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.847 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.9 m120 -61.63 162.06 8.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.889 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 27.7 m95 -52.68 -25.77 11.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.864 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.98 90.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.522 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.651 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.0 mmp_? -87.09 -22.43 25.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.926 -0.161 . . . . 0.0 110.758 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -54.71 -31.08 57.61 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.728 0.643 . . . . 0.0 110.229 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.838 HG11 ' HB2' ' A' ' 53' ' ' PHE . 17.6 t -59.77 -56.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.95 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -27.32 69.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.84 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.0 m-85 -58.49 -55.12 39.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 110.123 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 0.467 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 12.8 m-85 -76.16 -37.86 57.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.73 -37.88 80.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.801 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -54.5 -53.86 48.67 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.13 -35.66 52.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.444 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.61 99.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.136 0.468 . . . . 0.0 110.513 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -69.43 -40.17 77.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.821 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -59.65 -42.11 92.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.704 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.416 ' HB3' HD22 ' A' ' 22' ' ' LEU . 96.9 m -69.06 -41.16 77.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.024 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.424 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -53.86 -48.46 69.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.983 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -74.13 -20.22 60.31 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.874 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.494 ' HB3' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -78.78 -35.94 43.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.482 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 111' ' ' VAL . 24.6 t -67.81 -16.3 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.829 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 12.3 m-20 -45.73 -70.25 0.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.487 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -175.55 37.45 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.886 179.375 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . 0.559 ' HB3' ' HE1' ' A' ' 115' ' ' MET . 17.2 mt-10 -159.68 122.1 3.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.878 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' MET . . . . . 0.559 ' HE1' ' HB3' ' A' ' 114' ' ' GLU . 4.0 mtm 70.31 114.84 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.777 0.673 . . . . 0.0 112.106 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.702 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -102.05 -55.34 0.13 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.146 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.702 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 36.2 Cg_exo -59.85 -27.79 85.73 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.487 2.125 . . . . 0.0 113.967 -178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -62.3 -31.57 72.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 110' ' ' SER . 94.6 t -60.36 -55.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.623 0.249 . . . . 0.0 111.371 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.51 -28.88 72.0 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.016 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.9 mt-30 -68.52 -49.21 61.32 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.568 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 99.6 t -56.64 -36.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.64 -47.05 87.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.859 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.652 ' HA ' HG11 ' A' ' 127' ' ' VAL . 20.8 pt-20 -73.93 -36.72 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.626 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.1 m0 -57.12 -38.34 73.29 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.9 ttm -73.61 -54.28 8.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.22 -30.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.772 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 127' ' ' VAL . 1.5 tt0 -69.32 -50.0 50.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.263 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 129' ' ' TYR . 11.8 t80 -61.76 -34.4 75.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.0 110.599 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 0.857 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -72.12 -56.01 6.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.133 -178.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.99 -34.3 74.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.5 m -79.04 -40.92 30.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -121.61 -42.73 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 0.857 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.7 mm? -59.6 -46.0 90.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.227 0.467 . . . . 0.0 111.166 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.18 -39.5 56.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.376 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.5 -55.78 29.36 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.449 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.847 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 62.2 t90 -55.79 -46.34 77.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.117 0.484 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.24 -48.19 85.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.721 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -66.07 -32.22 73.56 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.372 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -84.0 -11.85 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -49.61 5.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.3 -18.08 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.15 170.6 35.06 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.017 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.44 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 92.9 m95 -60.48 -30.62 69.8 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.52 76.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.19 92.95 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 0.739 ' HZ ' ' HB3' ' A' ' 49' ' ' ALA . 5.9 t80 -66.05 -33.85 76.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.553 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -71.07 -24.49 62.34 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.468 178.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.35 -31.68 21.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -51.38 69.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.581 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 151' ' ' TYR . 1.9 m-85 -132.55 33.85 3.75 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.04 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -103.54 -127.79 6.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.431 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.42 -37.61 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 111.078 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -108.32 61.81 0.3 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.465 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.56 72.85 9.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.136 0.493 . . . . 0.0 110.637 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.2 164.16 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.837 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -59.72 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.574 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . 0.719 ' HB2' HD11 ' A' ' 156' ' ' LEU . 1.5 mt-10 -71.47 -35.78 70.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.26 62.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 0.0 109.73 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . 0.637 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 4.0 mtp180 -61.75 -51.64 67.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.294 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' GLU . 1.3 ptm180 -67.64 -28.39 67.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.652 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -66.85 -45.3 78.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.525 ' NH2' ' HA ' ' A' ' 49' ' ' ALA . 13.0 ttp180 -67.26 -38.04 84.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.1 OUTLIER -67.66 -47.12 70.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.214 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.75 -21.79 75.11 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.503 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.5 OUTLIER -68.96 -54.04 17.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.277 . . . . 0.0 110.827 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.733 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.0 p-90 -67.76 -25.08 65.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.985 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.14 74.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 110.262 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.59 -28.75 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 167' ' ' TRP . 27.8 m -93.04 -31.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -41.0 67.54 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.544 -0.722 . . . . 0.0 110.29 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.892 ' HA ' HG23 ' A' ' 175' ' ' THR . 3.7 m -74.66 -28.47 60.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 0.927 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -70.44 -26.09 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.569 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.927 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -120.72 39.73 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.726 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.892 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -68.5 -16.2 63.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -87.96 14.08 59.65 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.184 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -79.34 8.2 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.942 0.371 . . . . 0.0 111.806 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 58.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.925 0.393 . . . . 0.0 110.475 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.09 51.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.967 0.32 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.63 -161.4 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.458 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -43.33 74.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.385 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -58.65 -39.33 80.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.631 0.253 . . . . 0.0 110.726 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -47.91 51.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.78 -45.09 90.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.654 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 9.9 p -65.9 -39.29 84.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.87 76.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.87 -48.85 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.908 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PHE . . . . . 1.62 ' HE2' ' CE1' ' A' ' 17' ' ' PHE . 5.8 t80 -59.31 -51.06 71.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.756 HG12 HD11 ' A' ' 22' ' ' LEU . 53.5 t -65.24 -40.99 90.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.96 -48.02 87.83 Favored Glycine 0 C--O 1.222 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.94 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' TYR . . . . . 0.723 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.2 t80 -58.12 -47.75 82.34 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.821 0.448 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.68 85.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.175 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' LEU . . . . . 0.756 HD11 HG12 ' A' ' 18' ' ' VAL . 8.1 mp -67.15 -46.93 72.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.416 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 35.4 ttp85 -62.96 -20.34 65.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.841 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.7 tt0 -82.19 -36.41 27.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.926 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.44 77.89 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.49 -68.3 0.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.09 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' TYR . . . . . 1.601 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.1 t80 -92.57 59.67 3.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.0 110.701 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . 0.474 ' H ' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -79.16 -26.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.92 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -36.86 77.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.791 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.46 50.6 1.61 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.955 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -67.75 131.28 45.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.01 -53.75 0.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.612 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -68.56 -49.22 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.217 1.945 . . . . 0.0 111.643 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.5 31.88 4.69 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.517 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.83 -59.44 2.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.437 0.637 . . . . 0.0 109.314 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.19 124.88 7.23 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.422 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.82 -112.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.998 2.465 . . . . 0.0 112.955 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 44' ' ' GLN . . . -70.44 97.15 1.24 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.7 20.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.067 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 30.8 m-20 -146.26 162.35 35.18 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -79.22 52.33 4.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.366 2.711 . . . . 0.0 111.468 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.29 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.03 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -62.66 -50.4 71.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.575 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 30.9 tt0 -64.06 -25.23 68.01 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -75.94 -54.22 7.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.465 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' MET . . . . . 0.452 ' HE3' ' CD1' ' A' ' 100' ' ' PHE . 3.3 ttm -61.97 -38.29 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.976 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -61.32 -37.91 84.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.075 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.51 34.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.519 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 97' ' ' VAL . . . -59.56 -55.88 28.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.308 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.67 -49.45 40.37 Favored Glycine 0 C--O 1.217 -0.963 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.206 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.74 -53.15 58.8 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.906 0.384 . . . . 0.0 111.929 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.1 -46.6 86.6 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.355 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 1.625 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -69.77 -36.72 75.98 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.778 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -61.04 -32.86 72.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.503 0.668 . . . . 0.0 109.742 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 m -79.34 -28.92 42.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.351 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -92.44 -31.89 15.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -86.44 93.39 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.191 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -71.64 -25.42 62.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.875 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -94.27 77.31 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.122 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.85 -62.51 1.44 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.097 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PHE . . . . . 1.634 ' HE2' ' CE1' ' A' ' 61' ' ' PHE . 23.0 m-85 -76.79 -10.81 59.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -47.61 80.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -68.41 -21.23 64.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.201 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . 0.805 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -68.86 -42.01 77.66 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.77 -43.38 37.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.567 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.22 67.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.657 HE22 HD11 ' A' ' 106' ' ' LEU . 26.6 mt-30 -71.33 -58.05 3.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 3.8 6.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 65.5 t60 -78.81 -26.89 44.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.873 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -91.07 -71.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.277 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.13 147.58 11.47 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -89.54 -169.81 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.138 2.559 . . . . 0.0 111.917 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 79.76 -70.24 2.91 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.343 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.41 37.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 111.905 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -85.84 -16.42 38.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.368 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' GLN . . . . . 0.617 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.0 pt20 -60.95 -42.0 97.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.588 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.3 -39.57 94.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.36 . . . . 0.0 110.499 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -67.58 -43.58 80.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.021 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 6.8 t80 -63.06 -48.9 76.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -57.73 -31.88 66.87 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.394 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -62.43 -63.27 1.28 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.891 0.376 . . . . 0.0 110.636 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . 0.538 HG13 HD23 ' A' ' 180' ' ' LEU . 20.9 m -58.78 -32.12 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.512 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 m -65.91 -43.48 88.01 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -69.26 -40.6 77.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.638 178.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -64.14 -28.3 69.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.412 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.696 ' HG ' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -83.62 -28.5 28.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 110.088 179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PHE . . . . . 1.656 ' HD2' ' CD1' ' A' ' 87' ' ' PHE . 9.4 t80 -91.08 0.5 57.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.07 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 9.1 mm100 -49.0 -33.27 10.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.003 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.67 55.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.962 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.61 54.95 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 C-N-CA 119.953 -1.118 . . . . 0.0 114.324 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -80.87 43.06 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.169 1.913 . . . . 0.0 111.977 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.798 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.3 t-20 -67.71 161.74 25.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.896 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' TRP . . . . . 0.576 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.3 m95 -55.33 -26.98 44.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.76 98.47 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.696 HH11 ' HG ' ' A' ' 86' ' ' LEU . 5.2 mmt180 -86.31 -18.77 31.1 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.819 -0.224 . . . . 0.0 110.716 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.761 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.86 -31.66 65.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.329 0.585 . . . . 0.0 110.218 179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 53' ' ' PHE . 5.9 t -61.3 -53.73 44.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.521 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.64 -26.85 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.395 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' A' ' 99' ' ' PHE . 4.1 m-85 -57.42 -57.53 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.068 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 100' ' ' PHE . 8.6 m-85 -74.79 -40.07 61.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.724 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.02 -38.91 69.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.71 -49.49 75.01 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.729 0.3 . . . . 0.0 111.317 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.36 -37.91 30.37 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.003 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.04 97.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.025 0.413 . . . . 0.0 110.688 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -68.56 -40.07 80.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.767 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.79 -43.66 90.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.281 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' CYS . . . . . 0.591 ' HB3' HD22 ' A' ' 22' ' ' LEU . 88.5 m -63.57 -44.37 94.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.071 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . 0.407 ' N ' HD13 ' A' ' 22' ' ' LEU . . . -54.36 -45.03 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.569 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . 0.627 ' HA ' HD22 ' A' ' 112' ' ' ASN . 0.4 OUTLIER -75.09 -23.06 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.658 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' SER . . . . . 0.418 ' HB2' HG21 ' A' ' 119' ' ' VAL . 49.1 m -79.56 -22.24 44.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.116 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' VAL . . . . . 0.476 HG23 HG22 ' A' ' 119' ' ' VAL . 96.3 t -75.97 -35.44 29.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' ASN . . . . . 0.627 HD22 ' HA ' ' A' ' 109' ' ' GLU . 14.7 p30 -85.04 1.13 49.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -123.6 -174.6 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.5 48.74 1.56 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.94 37.84 3.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -54.68 -53.73 57.09 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . 0.505 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 23.4 Cg_exo -65.15 -32.12 53.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.005 1.804 . . . . 0.0 112.299 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -59.61 -31.06 69.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.609 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 111' ' ' VAL . 87.2 t -58.17 -51.2 73.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.903 0.382 . . . . 0.0 111.256 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.06 -31.58 81.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.089 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 14.3 mm100 -66.27 -51.81 53.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' VAL . . . . . 0.465 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 61.2 t -58.15 -33.71 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.16 -47.57 82.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.325 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' A' ' 127' ' ' VAL . 18.4 pt-20 -72.4 -39.44 67.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' TRP . . . . . 0.617 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.7 m0 -57.61 -38.61 75.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.0 ttm -73.77 -52.83 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.795 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 124' ' ' GLU . 4.5 p -62.15 -33.32 58.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 127' ' ' VAL . 1.6 mt-10 -68.55 -52.07 35.97 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.605 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' TYR . . . . . 1.591 ' HD1' ' CD2' ' A' ' 129' ' ' TYR . 5.7 t80 -57.49 -33.32 67.89 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.467 0.651 . . . . 0.0 110.568 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' LEU . . . . . 1.026 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.07 -55.81 5.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.748 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -32.02 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.7 m -82.61 -34.7 27.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -126.97 -44.91 1.6 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . 1.026 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.05 -46.54 87.98 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.429 -178.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.64 -38.85 61.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.259 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -60.03 -52.59 64.73 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.418 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TRP . . . . . 0.798 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 52.8 t90 -56.62 -48.69 76.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ILE . . . . . 0.5 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.7 mt -57.09 -47.77 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.016 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -66.39 -29.17 69.28 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -88.04 -16.13 34.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.56 -54.39 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.78 -9.74 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.545 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.03 166.88 40.98 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.009 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TRP . . . . . 0.412 ' CZ3' ' HE1' ' A' ' 46' ' ' MET . 91.6 m95 -60.67 -29.15 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.22 80.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.89 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' GLU . . . . . 0.44 ' HG3' HD11 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -62.78 -42.77 99.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' PHE . . . . . 1.619 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 14.3 t80 -66.1 -33.17 75.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.137 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . 0.623 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.39 -27.7 68.06 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.738 0.304 . . . . 0.0 111.02 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.0 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LEU . . . . . 0.44 HD11 ' HG3' ' A' ' 146' ' ' GLU . 5.0 mt -63.61 -42.95 98.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.536 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 151' ' ' TYR . 1.4 m-85 -123.39 31.29 5.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.814 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -122.94 -138.37 5.26 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.752 -1.214 . . . . 0.0 113.107 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -42.77 36.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.785 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.52 53.43 4.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.44 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.5 71.76 10.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 157.68 21.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -53.07 -33.68 53.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.209 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.8 -39.41 66.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.919 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.36 72.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.993 0.425 . . . . 0.0 110.83 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -60.66 -51.46 69.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.037 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -69.16 -26.12 64.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.019 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.68 -46.02 55.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ARG . . . . . 0.411 ' HB3' HD23 ' A' ' 150' ' ' LEU . 3.8 ptt180 -65.1 -38.62 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLU . . . . . 0.565 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -71.02 -43.54 67.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.204 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.81 -28.46 73.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.647 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.1 -57.76 6.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' TRP . . . . . 0.841 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.7 p-90 -62.12 -25.34 67.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.491 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.4 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.051 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 -29.19 22.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' VAL . . . . . 0.841 HG23 ' HA ' ' A' ' 167' ' ' TRP . 26.8 m -79.4 -23.9 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.265 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' ARG . . . . . 0.552 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 3.7 ttp180 -83.09 -14.43 53.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' THR . . . . . 0.653 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.7 OUTLIER -98.52 -33.21 11.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.471 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' VAL . . . . . 1.051 HG12 ' HG ' ' A' ' 174' ' ' LEU . 11.7 p -63.19 -33.14 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.57 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 1.051 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -112.34 39.4 2.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.77 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' THR . . . . . 0.653 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -54.37 -42.86 70.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.372 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.72 59.55 4.43 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.131 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -120.14 6.69 10.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.413 0.625 . . . . 0.0 109.62 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.65 61.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.455 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.41 -8.11 59.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.802 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.34 -50.12 1.56 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.865 2.376 . . . . 0.0 112.003 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.88 -149.77 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.247 179.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 99.68 -77.51 0.48 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.111 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -18.03 65.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.09 23.8 12.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.506 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -140.41 121.55 14.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.152 -179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 p -102.62 149.24 36.55 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.308 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.33 134.16 50.43 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.676 2.251 . . . . 0.0 111.64 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.18 147.91 32.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.035 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 m 59.23 88.65 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.944 0.777 . . . . 0.0 112.225 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.61 161.84 65.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.702 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.13 52.38 0.78 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.322 2.681 . . . . 0.0 113.238 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -166.0 1.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.883 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -39.45 82.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.393 0.139 . . . . 0.0 111.158 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.417 ' O ' HG11 ' A' ' 14' ' ' VAL . 13.1 ttp180 -62.2 -38.01 87.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.716 179.657 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.84 66.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.686 HD22 ' HE1' ' A' ' 46' ' ' MET . 1.6 tp -72.4 -42.28 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.494 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 9.7 p -66.49 -36.07 76.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 109.969 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.23 -22.96 60.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.322 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -73.16 -66.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.644 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -53.44 -50.66 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.798 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.582 HG11 HD13 ' A' ' 22' ' ' LEU . 96.4 t -67.64 -42.31 86.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.429 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.48 -52.29 52.2 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.211 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.661 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -55.57 -45.33 77.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.148 0.579 . . . . 0.0 111.223 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -48.37 66.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -63.38 -45.31 91.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.578 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.732 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -62.17 -26.98 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.026 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -85.99 -23.97 26.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.57 66.12 1.12 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.9 -72.17 0.29 Allowed Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.833 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.426 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.2 t80 -91.2 52.96 2.22 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.163 0.506 . . . . 0.0 110.332 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.15 -31.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.668 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -35.35 79.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.392 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.77 57.39 2.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.659 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.732 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -60.18 128.26 35.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.617 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 165.6 -60.91 0.24 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.278 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.466 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 32.1 Cg_exo -58.8 -52.51 5.12 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 121.96 1.773 . . . . 0.0 111.024 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.54 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -92.57 42.48 2.68 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.51 -18.32 31.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 110.313 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -110.55 147.5 17.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.622 179.557 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -93.94 -158.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.964 2.443 . . . . 0.0 113.135 -179.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.645 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -83.3 96.77 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.31 -24.44 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.737 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 20.6 m-20 -79.5 163.25 59.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.105 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 25.3 Cg_endo -78.0 50.39 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.42 2.746 . . . . 0.0 112.102 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.656 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.49 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.345 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.645 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.3 m170 -59.23 -60.48 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.09 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.561 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.4 -24.88 61.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.045 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.821 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -73.82 -50.71 19.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.92 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.686 ' HE1' HD22 ' A' ' 13' ' ' LEU . 3.8 ttm -66.74 -37.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.43 -179.707 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.98 84.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.542 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.62 -27.69 51.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.348 0.595 . . . . 0.0 110.678 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.653 ' HB1' ' HZ ' ' A' ' 147' ' ' PHE . . . -68.98 -62.65 1.29 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.563 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.644 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.94 -45.85 41.1 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.72 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.34 -50.11 72.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.054 0.455 . . . . 0.0 111.697 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -46.37 84.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.198 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.509 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -68.73 -36.33 78.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.274 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.21 -32.5 71.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.302 0.572 . . . . 0.0 109.547 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -83.12 -25.76 31.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.414 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -91.47 -29.43 17.02 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.663 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.21 96.86 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 110.992 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt-85 -72.54 -3.69 26.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.601 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.453 HH12 HG13 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -132.2 87.89 2.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.761 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.05 -61.02 1.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.658 -178.486 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 6.9 m-85 -79.67 0.44 30.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.471 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 p -73.42 -53.99 9.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.33 -24.27 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.919 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.746 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -63.15 -44.77 94.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.862 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.65 51.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.898 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.412 ' HB3' ' HA ' ' A' ' 63' ' ' ASP . . . -51.66 -44.28 62.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.201 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.476 HE22 HD13 ' A' ' 106' ' ' LEU . 19.7 mt-30 -69.2 -51.24 39.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.716 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -86.17 20.22 2.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.097 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.74 -40.88 32.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.466 HG12 ' H ' ' A' ' 71' ' ' THR . 1.5 p -90.88 -60.83 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.466 ' H ' HG12 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -172.7 145.7 1.41 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.11 -158.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.075 2.516 . . . . 0.0 112.623 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.99 -71.07 2.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.77 50.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.54 0.686 . . . . 0.0 111.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.484 ' HB2' ' HH2' ' A' ' 125' ' ' TRP . . . -102.61 -20.51 14.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.646 179.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.677 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -65.13 -38.06 89.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.657 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 26.1 mp0 -67.43 -42.05 83.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -64.06 -45.57 88.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 5.7 t80 -62.39 -51.86 65.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.712 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -58.33 -32.62 68.68 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.657 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 22.8 mm-40 -64.15 -56.74 12.67 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.417 ' O ' HD12 ' A' ' 86' ' ' LEU . 12.3 m -63.84 -31.88 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.315 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.0 m -65.56 -43.41 89.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.356 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.621 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -66.96 -36.67 82.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.244 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.46 -26.25 64.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.894 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.714 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -79.81 -30.91 40.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.087 179.239 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -95.96 1.48 52.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -50.15 21.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.747 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.14 61.71 0.15 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.844 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.13 58.67 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.004 -1.093 . . . . 0.0 114.129 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.581 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.5 Cg_endo -81.08 41.89 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.43 2.087 . . . . 0.0 111.741 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.769 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.2 t-20 -64.47 162.89 14.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -56.05 -26.28 48.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.698 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.02 94.14 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.714 ' HG3' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -87.54 -27.23 22.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.952 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.793 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.05 -30.88 49.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.388 0.614 . . . . 0.0 110.149 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.509 HG13 ' HB2' ' A' ' 53' ' ' PHE . 13.3 t -63.18 -55.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.66 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.56 -28.66 69.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.322 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 99' ' ' PHE . 8.1 m-85 -57.46 -57.62 11.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 109.956 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.622 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 13.6 m-85 -74.88 -37.68 62.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.2 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.74 -37.5 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.157 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -57.15 -52.33 65.72 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.697 0.284 . . . . 0.0 111.202 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.605 ' HA3' ' HE2' ' A' ' 126' ' ' MET . . . -74.41 -40.85 38.89 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.225 -179.594 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.29 89.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.189 0.495 . . . . 0.0 111.016 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.416 ' C ' HD23 ' A' ' 64' ' ' LEU . . . -71.36 -41.04 70.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.746 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.7 -48.74 80.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.584 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.689 ' HB3' HD21 ' A' ' 22' ' ' LEU . 67.0 m -59.66 -42.26 92.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.316 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.433 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -54.89 -55.96 24.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 0.0 110.855 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.4 -17.87 64.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -77.88 -32.97 52.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.583 HG23 HG21 ' A' ' 119' ' ' VAL . 35.0 t -75.21 -22.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.658 0.742 . . . . 0.0 109.356 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -4.89 59.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.609 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.444 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.2 tttt -132.06 -162.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.585 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.18 55.19 3.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.539 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.52 43.64 2.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.023 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.605 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.7 mp0 -60.54 -55.32 46.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.962 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.605 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.4 Cg_exo -64.72 -26.84 60.43 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.956 1.771 . . . . 0.0 112.198 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.45 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.6 mm? -65.72 -28.11 68.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.313 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.583 HG21 HG23 ' A' ' 111' ' ' VAL . 79.3 t -59.23 -50.69 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.956 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.87 -32.58 84.36 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.838 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.564 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 7.9 mm100 -64.63 -52.88 55.09 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 118' ' ' LEU . 44.8 t -58.3 -33.49 47.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.958 0.408 . . . . 0.0 110.115 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.21 -46.92 81.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.427 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.684 ' HA ' HG13 ' A' ' 127' ' ' VAL . 19.0 pt-20 -72.31 -39.43 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.064 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.677 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.9 m0 -57.8 -38.7 75.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.483 0.658 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.605 ' HE2' ' HA3' ' A' ' 103' ' ' GLY . 4.7 ttm -71.96 -56.07 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.69 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.684 HG13 ' HA ' ' A' ' 124' ' ' GLU . 4.2 p -61.19 -33.21 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.424 ' N ' HG12 ' A' ' 127' ' ' VAL . 31.0 mt-10 -73.09 -45.79 55.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.853 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.621 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.6 t80 -59.88 -37.39 79.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.704 0.764 . . . . 0.0 109.894 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 1.015 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.51 -54.98 8.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.822 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.17 -32.6 70.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -82.43 -35.11 27.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.87 -43.5 1.22 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 1.015 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.51 -48.49 81.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.595 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.8 -38.92 57.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.603 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.15 -50.02 73.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.796 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.769 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.8 t90 -58.17 -49.28 77.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 109.525 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.639 HG13 ' HE3' ' A' ' 137' ' ' TRP . 11.3 mt -58.08 -47.14 87.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.152 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -61.12 -40.0 92.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -30.54 43.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -60.03 3.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.947 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.3 -11.07 0.02 OUTLIER Glycine 0 C--N 1.319 -0.367 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.32 169.16 41.89 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.612 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.487 ' CZ2' HD12 ' A' ' 138' ' ' ILE . 96.0 m95 -62.2 -29.03 70.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.51 78.66 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.578 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.81 -44.06 94.4 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.629 ' HD1' ' CD2' ' A' ' 147' ' ' PHE . 9.2 t80 -64.83 -34.21 77.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.579 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.821 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -70.55 -25.55 63.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.37 -32.66 20.84 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.454 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -57.95 -51.49 69.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.643 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.66 ' HD2' ' CD1' ' A' ' 151' ' ' TYR . 1.4 m-85 -130.32 30.23 4.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.85 -133.13 8.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.927 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -68.59 -45.45 71.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.548 ' O ' HD21 ' A' ' 156' ' ' LEU . . . -93.68 48.78 2.3 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.12 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.23 73.26 8.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.12 0.486 . . . . 0.0 110.734 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.609 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -65.77 160.05 23.85 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.575 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.525 ' HG3' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -57.01 -32.18 65.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.281 -178.874 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.609 ' HB2' HD11 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -69.62 -39.41 77.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.651 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.528 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -68.38 -36.31 78.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.402 ' HA ' ' HE2' ' A' ' 151' ' ' TYR . 61.9 mtt180 -67.56 -50.57 57.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -64.47 -27.32 68.91 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.019 0.438 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.444 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -63.34 -47.52 81.81 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.47 178.557 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.445 HH11 ' HE2' ' A' ' 147' ' ' PHE . 11.0 ttp180 -63.4 -39.2 93.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.624 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.19 -49.12 70.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.888 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.54 -27.23 73.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.585 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -70.11 -56.63 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.464 -0.368 . . . . 0.0 111.532 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.835 ' HA ' HG23 ' A' ' 170' ' ' VAL . 9.8 p-90 -60.34 -27.87 67.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.453 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.73 74.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.688 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -24.09 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.835 HG23 ' HA ' ' A' ' 167' ' ' TRP . 28.7 m -96.38 -41.15 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.588 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -75.35 -27.4 59.17 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.411 -0.805 . . . . 0.0 111.079 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.42 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 1.4 m -81.51 -29.92 33.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.414 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.927 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.2 p -71.57 -28.24 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 110.398 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.927 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -114.44 33.91 5.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.209 0.528 . . . . 0.0 109.628 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.42 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.3 t -81.52 -4.72 56.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.242 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -89.39 6.13 83.52 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.647 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 29.29 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.453 HG13 HH12 ' A' ' 59' ' ' ARG . 0.7 OUTLIER -87.23 50.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.054 0.454 . . . . 0.0 110.731 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.14 -1.85 53.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.482 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 10.4 mt -92.22 -7.28 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.159 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.9 84.57 1.22 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.896 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -109.85 -168.2 1.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.643 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.3 -19.02 34.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.899 2.4 . . . . 0.0 112.523 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 5.7 mt -104.15 109.45 21.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.889 0.376 . . . . 0.0 111.071 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -68.56 103.26 1.0 Allowed Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.715 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.34 -28.42 29.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -4.77 20.6 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.75 128.26 34.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.801 0.334 . . . . 0.0 111.003 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 p -99.87 119.93 58.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.804 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -82.7 37.18 0.65 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.344 2.696 . . . . 0.0 112.912 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.47 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -98.76 116.43 30.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 143.02 58.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.34 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.37 102.24 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.251 2.634 . . . . 0.0 111.899 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -72.49 -174.12 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.095 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -37.8 52.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.292 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.401 ' HA ' HG12 ' A' ' 14' ' ' VAL . 23.8 ttp180 -64.13 -38.67 91.89 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.939 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.49 -35.25 68.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.593 HD23 ' HE3' ' A' ' 46' ' ' MET . 3.0 tp -71.66 -43.19 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.401 HG12 ' HA ' ' A' ' 11' ' ' ARG . 4.3 p -65.85 -33.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.971 0.415 . . . . 0.0 110.159 179.455 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.15 -24.77 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.456 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.36 -63.16 1.39 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -55.54 -51.77 65.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.619 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 97.4 t -68.62 -38.94 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.789 0.328 . . . . 0.0 110.281 179.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.479 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.63 -51.78 55.3 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.477 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.67 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 73.3 t80 -61.38 -42.27 98.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 0.0 110.847 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.46 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -62.61 -46.81 86.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.447 ' N ' HD13 ' A' ' 22' ' ' LEU . 8.1 mp -68.24 -44.72 75.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.726 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.6 -29.14 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.46 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.2 pt20 -85.84 -22.94 27.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.84 65.75 1.11 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.26 -70.45 0.31 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.965 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.425 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -89.83 51.14 2.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.213 0.53 . . . . 0.0 110.155 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.88 -28.24 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.545 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.63 -29.26 64.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.94 57.87 1.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.726 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.51 112.5 3.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.855 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 178.57 -58.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.403 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -57.86 -48.95 14.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.227 1.951 . . . . 0.0 111.992 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.16 32.69 5.96 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.709 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.3 -20.63 29.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.908 0.385 . . . . 0.0 110.109 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.86 145.6 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 179.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -97.55 -159.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.199 2.599 . . . . 0.0 113.647 -178.717 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.678 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -81.59 84.41 6.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.05 1.19 7.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.034 0.445 . . . . 0.0 111.273 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.446 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 40.6 m-20 -104.98 163.0 18.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.58 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.406 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 37.6 Cg_endo -80.12 47.03 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.443 2.762 . . . . 0.0 111.85 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -175.07 -31.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.755 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.678 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.3 m170 -58.0 -58.82 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.342 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.497 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 4.0 tt0 -58.18 -25.02 61.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.945 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.27 -50.31 16.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.266 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.593 ' HE3' HD23 ' A' ' 13' ' ' LEU . 3.2 ttm -66.89 -37.6 84.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.044 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.33 -42.01 23.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.324 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.745 ' HB3' HG22 ' A' ' 97' ' ' VAL . . . -59.16 -54.89 41.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.523 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.6 -50.58 41.93 Favored Glycine 0 C--O 1.22 -0.726 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.294 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.36 -50.05 68.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -48.48 80.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.591 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -71.28 -33.46 69.77 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.212 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.76 -25.34 67.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.55 0.691 . . . . 0.0 109.327 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -84.82 -37.32 20.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.327 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -92.92 -61.22 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.073 0.463 . . . . 0.0 112.165 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.9 69.7 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.402 0.681 . . . . 0.0 111.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -77.82 -16.97 57.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -81.39 46.43 0.94 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.36 . . . . 0.0 111.476 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 t -120.98 -6.45 9.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.649 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.8 m-85 -92.98 -26.31 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -39.3 93.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.538 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.589 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.55 -24.99 66.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.706 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -66.16 -41.29 90.57 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.446 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -76.67 -46.65 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.535 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -50.26 -43.03 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.544 HE22 HD13 ' A' ' 106' ' ' LEU . 25.0 mt-30 -67.57 -59.32 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.938 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.494 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.35 16.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.654 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.446 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.62 -26.8 45.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 0.0 110.529 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.554 HG11 ' H ' ' A' ' 71' ' ' THR . 3.4 p -93.01 -60.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.449 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.554 ' H ' HG11 ' A' ' 70' ' ' VAL . 8.6 t -174.69 146.96 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.817 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.58 178.12 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.457 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.651 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 101.91 -76.62 0.35 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.947 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.81 48.96 0.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.176 0.512 . . . . 0.0 111.77 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -95.37 -24.01 16.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 5.9 pt20 -60.66 -42.0 96.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.845 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.24 87.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.719 0.295 . . . . 0.0 110.54 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -62.83 -42.2 99.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.07 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.12 -51.62 65.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.282 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 p -55.86 -32.93 64.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.383 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.472 HE21 ' HB3' ' A' ' 81' ' ' GLN . 0.8 OUTLIER -60.18 -65.0 0.75 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.118 0.485 . . . . 0.0 110.611 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.817 HG13 ' HG ' ' A' ' 180' ' ' LEU . 13.4 m -58.45 -32.2 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.594 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.457 ' N ' HG23 ' A' ' 82' ' ' VAL . 40.9 m -65.79 -43.6 88.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 0.0 110.106 179.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -71.28 -33.73 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' HD23 ' A' ' 174' ' ' LEU . 14.3 mt-10 -71.46 -29.82 65.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.338 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.469 ' O ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -81.37 -34.82 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.909 -179.905 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -87.65 -8.64 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.099 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -44.22 -45.15 8.34 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.408 ' H ' HD21 ' A' ' 174' ' ' LEU . . . -170.66 63.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.218 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.491 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.8 55.83 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.792 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.558 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.7 Cg_endo -80.47 38.38 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.116 1.877 . . . . 0.0 111.569 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.831 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.4 t-20 -68.3 162.76 24.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.089 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.478 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 25.8 m95 -53.53 -26.98 23.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.71 -42.3 98.69 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.687 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.9 mtp180 -86.72 -22.47 26.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.82 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.829 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.31 -31.69 54.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 110.25 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.831 HG12 ' HB2' ' A' ' 53' ' ' PHE . 9.5 t -61.62 -56.84 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -27.56 69.36 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.618 179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.829 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.3 m-85 -57.07 -55.82 29.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.054 0.454 . . . . 0.0 109.942 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.622 ' HE1' HD21 ' A' ' 130' ' ' LEU . 12.5 m-85 -75.96 -38.68 57.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.938 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.8 t -60.85 -37.66 77.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.599 ' HE2' ' CE1' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -55.74 -50.5 70.2 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.77 0.319 . . . . 0.0 111.219 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.21 -38.44 34.41 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.056 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.5 96.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.081 0.44 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.533 ' HB2' HD23 ' A' ' 64' ' ' LEU . . . -68.74 -38.27 80.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.706 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.13 -45.19 95.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.186 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 85.2 m -63.86 -42.51 97.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.034 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.43 31.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 110.843 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.97 -16.12 63.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 m -77.98 -33.83 51.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 22.2 t -77.08 -20.85 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.708 0.766 . . . . 0.0 109.019 177.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -82.09 -2.33 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.235 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.459 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 12.3 mtmt -138.27 -155.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.459 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 21.0 mt-10 -99.16 53.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.698 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.817 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -127.66 44.87 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.556 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 8.7 mt-10 -54.08 -56.2 28.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.556 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 22.0 Cg_exo -66.54 -32.13 40.02 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.018 1.812 . . . . 0.0 112.954 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.651 HD23 ' H ' ' A' ' 73' ' ' GLY . 3.9 mp -59.57 -31.93 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.11 -53.74 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.42 86.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.084 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.586 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 4.5 mm100 -65.09 -50.81 64.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.555 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 91.8 t -57.87 -35.07 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -63.02 -47.07 84.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.687 ' HA ' HG11 ' A' ' 127' ' ' VAL . 16.9 pt-20 -71.49 -39.04 71.12 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.008 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 35.7 m0 -58.1 -38.08 75.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 109.128 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.575 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.6 ttm -73.1 -55.6 6.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.67 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.687 HG11 ' HA ' ' A' ' 124' ' ' GLU . 4.7 p -60.3 -33.34 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.12 -50.89 36.04 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.598 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.647 ' HE1' ' CE2' ' A' ' 129' ' ' TYR . 9.5 t80 -58.2 -33.59 69.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.465 0.65 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.824 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.89 -52.51 9.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.116 -178.376 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -34.76 76.57 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 m -81.72 -39.21 24.57 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -43.32 2.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.824 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.9 mm? -61.61 -44.08 97.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.295 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.62 61.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.62 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.69 -53.7 30.84 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.831 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.1 t90 -56.68 -46.69 81.01 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.647 HG21 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.29 -49.05 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.418 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -64.07 -34.97 79.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -80.97 -13.28 59.02 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -43.38 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.851 0.358 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.9 -26.86 0.11 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.647 ' HA2' HG21 ' A' ' 138' ' ' ILE . . . 102.99 171.29 26.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.061 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.469 ' CZ2' HD11 ' A' ' 138' ' ' ILE . 98.0 m95 -58.78 -29.47 66.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.87 79.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.821 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.478 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.29 -41.01 97.08 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.648 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.507 ' HE1' HH21 ' A' ' 163' ' ' ARG . 9.7 t80 -66.01 -35.27 80.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.499 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.945 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -67.02 -29.1 68.83 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.127 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -26.72 24.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.186 0.517 . . . . 0.0 109.976 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.467 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 8.6 mt -71.2 -40.98 70.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.773 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.505 ' HD1' ' HA ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -130.65 31.79 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.153 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.29 -133.18 7.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.527 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.14 -43.27 17.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.162 0.506 . . . . 0.0 110.302 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -87.71 52.27 4.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.454 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.31 73.62 10.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.154 0.502 . . . . 0.0 110.077 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.756 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -62.79 169.97 2.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.425 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.47 -33.93 66.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.403 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.756 ' HB2' HD12 ' A' ' 156' ' ' LEU . 23.1 mt-10 -72.15 -45.22 61.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.69 0.281 . . . . 0.0 110.524 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.467 ' HB3' ' HA ' ' A' ' 150' ' ' LEU . . . -61.97 -42.68 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -62.48 -50.7 70.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.795 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.62 -35.4 80.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.61 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 2.9 mt -67.94 -29.89 69.07 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.361 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.507 HH21 ' HE1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.22 -48.27 62.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.554 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.534 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.4 OUTLIER -67.43 -44.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.587 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.87 -25.32 73.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.989 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.61 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -69.13 -51.22 40.56 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.571 0.224 . . . . 0.0 111.379 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.956 ' HA ' HG23 ' A' ' 170' ' ' VAL . 19.5 p-90 -71.98 -21.23 61.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.239 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.71 82.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.309 0.576 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.4 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -86.26 -32.84 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.572 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.956 HG23 ' HA ' ' A' ' 167' ' ' TRP . 29.5 m -86.99 -31.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -73.13 -32.97 65.26 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.938 -0.477 . . . . 0.0 110.413 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.862 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.6 OUTLIER -85.63 -27.6 25.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.095 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 1.01 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.5 p -71.0 -26.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 0.0 110.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 1.01 ' HG ' HG11 ' A' ' 173' ' ' VAL . 1.1 mt -120.46 39.54 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.298 0.571 . . . . 0.0 110.388 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.862 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.3 OUTLIER -62.42 -29.93 70.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.794 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.67 40.88 2.99 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.496 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -105.0 10.56 34.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 109.896 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.86 57.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.438 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -85.47 -4.7 59.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.694 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.817 ' HG ' HG13 ' A' ' 82' ' ' VAL . 9.2 mt -87.11 -17.78 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.3 89.18 0.8 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.752 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.535 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -95.86 142.0 28.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . 0.422 ' H ' ' HG ' ' A' ' 183' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.066 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.33 95.27 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.013 2.475 . . . . 0.0 112.141 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . 0.502 HD12 ' HA ' ' A' ' -2' ' ' LEU . 0.6 OUTLIER -68.12 -37.45 81.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.438 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 161.64 -129.15 2.04 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.0 134.65 40.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.813 0.34 . . . . 0.0 110.887 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttm -112.03 137.55 49.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.82 125.38 45.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.43 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 p -99.8 123.92 45.82 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 23.6 Cg_exo -63.98 124.52 13.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.673 2.249 . . . . 0.0 112.127 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.64 -43.08 57.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -160.18 156.72 27.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.485 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -148.96 136.38 10.99 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.485 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -78.28 55.17 5.28 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.362 2.708 . . . . 0.0 112.003 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -162.85 0.56 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -36.88 71.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.997 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -37.84 87.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.79 -35.62 62.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.297 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD22 ' HE1' ' A' ' 46' ' ' MET . 6.2 tp -73.69 -40.47 63.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.333 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.695 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 6.7 p -65.19 -37.71 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 110.06 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -24.65 59.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -60.33 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.605 ' HE2' ' CE1' ' A' ' 17' ' ' PHE . 3.1 t80 -59.12 -56.04 27.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.684 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.508 HG12 HD13 ' A' ' 22' ' ' LEU . 95.9 t -64.32 -38.99 83.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.82 -52.22 53.72 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 20' ' ' TYR . 41.2 t80 -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.696 0.284 . . . . 0.0 110.869 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.466 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.93 -42.03 97.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.782 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.508 HD13 HG12 ' A' ' 18' ' ' VAL . 7.5 mp -71.21 -45.17 63.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.855 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.648 HH11 ' HB2' ' A' ' 31' ' ' ALA . 26.5 ttp85 -65.56 -15.56 62.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.659 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.36 -36.07 24.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -153.6 78.43 1.14 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 111.836 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.95 -68.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.444 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.605 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 1.6 t80 -91.85 56.52 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.165 0.507 . . . . 0.0 110.01 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.42 HG13 ' N ' ' A' ' 29' ' ' CYS . 8.7 p -78.56 -32.36 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.87 -179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.42 ' N ' HG13 ' A' ' 28' ' ' VAL . 34.7 m -70.54 -33.31 71.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.09 56.25 3.26 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.399 178.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.648 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -68.21 112.26 5.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.416 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.23 -51.73 0.12 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 119.88 -1.153 . . . . 0.0 113.849 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.467 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 38.4 Cg_exo -63.47 -43.71 16.74 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.093 1.862 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.783 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.95 32.36 7.54 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.107 -0.952 . . . . 0.0 112.659 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.87 -14.26 39.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.242 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.0 142.18 15.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.781 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.39 -154.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.033 2.489 . . . . 0.0 113.242 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.58 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -85.23 80.15 9.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.628 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.51 16.31 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.809 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.433 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 13.1 m-20 -126.57 157.81 69.64 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' C ' HG23 ' A' ' 148' ' ' THR . 2.9 Cg_exo -71.36 36.58 0.3 Allowed 'Trans proline' 0 N--CA 1.474 0.34 0 C-N-CA 124.251 3.3 . . . . 0.0 113.12 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.414 ' H ' ' C ' ' A' ' 40' ' ' ASP . 0.1 OUTLIER -167.81 -27.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.58 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.2 m170 -59.66 -55.25 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.959 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.488 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -63.1 -22.42 66.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.942 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.743 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -76.76 -48.73 17.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.994 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.549 ' HE1' ' CZ3' ' A' ' 144' ' ' TRP . 1.0 OUTLIER -68.98 -32.91 72.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.368 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.25 -43.02 96.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.843 -179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.13 50.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 110.174 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.809 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -62.64 -62.19 1.91 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.278 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.682 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.15 -48.34 32.33 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.834 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.96 -45.5 82.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.124 0.462 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.9 96.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.644 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.5 OUTLIER -76.93 -28.19 55.17 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.097 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.98 -23.09 66.52 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 m -94.85 -39.19 10.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.101 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -84.81 -57.71 3.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.7 OUTLIER -82.83 73.6 9.85 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.986 0.514 . . . . 0.0 111.383 -179.058 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 12.6 mtt180 -76.5 -10.28 59.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.522 -179.876 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 54.43 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -57.43 1.84 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.052 0.453 . . . . 0.0 111.875 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.611 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 70.5 m-85 -55.17 -31.74 61.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -39.04 87.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.8 m-20 -70.69 -20.56 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 110.267 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.907 HD11 ' HA ' ' A' ' 61' ' ' PHE . 25.0 mt -70.13 -41.43 73.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.561 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.99 -43.97 61.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.09 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.642 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -54.84 -43.63 73.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.616 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.69 HE22 HD13 ' A' ' 106' ' ' LEU . 26.9 mt-30 -63.22 -58.07 8.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.448 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HG ' ' HE3' ' A' ' 115' ' ' MET . 0.5 OUTLIER -80.43 8.02 8.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.178 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.561 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 11.9 t60 -79.0 -23.06 44.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -63.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 9.0 t -172.88 144.47 1.22 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.182 -179.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.563 ' HG3' ' HE2' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.85 171.71 16.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.88 2.387 . . . . 0.0 111.598 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.623 ' H ' HD22 ' A' ' 118' ' ' LEU . . . 97.54 -60.8 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.342 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 19.19 0.13 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -75.9 -22.37 56.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.606 0.241 . . . . 0.0 111.185 179.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.628 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -62.06 -39.5 92.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.612 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 3.9 mt-30 -67.62 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.406 ' HB3' HD22 ' A' ' 180' ' ' LEU . 0.7 OUTLIER -59.86 -45.12 93.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.813 0.34 . . . . 0.0 110.154 179.193 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 79' ' ' PHE . 21.2 t80 -62.35 -51.74 66.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.928 179.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -59.24 -33.81 71.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.612 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 74.4 mm-40 -63.56 -50.67 68.59 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.126 0.489 . . . . 0.0 109.991 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.678 HG21 HD21 ' A' ' 180' ' ' LEU . 65.5 t -63.7 -37.34 79.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.461 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 m -61.64 -46.73 88.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.756 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.641 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.37 -39.45 93.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 110.243 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.0 mm-40 -67.91 -28.68 67.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.28 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.496 HD23 HH11 ' A' ' 95' ' ' ARG . 0.3 OUTLIER -76.61 -38.57 54.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -82.29 -8.79 59.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -38.58 12.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.807 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.4 57.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.131 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.518 ' N ' ' HD3' ' A' ' 91' ' ' PRO . . . 173.7 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.498 -1.334 . . . . 0.0 115.098 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.54 ' HA ' ' HE2' ' A' ' 99' ' ' PHE . 9.4 Cg_endo -82.35 23.89 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.454 2.102 . . . . 0.0 111.249 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.792 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 m-20 -63.94 158.0 23.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.078 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.655 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 5.8 m95 -50.35 -24.97 3.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.23 -49.94 66.95 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.467 -0.873 . . . . 0.0 110.955 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.759 ' HD2' HD13 ' A' ' 174' ' ' LEU . 8.4 mtt180 -86.66 -18.67 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.052 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.67 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.13 -31.51 63.38 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.471 0.653 . . . . 0.0 110.259 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.66 HG12 ' HB2' ' A' ' 53' ' ' PHE . 28.8 t -60.99 -52.63 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.49 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.64 69.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.312 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.67 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.31 -55.11 39.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.695 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 m-85 -76.65 -38.26 54.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.06 -35.69 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.613 ' HE1' ' CE2' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -52.75 -60.76 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 111.551 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.23 -34.54 69.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.143 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.288 0.544 . . . . 0.0 110.517 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.703 ' HB2' HD12 ' A' ' 64' ' ' LEU . . . -68.05 -39.94 82.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.69 HD13 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -60.59 -44.92 95.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.663 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.443 ' O ' HG21 ' A' ' 111' ' ' VAL . 95.7 m -66.51 -40.73 89.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.203 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.436 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -55.68 -54.6 42.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.82 -15.46 62.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.1 m -78.31 -33.07 49.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 107' ' ' CYS . 47.3 t -75.45 -31.67 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.347 0.594 . . . . 0.0 109.556 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -77.12 0.7 20.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.208 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.68 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -132.53 -151.45 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.813 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.448 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 1.3 mt-10 -108.69 51.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.83 0.348 . . . . 0.0 111.353 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.68 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -146.87 42.24 1.13 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.69 -45.84 97.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.344 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -58.13 -16.98 29.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.279 1.986 . . . . 0.0 113.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.623 HD22 ' H ' ' A' ' 73' ' ' GLY . 0.4 OUTLIER -82.42 -22.51 35.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.606 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 49.9 t -56.02 -54.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.243 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.43 77.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.438 -0.886 . . . . 0.0 111.968 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.554 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.5 mm-40 -67.34 -50.92 58.0 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.575 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 30.5 t -57.84 -33.86 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 0.0 109.767 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.33 -46.8 78.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.293 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.583 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.9 pt-20 -73.55 -35.12 65.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.021 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.628 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.5 m0 -58.92 -40.71 85.37 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.5 ttm -72.45 -52.79 14.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.849 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.583 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -62.01 -32.22 53.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.446 ' N ' HG11 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -68.02 -52.64 33.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.994 179.096 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.641 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 6.4 t80 -56.6 -34.72 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 110.81 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 1.03 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.45 -53.37 8.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.454 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -62.6 -32.01 72.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.1 m -86.75 -43.61 12.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -44.5 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 1.03 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -59.97 -42.27 93.76 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.348 0.522 . . . . 0.0 111.632 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.32 -31.1 53.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -53.4 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.792 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 57.9 t90 -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.522 HG21 ' HA2' ' A' ' 143' ' ' GLY . 3.5 mt -57.07 -46.86 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.959 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -67.55 -29.28 68.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -94.52 -2.06 52.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.497 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -126.37 48.62 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 111.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.78 -67.41 0.92 Allowed Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.554 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.522 ' HA2' HG21 ' A' ' 138' ' ' ILE . . . 124.79 177.23 14.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.974 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.549 ' CZ3' ' HE1' ' A' ' 46' ' ' MET . 96.5 m95 -60.93 -28.84 69.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.07 69.67 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.794 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.655 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -68.6 -38.96 81.05 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.791 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.427 ' HZ ' ' CB ' ' A' ' 49' ' ' ALA . 7.7 t80 -63.14 -41.44 99.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.363 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.743 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -64.22 -30.85 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.01 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 -16.22 35.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.761 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.93 -45.15 24.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.736 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 30.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -99.85 -119.86 4.38 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -74.22 -51.07 16.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -94.13 64.53 1.68 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.204 179.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.62 71.78 10.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.315 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -64.24 158.16 23.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.88 -31.71 50.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.141 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.751 ' HB2' HD11 ' A' ' 156' ' ' LEU . 6.9 mm-40 -68.19 -48.92 63.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.497 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.469 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -64.15 -36.31 83.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.417 179.313 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -59.86 -56.1 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.928 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.406 HH21 ' CD ' ' A' ' 158' ' ' GLU . 19.5 ptt180 -69.44 -29.1 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -63.82 -39.93 95.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.335 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.809 HH22 ' HA ' ' A' ' 49' ' ' ALA . 4.0 ttp180 -70.06 -38.72 75.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.324 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.547 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.5 OUTLIER -62.85 -46.06 89.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.237 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.33 75.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.195 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 4.7 t-20 -67.67 -56.69 8.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.972 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.857 ' HA ' HG21 ' A' ' 170' ' ' VAL . 21.4 p-90 -67.73 -21.44 65.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.412 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.8 52.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.215 0.322 . . . . 0.0 110.766 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 m -88.02 -26.91 22.35 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.857 HG21 ' HA ' ' A' ' 167' ' ' TRP . 35.1 m -80.03 -24.64 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.017 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.668 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 13.0 ttp85 -81.09 -23.06 38.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.601 ' HA ' HG22 ' A' ' 175' ' ' THR . 0.7 OUTLIER -90.19 -35.54 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.162 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.862 HG12 ' HG ' ' A' ' 174' ' ' LEU . 7.1 p -62.77 -30.15 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.163 0.506 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.862 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -118.54 40.13 3.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.992 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.601 HG22 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.69 -25.84 67.66 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.34 9.34 55.12 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.712 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.585 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -72.43 -7.64 50.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.011 0.405 . . . . 0.0 111.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.37 66.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.027 0.441 . . . . 0.0 110.513 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.45 12.65 34.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.236 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.678 HD21 HG21 ' A' ' 82' ' ' VAL . 7.9 mt -100.27 -13.67 18.76 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.18 86.75 0.58 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.941 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.642 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -95.49 114.74 26.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.784 0.326 . . . . 0.0 110.355 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' -4' ' ' GLY . 16.0 Cg_exo -69.17 -28.8 27.67 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 67.84 92.38 0.08 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.965 0.791 . . . . 0.0 111.785 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -143.62 75.59 0.31 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.636 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.8 m -153.04 164.21 38.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.645 0.259 . . . . 0.0 110.364 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttm -123.68 128.57 49.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.645 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.63 123.11 47.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.44 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -99.5 140.5 21.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.63 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.44 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.7 Cg_exo -77.42 4.15 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.153 2.568 . . . . 0.0 112.436 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.84 -28.89 8.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.745 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -152.23 129.48 11.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 0.0 110.728 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.476 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -149.74 119.22 3.84 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.638 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.7 Cg_exo -78.26 53.55 4.56 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.338 2.692 . . . . 0.0 112.106 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.34 -157.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -41.45 72.75 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.922 0.489 . . . . 0.0 112.279 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -61.12 -37.78 83.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.13 -35.76 61.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.178 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.589 ' HB2' HD11 ' A' ' 42' ' ' LEU . 4.6 tp -73.63 -42.24 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.477 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.538 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 8.0 p -64.6 -36.11 76.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.42 60.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.318 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -65.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.94 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.665 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.2 t80 -55.13 -54.77 39.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 22' ' ' LEU . 59.9 t -67.61 -38.34 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 -179.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.432 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -62.75 -55.39 27.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.91 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.686 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 t80 -60.1 -42.64 95.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.783 0.433 . . . . 0.0 110.852 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.541 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.86 -44.8 95.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.259 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.551 HD11 HG11 ' A' ' 18' ' ' VAL . 7.6 mp -71.13 -44.26 65.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.757 HH11 ' HB1' ' A' ' 31' ' ' ALA . 16.6 ttp85 -67.64 -13.01 61.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.41 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 2.5 mt-30 -84.36 -37.44 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.229 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -154.56 83.4 1.11 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.45 -69.13 0.35 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.664 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.594 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.3 t80 -98.68 54.79 1.04 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.236 0.541 . . . . 0.0 110.201 179.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -78.67 -27.12 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.179 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -39.16 80.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.87 57.34 4.64 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.169 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.757 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -65.98 110.97 3.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.413 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.5 -53.54 0.09 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.878 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.432 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 24.8 Cg_exo -65.12 -48.72 3.3 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.016 1.81 . . . . 0.0 111.27 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.686 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.03 31.46 6.26 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.301 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.33 -19.81 35.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 0.0 109.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.51 132.84 11.25 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -91.33 -147.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.617 2.211 . . . . 0.0 113.882 -178.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.625 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -75.31 76.3 2.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.73 31.84 5.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.793 0.33 . . . . 0.0 111.291 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.476 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 12.7 m-20 -142.04 163.29 41.05 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.74 48.46 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.247 2.631 . . . . 0.0 112.331 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.589 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.924 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.625 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.2 m170 -59.35 -56.47 21.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.944 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.571 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.03 -24.65 64.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.906 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.97 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -75.31 -51.49 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.23 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.607 ' HE3' ' CZ3' ' A' ' 144' ' ' TRP . 5.2 ttm -68.92 -39.36 79.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.673 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -61.95 -35.53 78.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.785 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.45 -43.76 18.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.518 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.63 ' HB2' HG23 ' A' ' 97' ' ' VAL . . . -58.57 -54.32 48.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.601 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.2 -47.8 54.65 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.667 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.01 -48.51 81.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 110.898 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.474 ' CD ' HH21 ' A' ' 56' ' ' ARG . 4.1 tp10 -60.03 -48.74 80.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.926 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.647 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.4 OUTLIER -68.87 -35.24 76.66 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.927 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.98 -28.0 68.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.65 0.738 . . . . 0.0 109.409 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.1 m -85.81 -32.16 21.92 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.397 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.474 HH21 ' CD ' ' A' ' 52' ' ' GLU . 7.6 mtt180 -88.73 -21.21 23.97 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.638 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -85.16 95.9 9.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.375 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -60.67 -32.94 72.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.482 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.547 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -108.62 94.64 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.126 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.638 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.41 -70.94 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.666 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 48.9 m-85 -78.51 -7.3 57.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -46.99 58.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' OD1' ' HD3' ' A' ' 59' ' ' ARG . 2.5 m-20 -68.71 -18.32 64.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.199 0.524 . . . . 0.0 110.472 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.57 ' CD1' ' HA ' ' A' ' 61' ' ' PHE . 31.8 mt -72.78 -40.41 65.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.45 -45.88 51.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.413 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -53.67 -43.17 68.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.709 HE22 HD11 ' A' ' 106' ' ' LEU . 22.9 mt-30 -64.06 -54.77 28.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.041 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.497 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.09 16.06 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 -177.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -26.53 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 0.0 110.691 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -68.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.668 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t -165.92 145.72 5.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.501 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.655 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 8.2 Cg_exo -72.11 176.1 8.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.964 2.443 . . . . 0.0 111.974 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.675 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 90.64 -60.09 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -77.07 52.85 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 0.0 110.967 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.85 -25.52 10.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.709 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.3 pt20 -62.72 -35.36 79.5 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.856 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.593 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 24.4 mp0 -67.35 -45.14 77.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -63.56 -44.19 94.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.892 0.377 . . . . 0.0 110.086 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.595 ' O ' HG13 ' A' ' 82' ' ' VAL . 10.9 t80 -62.26 -49.27 76.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.789 179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 p -59.68 -32.95 70.96 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.849 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.593 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.3 mm-40 -64.82 -54.95 23.09 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.595 HG13 ' O ' ' A' ' 79' ' ' PHE . 7.4 p -61.58 -35.3 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.914 0.387 . . . . 0.0 110.406 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.4 m -66.99 -43.1 83.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.83 -44.52 92.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.232 0.539 . . . . 0.0 110.015 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.493 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 40.1 mt-10 -69.7 -18.21 63.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.782 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.432 HD11 ' CZ ' ' A' ' 95' ' ' ARG . 1.1 mp -83.88 -39.74 19.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.146 0.498 . . . . 0.0 109.913 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.63 -4.86 58.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -44.33 -43.32 7.42 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.876 0.735 . . . . 0.0 111.666 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.48 57.34 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.93 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 168.0 56.85 0.03 OUTLIER Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.775 -1.203 . . . . 0.0 114.655 179.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.563 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.1 Cg_endo -80.5 39.8 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.326 2.017 . . . . 0.0 111.646 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.806 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 11.5 t-20 -65.56 158.93 25.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.414 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.698 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.4 m95 -54.97 -27.44 43.82 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.321 0.388 . . . . 0.0 110.297 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.584 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.75 -39.56 97.59 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.523 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.3 -24.64 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.551 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.698 ' HB2' ' HA ' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -55.26 -30.62 60.43 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 49' ' ' ALA . 9.4 t -63.07 -53.34 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.374 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.411 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -64.63 -28.09 69.38 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.282 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.596 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 4.5 m-85 -56.83 -56.82 16.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.131 0.491 . . . . 0.0 109.928 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 8.0 m-85 -76.1 -36.33 58.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.838 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 1.7 t -60.15 -38.05 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.644 ' HE1' ' CE2' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -58.13 -47.47 83.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.68 0.276 . . . . 0.0 111.061 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.425 ' HA3' ' HE2' ' A' ' 126' ' ' MET . . . -77.6 -40.0 23.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.905 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.51 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.072 0.436 . . . . 0.0 110.608 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.501 ' HB2' HD11 ' A' ' 64' ' ' LEU . . . -68.43 -41.38 80.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.709 HD11 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -58.75 -47.5 84.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . . . . . . . . . 63.3 m -60.93 -41.45 96.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.23 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.58 -55.79 25.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.53 -18.18 64.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.604 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -77.94 -27.99 49.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 43.6 t -81.77 -23.03 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.143 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -78.97 -15.26 58.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.9 -169.25 2.0 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.02 60.99 6.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.655 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -135.66 32.19 3.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.005 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.606 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 5.9 mp0 -54.86 -51.96 74.7 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.194 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.606 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 35.3 Cg_exo -61.14 -27.45 84.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.92 1.747 . . . . 0.0 112.433 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.675 HD23 ' H ' ' A' ' 73' ' ' GLY . 2.6 mp -71.44 -26.67 62.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.52 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.14 -53.6 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.687 0.279 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.71 83.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.79 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.492 ' HG3' ' O ' ' A' ' 117' ' ' PRO . 28.4 mt-30 -63.36 -53.68 48.73 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 118' ' ' LEU . 48.2 t -57.54 -33.9 45.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.05 0.452 . . . . 0.0 110.156 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.5 -46.48 82.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.553 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.539 ' HA ' HG11 ' A' ' 127' ' ' VAL . 21.2 pt-20 -74.09 -37.72 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.906 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.709 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.3 m0 -56.79 -37.43 71.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.633 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.9 ttm -72.36 -57.91 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.888 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.539 HG11 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -61.36 -30.36 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.975 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.459 ' N ' HG13 ' A' ' 127' ' ' VAL . 10.6 mm-40 -68.8 -50.55 49.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.148 178.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.658 ' HE2' ' CE1' ' A' ' 129' ' ' TYR . 3.6 t80 -62.26 -31.18 71.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 111.107 179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.912 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.3 -54.04 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.481 -178.762 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.02 -35.85 77.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.892 0.377 . . . . 0.0 111.876 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.1 m -78.18 -36.21 47.75 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -43.8 1.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.912 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.2 mm? -58.27 -46.51 85.88 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.394 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.82 -35.82 45.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.19 -52.05 51.86 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.806 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.5 t90 -58.13 -47.65 82.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.482 HG23 ' HH2' ' A' ' 93' ' ' TRP . 9.2 mt -56.94 -48.1 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.755 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -63.31 -32.98 74.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 m -81.88 -18.38 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 t -84.24 -55.03 4.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 111.544 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.46 -17.32 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.63 171.58 29.18 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.615 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.607 ' CZ3' ' HE3' ' A' ' 46' ' ' MET . 95.4 m95 -59.51 -28.0 66.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.95 0.405 . . . . 0.0 109.99 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.59 78.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.788 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.494 ' HG3' HD11 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -63.58 -41.58 98.36 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.563 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.635 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 14.8 t80 -66.46 -34.07 77.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.49 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.97 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.06 -29.18 70.05 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.804 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.13 -26.07 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.188 0.518 . . . . 0.0 110.043 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.494 HD11 ' HG3' ' A' ' 146' ' ' GLU . 3.5 mt -73.96 -39.14 63.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.628 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 151' ' ' TYR . 26.7 m-85 -126.83 29.24 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.666 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.16 -140.49 5.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.557 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -54.76 12.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.075 -0.563 . . . . 0.0 111.414 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -81.25 53.59 4.66 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.72 -179.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.94 72.02 10.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.0 109.71 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.535 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.09 165.47 3.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.627 -179.061 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -56.99 -33.66 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.327 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.535 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 15.8 mm-40 -71.17 -45.57 63.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.951 0.405 . . . . 0.0 110.305 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.677 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -59.96 -47.1 87.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.777 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 6.0 ptp180 -63.72 -43.37 96.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.11 -22.37 61.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.277 0.56 . . . . 0.0 110.57 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 -47.05 17.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.677 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -62.42 -46.52 88.22 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.419 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.648 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.19 -44.3 95.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.07 -10.22 72.97 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.757 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -85.28 -58.05 2.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.861 -0.169 . . . . 0.0 110.82 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.799 ' HA ' HG22 ' A' ' 170' ' ' VAL . 17.3 p-90 -61.37 -24.91 66.81 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 123.163 0.289 . . . . 0.0 111.311 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.34 84.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.407 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.416 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.9 OUTLIER -88.02 -28.02 21.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.799 HG22 ' HA ' ' A' ' 167' ' ' TRP . 3.2 m -91.16 -42.71 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.632 ' HD3' ' CE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -70.31 -24.83 63.08 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.534 -0.729 . . . . 0.0 111.007 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.813 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.2 OUTLIER -93.21 -9.96 37.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.913 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.777 HG12 ' HG ' ' A' ' 174' ' ' LEU . 3.6 p -85.62 -23.22 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 0.0 109.373 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.777 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -120.35 40.33 3.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.802 178.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.813 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -69.52 -22.37 63.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.104 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.45 9.8 53.23 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.937 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.493 ' HA ' ' OE1' ' A' ' 85' ' ' GLU . . . -76.82 7.41 4.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.095 0.448 . . . . 0.0 111.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.12 65.18 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.357 0.598 . . . . 0.0 111.09 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.32 13.87 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.212 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.455 HD11 ' N ' ' A' ' 180' ' ' LEU . 6.9 mp -100.12 -46.65 5.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.721 -178.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.413 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -77.54 103.43 1.85 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.123 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.41 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -94.51 -3.4 49.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.142 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.6 152.72 70.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.808 2.338 . . . . 0.0 111.888 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.65 136.79 46.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.954 0.407 . . . . 0.0 110.824 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -149.96 -160.17 9.11 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.548 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.9 t -75.95 135.16 40.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt -100.04 -4.51 29.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.65 154.43 42.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.46 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 p -114.1 140.09 24.5 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.46 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 4.7 Cg_exo -75.42 155.1 40.98 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.963 2.442 . . . . 0.0 111.874 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 135.26 29.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.61 119.32 37.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.07 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.45 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.69 133.17 59.44 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.002 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.45 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 7.4 Cg_exo -73.33 55.96 3.14 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.358 2.705 . . . . 0.0 112.12 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -85.58 -167.45 1.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.461 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -37.6 65.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.544 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.07 -37.04 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.734 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.72 62.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.849 0.357 . . . . 0.0 110.097 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.453 ' HB2' HD12 ' A' ' 42' ' ' LEU . 10.5 tp -70.32 -42.15 72.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.608 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 4.8 p -65.9 -35.39 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.939 0.4 . . . . 0.0 110.061 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.495 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -74.31 -20.48 60.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.659 178.838 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.06 -63.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.72 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.527 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 3.1 t80 -55.35 -51.28 67.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.579 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.0 t -70.14 -41.14 78.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 110.365 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.588 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.38 -54.25 38.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.576 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.734 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 58.3 t80 -60.64 -42.91 97.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.537 0.335 . . . . 0.0 110.979 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.527 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.2 -49.09 77.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.57 HD22 HG11 ' A' ' 119' ' ' VAL . 7.8 mp -65.78 -48.78 70.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.604 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.614 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 6.1 ttp180 -62.6 -20.34 64.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.446 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.456 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.3 mt-30 -85.39 -32.58 22.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.311 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -148.52 75.86 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.849 0.356 . . . . 0.0 111.856 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.37 -69.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.624 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.616 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.7 t80 -92.21 51.15 1.74 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.404 HG11 ' N ' ' A' ' 29' ' ' CYS . 12.4 p -78.19 -26.52 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.404 ' N ' HG11 ' A' ' 28' ' ' VAL . 4.1 t -76.09 -16.01 59.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.412 178.411 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.39 49.28 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.332 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.614 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -63.67 114.36 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.08 -48.23 0.05 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.692 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.588 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 6.1 Cg_exo -77.03 -48.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.201 1.934 . . . . 0.0 111.867 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.734 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -83.77 22.76 7.39 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.557 -0.747 . . . . 0.0 114.229 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -76.03 -32.69 59.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.37 0.585 . . . . 0.0 109.86 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.61 111.95 4.23 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 84.1 Cg_endo -84.54 -139.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.563 2.175 . . . . 0.0 114.264 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.701 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -70.03 80.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.821 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.58 -0.41 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.495 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 8.0 m-20 -110.82 161.11 26.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.447 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -77.08 45.61 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.529 2.819 . . . . 0.0 112.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.453 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -173.93 -27.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.331 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.701 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.4 m170 -62.89 -51.26 67.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.559 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.505 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -64.01 -21.68 66.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.27 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.721 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.97 -52.32 11.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.846 ' HE2' ' HZ3' ' A' ' 144' ' ' TRP . 0.0 OUTLIER -64.86 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.297 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -60.27 -40.33 89.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.206 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.94 -28.44 43.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 110.192 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.629 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -67.71 -60.47 2.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.407 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.41 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -48.91 -49.01 29.96 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.46 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.96 -53.0 58.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 111.764 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.403 ' HG3' ' HE ' ' A' ' 56' ' ' ARG . 8.2 tt0 -63.16 -45.66 90.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.656 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.502 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.75 -30.99 66.19 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.549 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -65.13 -30.9 71.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -86.14 -19.16 30.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.342 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.403 ' HE ' ' HG3' ' A' ' 52' ' ' GLU . 16.1 mtt-85 -98.09 -49.25 4.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.187 0.518 . . . . 0.0 112.209 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.425 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.2 90.13 7.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.236 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -67.48 -21.97 65.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.166 0.508 . . . . 0.0 110.881 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -88.67 66.53 8.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 -14.43 8.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.013 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.59 ' HE2' ' CE1' ' A' ' 61' ' ' PHE . 7.9 m-85 -114.52 -0.06 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.28 -178.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -51.84 23.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.257 0.551 . . . . 0.0 111.088 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.466 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -57.04 -33.82 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.806 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.849 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 7.5 mp -56.93 -43.25 81.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.49 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.555 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -81.47 -42.77 19.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.63 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 63' ' ' ASP . . . -48.09 -46.33 33.69 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.639 0.587 . . . . 0.0 111.799 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' NE2' ' HG ' ' A' ' 180' ' ' LEU . 65.0 mt-30 -80.65 -47.71 13.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.489 HD11 ' HA ' ' A' ' 68' ' ' LEU . 0.6 OUTLIER -90.28 20.89 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.555 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -80.2 -38.13 31.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.222 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 2.4 p -90.56 -62.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 -178.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -158.66 152.77 19.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.428 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 2.9 Cg_endo -79.66 178.17 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.847 2.365 . . . . 0.0 111.497 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.426 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.17 -56.52 4.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.759 179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.44 34.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.129 0.49 . . . . 0.0 111.61 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.426 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -94.93 -24.66 16.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.66 179.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.643 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -58.45 -47.15 84.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.953 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.26 -45.0 88.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.034 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.826 ' HB3' HD11 ' A' ' 180' ' ' LEU . 11.0 mtt180 -64.91 -40.82 95.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -67.21 -48.04 69.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.459 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -59.11 -28.64 66.72 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -68.14 -60.43 2.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.799 0.333 . . . . 0.0 110.29 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.496 HG21 ' O ' ' A' ' 177' ' ' ALA . 10.6 p -54.52 -36.05 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.594 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.468 ' N ' HG13 ' A' ' 82' ' ' VAL . 2.4 p -68.81 -41.85 78.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.767 0.318 . . . . 0.0 110.475 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.593 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -69.83 -38.6 76.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.55 -26.34 64.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.47 ' O ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.54 -33.09 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.176 0.512 . . . . 0.0 110.392 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -85.35 -10.07 56.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -41.3 -48.73 3.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.507 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.78 54.38 0.23 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.185 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 165.7 57.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 119.376 -1.392 . . . . 0.0 114.683 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 41.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.072 1.848 . . . . 0.0 111.377 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.813 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -70.65 163.14 27.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.069 -178.542 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.648 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.3 m95 -53.59 -27.54 27.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.37 97.88 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.745 HH11 ' HB2' ' A' ' 174' ' ' LEU . 5.0 mtp180 -87.46 -19.99 27.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.579 -0.31 . . . . 0.0 111.353 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.789 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -54.97 -31.87 61.04 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 110.326 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.502 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.8 t -61.52 -54.01 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.89 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.42 70.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.272 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.654 ' HD2' ' CD1' ' A' ' 99' ' ' PHE . 6.0 m-85 -56.72 -55.18 37.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.374 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.653 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 6.8 m-85 -76.93 -37.91 54.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.179 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.29 -37.99 78.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' CE2' HG23 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -54.13 -51.54 63.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.696 -179.534 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.24 -37.54 36.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.996 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.68 95.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.126 0.463 . . . . 0.0 110.745 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.422 ' O ' HD23 ' A' ' 64' ' ' LEU . . . -69.96 -43.85 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.849 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -59.65 -42.34 92.56 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.279 0.561 . . . . 0.0 110.832 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.498 ' HB3' HD22 ' A' ' 22' ' ' LEU . 95.8 m -63.74 -44.99 91.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.047 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.2 76.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.572 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HA ' HD22 ' A' ' 112' ' ' ASN . 1.0 OUTLIER -76.8 -17.75 58.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.8 m -82.63 -26.43 32.23 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.715 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 96.2 t -70.06 -38.27 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.837 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.576 HD22 ' HA ' ' A' ' 109' ' ' GLU . 21.1 p30 -82.48 1.79 35.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.742 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -120.69 -172.65 2.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.267 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.95 46.92 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.243 0.544 . . . . 0.0 111.202 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.742 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -142.22 37.15 1.54 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.199 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.3 OUTLIER -56.13 -50.12 89.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.045 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 42.8 Cg_exo -57.77 -25.94 71.09 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.163 1.909 . . . . 0.0 112.841 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.526 ' O ' HG22 ' A' ' 122' ' ' VAL . 1.4 mm? -69.05 -25.47 64.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.57 HG11 HD22 ' A' ' 22' ' ' LEU . 43.1 t -57.42 -45.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.96 179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.34 -34.75 86.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.712 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -66.0 -50.25 64.92 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.526 HG22 ' O ' ' A' ' 118' ' ' LEU . 29.0 t -58.17 -32.61 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.164 0.507 . . . . 0.0 109.78 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.0 -45.86 80.03 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.429 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.794 ' HA ' HG13 ' A' ' 127' ' ' VAL . 14.4 pt-20 -74.51 -36.53 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.643 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 43.3 m0 -57.4 -39.4 76.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.1 ttm -73.74 -54.96 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.784 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.794 HG13 ' HA ' ' A' ' 124' ' ' GLU . 4.3 p -61.58 -33.03 55.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -46.73 66.0 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.304 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.665 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 21.0 t80 -61.6 -36.45 80.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.564 0.697 . . . . 0.0 110.336 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.928 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.65 -54.14 15.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.254 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.59 -37.27 80.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -74.72 -36.28 62.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -130.59 -41.36 1.2 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.928 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -60.89 -49.02 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.334 0.515 . . . . 0.0 111.813 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.73 60.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.292 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.4 -55.7 19.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.192 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.813 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 42.5 t90 -53.68 -48.48 69.45 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.126 0.488 . . . . 0.0 109.797 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.608 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.2 mt -56.27 -48.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.724 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -64.53 -36.34 83.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 p -80.82 -14.93 57.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.927 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -55.65 3.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.87 -10.91 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.577 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.28 169.28 44.21 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.698 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.846 ' HZ3' ' HE2' ' A' ' 46' ' ' MET . 96.4 m95 -60.52 -30.52 69.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.84 73.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.106 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.423 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.99 -41.31 95.53 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.533 ' HE1' HH11 ' A' ' 163' ' ' ARG . 6.9 t80 -64.93 -40.83 95.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.601 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.721 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.24 -26.23 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 110.947 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.23 -29.02 22.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.439 . . . . 0.0 110.306 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -62.67 -51.84 65.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.338 -179.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.511 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -132.43 32.93 3.87 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.26 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.534 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.84 -129.61 6.75 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.864 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -51.61 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.249 0.547 . . . . 0.0 110.642 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.542 ' O ' HD22 ' A' ' 156' ' ' LEU . . . -93.13 55.89 2.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.394 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.78 73.84 7.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 110.042 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.721 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.54 161.04 15.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.776 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 3.2 mt-10 -59.21 -30.37 68.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.061 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.721 ' HB2' HD11 ' A' ' 156' ' ' LEU . 9.1 mm-40 -72.88 -36.26 67.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.487 ' HB3' ' HG ' ' A' ' 156' ' ' LEU . . . -70.32 -34.79 73.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.013 178.858 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.776 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 25.3 mtt-85 -63.09 -55.24 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.386 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.448 ' HD3' ' OE1' ' A' ' 158' ' ' GLU . 2.9 ptm180 -65.0 -25.15 67.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.529 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -68.47 -43.42 77.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.93 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.629 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.4 ttp180 -70.95 -34.52 71.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.521 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.515 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER -69.49 -45.6 68.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.172 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.19 -22.14 77.32 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.529 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 18.8 t-20 -64.13 -66.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.406 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.717 ' HA ' HG22 ' A' ' 170' ' ' VAL . 26.7 p-90 -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.931 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.47 75.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.428 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.99 -29.46 20.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.717 HG22 ' HA ' ' A' ' 167' ' ' TRP . 8.4 m -92.13 -35.64 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -70.23 -34.36 72.78 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.925 -0.484 . . . . 0.0 110.595 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.95 -13.39 50.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.905 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.926 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -86.22 -23.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 109.893 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.926 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -121.07 34.29 5.26 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.012 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -18.1 65.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.823 -179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.69 -4.58 76.38 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.185 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.496 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -69.94 -5.12 23.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.9 t -80.02 65.54 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 110.994 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.28 -10.11 58.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.826 HD11 ' HB3' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -101.04 63.93 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.752 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.97 -55.33 4.9 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.591 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -161.45 -4.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 0.0 111.244 -179.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.1 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.733 -179.73 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' -4' ' ' GLY . 13.4 Cg_exo -69.91 -19.6 35.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.891 2.394 . . . . 0.0 112.077 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . 0.413 HD11 ' HA ' ' A' ' -2' ' ' LEU . 2.3 mm? -93.96 122.01 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.41 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 173.33 179.18 43.83 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.17 -45.27 4.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.168 0.484 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.53 -171.0 0.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.21 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 124.15 7.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.466 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.5 p -99.4 126.63 36.96 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.466 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 14.2 Cg_exo -69.54 117.16 4.9 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.866 2.377 . . . . 0.0 111.772 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.98 122.16 36.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.576 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m -113.15 34.1 4.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 110.409 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.412 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -143.42 141.85 20.0 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 6.9 Cg_exo -73.71 84.96 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.07 2.513 . . . . 0.0 112.103 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.18 -162.27 0.33 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.219 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -47.64 64.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.416 ' O ' HG12 ' A' ' 14' ' ' VAL . 15.4 ttp180 -59.07 -37.74 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.491 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.14 -36.6 61.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.989 0.424 . . . . 0.0 109.966 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD13 HD13 ' A' ' 42' ' ' LEU . 2.1 tp -70.44 -42.37 71.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.249 179.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.603 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 5.9 p -63.57 -37.38 79.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.06 0.457 . . . . 0.0 109.775 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.03 -23.87 61.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.88 -63.42 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.255 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.62 -50.06 66.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.522 HG13 HD12 ' A' ' 22' ' ' LEU . 74.5 t -69.06 -41.14 81.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.107 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.585 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.17 -49.2 81.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 20' ' ' TYR . 65.2 t80 -62.32 -47.17 85.45 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.594 0.358 . . . . 0.0 111.475 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -40.9 96.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.285 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.598 HD23 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -72.15 -46.9 54.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.808 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 18.6 ttp85 -63.5 -17.06 62.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.804 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -80.87 -36.2 31.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.71 78.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.101 0.476 . . . . 0.0 112.082 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.35 -63.12 0.41 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.449 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.552 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 1.4 t80 -90.59 50.5 1.83 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.199 0.523 . . . . 0.0 109.915 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.3 -34.16 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.161 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -22.83 63.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.666 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.29 49.83 0.85 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.614 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.79 126.81 29.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.51 ' HA2' ' HG3' ' A' ' 35' ' ' GLU . . . 168.36 -54.23 0.22 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.736 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.585 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 17.4 Cg_exo -68.83 -49.22 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.312 2.008 . . . . 0.0 112.21 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -90.1 31.53 5.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.521 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.51 ' HG3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 mm-40 -79.14 -43.05 24.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.608 . . . . 0.0 109.758 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.414 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.92 147.17 33.18 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.892 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.414 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.7 Cg_endo -98.41 -151.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.196 2.598 . . . . 0.0 113.579 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -80.7 87.33 5.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.52 -14.09 5.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.4 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 47.7 m-20 -94.41 158.74 35.18 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.076 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_endo -75.17 50.7 2.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.721 2.947 . . . . 0.0 111.816 178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.567 HD13 HD13 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -178.97 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.345 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.565 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.6 m170 -60.58 -56.57 19.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.119 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.74 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -59.37 -24.73 63.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.041 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.923 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -77.81 -51.48 10.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.547 ' HE1' ' HZ3' ' A' ' 144' ' ' TRP . 3.6 ttm -64.72 -41.75 95.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -62.83 -31.55 72.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.665 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.16 -44.68 19.43 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.737 0.304 . . . . 0.0 110.468 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.426 ' HB2' HG13 ' A' ' 97' ' ' VAL . . . -58.73 -54.19 49.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.09 -49.18 50.63 Favored Glycine 0 C--O 1.213 -1.165 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.238 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -56.4 -51.61 67.72 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.841 0.456 . . . . 0.0 111.627 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -48.25 82.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.634 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 6.4 m-85 -69.97 -32.83 71.26 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.391 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.02 -27.05 68.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.706 0.765 . . . . 0.0 109.029 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -79.65 -31.94 41.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.617 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 34.1 mtt180 -89.84 -54.01 4.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.187 0.517 . . . . 0.0 111.376 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.639 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -85.36 68.81 10.6 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.555 0.742 . . . . 0.0 111.099 -179.693 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -74.47 -26.19 59.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.955 0.407 . . . . 0.0 111.912 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -82.11 61.82 5.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.26 -31.14 4.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 111.516 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.601 ' HE2' ' CE1' ' A' ' 61' ' ' PHE . 50.2 m-85 -72.78 -17.0 61.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.163 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.804 0.335 . . . . 0.0 111.499 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.667 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -71.97 -23.44 61.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.727 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.1 OUTLIER -67.02 -41.82 85.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.532 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.85 -48.74 35.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.156 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.531 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -52.24 -42.16 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.458 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.792 HE22 HD12 ' A' ' 106' ' ' LEU . 25.3 mt-30 -65.92 -58.5 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.304 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 14.1 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.532 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 30.2 t60 -79.24 -27.25 42.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.862 0.363 . . . . 0.0 110.495 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.85 -70.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.675 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.414 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -163.64 150.83 10.57 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.908 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.591 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 4.1 Cg_exo -80.49 175.8 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.052 2.502 . . . . 0.0 112.404 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.599 ' H ' HD22 ' A' ' 118' ' ' LEU . . . 93.33 -65.11 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.852 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.39 46.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.316 0.579 . . . . 0.0 111.907 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.91 -18.41 14.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.433 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.669 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.3 pt20 -64.15 -38.54 91.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.695 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.485 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 10.2 mp0 -69.44 -36.05 76.27 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.865 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.625 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 1.5 ttt180 -67.15 -47.19 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.62 -48.94 78.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 p -60.2 -33.55 72.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.485 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 89.9 mm-40 -63.3 -57.37 10.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 110.812 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.57 HG22 ' N ' ' A' ' 83' ' ' SER . 4.1 m -62.73 -33.06 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.366 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.57 ' N ' HG22 ' A' ' 82' ' ' VAL . 64.8 m -65.78 -43.41 88.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.724 179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.511 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.58 -37.27 87.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.98 -30.35 63.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.628 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.922 ' HG ' HD21 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -75.05 -35.33 61.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.806 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.493 ' CD1' ' HG3' ' A' ' 91' ' ' PRO . 33.7 t80 -89.51 -13.27 37.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.567 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -33.55 -61.01 0.34 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.506 1.123 . . . . 0.0 113.891 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.2 62.81 0.49 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.163 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.79 70.53 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.944 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.493 ' HG3' ' CD1' ' A' ' 87' ' ' PHE . 6.8 Cg_endo -75.87 46.95 1.82 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 111.505 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.743 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -66.29 165.23 14.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.149 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.512 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 26.9 m95 -55.33 -28.36 53.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.402 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.4 89.8 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.746 HH11 ' HB ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -85.85 -28.4 24.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.317 178.907 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.821 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.39 -30.9 61.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.301 0.572 . . . . 0.0 110.57 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.738 HG12 ' HB2' ' A' ' 53' ' ' PHE . 4.7 t -66.49 -56.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.818 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.34 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.119 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.821 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.8 m-85 -56.35 -58.19 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 110.473 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 9.6 m-85 -75.07 -35.45 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.228 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.79 -39.05 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.611 ' HE1' ' CE2' ' A' ' 102' ' ' PHE . 0.9 OUTLIER -56.38 -51.86 66.74 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.7 0.286 . . . . 0.0 111.286 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.58 -41.11 44.95 Favored Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.285 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.54 88.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.347 0.573 . . . . 0.0 110.905 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.569 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -71.34 -40.95 70.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.792 HD12 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -59.32 -46.85 87.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.465 179.187 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.598 ' HB3' HD23 ' A' ' 22' ' ' LEU . 68.9 m -62.17 -41.63 98.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.423 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -55.5 -54.94 37.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.14 66.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.578 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.1 m -76.74 -31.61 57.22 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.561 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 119' ' ' VAL . 14.1 t -79.06 -23.34 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.451 0.643 . . . . 0.0 109.295 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -84.06 -5.03 59.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.189 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 13.3 mttt -125.72 -152.44 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.295 179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -108.19 50.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.205 0.526 . . . . 0.0 110.106 179.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.591 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -130.32 56.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.445 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.524 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.5 mp0 -62.38 -52.71 64.11 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.524 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.2 Cg_exo -65.41 -25.44 56.13 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.356 2.037 . . . . 0.0 113.112 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.599 HD22 ' H ' ' A' ' 73' ' ' GLY . 4.5 mp -67.5 -30.68 70.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.425 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.5 HG22 HG22 ' A' ' 111' ' ' VAL . 91.6 t -57.61 -55.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.186 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.89 85.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.061 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.536 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.5 mt-30 -65.18 -51.42 61.2 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' CZ3' ' A' ' 125' ' ' TRP . 86.2 t -57.05 -35.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 109.867 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.16 -47.52 82.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.536 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 21.8 pt-20 -72.8 -37.1 67.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.085 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.669 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 42.8 m0 -58.89 -39.41 81.34 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.4 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 9.8 ttm -72.6 -53.94 10.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.852 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.51 HG12 ' N ' ' A' ' 128' ' ' GLU . 2.2 p -61.97 -33.16 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.592 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.51 ' N ' HG12 ' A' ' 127' ' ' VAL . 0.1 OUTLIER -67.26 -51.02 58.08 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.077 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 129' ' ' TYR . 23.9 t80 -58.36 -35.69 72.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.542 0.687 . . . . 0.0 110.742 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.944 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.29 -56.05 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.559 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.75 -24.04 67.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.0 m -82.2 -43.13 18.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.93 -37.29 2.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.944 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -61.41 -48.17 82.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.229 0.468 . . . . 0.0 111.377 -178.585 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -37.54 62.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.257 0.348 . . . . 0.0 110.952 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.99 -53.53 52.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.413 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.743 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 59.4 t90 -57.31 -48.99 77.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.529 HG13 ' HE3' ' A' ' 137' ' ' TRP . 26.6 mt -57.77 -47.46 85.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.812 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -68.05 -26.93 66.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 m -96.23 -3.48 44.12 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.75 -53.16 3.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 111.724 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.97 -13.09 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.76 166.24 42.04 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.547 ' HZ3' ' HE1' ' A' ' 46' ' ' MET . 92.9 m95 -59.36 -30.24 68.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.5 81.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.1 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.69 -42.95 99.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.084 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 147' ' ' PHE . 17.0 t80 -66.17 -34.14 77.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.504 178.546 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.923 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.57 -26.38 67.09 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.723 0.297 . . . . 0.0 110.836 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.79 -47.1 12.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.582 HD22 ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -54.09 -42.67 69.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.35 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -119.19 24.91 10.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.483 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.41 -135.89 4.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.647 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.64 -45.33 59.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.189 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -82.0 52.43 4.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.608 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.11 70.18 10.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.054 0.454 . . . . 0.0 110.381 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -64.89 158.92 23.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.902 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.476 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.1 tp10 -57.01 -33.86 67.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.072 0.463 . . . . 0.0 110.82 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -68.12 -38.3 82.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -75.62 -37.31 59.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 110.613 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.424 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.4 mtm180 -58.56 -53.36 59.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.476 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 7.8 ptm180 -69.11 -23.54 64.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.595 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.532 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.3 mt -71.95 -41.87 67.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.364 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.582 ' HB3' HD22 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -70.57 -35.86 73.29 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.111 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.95 -43.76 64.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.797 178.865 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.29 -20.27 74.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.904 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.565 ' O ' HG23 ' A' ' 170' ' ' VAL . 8.3 t-20 -65.3 -63.9 0.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.684 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.725 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 28.1 p-90 -64.72 -22.91 67.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.777 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.15 57.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 0.0 110.591 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -16.43 33.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.746 ' HB ' HH11 ' A' ' 95' ' ' ARG . 29.9 m -101.79 -35.75 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.477 ' HA ' HD12 ' A' ' 174' ' ' LEU . 3.0 ttp180 -78.16 -27.84 48.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 122.229 -0.294 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 m -82.8 -15.07 53.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.86 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.08 -9.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.922 HD21 ' HG ' ' A' ' 86' ' ' LEU . 81.5 mt -79.74 -8.59 59.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.75 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 p -57.01 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.42 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.405 ' C ' ' H ' ' A' ' 178' ' ' VAL . . . 141.0 -24.02 2.58 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.441 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -76.39 13.84 0.87 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.98 0.419 . . . . 0.0 111.154 179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.405 ' H ' ' C ' ' A' ' 176' ' ' GLY . 1.2 t -84.25 68.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.051 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' H ' HG11 ' A' ' 82' ' ' VAL . . . -99.73 0.92 42.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.022 -178.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.667 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 8.9 mt -86.78 -38.5 16.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.531 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -75.26 95.49 0.96 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.501 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -81.06 98.87 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.663 179.581 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.7 130.59 30.14 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 112.075 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -49.82 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -170.29 -122.18 0.62 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.374 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -40.16 63.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.036 0.446 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -133.98 159.05 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.67 145.17 18.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.479 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 p -108.23 134.7 20.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.359 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.4 Cg_exo -76.76 1.99 7.96 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.993 2.462 . . . . 0.0 112.6 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.73 84.27 0.96 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.646 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.39 112.03 24.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -100.75 131.67 23.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 9.5 Cg_endo -89.31 76.78 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.361 2.707 . . . . 0.0 111.743 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.64 -160.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.674 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.19 -45.95 44.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.501 ' HA ' HG11 ' A' ' 14' ' ' VAL . 13.3 ptm180 -61.8 -33.29 73.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.569 0.223 . . . . 0.0 111.281 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.51 -34.03 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.536 HD21 ' HE3' ' A' ' 46' ' ' MET . 2.5 tp -73.33 -41.7 63.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.501 HG11 ' HA ' ' A' ' 11' ' ' ARG . 9.9 p -66.05 -36.24 76.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.407 ' N ' HG13 ' A' ' 14' ' ' VAL . . . -73.75 -23.55 59.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 178.791 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.7 -66.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.65 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 3.4 t80 -54.73 -50.71 67.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.922 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.463 HG11 HD13 ' A' ' 22' ' ' LEU . 74.1 t -67.34 -42.53 87.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.255 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.563 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.27 -52.55 52.01 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.2 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.677 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.5 t80 -55.82 -46.18 78.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.992 0.517 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -66.24 -41.31 90.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.6 HD22 ' HB3' ' A' ' 107' ' ' CYS . 8.2 mp -70.16 -47.37 61.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.118 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.694 HH11 ' HB2' ' A' ' 31' ' ' ALA . 27.1 ttp85 -64.17 -18.83 64.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.541 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.432 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -78.86 -34.63 44.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -156.31 77.7 0.93 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 111.667 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.22 -70.12 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.732 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -87.31 52.31 2.47 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.144 0.497 . . . . 0.0 110.352 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.35 -34.09 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.078 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -39.62 93.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.06 57.48 2.11 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.449 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.694 ' HB2' HH11 ' A' ' 23' ' ' ARG . . . -64.71 130.97 45.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.309 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.42 -51.61 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.665 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.563 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 36.6 Cg_exo -62.05 -46.45 13.03 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.82 1.68 . . . . 0.0 111.446 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.48 38.01 3.32 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.194 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -89.01 -23.11 22.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.111 0.481 . . . . 0.0 109.965 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -98.86 142.2 15.95 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -93.5 -155.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.772 2.315 . . . . 0.0 113.71 -178.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -79.18 83.16 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.333 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.82 33.44 3.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 111.087 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.429 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.8 m-20 -139.91 165.79 28.42 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.063 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.427 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 60.5 Cg_endo -81.54 49.39 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.266 2.644 . . . . 0.0 111.8 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.525 ' HB2' HD12 ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.68 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.85 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.0 m170 -60.47 -57.52 12.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.608 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 3.8 mt-30 -59.32 -25.99 64.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.751 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.796 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.07 -52.59 10.66 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.184 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.536 ' HE3' HD21 ' A' ' 13' ' ' LEU . 7.0 ttm -66.53 -38.53 87.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.88 -179.214 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.92 -38.29 85.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.885 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 -42.25 29.19 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.415 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.943 ' HB1' HG21 ' A' ' 97' ' ' VAL . . . -58.28 -56.73 18.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.593 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.96 -48.06 46.6 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.643 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.01 -47.6 84.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.056 0.428 . . . . 0.0 110.994 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -45.67 91.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -71.34 -34.91 70.95 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -24.43 67.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.532 0.682 . . . . 0.0 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -95.45 -18.59 20.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -98.67 -38.37 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.848 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.645 ' HE2' ' CE1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.99 104.03 15.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.528 0.68 . . . . 0.0 110.467 -179.519 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 58' ' ' ARG . 9.9 mtt180 -87.81 -0.19 56.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.501 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -125.48 58.07 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.863 0.363 . . . . 0.0 111.18 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.536 HG22 ' HD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -120.38 0.55 10.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.936 -179.302 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.69 ' HA ' HD21 ' A' ' 64' ' ' LEU . 10.9 m-85 -118.65 -28.75 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.716 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -31.56 72.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.653 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -72.8 -20.06 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.984 -179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.741 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -71.25 -40.5 70.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.28 -43.62 50.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.491 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -54.59 -43.01 71.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.886 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.828 HE22 HD11 ' A' ' 106' ' ' LEU . 26.9 mt-30 -64.66 -56.92 10.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.005 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.526 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.85 12.25 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.481 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 3.4 t-80 -77.7 -24.86 49.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.05 0.452 . . . . 0.0 109.96 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -91.49 -76.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.102 -179.886 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.439 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -160.65 145.47 10.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.608 ' HG3' ' HE2' ' A' ' 115' ' ' MET . 9.5 Cg_exo -71.46 174.88 10.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.825 2.35 . . . . 0.0 111.722 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.697 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 85.84 -57.81 4.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.249 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.14 50.83 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 111.346 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.6 -25.05 9.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.679 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -64.79 -32.78 74.63 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.307 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -72.38 -35.0 68.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.06 0.457 . . . . 0.0 109.885 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.424 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 11.7 mtt-85 -70.19 -44.53 68.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 3.3 t80 -62.41 -48.61 78.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.567 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -57.92 -34.55 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.248 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -59.75 -63.03 1.45 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 110.501 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.473 HG22 ' O ' ' A' ' 79' ' ' PHE . 10.8 m -59.31 -31.85 47.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.775 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -66.51 -41.96 88.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 109.982 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -38.71 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.857 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.496 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 72.0 mt-10 -70.27 -31.99 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' O ' HD11 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -78.74 -35.69 44.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.955 179.826 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.613 ' HD1' ' CD2' ' A' ' 87' ' ' PHE . 40.8 t80 -88.83 -4.19 58.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.0 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.496 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -45.55 -43.2 11.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.03 -179.295 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.88 63.09 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.498 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.06 54.36 0.02 OUTLIER Glycine 0 CA--C 1.524 0.595 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.752 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.676 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 28.0 Cg_endo -80.65 42.07 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.964 1.776 . . . . 0.0 111.785 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.773 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -69.36 161.12 30.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.407 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.494 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 14.2 m95 -54.33 -26.89 32.3 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -40.69 96.99 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.592 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.0 mmp_? -87.49 -22.22 25.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.281 . . . . 0.0 110.786 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.817 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -55.5 -31.38 61.98 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.407 0.622 . . . . 0.0 110.151 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.943 HG21 ' HB1' ' A' ' 49' ' ' ALA . 6.9 t -61.43 -53.97 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.678 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.59 -29.0 70.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.315 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.634 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 6.4 m-85 -56.87 -56.56 20.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.016 0.436 . . . . 0.0 110.078 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.552 ' HE1' HD21 ' A' ' 130' ' ' LEU . 8.1 m-85 -76.52 -36.53 57.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.362 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.418 ' O ' HG13 ' A' ' 101' ' ' VAL . 3.6 t -61.8 -36.44 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 -179.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.429 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -56.31 -55.71 30.09 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 111.321 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.3 59.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.367 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.64 99.1 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.344 0.572 . . . . 0.0 110.709 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.8 -40.61 75.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.534 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.828 HD11 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -57.12 -47.14 81.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.442 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 22' ' ' LEU . 87.9 m -61.98 -44.64 96.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.787 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.44 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -57.6 -34.43 69.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.417 . . . . 0.0 111.363 -179.814 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.617 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -82.73 -23.41 34.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -27.95 40.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.951 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.562 HG22 ' O ' ' A' ' 107' ' ' CYS . 53.8 t -69.8 -37.03 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.617 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 12.6 p30 -84.82 1.68 45.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.458 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -121.42 -152.79 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.483 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.458 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 6.1 mt-10 -108.68 47.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.608 ' HE2' ' HG3' ' A' ' 72' ' ' PRO . 0.3 OUTLIER -136.81 39.13 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.447 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -57.82 -51.0 84.97 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.109 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.447 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.7 Cg_exo -63.92 -12.01 29.86 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.169 1.913 . . . . 0.0 112.908 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.697 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.7 mp -85.05 -24.05 28.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.012 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.41 -54.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.93 72.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.129 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.553 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 74.5 mt-30 -67.84 -53.47 26.53 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.531 HG23 ' CZ3' ' A' ' 125' ' ' TRP . 54.8 t -56.02 -34.81 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 0.0 109.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.47 -46.49 85.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.47 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.573 ' HA ' HG11 ' A' ' 127' ' ' VAL . 16.6 pt-20 -73.69 -38.01 65.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.952 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.679 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.8 m0 -58.39 -38.95 78.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.713 0.768 . . . . 0.0 109.091 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.2 ttp -72.58 -55.2 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.988 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.573 HG11 ' HA ' ' A' ' 124' ' ' GLU . 2.3 p -62.89 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.554 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.567 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 2.9 tt0 -67.78 -53.32 28.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.155 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -59.36 -33.28 70.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.377 0.608 . . . . 0.0 110.746 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.951 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.35 -56.43 5.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.153 -178.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.52 -29.05 68.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 m -84.62 -36.53 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -125.51 -44.88 1.82 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.951 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -59.12 -46.9 87.13 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.37 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.77 65.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.263 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.44 -48.36 73.02 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.196 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.773 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.6 t90 -58.31 -50.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.581 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -56.19 -48.91 78.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.405 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -60.73 -34.17 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.754 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 m -86.3 -16.15 38.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.15 -58.81 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.94 -5.3 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.534 -179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.1 171.65 48.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.955 179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -62.48 -26.48 68.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.2 -35.99 82.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.443 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.5 tt0 -63.52 -44.02 95.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.609 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 12.9 t80 -64.86 -36.43 84.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.684 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.796 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 m -66.34 -27.18 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.201 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.34 25.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.684 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -72.05 -42.65 66.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.338 179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.622 ' HE2' ' CE1' ' A' ' 151' ' ' TYR . 12.6 m-85 -118.65 25.43 10.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.931 -178.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -109.48 -143.09 9.89 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.12 -22.4 28.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.263 0.554 . . . . 0.0 110.567 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -95.14 33.26 5.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.615 179.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.56 70.62 4.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.666 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.896 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.6 OUTLIER -63.5 170.55 3.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.163 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.18 -35.84 60.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.241 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.896 ' HB2' HD11 ' A' ' 156' ' ' LEU . 40.2 mt-10 -68.12 -40.27 82.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.759 0.314 . . . . 0.0 110.706 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -69.68 -36.66 76.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.4 mtm180 -60.28 -56.62 19.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.229 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.3 -23.81 65.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.606 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -70.75 -47.92 57.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.229 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 3.5 ptt85 -66.94 -36.76 82.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.309 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.428 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 1.7 mt-10 -70.26 -44.21 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.298 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.84 75.1 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.567 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.7 t-20 -59.94 -66.13 0.57 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.577 -0.812 . . . . 0.0 111.111 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.631 ' HA ' HG22 ' A' ' 170' ' ' VAL . 32.2 p-90 -61.56 -27.8 68.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.342 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.38 -41.32 69.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 110.79 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -30.1 20.27 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.657 HG11 ' HB2' ' A' ' 92' ' ' ASN . 2.7 m -92.18 -36.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -66.22 -29.47 69.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.927 0.394 . . . . 0.0 110.596 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -15.16 29.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.848 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.916 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.4 p -86.11 -25.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.557 . . . . 0.0 110.365 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.916 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.9 OUTLIER -120.66 32.95 5.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.016 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.71 70.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.409 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.35 48.23 3.77 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.277 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -111.36 15.53 21.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.489 0.661 . . . . 0.0 109.272 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.17 67.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.271 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -100.8 10.4 41.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.914 -179.306 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 19.1 mt -99.81 -52.63 3.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.683 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.491 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -65.51 95.77 0.23 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.088 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -102.73 148.75 25.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.096 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.39 -31.72 21.59 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.904 2.403 . . . . 0.0 111.974 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.14 132.4 34.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.321 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -168.5 44.21 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.544 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.2 m -106.93 122.21 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.774 0.321 . . . . 0.0 110.456 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtm -106.8 6.67 29.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.22 146.05 26.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 p -106.16 134.55 19.72 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 6.7 Cg_exo -73.34 102.87 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 111.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.64 141.8 33.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.33 65.51 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.19 0.519 . . . . 0.0 110.938 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.403 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -118.23 150.43 47.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.658 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.408 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 6.6 Cg_exo -74.43 62.27 5.31 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.155 2.57 . . . . 0.0 112.374 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.3 -151.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -45.09 72.58 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.267 0.627 . . . . 0.0 112.682 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -36.25 79.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.727 0.298 . . . . 0.0 111.133 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.408 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . . . -76.55 -35.68 58.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 110.057 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.69 -40.21 66.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.695 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 7.0 p -65.69 -39.2 84.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.074 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.29 60.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.504 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -59.31 2.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.185 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.655 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.3 t80 -57.13 -53.91 52.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.749 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.672 HG12 HD11 ' A' ' 22' ' ' LEU . 96.6 t -66.62 -40.18 85.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.532 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.36 -51.3 59.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.011 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.653 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 73.4 t80 -63.2 -41.7 99.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.711 0.291 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.63 -40.77 97.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.649 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.724 HD23 ' HB3' ' A' ' 107' ' ' CYS . 7.4 mp -73.36 -42.7 61.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.503 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 8.2 ttp85 -65.69 -15.52 62.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.272 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.03 -35.29 25.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.04 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -158.16 79.4 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.553 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.58 -70.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.665 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -88.84 58.98 4.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.13 0.49 . . . . 0.0 110.537 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.48 -29.82 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.036 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -42.87 78.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.577 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.35 59.37 3.79 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.076 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.462 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.6 127.34 32.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.26 -54.51 0.36 Allowed Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.793 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.532 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 45.0 Cg_exo -58.53 -42.92 49.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.026 1.818 . . . . 0.0 111.407 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.771 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.94 37.65 3.65 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.478 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.84 -6.91 53.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.139 0.495 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.28 144.9 15.84 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.78 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.411 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 88.2 Cg_endo -96.06 -150.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.995 2.463 . . . . 0.0 113.118 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.552 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -88.59 86.48 7.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.62 1.93 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 55.0 m-20 -107.03 160.4 26.48 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -78.27 41.12 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.23 2.62 . . . . 0.0 111.991 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.44 -28.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.932 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.465 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.7 m170 -59.02 -56.5 21.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.848 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.552 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.67 -27.06 67.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.506 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -71.99 -49.58 36.0 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.615 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 0.9 OUTLIER -67.8 -31.57 71.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -40.99 97.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.45 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -23.27 43.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 109.851 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.703 ' HB3' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.27 -63.88 1.0 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.099 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.655 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.35 -48.41 41.08 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.864 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -42.65 79.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.089 0.471 . . . . 0.0 111.262 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -62.88 -44.32 96.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.666 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.9 OUTLIER -75.64 -29.33 59.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.919 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.18 -24.09 66.57 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -40.48 10.15 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.634 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -88.96 -54.36 4.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 2.1 t80 -85.3 68.64 10.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.75 0.42 . . . . 0.0 111.324 -179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -75.93 -22.99 55.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.358 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.19 37.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.035 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -120.79 -5.01 9.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.658 ' HE1' ' CE2' ' A' ' 61' ' ' PHE . 4.9 m-85 -93.6 -31.05 14.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.891 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.18 67.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.831 0.348 . . . . 0.0 111.425 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.48 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 2.0 m-20 -77.79 -18.02 56.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.892 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.833 HD23 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -72.83 -39.63 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.457 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.36 -46.0 35.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.979 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.87 -42.87 63.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.955 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.689 HE22 HD13 ' A' ' 106' ' ' LEU . 25.2 mt-30 -67.8 -61.61 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.656 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.465 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -79.61 13.33 2.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.457 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 47.0 t60 -79.13 -26.45 42.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.46 ' C ' ' HG1' ' A' ' 71' ' ' THR . 0.0 OUTLIER -90.54 -74.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.998 -179.951 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.46 ' HG1' ' C ' ' A' ' 70' ' ' VAL . 0.1 OUTLIER -159.84 142.77 10.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.075 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.8 Cg_exo -75.6 -175.34 2.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.009 2.473 . . . . 0.0 112.069 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 89.74 -65.81 2.94 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.027 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.24 41.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.833 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.501 ' HB2' ' HH2' ' A' ' 125' ' ' TRP . . . -97.11 -21.17 17.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.659 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -63.83 -37.97 89.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.589 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 4.4 mm100 -68.95 -35.22 76.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.32 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.488 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.49 -48.15 61.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.14 0.495 . . . . 0.0 109.769 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 7.1 t80 -61.53 -47.62 84.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.068 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -58.66 -34.98 71.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.429 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.589 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 73.4 mm-40 -60.23 -56.63 19.25 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.177 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG12 ' CE2' ' A' ' 102' ' ' PHE . 12.3 t -59.0 -37.86 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.081 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.2 m -62.47 -46.37 88.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.543 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.8 OUTLIER -69.46 -36.32 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.533 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 33.4 mm-40 -67.53 -32.87 73.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.872 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.532 ' HA ' HD13 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -77.17 -36.73 54.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.23 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.641 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 55.2 t80 -85.21 -5.61 59.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.533 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -53.79 -37.09 63.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.563 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.46 59.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.813 -1.184 . . . . 0.0 113.384 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.578 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 167.27 49.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.605 -1.284 . . . . 0.0 115.17 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -80.7 38.98 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 119.913 1.856 . . . . 0.0 111.715 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.754 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -70.15 162.61 27.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.529 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.544 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 15.1 m95 -53.22 -27.86 24.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.03 -43.49 97.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.436 ' CZ ' HD11 ' A' ' 86' ' ' LEU . 0.4 OUTLIER -85.65 -23.15 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.675 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.766 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.35 -30.85 61.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 110.036 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.666 HG12 ' HB2' ' A' ' 53' ' ' PHE . 41.2 t -60.93 -56.3 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.41 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.93 -28.44 70.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.406 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.608 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 5.7 m-85 -56.45 -51.84 66.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.201 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.638 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 5.8 m-85 -81.53 -35.05 30.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.449 ' O ' HG12 ' A' ' 101' ' ' VAL . 15.2 t -63.75 -34.53 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.758 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.603 ' CE2' HG12 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -54.23 -59.08 5.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 111.496 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.4 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -69.78 -35.91 74.02 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.226 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.19 90.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.2 0.5 . . . . 0.0 110.602 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.812 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.19 -39.1 82.59 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.691 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.7 -45.3 94.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.724 ' HB3' HD23 ' A' ' 22' ' ' LEU . 82.5 m -64.14 -41.69 97.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.86 -53.7 52.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.293 . . . . 0.0 111.041 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.47 ' CD ' ' HZ2' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -67.5 -19.95 65.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.661 179.801 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -78.71 -33.78 46.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.594 0.235 . . . . 0.0 110.716 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 107' ' ' CYS . 32.1 t -74.52 -25.88 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.481 0.658 . . . . 0.0 109.669 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.55 1.42 45.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.147 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.47 ' HZ2' ' CD ' ' A' ' 109' ' ' GLU . 42.7 mttt -133.93 -169.78 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.78 57.84 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 110.025 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.465 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.54 46.44 2.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.716 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.553 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.4 mp0 -62.47 -54.25 50.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.553 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 26.3 Cg_exo -63.58 -20.19 68.95 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.077 1.852 . . . . 0.0 112.864 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.518 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.5 mp -71.98 -29.49 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.62 -51.25 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.03 -31.5 80.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.603 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 5.8 mm100 -68.06 -49.82 59.01 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.518 HG23 ' O ' ' A' ' 118' ' ' LEU . 42.0 t -58.72 -33.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -63.33 -46.49 86.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.603 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 12.2 pt-20 -71.55 -40.44 69.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.702 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.659 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 32.3 m0 -57.99 -39.98 79.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.555 0.693 . . . . 0.0 109.337 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.4 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.4 ttp -73.56 -53.0 11.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.956 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.48 HG12 ' N ' ' A' ' 128' ' ' GLU . 2.9 p -63.66 -31.87 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.48 ' N ' HG12 ' A' ' 127' ' ' VAL . 3.1 mt-10 -69.92 -50.52 41.29 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.068 179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.643 ' HE1' ' CE2' ' A' ' 129' ' ' TYR . 7.0 t80 -58.92 -33.15 70.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 110.983 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.978 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.15 -52.27 9.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.89 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -35.32 79.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 m -81.15 -39.22 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.72 -41.33 2.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.978 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -63.36 -47.09 83.59 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.545 -178.501 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.58 -34.53 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.275 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.4 -50.0 67.16 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.219 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.754 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 45.6 t90 -59.08 -49.05 79.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.58 HG13 ' HE3' ' A' ' 137' ' ' TRP . 14.8 mt -56.92 -48.41 81.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.074 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -65.59 -30.52 71.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.2 m -83.55 -30.37 27.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -57.69 4.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -170.83 -10.86 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.559 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.3 170.24 40.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.626 179.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.615 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 94.7 m95 -62.84 -30.77 71.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.75 72.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.204 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.432 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -65.44 -41.12 93.82 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.616 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 8.2 t80 -65.85 -39.04 90.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.514 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.506 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.78 -25.73 67.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.024 0.44 . . . . 0.0 110.815 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.4 -28.04 23.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.083 0.468 . . . . 0.0 109.849 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.412 ' HA ' ' HB3' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.15 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.27 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -134.3 30.26 3.58 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.492 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.62 -111.03 3.56 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 119.84 -1.172 . . . . 0.0 112.862 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.6 -67.27 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.041 0.448 . . . . 0.0 110.973 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.94 69.88 1.86 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.553 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.54 71.38 9.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 110.343 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.563 HD13 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.1 165.04 14.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.039 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.417 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -58.91 -36.27 74.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.1 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.563 ' HB2' HD13 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -68.63 -38.96 80.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.344 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -69.98 -40.14 75.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -68.04 -49.55 60.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD2' ' OE1' ' A' ' 157' ' ' GLU . 9.7 ptm180 -62.3 -28.57 69.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 110.385 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.613 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -67.42 -42.32 83.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.833 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.6 HH22 ' HA ' ' A' ' 49' ' ' ALA . 5.2 ttp180 -67.08 -44.04 81.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.23 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.622 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.11 -47.29 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.41 -23.63 75.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.739 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.613 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 2.9 t-20 -74.43 -54.53 7.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.532 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.855 ' HA ' HG21 ' A' ' 170' ' ' VAL . 11.7 p-90 -64.25 -24.29 67.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.055 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -51.36 -52.97 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.215 0.322 . . . . 0.0 110.811 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -27.72 22.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.855 HG21 ' HA ' ' A' ' 167' ' ' TRP . 25.0 m -80.02 -25.98 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.273 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 8.7 ttp180 -83.13 -15.11 52.04 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.673 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.8 OUTLIER -96.22 -39.16 9.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.96 HG11 ' HG ' ' A' ' 174' ' ' LEU . 13.2 p -59.39 -33.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.403 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.96 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -115.7 44.5 1.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.634 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.673 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.16 -43.08 92.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.294 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.21 41.42 1.32 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.724 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.415 ' O ' HG21 ' A' ' 82' ' ' VAL . . . -100.77 -4.24 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.264 0.554 . . . . 0.0 109.878 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.41 67.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.397 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.35 8.2 45.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.446 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.583 HD13 ' HE2' ' A' ' 102' ' ' PHE . 8.7 mt -90.94 -45.24 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.64 101.58 0.31 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.183 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -104.21 157.04 17.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.7 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.994 -0.527 . . . . 0.0 109.847 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.75 151.77 36.6 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.122 2.548 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.22 14.97 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 122.08 124.2 2.99 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.471 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 128.19 43.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.795 0.331 . . . . 0.0 110.67 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.71 -52.51 17.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.3 0.571 . . . . 0.0 110.153 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.47 121.79 34.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.032 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.429 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.9 p -99.84 117.27 63.79 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 120.909 0.385 . . . . 0.0 110.96 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 21.8 Cg_exo -65.19 127.47 18.42 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.9 2.4 . . . . 0.0 111.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.77 136.53 34.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.504 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.55 138.24 17.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.769 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -86.55 127.41 60.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.439 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 8.7 Cg_exo -72.99 40.75 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.618 2.878 . . . . 0.0 112.894 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -156.65 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.42 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.22 72.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -42.8 99.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.15 -35.03 66.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.546 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.6 tp -72.91 -42.18 63.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.486 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.572 HG12 ' N ' ' A' ' 15' ' ' ALA . 7.8 p -66.47 -37.42 79.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.572 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -72.0 -21.05 61.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.534 ' HB2' ' CE1' ' A' ' 43' ' ' HIS . 1.2 t70 -77.81 -68.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 0.534 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 t80 -52.3 -50.33 62.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.206 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.789 HG12 HD12 ' A' ' 22' ' ' LEU . 19.3 t -75.93 -39.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.935 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.422 ' HA3' ' O ' ' A' ' 15' ' ' ALA . . . -61.22 -53.69 42.53 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.527 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.729 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 85.9 t80 -60.8 -45.47 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.029 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.534 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -61.04 -47.73 85.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.789 HD12 HG12 ' A' ' 18' ' ' VAL . 8.3 mp -67.93 -47.85 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.556 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 29.6 ttp85 -58.75 -30.95 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.554 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.63 -12.03 49.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -156.47 63.09 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.46 -71.21 0.33 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.73 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.635 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 1.3 t80 -82.2 56.62 3.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.15 0.5 . . . . 0.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 t -78.31 -32.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 m -66.27 -35.38 80.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.774 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.23 51.62 2.46 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.639 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 116.16 9.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.746 0.308 . . . . 0.0 110.668 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.22 -51.05 0.13 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.599 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.7 -48.46 2.12 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.187 1.925 . . . . 0.0 111.667 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.729 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -89.47 27.48 7.76 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.94 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.25 -58.54 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.604 0.716 . . . . 0.0 109.388 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.94 139.22 30.91 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.699 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.49 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -90.53 -133.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.722 2.281 . . . . 0.0 113.567 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.566 ' HB3' ' HB2' ' A' ' 44' ' ' GLN . . . -83.63 92.02 7.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.452 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.84 10.63 5.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.489 0.661 . . . . 0.0 109.576 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.409 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.8 m-20 -121.11 160.51 44.95 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.365 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' C ' HG21 ' A' ' 148' ' ' THR . 58.3 Cg_endo -81.36 37.03 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.246 2.631 . . . . 0.0 112.4 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.546 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -165.61 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.414 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 16' ' ' ASP . 2.5 m170 -56.21 -56.98 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.566 ' HB2' ' HB3' ' A' ' 38' ' ' ALA . 9.1 tt0 -57.67 -23.4 51.23 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.557 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.91 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -82.52 -49.62 9.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.559 ' HE3' ' CZ3' ' A' ' 144' ' ' TRP . 4.5 ttm -66.42 -42.14 88.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -30.74 71.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.498 0.19 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.87 33.57 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.564 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . . . -59.51 -55.76 30.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.097 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.426 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.98 -44.75 41.57 Favored Glycine 0 C--O 1.217 -0.93 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.613 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.01 -54.14 50.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.453 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -43.43 97.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.965 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.894 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.87 -30.24 62.53 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.495 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.97 -30.35 71.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.78 0.8 . . . . 0.0 108.864 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.1 m -79.54 -33.69 41.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.297 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . 0.406 HH11 ' HD3' ' A' ' 56' ' ' ARG . 19.0 mtt180 -89.56 -52.12 5.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.174 0.512 . . . . 0.0 111.716 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -86.27 64.13 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.303 0.641 . . . . 0.0 110.958 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -18.29 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.768 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.59 58.43 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -51.07 2.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 111.746 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.789 ' HA ' HD13 ' A' ' 64' ' ' LEU . 5.1 m-85 -62.17 -19.73 63.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -38.79 66.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.835 0.35 . . . . 0.0 111.311 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.783 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 3.3 m-20 -67.03 -28.41 68.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.491 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.789 HD13 ' HA ' ' A' ' 61' ' ' PHE . 20.1 mt -61.19 -43.63 98.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.338 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.8 -40.49 47.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.02 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.51 ' HB2' ' H ' ' A' ' 182' ' ' ALA . . . -51.59 -45.52 63.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.699 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.724 HE22 HD13 ' A' ' 106' ' ' LEU . 36.9 mt-30 -67.64 -54.73 17.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.255 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 HD11 ' HA ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -84.38 17.52 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.9 t60 -78.17 -30.28 49.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.602 HG11 ' H ' ' A' ' 71' ' ' THR . 2.4 p -91.5 -65.25 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.602 ' H ' HG11 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -162.3 145.95 9.15 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 122.138 0.175 . . . . 0.0 110.708 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.505 ' HA ' HD11 ' A' ' 68' ' ' LEU . 2.9 Cg_exo -76.45 172.18 16.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.818 2.345 . . . . 0.0 111.355 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.92 -60.99 1.13 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.625 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.17 50.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.418 0.628 . . . . 0.0 110.93 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.76 -22.12 13.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.32 -39.94 94.91 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.509 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.82 -47.71 82.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.998 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -47.66 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.81 -50.02 75.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.774 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' THR . . . . . 0.406 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 18.5 p -60.61 -30.01 69.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -68.01 -53.11 28.34 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.002 0.43 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.603 HG11 HD12 ' A' ' 180' ' ' LEU . 34.2 m -65.77 -32.3 57.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.089 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.406 ' OG ' ' HA ' ' A' ' 80' ' ' THR . 1.3 p -69.13 -39.94 78.59 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.892 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -46.5 82.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.239 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -68.87 -25.03 64.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.669 HD11 ' HB2' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -79.82 -26.15 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.501 . . . . 0.0 109.952 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -97.37 -4.24 38.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.395 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -39.04 -50.47 1.81 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.542 0.737 . . . . 0.0 112.378 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.3 48.99 0.16 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.901 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.12 56.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.221 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.584 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.6 Cg_endo -77.8 45.78 1.87 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.21 1.94 . . . . 0.0 111.817 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.796 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.8 162.92 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.598 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.616 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 17.6 m95 -54.01 -28.85 40.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.639 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.86 -40.78 98.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.204 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.57 ' HE ' ' HA ' ' A' ' 171' ' ' ARG . 6.9 mmt180 -86.35 -21.56 27.16 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.812 -0.228 . . . . 0.0 110.551 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.774 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -57.66 -30.62 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.346 0.593 . . . . 0.0 110.132 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.894 HG13 ' HB2' ' A' ' 53' ' ' PHE . 7.5 t -62.9 -55.16 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.417 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -61.61 -29.06 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.053 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.774 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 3.6 m-85 -56.42 -54.21 48.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.082 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.624 ' HE1' ' CE2' ' A' ' 100' ' ' PHE . 6.6 m-85 -79.03 -36.33 41.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.02 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.417 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 t -59.99 -38.45 76.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -57.41 -50.0 74.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.71 0.291 . . . . 0.0 111.613 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.615 ' HA3' ' HE2' ' A' ' 126' ' ' MET . . . -76.68 -37.65 34.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.261 -179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.63 98.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.245 0.523 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.447 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -69.22 -38.88 78.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.724 HD13 HE22 ' A' ' 67' ' ' GLN . 0.1 OUTLIER -60.31 -44.9 95.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.494 ' HB3' HD22 ' A' ' 22' ' ' LEU . 86.6 m -64.06 -41.01 97.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.172 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.25 -54.7 40.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -17.72 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.516 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.2 m -77.97 -31.0 50.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.266 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.437 HG22 ' O ' ' A' ' 107' ' ' CYS . 15.6 t -80.95 -13.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.905 0.859 . . . . 0.0 109.163 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -85.02 0.07 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -144.64 -170.38 3.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.519 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.84 55.59 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 110.034 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.469 ' HE3' ' HG ' ' A' ' 68' ' ' LEU . 0.1 OUTLIER -129.85 29.69 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.513 -179.377 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.503 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -53.51 -51.07 79.29 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.503 ' HD2' ' N ' ' A' ' 116' ' ' GLU . 19.1 Cg_endo -59.84 -23.19 71.39 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.238 1.959 . . . . 0.0 113.243 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.413 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 mm? -76.04 -26.68 56.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.591 0.234 . . . . 0.0 110.777 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.9 t -59.25 -54.3 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.193 179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.29 71.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.446 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 mm100 -69.45 -49.77 51.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.532 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 46.1 t -58.52 -35.16 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.15 -50.38 73.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.359 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.514 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 10.7 pt-20 -69.27 -39.78 78.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.681 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.9 m0 -57.3 -40.93 78.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.391 0.615 . . . . 0.0 109.524 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.615 ' HE2' ' HA3' ' A' ' 103' ' ' GLY . 0.0 OUTLIER -76.04 -44.53 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.376 -178.323 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.523 ' N ' ' HG2' ' A' ' 126' ' ' MET . 5.0 p -71.45 -31.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.741 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 127' ' ' VAL . 4.0 mm-40 -69.57 -48.14 61.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.09 179.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.654 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 13.7 t80 -59.34 -35.16 73.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.692 . . . . 0.0 110.473 179.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.926 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.39 -53.19 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.908 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -62.36 -28.78 70.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.9 m -85.1 -36.11 21.37 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -128.14 -40.77 1.64 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.926 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.67 -45.83 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.129 0.422 . . . . 0.0 111.325 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.04 61.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.356 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -65.71 -53.96 33.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.796 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 47.8 t90 -57.12 -47.31 81.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.463 HG13 ' HE3' ' A' ' 137' ' ' TRP . 8.3 mt -57.02 -49.18 80.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -65.1 -32.71 74.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.97 -4.41 58.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.437 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -99.31 -50.71 4.03 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.871 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . 0.443 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -176.35 -19.97 0.02 OUTLIER Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.81 168.36 35.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.559 ' CZ3' ' HE3' ' A' ' 46' ' ' MET . 89.3 m95 -60.14 -31.15 69.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.3 75.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.012 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.443 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.8 tt0 -65.74 -38.15 88.34 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.35 -38.94 81.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.747 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.91 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -61.91 -33.84 74.96 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.686 0.279 . . . . 0.0 111.401 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.78 32.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.813 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.408 HD23 ' HG3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -61.74 -44.65 96.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.084 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.644 ' HD1' ' CD2' ' A' ' 151' ' ' TYR . 1.5 m-85 -111.27 16.45 20.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -108.24 -137.88 8.34 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.9 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -29.66 26.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 111.217 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.468 ' O ' HD22 ' A' ' 156' ' ' LEU . . . -83.84 37.9 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.092 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.13 68.81 9.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.814 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.46 176.78 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.206 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -53.54 -38.42 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.814 ' HB2' HD11 ' A' ' 156' ' ' LEU . 17.0 mt-10 -68.47 -46.56 69.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.91 73.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -56.78 9.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.009 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -65.36 -34.1 77.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.351 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.579 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.0 OUTLIER -67.86 -31.47 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.652 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.408 ' HG3' HD23 ' A' ' 150' ' ' LEU . 6.2 mtp180 -70.14 -51.59 30.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 168' ' ' ALA . 12.8 mt-10 -67.57 -38.63 84.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.36 76.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.122 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.579 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.6 t-20 -69.4 -71.39 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.545 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.446 ' CD1' ' HA ' ' A' ' 164' ' ' GLU . 35.8 p-90 -58.36 -25.4 61.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.854 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . 0.49 ' HB2' ' O ' ' A' ' 164' ' ' GLU . . . -54.56 -63.14 1.25 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 110.883 179.54 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.75 -23.4 24.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.482 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 8.3 t -77.99 -39.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 111.682 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.57 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 16.2 ttp180 -74.15 -24.1 59.36 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.091 -0.381 . . . . 0.0 110.699 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.766 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.8 OUTLIER -84.24 -27.75 27.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.659 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.858 HG13 ' HG ' ' A' ' 174' ' ' LEU . 0.7 OUTLIER -68.27 -22.98 27.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.983 0.421 . . . . 0.0 110.497 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.858 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.4 OUTLIER -120.38 38.49 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.634 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.766 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.37 -23.24 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.297 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 6.86 67.91 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.465 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.669 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -80.08 7.03 9.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.83 65.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.27 0.557 . . . . 0.0 110.713 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.44 ' H ' HG13 ' A' ' 82' ' ' VAL . . . -102.48 13.67 33.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.19 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.783 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -100.34 -28.5 12.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.846 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -83.21 94.76 1.8 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.831 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.51 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -93.9 -168.08 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.064 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.96 126.01 15.15 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.809 2.339 . . . . 0.0 112.253 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.44 -63.21 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 171.56 -178.77 43.7 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.836 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.475 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -85.12 137.94 32.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.492 0.146 . . . . 0.0 110.659 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' HB2' ' O ' ' A' ' 0' ' ' SER . 0.0 OUTLIER 73.81 146.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.012 0.82 . . . . 0.0 111.648 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.71 138.08 35.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.365 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.432 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 p -99.42 134.58 21.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.236 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.0 Cg_exo -75.04 132.27 15.18 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.027 2.485 . . . . 0.0 112.094 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.46 122.18 27.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 111.003 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.99 115.51 28.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.6 151.36 38.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.95 108.81 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.156 2.571 . . . . 0.0 112.079 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.83 -172.04 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.81 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -28.04 50.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 111.929 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.78 -39.98 88.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 110.093 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -34.3 62.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.654 HD12 HD11 ' A' ' 42' ' ' LEU . 2.1 tp -72.82 -41.58 64.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.525 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.2 p -64.98 -36.96 79.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.71 62.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -66.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.619 ' HD2' ' CD1' ' A' ' 17' ' ' PHE . 4.0 t80 -54.21 -52.07 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.07 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.8 t -65.5 -42.02 92.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.462 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.561 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.97 -51.83 56.09 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.18 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' A' ' 20' ' ' TYR . 42.8 t80 -58.32 -45.45 88.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.009 0.524 . . . . 0.0 111.292 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -64.52 -47.87 77.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.301 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.466 HD13 ' O ' ' A' ' 18' ' ' VAL . 8.6 mp -65.23 -46.71 79.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.538 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 12.6 ttp85 -62.84 -20.42 65.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.87 -31.16 23.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.798 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.32 71.97 1.14 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.163 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.16 -69.83 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.756 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.625 ' HD1' ' CD2' ' A' ' 27' ' ' TYR . 1.5 t80 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.114 0.483 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.42 -33.94 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -37.9 89.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.29 52.42 1.37 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.716 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.538 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -65.47 141.7 58.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.51 -45.71 0.53 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.111 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.561 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 11.5 Cg_exo -73.37 -47.62 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.138 1.892 . . . . 0.0 111.869 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.776 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.95 27.22 7.54 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.216 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.498 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 19.9 mm-40 -80.57 -41.96 23.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.504 0.652 . . . . 0.0 109.403 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.3 142.66 46.2 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.006 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -93.49 -166.27 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.784 2.323 . . . . 0.0 113.806 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.809 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -83.22 85.51 7.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.392 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.04 -23.44 4.96 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 4.2 m-20 -79.32 160.28 70.79 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.472 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 27.8 Cg_endo -77.61 50.16 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.279 2.653 . . . . 0.0 111.568 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD11 HD12 ' A' ' 13' ' ' LEU . 0.2 OUTLIER -178.96 -31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.287 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.8 m170 -60.42 -59.58 5.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.963 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.809 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -57.54 -27.1 62.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.732 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.654 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -71.88 -52.78 15.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.584 ' HE2' HD21 ' A' ' 13' ' ' LEU . 2.9 ttm -65.58 -38.3 89.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.639 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -38.63 80.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.402 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.67 45.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.22 0.533 . . . . 0.0 110.107 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.786 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -63.73 -63.21 1.23 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.424 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.48 -47.41 36.25 Favored Glycine 0 C--O 1.215 -1.038 0 O-C-N 124.137 0.898 . . . . 0.0 112.502 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -51.74 -51.62 54.84 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.855 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.06 -46.9 79.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.837 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -68.88 -35.7 77.19 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.74 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.27 -32.77 73.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 109.468 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -85.35 -18.24 34.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.606 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.06 -65.62 1.03 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.097 0.475 . . . . 0.0 111.861 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.8 67.63 8.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.243 0.617 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.416 ' H ' ' HG3' ' A' ' 58' ' ' ARG . 0.4 OUTLIER -80.26 -8.95 59.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.952 -179.074 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 40.9 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -120.35 0.06 10.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.653 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 30.3 m-85 -89.65 -17.11 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.172 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -41.05 93.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.725 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.7 m-20 -63.18 -27.2 69.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.821 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.922 HD21 ' HB3' ' A' ' 105' ' ' ALA . 0.2 OUTLIER -63.74 -42.55 97.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.722 0.773 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.538 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.51 -44.05 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.409 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.439 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -52.33 -42.24 63.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.441 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.673 HE22 HD11 ' A' ' 106' ' ' LEU . 21.0 mt-30 -73.01 -52.44 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.326 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.34 19.91 3.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.538 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t60 -79.34 -35.3 41.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.234 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.508 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.42 -68.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.275 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -162.7 145.66 8.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.416 -179.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.523 ' HB2' HD11 ' A' ' 118' ' ' LEU . 96.6 Cg_endo -80.45 -178.01 4.16 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.623 2.215 . . . . 0.0 112.185 179.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.652 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.28 -71.3 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.879 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.68 44.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.97 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.15 -19.25 18.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.947 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.642 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.3 pt20 -63.78 -36.22 83.17 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.728 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -70.43 -38.73 74.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.398 . . . . 0.0 110.164 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -68.13 -44.47 76.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.946 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.45 -45.84 91.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.92 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -60.2 -33.5 72.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.195 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -61.63 -60.14 4.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.759 0.314 . . . . 0.0 111.109 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.681 HG21 ' HB3' ' A' ' 177' ' ' ALA . 2.8 p -58.61 -36.57 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -65.59 -41.97 92.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.091 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -43.3 81.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.574 ' HB2' ' HB2' ' A' ' 177' ' ' ALA . 74.9 mm-40 -70.21 -21.21 63.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.845 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.478 HD13 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -84.42 -34.88 23.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 110.291 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -85.43 -7.64 58.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.484 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.48 -50.54 2.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.019 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.3 56.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.861 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.473 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.31 51.28 0.05 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.599 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.512 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.3 Cg_endo -80.44 40.81 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.149 1.9 . . . . 0.0 111.842 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.808 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.9 OUTLIER -70.35 166.12 20.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.684 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.566 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 30.6 m95 -53.19 -30.32 36.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.437 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.49 99.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.283 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -87.12 -25.76 23.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.839 -0.181 . . . . 0.0 110.931 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.773 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.74 -31.86 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.45 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG11 ' HB2' ' A' ' 53' ' ' PHE . 16.4 t -62.65 -56.12 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.6 -28.38 69.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.666 ' HE2' ' CE1' ' A' ' 99' ' ' PHE . 2.9 m-85 -55.73 -54.59 42.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.198 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.525 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.2 m-85 -78.27 -35.13 48.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.223 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.427 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 t -62.66 -36.36 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.563 ' HE2' HD11 ' A' ' 180' ' ' LEU . 0.5 OUTLIER -55.2 -55.68 28.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.466 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.89 56.1 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.41 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.135 0.468 . . . . 0.0 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.922 ' HB3' HD21 ' A' ' 64' ' ' LEU . . . -71.07 -39.33 72.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.712 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.0 -49.92 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.58 ' O ' HG22 ' A' ' 111' ' ' VAL . 79.8 m -60.17 -40.13 88.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.097 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.53 30.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.1 -15.96 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.517 ' HB2' HG22 ' A' ' 119' ' ' VAL . 66.8 m -77.88 -29.02 50.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.586 HG23 HG23 ' A' ' 119' ' ' VAL . 16.9 t -82.1 -17.01 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.685 0.755 . . . . 0.0 109.057 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -79.69 -8.57 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.892 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -166.16 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.511 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.25 67.64 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.02 0.438 . . . . 0.0 110.036 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.95 37.23 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.223 -179.05 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.573 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 3.3 mp0 -57.9 -51.7 79.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.573 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 34.1 Cg_exo -58.53 -30.73 92.69 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.044 1.829 . . . . 0.0 112.32 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.652 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -71.35 -30.95 66.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.586 HG23 HG23 ' A' ' 111' ' ' VAL . 73.4 t -57.68 -52.02 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.77 -31.73 79.18 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.503 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.9 mm-40 -66.05 -50.7 63.24 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.531 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 96.3 t -56.56 -36.46 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.02 -48.32 80.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.488 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.503 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 13.1 pt-20 -72.46 -36.42 68.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.195 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.642 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.7 m0 -58.16 -39.77 79.71 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.8 ttp -72.89 -53.4 11.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.581 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.464 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.4 p -60.45 -32.54 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.783 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -67.12 -54.7 18.9 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.061 0.458 . . . . 0.0 110.24 179.221 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 129' ' ' TYR . 2.5 t80 -58.78 -30.2 67.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.896 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.38 -52.9 8.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.526 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.29 77.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.8 m -80.83 -33.86 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 -46.31 1.95 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.896 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.31 -42.1 90.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.645 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.28 64.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.05 -51.17 60.62 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.808 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 69.8 t90 -57.81 -47.5 82.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.582 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -58.23 -47.53 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.555 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -63.52 -25.59 68.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 111.567 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -100.37 -5.64 26.96 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.406 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -122.17 44.76 2.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.722 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.33 -65.97 0.89 Allowed Glycine 0 CA--C 1.506 -0.484 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.25 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.582 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 123.59 173.45 13.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.906 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.5 m95 -56.04 -36.75 68.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.04 77.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.566 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.52 -43.01 98.41 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.516 ' HZ ' ' CB ' ' A' ' 49' ' ' ALA . 13.7 t80 -67.48 -31.63 71.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.699 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.654 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -69.47 -25.0 63.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.155 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.57 -34.4 19.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.637 ' HA ' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -56.21 -51.81 66.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.929 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.414 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.7 m-85 -130.35 31.76 4.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -98.52 -134.85 8.58 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.177 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.26 -53.42 44.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 110.334 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.483 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.61 64.06 1.87 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.708 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.24 73.3 7.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.391 0.615 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.483 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -59.22 153.39 18.53 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.114 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.581 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 2.6 mm-40 -56.66 -27.64 59.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.099 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.49 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -73.37 -42.39 62.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 110.643 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.637 ' HB2' ' HA ' ' A' ' 150' ' ' LEU . . . -66.89 -37.56 84.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.271 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.407 HH11 ' HD3' ' A' ' 160' ' ' ARG . 25.4 mtm-85 -65.64 -52.81 48.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.24 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.581 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 17.8 ptt180 -63.65 -31.36 72.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.554 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -65.74 -39.33 90.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.786 HH22 ' HA ' ' A' ' 49' ' ' ALA . 2.5 ttp180 -68.13 -43.65 77.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.572 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 29.2 mt-10 -62.44 -47.38 84.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.398 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.8 -23.76 75.66 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.953 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.554 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -74.04 -52.25 13.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.773 ' HA ' HG23 ' A' ' 170' ' ' VAL . 11.9 p-90 -65.28 -24.3 67.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.855 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.23 77.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.341 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -31.26 20.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.773 HG23 ' HA ' ' A' ' 167' ' ' TRP . 27.4 m -89.51 -37.04 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -68.77 -30.91 69.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.804 -0.56 . . . . 0.0 110.939 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.29 -37.47 21.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.663 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.662 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -66.35 -27.08 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.952 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.662 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.7 OUTLIER -115.8 32.94 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.323 0.582 . . . . 0.0 109.875 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.8 -9.99 59.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.107 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.55 15.03 62.4 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.703 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.681 ' HB3' HG21 ' A' ' 82' ' ' VAL . . . -88.38 6.53 36.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.569 -179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.61 71.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.531 0.682 . . . . 0.0 109.979 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.44 8.08 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.483 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.725 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -98.46 -39.25 8.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.656 0.265 . . . . 0.0 110.849 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.439 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.69 89.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.275 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -97.05 9.43 42.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.991 0.424 . . . . 0.0 111.018 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -87.85 157.43 7.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.373 2.715 . . . . 0.0 111.999 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.09 128.1 9.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.104 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 167.88 -165.6 38.83 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.721 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.93 156.53 37.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm -117.53 -41.7 2.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.53 149.69 33.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 p -104.63 144.87 29.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.783 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 1.2 Cg_endo -84.23 82.23 1.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.077 2.518 . . . . 0.0 111.873 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.2 4.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.61 141.47 41.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 111.841 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.427 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -142.24 138.93 17.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.975 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.1 Cg_exo -77.03 57.79 5.92 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.249 2.632 . . . . 0.0 112.953 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 -160.25 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -43.19 66.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -61.18 -38.23 85.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.292 . . . . 0.0 111.213 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.72 -34.91 60.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.1 0.476 . . . . 0.0 110.137 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.764 HD23 ' HE1' ' A' ' 46' ' ' MET . 4.6 tp -72.28 -42.86 65.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.574 HG13 ' N ' ' A' ' 15' ' ' ALA . 8.3 p -65.98 -35.8 75.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.574 ' N ' HG13 ' A' ' 14' ' ' VAL . . . -71.99 -24.21 61.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.333 178.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -66.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.633 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 4.5 t80 -55.08 -53.78 51.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.968 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.441 HG11 HD11 ' A' ' 22' ' ' LEU . 58.4 t -67.16 -37.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.221 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.68 -51.79 53.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.059 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.665 ' HE2' ' CE1' ' A' ' 20' ' ' TYR . 1.1 t80 -63.32 -47.06 83.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.44 0.296 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 1.9 tmtm? -57.84 -37.3 73.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 111.222 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.645 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -78.44 -47.34 17.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.533 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.741 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -59.35 -27.16 65.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.853 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.449 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 14.0 pt20 -85.65 -11.09 54.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.16 -56.19 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.53 -57.43 0.66 Allowed Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.665 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.542 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -78.32 46.06 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 122.782 0.433 . . . . 0.0 111.101 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.417 HG13 ' N ' ' A' ' 29' ' ' CYS . 7.6 p -78.1 -31.95 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.001 0.429 . . . . 0.0 110.222 -179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.417 ' N ' HG13 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -68.03 -39.04 83.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.39 0.614 . . . . 0.0 109.356 178.589 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.61 58.43 3.75 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.575 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.741 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.26 109.76 1.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.474 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.581 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -172.56 -57.46 0.05 OUTLIER Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.44 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 35.8 Cg_exo -62.33 -50.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.235 1.956 . . . . 0.0 111.482 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.647 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -85.94 27.23 5.55 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.404 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.581 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -77.4 -31.15 53.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.079 0.466 . . . . 0.0 109.891 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.43 124.82 8.05 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.472 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 92.7 Cg_endo -87.5 -150.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.591 2.194 . . . . 0.0 113.657 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.65 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -78.22 82.81 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.78 26.82 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.439 . . . . 0.0 110.627 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.464 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 9.7 m-20 -135.76 161.63 61.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.098 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.464 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 47.1 Cg_endo -78.83 50.78 3.57 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.274 2.649 . . . . 0.0 112.279 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.544 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER 179.82 -32.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.579 179.294 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.65 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.7 m170 -60.02 -56.49 21.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.508 ' H ' ' HG3' ' A' ' 44' ' ' GLN . 2.5 mt-30 -61.27 -25.19 66.93 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.637 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.48 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -72.82 -50.45 24.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.966 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.764 ' HE1' HD23 ' A' ' 13' ' ' LEU . 3.6 ttm -66.88 -37.37 84.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.667 -179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -60.93 -40.66 94.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.53 -29.38 56.72 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 110.054 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.648 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -66.19 -62.15 1.64 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.39 -45.97 28.77 Favored Glycine 0 C--O 1.216 -0.981 0 O-C-N 124.224 0.953 . . . . 0.0 112.572 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.6 -53.82 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.51 -45.87 81.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.513 ' HZ ' ' HD2' ' A' ' 171' ' ' ARG . 0.5 OUTLIER -65.16 -38.56 90.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.27 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.65 -36.53 78.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.621 . . . . 0.0 109.967 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -83.2 -12.78 56.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.352 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.88 -24.88 12.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.607 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -86.78 92.22 8.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.49 -31.32 70.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.421 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -119.65 79.11 1.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -120.81 -7.59 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.664 ' HA ' HD21 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.88 -29.62 4.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -32.84 71.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.413 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -71.58 -20.59 61.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.925 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.784 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -71.06 -41.06 71.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -74.34 -42.26 59.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.599 ' HB2' ' H ' ' A' ' 182' ' ' ALA . . . -56.46 -43.31 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.785 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.592 HE22 HD11 ' A' ' 106' ' ' LEU . 28.1 mt-30 -63.42 -52.78 60.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.464 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.541 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.21 7.43 22.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.267 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 4.2 t60 -78.85 -23.27 45.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -68.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.391 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.436 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -164.67 143.12 5.55 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.557 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.1 Cg_exo -81.05 -175.96 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.412 2.741 . . . . 0.0 111.897 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.463 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 80.9 -62.3 4.44 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.82 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.83 28.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.472 . . . . 0.0 111.897 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.463 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -81.4 -23.43 37.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.662 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -59.91 -40.83 90.16 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.927 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.28 -49.07 77.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.115 0.259 . . . . 0.0 110.757 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -59.76 -43.56 94.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.966 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.81 -52.26 64.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.646 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.59 -33.6 66.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -61.92 -51.66 67.23 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.306 0.574 . . . . 0.0 109.988 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.487 HG11 ' O ' ' A' ' 177' ' ' ALA . 31.2 t -64.51 -35.82 75.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.711 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.998 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.617 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.84 -34.21 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.377 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.439 ' O ' HD23 ' A' ' 174' ' ' LEU . 3.5 mm-40 -65.99 -30.41 70.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.53 . . . . 0.0 109.948 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -78.38 -36.92 45.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.643 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 41.6 t80 -86.21 -2.03 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.731 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -36.9 61.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.475 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.8 59.69 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.898 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.513 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.31 53.36 0.02 OUTLIER Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.835 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.572 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.2 Cg_endo -81.37 36.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.325 2.017 . . . . 0.0 111.551 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.764 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -68.47 163.9 22.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.907 -178.772 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.42 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 14.6 m95 -53.67 -27.73 29.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.53 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.32 98.48 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER -86.61 -23.83 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.69 -0.255 . . . . 0.0 110.918 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -54.25 -32.07 55.13 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.381 0.61 . . . . 0.0 110.488 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 HG11 ' CB ' ' A' ' 53' ' ' PHE . 6.1 t -61.95 -54.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.571 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.449 ' HB3' ' CE2' ' A' ' 53' ' ' PHE . . . -62.11 -30.69 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.247 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.1 m-85 -55.5 -51.82 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.602 ' HA ' ' HE3' ' A' ' 126' ' ' MET . 8.1 m-85 -82.48 -32.72 28.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.412 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.441 ' O ' HG11 ' A' ' 101' ' ' VAL . 3.5 t -64.95 -34.0 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.813 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.668 ' HD2' ' CD1' ' A' ' 102' ' ' PHE . 0.3 OUTLIER -52.33 -60.05 3.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.908 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.63 61.42 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.206 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.21 83.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.157 0.479 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -72.92 -42.49 63.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.784 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.03 -51.85 67.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.603 179.272 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.645 ' HB3' HD21 ' A' ' 22' ' ' LEU . 87.1 m -60.55 -43.8 96.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.22 67.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.811 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.576 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.7 tt0 -78.63 -25.63 45.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB2' HG21 ' A' ' 119' ' ' VAL . 50.6 m -78.25 -37.02 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.676 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.9 t -66.51 -32.96 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.207 -0.308 . . . . 0.0 111.523 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.576 HD21 ' HA ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -79.3 -30.99 43.15 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.411 -0.516 . . . . 0.0 112.253 -178.713 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.15 113.99 2.74 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.421 ' O ' ' HB2' ' A' ' 115' ' ' MET . 23.0 mt-10 65.35 143.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.557 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 7.5 mtm 76.86 126.47 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.771 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 1.7 tt0 -120.53 -58.11 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.425 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.771 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.34 -29.23 88.4 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.218 1.946 . . . . 0.0 113.09 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.517 ' O ' HG21 ' A' ' 122' ' ' VAL . 1.2 mm? -60.0 -31.65 70.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.597 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.46 HG22 HG21 ' A' ' 111' ' ' VAL . 89.3 t -60.86 -51.22 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.85 -30.48 72.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.467 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -64.83 -52.57 56.0 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.534 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 89.0 t -55.6 -37.55 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.025 0.44 . . . . 0.0 109.915 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -61.69 -47.04 87.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.643 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.467 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 23.2 pt-20 -74.1 -35.88 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.662 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.0 m0 -56.24 -37.98 70.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.602 ' HE3' ' HA ' ' A' ' 100' ' ' PHE . 1.2 mtp -73.34 -56.45 5.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.462 -179.471 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.502 HG13 ' N ' ' A' ' 128' ' ' GLU . 1.4 p -60.64 -32.83 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.502 ' N ' HG13 ' A' ' 127' ' ' VAL . 3.7 mt-10 -69.7 -47.6 62.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.185 179.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.617 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.5 t80 -61.45 -36.14 79.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.545 0.688 . . . . 0.0 110.421 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.977 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.47 -55.57 7.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.196 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.95 -32.75 72.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.1 m -78.68 -40.78 32.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -41.05 1.88 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.977 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -60.53 -48.3 82.39 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.337 0.517 . . . . 0.0 111.709 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -35.9 41.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.238 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.75 -51.92 65.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.373 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.764 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.0 t90 -58.65 -47.58 83.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.597 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.7 mt -57.44 -48.05 83.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.389 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -68.97 -26.45 65.04 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.666 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -92.04 -9.08 44.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.13 -53.8 3.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.91 -15.64 0.02 OUTLIER Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.423 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.63 168.75 36.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.518 ' CZ2' HD12 ' A' ' 138' ' ' ILE . 94.6 m95 -63.46 -30.26 71.41 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.58 75.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.741 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.42 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -64.27 -42.8 96.28 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.643 ' HD1' ' CD2' ' A' ' 147' ' ' PHE . 11.1 t80 -66.2 -33.93 76.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.631 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.52 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.2 OUTLIER -68.25 -27.07 66.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.706 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.78 -26.5 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.123 0.487 . . . . 0.0 109.936 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.433 ' O ' ' HB3' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.64 -50.78 65.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.39 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.539 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.5 m-85 -133.05 33.24 3.67 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.991 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.52 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -102.05 -137.28 9.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.98 -39.31 79.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.166 0.507 . . . . 0.0 110.716 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.548 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -102.47 53.98 0.75 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.766 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.88 76.13 3.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.331 0.586 . . . . 0.0 110.288 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.733 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -64.37 162.59 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.24 -32.98 64.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.242 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.733 ' HB2' HD12 ' A' ' 156' ' ' LEU . 45.8 mt-10 -74.06 -35.31 64.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.716 0.294 . . . . 0.0 111.291 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.621 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -71.04 -39.18 72.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 mtm-85 -62.18 -56.36 19.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.735 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.43 -33.13 73.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.571 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -64.18 -42.64 96.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.648 HH22 ' HA ' ' A' ' 49' ' ' ALA . 3.2 ttp180 -68.2 -41.19 81.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.994 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.706 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -64.92 -40.99 95.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.43 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.75 -31.22 67.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.963 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.448 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 t-20 -67.03 -55.65 13.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.214 -0.493 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.867 ' HA ' HG23 ' A' ' 170' ' ' VAL . 12.0 p-90 -61.98 -28.94 69.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.193 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.54 -42.88 79.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 110.75 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' SER . . . . . 0.573 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.86 -30.56 20.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.867 HG23 ' HA ' ' A' ' 167' ' ' TRP . 35.3 m -87.03 -29.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.513 ' HD2' ' HZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -77.12 -34.72 56.63 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.804 -0.56 . . . . 0.0 110.153 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 -8.78 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.045 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.573 ' CG1' ' HG ' ' A' ' 174' ' ' LEU . 2.9 p -85.19 -26.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.26 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.573 ' HG ' ' CG1' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -121.35 43.22 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.139 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -22.61 62.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.765 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.82 8.48 49.72 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.339 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.487 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -78.17 -0.29 27.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.7 69.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.344 0.592 . . . . 0.0 110.546 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -103.56 16.11 27.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.12 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.484 HD22 HG23 ' A' ' 82' ' ' VAL . 35.4 mt -100.06 -43.34 6.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 92.49 0.27 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.599 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -101.77 139.11 37.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.978 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.71 117.27 5.06 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.895 2.397 . . . . 0.0 111.693 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -25.2 58.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 158.14 159.98 9.95 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.995 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.0 m -155.32 140.92 17.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt -104.57 8.82 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.807 0.337 . . . . 0.0 111.025 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.29 132.48 23.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.807 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.453 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p -110.01 131.38 22.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.691 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 15.6 Cg_exo -68.55 151.11 75.51 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.955 2.437 . . . . 0.0 112.959 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.11 50.92 14.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.009 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.42 88.74 7.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.87 112.25 65.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 2.8 Cg_exo -76.33 54.32 4.23 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.451 2.767 . . . . 0.0 112.238 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.63 -167.17 1.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.578 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.55 75.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.449 ' O ' HG13 ' A' ' 14' ' ' VAL . 0.1 OUTLIER -62.5 -39.47 93.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.679 179.557 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.43 69.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.007 0.432 . . . . 0.0 110.018 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.424 HD11 ' SD ' ' A' ' 46' ' ' MET . 4.3 tp -70.66 -43.14 69.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.692 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 9.9 p -66.84 -34.9 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.011 0.434 . . . . 0.0 110.009 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.19 60.94 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.448 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -66.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.917 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.645 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.1 t80 -55.08 -50.73 68.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.439 HG12 HD12 ' A' ' 22' ' ' LEU . 44.2 t -72.59 -39.01 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.665 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.448 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.8 -55.92 25.7 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.271 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.69 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 13.0 t80 -56.45 -44.77 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.856 0.462 . . . . 0.0 110.798 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.42 -45.58 90.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.525 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.616 HD22 ' HB3' ' A' ' 107' ' ' CYS . 7.3 mp -68.7 -43.3 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.557 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 24.3 ttp85 -66.76 -15.31 63.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.597 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -84.14 -38.61 20.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.71 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.04 79.9 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.765 0.317 . . . . 0.0 111.841 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.14 -66.33 0.38 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.911 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -96.68 55.57 1.41 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.306 0.574 . . . . 0.0 110.333 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.445 HG11 ' N ' ' A' ' 29' ' ' CYS . 7.8 p -79.04 -27.75 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.977 179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.445 ' N ' HG11 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -68.9 -41.07 78.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.528 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 58.69 4.02 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.772 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.557 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.26 118.13 10.22 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.81 -54.16 0.16 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.348 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.448 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.8 Cg_exo -60.55 -46.94 15.26 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 121.936 1.757 . . . . 0.0 111.021 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.69 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -97.93 36.76 3.77 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.218 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -18.24 43.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.26 140.78 16.34 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.448 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 83.2 Cg_endo -94.58 -141.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.98 2.454 . . . . 0.0 113.283 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -76.29 86.96 3.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.359 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.69 20.8 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.067 0.461 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.481 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 3.8 m-20 -131.69 161.67 60.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.938 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 56.8 Cg_endo -81.31 45.51 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.253 2.635 . . . . 0.0 111.964 179.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -174.27 -30.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.13 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.481 ' CG ' ' HB2' ' A' ' 40' ' ' ASP . 3.8 m170 -57.84 -57.13 14.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.819 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' CA ' ' HB2' ' A' ' 38' ' ' ALA . 25.1 tt0 -58.58 -26.81 64.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.685 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -74.45 -50.71 17.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.381 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.424 ' SD ' HD11 ' A' ' 13' ' ' LEU . 3.7 ttm -67.11 -41.72 85.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.613 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -62.87 -33.76 75.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.759 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.23 -41.87 27.26 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.234 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.433 ' HB2' HG23 ' A' ' 97' ' ' VAL . . . -60.59 -55.66 30.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.649 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.658 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.3 -46.55 57.23 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.742 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.64 -49.0 79.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 111.502 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -65.17 -46.29 81.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.38 0.61 . . . . 0.0 110.257 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.621 ' HE1' ' CE2' ' A' ' 53' ' ' PHE . 45.7 t80 -63.34 -40.46 97.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.635 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.25 -33.03 70.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.341 0.591 . . . . 0.0 109.973 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 m -78.02 -24.8 47.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.278 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -98.71 -18.86 17.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.642 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.26 93.74 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.926 0.393 . . . . 0.0 111.409 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -61.22 -46.64 89.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.25 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.818 HH21 HG11 ' A' ' 178' ' ' VAL . 3.2 mtm-85 -91.17 86.71 6.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.106 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.448 HG22 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -113.22 -57.08 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.001 -178.853 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.608 ' HE1' ' CE2' ' A' ' 61' ' ' PHE . 7.8 m-85 -90.96 0.98 57.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' SER . . . . . 0.405 ' OG ' ' HD2' ' A' ' 59' ' ' ARG . 2.1 p -70.17 -56.49 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 111.33 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.616 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -63.92 -23.52 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.169 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.76 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 1.8 mp -64.69 -43.24 94.17 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.577 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.86 -41.6 29.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.503 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -36.47 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.879 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.726 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 23.5 mt-30 -75.32 -58.86 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.033 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.46 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -76.6 9.17 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -177.512 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.577 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.8 t60 -79.01 -18.42 53.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.957 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.34 -77.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -160.1 144.57 10.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.306 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 5.4 Cg_exo -74.84 162.96 36.54 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.811 2.341 . . . . 0.0 112.04 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.732 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 103.48 -64.06 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.643 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.57 42.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.259 0.552 . . . . 0.0 111.867 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.59 -23.23 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.685 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.9 pt20 -60.86 -41.89 96.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.423 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 1.1 mt-30 -63.45 -39.68 95.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.76 0.314 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.726 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 56.0 mtt-85 -68.24 -43.56 77.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.986 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.501 ' O ' HG12 ' A' ' 82' ' ' VAL . 8.4 t80 -62.98 -47.96 80.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -58.45 -31.28 67.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.332 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.0 mm100 -63.77 -65.43 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.646 HG13 HD22 ' A' ' 180' ' ' LEU . 4.8 p -54.93 -36.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.3 m -65.81 -46.62 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.821 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.654 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.1 -37.73 86.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.163 0.506 . . . . 0.0 109.862 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.419 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 4.9 mt-10 -68.55 -25.92 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.557 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.458 HD12 ' NH2' ' A' ' 95' ' ' ARG . 1.8 mp -78.96 -38.31 37.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.549 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -84.9 -6.54 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.386 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.419 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mt-30 -47.06 -43.16 19.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.309 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.16 56.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.529 -1.32 . . . . 0.0 113.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.45 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 158.43 57.66 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.643 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 19.1 Cg_endo -78.77 42.18 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.127 1.885 . . . . 0.0 111.54 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.76 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 4.1 t-20 -66.48 161.31 23.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.508 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.467 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.5 m95 -55.44 -27.17 46.36 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.53 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.547 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.653 ' HD3' ' HG2' ' A' ' 171' ' ' ARG . 2.3 tpt180 -86.61 -22.96 25.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.76 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -31.45 63.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 109.945 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.477 HG13 ' CB ' ' A' ' 53' ' ' PHE . 4.2 t -62.55 -50.3 80.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.307 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.44 -32.49 73.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.588 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 9.6 m-85 -55.01 -53.89 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.267 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.629 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 8.8 m-85 -78.55 -37.58 42.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.24 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.16 -37.67 74.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.349 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.496 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.1 -51.19 68.77 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.91 -39.19 33.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.055 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.26 -42.57 86.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.122 0.461 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.471 ' C ' HD23 ' A' ' 64' ' ' LEU . . . -71.91 -43.78 64.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.76 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.3 -48.18 77.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.614 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.616 ' HB3' HD22 ' A' ' 22' ' ' LEU . 54.7 m -61.08 -43.34 99.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.678 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.64 -36.92 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 111.114 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.641 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 3.5 tt0 -81.35 -25.08 36.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.538 ' HB2' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -79.03 -28.95 43.31 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.051 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.585 HG22 HG21 ' A' ' 119' ' ' VAL . 59.7 t -70.4 -36.39 66.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.641 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.4 p30 -84.35 0.83 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -124.89 -170.78 2.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.226 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -89.52 55.35 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.37 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.46 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.32 36.87 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.066 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.586 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.9 mp0 -56.13 -53.79 59.73 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.21 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.586 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.43 -26.96 83.94 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.05 1.833 . . . . 0.0 112.614 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.732 HD23 ' H ' ' A' ' 73' ' ' GLY . 1.4 mp -70.64 -25.82 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.585 HG21 HG22 ' A' ' 111' ' ' VAL . 85.2 t -59.62 -52.74 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.041 179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.67 87.87 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.728 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 6.5 mm100 -62.61 -53.97 46.66 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.566 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 92.7 t -56.46 -37.12 49.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.941 0.401 . . . . 0.0 110.166 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -61.84 -47.45 84.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.807 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.862 ' HA ' HG11 ' A' ' 127' ' ' VAL . 9.7 pt-20 -74.81 -35.63 62.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.035 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.685 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.4 m0 -57.55 -37.55 73.28 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 27.6 ttm -74.9 -53.35 9.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.601 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.862 HG11 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -61.93 -33.31 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.51 -48.41 55.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.207 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.656 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 24.4 t80 -57.81 -37.96 74.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.28 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.94 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.91 -53.34 13.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.086 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.33 -29.29 69.79 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 m -84.62 -37.15 21.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.418 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -126.08 -43.39 1.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.852 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.94 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.6 mm? -59.67 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.081 0.401 . . . . 0.0 111.678 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.47 -36.62 55.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 123.237 0.336 . . . . 0.0 111.199 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -63.13 -52.63 61.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.76 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 63.1 t90 -57.78 -48.27 80.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.247 0.546 . . . . 0.0 109.545 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.545 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.6 mt -57.77 -46.64 86.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.322 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -65.83 -31.12 71.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.695 0.283 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -85.29 -24.84 27.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -56.37 4.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.17 -10.05 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.43 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.69 167.18 40.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.958 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.43 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 97.6 m95 -60.9 -26.46 67.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.25 -32.53 73.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.756 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.442 ' HG3' HD11 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -65.4 -40.68 93.73 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.775 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.614 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 11.0 t80 -65.84 -36.58 83.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.405 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.685 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -64.32 -31.52 72.76 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.192 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.65 -19.01 31.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.357 0.599 . . . . 0.0 110.105 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.442 HD11 ' HG3' ' A' ' 146' ' ' GLU . 9.1 mt -79.92 -40.65 27.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.146 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.663 ' HE2' ' CE1' ' A' ' 151' ' ' TYR . 1.6 m-85 -125.53 28.95 6.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -118.86 -146.7 8.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.668 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -32.77 61.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.76 40.31 2.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.106 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.13 77.17 8.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.691 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -62.37 162.02 10.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.857 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.88 -31.3 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.691 ' HB2' HD11 ' A' ' 156' ' ' LEU . 17.9 mt-10 -72.15 -42.37 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.549 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -66.14 -39.59 89.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.54 -52.07 66.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -71.11 -21.73 62.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -75.27 -48.52 22.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.451 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.549 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -65.32 -43.61 90.46 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.581 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.66 -42.81 90.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.456 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.19 -28.93 72.29 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.473 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -66.53 -56.07 12.54 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.252 -179.818 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.897 ' HA ' HG23 ' A' ' 170' ' ' VAL . 13.6 p-90 -63.04 -26.12 68.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.016 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.023 0.44 . . . . 0.0 110.325 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.6 m -87.13 -32.2 20.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.897 HG23 ' HA ' ' A' ' 167' ' ' TRP . 19.0 m -88.66 -33.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.653 ' HG2' ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -73.85 -29.74 62.29 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.656 -0.653 . . . . 0.0 110.541 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.588 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 1.8 m -85.33 -33.87 21.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.673 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.903 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.7 p -65.89 -31.29 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.903 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -110.66 33.12 4.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.087 0.47 . . . . 0.0 110.395 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.588 ' OG1' ' HA ' ' A' ' 172' ' ' THR . 8.4 m -67.68 -32.82 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.124 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.83 50.31 3.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.085 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.595 ' HB3' HG22 ' A' ' 82' ' ' VAL . . . -118.01 13.24 13.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.818 HG11 HH21 ' A' ' 59' ' ' ARG . 2.1 t -83.34 61.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.573 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.93 56.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.391 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.646 HD22 HG13 ' A' ' 82' ' ' VAL . 3.3 mt -92.69 -45.49 8.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.69 98.63 0.42 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.984 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -83.37 -160.41 0.42 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.788 0.327 . . . . 0.0 110.631 179.647 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.19 151.08 81.37 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.984 2.456 . . . . 0.0 112.14 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -117.75 -47.0 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.638 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.71 -176.66 48.35 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.087 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.08 63.69 2.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.189 0.518 . . . . 0.0 111.391 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt -90.68 141.57 28.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.807 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.97 151.04 40.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.385 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p -105.57 135.93 19.31 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.3 Cg_endo -85.52 125.64 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.328 2.686 . . . . 0.0 112.405 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.55 129.35 38.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.56 159.3 42.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.513 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -91.48 143.39 28.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.597 0.236 . . . . 0.0 111.155 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.3 Cg_exo -74.92 77.62 3.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.135 2.557 . . . . 0.0 111.858 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -170.89 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.917 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -37.15 68.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.819 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.05 -35.71 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.722 0.296 . . . . 0.0 110.563 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.2 -36.47 58.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.683 ' HB2' HD11 ' A' ' 42' ' ' LEU . 8.0 tp -70.3 -41.78 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.987 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.424 HG11 ' N ' ' A' ' 15' ' ' ALA . 3.9 p -66.27 -34.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.424 ' N ' HG11 ' A' ' 14' ' ' VAL . . . -74.08 -20.84 60.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.453 178.62 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -64.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.625 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.9 t80 -56.21 -52.66 63.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.38 -37.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.227 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.528 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.22 -52.59 48.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.253 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.624 ' HD2' ' CD1' ' A' ' 20' ' ' TYR . 0.6 OUTLIER -62.29 -44.58 96.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 2.7 mmtt -62.36 -41.46 98.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.571 HD22 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -73.28 -43.86 60.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.688 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -57.56 -33.85 68.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.558 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.41 HE21 ' HB2' ' A' ' 24' ' ' GLN . 1.1 pt20 -86.61 -8.61 57.34 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -121.19 -58.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.92 -48.24 0.5 Allowed Glycine 0 C--O 1.23 -0.149 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.854 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.502 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 2.4 t80 -81.44 49.44 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.21 0.528 . . . . 0.0 110.963 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.44 -27.55 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -42.6 72.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 58.98 3.8 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.029 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.688 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -62.1 115.64 4.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 179.55 -53.88 0.09 OUTLIER Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.356 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -60.55 -50.19 7.35 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.836 1.69 . . . . 0.0 111.19 -179.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.683 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.06 30.29 5.18 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.438 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HG3' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -65.69 -38.59 89.66 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.067 0.434 . . . . 0.0 110.981 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . 0.504 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . -110.69 132.96 11.27 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.482 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.9 Cg_endo -89.31 -143.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.505 2.137 . . . . 0.0 113.785 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.934 ' HB2' ' HA ' ' A' ' 44' ' ' GLN . . . -67.42 106.92 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.022 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.59 -33.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 0.0 111.406 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.479 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.2 m-20 -79.2 163.49 59.47 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.373 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.479 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 29.6 Cg_endo -77.83 48.7 2.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.378 2.718 . . . . 0.0 111.549 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.998 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.55 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.3 m170 -62.29 -58.21 8.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.85 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.934 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.97 -28.18 66.07 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.349 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.834 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -69.08 -55.03 11.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.77 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.734 ' HE2' ' HZ3' ' A' ' 144' ' ' TRP . 2.7 tpp -67.4 -36.7 81.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.807 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . 0.485 ' HD3' ' HB1' ' A' ' 38' ' ' ALA . 3.8 ttp180 -61.92 -37.57 85.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.891 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.6 23.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.503 ' HB3' HG11 ' A' ' 97' ' ' VAL . . . -59.26 -53.74 54.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.414 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.84 -48.51 44.48 Favored Glycine 0 C--O 1.215 -1.08 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.25 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.13 -49.6 75.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.87 -44.08 97.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.606 ' HD2' ' CD1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -73.06 -33.42 65.65 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.986 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.47 -26.65 68.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.0 109.267 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 m -88.61 -25.61 22.35 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.556 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -99.83 -55.25 2.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 111.952 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.57 73.43 10.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.92 0.488 . . . . 0.0 110.567 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD3' ' A' ' 58' ' ' ARG . 3.1 mpt_? -73.82 -18.49 60.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.011 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . 0.438 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -79.35 58.55 2.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.45 . . . . 0.0 111.259 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.07 -48.95 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.664 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 86.0 m-85 -64.17 -28.28 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.197 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -34.29 76.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -74.54 -18.47 60.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.964 0.411 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.937 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -73.01 -39.05 66.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.515 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.16 -48.02 25.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.432 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -51.28 -43.64 61.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.902 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.699 HE22 HD11 ' A' ' 106' ' ' LEU . 24.8 mt-30 -69.54 -58.12 4.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.702 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.464 HD12 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -82.02 16.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.778 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.515 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -78.17 -33.78 50.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.695 HG12 ' H ' ' A' ' 71' ' ' THR . 2.2 p -92.26 -67.9 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.342 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.695 ' H ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -163.43 154.95 14.68 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.415 ' HB2' ' H ' ' A' ' 73' ' ' GLY . 98.3 Cg_endo -89.36 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.935 2.423 . . . . 0.0 112.108 179.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.415 ' H ' ' HB2' ' A' ' 72' ' ' PRO . . . 81.25 -78.73 1.89 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.41 179.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.94 47.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.357 0.599 . . . . 0.0 112.209 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.29 -18.21 22.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.262 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.654 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.8 pt20 -61.86 -38.35 87.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.6 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -66.7 -40.44 88.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.533 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.449 ' HB3' HD22 ' A' ' 180' ' ' LEU . 17.5 mtt180 -67.22 -45.8 75.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.0 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.657 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 8.3 t80 -60.17 -49.76 76.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.853 179.786 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 p -57.6 -34.56 69.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -60.55 -57.74 11.44 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.565 HG11 ' O ' ' A' ' 177' ' ' ALA . 31.3 t -58.65 -38.44 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.877 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -65.73 -46.08 80.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.566 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.48 -36.82 81.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.789 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.44 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 24.8 mt-10 -72.98 -23.57 60.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.395 . . . . 0.0 110.582 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.443 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 1.2 tp -81.74 -37.69 26.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.659 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.633 ' HD2' ' CD1' ' A' ' 87' ' ' PHE . 45.3 t80 -83.93 -8.23 59.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.574 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -42.01 14.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.095 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.19 48.38 0.13 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.723 -1.227 . . . . 0.0 113.13 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.408 ' N ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.12 53.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.442 -1.361 . . . . 0.0 114.747 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.2 Cg_endo -80.09 41.36 1.11 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.12 1.88 . . . . 0.0 111.441 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.774 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.34 163.95 23.97 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.618 -178.822 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.556 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.5 m95 -54.2 -29.05 44.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.61 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.22 -37.74 95.37 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -87.68 -24.89 23.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.703 178.825 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.783 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -54.96 -31.52 60.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.875 HG13 ' HB2' ' A' ' 53' ' ' PHE . 10.7 t -62.89 -52.95 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.472 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.18 72.27 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.331 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.783 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.2 m-85 -56.55 -54.6 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.037 0.446 . . . . 0.0 110.231 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.67 ' HE1' ' CE2' ' A' ' 100' ' ' PHE . 15.3 m-85 -74.94 -39.48 61.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.002 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.42 HG23 ' HE1' ' A' ' 17' ' ' PHE . 2.7 t -61.39 -36.76 75.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.254 -179.591 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.502 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -53.18 -59.77 4.13 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.821 0.343 . . . . 0.0 111.562 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.57 -38.67 78.89 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.28 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.8 94.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.192 0.496 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.707 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -70.33 -41.24 73.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.737 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.42 -47.37 84.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.403 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.571 ' HB3' HD22 ' A' ' 22' ' ' LEU . 60.6 m -65.18 -45.39 85.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.206 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.464 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -55.1 -40.05 70.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.772 0.32 . . . . 0.0 111.601 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.59 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -85.05 -8.77 58.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.683 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -89.92 -29.03 18.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.791 0.329 . . . . 0.0 110.16 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . . . . . . . . . 51.9 t -68.65 -32.42 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.59 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 14.5 p30 -85.32 0.96 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 0.0 111.151 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -125.72 -170.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.395 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.21 53.24 2.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.029 0.443 . . . . 0.0 110.633 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.425 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.16 46.44 2.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.408 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.737 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 15.5 mp0 -64.17 -56.19 25.8 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.424 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.737 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.1 Cg_exo -64.31 -26.52 63.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.051 1.834 . . . . 0.0 112.614 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.505 ' O ' HG23 ' A' ' 122' ' ' VAL . 12.4 tp -66.4 -29.11 69.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.3 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.24 -52.54 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.284 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.42 -32.27 83.59 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.296 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.481 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 19.1 mm100 -65.95 -52.33 50.71 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.531 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 48.6 t -58.28 -35.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.009 0.433 . . . . 0.0 109.91 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.19 -47.02 86.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.26 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.69 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.0 pt-20 -72.69 -39.63 66.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.934 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.654 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 38.9 m0 -55.75 -37.81 68.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.3 ttm -74.11 -53.67 9.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.638 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.69 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.6 p -62.81 -34.07 63.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.491 ' N ' HG11 ' A' ' 127' ' ' VAL . 6.3 mt-10 -69.62 -46.3 66.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.476 179.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.566 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 10.0 t80 -61.51 -35.1 76.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.582 0.706 . . . . 0.0 110.123 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.983 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.93 -56.6 5.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.132 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.84 -31.76 72.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.8 m -82.9 -36.86 24.96 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -125.86 -42.5 1.9 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -177.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.983 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -60.85 -46.31 91.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.371 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.21 54.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.444 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.08 -54.95 22.14 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.774 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.7 t90 -56.66 -48.3 77.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.523 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -57.36 -47.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.569 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.27 -30.11 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -89.09 -9.02 52.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.52 -57.07 2.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.0 111.609 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.97 -13.3 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.6 168.4 39.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.117 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.734 ' HZ3' ' HE2' ' A' ' 46' ' ' MET . 96.9 m95 -61.75 -29.47 70.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.43 80.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.14 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.6 -47.49 81.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 109.55 179.419 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.612 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 15.7 t80 -63.27 -38.25 90.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.078 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.834 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 7.5 m -65.98 -27.24 68.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 111.282 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.73 -34.92 27.08 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.68 HD21 ' HB3' ' A' ' 163' ' ' ARG . 0.3 OUTLIER -66.15 -39.95 90.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.615 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -116.47 20.39 14.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -107.13 -140.33 9.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.444 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.21 -34.67 23.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.448 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.16 42.23 2.98 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.022 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.23 68.19 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.985 0.422 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.942 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.89 173.23 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.272 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.84 -39.3 38.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -179.575 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.942 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.6 mm-40 -63.56 -52.3 61.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -61.38 -38.78 88.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.517 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -59.65 -57.1 14.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -67.8 -29.24 68.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.684 0.278 . . . . 0.0 111.581 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 4.3 tp -69.02 -46.68 67.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.68 ' HB3' HD21 ' A' ' 150' ' ' LEU . 1.8 ptt180 -68.87 -37.2 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.357 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.56 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 3.9 mt-10 -70.67 -43.2 69.58 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.141 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.7 -14.17 72.37 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.3 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.612 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 15.4 t-20 -73.25 -65.46 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.017 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.6 ' HE3' ' HD3' ' A' ' 171' ' ' ARG . 48.0 p-90 -61.54 -24.7 66.81 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.576 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.35 -64.11 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.116 0.26 . . . . 0.0 110.734 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -21.46 25.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.612 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 2.1 t -81.01 -36.32 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.6 ' HD3' ' HE3' ' A' ' 167' ' ' TRP . 0.9 OUTLIER -82.87 -13.35 56.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.516 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.848 ' HA ' HG22 ' A' ' 175' ' ' THR . 1.1 p -88.49 -31.62 18.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.76 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.946 HG11 ' HG ' ' A' ' 174' ' ' LEU . 5.7 p -67.07 -24.51 32.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.476 0.655 . . . . 0.0 110.136 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.946 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.81 42.91 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.231 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.848 HG22 ' HA ' ' A' ' 172' ' ' THR . 0.6 OUTLIER -69.28 -43.23 74.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.912 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.62 27.19 1.89 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.565 ' O ' HG11 ' A' ' 82' ' ' VAL . . . -89.69 2.07 55.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.225 0.513 . . . . 0.0 111.046 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . 0.429 ' H ' HG22 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -80.02 68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.925 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.03 9.65 32.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.785 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.552 HD21 HG21 ' A' ' 82' ' ' VAL . 12.4 mt -95.84 -43.6 7.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.914 0.388 . . . . 0.0 110.509 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.432 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.09 94.62 0.46 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.733 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -86.68 149.2 25.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.055 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.09 -36.52 88.81 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.155 2.57 . . . . 0.0 113.07 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 65.36 77.15 0.31 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.475 0.484 . . . . 0.0 111.489 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -122.46 36.57 3.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.423 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.34 116.21 16.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.292 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.24 167.92 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.741 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.47 150.85 40.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.6 p -114.27 130.49 23.92 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 110.851 -179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 7.8 Cg_exo -73.47 158.01 48.47 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.207 2.605 . . . . 0.0 112.267 -179.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.38 129.14 56.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.16 110.46 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.187 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.454 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.07 132.74 62.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.409 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 7.9 Cg_exo -73.56 49.32 1.76 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.662 2.908 . . . . 0.0 112.453 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.11 -164.48 1.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.617 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -37.93 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.204 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.459 ' H ' ' HG3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -62.1 -35.4 78.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.93 -36.13 49.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.0 109.886 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.653 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.4 tp -70.44 -43.28 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -65.87 -35.35 74.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.437 ' HB1' ' O ' ' A' ' 11' ' ' ARG . . . -72.23 -22.59 61.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.7 -64.24 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 4.8 t80 -54.95 -52.71 62.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.829 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.513 HG11 HD12 ' A' ' 22' ' ' LEU . 46.5 t -72.29 -40.0 64.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.32 -54.3 37.39 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.847 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.748 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 48.9 t80 -62.8 -39.69 95.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 0.186 . . . . 0.0 111.271 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.544 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.46 -42.99 98.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.645 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.634 HD23 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -70.42 -44.79 67.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.618 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.807 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -62.47 -20.69 64.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.058 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.632 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.93 -35.38 26.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.47 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.632 ' HD3' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -151.08 76.25 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.96 0.409 . . . . 0.0 112.025 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.67 -70.43 0.3 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.123 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.615 ' HE2' ' CE1' ' A' ' 27' ' ' TYR . 0.7 OUTLIER -90.26 56.43 3.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.389 0.614 . . . . 0.0 109.537 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.21 -34.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.757 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -41.65 72.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.386 0.612 . . . . 0.0 109.605 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.45 56.71 4.9 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.913 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.807 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.83 120.99 13.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.484 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 172.31 -58.36 0.16 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.173 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.482 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.4 Cg_exo -60.35 -48.45 11.6 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.785 1.657 . . . . 0.0 111.014 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.748 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.91 40.04 2.71 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.898 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 10.1 pt-20 -93.76 -8.09 41.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.77 164.49 12.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.724 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -99.31 -164.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.606 2.871 . . . . 0.0 113.191 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.657 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -89.01 73.11 8.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.931 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.11 34.01 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.099 0.476 . . . . 0.0 111.589 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.509 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 5.4 m-20 -130.11 161.1 62.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -70.76 28.77 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.912 3.075 . . . . 0.0 113.055 179.615 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.653 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -166.78 -23.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.657 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.0 m170 -55.52 -64.78 0.74 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.512 ' CA ' ' HB3' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -58.4 -23.9 58.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.536 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.81 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -74.37 -46.5 40.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HE2' ' CD1' ' A' ' 100' ' ' PHE . 15.2 ttm -72.25 -39.78 68.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.819 -179.187 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -60.81 -36.14 78.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.569 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -31.34 42.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 109.98 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.644 ' HA ' HH22 ' A' ' 163' ' ' ARG . . . -65.19 -56.7 11.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.552 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.62 -48.47 42.95 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.61 -46.45 80.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.479 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -46.23 91.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.935 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.61 -31.78 65.43 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.871 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.86 -24.9 67.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.651 0.738 . . . . 0.0 109.211 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -89.38 -36.54 15.43 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.913 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -84.44 -64.43 1.16 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.93 72.01 8.98 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.843 0.857 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -82.8 -0.03 45.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.04 23.82 4.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.245 -0.284 . . . . 0.0 111.361 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.53 -1.24 30.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.596 ' HA ' HD21 ' A' ' 64' ' ' LEU . 10.4 m-85 -92.6 -19.77 21.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.63 80.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.755 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 3.2 m-20 -62.76 -22.86 66.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.102 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.596 HD21 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -68.69 -39.62 80.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.064 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.46 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -79.56 -44.72 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.141 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.452 ' HB2' ' O ' ' A' ' 180' ' ' LEU . . . -51.3 -42.66 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.386 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.637 HE22 HD12 ' A' ' 106' ' ' LEU . 27.2 mt-30 -73.16 -53.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.563 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -83.26 14.74 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.32 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 82.6 t60 -77.98 -32.64 51.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.266 0.555 . . . . 0.0 109.631 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.435 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.76 -73.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.195 179.837 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.35 153.74 16.91 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.512 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.647 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 6.6 Cg_endo -86.64 -167.27 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.199 2.599 . . . . 0.0 111.985 179.805 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.448 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.78 -63.41 4.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.998 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.99 24.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.088 0.471 . . . . 0.0 111.85 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.448 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -80.23 -23.32 40.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.622 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.593 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 1.8 pt20 -62.01 -43.42 98.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.618 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -62.15 -42.43 99.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.433 ' HB3' HD23 ' A' ' 180' ' ' LEU . 6.9 mtt180 -63.23 -44.98 93.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.88 179.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 9.1 t80 -62.84 -50.78 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.496 179.484 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 p -56.1 -33.68 65.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.419 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.464 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.3 mm100 -60.27 -66.58 0.5 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.485 HG13 HD22 ' A' ' 180' ' ' LEU . 12.0 m -56.52 -32.73 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.681 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.1 m -65.85 -43.82 87.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.353 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.565 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.8 -37.02 73.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 109.694 179.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -29.05 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.884 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.522 HD21 ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -80.84 -31.79 35.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.309 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.432 ' CE1' ' HG3' ' A' ' 91' ' ' PRO . 37.3 t80 -93.27 1.89 56.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -24.99 36.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.256 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 60.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.344 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.421 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.25 59.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.607 -1.282 . . . . 0.0 114.648 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.574 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -82.78 39.06 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.275 1.983 . . . . 0.0 111.642 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.797 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 t-20 -66.86 164.36 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.606 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -54.49 -27.15 35.84 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.235 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.457 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.34 -38.62 95.2 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.633 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.7 mmp_? -87.53 -26.61 23.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.974 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.828 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.61 -31.57 57.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.421 0.629 . . . . 0.0 109.969 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.935 HG13 ' HB2' ' A' ' 53' ' ' PHE . 22.0 t -62.09 -55.87 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.456 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.82 -29.22 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.47 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.651 ' HE2' ' CE1' ' A' ' 99' ' ' PHE . 4.4 m-85 -55.79 -54.65 41.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.095 0.474 . . . . 0.0 110.191 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.5 m-85 -77.83 -35.54 51.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.456 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -60.73 -39.86 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.529 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.4 m-85 -55.11 -51.11 67.43 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.23 -38.77 38.53 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.138 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.33 99.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.131 0.465 . . . . 0.0 110.927 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.523 ' HB1' HD22 ' A' ' 64' ' ' LEU . . . -70.36 -37.91 74.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.637 HD12 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.29 -44.48 97.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.156 179.151 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.634 ' HB3' HD23 ' A' ' 22' ' ' LEU . 94.8 m -63.92 -45.79 87.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.284 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.413 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -52.06 -47.96 64.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.726 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.601 ' HA ' HD22 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -77.34 -12.25 59.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.806 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -88.53 -24.96 22.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.941 0.401 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.401 HG21 ' O ' ' A' ' 107' ' ' CYS . 57.4 t -75.64 -35.77 32.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.601 HD22 ' HA ' ' A' ' 109' ' ' GLU . 22.8 p30 -81.44 0.56 37.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.408 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.48 -167.51 1.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -91.27 62.66 4.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.471 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.647 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -141.66 37.75 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.946 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.627 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.3 mp0 -55.84 -55.86 36.47 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.307 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.627 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.7 Cg_exo -65.02 -18.55 62.37 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.082 1.855 . . . . 0.0 112.341 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.491 HD23 ' HB2' ' A' ' 72' ' ' PRO . 2.2 mm? -74.77 -35.22 62.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.3 t -54.91 -57.72 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.491 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.51 79.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.965 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.498 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 5.5 mm-40 -66.35 -49.78 65.75 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.587 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 59.8 t -57.35 -36.12 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.24 -45.61 92.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.786 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.4 pt-20 -76.2 -36.86 58.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.114 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.593 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 39.4 m0 -56.69 -38.62 72.51 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.6 ttm -72.85 -54.94 7.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.685 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.5 p -60.97 -32.49 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.435 ' N ' HG11 ' A' ' 127' ' ' VAL . 43.2 mt-10 -67.9 -50.41 56.38 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.306 179.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.649 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 13.3 t80 -58.74 -35.21 72.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.642 0.734 . . . . 0.0 110.284 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 1.027 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.93 -48.5 30.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.956 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.04 -42.22 84.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 m -80.78 -40.57 24.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -42.1 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 1.027 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -63.2 -46.71 85.77 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.418 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.85 55.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.613 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.66 -53.06 30.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.571 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.797 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 55.6 t90 -55.3 -47.51 75.46 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.263 0.554 . . . . 0.0 109.567 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 4.3 mt -57.85 -49.17 81.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.402 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -60.62 -39.69 89.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m -78.0 -26.89 48.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -56.04 5.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.28 -15.75 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.655 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.424 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 92.32 170.85 41.1 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.183 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.493 ' CZ2' HD12 ' A' ' 138' ' ' ILE . 98.2 m95 -61.82 -26.09 67.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.24 -33.91 77.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.449 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -66.74 -38.71 87.18 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.79 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.414 ' HZ ' ' CB ' ' A' ' 49' ' ' ALA . 6.5 t80 -65.79 -38.88 90.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.659 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.81 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -67.46 -27.69 67.24 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.8 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.96 -18.06 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.094 0.474 . . . . 0.0 110.349 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.5 HD11 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -75.78 -49.42 18.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.673 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.45 31.51 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.476 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -93.3 -113.85 2.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.359 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.43 -62.94 1.43 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.14 0.495 . . . . 0.0 109.691 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.462 ' O ' HD22 ' A' ' 156' ' ' LEU . . . -83.7 64.11 4.34 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.348 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.74 74.99 7.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.462 HD22 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -60.54 153.81 22.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.153 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.623 ' HA ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -57.99 -27.36 63.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.753 -179.438 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.596 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 1.2 mm-40 -73.83 -32.43 63.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.422 ' HB1' ' HG ' ' A' ' 156' ' ' LEU . . . -78.33 -41.56 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.623 ' HG2' ' HA ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -66.61 -37.89 85.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.579 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.596 ' HD2' ' OE1' ' A' ' 158' ' ' GLU . 9.8 ptp85 -72.65 -29.11 63.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.088 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -38.3 81.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.716 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.644 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.3 ttp180 -65.89 -41.9 90.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.571 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -61.62 -48.25 81.76 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.346 0.404 . . . . 0.0 110.295 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.13 -28.52 73.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.408 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.06 -58.66 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.253 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.81 ' HA ' HG21 ' A' ' 170' ' ' VAL . 14.2 p-90 -62.08 -27.42 68.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.416 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.17 76.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.446 . . . . 0.0 110.344 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.21 -28.73 20.98 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.81 HG21 ' HA ' ' A' ' 167' ' ' TRP . 8.1 m -95.3 -36.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.618 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -81.34 -15.71 54.54 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.46 -0.775 . . . . 0.0 111.138 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 m -96.08 -17.04 21.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.156 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 1.037 HG12 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -81.2 -26.5 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.529 0.68 . . . . 0.0 109.521 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 1.037 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -120.88 39.54 3.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.692 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -30.49 71.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.15 1.93 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.541 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.483 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -99.42 6.54 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.185 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.56 60.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.99 -11.14 60.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.277 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.492 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -96.39 -9.38 30.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.848 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.87 89.7 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.651 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -108.87 171.46 7.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.64 0.257 . . . . 0.0 110.4 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.84 -39.79 49.4 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.726 2.284 . . . . 0.0 111.643 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.06 176.78 5.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.479 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 141.4 -25.74 2.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.581 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 58.9 m -157.27 151.58 25.0 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.22 160.65 43.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 118.15 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.368 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.409 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 p -99.78 118.41 61.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.359 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.8 Cg_exo -77.5 139.09 17.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.316 2.677 . . . . 0.0 112.02 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.22 133.36 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.666 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 m -77.17 157.87 30.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.49 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -84.67 128.37 61.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.49 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 11.4 Cg_exo -71.52 99.87 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.103 2.536 . . . . 0.0 111.704 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -163.32 0.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.652 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.53 -38.59 69.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.959 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.481 ' HA ' HG13 ' A' ' 14' ' ' VAL . 28.3 ttp180 -63.12 -35.47 80.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.294 . . . . 0.0 110.729 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.99 60.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.208 0.528 . . . . 0.0 109.756 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.582 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -71.91 -42.73 66.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.056 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.4 p -65.11 -36.0 76.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.131 0.491 . . . . 0.0 109.703 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.25 -21.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.375 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 -63.95 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.903 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.652 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 3.4 t80 -54.45 -54.04 46.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.51 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 58.0 t -67.75 -39.55 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.717 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -59.47 -54.71 35.5 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.246 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.673 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 34.5 t80 -61.86 -43.21 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.563 0.345 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.425 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 12.7 mmtt -61.13 -40.27 93.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.619 HD23 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -79.16 -46.65 17.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.078 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.424 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 39.6 ttp85 -63.75 -17.25 62.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.397 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.494 ' HB3' ' O ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -85.02 -24.05 28.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.971 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -160.1 76.14 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.81 -68.78 0.37 Allowed Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.271 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.553 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 2.0 t80 -84.85 52.08 2.32 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.008 0.523 . . . . 0.0 109.785 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.63 -40.05 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.59 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -40.42 96.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.409 0.623 . . . . 0.0 109.626 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.25 52.06 4.04 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.043 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.69 124.49 22.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.526 ' CA ' ' HG3' ' A' ' 35' ' ' GLU . . . 176.92 -54.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.603 -1.284 . . . . 0.0 113.637 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.717 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 13.0 Cg_exo -72.26 -49.88 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.406 2.071 . . . . 0.0 112.284 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.673 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -86.04 28.12 5.22 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.774 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HG3' ' CA ' ' A' ' 32' ' ' GLY . 3.1 mt-10 -88.04 -26.22 22.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.387 0.613 . . . . 0.0 110.241 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.3 147.86 23.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.301 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -94.79 -155.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.062 2.508 . . . . 0.0 112.833 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.458 ' HB3' ' HA ' ' A' ' 44' ' ' GLN . . . -88.82 85.94 6.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.524 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.29 21.93 5.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 110.333 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.438 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 1.5 m-20 -125.58 159.35 61.1 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.29 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.41 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 61.2 Cg_endo -81.32 47.2 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 111.576 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.582 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -177.94 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.515 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 1.6 m170 -57.25 -62.11 2.0 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.735 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.458 ' HA ' ' HB3' ' A' ' 38' ' ' ALA . 44.4 tt0 -55.8 -30.84 62.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.588 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -70.56 -51.49 28.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.999 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.1 ttm -67.9 -41.83 82.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -61.77 -35.18 77.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.89 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.46 -41.31 27.84 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.614 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.559 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . . . -59.49 -54.25 48.74 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.491 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.72 -47.24 58.76 Favored Glycine 0 C--O 1.219 -0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.441 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.43 -46.83 87.63 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.95 -45.2 93.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.743 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.433 ' HB2' HG12 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -72.57 -33.0 66.46 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.143 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.87 -26.7 68.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 109.706 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -87.43 -29.21 21.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.479 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -91.68 -46.34 7.97 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.69 -179.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.16 86.68 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.19 0.596 . . . . 0.0 110.207 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -68.52 -23.45 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -86.06 65.97 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.72 -38.12 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.507 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.59 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 42.1 m-85 -91.15 -3.4 57.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 -47.47 55.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.313 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.435 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -59.84 -32.11 70.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.469 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.816 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 4.8 mp -56.84 -44.89 82.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.589 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.653 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -80.46 -42.2 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.428 ' O ' ' HD2' ' A' ' 69' ' ' HIS . . . -50.6 -41.82 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.643 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.8 mt-30 -79.31 -53.47 6.91 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.505 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -82.37 13.1 3.79 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.708 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.653 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.6 -25.87 41.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.458 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -71.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.04 151.66 16.52 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.387 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.79 -177.52 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.065 2.51 . . . . 0.0 111.599 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 89.27 -71.5 2.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.972 179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 45.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.226 0.536 . . . . 0.0 112.026 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.17 -21.1 16.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.681 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -63.77 -40.25 96.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.795 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.426 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 18.2 mp0 -63.79 -44.4 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.176 0.297 . . . . 0.0 111.104 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.643 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 42.8 mtt180 -65.52 -38.21 89.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.04 0.448 . . . . 0.0 110.033 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.659 ' HD1' ' CD2' ' A' ' 79' ' ' PHE . 5.0 t80 -66.17 -51.25 59.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.421 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -56.66 -35.39 68.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . 0.426 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 38.4 mm-40 -59.88 -54.66 43.56 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.518 HG21 ' N ' ' A' ' 83' ' ' SER . 9.9 m -66.89 -32.15 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.097 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.518 ' N ' HG21 ' A' ' 82' ' ' VAL . 29.9 m -66.2 -46.8 76.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.755 179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.571 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -67.2 -35.62 79.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 110.323 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.49 -27.03 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.259 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.476 HD11 ' O ' ' A' ' 82' ' ' VAL . 0.1 OUTLIER -80.39 -28.15 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.694 179.769 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -95.24 -6.4 41.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.07 -50.18 6.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.429 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.56 66.35 0.22 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.4 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.406 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 150.48 62.05 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.677 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.521 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.5 Cg_endo -81.74 41.66 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.49 2.127 . . . . 0.0 111.582 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.784 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.2 t-20 -66.71 164.3 17.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -53.88 -29.15 40.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.627 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -64.84 -36.05 92.64 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.704 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.3 mmp_? -87.23 -27.18 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.447 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.928 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -55.93 -30.55 61.83 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.941 179.388 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG12 ' HB2' ' A' ' 53' ' ' PHE . 18.0 t -63.84 -55.04 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.525 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.22 -29.74 70.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.928 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 7.8 m-85 -57.01 -59.87 4.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.094 0.474 . . . . 0.0 110.354 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.551 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 8.1 m-85 -72.88 -37.91 67.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.348 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.16 -38.76 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.303 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.478 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -59.27 -46.17 89.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.379 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.97 -40.32 17.3 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.064 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.92 96.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.413 ' O ' HD23 ' A' ' 64' ' ' LEU . . . -68.06 -42.37 80.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.826 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.816 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -57.99 -45.45 86.77 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.645 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.619 ' HB3' HD23 ' A' ' 22' ' ' LEU . 88.6 m -59.55 -41.73 90.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.458 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -59.33 -36.74 76.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.968 0.413 . . . . 0.0 110.825 179.69 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.573 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -78.27 -24.25 46.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.767 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -24.62 41.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.953 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.528 HG21 ' O ' ' A' ' 107' ' ' CYS . 50.6 t -72.07 -37.57 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.976 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.573 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.7 p30 -85.78 -0.06 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.335 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -123.66 -173.53 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.903 0.382 . . . . 0.0 110.935 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.8 53.31 2.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.81 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.505 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.23 48.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.484 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.509 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -60.24 -54.99 49.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.52 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 16.9 Cg_exo -68.71 -12.81 35.6 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.147 1.898 . . . . 0.0 112.96 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.414 ' HB2' ' HB3' ' A' ' 115' ' ' MET . 1.5 mp -78.77 -27.97 44.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.183 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.56 -57.44 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 111.365 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.21 -29.65 71.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.265 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.435 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.4 mm-40 -67.68 -52.67 35.13 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.409 HG22 ' O ' ' A' ' 118' ' ' LEU . 63.8 t -56.34 -34.57 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -62.62 -47.89 81.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.342 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.461 ' HA ' HG11 ' A' ' 127' ' ' VAL . 21.3 pt-20 -74.48 -37.49 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.84 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.681 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.5 m0 -54.68 -36.75 64.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.551 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 1.6 mtm -73.95 -57.57 3.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.518 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.488 HG13 ' N ' ' A' ' 128' ' ' GLU . 1.5 p -60.36 -32.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.488 ' N ' HG13 ' A' ' 127' ' ' VAL . 4.4 mm-40 -71.25 -47.35 57.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.038 179.332 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.571 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.7 t80 -59.72 -37.21 78.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.708 0.765 . . . . 0.0 110.161 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.982 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.89 -52.74 15.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.85 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -58.73 -35.2 72.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.789 0.328 . . . . 0.0 111.784 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.5 m -79.54 -43.25 23.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.408 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -123.64 -38.13 2.56 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.31 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.982 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -64.04 -49.1 73.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.358 0.526 . . . . 0.0 111.571 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.28 -33.32 52.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.111 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.31 -56.26 17.95 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.784 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.6 t90 -56.59 -46.59 80.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.126 0.488 . . . . 0.0 109.863 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.552 HG13 ' HE3' ' A' ' 137' ' ' TRP . 15.1 mt -58.88 -47.02 90.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.251 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -68.06 -31.66 71.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.64 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.2 m -90.14 -4.83 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.517 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.68 -51.67 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.62 -10.66 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.475 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.84 166.55 42.66 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.101 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 95.5 m95 -60.93 -27.79 68.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.18 86.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.814 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.525 ' HG3' HD11 ' A' ' 150' ' ' LEU . 1.2 tt0 -62.76 -41.83 99.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.58 -34.68 78.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.517 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.588 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -67.04 -28.15 67.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.53 -27.41 25.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.376 0.608 . . . . 0.0 109.811 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.525 HD11 ' HG3' ' A' ' 146' ' ' GLU . 2.2 mt -74.24 -38.68 63.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.353 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.559 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 6.2 m-85 -122.29 26.67 8.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.456 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -117.9 -141.3 6.75 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.914 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -41.79 36.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.299 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -83.49 41.55 2.94 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.479 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.24 72.85 10.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 110.268 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.772 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -66.83 170.09 7.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.006 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . 0.7 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 5.6 mm-40 -52.97 -37.93 61.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.746 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.772 ' HB2' HD12 ' A' ' 156' ' ' LEU . 3.9 mp0 -63.64 -47.63 80.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.437 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -65.34 -37.05 85.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.7 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 77.5 mtt180 -58.18 -58.53 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.481 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 3.6 ptt180 -67.4 -28.77 68.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.467 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -67.22 -49.77 63.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.489 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.439 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.9 OUTLIER -64.79 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.142 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.56 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 5.5 mt-10 -69.08 -47.01 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.632 0.253 . . . . 0.0 110.442 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.84 -24.51 72.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.169 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -66.04 -60.86 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.977 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.812 ' HA ' HG21 ' A' ' 170' ' ' VAL . 14.3 p-90 -61.72 -26.32 67.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.742 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.94 93.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.241 0.543 . . . . 0.0 110.228 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 m -86.87 -24.44 24.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.834 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.812 HG21 ' HA ' ' A' ' 167' ' ' TRP . 5.3 m -97.07 -38.93 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -73.83 -26.18 60.46 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.625 -0.672 . . . . 0.0 111.396 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.672 ' HA ' HG21 ' A' ' 175' ' ' THR . 1.5 m -86.28 -25.71 25.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.43 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.875 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -73.7 -22.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.367 0.604 . . . . 0.0 109.763 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.875 ' HG ' HG11 ' A' ' 173' ' ' VAL . 2.9 mt -120.33 40.42 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.178 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.672 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -62.77 -22.27 66.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.806 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.36 9.46 61.33 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.714 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.59 28.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.875 0.338 . . . . 0.0 111.744 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.11 69.8 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -81.1 -9.41 59.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.055 -179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.49 ' HG ' ' HG3' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -92.98 36.03 1.04 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.0 0.429 . . . . 0.0 111.319 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.37 76.23 2.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.168 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -117.48 150.83 38.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.794 0.297 . . . . 0.0 110.555 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.031 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.89 136.15 51.59 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.83 2.353 . . . . 0.0 112.263 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 5.9 mt -110.33 160.24 16.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.457 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -175.97 118.73 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 0' ' ' SER . . . . . 0.532 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.9 OUTLIER -98.25 85.21 3.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.488 0.185 . . . . 0.0 110.763 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' HB2' ' O ' ' A' ' 0' ' ' SER . 25.8 mtm 76.65 123.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.108 0.88 . . . . 0.0 111.491 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.26 132.24 21.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.964 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.441 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.0 p -99.54 138.77 20.52 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.401 . . . . 0.0 110.907 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.441 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 4.0 Cg_endo -85.59 25.46 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.178 2.585 . . . . 0.0 112.219 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.35 -10.75 14.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.65 127.68 46.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.481 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -134.41 132.97 21.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.559 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.8 Cg_exo -74.38 80.9 2.15 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.144 2.563 . . . . 0.0 111.739 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.33 -173.95 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.57 -33.83 66.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -66.36 -33.37 75.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.393 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.83 -47.47 18.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 42' ' ' LEU . 1.2 tp -59.4 -41.26 89.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.682 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -65.64 -42.55 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.284 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 14' ' ' VAL . . . -69.07 -29.73 67.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.987 0.422 . . . . 0.0 110.379 178.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.38 -57.28 4.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.101 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.63 -52.32 65.91 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.443 ' O ' HD13 ' A' ' 22' ' ' LEU . 60.6 t -63.49 -42.68 97.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.658 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.2 -46.12 94.81 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.013 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.769 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 63.5 t80 -64.38 -42.43 96.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.979 0.419 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.483 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.27 -41.34 94.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.542 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.587 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.1 mp -71.7 -43.49 65.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.773 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.677 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -62.99 -20.04 64.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.113 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -78.93 -42.42 27.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.927 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -153.95 79.93 1.13 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.964 0.411 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.25 -65.79 0.32 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.88 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.604 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.35 60.3 1.16 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.296 0.57 . . . . 0.0 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.461 HG12 ' N ' ' A' ' 29' ' ' CYS . 1.9 p -79.6 -24.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.633 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . 0.461 ' N ' HG12 ' A' ' 28' ' ' VAL . 0.0 OUTLIER -74.87 -40.97 60.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.608 179.056 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 59.83 4.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.357 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.677 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -69.96 116.01 9.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.474 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.509 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 173.71 -57.7 0.14 Allowed Glycine 0 C--O 1.226 -0.405 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.501 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.658 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 52.0 Cg_exo -57.46 -46.04 30.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.337 2.024 . . . . 0.0 111.698 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.769 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.79 31.13 7.52 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.574 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -80.97 -23.75 38.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 109.879 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.44 135.67 13.01 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.534 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.505 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 86.3 Cg_endo -89.31 -138.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.965 2.443 . . . . 0.0 113.121 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.513 ' HB2' ' HA ' ' A' ' 44' ' ' GLN . . . -96.75 94.33 7.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.0 21.67 2.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.943 0.402 . . . . 0.0 110.846 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.527 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 6.2 m-20 -132.83 159.73 71.42 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.761 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.419 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 57.4 Cg_endo -79.96 51.87 4.07 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 111.685 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.737 HD11 HD11 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.16 -33.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.058 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.527 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -58.95 -59.82 4.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.907 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.513 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 29.9 tt0 -58.21 -29.1 65.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.693 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.601 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.83 -51.44 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.308 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.482 ' SD ' HD13 ' A' ' 13' ' ' LEU . 4.0 ttm -64.98 -36.58 84.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.524 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -38.26 87.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.688 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.9 31.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.76 0.314 . . . . 0.0 110.322 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.698 ' HB1' HG21 ' A' ' 97' ' ' VAL . . . -59.05 -57.39 13.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.369 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.64 -47.21 37.82 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.598 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.05 -48.94 79.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.016 0.408 . . . . 0.0 111.22 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -43.25 92.97 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.187 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.834 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.46 -38.6 68.2 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.624 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.88 -22.59 62.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.739 0.781 . . . . 0.0 109.725 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -94.91 -37.23 11.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.672 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -84.96 -26.36 27.21 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.445 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -86.83 98.78 11.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.161 0.505 . . . . 0.0 110.717 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -64.18 -34.09 77.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.662 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 93.61 4.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.125 0.488 . . . . 0.0 110.289 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' THR . . . . . 0.405 HG21 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.1 -59.16 1.81 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.477 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.648 ' HD1' ' CD2' ' A' ' 61' ' ' PHE . 23.7 m-85 -87.79 -10.51 50.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -41.4 88.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.948 0.404 . . . . 0.0 111.518 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.445 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.9 m-20 -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.076 0.465 . . . . 0.0 110.663 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.99 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -75.99 -40.04 54.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.572 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -73.7 -45.54 51.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.747 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.577 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -51.89 -43.84 63.5 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.711 HE22 HD13 ' A' ' 106' ' ' LEU . 27.6 mt-30 -68.79 -56.43 8.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.539 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -88.25 16.66 5.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.853 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.572 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.63 -24.82 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.025 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.68 -64.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.578 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 1.1 t -170.02 150.88 3.82 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.593 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 1.9 Cg_endo -81.83 -165.19 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.03 2.487 . . . . 0.0 112.083 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.408 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 84.24 -70.73 3.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.018 179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.92 39.81 0.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.059 0.457 . . . . 0.0 112.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -94.59 -23.24 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.087 179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.671 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.3 pt20 -62.81 -39.2 93.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -63.07 -44.63 95.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.747 0.308 . . . . 0.0 110.304 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -63.34 -43.39 97.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.984 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' O ' HG23 ' A' ' 82' ' ' VAL . 8.2 t80 -62.77 -50.94 69.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.362 179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.77 -33.1 66.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -62.1 -64.23 1.0 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.489 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.481 HG12 ' CD2' ' A' ' 180' ' ' LEU . 13.6 m -58.61 -32.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -66.02 -43.15 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.31 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.57 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -69.45 -36.36 76.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.244 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.406 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 3.2 mm-40 -70.33 -29.68 66.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.067 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.606 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.1 OUTLIER -76.47 -34.99 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 179.518 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.623 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 47.7 t80 -88.42 -5.51 58.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.655 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.406 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -45.62 -46.61 14.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.118 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.23 62.64 0.12 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.758 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.522 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 163.46 53.6 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.6 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.626 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 39.37 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.183 1.922 . . . . 0.0 111.555 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.687 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.4 t-20 -67.04 162.9 21.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.401 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.488 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 23.1 m95 -55.98 -27.48 52.96 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.299 0.375 . . . . 0.0 111.177 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.31 92.41 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.606 ' HG3' HD23 ' A' ' 86' ' ' LEU . 1.3 tpt180 -86.29 -26.63 24.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.291 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.781 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -30.17 61.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.309 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.834 HG13 ' HB2' ' A' ' 53' ' ' PHE . 7.4 t -62.89 -52.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.38 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.64 69.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.398 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.637 ' HD1' ' CD2' ' A' ' 99' ' ' PHE . 9.1 m-85 -57.75 -57.01 14.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.215 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.815 ' HE1' HD22 ' A' ' 130' ' ' LEU . 10.9 m-85 -74.97 -39.9 61.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.941 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.9 -38.85 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.441 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.565 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -57.15 -51.1 70.65 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.639 0.257 . . . . 0.0 111.211 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.21 -38.15 40.41 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.266 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.11 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.174 0.487 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.825 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -68.57 -38.91 81.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.763 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.09 -43.31 91.81 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.128 179.016 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.587 ' HB3' HD21 ' A' ' 22' ' ' LEU . 90.0 m -65.51 -42.92 91.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.74 77.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.478 ' HA ' HD22 ' A' ' 112' ' ' ASN . 0.3 OUTLIER -80.7 -9.54 59.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.81 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.2 m -91.16 -23.28 20.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.926 0.393 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.426 HG22 HG23 ' A' ' 119' ' ' VAL . 71.9 t -74.44 -34.35 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.641 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.478 HD22 ' HA ' ' A' ' 109' ' ' GLU . 24.1 p30 -85.3 0.81 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.302 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.85 -174.81 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -82.99 62.31 6.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 0.0 110.522 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.593 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -135.29 45.55 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.479 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.658 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.6 mt-10 -52.12 -59.38 8.51 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.609 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.658 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 7.4 Cg_exo -74.26 -22.09 16.95 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.134 1.889 . . . . 0.0 112.627 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.535 ' O ' HG22 ' A' ' 122' ' ' VAL . 3.0 mm? -64.57 -37.47 87.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.302 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.426 HG23 HG22 ' A' ' 111' ' ' VAL . 90.4 t -57.22 -54.55 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.56 -32.37 83.98 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.95 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.574 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.6 mt-30 -65.59 -52.22 53.74 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.554 HG23 ' CZ3' ' A' ' 125' ' ' TRP . 82.8 t -56.16 -35.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.29 -47.34 82.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.365 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.793 ' HA ' HG11 ' A' ' 127' ' ' VAL . 18.2 pt-20 -72.58 -38.19 67.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.671 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.9 m0 -58.1 -40.58 81.52 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.478 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 6.2 ttm -73.22 -51.28 18.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.793 HG11 ' HA ' ' A' ' 124' ' ' GLU . 3.9 p -63.23 -34.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.485 ' N ' HG13 ' A' ' 127' ' ' VAL . 33.7 mt-10 -73.35 -39.5 65.14 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.677 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.646 ' HD2' ' CD1' ' A' ' 129' ' ' TYR . 12.6 t80 -66.6 -34.53 78.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.647 0.736 . . . . 0.0 110.129 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.46 -53.0 8.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.828 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -31.6 71.55 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.6 m -85.46 -37.92 19.2 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -119.75 -43.66 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -61.49 -46.57 89.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.377 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.09 62.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.47 -50.3 70.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.687 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 51.9 t90 -59.28 -46.82 87.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.493 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.6 mt -57.34 -48.44 82.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.995 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -65.04 -32.06 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.2 m -82.43 -17.48 45.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.0 t -85.45 -54.74 4.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.845 0.355 . . . . 0.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -177.37 -19.31 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.355 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.41 170.93 29.35 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.468 ' HZ3' ' HE1' ' A' ' 46' ' ' MET . 96.1 m95 -59.41 -30.23 68.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.526 ' HA ' ' HG1' ' A' ' 148' ' ' THR . . . -62.08 -37.31 84.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 178.466 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -41.55 98.57 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.488 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.5 t80 -64.88 -38.23 90.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.485 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.601 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -63.1 -28.12 69.86 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.19 -26.75 26.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.668 . . . . 0.0 109.71 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.683 HD23 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -75.46 -39.88 58.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.45 28.11 7.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.972 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -119.2 -141.44 6.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.239 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.52 -40.0 44.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.862 0.363 . . . . 0.0 111.42 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.92 46.13 3.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.157 179.782 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.57 72.32 10.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 110.631 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.564 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -65.28 168.54 6.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.84 -34.77 63.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.564 ' HB2' HD11 ' A' ' 156' ' ' LEU . 1.1 mm-40 -73.17 -32.72 65.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 111.187 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.409 ' HB3' ' HA ' ' A' ' 150' ' ' LEU . . . -74.6 -42.83 57.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.911 0.386 . . . . 0.0 111.386 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -66.68 -39.54 88.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.219 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -72.01 -28.53 63.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.896 0.379 . . . . 0.0 110.581 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.68 -47.07 33.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.683 ' HB3' HD23 ' A' ' 150' ' ' LEU . 1.1 ptt180 -64.27 -37.57 87.96 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.7 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.467 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 2.4 tt0 -68.24 -45.81 72.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.93 0.395 . . . . 0.0 110.109 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.91 -25.82 75.05 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.552 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -66.1 -58.86 4.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.656 0.265 . . . . 0.0 111.102 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.854 ' HA ' HG21 ' A' ' 170' ' ' VAL . 17.3 p-90 -61.71 -27.52 68.76 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.067 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -43.9 74.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.84 -33.61 19.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.854 HG21 ' HA ' ' A' ' 167' ' ' TRP . 17.0 m -85.05 -26.14 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -79.07 -30.46 43.97 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.759 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -89.21 -27.98 20.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.448 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.948 HG12 ' HG ' ' A' ' 174' ' ' LEU . 4.2 p -66.34 -27.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.161 0.505 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.948 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.24 44.35 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.0 110.242 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.759 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.42 -29.05 69.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.901 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.97 9.93 43.18 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.397 0.519 . . . . 0.0 114.397 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.33 11.12 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.134 0.467 . . . . 0.0 111.719 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.94 70.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.242 0.544 . . . . 0.0 110.372 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . 0.46 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -104.19 13.55 32.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.087 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.481 ' CD2' HG12 ' A' ' 82' ' ' VAL . 18.4 mt -99.52 -51.55 3.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.154 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . 0.577 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -72.07 96.68 0.71 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.794 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -92.57 152.43 19.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.912 0.386 . . . . 0.0 111.088 -179.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.754 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.4 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.19 134.24 58.06 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.876 2.384 . . . . 0.0 111.634 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER 72.51 -55.36 0.67 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.978 0.799 . . . . 0.0 111.38 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -176.35 -131.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.134 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 33.9 m -124.31 173.85 8.11 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.68 125.1 31.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.018 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.24 144.86 28.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.615 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.2 p -105.5 139.5 20.24 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.6 Cg_exo -77.26 1.92 8.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.968 2.445 . . . . 0.0 112.355 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.04 133.98 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.184 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -148.35 172.12 14.91 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.434 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -124.47 138.08 30.41 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.616 0.246 . . . . 0.0 111.029 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.1 Cg_exo -77.58 70.4 6.9 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.201 2.6 . . . . 0.0 111.571 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.48 -168.35 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -38.27 60.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -62.35 -38.85 91.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.09 62.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.0 109.977 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.567 HD23 ' HE2' ' A' ' 46' ' ' MET . 1.5 tp -72.32 -42.07 65.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.138 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.687 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 7.9 p -65.87 -36.0 76.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -23.66 60.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -65.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.02 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.619 ' HE1' ' CE2' ' A' ' 17' ' ' PHE . 4.1 t80 -53.41 -51.57 62.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.933 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.405 HG11 HD12 ' A' ' 22' ' ' LEU . 97.4 t -69.5 -43.67 80.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.483 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.42 -50.86 62.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.23 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 1.658 ' HE1' ' CE2' ' A' ' 20' ' ' TYR . 4.6 t80 -58.23 -49.66 76.3 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.976 0.51 . . . . 0.0 111.33 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.41 ' HZ3' ' CD ' ' A' ' 54' ' ' GLU . 1.2 tmtm? -62.41 -35.98 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.546 -179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.702 HD22 ' HB3' ' A' ' 107' ' ' CYS . 8.0 mp -76.33 -48.36 20.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.524 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 3.2 ttp180 -63.92 -18.4 64.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.49 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -84.63 -14.25 49.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -146.26 -52.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.97 -68.77 1.22 Allowed Glycine 0 C--O 1.229 -0.167 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.741 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.64 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.1 t80 -82.61 53.15 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.529 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.94 -30.54 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -42.51 77.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.35 59.24 4.86 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.834 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.518 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.21 117.9 7.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.632 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.418 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 175.57 -49.38 0.12 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.725 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.483 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 21.1 Cg_exo -67.15 -50.0 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 121.894 1.729 . . . . 0.0 111.548 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.725 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.14 34.0 4.8 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.84 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 14.6 pt-20 -88.76 -13.48 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.44 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.98 144.27 17.54 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.847 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -92.87 -175.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.832 2.355 . . . . 0.0 113.137 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.664 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -82.49 80.95 8.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.065 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.39 -11.55 7.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.41 . . . . 0.0 111.949 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.42 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.1 m-20 -86.45 160.35 51.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.42 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 30.2 Cg_endo -77.96 50.12 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.263 2.642 . . . . 0.0 111.423 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.462 HD12 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.53 -31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.783 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.664 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -58.67 -61.28 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.592 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.94 -25.01 63.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.917 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -74.99 -50.23 17.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.61 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.567 ' HE2' HD23 ' A' ' 13' ' ' LEU . 6.3 ttm -67.15 -41.93 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -33.23 73.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.059 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.63 -40.05 26.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.284 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.476 ' CB ' HG22 ' A' ' 97' ' ' VAL . . . -59.81 -54.93 40.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . 0.417 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.46 -46.21 45.62 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.112 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.44 -56.16 24.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.122 0.486 . . . . 0.0 111.423 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -44.4 90.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.584 ' HB2' HG13 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -72.45 -34.84 68.06 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.611 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.41 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 6.4 tt0 -62.9 -28.06 69.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.755 0.788 . . . . 0.0 109.556 179.364 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 m -83.47 -31.12 26.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.455 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -92.3 -45.23 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 87.38 7.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.149 0.579 . . . . 0.0 111.077 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -81.19 -15.47 55.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -90.38 61.47 5.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.116 0.484 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.55 -55.82 1.91 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.277 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.899 ' HA ' HD22 ' A' ' 64' ' ' LEU . 58.5 m-85 -66.16 -18.89 65.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.403 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -44.12 86.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.683 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -68.09 -26.89 66.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.899 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.96 -45.29 28.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.337 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.94 -43.08 63.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.654 HE22 HD11 ' A' ' 106' ' ' LEU . 23.8 mt-30 -69.75 -54.36 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.474 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.44 18.99 3.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.561 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.537 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 2.1 t-160 -78.46 -38.66 40.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.545 HG12 ' H ' ' A' ' 71' ' ' THR . 2.9 p -92.01 -63.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.155 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.545 ' H ' HG12 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.6 149.19 10.66 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 122.371 -0.206 . . . . 0.0 110.742 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.444 ' HB2' HD12 ' A' ' 118' ' ' LEU . 86.5 Cg_endo -85.32 -163.19 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.896 2.397 . . . . 0.0 112.203 179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.52 -72.77 2.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.897 179.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.45 47.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.719 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.491 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -94.66 -21.98 18.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.1 pt20 -62.11 -38.03 87.38 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.878 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.91 -39.06 90.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.701 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -68.5 -43.78 76.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -63.39 -50.2 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.756 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -57.69 -34.12 69.09 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -63.93 -61.09 2.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.746 HG13 ' HG ' ' A' ' 180' ' ' LEU . 16.2 m -58.57 -31.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.48 ' N ' HG22 ' A' ' 82' ' ' VAL . 49.0 m -66.8 -43.95 82.52 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.463 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -68.93 -31.48 70.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 109.738 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 74.5 mt-10 -73.09 -31.24 64.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.566 HD21 ' HG3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.35 -36.26 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.611 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.667 ' HE2' ' CE1' ' A' ' 87' ' ' PHE . 64.8 t80 -86.67 -8.02 57.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.608 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.426 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -42.54 -48.77 5.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.622 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.39 58.25 0.2 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.225 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.433 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 161.43 57.14 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.705 -1.235 . . . . 0.0 114.726 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.1 Cg_endo -79.43 44.94 1.81 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.085 1.856 . . . . 0.0 111.4 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.819 ' HB2' HG22 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -69.29 164.98 21.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.673 -178.84 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.447 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.0 m95 -56.22 -29.64 61.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.35 -37.3 94.31 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.566 ' HG3' HD21 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -86.13 -26.53 25.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.63 179.058 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.688 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.37 -30.7 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.435 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.584 HG13 ' HB2' ' A' ' 53' ' ' PHE . 6.2 t -64.17 -54.57 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.504 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.24 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.237 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.688 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -57.54 -56.87 16.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.98 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.647 ' HD2' ' CD1' ' A' ' 100' ' ' PHE . 7.4 m-85 -75.85 -36.96 59.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.34 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.75 -36.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.64 ' HD2' ' CD1' ' A' ' 102' ' ' PHE . 0.4 OUTLIER -56.75 -53.97 51.7 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 111.363 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.11 -36.89 44.56 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.362 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.93 99.73 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.254 0.527 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.571 ' HB3' HD23 ' A' ' 64' ' ' LEU . . . -70.36 -40.91 73.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.793 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.71 -51.19 69.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.062 179.037 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.702 ' HB3' HD22 ' A' ' 22' ' ' LEU . 93.7 m -57.02 -47.06 81.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.619 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.491 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -54.24 -37.74 64.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.612 ' HA ' HD22 ' A' ' 112' ' ' ASN . 1.9 mt-10 -83.98 -25.37 30.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 1.4 p -79.07 -24.01 43.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.919 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.614 HG21 HG22 ' A' ' 119' ' ' VAL . 89.5 t -71.16 -35.19 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.966 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.612 HD22 ' HA ' ' A' ' 109' ' ' GLU . 15.6 p30 -84.41 1.09 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.401 . . . . 0.0 110.765 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -119.67 -168.29 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.668 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.86 58.43 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.086 0.47 . . . . 0.0 110.562 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.417 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.91 47.01 2.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.392 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.598 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 6.9 mt-10 -57.33 -55.62 42.46 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.7 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.598 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.8 Cg_exo -63.17 -31.6 74.85 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.958 1.772 . . . . 0.0 112.584 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.444 HD12 ' HB2' ' A' ' 72' ' ' PRO . 1.6 mp -60.16 -34.33 73.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.79 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.614 HG22 HG21 ' A' ' 111' ' ' VAL . 92.6 t -57.2 -52.27 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 111.368 -179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.04 85.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.208 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.66 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.2 mm100 -67.0 -47.0 72.81 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.501 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 91.9 t -59.82 -35.55 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.27 -46.35 89.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.412 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.66 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 19.3 pt-20 -71.5 -40.47 70.16 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.824 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.4 m0 -57.3 -40.42 77.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.419 0.628 . . . . 0.0 109.371 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 2.6 ttp -71.07 -53.62 14.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.641 -179.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.662 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 5.6 p -62.46 -38.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.469 ' N ' HG11 ' A' ' 127' ' ' VAL . 1.2 mm-40 -63.54 -46.49 85.72 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 0.463 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 14.6 t80 -62.47 -33.42 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.479 0.657 . . . . 0.0 110.597 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.96 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.93 -58.76 3.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.174 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . 0.662 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 6.2 pt-20 -64.95 -20.75 66.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -89.32 -32.05 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 -42.91 0.99 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.96 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.77 -47.38 85.93 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.268 -178.6 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . 0.402 ' O ' ' HD2' ' A' ' 139' ' ' HIS . . . -51.93 -39.97 60.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.544 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.01 -47.12 87.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.744 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.775 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 56.5 t90 -60.47 -50.18 74.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.624 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.8 mt -57.11 -47.47 83.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.266 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 135' ' ' ALA . 43.3 m-70 -62.97 -34.25 77.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -90.9 -9.85 44.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . 0.43 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -91.35 -45.09 8.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.493 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.62 -15.09 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.55 165.78 39.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.397 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.522 ' CZ2' HD11 ' A' ' 138' ' ' ILE . 95.4 m95 -60.53 -29.62 69.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.93 82.42 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.005 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.02 -41.85 98.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.639 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 17.9 t80 -67.93 -33.41 74.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.627 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.917 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -66.6 -26.54 67.15 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.055 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.89 -36.89 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.695 HD23 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -63.56 -41.15 98.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.004 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 2.4 m-85 -122.83 26.77 8.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.83 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.446 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -127.46 -138.55 4.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.493 -1.336 . . . . 0.0 114.043 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -62.46 1.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -0.721 . . . . 0.0 112.347 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.481 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -79.42 54.0 4.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.341 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.34 69.12 10.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.782 HD13 ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.22 167.01 13.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.297 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -51.6 -35.83 43.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.371 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.782 ' HB2' HD13 ' A' ' 156' ' ' LEU . 4.2 mm-40 -65.48 -48.07 73.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.926 0.393 . . . . 0.0 110.308 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.55 ' HB2' ' HA ' ' A' ' 150' ' ' LEU . . . -62.8 -34.54 77.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.731 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -59.55 -57.2 14.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -70.4 -27.66 64.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 35.3 tp -66.69 -47.29 72.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.287 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.695 ' HB3' HD23 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -69.88 -33.15 71.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.297 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.402 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.29 -43.7 66.62 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.103 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.11 -26.37 74.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.722 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.518 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 7.2 t-20 -59.9 -61.03 2.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.265 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.402 ' HE1' ' HG2' ' A' ' 164' ' ' GLU . 32.4 p-90 -69.48 -22.82 63.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.84 -58.72 5.26 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.994 0.184 . . . . 0.0 110.745 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.6 m -88.93 -24.04 22.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.819 HG22 ' HB2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -81.62 -28.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.398 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.406 ' HA ' HH11 ' A' ' 95' ' ' ARG . 1.3 ttt180 -82.16 -22.34 36.13 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.847 -0.533 . . . . 0.0 109.614 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.425 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -83.61 -43.01 16.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.85 HG13 ' HG ' ' A' ' 174' ' ' LEU . 14.4 p -57.89 -37.0 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.12 0.486 . . . . 0.0 110.861 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.85 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -110.61 36.26 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.208 0.527 . . . . 0.0 110.16 178.969 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.425 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.9 t -77.66 -9.71 59.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 7.27 80.55 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.732 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.431 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -79.97 25.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.26 51.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.913 0.387 . . . . 0.0 110.514 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.81 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.746 ' HG ' HG13 ' A' ' 82' ' ' VAL . 15.8 mt -86.67 -30.71 21.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.816 0.341 . . . . 0.0 110.29 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -77.75 91.05 1.07 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.685 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -79.93 136.4 36.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 111.632 -179.237 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.915 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' -2' ' ' LEU . 13.8 Cg_exo -69.0 128.34 16.57 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.807 2.338 . . . . 0.0 111.705 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' -3' ' ' PRO . 0.4 OUTLIER 73.54 -55.17 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.85 0.719 . . . . 0.0 111.128 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -158.94 -168.48 21.07 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.6 m -151.48 143.71 24.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.88 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.33 136.92 51.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.425 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.8 p -99.36 131.1 25.63 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 16.9 Cg_exo -67.54 98.04 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.948 2.432 . . . . 0.0 112.341 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.65 42.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 111.246 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.6 m -158.13 124.3 4.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.443 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.56 149.13 25.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.339 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.443 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 11.9 Cg_exo -70.74 108.0 2.17 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.051 2.501 . . . . 0.0 112.112 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.31 -176.58 5.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -32.19 67.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -68.23 -32.66 73.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.396 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.26 -43.59 32.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 1.4 tp -62.01 -43.55 98.59 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.339 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 HG13 ' HB ' ' A' ' 127' ' ' VAL . 4.4 p -66.14 -37.65 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.512 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.9 70.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 110.422 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -70.28 -52.55 22.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.045 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.621 ' HD1' ' CD2' ' A' ' 17' ' ' PHE . 4.7 t80 -58.1 -52.99 63.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.65 HG13 HD13 ' A' ' 22' ' ' LEU . 72.1 t -64.15 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.576 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.75 -51.81 56.8 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.745 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.733 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.9 t80 -61.98 -38.84 90.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.638 0.375 . . . . 0.0 110.926 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.508 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 7.4 mmtt -66.35 -43.56 85.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.704 HD23 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -75.94 -46.35 30.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.584 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -62.22 -21.19 64.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.508 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -85.74 -24.03 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.326 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.36 75.34 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 111.456 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.34 -74.62 0.26 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.645 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 0.491 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 2.0 t80 -85.74 58.14 4.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.957 0.408 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.39 -33.87 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.182 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.72 -14.15 61.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.182 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.491 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -109.8 40.27 2.61 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.584 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -60.27 130.48 46.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.93 -48.43 0.19 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.819 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . 0.576 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 3.2 Cg_exo -84.11 -48.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.733 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -78.38 22.57 3.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.989 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.481 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -79.84 -26.75 40.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.72 0.76 . . . . 0.0 109.46 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.43 132.44 11.14 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.356 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -89.05 -148.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.985 2.457 . . . . 0.0 113.275 -179.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.614 ' CB ' ' HA ' ' A' ' 44' ' ' GLN . . . -86.33 97.79 10.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.7 -34.78 1.01 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.466 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.7 m-20 -78.97 160.43 71.4 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.686 0.279 . . . . 0.0 111.617 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 25.6 Cg_endo -74.43 51.75 2.65 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.525 2.816 . . . . 0.0 112.44 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' HB3' ' HB3' ' A' ' 144' ' ' TRP . 0.2 OUTLIER 179.59 -34.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.881 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.433 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -59.64 -58.0 10.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.089 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.614 ' HA ' ' CB ' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -59.72 -28.0 66.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.693 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.74 ' HB1' ' HA ' ' A' ' 148' ' ' THR . . . -69.88 -49.66 50.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.419 ' HE2' ' CZ3' ' A' ' 144' ' ' TRP . 0.5 OUTLIER -63.55 -31.02 72.06 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.976 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -62.6 -42.37 99.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.413 -179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.3 -23.62 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.84 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.32 -64.88 0.81 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.301 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.31 -46.18 35.51 Favored Glycine 0 C--O 1.216 -1.013 0 O-C-N 124.107 0.879 . . . . 0.0 112.397 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -51.64 -51.87 52.28 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.382 0.61 . . . . 0.0 111.425 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.45 -45.69 93.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.047 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.667 ' HD1' ' CD2' ' A' ' 53' ' ' PHE . 0.8 OUTLIER -75.53 -33.74 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.922 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.419 ' CD ' ' HZ3' ' A' ' 21' ' ' LYS . 4.2 tt0 -63.46 -26.85 68.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.2 m -88.58 -41.84 12.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.485 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -87.27 -64.43 1.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 112.205 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.614 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 5.2 t80 -80.41 61.26 4.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.121 0.486 . . . . 0.0 111.338 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -85.24 0.38 52.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -89.11 18.21 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -104.38 -0.07 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.614 ' HD2' ' CD1' ' A' ' 61' ' ' PHE . 80.3 m-85 -84.89 -23.25 29.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.112 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -35.61 81.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.979 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 1.4 m-20 -62.0 -33.49 74.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.299 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.695 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 0.0 OUTLIER -58.84 -41.76 87.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.529 0.681 . . . . 0.0 109.325 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.491 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -80.39 -40.56 26.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.579 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.13 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.522 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.736 HE22 HD13 ' A' ' 106' ' ' LEU . 35.2 mt-30 -76.52 -49.16 17.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.433 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.28 6.35 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -176.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.491 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.1 t60 -82.64 -31.99 28.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.872 0.368 . . . . 0.0 110.66 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.486 HG23 HG22 ' A' ' 71' ' ' THR . 2.3 p -91.76 -54.77 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.486 HG22 HG23 ' A' ' 70' ' ' VAL . 5.0 t -171.97 144.51 1.5 Allowed Pre-proline 0 C--O 1.237 0.437 0 CA-C-O 120.91 0.386 . . . . 0.0 111.007 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.578 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 3.6 Cg_endo -84.36 -171.81 1.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.258 2.639 . . . . 0.0 111.258 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.404 ' H ' HD11 ' A' ' 118' ' ' LEU . . . 82.27 -67.4 3.7 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.74 179.477 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 48.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.385 0.612 . . . . 0.0 111.674 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.7 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . . . -104.39 -17.16 14.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.663 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.27 -35.69 81.66 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.251 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -67.58 -39.63 84.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.891 0.377 . . . . 0.0 110.428 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . 0.7 ' HD2' ' HA ' ' A' ' 75' ' ' ALA . 23.1 mtt180 -68.59 -45.87 70.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.646 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 6.8 t80 -61.34 -47.84 84.06 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.906 179.67 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -58.28 -33.75 69.77 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.09 -64.07 1.08 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.721 HG11 HD11 ' A' ' 180' ' ' LEU . 9.1 p -57.87 -34.58 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -68.21 -45.63 72.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.658 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -71.36 -38.02 71.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.851 0.358 . . . . 0.0 110.519 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.429 ' HB3' ' HB3' ' A' ' 177' ' ' ALA . 0.2 OUTLIER -70.19 -19.38 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.269 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.502 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -85.28 -39.47 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.833 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 0.41 ' HB2' ' HE2' ' A' ' 129' ' ' TYR . 32.9 t80 -79.24 -7.67 58.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.243 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -48.59 -35.97 14.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.431 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.51 62.46 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.834 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.562 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 164.05 51.35 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.541 -1.314 . . . . 0.0 115.04 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.603 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.3 Cg_endo -81.37 37.01 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 119.762 1.781 . . . . 0.0 111.542 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.795 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.2 t-20 -68.04 164.87 19.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.903 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.588 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 26.0 m95 -53.97 -28.2 36.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.458 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -41.14 97.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.117 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.447 ' CZ ' HD13 ' A' ' 86' ' ' LEU . 0.3 OUTLIER -86.09 -23.67 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.654 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.871 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -56.21 -31.59 63.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.479 0.657 . . . . 0.0 109.852 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.669 HG11 ' HB2' ' A' ' 53' ' ' PHE . 38.7 t -61.26 -54.15 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.391 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.33 69.45 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.351 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.668 ' HE1' ' CE2' ' A' ' 99' ' ' PHE . 5.7 m-85 -56.17 -57.27 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 110.509 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.61 ' HD1' ' CD2' ' A' ' 100' ' ' PHE . 40.9 m-85 -74.56 -38.74 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.4 -40.16 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.793 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 1.616 ' HE2' ' CE1' ' A' ' 102' ' ' PHE . 0.6 OUTLIER -54.79 -52.68 61.88 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . 0.655 ' HA3' ' HE3' ' A' ' 126' ' ' MET . . . -74.21 -38.11 47.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.078 -179.583 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.11 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.12 0.46 . . . . 0.0 110.756 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -67.54 -39.12 85.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.736 HD13 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -59.97 -42.41 94.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.456 179.282 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.704 ' HB3' HD23 ' A' ' 22' ' ' LEU . 95.0 m -69.19 -39.37 78.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.455 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.42 ' N ' HD12 ' A' ' 22' ' ' LEU . . . -58.77 -38.75 79.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.395 -179.712 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.532 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -84.67 -15.0 46.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.479 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.443 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -82.81 -24.64 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.354 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.53 HG22 ' O ' ' A' ' 107' ' ' CYS . 91.4 t -69.23 -33.22 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.318 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.532 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 21.6 p30 -84.99 1.06 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -126.94 -173.26 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.435 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -84.61 56.37 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.703 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.578 ' HE1' ' HG3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -135.06 43.31 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.529 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.8 mt-10 -57.33 -53.55 64.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.396 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.529 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 17.3 Cg_exo -67.7 -27.52 38.12 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.072 1.848 . . . . 0.0 112.636 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.421 HD13 ' HB2' ' A' ' 75' ' ' ALA . 1.3 tp -62.78 -35.66 80.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.74 -51.28 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.56 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.34 -33.52 87.46 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.524 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.4 mm100 -67.18 -50.35 61.33 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.456 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 45.1 t -58.68 -33.71 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -63.04 -46.58 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.263 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.846 ' HA ' HG13 ' A' ' 127' ' ' VAL . 15.4 pt-20 -74.03 -39.31 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.663 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.2 m0 -56.41 -37.88 70.76 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' MET . . . . . 0.655 ' HE3' ' HA3' ' A' ' 103' ' ' GLY . 8.9 ttm -73.61 -55.43 6.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.506 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.846 HG13 ' HA ' ' A' ' 124' ' ' GLU . 9.8 p -60.32 -36.19 67.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.403 ' N ' HG12 ' A' ' 127' ' ' VAL . 4.5 mt-10 -67.54 -48.76 66.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.823 179.764 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.654 ' HD1' ' CD2' ' A' ' 129' ' ' TYR . 8.7 t80 -59.01 -34.72 72.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.63 0.729 . . . . 0.0 110.148 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.955 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -73.07 -56.93 4.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.573 -179.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -77.43 -38.52 49.37 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -42.61 2.04 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -177.607 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.955 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.82 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.321 0.509 . . . . 0.0 111.676 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.94 61.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -49.52 67.21 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.795 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.0 t90 -57.96 -48.08 81.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.471 HD11 HD12 ' A' ' 134' ' ' LEU . 0.6 OUTLIER -56.65 -49.55 77.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.944 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.65 -39.51 73.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.1 m -86.79 -11.27 51.5 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.2 -22.02 16.4 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.35 -24.99 0.97 Allowed Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.499 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.435 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 95.86 169.55 35.26 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.011 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.55 ' HZ3' HD12 ' A' ' 96' ' ' LEU . 96.2 m95 -60.06 -29.4 68.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . 0.429 ' HA ' ' HG1' ' A' ' 148' ' ' THR . . . -61.75 -35.87 79.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.571 178.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.46 -42.0 96.2 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 5.9 t80 -61.95 -39.47 92.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.318 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.74 ' HA ' ' HB1' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -66.07 -27.16 67.87 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 110.75 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -15.31 41.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 0.0 109.856 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.402 HD11 ' HG3' ' A' ' 146' ' ' GLU . 0.0 OUTLIER -79.03 -48.87 13.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.22 179.497 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 155' ' ' ALA . 1.5 m-85 -138.99 30.75 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.429 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -95.09 -132.17 6.75 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.189 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.48 -31.42 70.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.43 ' O ' HD21 ' A' ' 156' ' ' LEU . . . -115.5 65.85 0.3 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 151' ' ' TYR . . . -83.77 76.33 10.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.207 0.527 . . . . 0.0 110.481 -179.909 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.651 ' HG ' ' HB2' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -60.7 153.59 23.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.324 -179.588 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.66 -28.03 53.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.308 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.46 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -74.75 -42.14 58.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 110.801 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.651 ' HB2' ' HG ' ' A' ' 156' ' ' LEU . . . -68.79 -34.66 75.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.242 0.544 . . . . 0.0 110.541 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.57 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 8.3 mtm-85 -63.97 -50.45 68.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.074 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -68.9 -30.11 68.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.569 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.475 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -64.77 -37.38 87.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.254 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -69.48 -42.21 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.555 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.635 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 3.4 tt0 -65.46 -44.62 86.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.403 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 -22.45 75.63 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.632 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.475 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.6 t-20 -74.66 -52.96 10.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.0 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.865 ' HA ' HG21 ' A' ' 170' ' ' VAL . 14.7 p-90 -66.97 -23.8 65.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.274 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.07 77.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.15 0.5 . . . . 0.0 110.382 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 -32.59 19.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.516 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.865 HG21 ' HA ' ' A' ' 167' ' ' TRP . 34.3 m -86.12 -25.57 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.412 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.4 ttp180 -80.84 -25.38 37.76 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.588 -0.695 . . . . 0.0 109.938 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.485 ' HA ' HG21 ' A' ' 175' ' ' THR . 2.2 m -90.09 -28.6 18.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.763 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.813 HG11 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -65.32 -29.05 46.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.388 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.813 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -120.07 46.15 2.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.185 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.485 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -64.99 -42.33 94.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.94 25.18 1.53 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.499 0.56 . . . . 0.0 114.499 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.429 ' HB3' ' HB3' ' A' ' 85' ' ' GLU . . . -88.96 -2.21 58.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.323 0.561 . . . . 0.0 110.457 179.049 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.36 66.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.805 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.03 12.03 37.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.433 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.979 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 5.6 mp -91.41 -47.06 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.656 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -70.02 92.77 0.39 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -89.6 100.48 13.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 -178.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.53 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.75 133.77 30.55 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.842 2.361 . . . . 0.0 111.478 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.5 mp -78.7 -83.71 0.09 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.997 0.427 . . . . 0.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -147.14 140.07 8.34 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -47.3 14.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 110.541 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.83 152.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.787 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.31 160.49 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.892 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.619 HG23 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -102.48 141.38 22.41 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . 0.484 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 5.9 Cg_exo -78.9 -7.62 15.48 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.022 2.481 . . . . 0.0 112.967 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.59 -47.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.702 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 m -153.92 148.32 26.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.644 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.619 ' HB2' HG23 ' A' ' 3' ' ' THR . . . -88.37 137.61 30.7 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 3.6 Cg_exo -75.13 34.93 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.589 2.86 . . . . 0.0 112.303 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . 0.461 ' HB3' ' H ' ' A' ' 10' ' ' THR . 1.5 m-20 -84.75 -159.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.461 ' H ' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -56.47 -35.04 67.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.15 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -63.58 -39.59 94.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.689 0.28 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -32.95 57.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.814 0.34 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.621 ' HB2' HD11 ' A' ' 42' ' ' LEU . 7.4 tp -74.74 -42.22 58.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.427 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 5.5 p -66.37 -37.93 80.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.834 0.349 . . . . 0.0 110.23 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.72 60.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.75 0.31 . . . . 0.0 110.588 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.082 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.609 ' HD1' ' CD2' ' A' ' 17' ' ' PHE . 6.7 t80 -56.63 -50.11 73.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 74.4 t -66.83 -42.18 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.19 179.898 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . 0.439 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.47 -52.75 49.23 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.888 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.799 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 23.6 t80 -57.19 -46.55 82.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.073 0.549 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.52 -45.46 90.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 111.059 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.492 ' N ' HD13 ' A' ' 22' ' ' LEU . 7.7 mp -66.85 -47.24 72.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.439 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 23.7 ttp85 -60.77 -25.81 66.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.3 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.94 -21.79 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.952 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -157.43 72.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.759 0.314 . . . . 0.0 111.654 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.68 -75.99 0.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.599 ' HD2' ' CD1' ' A' ' 27' ' ' TYR . 1.2 t80 -84.37 56.13 3.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.05 -28.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.087 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.36 -15.16 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.478 0.656 . . . . 0.0 109.962 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.462 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -111.85 53.9 0.57 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.963 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.428 ' HB3' ' OE2' ' A' ' 35' ' ' GLU . . . -63.49 144.59 56.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.204 -0.498 . . . . 0.0 110.408 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.4 ' CA ' ' HG2' ' A' ' 35' ' ' GLU . . . 142.77 -57.25 0.56 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.979 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -61.7 -45.36 17.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.579 2.186 . . . . 0.0 112.403 -179.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.799 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.43 39.44 2.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.743 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' OE2' ' HB3' ' A' ' 31' ' ' ALA . 74.4 mm-40 -79.31 -59.92 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.349 0.574 . . . . 0.0 109.95 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.05 128.96 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . 0.514 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.3 Cg_endo -88.28 -132.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.835 2.357 . . . . 0.0 113.476 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.514 ' H ' ' HB2' ' A' ' 37' ' ' PRO . . . -73.79 92.4 2.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.493 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.93 39.9 1.04 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -156.41 164.9 19.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.654 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -82.39 49.63 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.135 2.557 . . . . 0.0 112.275 179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.621 HD11 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.8 -27.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.485 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . . . . . . . . . 4.4 m170 -62.55 -56.03 21.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.929 -179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -63.98 -23.81 67.48 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.044 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.549 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -67.63 -54.1 22.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.493 ' HB2' ' HE3' ' A' ' 46' ' ' MET . 3.8 tpp -70.13 -30.07 67.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.338 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -39.87 95.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.572 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.22 -28.52 47.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 109.685 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.739 ' HB3' ' HZ ' ' A' ' 147' ' ' PHE . . . -68.5 -61.08 1.99 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.643 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.12 -45.9 42.72 Favored Glycine 0 C--O 1.215 -1.081 0 O-C-N 124.108 0.88 . . . . 0.0 112.292 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.28 -52.75 51.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.588 0.355 . . . . 0.0 111.884 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -44.0 95.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.404 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.838 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -72.56 -35.0 67.87 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.366 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.25 -27.15 68.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.323 0.583 . . . . 0.0 109.518 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -88.01 -39.24 14.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -90.37 -57.23 2.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.644 ' HD2' ' CD1' ' A' ' 57' ' ' PHE . 1.4 t80 -81.4 69.21 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 17.7 mtt180 -72.89 0.59 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.592 -178.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.88 51.69 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 110.198 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.0 0.15 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.412 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 0.867 ' HA ' HD23 ' A' ' 64' ' ' LEU . 36.6 m-85 -110.51 -25.91 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 0.0 111.592 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -41.11 97.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.74 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.434 ' HA ' ' HB1' ' A' ' 66' ' ' ALA . 3.3 m-20 -68.99 -18.95 64.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.748 -179.067 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.867 HD23 ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -66.87 -45.41 78.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.668 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -75.67 -47.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 63' ' ' ASP . . . -47.77 -41.63 23.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.18 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.543 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 27.9 mt-30 -71.83 -65.65 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.406 HD13 ' HA ' ' A' ' 68' ' ' LEU . 0.7 OUTLIER -78.49 14.48 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.339 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.668 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 1.6 p-80 -79.15 -20.56 48.23 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.533 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.414 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -91.87 -72.69 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.825 -179.65 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -157.15 135.64 7.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 21.2 Cg_exo -66.44 170.14 12.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.115 2.543 . . . . 0.0 112.378 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.72 ' H ' HD23 ' A' ' 118' ' ' LEU . . . 92.18 -58.49 2.76 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.67 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.55 50.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.43 0.634 . . . . 0.0 110.848 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.512 ' HB2' ' HH2' ' A' ' 125' ' ' TRP . . . -110.67 -25.08 10.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.739 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.626 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -63.03 -42.1 99.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.848 -179.02 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.95 -44.71 95.33 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.383 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -61.7 -42.68 99.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.246 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.624 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 9.0 t80 -62.47 -51.0 69.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.469 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -59.07 -32.2 69.57 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.725 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -61.07 -60.52 3.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.72 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.483 HG13 HD23 ' A' ' 180' ' ' LEU . 16.7 m -60.29 -32.53 51.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.6 m -65.61 -42.42 91.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.452 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.16 -40.44 86.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 178.938 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.459 ' O ' HD22 ' A' ' 174' ' ' LEU . 87.4 mt-10 -67.13 -31.79 72.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.486 179.082 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.44 HD12 ' O ' ' A' ' 82' ' ' VAL . 0.2 OUTLIER -76.01 -36.59 59.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.45 179.633 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -85.83 -5.81 59.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -34.46 25.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.018 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.83 62.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.352 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.472 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.88 56.64 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.544 -1.313 . . . . 0.0 115.014 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.539 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 11.8 Cg_endo -82.13 29.37 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.396 2.064 . . . . 0.0 111.194 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.847 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.9 m120 -61.63 162.06 8.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.889 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.432 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 27.7 m95 -52.68 -25.77 11.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.864 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.98 90.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.522 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.651 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.0 mmp_? -87.09 -22.43 25.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.926 -0.161 . . . . 0.0 110.758 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -54.71 -31.08 57.61 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.728 0.643 . . . . 0.0 110.229 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.838 HG11 ' HB2' ' A' ' 53' ' ' PHE . 17.6 t -59.77 -56.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.95 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -27.32 69.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.84 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.0 m-85 -58.49 -55.12 39.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 110.123 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.467 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 12.8 m-85 -76.16 -37.86 57.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.73 -37.88 80.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.801 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.409 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -54.5 -53.86 48.67 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.13 -35.66 52.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.444 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.61 99.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.136 0.468 . . . . 0.0 110.513 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.528 ' HB2' HD21 ' A' ' 64' ' ' LEU . . . -69.43 -40.17 77.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.821 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -59.65 -42.11 92.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.704 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.416 ' HB3' HD22 ' A' ' 22' ' ' LEU . 96.9 m -69.06 -41.16 77.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.024 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.424 ' N ' HD11 ' A' ' 22' ' ' LEU . . . -53.86 -48.46 69.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.983 -179.753 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.451 ' O ' ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -74.13 -20.22 60.31 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.874 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.494 ' HB3' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -78.78 -35.94 43.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.482 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.444 ' O ' HG12 ' A' ' 111' ' ' VAL . 24.6 t -67.81 -16.3 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.829 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.451 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 12.3 m-20 -45.73 -70.25 0.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.487 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . 0.517 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -175.55 37.45 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.886 179.375 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . 0.559 ' HB3' ' HE1' ' A' ' 115' ' ' MET . 17.2 mt-10 -159.68 122.1 3.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.878 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' MET . . . . . 0.559 ' HE1' ' HB3' ' A' ' 114' ' ' GLU . 4.0 mtm 70.31 114.84 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.777 0.673 . . . . 0.0 112.106 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.702 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -102.05 -55.34 0.13 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.146 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.702 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 36.2 Cg_exo -59.85 -27.79 85.73 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.487 2.125 . . . . 0.0 113.967 -178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.72 HD23 ' H ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -62.3 -31.57 72.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.915 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.494 HG22 ' HB3' ' A' ' 110' ' ' SER . 94.6 t -60.36 -55.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.623 0.249 . . . . 0.0 111.371 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.51 -28.88 72.0 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.016 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.51 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.9 mt-30 -68.52 -49.21 61.32 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.568 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 99.6 t -56.64 -36.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.64 -47.05 87.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.859 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.652 ' HA ' HG11 ' A' ' 127' ' ' VAL . 20.8 pt-20 -73.93 -36.72 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.626 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.1 m0 -57.12 -38.34 73.29 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.9 ttm -73.61 -54.28 8.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.652 HG11 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.22 -30.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.772 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.462 ' N ' HG13 ' A' ' 127' ' ' VAL . 1.5 tt0 -69.32 -50.0 50.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.263 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.642 ' HE2' ' CE1' ' A' ' 129' ' ' TYR . 11.8 t80 -61.76 -34.4 75.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.0 110.599 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 0.857 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -72.12 -56.01 6.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.133 -178.854 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.99 -34.3 74.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.5 m -79.04 -40.92 30.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -121.61 -42.73 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 0.857 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.7 mm? -59.6 -46.0 90.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.227 0.467 . . . . 0.0 111.166 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.18 -39.5 56.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.376 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.5 -55.78 29.36 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.449 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.847 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 62.2 t90 -55.79 -46.34 77.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.117 0.484 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -58.24 -48.19 85.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.721 -179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -66.07 -32.22 73.56 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.372 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -84.0 -11.85 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -49.61 5.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.3 -18.08 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 96.15 170.6 35.06 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.017 179.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.44 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 92.9 m95 -60.48 -30.62 69.8 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.52 76.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.38 -42.19 92.95 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.064 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 0.739 ' HZ ' ' HB3' ' A' ' 49' ' ' ALA . 5.9 t80 -66.05 -33.85 76.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.553 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -71.07 -24.49 62.34 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.468 178.754 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.35 -31.68 21.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -60.39 -51.38 69.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.581 -179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.664 ' HE2' ' CE1' ' A' ' 151' ' ' TYR . 1.9 m-85 -132.55 33.85 3.75 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.04 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.553 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -103.54 -127.79 6.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.431 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.42 -37.61 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 111.078 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . 0.499 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -108.32 61.81 0.3 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.465 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.56 72.85 9.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.136 0.493 . . . . 0.0 110.637 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.2 164.16 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.837 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -59.72 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.574 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . 0.719 ' HB2' HD11 ' A' ' 156' ' ' LEU . 1.5 mt-10 -71.47 -35.78 70.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.26 62.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 0.0 109.73 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . 0.637 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 4.0 mtp180 -61.75 -51.64 67.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.294 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' GLU . 1.3 ptm180 -67.64 -28.39 67.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.652 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . 0.503 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -66.85 -45.3 78.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.525 ' NH2' ' HA ' ' A' ' 49' ' ' ALA . 13.0 ttp180 -67.26 -38.04 84.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.409 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.1 OUTLIER -67.66 -47.12 70.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.214 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.75 -21.79 75.11 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.503 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . 0.503 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 0.5 OUTLIER -68.96 -54.04 17.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.277 . . . . 0.0 110.827 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.733 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.0 p-90 -67.76 -25.08 65.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.985 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.14 74.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 110.262 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.59 -28.75 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.733 HG23 ' HA ' ' A' ' 167' ' ' TRP . 27.8 m -93.04 -31.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -41.0 67.54 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.544 -0.722 . . . . 0.0 110.29 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.892 ' HA ' HG23 ' A' ' 175' ' ' THR . 3.7 m -74.66 -28.47 60.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 0.927 HG11 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -70.44 -26.09 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.569 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.927 ' HG ' HG11 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -120.72 39.73 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.726 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.892 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -68.5 -16.2 63.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -87.96 14.08 59.65 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.184 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 82' ' ' VAL . . . -79.34 8.2 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.942 0.371 . . . . 0.0 111.806 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 58.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.925 0.393 . . . . 0.0 110.475 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.09 51.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.543 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -100.7 -7.84 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.03 89.48 0.2 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.141 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -127.98 -172.44 2.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 179.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.89 133.1 34.71 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.969 2.446 . . . . 0.0 112.348 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -3.44 35.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 109.04 -78.42 0.24 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -56.98 4.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.726 0.298 . . . . 0.0 110.697 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpp? 70.86 -56.41 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.234 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.7 138.66 36.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.68 0.276 . . . . 0.0 110.906 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -99.74 140.87 21.89 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.63 160.46 49.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.747 2.298 . . . . 0.0 111.765 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.57 141.5 51.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.521 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m 62.68 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ALA . . . . . 0.465 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.11 138.26 20.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 15.3 Cg_exo -68.88 101.95 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.984 2.456 . . . . 0.0 111.872 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.63 -161.4 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.458 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -43.33 74.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.385 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -58.65 -39.33 80.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.631 0.253 . . . . 0.0 110.726 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -47.91 51.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 4.2 tp -58.78 -45.09 90.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.377 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.654 ' HA ' ' HE1' ' A' ' 100' ' ' PHE . 9.9 p -65.9 -39.29 84.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.87 76.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.87 -48.85 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.908 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PHE . . . . . 1.62 ' HE2' ' CE1' ' A' ' 17' ' ' PHE . 5.8 t80 -59.31 -51.06 71.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.701 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.756 HG12 HD11 ' A' ' 22' ' ' LEU . 53.5 t -65.24 -40.99 90.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . -58.96 -48.02 87.83 Favored Glycine 0 C--O 1.222 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.94 178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' TYR . . . . . 0.723 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.2 t80 -58.12 -47.75 82.34 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.821 0.448 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.68 85.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.175 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' LEU . . . . . 0.756 HD11 HG12 ' A' ' 18' ' ' VAL . 8.1 mp -67.15 -46.93 72.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.416 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 35.4 ttp85 -62.96 -20.34 65.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.841 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.7 tt0 -82.19 -36.41 27.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.926 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.44 77.89 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.49 -68.3 0.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.09 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' TYR . . . . . 1.601 ' HE1' ' CE2' ' A' ' 27' ' ' TYR . 1.1 t80 -92.57 59.67 3.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.0 110.701 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . 0.474 ' H ' HG21 ' A' ' 28' ' ' VAL . 0.4 OUTLIER -79.16 -26.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.92 179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -36.86 77.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.791 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -96.46 50.6 1.61 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.955 179.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ALA . . . . . 0.485 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -67.75 131.28 45.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.01 -53.75 0.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.612 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_exo -68.56 -49.22 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.217 1.945 . . . . 0.0 111.643 -179.29 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.723 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.5 31.88 4.69 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.517 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.83 -59.44 2.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.437 0.637 . . . . 0.0 109.314 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.19 124.88 7.23 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.422 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.82 -112.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.998 2.465 . . . . 0.0 112.955 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . 0.457 ' HB2' ' HA ' ' A' ' 44' ' ' GLN . . . -70.44 97.15 1.24 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -179.297 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.7 20.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.067 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASP . . . . . 0.589 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 30.8 m-20 -146.26 162.35 35.18 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.509 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -79.22 52.33 4.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.366 2.711 . . . . 0.0 111.468 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.29 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.03 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' HIS . . . . . 0.589 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -62.66 -50.4 71.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.575 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.457 ' HA ' ' HB2' ' A' ' 38' ' ' ALA . 30.9 tt0 -64.06 -25.23 68.01 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ALA . . . . . 0.623 ' HB3' ' HA ' ' A' ' 148' ' ' THR . . . -75.94 -54.22 7.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.465 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' MET . . . . . 0.452 ' HE3' ' CD1' ' A' ' 100' ' ' PHE . 3.3 ttm -61.97 -38.29 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.976 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -61.32 -37.91 84.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.075 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.51 34.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.519 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . 0.732 ' HB2' HG21 ' A' ' 97' ' ' VAL . . . -59.56 -55.88 28.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.308 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.67 -49.45 40.37 Favored Glycine 0 C--O 1.217 -0.963 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.206 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.74 -53.15 58.8 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.906 0.384 . . . . 0.0 111.929 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.1 -46.6 86.6 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.355 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 1.625 ' HE2' ' CE1' ' A' ' 53' ' ' PHE . 0.1 OUTLIER -69.77 -36.72 75.98 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.778 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -61.04 -32.86 72.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.503 0.668 . . . . 0.0 109.742 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 m -79.34 -28.92 42.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.351 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -92.44 -31.89 15.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 1.627 ' HD1' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -86.44 93.39 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.191 -179.286 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -71.64 -25.42 62.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.875 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -94.27 77.31 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.122 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.85 -62.51 1.44 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.097 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PHE . . . . . 1.634 ' HE2' ' CE1' ' A' ' 61' ' ' PHE . 23.0 m-85 -76.79 -10.81 59.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -47.61 80.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.522 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -68.41 -21.23 64.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.201 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . 0.805 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -68.86 -42.01 77.66 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.506 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.77 -43.38 37.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.567 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . 0.541 ' HB2' ' H ' ' A' ' 182' ' ' ALA . . . -53.48 -43.22 67.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.657 HE22 HD11 ' A' ' 106' ' ' LEU . 26.6 mt-30 -71.33 -58.05 3.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 3.8 6.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' HIS . . . . . 0.506 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 65.5 t60 -78.81 -26.89 44.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.873 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' VAL . . . . . 0.417 ' H ' HG22 ' A' ' 70' ' ' VAL . 0.3 OUTLIER -91.07 -71.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.277 -179.766 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.13 147.58 11.47 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -89.54 -169.81 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.138 2.559 . . . . 0.0 111.917 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . 0.435 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 79.76 -70.24 2.91 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.343 179.11 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.41 37.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 111.905 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ALA . . . . . 0.435 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -85.84 -16.42 38.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.368 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' GLN . . . . . 0.617 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.0 pt20 -60.95 -42.0 97.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.588 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.3 -39.57 94.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.36 . . . . 0.0 110.499 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -67.58 -43.58 80.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.021 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 1.655 ' HE2' ' CE1' ' A' ' 79' ' ' PHE . 6.8 t80 -63.06 -48.9 76.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.434 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -57.73 -31.88 66.87 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.394 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -62.43 -63.27 1.28 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.891 0.376 . . . . 0.0 110.636 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . 0.538 HG13 HD23 ' A' ' 180' ' ' LEU . 20.9 m -58.78 -32.12 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.512 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 m -65.91 -43.48 88.01 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.423 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -69.26 -40.6 77.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.638 178.708 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -64.14 -28.3 69.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.412 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.696 ' HG ' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -83.62 -28.5 28.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 110.088 179.075 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PHE . . . . . 1.656 ' HD2' ' CD1' ' A' ' 87' ' ' PHE . 9.4 t80 -91.08 0.5 57.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.07 -179.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLN . . . . . 0.423 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 9.1 mm100 -49.0 -33.27 10.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.003 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.67 55.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.962 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 172.61 54.95 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 C-N-CA 119.953 -1.118 . . . . 0.0 114.324 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' PRO . . . . . 0.651 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -80.87 43.06 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.169 1.913 . . . . 0.0 111.977 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.798 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.3 t-20 -67.71 161.74 25.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.896 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' TRP . . . . . 0.576 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.3 m95 -55.33 -26.98 44.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.76 98.47 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.696 HH11 ' HG ' ' A' ' 86' ' ' LEU . 5.2 mmt180 -86.31 -18.77 31.1 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.819 -0.224 . . . . 0.0 110.716 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.761 ' HA ' ' HD1' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.86 -31.66 65.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.329 0.585 . . . . 0.0 110.218 179.574 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.761 HG12 ' HB2' ' A' ' 53' ' ' PHE . 5.9 t -61.3 -53.73 44.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.521 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.64 -26.85 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.395 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 1.638 ' HE1' ' CE2' ' A' ' 99' ' ' PHE . 4.1 m-85 -57.42 -57.53 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.068 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 1.656 ' HD1' ' CD2' ' A' ' 100' ' ' PHE . 8.6 m-85 -74.79 -40.07 61.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.724 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.02 -38.91 69.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.487 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.71 -49.49 75.01 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.729 0.3 . . . . 0.0 111.317 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.36 -37.91 30.37 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.003 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.04 97.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.025 0.413 . . . . 0.0 110.688 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.702 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -68.56 -40.07 80.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.767 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.79 -43.66 90.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.281 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' CYS . . . . . 0.591 ' HB3' HD22 ' A' ' 22' ' ' LEU . 88.5 m -63.57 -44.37 94.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.071 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . 0.407 ' N ' HD13 ' A' ' 22' ' ' LEU . . . -54.36 -45.03 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.569 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . 0.627 ' HA ' HD22 ' A' ' 112' ' ' ASN . 0.4 OUTLIER -75.09 -23.06 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.658 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' SER . . . . . 0.418 ' HB2' HG21 ' A' ' 119' ' ' VAL . 49.1 m -79.56 -22.24 44.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.116 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' VAL . . . . . 0.476 HG23 HG22 ' A' ' 119' ' ' VAL . 96.3 t -75.97 -35.44 29.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' ASN . . . . . 0.627 HD22 ' HA ' ' A' ' 109' ' ' GLU . 14.7 p30 -85.04 1.13 49.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 8.9 mtmt -123.6 -174.6 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 179.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.5 48.74 1.56 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -129.94 37.84 3.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.679 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.449 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -54.68 -53.73 57.09 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . 0.505 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 23.4 Cg_exo -65.15 -32.12 53.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.005 1.804 . . . . 0.0 112.299 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' LEU . . . . . 0.446 ' O ' HG23 ' A' ' 122' ' ' VAL . 0.1 OUTLIER -59.61 -31.06 69.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.609 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.476 HG22 HG23 ' A' ' 111' ' ' VAL . 87.2 t -58.17 -51.2 73.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.903 0.382 . . . . 0.0 111.256 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.06 -31.58 81.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.089 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' GLN . . . . . 0.505 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 14.3 mm100 -66.27 -51.81 53.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' VAL . . . . . 0.465 HG21 ' CZ3' ' A' ' 125' ' ' TRP . 61.2 t -58.15 -33.71 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.16 -47.57 82.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.325 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLU . . . . . 0.507 ' HA ' HG13 ' A' ' 127' ' ' VAL . 18.4 pt-20 -72.4 -39.44 67.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' TRP . . . . . 0.617 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.7 m0 -57.61 -38.61 75.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.0 ttm -73.77 -52.83 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.795 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' VAL . . . . . 0.507 HG13 ' HA ' ' A' ' 124' ' ' GLU . 4.5 p -62.15 -33.32 58.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . 0.482 ' N ' HG12 ' A' ' 127' ' ' VAL . 1.6 mt-10 -68.55 -52.07 35.97 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.605 179.542 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' TYR . . . . . 1.591 ' HD1' ' CD2' ' A' ' 129' ' ' TYR . 5.7 t80 -57.49 -33.32 67.89 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.467 0.651 . . . . 0.0 110.568 179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' LEU . . . . . 1.026 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.07 -55.81 5.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.748 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -32.02 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.7 m -82.61 -34.7 27.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . 0.428 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -126.97 -44.91 1.6 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . 1.026 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.05 -46.54 87.98 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.429 -178.394 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.64 -38.85 61.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.259 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -60.03 -52.59 64.73 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.418 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TRP . . . . . 0.798 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 52.8 t90 -56.62 -48.69 76.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ILE . . . . . 0.5 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.7 mt -57.09 -47.77 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.016 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -66.39 -29.17 69.28 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -88.04 -16.13 34.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.56 -54.39 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.78 -9.74 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.545 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.03 166.88 40.98 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.009 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TRP . . . . . 0.412 ' CZ3' ' HE1' ' A' ' 46' ' ' MET . 91.6 m95 -60.67 -29.15 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.22 80.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.89 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.44 ' HG3' HD11 ' A' ' 150' ' ' LEU . 0.4 OUTLIER -62.78 -42.77 99.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' PHE . . . . . 1.619 ' HE1' ' CE2' ' A' ' 147' ' ' PHE . 14.3 t80 -66.1 -33.17 75.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.137 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . 0.623 ' HA ' ' HB3' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.39 -27.7 68.06 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.738 0.304 . . . . 0.0 111.02 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.0 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LEU . . . . . 0.44 HD11 ' HG3' ' A' ' 146' ' ' GLU . 5.0 mt -63.61 -42.95 98.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.536 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' TYR . . . . . 1.658 ' HD1' ' CD2' ' A' ' 151' ' ' TYR . 1.4 m-85 -123.39 31.29 5.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.814 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -122.94 -138.37 5.26 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.752 -1.214 . . . . 0.0 113.107 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -42.77 36.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.785 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -85.52 53.43 4.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.44 -179.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.5 71.76 10.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -63.02 157.68 21.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.39 -179.918 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -53.07 -33.68 53.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.209 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -72.8 -39.41 66.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.919 -179.848 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.36 72.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.993 0.425 . . . . 0.0 110.83 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -60.66 -51.46 69.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.037 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -69.16 -26.12 64.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.019 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.68 -46.02 55.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ARG . . . . . 0.411 ' HB3' HD23 ' A' ' 150' ' ' LEU . 3.8 ptt180 -65.1 -38.62 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLU . . . . . 0.565 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -71.02 -43.54 67.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.204 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.81 -28.46 73.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.647 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -67.1 -57.76 6.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 -179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' TRP . . . . . 0.841 ' HA ' HG23 ' A' ' 170' ' ' VAL . 15.7 p-90 -62.12 -25.34 67.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.491 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.4 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.051 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 -29.19 22.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' VAL . . . . . 0.841 HG23 ' HA ' ' A' ' 167' ' ' TRP . 26.8 m -79.4 -23.9 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.265 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' ARG . . . . . 0.552 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 3.7 ttp180 -83.09 -14.43 53.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' THR . . . . . 0.653 ' HA ' HG21 ' A' ' 175' ' ' THR . 0.7 OUTLIER -98.52 -33.21 11.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.471 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' VAL . . . . . 1.051 HG12 ' HG ' ' A' ' 174' ' ' LEU . 11.7 p -63.19 -33.14 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.57 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 1.051 ' HG ' HG12 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -112.34 39.4 2.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.77 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' THR . . . . . 0.653 HG21 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -54.37 -42.86 70.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.372 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.72 59.55 4.43 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.131 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -120.14 6.69 10.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.413 0.625 . . . . 0.0 109.62 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.65 61.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.455 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -82.41 -8.11 59.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.568 -178.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' LEU . . . . . 0.538 HD23 HG13 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -94.43 -33.76 13.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.802 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.14 96.62 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.627 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.541 ' H ' ' HB2' ' A' ' 66' ' ' ALA . . . -110.81 43.25 1.46 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.835 0.35 . . . . 0.0 110.588 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.755 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 CA-C-O 121.26 0.442 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -166.0 1.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.883 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -39.45 82.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.393 0.139 . . . . 0.0 111.158 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -62.2 -38.01 87.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.84 66.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.6 tp -72.4 -42.28 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.519 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -66.49 -36.07 76.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 109.969 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.23 -22.96 60.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.322 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -73.16 -66.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -53.44 -50.66 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.798 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.453 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.4 t -67.64 -42.31 86.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.429 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.48 -52.29 52.2 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.211 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -55.57 -45.33 77.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.148 0.579 . . . . 0.0 111.223 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -48.37 66.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -63.38 -45.31 91.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.578 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -62.17 -26.98 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.026 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -85.99 -23.97 26.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.57 66.12 1.12 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.9 -72.17 0.29 Allowed Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.833 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.2 t80 -91.2 52.96 2.22 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.163 0.506 . . . . 0.0 110.332 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.15 -31.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.668 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -35.35 79.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.392 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.77 57.39 2.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.659 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -60.18 128.26 35.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.61 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 165.6 -60.91 0.24 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.278 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 32.1 Cg_exo -58.8 -52.51 5.12 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 121.96 1.773 . . . . 0.0 111.024 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -92.57 42.48 2.68 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.51 -18.32 31.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 110.313 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -110.55 147.5 17.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.622 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.5 Cg_endo -93.94 -158.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.964 2.443 . . . . 0.0 113.135 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.909 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.3 96.77 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.31 -24.44 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.737 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 20.6 m-20 -79.5 163.25 59.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.105 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.3 Cg_endo -78.0 50.39 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.42 2.746 . . . . 0.0 112.102 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.78 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.49 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.345 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.3 m170 -59.23 -60.48 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.09 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.909 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.4 -24.88 61.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.045 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -73.82 -50.71 19.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.92 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttm -66.74 -37.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.43 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.98 84.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.542 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.62 -27.69 51.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.348 0.595 . . . . 0.0 110.678 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.98 -62.65 1.29 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.563 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.659 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.94 -45.85 41.1 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.72 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.34 -50.11 72.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.054 0.455 . . . . 0.0 111.697 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -46.37 84.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.198 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.846 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -68.73 -36.33 78.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.274 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.21 -32.5 71.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.302 0.572 . . . . 0.0 109.547 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -83.12 -25.76 31.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.414 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -91.47 -29.43 17.02 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.21 96.86 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 110.992 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt-85 -72.54 -3.69 26.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.601 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.422 HH12 HG11 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -132.2 87.89 2.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.761 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -120.05 -61.02 1.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.658 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.953 ' HA ' HD22 ' A' ' 64' ' ' LEU . 6.9 m-85 -79.67 0.44 30.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.471 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 p -73.42 -53.99 9.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.33 -24.27 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.919 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.953 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -63.15 -44.77 94.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.862 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.65 51.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.898 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.66 -44.28 62.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.201 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.509 ' NE2' HD22 ' A' ' 180' ' ' LEU . 34.3 mt-30 -69.2 -51.24 39.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.716 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.553 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -86.17 20.22 2.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.097 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.74 -40.88 32.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' H ' ' A' ' 71' ' ' THR . 1.5 p -90.88 -60.83 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -172.7 145.7 1.41 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.11 -158.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.075 2.516 . . . . 0.0 112.623 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.99 -71.07 2.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.77 50.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.54 0.686 . . . . 0.0 111.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.61 -20.51 14.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.646 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.5 pt20 -65.13 -38.06 89.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.674 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 26.1 mp0 -67.43 -42.05 83.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -64.06 -45.57 88.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.39 -51.86 65.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.712 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -58.33 -32.62 68.68 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 22.8 mm-40 -64.15 -56.74 12.67 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.3 m -63.84 -31.88 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.315 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.0 m -65.56 -43.41 89.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.356 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -66.96 -36.67 82.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.244 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.46 -26.25 64.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.894 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -30.91 40.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.087 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -95.96 1.48 52.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -50.15 21.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.747 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.14 61.71 0.15 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.844 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.13 58.67 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.004 -1.093 . . . . 0.0 114.129 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.5 Cg_endo -81.08 41.89 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.43 2.087 . . . . 0.0 111.741 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.2 t-20 -64.47 162.89 14.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -56.05 -26.28 48.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.698 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.02 94.14 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.54 -27.23 22.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.952 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.05 -30.88 49.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.388 0.614 . . . . 0.0 110.149 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.846 HG11 ' HB2' ' A' ' 53' ' ' PHE . 13.3 t -63.18 -55.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.66 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.56 -28.66 69.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.322 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.79 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 8.1 m-85 -57.46 -57.62 11.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 109.956 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.568 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 13.6 m-85 -74.88 -37.68 62.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.2 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.74 -37.5 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.157 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -57.15 -52.33 65.72 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.697 0.284 . . . . 0.0 111.202 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.41 -40.85 38.89 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.225 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.29 89.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.189 0.495 . . . . 0.0 111.016 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.594 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.36 -41.04 70.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.765 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.7 -48.74 80.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.584 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.677 ' HB3' HD21 ' A' ' 22' ' ' LEU . 67.0 m -59.66 -42.26 92.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.316 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.89 -55.96 24.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 0.0 110.855 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.4 -17.87 64.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -77.88 -32.97 52.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' CYS . 35.0 t -75.21 -22.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.658 0.742 . . . . 0.0 109.356 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -4.89 59.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.609 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.2 tttt -132.06 -162.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.585 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.18 55.19 3.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.553 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.52 43.64 2.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.023 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.7 mp0 -60.54 -55.32 46.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.962 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.4 Cg_exo -64.72 -26.84 60.43 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.956 1.771 . . . . 0.0 112.198 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.6 mm? -65.72 -28.11 68.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.313 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 111' ' ' VAL . 79.3 t -59.23 -50.69 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.956 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.87 -32.58 84.36 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.838 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 53.3 mm-40 -64.63 -52.88 55.09 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 118' ' ' LEU . 44.8 t -58.3 -33.49 47.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.958 0.408 . . . . 0.0 110.115 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.21 -46.92 81.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.427 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HA ' HG12 ' A' ' 127' ' ' VAL . 19.0 pt-20 -72.31 -39.43 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.064 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.9 m0 -57.8 -38.7 75.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.483 0.658 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 4.7 ttm -71.96 -56.07 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.69 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.2 p -61.19 -33.21 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -73.09 -45.79 55.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.6 t80 -59.88 -37.39 79.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.704 0.764 . . . . 0.0 109.894 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.51 -54.98 8.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.822 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.17 -32.6 70.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -82.43 -35.11 27.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.87 -43.5 1.22 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.51 -48.49 81.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.595 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.8 -38.92 57.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.603 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.15 -50.02 73.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.796 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.8 t90 -58.17 -49.28 77.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 109.525 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.65 HG13 ' HE3' ' A' ' 137' ' ' TRP . 11.3 mt -58.08 -47.14 87.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.152 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -61.12 -40.0 92.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -30.54 43.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -60.03 3.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.947 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.3 -11.07 0.02 OUTLIER Glycine 0 C--N 1.319 -0.367 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.32 169.16 41.89 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.612 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.0 m95 -62.2 -29.03 70.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.51 78.66 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.578 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.81 -44.06 94.4 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 t80 -64.83 -34.21 77.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.579 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.761 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -70.55 -25.55 63.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.37 -32.66 20.84 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.521 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -57.95 -51.49 69.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.643 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -130.32 30.23 4.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.85 -133.13 8.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.927 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -68.59 -45.45 71.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.568 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.68 48.78 2.3 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.12 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.23 73.26 8.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.12 0.486 . . . . 0.0 110.734 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -65.77 160.05 23.85 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.575 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -57.01 -32.18 65.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.281 -178.874 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -69.62 -39.41 77.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.651 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.38 -36.31 78.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.42 ' HA ' ' HE1' ' A' ' 151' ' ' TYR . 61.9 mtt180 -67.56 -50.57 57.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -64.47 -27.32 68.91 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.019 0.438 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -63.34 -47.52 81.81 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.47 178.557 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.458 HH11 ' HE1' ' A' ' 147' ' ' PHE . 11.0 ttp180 -63.4 -39.2 93.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.636 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.19 -49.12 70.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.888 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.54 -27.23 73.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.585 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.648 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.7 m-20 -70.11 -56.63 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.464 -0.368 . . . . 0.0 111.532 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.645 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 9.8 p-90 -60.34 -27.87 67.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.453 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.73 74.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.688 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -24.09 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 166' ' ' ASN . 28.7 m -96.38 -41.15 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.575 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -75.35 -27.4 59.17 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.411 -0.805 . . . . 0.0 111.079 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 1.4 m -81.51 -29.92 33.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.414 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.593 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.2 p -71.57 -28.24 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 110.398 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.593 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -114.44 33.91 5.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.209 0.528 . . . . 0.0 109.628 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.3 t -81.52 -4.72 56.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.242 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -89.39 6.13 83.52 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.647 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 29.29 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.422 HG11 HH12 ' A' ' 59' ' ' ARG . 0.7 OUTLIER -87.23 50.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.054 0.454 . . . . 0.0 110.731 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.14 -1.85 53.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 82' ' ' VAL . 10.4 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.233 0.259 0 CA-C-O 121.047 0.353 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -72.49 -174.12 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.095 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -37.8 52.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.292 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -64.13 -38.67 91.89 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.49 -35.25 68.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 42' ' ' LEU . 3.0 tp -71.66 -43.19 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.85 -33.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.971 0.415 . . . . 0.0 110.159 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.15 -24.77 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.456 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.36 -63.16 1.39 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -55.54 -51.77 65.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.619 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -68.62 -38.94 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.789 0.328 . . . . 0.0 110.281 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.63 -51.78 55.3 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.477 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.791 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.3 t80 -61.38 -42.27 98.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 0.0 110.847 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -62.61 -46.81 86.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -68.24 -44.72 75.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.737 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.6 -29.14 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.2 pt20 -85.84 -22.94 27.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.84 65.75 1.11 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.26 -70.45 0.31 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.965 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -89.83 51.14 2.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.213 0.53 . . . . 0.0 110.155 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.88 -28.24 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.545 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.63 -29.26 64.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.94 57.87 1.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.737 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.51 112.5 3.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.855 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 178.57 -58.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.403 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -57.86 -48.95 14.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.227 1.951 . . . . 0.0 111.992 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.791 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.16 32.69 5.96 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.709 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.3 -20.63 29.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.908 0.385 . . . . 0.0 110.109 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -94.86 145.6 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 65.8 Cg_endo -97.55 -159.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.199 2.599 . . . . 0.0 113.647 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -81.59 84.41 6.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.05 1.19 7.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.034 0.445 . . . . 0.0 111.273 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 40.6 m-20 -104.98 163.0 18.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.58 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -80.12 47.03 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.443 2.762 . . . . 0.0 111.85 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -175.07 -31.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.755 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.3 m170 -58.0 -58.82 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.342 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.54 ' CA ' ' HB1' ' A' ' 38' ' ' ALA . 4.0 tt0 -58.18 -25.02 61.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.867 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.27 -50.31 16.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.266 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.462 ' HE1' HD21 ' A' ' 13' ' ' LEU . 3.2 ttm -66.89 -37.6 84.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.577 HH11 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HB2' HH11 ' A' ' 47' ' ' ARG . . . -80.33 -42.01 23.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.324 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.862 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.16 -54.89 41.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.523 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.6 -50.58 41.93 Favored Glycine 0 C--O 1.22 -0.726 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.294 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.36 -50.05 68.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -48.48 80.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -71.28 -33.46 69.77 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.212 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.76 -25.34 67.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.55 0.691 . . . . 0.0 109.327 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -84.82 -37.32 20.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.327 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -92.92 -61.22 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.073 0.463 . . . . 0.0 112.165 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.9 69.7 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.402 0.681 . . . . 0.0 111.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -77.82 -16.97 57.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -81.39 46.43 0.94 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.36 . . . . 0.0 111.476 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 t -120.98 -6.45 9.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.819 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.8 m-85 -92.98 -26.31 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -39.3 93.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.538 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.55 -24.99 66.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -66.16 -41.29 90.57 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -76.67 -46.65 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.26 -43.03 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.551 ' NE2' HD22 ' A' ' 180' ' ' LEU . 42.6 mt-30 -67.57 -59.32 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.938 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.35 16.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.654 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.62 -26.8 45.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 0.0 110.529 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 71' ' ' THR . 3.4 p -93.01 -60.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.449 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.551 ' H ' HG13 ' A' ' 70' ' ' VAL . 8.6 t -174.69 146.96 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.58 178.12 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.714 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 101.91 -76.62 0.35 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.947 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.81 48.96 0.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.176 0.512 . . . . 0.0 111.77 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -95.37 -24.01 16.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.68 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 5.9 pt20 -60.66 -42.0 96.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.845 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.24 87.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.719 0.295 . . . . 0.0 110.54 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -62.83 -42.2 99.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.07 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.12 -51.62 65.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.282 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 p -55.86 -32.93 64.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.383 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -60.18 -65.0 0.75 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.118 0.485 . . . . 0.0 110.611 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.82 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.4 m -58.45 -32.2 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.594 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -65.79 -43.6 88.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 0.0 110.106 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -71.28 -33.73 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.46 -29.82 65.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.338 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -34.82 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -87.65 -8.64 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.099 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -44.22 -45.15 8.34 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.66 63.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.218 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.8 55.83 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.792 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.7 Cg_endo -80.47 38.38 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.116 1.877 . . . . 0.0 111.569 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.839 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.4 t-20 -68.3 162.76 24.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.089 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.481 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 25.8 m95 -53.53 -26.98 23.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.71 -42.3 98.69 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.71 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.9 mtp180 -86.72 -22.47 26.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.82 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.31 -31.69 54.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 110.25 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.862 HG22 ' HB1' ' A' ' 49' ' ' ALA . 9.5 t -61.62 -56.84 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.5 -27.56 69.36 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.618 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.824 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.3 m-85 -57.07 -55.82 29.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.054 0.454 . . . . 0.0 109.942 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.585 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 12.5 m-85 -75.96 -38.68 57.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.938 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 5.8 t -60.85 -37.66 77.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -55.74 -50.5 70.2 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.77 0.319 . . . . 0.0 111.219 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.21 -38.44 34.41 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.056 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.5 96.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.081 0.44 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.546 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.74 -38.27 80.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.13 -45.19 95.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.186 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.603 ' HB2' HD11 ' A' ' 22' ' ' LEU . 85.2 m -63.86 -42.51 97.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.034 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.43 31.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 110.843 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.97 -16.12 63.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 m -77.98 -33.83 51.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 107' ' ' CYS . 22.2 t -77.08 -20.85 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.708 0.766 . . . . 0.0 109.019 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -82.09 -2.33 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.235 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -138.27 -155.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.16 53.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.698 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.506 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -127.66 44.87 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 8.7 mt-10 -54.08 -56.2 28.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 22.0 Cg_exo -66.54 -32.13 40.02 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.018 1.812 . . . . 0.0 112.954 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.714 HD21 ' H ' ' A' ' 73' ' ' GLY . 3.9 mp -59.57 -31.93 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.11 -53.74 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.42 86.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.084 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 14.0 mm-40 -65.09 -50.81 64.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.8 t -57.87 -35.07 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -63.02 -47.07 84.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.703 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.9 pt-20 -71.49 -39.04 71.12 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.008 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.68 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 35.7 m0 -58.1 -38.08 75.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 109.128 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.6 ttm -73.1 -55.6 6.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.67 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.7 p -60.3 -33.34 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.12 -50.89 36.04 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.598 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.458 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 9.5 t80 -58.2 -33.59 69.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.465 0.65 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.846 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.89 -52.51 9.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.116 -178.376 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -34.76 76.57 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 m -81.72 -39.21 24.57 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -43.32 2.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.9 mm? -61.61 -44.08 97.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.295 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.62 61.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.62 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.69 -53.7 30.84 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.839 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.1 t90 -56.68 -46.69 81.01 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.51 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.29 -49.05 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.418 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -64.07 -34.97 79.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -80.97 -13.28 59.02 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -43.38 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.851 0.358 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.9 -26.86 0.11 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 102.99 171.29 26.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.061 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -58.78 -29.47 66.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.87 79.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.821 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.29 -41.01 97.08 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.524 ' HE1' HH21 ' A' ' 163' ' ' ARG . 9.7 t80 -66.01 -35.27 80.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.499 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.867 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -67.02 -29.1 68.83 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.127 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -26.72 24.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.186 0.517 . . . . 0.0 109.976 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 8.6 mt -71.2 -40.98 70.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.773 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -130.65 31.79 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.153 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.29 -133.18 7.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.527 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.14 -43.27 17.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.162 0.506 . . . . 0.0 110.302 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.455 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -87.71 52.27 4.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.454 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.31 73.62 10.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.154 0.502 . . . . 0.0 110.077 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -62.79 169.97 2.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.425 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.47 -33.93 66.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.403 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.714 ' HB2' HD12 ' A' ' 156' ' ' LEU . 23.1 mt-10 -72.15 -45.22 61.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.69 0.281 . . . . 0.0 110.524 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.97 -42.68 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -62.48 -50.7 70.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.795 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.62 -35.4 80.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 2.9 mt -67.94 -29.89 69.07 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.361 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.524 HH21 ' HE1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.22 -48.27 62.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.554 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.545 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.4 OUTLIER -67.43 -44.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.587 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.87 -25.32 73.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.989 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -69.13 -51.22 40.56 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.571 0.224 . . . . 0.0 111.379 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.871 ' HA ' HG22 ' A' ' 170' ' ' VAL . 19.5 p-90 -71.98 -21.23 61.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.239 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.71 82.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.309 0.576 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -86.26 -32.84 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.572 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.871 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.5 m -86.99 -31.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -73.13 -32.97 65.26 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.938 -0.477 . . . . 0.0 110.413 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.837 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.6 OUTLIER -85.63 -27.6 25.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.095 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.5 p -71.0 -26.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 0.0 110.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 1.1 mt -120.46 39.54 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.298 0.571 . . . . 0.0 110.388 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.837 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.3 OUTLIER -62.42 -29.93 70.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.794 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.67 40.88 2.99 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.496 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -105.0 10.56 34.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 109.896 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.86 57.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -85.47 -4.7 59.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.694 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.82 ' HG ' HG11 ' A' ' 82' ' ' VAL . 9.2 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 CA--C 1.529 0.258 0 CA-C-O 120.932 0.305 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -162.85 0.56 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -36.88 71.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.997 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -37.84 87.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.79 -35.62 62.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.297 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.2 tp -73.69 -40.47 63.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.333 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.714 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 6.7 p -65.19 -37.71 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 110.06 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -24.65 59.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -60.33 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.698 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -59.12 -56.04 27.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.684 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.429 ' O ' HD13 ' A' ' 22' ' ' LEU . 95.9 t -64.32 -38.99 83.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.82 -52.22 53.72 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.795 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 41.2 t80 -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.696 0.284 . . . . 0.0 110.869 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.93 -42.03 97.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.782 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.5 mp -71.21 -45.17 63.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.855 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 26.5 ttp85 -65.56 -15.56 62.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.659 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.36 -36.07 24.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -153.6 78.43 1.14 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 111.836 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.95 -68.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.444 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.6 t80 -91.85 56.52 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.165 0.507 . . . . 0.0 110.01 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.56 -32.36 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.87 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.54 -33.31 71.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -91.09 56.25 3.26 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.399 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -68.21 112.26 5.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.416 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.23 -51.73 0.12 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 119.88 -1.153 . . . . 0.0 113.849 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 38.4 Cg_exo -63.47 -43.71 16.74 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.093 1.862 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.95 32.36 7.54 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.107 -0.952 . . . . 0.0 112.659 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.87 -14.26 39.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.242 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.0 142.18 15.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.781 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.39 -154.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.033 2.489 . . . . 0.0 113.242 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -85.23 80.15 9.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.628 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.51 16.31 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.809 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 13.1 m-20 -126.57 157.81 69.64 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 Cg_exo -71.36 36.58 0.3 Allowed 'Trans proline' 0 N--CA 1.474 0.34 0 C-N-CA 124.251 3.3 . . . . 0.0 113.12 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -167.81 -27.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.2 m170 -59.66 -55.25 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.959 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.502 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.1 -22.42 66.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.942 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.728 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -76.76 -48.73 17.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.994 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.406 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 1.0 OUTLIER -68.98 -32.91 72.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.368 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.25 -43.02 96.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.13 50.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 110.174 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.861 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -62.64 -62.19 1.91 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.278 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.698 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.15 -48.34 32.33 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.834 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.96 -45.5 82.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.124 0.462 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.9 96.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.695 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -76.93 -28.19 55.17 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.097 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.98 -23.09 66.52 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 m -94.85 -39.19 10.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.101 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 56' ' ' ARG . 2.7 mtt180 -84.81 -57.71 3.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 73.6 9.85 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.986 0.514 . . . . 0.0 111.383 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 58' ' ' ARG . 12.6 mtt180 -76.5 -10.28 59.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.522 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 54.43 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -57.43 1.84 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.052 0.453 . . . . 0.0 111.875 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 70.5 m-85 -55.17 -31.74 61.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -39.04 87.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.8 m-20 -70.69 -20.56 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 110.267 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 61' ' ' PHE . 25.0 mt -70.13 -41.43 73.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.99 -43.97 61.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.09 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.84 -43.63 73.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 41.7 mt-30 -63.22 -58.07 8.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.448 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.43 8.02 8.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 11.9 t60 -79.0 -23.06 44.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -63.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t -172.88 144.47 1.22 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.182 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.85 171.71 16.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.88 2.387 . . . . 0.0 111.598 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 97.54 -60.8 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.342 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 19.19 0.13 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.9 -22.37 56.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.606 0.241 . . . . 0.0 111.185 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.632 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -62.06 -39.5 92.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 3.9 mt-30 -67.62 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.86 -45.12 93.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.813 0.34 . . . . 0.0 110.154 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -62.35 -51.74 66.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.928 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -59.24 -33.81 71.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 74.4 mm-40 -63.56 -50.67 68.59 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.126 0.489 . . . . 0.0 109.991 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 86' ' ' LEU . 65.5 t -63.7 -37.34 79.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.461 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 m -61.64 -46.73 88.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.756 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.646 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.37 -39.45 93.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 110.243 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.0 mm-40 -67.91 -28.68 67.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.28 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -76.61 -38.57 54.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.405 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 26.9 t80 -82.29 -8.79 59.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -47.16 -38.58 12.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.807 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.4 57.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.131 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.554 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 173.7 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.498 -1.334 . . . . 0.0 115.098 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 9.4 Cg_endo -82.35 23.89 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.454 2.102 . . . . 0.0 111.249 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.793 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 m-20 -63.94 158.0 23.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.078 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.668 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 5.8 m95 -50.35 -24.97 3.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.23 -49.94 66.95 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.467 -0.873 . . . . 0.0 110.955 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.736 ' HD2' HD12 ' A' ' 174' ' ' LEU . 8.4 mtt180 -86.66 -18.67 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.052 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.13 -31.51 63.38 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.471 0.653 . . . . 0.0 110.259 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.861 HG22 ' HB1' ' A' ' 49' ' ' ALA . 28.8 t -60.99 -52.63 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.49 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.64 69.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.312 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.31 -55.11 39.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.714 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 m-85 -76.65 -38.26 54.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.06 -35.69 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -52.75 -60.76 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 111.551 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.23 -34.54 69.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.143 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.288 0.544 . . . . 0.0 110.517 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.05 -39.94 82.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -60.59 -44.92 95.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.663 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.65 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.7 m -66.51 -40.73 89.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.203 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.68 -54.6 42.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.82 -15.46 62.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.1 m -78.31 -33.07 49.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' CYS . 47.3 t -75.45 -31.67 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.347 0.594 . . . . 0.0 109.556 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -77.12 0.7 20.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.208 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.695 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -132.53 -151.45 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.813 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 1.3 mt-10 -108.69 51.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.83 0.348 . . . . 0.0 111.353 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -146.87 42.24 1.13 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.69 -45.84 97.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.344 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -58.13 -16.98 29.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.279 1.986 . . . . 0.0 113.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.4 OUTLIER -82.42 -22.51 35.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.606 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 107' ' ' CYS . 49.9 t -56.02 -54.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.43 77.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.438 -0.886 . . . . 0.0 111.968 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.5 mm-40 -67.34 -50.92 58.0 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' LEU . 30.5 t -57.84 -33.86 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 0.0 109.767 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.33 -46.8 78.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.293 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.79 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.9 pt-20 -73.55 -35.12 65.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.021 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.632 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.5 m0 -58.92 -40.71 85.37 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.5 ttm -72.45 -52.79 14.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.849 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -62.01 -32.22 53.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -52.64 33.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.994 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 6.4 t80 -56.6 -34.72 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 110.81 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.061 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.45 -53.37 8.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.454 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 127' ' ' VAL . 10.9 mt-10 -62.6 -32.01 72.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.1 m -86.75 -43.61 12.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -44.5 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.061 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -59.97 -42.27 93.76 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.348 0.522 . . . . 0.0 111.632 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.32 -31.1 53.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -53.4 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.793 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 57.9 t90 -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.492 HG13 ' HE3' ' A' ' 137' ' ' TRP . 3.5 mt -57.07 -46.86 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.959 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -67.55 -29.28 68.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -94.52 -2.06 52.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -126.37 48.62 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 111.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.78 -67.41 0.92 Allowed Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.554 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.79 177.23 14.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 96.5 m95 -60.93 -28.84 69.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.07 69.67 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.794 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.668 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -68.6 -38.96 81.05 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.791 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.59 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 7.7 t80 -63.14 -41.44 99.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.363 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.728 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -64.22 -30.85 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.01 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 -16.22 35.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.761 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -77.93 -45.15 24.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.736 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 30.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -99.85 -119.86 4.38 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -74.22 -51.07 16.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -94.13 64.53 1.68 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.204 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.62 71.78 10.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.315 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.904 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -64.24 158.16 23.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.88 -31.71 50.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.141 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.904 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.9 mm-40 -68.19 -48.92 63.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.497 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.31 83.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.417 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -59.86 -56.1 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.928 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 158' ' ' GLU . 19.5 ptt180 -69.44 -29.1 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -63.82 -39.93 95.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.335 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.843 HH22 ' HA ' ' A' ' 49' ' ' ALA . 4.0 ttp180 -70.06 -38.72 75.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.324 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.589 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.5 OUTLIER -62.85 -46.06 89.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.237 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.33 75.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.195 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.442 ' O ' HG22 ' A' ' 170' ' ' VAL . 4.7 t-20 -67.67 -56.69 8.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.972 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.938 ' HA ' HG22 ' A' ' 170' ' ' VAL . 21.4 p-90 -67.73 -21.44 65.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.412 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.8 52.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.215 0.322 . . . . 0.0 110.766 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 m -88.02 -26.91 22.35 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.938 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.1 m -80.03 -24.64 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.017 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.697 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 13.0 ttp85 -81.09 -23.06 38.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.726 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -90.19 -35.54 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.162 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.953 HG13 ' HG ' ' A' ' 174' ' ' LEU . 7.1 p -62.77 -30.15 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.163 0.506 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.953 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -118.54 40.13 3.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.992 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.726 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.69 -25.84 67.66 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.34 9.34 55.12 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.712 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -72.43 -7.64 50.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.011 0.405 . . . . 0.0 111.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.37 66.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.027 0.441 . . . . 0.0 110.513 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.45 12.65 34.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.236 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 102' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.114 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.529 0.274 0 CA-C-O 121.051 0.355 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.34 -157.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -41.45 72.75 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.922 0.489 . . . . 0.0 112.279 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -61.12 -37.78 83.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.13 -35.76 61.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.178 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.592 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -73.63 -42.24 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.477 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.0 p -64.6 -36.11 76.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.42 60.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.318 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -65.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.94 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.2 t80 -55.13 -54.77 39.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.61 -38.34 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -62.75 -55.39 27.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.91 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.697 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 t80 -60.1 -42.64 95.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.783 0.433 . . . . 0.0 110.852 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.86 -44.8 95.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.259 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -71.13 -44.26 65.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 16.6 ttp85 -67.64 -13.01 61.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 2.5 mt-30 -84.36 -37.44 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.229 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -154.56 83.4 1.11 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.45 -69.13 0.35 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.664 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.68 54.79 1.04 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.236 0.541 . . . . 0.0 110.201 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -78.67 -27.12 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.179 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -39.16 80.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.87 57.34 4.64 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.169 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -65.98 110.97 3.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.413 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.5 -53.54 0.09 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.878 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 24.8 Cg_exo -65.12 -48.72 3.3 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.016 1.81 . . . . 0.0 111.27 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.03 31.46 6.26 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.301 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.33 -19.81 35.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 0.0 109.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.51 132.84 11.25 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -91.33 -147.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.617 2.211 . . . . 0.0 113.882 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -75.31 76.3 2.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.73 31.84 5.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.793 0.33 . . . . 0.0 111.291 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 12.7 m-20 -142.04 163.29 41.05 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.74 48.46 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.247 2.631 . . . . 0.0 112.331 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.924 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.2 m170 -59.35 -56.47 21.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.944 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.03 -24.65 64.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.906 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.31 -51.49 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.23 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.456 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 5.2 ttm -68.92 -39.36 79.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.673 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -61.95 -35.53 78.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.785 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.45 -43.76 18.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.518 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.57 -54.32 48.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.2 -47.8 54.65 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.667 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.01 -48.51 81.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 110.898 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 56' ' ' ARG . 4.1 tp10 -60.03 -48.74 80.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.926 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -68.87 -35.24 76.66 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.927 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.98 -28.0 68.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.65 0.738 . . . . 0.0 109.409 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.1 m -85.81 -32.16 21.92 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.397 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 52' ' ' GLU . 7.6 mtt180 -88.73 -21.21 23.97 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.548 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -85.16 95.9 9.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.375 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -60.67 -32.94 72.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.482 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.564 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -108.62 94.64 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.126 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.41 -70.94 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 64' ' ' LEU . 48.9 m-85 -78.51 -7.3 57.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -46.99 58.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.564 ' OD1' ' HD3' ' A' ' 59' ' ' ARG . 2.5 m-20 -68.71 -18.32 64.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.199 0.524 . . . . 0.0 110.472 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 61' ' ' PHE . 31.8 mt -72.78 -40.41 65.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.45 -45.88 51.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.17 68.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.06 -54.77 28.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.09 16.06 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 -177.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -26.53 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 0.0 110.691 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -68.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.668 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t -165.92 145.72 5.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.501 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 8.2 Cg_exo -72.11 176.1 8.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.964 2.443 . . . . 0.0 111.974 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.775 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 90.64 -60.09 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -77.07 52.85 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 0.0 110.967 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.85 -25.52 10.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.714 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.3 pt20 -62.72 -35.36 79.5 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.856 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 24.4 mp0 -67.35 -45.14 77.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -63.56 -44.19 94.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.892 0.377 . . . . 0.0 110.086 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.26 -49.27 76.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.789 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 p -59.68 -32.95 70.96 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.849 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.9 mm100 -64.82 -54.95 23.09 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' HB1' ' A' ' 177' ' ' ALA . 7.4 p -61.58 -35.3 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.914 0.387 . . . . 0.0 110.406 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.4 m -66.99 -43.1 83.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.83 -44.52 92.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.232 0.539 . . . . 0.0 110.015 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 40.1 mt-10 -69.7 -18.21 63.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.782 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.88 -39.74 19.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.146 0.498 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.63 -4.86 58.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -44.33 -43.32 7.42 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.876 0.735 . . . . 0.0 111.666 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.48 57.34 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.93 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.444 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 168.0 56.85 0.03 OUTLIER Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.775 -1.203 . . . . 0.0 114.655 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.1 Cg_endo -80.5 39.8 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.326 2.017 . . . . 0.0 111.646 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.81 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 11.5 t-20 -65.56 158.93 25.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.414 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.4 m95 -54.97 -27.44 43.82 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.321 0.388 . . . . 0.0 110.297 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.75 -39.56 97.59 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.3 -24.64 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.551 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -55.26 -30.62 60.43 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 53' ' ' PHE . 9.4 t -63.07 -53.34 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.374 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.445 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -64.63 -28.09 69.38 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.282 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.5 m-85 -56.83 -56.82 16.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.131 0.491 . . . . 0.0 109.928 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 8.0 m-85 -76.1 -36.33 58.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.838 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 1.7 t -60.15 -38.05 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -58.13 -47.47 83.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.68 0.276 . . . . 0.0 111.061 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 -40.0 23.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.51 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.072 0.436 . . . . 0.0 110.608 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.43 -41.38 80.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -58.75 -47.5 84.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.76 ' HB3' HD21 ' A' ' 22' ' ' LEU . 63.3 m -60.93 -41.45 96.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.23 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.58 -55.79 25.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.53 -18.18 64.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.604 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -77.94 -27.99 49.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 43.6 t -81.77 -23.03 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -78.97 -15.26 58.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.9 -169.25 2.0 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.02 60.99 6.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.512 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.66 32.19 3.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.005 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.6 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 5.9 mp0 -54.86 -51.96 74.7 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.194 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 35.3 Cg_exo -61.14 -27.45 84.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.92 1.747 . . . . 0.0 112.433 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.775 HD21 ' H ' ' A' ' 73' ' ' GLY . 2.6 mp -71.44 -26.67 62.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.52 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.14 -53.6 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.687 0.279 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.71 83.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.79 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 117' ' ' PRO . 28.4 mt-30 -63.36 -53.68 48.73 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 118' ' ' LEU . 48.2 t -57.54 -33.9 45.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.05 0.452 . . . . 0.0 110.156 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.5 -46.48 82.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.553 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.2 pt-20 -74.09 -37.72 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.906 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.714 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.3 m0 -56.79 -37.43 71.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.9 ttm -72.36 -57.91 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.888 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -61.36 -30.36 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.975 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.8 -50.55 49.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -62.26 -31.18 71.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 111.107 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.918 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.3 -54.04 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.481 -178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.02 -35.85 77.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.892 0.377 . . . . 0.0 111.876 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.1 m -78.18 -36.21 47.75 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -43.8 1.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.2 mm? -58.27 -46.51 85.88 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.394 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.82 -35.82 45.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.19 -52.05 51.86 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.81 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.5 t90 -58.13 -47.65 82.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.5 HG23 ' HH2' ' A' ' 93' ' ' TRP . 9.2 mt -56.94 -48.1 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.755 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -63.31 -32.98 74.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 m -81.88 -18.38 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 t -84.24 -55.03 4.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 111.544 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.46 -17.32 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.63 171.58 29.18 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.615 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.456 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 95.4 m95 -59.51 -28.0 66.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.95 0.405 . . . . 0.0 109.99 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.59 78.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.788 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -41.58 98.36 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.515 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.8 t80 -66.46 -34.07 77.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.49 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.926 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.06 -29.18 70.05 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.804 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.13 -26.07 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.188 0.518 . . . . 0.0 110.043 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 163' ' ' ARG . 3.5 mt -73.96 -39.14 63.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.628 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.517 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 26.7 m-85 -126.83 29.24 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.666 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.16 -140.49 5.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.557 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -54.76 12.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.075 -0.563 . . . . 0.0 111.414 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -81.25 53.59 4.66 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.72 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.94 72.02 10.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.0 109.71 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.09 165.47 3.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.627 -179.061 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HG3' ' NH1' ' A' ' 160' ' ' ARG . 2.7 mt-10 -56.99 -33.66 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.327 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.922 ' HB2' HD12 ' A' ' 156' ' ' LEU . 15.8 mm-40 -71.17 -45.57 63.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.951 0.405 . . . . 0.0 110.305 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -59.96 -47.1 87.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.777 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.4 ' NH1' ' HG3' ' A' ' 157' ' ' GLU . 6.0 ptp180 -63.72 -43.37 96.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.11 -22.37 61.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.277 0.56 . . . . 0.0 110.57 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 -47.05 17.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -62.42 -46.52 88.22 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.419 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.664 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.19 -44.3 95.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.07 -10.22 72.97 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.757 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.655 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -85.28 -58.05 2.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.861 -0.169 . . . . 0.0 110.82 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.716 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.37 -24.91 66.81 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 123.163 0.289 . . . . 0.0 111.311 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.34 84.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.407 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.9 OUTLIER -88.02 -28.02 21.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.716 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 3.2 m -91.16 -42.71 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.65 ' HD3' ' CE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -70.31 -24.83 63.08 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.534 -0.729 . . . . 0.0 111.007 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.744 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.2 OUTLIER -93.21 -9.96 37.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.913 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 170' ' ' VAL . 3.6 p -85.62 -23.22 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 0.0 109.373 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.35 40.33 3.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.802 178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -69.52 -22.37 63.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.104 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.45 9.8 53.23 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.937 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -76.82 7.41 4.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.095 0.448 . . . . 0.0 111.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.12 65.18 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.357 0.598 . . . . 0.0 111.09 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.32 13.87 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.212 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.721 -178.741 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo . . . . . 0 CA--C 1.529 0.269 0 CA-C-O 121.37 0.488 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -85.58 -167.45 1.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.461 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -37.6 65.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.544 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.07 -37.04 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.734 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.72 62.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.849 0.357 . . . . 0.0 110.097 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.484 ' HB2' HD13 ' A' ' 42' ' ' LEU . 10.5 tp -70.32 -42.15 72.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.629 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 4.8 p -65.9 -35.39 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.939 0.4 . . . . 0.0 110.061 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -20.48 60.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.659 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.06 -63.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.72 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 3.1 t80 -55.35 -51.28 67.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.579 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 99.0 t -70.14 -41.14 78.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 110.365 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.38 -54.25 38.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.576 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.736 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 58.3 t80 -60.64 -42.91 97.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.537 0.335 . . . . 0.0 110.979 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.2 -49.09 77.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.8 mp -65.78 -48.78 70.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.604 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.62 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 6.1 ttp180 -62.6 -20.34 64.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.446 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.3 mt-30 -85.39 -32.58 22.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.311 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -148.52 75.86 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.849 0.356 . . . . 0.0 111.856 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.37 -69.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.624 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.7 t80 -92.21 51.15 1.74 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.19 -26.52 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.09 -16.01 59.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.412 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.39 49.28 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.332 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -63.67 114.36 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.08 -48.23 0.05 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.692 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 6.1 Cg_exo -77.03 -48.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.201 1.934 . . . . 0.0 111.867 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -83.77 22.76 7.39 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.557 -0.747 . . . . 0.0 114.229 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mm-40 -76.03 -32.69 59.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.37 0.585 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.61 111.95 4.23 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 84.1 Cg_endo -84.54 -139.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.563 2.175 . . . . 0.0 114.264 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -70.03 80.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.821 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.58 -0.41 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.499 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 8.0 m-20 -110.82 161.11 26.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.447 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -77.08 45.61 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.529 2.819 . . . . 0.0 112.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -173.93 -27.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.331 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.733 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.4 m170 -62.89 -51.26 67.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.559 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.525 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -64.01 -21.68 66.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.27 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.97 -52.32 11.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.544 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.0 OUTLIER -64.86 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.297 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -60.27 -40.33 89.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.206 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.94 -28.44 43.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 110.192 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.826 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -67.71 -60.47 2.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.407 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -48.91 -49.01 29.96 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.46 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.96 -53.0 58.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 111.764 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' HE ' ' A' ' 56' ' ' ARG . 8.2 tt0 -63.16 -45.66 90.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.656 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.75 -30.99 66.19 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.549 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -65.13 -30.9 71.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -86.14 -19.16 30.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.342 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HE ' ' HG3' ' A' ' 52' ' ' GLU . 16.1 mtt-85 -98.09 -49.25 4.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.187 0.518 . . . . 0.0 112.209 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.2 90.13 7.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.236 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -67.48 -21.97 65.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.166 0.508 . . . . 0.0 110.881 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -88.67 66.53 8.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 -14.43 8.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.013 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.52 -0.06 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.28 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -51.84 23.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.257 0.551 . . . . 0.0 111.088 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -57.04 -33.82 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.806 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 7.5 mp -56.93 -43.25 81.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.49 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -81.47 -42.77 19.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.63 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.33 33.69 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.639 0.587 . . . . 0.0 111.799 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.431 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.9 mt-30 -80.65 -47.71 13.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 115' ' ' MET . 0.6 OUTLIER -90.28 20.89 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.1 t60 -80.2 -38.13 31.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.222 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.553 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -90.56 -62.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.553 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -158.66 152.77 19.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 2.9 Cg_endo -79.66 178.17 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.847 2.365 . . . . 0.0 111.497 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.17 -56.52 4.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.759 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.44 34.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.129 0.49 . . . . 0.0 111.61 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.93 -24.66 16.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.648 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 12.5 pt20 -58.45 -47.15 84.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.953 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.26 -45.0 88.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.034 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.95 ' HB3' HD11 ' A' ' 180' ' ' LEU . 11.0 mtt180 -64.91 -40.82 95.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.0 t80 -67.21 -48.04 69.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.459 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -59.11 -28.64 66.72 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -68.14 -60.43 2.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.799 0.333 . . . . 0.0 110.29 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 177' ' ' ALA . 10.6 p -54.52 -36.05 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.594 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -68.81 -41.85 78.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.767 0.318 . . . . 0.0 110.475 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -69.83 -38.6 76.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.55 -26.34 64.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -82.54 -33.09 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.176 0.512 . . . . 0.0 110.392 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -85.35 -10.07 56.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -41.3 -48.73 3.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.507 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.78 54.38 0.23 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.185 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.7 57.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 119.376 -1.392 . . . . 0.0 114.683 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 41.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.072 1.848 . . . . 0.0 111.377 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.813 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -70.65 163.14 27.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.069 -178.542 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.669 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.3 m95 -53.59 -27.54 27.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.37 97.88 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.767 HH11 ' HB2' ' A' ' 174' ' ' LEU . 5.0 mtp180 -87.46 -19.99 27.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.579 -0.31 . . . . 0.0 111.353 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.789 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -54.97 -31.87 61.04 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 110.326 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.883 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.8 t -61.52 -54.01 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.89 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.42 70.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.272 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.789 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.0 m-85 -56.72 -55.18 37.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.374 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.629 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 6.8 m-85 -76.93 -37.91 54.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.179 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.29 -37.99 78.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -51.54 63.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.696 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.24 -37.54 36.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.996 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.68 95.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.126 0.463 . . . . 0.0 110.745 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.96 -43.85 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.85 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -59.65 -42.34 92.56 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.279 0.561 . . . . 0.0 110.832 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.8 m -63.74 -44.99 91.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.047 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.2 76.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.572 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.608 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.0 OUTLIER -76.8 -17.75 58.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.8 m -82.63 -26.43 32.23 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.715 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.2 t -70.06 -38.27 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.837 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.608 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.1 p30 -82.48 1.79 35.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -120.69 -172.65 2.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.267 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.95 46.92 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.243 0.544 . . . . 0.0 111.202 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.758 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -142.22 37.15 1.54 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.199 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.3 OUTLIER -56.13 -50.12 89.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.045 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 42.8 Cg_exo -57.77 -25.94 71.09 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.163 1.909 . . . . 0.0 112.841 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.4 mm? -69.05 -25.47 64.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.42 -45.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.96 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.34 -34.75 86.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.712 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -66.0 -50.25 64.92 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 118' ' ' LEU . 29.0 t -58.17 -32.61 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.164 0.507 . . . . 0.0 109.78 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.0 -45.86 80.03 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.429 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.763 ' HA ' HG12 ' A' ' 127' ' ' VAL . 14.4 pt-20 -74.51 -36.53 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.648 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 43.3 m0 -57.4 -39.4 76.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.1 ttm -73.74 -54.96 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.784 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.3 p -61.58 -33.03 55.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -46.73 66.0 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.304 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.602 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 21.0 t80 -61.6 -36.45 80.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.564 0.697 . . . . 0.0 110.336 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.943 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.65 -54.14 15.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.254 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.59 -37.27 80.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -74.72 -36.28 62.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -130.59 -41.36 1.2 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -60.89 -49.02 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.334 0.515 . . . . 0.0 111.813 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.73 60.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.292 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.4 -55.7 19.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.192 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.813 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 42.5 t90 -53.68 -48.48 69.45 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.126 0.488 . . . . 0.0 109.797 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.2 mt -56.27 -48.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.724 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -64.53 -36.34 83.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 p -80.82 -14.93 57.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.927 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -55.65 3.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.87 -10.91 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.577 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.28 169.28 44.21 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.698 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.544 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.4 m95 -60.52 -30.52 69.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.84 73.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.106 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.515 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -64.99 -41.31 95.53 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.641 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.9 t80 -64.93 -40.83 95.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.601 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.655 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.24 -26.23 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 110.947 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.23 -29.02 22.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.439 . . . . 0.0 110.306 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -62.67 -51.84 65.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.338 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -132.43 32.93 3.87 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.26 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.84 -129.61 6.75 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.864 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -51.61 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.249 0.547 . . . . 0.0 110.642 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.13 55.89 2.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.394 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.78 73.84 7.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 110.042 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.54 161.04 15.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.81 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 3.2 mt-10 -59.21 -30.37 68.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.061 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.789 ' HB2' HD12 ' A' ' 156' ' ' LEU . 9.1 mm-40 -72.88 -36.26 67.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.79 73.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.013 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.81 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 25.3 mtt-85 -63.09 -55.24 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.386 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 158' ' ' GLU . 2.9 ptm180 -65.0 -25.15 67.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -68.47 -43.42 77.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.93 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.647 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.4 ttp180 -70.95 -34.52 71.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.521 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.521 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER -69.49 -45.6 68.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.172 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.19 -22.14 77.32 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.632 ' O ' HG22 ' A' ' 170' ' ' VAL . 18.8 t-20 -64.13 -66.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.406 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.631 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 26.7 p-90 -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.931 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.47 75.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.99 -29.46 20.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 166' ' ' ASN . 8.4 m -92.13 -35.64 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -70.23 -34.36 72.78 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.925 -0.484 . . . . 0.0 110.595 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.95 -13.39 50.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.905 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.736 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -86.22 -23.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 109.893 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.767 ' HB2' HH11 ' A' ' 95' ' ' ARG . 0.8 OUTLIER -121.07 34.29 5.26 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.012 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -65.33 -18.1 65.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.823 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.69 -4.58 76.38 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.185 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.94 -5.12 23.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 175' ' ' THR . 2.9 t -80.02 65.54 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 110.994 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.28 -10.11 58.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.95 HD11 ' HB3' ' A' ' 78' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.752 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.463 -0.279 0 CA-C-O 120.832 0.263 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.18 -162.27 0.33 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.219 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -47.64 64.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -59.07 -37.74 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.491 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.14 -36.6 61.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.989 0.424 . . . . 0.0 109.966 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.44 -42.37 71.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.249 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.9 p -63.57 -37.38 79.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.06 0.457 . . . . 0.0 109.775 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.03 -23.87 61.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.88 -63.42 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.255 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.62 -50.06 66.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.5 t -69.06 -41.14 81.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.107 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.17 -49.2 81.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.79 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 65.2 t80 -62.32 -47.17 85.45 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.594 0.358 . . . . 0.0 111.475 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -40.9 96.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.285 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -72.15 -46.9 54.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.808 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.455 HH11 ' HB1' ' A' ' 31' ' ' ALA . 18.6 ttp85 -63.5 -17.06 62.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.804 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -80.87 -36.2 31.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.71 78.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.101 0.476 . . . . 0.0 112.082 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.35 -63.12 0.41 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.449 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 1.4 t80 -90.59 50.5 1.83 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.199 0.523 . . . . 0.0 109.915 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.3 -34.16 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.161 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -22.83 63.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.666 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.29 49.83 0.85 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.614 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -65.79 126.81 29.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.524 ' HA2' ' HG3' ' A' ' 35' ' ' GLU . . . 168.36 -54.23 0.22 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.736 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.62 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 17.4 Cg_exo -68.83 -49.22 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.312 2.008 . . . . 0.0 112.21 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -90.1 31.53 5.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.521 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 mm-40 -79.14 -43.05 24.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.608 . . . . 0.0 109.758 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.92 147.17 33.18 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.892 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.7 Cg_endo -98.41 -151.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.196 2.598 . . . . 0.0 113.579 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -80.7 87.33 5.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.52 -14.09 5.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 47.7 m-20 -94.41 158.74 35.18 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.076 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 148' ' ' THR . 3.2 Cg_endo -75.17 50.7 2.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.721 2.947 . . . . 0.0 111.816 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' HD2' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -178.97 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.345 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.6 m170 -60.58 -56.57 19.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.119 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.675 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -59.37 -24.73 63.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.041 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -77.81 -51.48 10.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.45 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.6 ttm -64.72 -41.75 95.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -62.83 -31.55 72.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.665 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.16 -44.68 19.43 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.737 0.304 . . . . 0.0 110.468 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.73 -54.19 49.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.09 -49.18 50.63 Favored Glycine 0 C--O 1.213 -1.165 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.238 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -56.4 -51.61 67.72 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.841 0.456 . . . . 0.0 111.627 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -48.25 82.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB2' HG11 ' A' ' 97' ' ' VAL . 6.4 m-85 -69.97 -32.83 71.26 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.391 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.02 -27.05 68.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.706 0.765 . . . . 0.0 109.029 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -79.65 -31.94 41.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.617 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.1 mtt180 -89.84 -54.01 4.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.187 0.517 . . . . 0.0 111.376 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 68.81 10.6 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.555 0.742 . . . . 0.0 111.099 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -74.47 -26.19 59.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.955 0.407 . . . . 0.0 111.912 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -82.11 61.82 5.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.26 -31.14 4.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 111.516 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HA ' HD22 ' A' ' 64' ' ' LEU . 50.2 m-85 -72.78 -17.0 61.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.163 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.804 0.335 . . . . 0.0 111.499 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -71.97 -23.44 61.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.014 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.02 -41.82 85.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.85 -48.74 35.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.156 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.16 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.458 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.653 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 42.6 mt-30 -65.92 -58.5 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.304 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 14.1 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 30.2 t60 -79.24 -27.25 42.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.862 0.363 . . . . 0.0 110.495 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.85 -70.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.675 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -163.64 150.83 10.57 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.908 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 4.1 Cg_exo -80.49 175.8 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.052 2.502 . . . . 0.0 112.404 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.659 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 93.33 -65.11 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.852 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.39 46.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.316 0.579 . . . . 0.0 111.907 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.91 -18.41 14.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.433 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.671 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.3 pt20 -64.15 -38.54 91.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.695 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 10.2 mp0 -69.44 -36.05 76.27 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.865 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.653 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 1.5 ttt180 -67.15 -47.19 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.62 -48.94 78.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 p -60.2 -33.55 72.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 89.9 mm-40 -63.3 -57.37 10.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 110.812 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.762 HG11 ' HG ' ' A' ' 180' ' ' LEU . 4.1 m -62.73 -33.06 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.366 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -65.78 -43.41 88.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.724 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.58 -37.27 87.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.98 -30.35 63.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.628 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.649 ' HG ' HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -75.05 -35.33 61.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.806 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 91' ' ' PRO . 33.7 t80 -89.51 -13.27 37.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.567 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -33.55 -61.01 0.34 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.506 1.123 . . . . 0.0 113.891 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.2 62.81 0.49 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.163 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.79 70.53 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.944 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 87' ' ' PHE . 6.8 Cg_endo -75.87 46.95 1.82 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 111.505 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.749 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -66.29 165.23 14.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.149 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 26.9 m95 -55.33 -28.36 53.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.402 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.4 89.8 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.778 HH11 ' HB ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -85.85 -28.4 24.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.317 178.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.817 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.39 -30.9 61.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.301 0.572 . . . . 0.0 110.57 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.7 t -66.49 -56.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.818 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.34 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.119 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.817 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.8 m-85 -56.35 -58.19 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 110.473 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 9.6 m-85 -75.07 -35.45 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.228 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.79 -39.05 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -56.38 -51.86 66.74 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.7 0.286 . . . . 0.0 111.286 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.58 -41.11 44.95 Favored Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.285 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.54 88.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.347 0.573 . . . . 0.0 110.905 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.34 -40.95 70.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.74 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.32 -46.85 87.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.465 179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.727 ' HB3' HD21 ' A' ' 22' ' ' LEU . 68.9 m -62.17 -41.63 98.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.5 -54.94 37.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.14 66.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.578 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.425 ' HB2' HG22 ' A' ' 119' ' ' VAL . 67.1 m -76.74 -31.61 57.22 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 14.1 t -79.06 -23.34 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.451 0.643 . . . . 0.0 109.295 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -84.06 -5.03 59.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.189 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 13.3 mttt -125.72 -152.44 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.432 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 2.0 mt-10 -108.19 50.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.205 0.526 . . . . 0.0 110.106 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.32 56.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.445 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.5 mp0 -62.38 -52.71 64.11 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.2 Cg_exo -65.41 -25.44 56.13 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.356 2.037 . . . . 0.0 113.112 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 73' ' ' GLY . 4.5 mp -67.5 -30.68 70.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.425 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 110' ' ' SER . 91.6 t -57.61 -55.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.186 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.89 85.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.061 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.535 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.5 mt-30 -65.18 -51.42 61.2 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 118' ' ' LEU . 86.2 t -57.05 -35.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 109.867 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.16 -47.52 82.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.588 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.8 pt-20 -72.8 -37.1 67.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.085 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.671 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 42.8 m0 -58.89 -39.41 81.34 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.409 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 9.8 ttm -72.6 -53.94 10.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.852 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.97 -33.16 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.592 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.1 OUTLIER -67.26 -51.02 58.08 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.077 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 23.9 t80 -58.36 -35.69 72.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.542 0.687 . . . . 0.0 110.742 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.29 -56.05 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.559 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.75 -24.04 67.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.0 m -82.2 -43.13 18.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.93 -37.29 2.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -61.41 -48.17 82.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.229 0.468 . . . . 0.0 111.377 -178.585 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -37.54 62.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.257 0.348 . . . . 0.0 110.952 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.99 -53.53 52.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.413 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 59.4 t90 -57.31 -48.99 77.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.546 HG13 ' HE3' ' A' ' 137' ' ' TRP . 26.6 mt -57.77 -47.46 85.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.812 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -68.05 -26.93 66.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 m -96.23 -3.48 44.12 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.75 -53.16 3.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 111.724 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.97 -13.09 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.76 166.24 42.04 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.45 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 92.9 m95 -59.36 -30.24 68.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.5 81.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.1 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -62.69 -42.95 99.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.17 -34.14 77.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.504 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.923 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.57 -26.38 67.09 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.723 0.297 . . . . 0.0 110.836 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.79 -47.1 12.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.52 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -54.09 -42.67 69.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.35 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -119.19 24.91 10.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.41 -135.89 4.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.647 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.64 -45.33 59.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.189 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -82.0 52.43 4.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.608 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.11 70.18 10.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.054 0.454 . . . . 0.0 110.381 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -64.89 158.92 23.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.902 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.1 tp10 -57.01 -33.86 67.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.072 0.463 . . . . 0.0 110.82 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.9 mp0 -68.12 -38.3 82.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -75.62 -37.31 59.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 110.613 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.4 mtm180 -58.56 -53.36 59.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 7.8 ptm180 -69.11 -23.54 64.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.595 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.3 mt -71.95 -41.87 67.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.364 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -70.57 -35.86 73.29 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.111 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.95 -43.76 64.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.797 178.865 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.29 -20.27 74.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.904 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 8.3 t-20 -65.3 -63.9 0.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.684 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.829 ' HA ' HG22 ' A' ' 170' ' ' VAL . 28.1 p-90 -64.72 -22.91 67.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.777 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.15 57.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 0.0 110.591 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -16.43 33.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.9 m -101.79 -35.75 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 167' ' ' TRP . 3.0 ttp180 -78.16 -27.84 48.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 122.229 -0.294 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 m -82.8 -15.07 53.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.86 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.08 -9.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 ' HG ' ' A' ' 86' ' ' LEU . 81.5 mt -79.74 -8.59 59.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.75 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 p -57.01 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.42 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.0 -24.02 2.58 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.39 13.84 0.87 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.98 0.419 . . . . 0.0 111.154 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.25 68.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.73 0.92 42.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.022 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.762 ' HG ' HG11 ' A' ' 82' ' ' VAL . 8.9 mt . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.456 -0.711 0 CA-C-O 120.895 0.289 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.64 -160.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.674 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.19 -45.95 44.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -61.8 -33.29 73.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.569 0.223 . . . . 0.0 111.281 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.51 -34.03 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.5 tp -73.33 -41.7 63.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.05 -36.24 76.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.55 59.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.7 -66.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.607 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.73 -50.71 67.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.922 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.1 t -67.34 -42.53 87.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.255 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.27 -52.55 52.01 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.2 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.695 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.5 t80 -55.82 -46.18 78.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.992 0.517 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -66.24 -41.31 90.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.2 mp -70.16 -47.37 61.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.118 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 27.1 ttp85 -64.17 -18.83 64.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.541 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -78.86 -34.63 44.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -156.31 77.7 0.93 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 111.667 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.22 -70.12 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.732 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -87.31 52.31 2.47 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.144 0.497 . . . . 0.0 110.352 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.35 -34.09 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.078 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -39.62 93.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.06 57.48 2.11 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.449 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.71 130.97 45.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.309 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.42 -51.61 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.665 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 36.6 Cg_exo -62.05 -46.45 13.03 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.82 1.68 . . . . 0.0 111.446 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.48 38.01 3.32 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.194 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -89.01 -23.11 22.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.111 0.481 . . . . 0.0 109.965 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -98.86 142.2 15.95 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 86.8 Cg_endo -93.5 -155.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.772 2.315 . . . . 0.0 113.71 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -79.18 83.16 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.333 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.82 33.44 3.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 111.087 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.8 m-20 -139.91 165.79 28.42 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.063 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 148' ' ' THR . 60.5 Cg_endo -81.54 49.39 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.266 2.644 . . . . 0.0 111.8 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.68 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.85 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.0 m170 -60.47 -57.52 12.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.698 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 3.8 mt-30 -59.32 -25.99 64.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.751 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.9 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.07 -52.59 10.66 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.184 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.0 ttm -66.53 -38.53 87.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.88 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.92 -38.29 85.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.885 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 -42.25 29.19 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.415 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.784 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.28 -56.73 18.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.96 -48.06 46.6 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.643 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.01 -47.6 84.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.056 0.428 . . . . 0.0 110.994 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -45.67 91.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.835 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.34 -34.91 70.95 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -24.43 67.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.532 0.682 . . . . 0.0 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -95.45 -18.59 20.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -98.67 -38.37 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.848 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.99 104.03 15.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.528 0.68 . . . . 0.0 110.467 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 58' ' ' ARG . 9.9 mtt180 -87.81 -0.19 56.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.501 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -125.48 58.07 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.863 0.363 . . . . 0.0 111.18 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 0.55 10.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.936 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.878 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.9 m-85 -118.65 -28.75 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.716 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -31.56 72.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.653 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -72.8 -20.06 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.878 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.25 -40.5 70.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.28 -43.62 50.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.59 -43.01 71.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.886 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' NE2' HD22 ' A' ' 180' ' ' LEU . 41.3 mt-30 -64.66 -56.92 10.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.005 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.85 12.25 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 3.4 t-80 -77.7 -24.86 49.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.05 0.452 . . . . 0.0 109.96 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -76.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -160.65 145.47 10.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 9.5 Cg_exo -71.46 174.88 10.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.825 2.35 . . . . 0.0 111.722 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.742 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 85.84 -57.81 4.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.249 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.14 50.83 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 111.346 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.6 -25.05 9.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -64.79 -32.78 74.63 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.307 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -72.38 -35.0 68.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.06 0.457 . . . . 0.0 109.885 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 11.7 mtt-85 -70.19 -44.53 68.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.41 -48.61 78.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -57.92 -34.55 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.248 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -59.75 -63.03 1.45 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 110.501 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 ' HG ' ' A' ' 180' ' ' LEU . 10.8 m -59.31 -31.85 47.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.775 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -66.51 -41.96 88.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 109.982 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -38.71 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.857 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -70.27 -31.99 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -35.69 44.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.955 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -88.83 -4.19 58.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.0 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.55 -43.2 11.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.03 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.88 63.09 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.56 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.06 54.36 0.02 OUTLIER Glycine 0 CA--C 1.524 0.595 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.752 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 28.0 Cg_endo -80.65 42.07 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.964 1.776 . . . . 0.0 111.785 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -69.36 161.12 30.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.407 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.495 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 14.2 m95 -54.33 -26.89 32.3 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -40.69 96.99 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.622 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.0 mmp_? -87.49 -22.22 25.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.281 . . . . 0.0 110.786 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.806 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -55.5 -31.38 61.98 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.407 0.622 . . . . 0.0 110.151 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.9 t -61.43 -53.97 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.678 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.59 -29.0 70.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.315 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.806 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.4 m-85 -56.87 -56.56 20.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.016 0.436 . . . . 0.0 110.078 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -76.52 -36.53 57.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.362 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 t -61.8 -36.44 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -56.31 -55.71 30.09 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 111.321 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.3 59.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.367 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.64 99.1 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.344 0.572 . . . . 0.0 110.709 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.8 -40.61 75.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.751 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.12 -47.14 81.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.442 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 22' ' ' LEU . 87.9 m -61.98 -44.64 96.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.787 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.43 69.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.417 . . . . 0.0 111.363 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.633 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -82.73 -23.41 34.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -27.95 40.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.951 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 53.8 t -69.8 -37.03 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 12.6 p30 -84.82 1.68 45.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -121.42 -152.79 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.483 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 6.1 mt-10 -108.68 47.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.538 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -136.81 39.13 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.419 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -57.82 -51.0 84.97 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.109 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.7 Cg_exo -63.92 -12.01 29.86 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.169 1.913 . . . . 0.0 112.908 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.742 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.7 mp -85.05 -24.05 28.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.012 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.41 -54.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.93 72.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.129 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 74.5 mt-30 -67.84 -53.47 26.53 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 54.8 t -56.02 -34.81 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 0.0 109.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.47 -46.49 85.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.47 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 16.6 pt-20 -73.69 -38.01 65.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.952 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.8 m0 -58.39 -38.95 78.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.713 0.768 . . . . 0.0 109.091 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.2 ttp -72.58 -55.2 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.988 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.3 p -62.89 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.554 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 2.9 tt0 -67.78 -53.32 28.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.155 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -59.36 -33.28 70.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.377 0.608 . . . . 0.0 110.746 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.95 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.35 -56.43 5.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.153 -178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.52 -29.05 68.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 m -84.62 -36.53 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -125.51 -44.88 1.82 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.95 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -59.12 -46.9 87.13 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.37 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.77 65.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.263 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.44 -48.36 73.02 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.196 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.6 t90 -58.31 -50.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -56.19 -48.91 78.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.405 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -60.73 -34.17 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.754 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 m -86.3 -16.15 38.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.15 -58.81 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.405 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -174.94 -5.3 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 86.1 171.65 48.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.955 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -62.48 -26.48 68.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.2 -35.99 82.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.443 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.405 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.5 tt0 -63.52 -44.02 95.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.495 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 12.9 t80 -64.86 -36.43 84.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.684 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.9 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 m -66.34 -27.18 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.201 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.34 25.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.684 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -72.05 -42.65 66.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.338 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -118.65 25.43 10.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.931 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -109.48 -143.09 9.89 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.12 -22.4 28.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.263 0.554 . . . . 0.0 110.567 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -95.14 33.26 5.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.615 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.56 70.62 4.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.666 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -63.5 170.55 3.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.163 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.18 -35.84 60.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.241 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 40.2 mt-10 -68.12 -40.27 82.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.759 0.314 . . . . 0.0 110.706 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.68 -36.66 76.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 163' ' ' ARG . 7.4 mtm180 -60.28 -56.62 19.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.3 -23.81 65.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -70.75 -47.92 57.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.229 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 3.5 ptt85 -66.94 -36.76 82.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.309 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 1.7 mt-10 -70.26 -44.21 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.298 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.84 75.1 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 170' ' ' VAL . 9.7 t-20 -59.94 -66.13 0.57 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.577 -0.812 . . . . 0.0 111.111 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 32.2 p-90 -61.56 -27.8 68.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.342 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.38 -41.32 69.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 110.79 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -30.1 20.27 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 92' ' ' ASN . 2.7 m -92.18 -36.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -66.22 -29.47 69.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.927 0.394 . . . . 0.0 110.596 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -15.16 29.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.848 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.814 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.4 p -86.11 -25.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.557 . . . . 0.0 110.365 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.9 OUTLIER -120.66 32.95 5.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.016 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.71 70.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.409 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.35 48.23 3.77 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.277 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -111.36 15.53 21.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.489 0.661 . . . . 0.0 109.272 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.17 67.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.271 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -100.8 10.4 41.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.914 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.739 ' HG ' HG11 ' A' ' 82' ' ' VAL . 19.1 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.683 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 6.6 Cg_exo . . . . . 0 CA--C 1.531 0.331 0 CA-C-O 120.833 0.264 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.3 -151.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -45.09 72.58 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.267 0.627 . . . . 0.0 112.682 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -36.25 79.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.727 0.298 . . . . 0.0 111.133 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . . . -76.55 -35.68 58.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 110.057 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.69 -40.21 66.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.0 p -65.69 -39.2 84.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.074 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.29 60.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.504 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -59.31 2.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.185 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.669 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.3 t80 -57.13 -53.91 52.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.749 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.6 t -66.62 -40.18 85.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.36 -51.3 59.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.011 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.787 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.4 t80 -63.2 -41.7 99.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.711 0.291 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.63 -40.77 97.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.649 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.4 mp -73.36 -42.7 61.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 8.2 ttp85 -65.69 -15.52 62.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.272 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.03 -35.29 25.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.04 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -158.16 79.4 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.553 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.58 -70.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.665 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -88.84 58.98 4.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.13 0.49 . . . . 0.0 110.537 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.48 -29.82 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.036 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -42.87 78.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.577 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.35 59.37 3.79 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.076 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.6 127.34 32.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.26 -54.51 0.36 Allowed Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.793 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.569 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 45.0 Cg_exo -58.53 -42.92 49.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.026 1.818 . . . . 0.0 111.407 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.94 37.65 3.65 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.478 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.84 -6.91 53.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.139 0.495 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.28 144.9 15.84 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.78 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 88.2 Cg_endo -96.06 -150.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.995 2.463 . . . . 0.0 113.118 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -88.59 86.48 7.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.62 1.93 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 55.0 m-20 -107.03 160.4 26.48 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -78.27 41.12 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.23 2.62 . . . . 0.0 111.991 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.44 -28.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.932 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.7 m170 -59.02 -56.5 21.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.848 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.491 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.67 -27.06 67.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.99 -49.58 36.0 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.421 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.9 OUTLIER -67.8 -31.57 71.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -40.99 97.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.45 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -23.27 43.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 109.851 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.808 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -70.27 -63.88 1.0 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.099 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.35 -48.41 41.08 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.864 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -42.65 79.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.089 0.471 . . . . 0.0 111.262 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -62.88 -44.32 96.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -75.64 -29.33 59.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.919 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.18 -24.09 66.57 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -40.48 10.15 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.634 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -88.96 -54.36 4.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -85.3 68.64 10.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.75 0.42 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -75.93 -22.99 55.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.358 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.19 37.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.035 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -120.79 -5.01 9.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.863 ' HA ' HD22 ' A' ' 64' ' ' LEU . 4.9 m-85 -93.6 -31.05 14.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.891 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.18 67.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.831 0.348 . . . . 0.0 111.425 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 2.0 m-20 -77.79 -18.02 56.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.892 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.863 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -72.83 -39.63 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.36 -46.0 35.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.979 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.87 -42.87 63.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.955 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 47.8 mt-30 -67.8 -61.61 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.656 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -79.61 13.33 2.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 47.0 t60 -79.13 -26.45 42.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -74.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.998 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -159.84 142.77 10.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.075 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.8 Cg_exo -75.6 -175.34 2.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.009 2.473 . . . . 0.0 112.069 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.713 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.74 -65.81 2.94 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.027 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.24 41.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.833 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -97.11 -21.17 17.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.663 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 8.3 pt20 -63.83 -37.97 89.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.607 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 4.4 mm100 -68.95 -35.22 76.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.32 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.49 -48.15 61.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.14 0.495 . . . . 0.0 109.769 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.53 -47.62 84.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.068 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -58.66 -34.98 71.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.429 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 73.4 mm-40 -60.23 -56.63 19.25 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.177 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.3 t -59.0 -37.86 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.081 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.2 m -62.47 -46.37 88.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.551 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.8 OUTLIER -69.46 -36.32 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 33.4 mm-40 -67.53 -32.87 73.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.872 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' HA ' HD13 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -77.17 -36.73 54.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.23 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' HB2' ' HE2' ' A' ' 129' ' ' TYR . 55.2 t80 -85.21 -5.61 59.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -53.79 -37.09 63.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.563 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.46 59.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.813 -1.184 . . . . 0.0 113.384 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.625 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 167.27 49.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.605 -1.284 . . . . 0.0 115.17 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -80.7 38.98 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 119.913 1.856 . . . . 0.0 111.715 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.761 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -70.15 162.61 27.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.529 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 15.1 m95 -53.22 -27.86 24.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.03 -43.49 97.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -85.65 -23.15 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.675 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.765 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.35 -30.85 61.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 110.036 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.808 HG22 ' HB1' ' A' ' 49' ' ' ALA . 41.2 t -60.93 -56.3 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.41 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' A' ' 53' ' ' PHE . . . -62.93 -28.44 70.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.406 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.765 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.45 -51.84 66.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.201 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.8 m-85 -81.53 -35.05 30.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 15.2 t -63.75 -34.53 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.758 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -54.23 -59.08 5.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 111.496 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -69.78 -35.91 74.02 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.226 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.19 90.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.2 0.5 . . . . 0.0 110.602 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.19 -39.1 82.59 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.7 -45.3 94.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.759 ' HB3' HD21 ' A' ' 22' ' ' LEU . 82.5 m -64.14 -41.69 97.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.86 -53.7 52.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.293 . . . . 0.0 111.041 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -19.95 65.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -78.71 -33.78 46.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.594 0.235 . . . . 0.0 110.716 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 32.1 t -74.52 -25.88 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.481 0.658 . . . . 0.0 109.669 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.55 1.42 45.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.147 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -133.93 -169.78 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.649 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.78 57.84 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 110.025 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.485 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.54 46.44 2.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.716 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.53 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.4 mp0 -62.47 -54.25 50.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 26.3 Cg_exo -63.58 -20.19 68.95 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.077 1.852 . . . . 0.0 112.864 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -71.98 -29.49 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.62 -51.25 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.03 -31.5 80.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.608 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 23.8 mm-40 -68.06 -49.82 59.01 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 118' ' ' LEU . 42.0 t -58.72 -33.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -63.33 -46.49 86.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 12.2 pt-20 -71.55 -40.44 69.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.702 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.663 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 32.3 m0 -57.99 -39.98 79.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.555 0.693 . . . . 0.0 109.337 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.408 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.4 ttp -73.56 -53.0 11.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.956 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -63.66 -31.87 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.92 -50.52 41.29 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.068 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 7.0 t80 -58.92 -33.15 70.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 110.983 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.009 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.15 -52.27 9.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.89 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -35.32 79.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 m -81.15 -39.22 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.72 -41.33 2.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.009 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -63.36 -47.09 83.59 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.545 -178.501 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.58 -34.53 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.275 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.4 -50.0 67.16 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.219 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.761 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 45.6 t90 -59.08 -49.05 79.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 14.8 mt -56.92 -48.41 81.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.074 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -65.59 -30.52 71.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.2 m -83.55 -30.37 27.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -57.69 4.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -170.83 -10.86 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.559 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 92.3 170.24 40.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.626 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.7 m95 -62.84 -30.77 71.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.75 72.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.204 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -65.44 -41.12 93.82 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.707 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 8.2 t80 -65.85 -39.04 90.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.514 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.738 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.78 -25.73 67.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.024 0.44 . . . . 0.0 110.815 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.4 -28.04 23.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.083 0.468 . . . . 0.0 109.849 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.712 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.15 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.27 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -134.3 30.26 3.58 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.62 -111.03 3.56 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 119.84 -1.172 . . . . 0.0 112.862 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.6 -67.27 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.041 0.448 . . . . 0.0 110.973 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.94 69.88 1.86 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.553 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.54 71.38 9.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 110.343 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.1 165.04 14.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.039 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -58.91 -36.27 74.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.1 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.621 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -68.63 -38.96 80.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.344 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.712 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.98 -40.14 75.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -68.04 -49.55 60.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 157' ' ' GLU . 9.7 ptm180 -62.3 -28.57 69.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 110.385 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -67.42 -42.32 83.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.833 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.619 HH22 ' HA ' ' A' ' 49' ' ' ALA . 5.2 ttp180 -67.08 -44.04 81.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.23 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.648 ' HG3' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.11 -47.29 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.41 -23.63 75.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.739 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 2.9 t-20 -74.43 -54.53 7.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.532 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.976 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.7 p-90 -64.25 -24.29 67.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.055 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -51.36 -52.97 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.215 0.322 . . . . 0.0 110.811 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -27.72 22.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.976 HG22 ' HA ' ' A' ' 167' ' ' TRP . 25.0 m -80.02 -25.98 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.273 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.4 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.7 ttp180 -83.13 -15.11 52.04 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.809 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -96.22 -39.16 9.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 13.2 p -59.39 -33.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.403 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -115.7 44.5 1.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.634 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.16 -43.08 92.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.294 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.21 41.42 1.32 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.724 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.554 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -100.77 -4.24 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.264 0.554 . . . . 0.0 109.878 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.41 67.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.397 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.35 8.2 45.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.446 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 102' ' ' PHE . 8.7 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.532 0.382 0 CA-C-O 121.047 0.353 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -156.65 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.42 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.22 72.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -42.8 99.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.15 -35.03 66.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.654 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.6 tp -72.91 -42.18 63.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.486 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.8 p -66.47 -37.42 79.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.0 -21.05 61.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' CE1' ' A' ' 43' ' ' HIS . 1.2 t70 -77.81 -68.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 t80 -52.3 -50.33 62.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.206 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 19.3 t -75.93 -39.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.935 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' ALA . . . -61.22 -53.69 42.53 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.527 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.735 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 85.9 t80 -60.8 -45.47 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.029 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -61.04 -47.73 85.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -67.93 -47.85 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 29.6 ttp85 -58.75 -30.95 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.554 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -86.63 -12.03 49.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -156.47 63.09 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.46 -71.21 0.33 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.73 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -82.2 56.62 3.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.15 0.5 . . . . 0.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 t -78.31 -32.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 m -66.27 -35.38 80.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.774 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.23 51.62 2.46 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.639 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 116.16 9.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.746 0.308 . . . . 0.0 110.668 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.22 -51.05 0.13 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.599 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.7 -48.46 2.12 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.187 1.925 . . . . 0.0 111.667 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.735 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -89.47 27.48 7.76 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.94 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.25 -58.54 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.604 0.716 . . . . 0.0 109.388 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.94 139.22 30.91 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.699 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -90.53 -133.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.722 2.281 . . . . 0.0 113.567 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -83.63 92.02 7.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.452 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.84 10.63 5.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.489 0.661 . . . . 0.0 109.576 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.8 m-20 -121.11 160.51 44.95 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.365 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -81.36 37.03 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.246 2.631 . . . . 0.0 112.4 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -165.61 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.414 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 16' ' ' ASP . 2.5 m170 -56.21 -56.98 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.586 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 9.1 tt0 -57.67 -23.4 51.23 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.557 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.948 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -82.52 -49.62 9.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.434 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 4.5 ttm -66.42 -42.14 88.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -30.74 71.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.498 0.19 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.87 33.57 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.78 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.51 -55.76 30.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.097 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.98 -44.75 41.57 Favored Glycine 0 C--O 1.217 -0.93 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.613 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.01 -54.14 50.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.453 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -43.43 97.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.965 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.88 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.87 -30.24 62.53 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.495 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.97 -30.35 71.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.78 0.8 . . . . 0.0 108.864 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.1 m -79.54 -33.69 41.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.297 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 56' ' ' ARG . 19.0 mtt180 -89.56 -52.12 5.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.174 0.512 . . . . 0.0 111.716 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.27 64.13 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.303 0.641 . . . . 0.0 110.958 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -18.29 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.768 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.59 58.43 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -51.07 2.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 111.746 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 5.1 m-85 -62.17 -19.73 63.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -38.79 66.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.835 0.35 . . . . 0.0 111.311 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 3.3 m-20 -67.03 -28.41 68.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.491 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.1 mt -61.19 -43.63 98.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.338 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.8 -40.49 47.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.02 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.52 63.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.699 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.497 ' CD ' ' HG ' ' A' ' 180' ' ' LEU . 44.0 mt-30 -67.64 -54.73 17.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.255 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -84.38 17.52 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.9 t60 -78.17 -30.28 49.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.635 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -91.5 -65.25 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.635 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -162.3 145.95 9.15 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 122.138 0.175 . . . . 0.0 110.708 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.9 Cg_exo -76.45 172.18 16.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.818 2.345 . . . . 0.0 111.355 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.92 -60.99 1.13 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.625 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.17 50.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.418 0.628 . . . . 0.0 110.93 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.76 -22.12 13.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.684 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 7.4 pt20 -64.32 -39.94 94.91 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.509 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.82 -47.71 82.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.998 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -47.66 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.81 -50.02 75.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.774 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' THR . . . . . 0.411 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 18.5 p -60.61 -30.01 69.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -68.01 -53.11 28.34 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.002 0.43 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 180' ' ' LEU . 34.2 m -65.77 -32.3 57.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.089 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 80' ' ' THR . 1.3 p -69.13 -39.94 78.59 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.892 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -46.5 82.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.239 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -68.87 -25.03 64.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -79.82 -26.15 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.501 . . . . 0.0 109.952 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -97.37 -4.24 38.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.395 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -39.04 -50.47 1.81 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.542 0.737 . . . . 0.0 112.378 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.3 48.99 0.16 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.901 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.12 56.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.221 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.6 Cg_endo -77.8 45.78 1.87 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.21 1.94 . . . . 0.0 111.817 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.8 162.92 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.598 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 17.6 m95 -54.01 -28.85 40.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.639 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.86 -40.78 98.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.204 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.607 ' HE ' ' HA ' ' A' ' 171' ' ' ARG . 6.9 mmt180 -86.35 -21.56 27.16 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.812 -0.228 . . . . 0.0 110.551 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.774 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -57.66 -30.62 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.346 0.593 . . . . 0.0 110.132 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.5 t -62.9 -55.16 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -61.61 -29.06 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.053 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.774 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 3.6 m-85 -56.42 -54.21 48.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.082 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.524 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 6.6 m-85 -79.03 -36.33 41.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.02 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 t -59.99 -38.45 76.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -57.41 -50.0 74.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.71 0.291 . . . . 0.0 111.613 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.68 -37.65 34.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.261 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.63 98.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.245 0.523 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -69.22 -38.88 78.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.549 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -60.31 -44.9 95.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.749 ' HB3' HD21 ' A' ' 22' ' ' LEU . 86.6 m -64.06 -41.01 97.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.172 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.25 -54.7 40.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -17.72 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.516 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB2' HG22 ' A' ' 119' ' ' VAL . 74.2 m -77.97 -31.0 50.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.6 t -80.95 -13.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.905 0.859 . . . . 0.0 109.163 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -85.02 0.07 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -144.64 -170.38 3.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.519 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.84 55.59 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 110.034 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.85 29.69 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.513 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -53.51 -51.07 79.29 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 116' ' ' GLU . 19.1 Cg_endo -59.84 -23.19 71.39 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.238 1.959 . . . . 0.0 113.243 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 mm? -76.04 -26.68 56.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.591 0.234 . . . . 0.0 110.777 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 110' ' ' SER . 88.9 t -59.25 -54.3 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.193 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.29 71.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.446 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 9.0 mm-40 -69.45 -49.77 51.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 46.1 t -58.52 -35.16 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.15 -50.38 73.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.359 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.666 ' HA ' HG12 ' A' ' 127' ' ' VAL . 10.7 pt-20 -69.27 -39.78 78.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.684 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.9 m0 -57.3 -40.93 78.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.391 0.615 . . . . 0.0 109.524 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.532 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.04 -44.53 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.376 -178.323 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.0 p -71.45 -31.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.741 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.57 -48.14 61.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -59.34 -35.16 73.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.692 . . . . 0.0 110.473 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.926 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.39 -53.19 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.908 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -62.36 -28.78 70.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.9 m -85.1 -36.11 21.37 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -128.14 -40.77 1.64 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.926 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.67 -45.83 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.129 0.422 . . . . 0.0 111.325 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.04 61.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.356 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -65.71 -53.96 33.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 47.8 t90 -57.12 -47.31 81.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.471 HG13 ' HE3' ' A' ' 137' ' ' TRP . 8.3 mt -57.02 -49.18 80.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -65.1 -32.71 74.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.97 -4.41 58.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -99.31 -50.71 4.03 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.871 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.462 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -176.35 -19.97 0.02 OUTLIER Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.81 168.36 35.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.434 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 89.3 m95 -60.14 -31.15 69.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.3 75.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.012 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.462 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.8 tt0 -65.74 -38.15 88.34 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.35 -38.94 81.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.747 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.948 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -61.91 -33.84 74.96 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.686 0.279 . . . . 0.0 111.401 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.78 32.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.813 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -61.74 -44.65 96.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.084 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -111.27 16.45 20.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -108.24 -137.88 8.34 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.9 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -29.66 26.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 111.217 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.84 37.9 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.092 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.13 68.81 9.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.5 OUTLIER -67.46 176.78 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.206 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -53.54 -38.42 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -68.47 -46.56 69.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.91 73.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -56.78 9.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.009 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -65.36 -34.1 77.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.351 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.0 OUTLIER -67.86 -31.47 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.652 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 150' ' ' LEU . 6.2 mtp180 -70.14 -51.59 30.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 12.8 mt-10 -67.57 -38.63 84.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.36 76.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.122 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.6 t-20 -69.4 -71.39 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.545 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 164' ' ' GLU . 35.8 p-90 -58.36 -25.4 61.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.854 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.56 -63.14 1.25 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 110.883 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.75 -23.4 24.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 8.3 t -77.99 -39.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 111.682 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.607 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 16.2 ttp180 -74.15 -24.1 59.36 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.091 -0.381 . . . . 0.0 110.699 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.732 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -84.24 -27.75 27.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.659 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 174' ' ' LEU . 0.7 OUTLIER -68.27 -22.98 27.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.983 0.421 . . . . 0.0 110.497 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.567 ' HG ' ' CG1' ' A' ' 173' ' ' VAL . 0.4 OUTLIER -120.38 38.49 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.634 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.37 -23.24 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.297 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 6.86 67.91 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.465 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.652 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -80.08 7.03 9.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.83 65.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.27 0.557 . . . . 0.0 110.713 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -102.48 13.67 33.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.19 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.846 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.974 0.322 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.83 -172.04 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.81 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -28.04 50.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 111.929 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.78 -39.98 88.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 110.093 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -34.3 62.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.606 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.1 tp -72.82 -41.58 64.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.2 p -64.98 -36.96 79.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.71 62.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -66.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.0 t80 -54.21 -52.07 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.07 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.8 t -65.5 -42.02 92.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.462 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.97 -51.83 56.09 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.18 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.758 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 42.8 t80 -58.32 -45.45 88.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.009 0.524 . . . . 0.0 111.292 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -64.52 -47.87 77.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.301 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -65.23 -46.71 79.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 12.6 ttp85 -62.84 -20.42 65.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.87 -31.16 23.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.798 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.32 71.97 1.14 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.163 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.16 -69.83 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.756 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.114 0.483 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.42 -33.94 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -37.9 89.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.29 52.42 1.37 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.716 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -65.47 141.7 58.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.51 -45.71 0.53 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.111 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 11.5 Cg_exo -73.37 -47.62 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.138 1.892 . . . . 0.0 111.869 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.95 27.22 7.54 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.216 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 19.9 mm-40 -80.57 -41.96 23.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.504 0.652 . . . . 0.0 109.403 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.3 142.66 46.2 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.006 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -93.49 -166.27 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.784 2.323 . . . . 0.0 113.806 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.22 85.51 7.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.392 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.04 -23.44 4.96 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 4.2 m-20 -79.32 160.28 70.79 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.472 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' HG21 ' A' ' 148' ' ' THR . 27.8 Cg_endo -77.61 50.16 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.279 2.653 . . . . 0.0 111.568 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -178.96 -31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.287 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.68 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.8 m170 -60.42 -59.58 5.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.963 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.932 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -57.54 -27.1 62.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.732 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.88 -52.78 15.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.423 ' HE1' HD21 ' A' ' 13' ' ' LEU . 2.9 ttm -65.58 -38.3 89.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.639 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -38.63 80.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.402 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.67 45.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.22 0.533 . . . . 0.0 110.107 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.877 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -63.73 -63.21 1.23 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.48 -47.41 36.25 Favored Glycine 0 C--O 1.215 -1.038 0 O-C-N 124.137 0.898 . . . . 0.0 112.502 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -51.74 -51.62 54.84 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.855 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.06 -46.9 79.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -68.88 -35.7 77.19 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.74 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.27 -32.77 73.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 109.468 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -85.35 -18.24 34.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.606 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.06 -65.62 1.03 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.097 0.475 . . . . 0.0 111.861 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.8 67.63 8.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.243 0.617 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.26 -8.95 59.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.952 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 40.9 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -120.35 0.06 10.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.766 ' HA ' HD22 ' A' ' 64' ' ' LEU . 30.3 m-85 -89.65 -17.11 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.172 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -41.05 93.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.7 m-20 -63.18 -27.2 69.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.821 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -63.74 -42.55 97.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.722 0.773 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.51 -44.05 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.409 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -42.24 63.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.441 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.01 -52.44 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.326 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.34 19.91 3.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t60 -79.34 -35.3 41.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.234 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -91.42 -68.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.275 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.7 145.66 8.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.416 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.45 -178.01 4.16 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.623 2.215 . . . . 0.0 112.185 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.718 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.28 -71.3 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.879 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.68 44.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.97 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.15 -19.25 18.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.947 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 8.0 pt20 -63.78 -36.22 83.17 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.728 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -70.43 -38.73 74.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.398 . . . . 0.0 110.164 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -68.13 -44.47 76.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.946 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.45 -45.84 91.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.92 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -60.2 -33.5 72.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.195 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -61.63 -60.14 4.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.759 0.314 . . . . 0.0 111.109 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.8 p -58.61 -36.57 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -65.59 -41.97 92.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.091 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -43.3 81.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -70.21 -21.21 63.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -84.42 -34.88 23.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 110.291 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -85.43 -7.64 58.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.484 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.48 -50.54 2.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.019 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.3 56.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.861 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.31 51.28 0.05 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.599 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 13.3 Cg_endo -80.44 40.81 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.149 1.9 . . . . 0.0 111.842 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.819 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.9 OUTLIER -70.35 166.12 20.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.684 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 30.6 m95 -53.19 -30.32 36.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.437 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.49 99.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.283 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -87.12 -25.76 23.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.839 -0.181 . . . . 0.0 110.931 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.77 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.74 -31.86 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.45 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 53' ' ' PHE . 16.4 t -62.65 -56.12 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.6 -28.38 69.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.77 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.9 m-85 -55.73 -54.59 42.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.198 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.2 m-85 -78.27 -35.13 48.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.223 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 t -62.66 -36.36 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -55.2 -55.68 28.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.466 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.89 56.1 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.41 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.135 0.468 . . . . 0.0 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.07 -39.33 72.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.0 -49.92 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.672 ' HB3' HD21 ' A' ' 22' ' ' LEU . 79.8 m -60.17 -40.13 88.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.097 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.53 30.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.1 -15.96 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 119' ' ' VAL . 66.8 m -77.88 -29.02 50.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 107' ' ' CYS . 16.9 t -82.1 -17.01 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.685 0.755 . . . . 0.0 109.057 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -79.69 -8.57 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.892 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -166.16 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.511 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.25 67.64 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.02 0.438 . . . . 0.0 110.036 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.401 ' O ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -140.95 37.23 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.223 -179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 3.3 mp0 -57.9 -51.7 79.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 34.1 Cg_exo -58.53 -30.73 92.69 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.044 1.829 . . . . 0.0 112.32 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -71.35 -30.95 66.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 111' ' ' VAL . 73.4 t -57.68 -52.02 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.77 -31.73 79.18 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.9 mm-40 -66.05 -50.7 63.24 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 96.3 t -56.56 -36.46 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.02 -48.32 80.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.488 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.1 pt-20 -72.46 -36.42 68.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.195 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.644 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.7 m0 -58.16 -39.77 79.71 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.8 ttp -72.89 -53.4 11.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.581 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.4 p -60.45 -32.54 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.783 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -67.12 -54.7 18.9 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.061 0.458 . . . . 0.0 110.24 179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.78 -30.2 67.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.902 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.38 -52.9 8.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.526 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.29 77.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.8 m -80.83 -33.86 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 -46.31 1.95 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.902 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.31 -42.1 90.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.645 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.28 64.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.05 -51.17 60.62 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.819 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 69.8 t90 -57.81 -47.5 82.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -58.23 -47.53 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.555 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -63.52 -25.59 68.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 111.567 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -100.37 -5.64 26.96 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -122.17 44.76 2.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.722 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.33 -65.97 0.89 Allowed Glycine 0 CA--C 1.506 -0.484 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.25 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 123.59 173.45 13.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.906 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 98.5 m95 -56.04 -36.75 68.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.04 77.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.52 -43.01 98.41 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.877 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 13.7 t80 -67.48 -31.63 71.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.699 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -69.47 -25.0 63.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.155 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.57 -34.4 19.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.779 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -56.21 -51.81 66.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.929 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.423 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.7 m-85 -130.35 31.76 4.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -98.52 -134.85 8.58 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.177 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.26 -53.42 44.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 110.334 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.477 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.61 64.06 1.87 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.708 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.24 73.3 7.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.391 0.615 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -59.22 153.39 18.53 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.114 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 2.6 mm-40 -56.66 -27.64 59.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.099 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -73.37 -42.39 62.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 110.643 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -66.89 -37.56 84.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.271 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 160' ' ' ARG . 25.4 mtm-85 -65.64 -52.81 48.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.24 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 17.8 ptt180 -63.65 -31.36 72.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -65.74 -39.33 90.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.818 HH22 ' HA ' ' A' ' 49' ' ' ALA . 2.5 ttp180 -68.13 -43.65 77.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 29.2 mt-10 -62.44 -47.38 84.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.398 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.8 -23.76 75.66 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.953 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -74.04 -52.25 13.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.759 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.9 p-90 -65.28 -24.3 67.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.855 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.23 77.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.341 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -31.26 20.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 167' ' ' TRP . 27.4 m -89.51 -37.04 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -68.77 -30.91 69.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.804 -0.56 . . . . 0.0 110.939 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.29 -37.47 21.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.663 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -66.35 -27.08 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.952 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.7 OUTLIER -115.8 32.94 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.323 0.582 . . . . 0.0 109.875 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.8 -9.99 59.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.107 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.55 15.03 62.4 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.703 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.38 6.53 36.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.569 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.61 71.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.531 0.682 . . . . 0.0 109.979 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.44 8.08 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.483 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.656 0.265 . . . . 0.0 110.849 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 CA--C 1.53 0.305 0 N-CA-C 112.953 0.328 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 -160.25 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -43.19 66.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -61.18 -38.23 85.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.292 . . . . 0.0 111.213 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.72 -34.91 60.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.1 0.476 . . . . 0.0 110.137 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -72.28 -42.86 65.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.3 p -65.98 -35.8 75.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.21 61.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.333 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -66.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.5 t80 -55.08 -53.78 51.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.968 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.4 t -67.16 -37.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.221 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.68 -51.79 53.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.059 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 1.1 t80 -63.32 -47.06 83.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.44 0.296 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 1.9 tmtm? -57.84 -37.3 73.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 111.222 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -78.44 -47.34 17.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.533 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.747 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -59.35 -27.16 65.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.853 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 14.0 pt20 -85.65 -11.09 54.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.16 -56.19 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.53 -57.43 0.66 Allowed Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.665 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -78.32 46.06 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 122.782 0.433 . . . . 0.0 111.101 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.1 -31.95 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.001 0.429 . . . . 0.0 110.222 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -39.04 83.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.39 0.614 . . . . 0.0 109.356 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.61 58.43 3.75 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.575 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.747 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.26 109.76 1.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.474 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -172.56 -57.46 0.05 OUTLIER Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 35.8 Cg_exo -62.33 -50.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.235 1.956 . . . . 0.0 111.482 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -85.94 27.23 5.55 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.404 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -77.4 -31.15 53.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.079 0.466 . . . . 0.0 109.891 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.43 124.82 8.05 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 92.7 Cg_endo -87.5 -150.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.591 2.194 . . . . 0.0 113.657 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -78.22 82.81 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.78 26.82 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.439 . . . . 0.0 110.627 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 9.7 m-20 -135.76 161.63 61.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.098 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 47.1 Cg_endo -78.83 50.78 3.57 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.274 2.649 . . . . 0.0 112.279 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER 179.82 -32.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.579 179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.7 m170 -60.02 -56.49 21.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 2.5 mt-30 -61.27 -25.19 66.93 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.637 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -72.82 -50.45 24.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.966 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.6 ttm -66.88 -37.37 84.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.667 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -60.93 -40.66 94.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.53 -29.38 56.72 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 110.054 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -66.19 -62.15 1.64 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.39 -45.97 28.77 Favored Glycine 0 C--O 1.216 -0.981 0 O-C-N 124.224 0.953 . . . . 0.0 112.572 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.6 -53.82 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.51 -45.87 81.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.837 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -65.16 -38.56 90.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.27 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.65 -36.53 78.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.621 . . . . 0.0 109.967 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -83.2 -12.78 56.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.352 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.88 -24.88 12.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.78 92.22 8.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.49 -31.32 70.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.421 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -119.65 79.11 1.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -120.81 -7.59 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.889 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.88 -29.62 4.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -32.84 71.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -71.58 -20.59 61.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.925 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.889 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.06 -41.06 71.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -74.34 -42.26 59.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.46 -43.31 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.785 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.491 ' NE2' HD22 ' A' ' 180' ' ' LEU . 40.8 mt-30 -63.42 -52.78 60.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.464 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.21 7.43 22.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.267 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 4.2 t60 -78.85 -23.27 45.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -68.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.391 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -164.67 143.12 5.55 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.1 Cg_exo -81.05 -175.96 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.412 2.741 . . . . 0.0 111.897 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 80.9 -62.3 4.44 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.82 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.83 28.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.472 . . . . 0.0 111.897 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -81.4 -23.43 37.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.662 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 12.4 pt20 -59.91 -40.83 90.16 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.927 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.28 -49.07 77.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.115 0.259 . . . . 0.0 110.757 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -59.76 -43.56 94.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.966 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.81 -52.26 64.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.646 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.59 -33.6 66.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -61.92 -51.66 67.23 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.306 0.574 . . . . 0.0 109.988 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG13 ' HB1' ' A' ' 177' ' ' ALA . 31.2 t -64.51 -35.82 75.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.711 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.998 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.84 -34.21 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.377 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.5 mm-40 -65.99 -30.41 70.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.53 . . . . 0.0 109.948 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.1 mp -78.38 -36.92 45.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.21 -2.03 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.731 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -36.9 61.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.475 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.8 59.69 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.898 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.582 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.31 53.36 0.02 OUTLIER Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.835 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 14.2 Cg_endo -81.37 36.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.325 2.017 . . . . 0.0 111.551 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.77 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -68.47 163.9 22.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.907 -178.772 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m95 -53.67 -27.73 29.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.53 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.32 98.48 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER -86.61 -23.83 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.69 -0.255 . . . . 0.0 110.918 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -54.25 -32.07 55.13 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.381 0.61 . . . . 0.0 110.488 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.1 t -61.95 -54.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.571 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -62.11 -30.69 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.247 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.1 m-85 -55.5 -51.82 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -82.48 -32.72 28.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.412 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.95 -34.0 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.813 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.33 -60.05 3.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.63 61.42 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.206 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.21 83.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.157 0.479 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -72.92 -42.49 63.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.785 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.03 -51.85 67.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.603 179.272 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.655 ' HB3' HD21 ' A' ' 22' ' ' LEU . 87.1 m -60.55 -43.8 96.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.22 67.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.811 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -78.63 -25.63 45.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG22 ' A' ' 119' ' ' VAL . 50.6 m -78.25 -37.02 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.676 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.9 t -66.51 -32.96 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.207 -0.308 . . . . 0.0 111.523 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -30.99 43.15 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.411 -0.516 . . . . 0.0 112.253 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.15 113.99 2.74 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 115' ' ' MET . 23.0 mt-10 65.35 143.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 7.5 mtm 76.86 126.47 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.772 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 1.7 tt0 -120.53 -58.11 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.425 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.34 -29.23 88.4 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.218 1.946 . . . . 0.0 113.09 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -60.0 -31.65 70.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.597 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 110' ' ' SER . 89.3 t -60.86 -51.22 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.85 -30.48 72.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.461 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -64.83 -52.57 56.0 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.542 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 89.0 t -55.6 -37.55 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.025 0.44 . . . . 0.0 109.915 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -61.69 -47.04 87.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.643 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.67 ' HA ' HG12 ' A' ' 127' ' ' VAL . 23.2 pt-20 -74.1 -35.88 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.662 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.0 m0 -56.24 -37.98 70.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.2 mtp -73.34 -56.45 5.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.462 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.4 p -60.64 -32.83 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.7 -47.6 62.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.185 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.5 t80 -61.45 -36.14 79.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.545 0.688 . . . . 0.0 110.421 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.007 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.47 -55.57 7.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.196 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.95 -32.75 72.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.1 m -78.68 -40.78 32.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -41.05 1.88 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -60.53 -48.3 82.39 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.337 0.517 . . . . 0.0 111.709 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -35.9 41.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.238 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.75 -51.92 65.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.373 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.77 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.0 t90 -58.65 -47.58 83.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.602 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.7 mt -57.44 -48.05 83.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.389 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.97 -26.45 65.04 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.666 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -92.04 -9.08 44.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.13 -53.8 3.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.91 -15.64 0.02 OUTLIER Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.423 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.63 168.75 36.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.6 m95 -63.46 -30.26 71.41 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.58 75.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.741 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.417 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -64.27 -42.8 96.28 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.704 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 11.1 t80 -66.2 -33.93 76.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.631 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -68.25 -27.07 66.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.706 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.78 -26.5 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.123 0.487 . . . . 0.0 109.936 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.64 -50.78 65.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.39 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.5 m-85 -133.05 33.24 3.67 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.991 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -102.05 -137.28 9.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.98 -39.31 79.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.166 0.507 . . . . 0.0 110.716 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -102.47 53.98 0.75 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.766 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.88 76.13 3.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.331 0.586 . . . . 0.0 110.288 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.761 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -64.37 162.59 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.24 -32.98 64.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.242 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.761 ' HB2' HD12 ' A' ' 156' ' ' LEU . 45.8 mt-10 -74.06 -35.31 64.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.716 0.294 . . . . 0.0 111.291 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -71.04 -39.18 72.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 mtm-85 -62.18 -56.36 19.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.735 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.43 -33.13 73.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -64.18 -42.64 96.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.68 HH22 ' HA ' ' A' ' 49' ' ' ALA . 3.2 ttp180 -68.2 -41.19 81.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.994 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.716 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -64.92 -40.99 95.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.43 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.75 -31.22 67.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.963 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.5 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -67.03 -55.65 13.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.214 -0.493 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.772 ' HA ' HG22 ' A' ' 170' ' ' VAL . 12.0 p-90 -61.98 -28.94 69.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.193 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.54 -42.88 79.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 110.75 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.86 -30.56 20.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.3 m -87.03 -29.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.531 ' HD2' ' HZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -77.12 -34.72 56.63 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.804 -0.56 . . . . 0.0 110.153 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 -8.78 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.045 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.9 p -85.19 -26.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.26 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -121.35 43.22 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.139 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -22.61 62.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.765 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.82 8.48 49.72 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.339 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.424 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -78.17 -0.29 27.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.7 69.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.344 0.592 . . . . 0.0 110.546 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -103.56 16.11 27.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.12 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.491 HD22 ' NE2' ' A' ' 67' ' ' GLN . 35.4 mt . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.805 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 CA--C 1.527 0.16 0 CA-C-O 121.177 0.407 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.63 -167.17 1.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.578 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.55 75.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -39.47 93.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.679 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.43 69.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.007 0.432 . . . . 0.0 110.018 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.3 tp -70.66 -43.14 69.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.84 -34.9 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.011 0.434 . . . . 0.0 110.009 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.19 60.94 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.448 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -66.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.917 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.671 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -55.08 -50.73 68.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . 44.2 t -72.59 -39.01 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.665 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.8 -55.92 25.7 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.271 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.702 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 13.0 t80 -56.45 -44.77 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.856 0.462 . . . . 0.0 110.798 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.42 -45.58 90.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.525 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.3 mp -68.7 -43.3 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 24.3 ttp85 -66.76 -15.31 63.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.597 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -84.14 -38.61 20.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.71 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.04 79.9 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.765 0.317 . . . . 0.0 111.841 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.14 -66.33 0.38 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.911 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -96.68 55.57 1.41 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.306 0.574 . . . . 0.0 110.333 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.04 -27.75 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.977 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -41.07 78.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 58.69 4.02 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.772 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.26 118.13 10.22 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.81 -54.16 0.16 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.348 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.8 Cg_exo -60.55 -46.94 15.26 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 121.936 1.757 . . . . 0.0 111.021 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.702 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -97.93 36.76 3.77 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.218 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -18.24 43.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.26 140.78 16.34 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 83.2 Cg_endo -94.58 -141.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.98 2.454 . . . . 0.0 113.283 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -76.29 86.96 3.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.359 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.69 20.8 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.067 0.461 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 3.8 m-20 -131.69 161.67 60.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.938 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.31 45.51 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.253 2.635 . . . . 0.0 111.964 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -174.27 -30.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.13 179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.8 m170 -57.84 -57.13 14.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.819 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 25.1 tt0 -58.58 -26.81 64.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.872 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.45 -50.71 17.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.381 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 13' ' ' LEU . 3.7 ttm -67.11 -41.72 85.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.613 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -62.87 -33.76 75.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.759 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.23 -41.87 27.26 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.234 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -60.59 -55.66 30.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.649 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.671 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.3 -46.55 57.23 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.742 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.64 -49.0 79.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 111.502 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -65.17 -46.29 81.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.38 0.61 . . . . 0.0 110.257 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.458 ' HB2' HG11 ' A' ' 97' ' ' VAL . 45.7 t80 -63.34 -40.46 97.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.635 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.25 -33.03 70.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.341 0.591 . . . . 0.0 109.973 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 m -78.02 -24.8 47.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.278 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -98.71 -18.86 17.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.26 93.74 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.926 0.393 . . . . 0.0 111.409 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -61.22 -46.64 89.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.25 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.844 HH21 HG11 ' A' ' 178' ' ' VAL . 3.2 mtm-85 -91.17 86.71 6.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.106 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -57.08 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.001 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.913 ' HA ' HD22 ' A' ' 64' ' ' LEU . 7.8 m-85 -90.96 0.98 57.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 59' ' ' ARG . 2.1 p -70.17 -56.49 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 111.33 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -63.92 -23.52 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.169 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 ' HA ' ' A' ' 61' ' ' PHE . 1.8 mp -64.69 -43.24 94.17 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.86 -41.6 29.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.503 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -36.47 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.879 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.751 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 48.0 mt-30 -75.32 -58.86 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.033 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.472 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -76.6 9.17 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -177.512 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.581 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.8 t60 -79.01 -18.42 53.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.957 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.34 -77.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -160.1 144.57 10.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.306 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 5.4 Cg_exo -74.84 162.96 36.54 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.811 2.341 . . . . 0.0 112.04 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.48 -64.06 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.643 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.57 42.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.259 0.552 . . . . 0.0 111.867 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.59 -23.23 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.69 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.9 pt20 -60.86 -41.89 96.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 1.1 mt-30 -63.45 -39.68 95.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.76 0.314 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.751 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 56.0 mtt-85 -68.24 -43.56 77.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.986 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -62.98 -47.96 80.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -58.45 -31.28 67.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.332 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.0 mm100 -63.77 -65.43 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' HB1' ' A' ' 177' ' ' ALA . 4.8 p -54.93 -36.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.3 m -65.81 -46.62 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.821 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.657 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.1 -37.73 86.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.163 0.506 . . . . 0.0 109.862 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 4.9 mt-10 -68.55 -25.92 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.557 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 1.8 mp -78.96 -38.31 37.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.549 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -84.9 -6.54 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.386 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mt-30 -47.06 -43.16 19.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.309 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.16 56.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.529 -1.32 . . . . 0.0 113.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.512 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 158.43 57.66 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.643 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.675 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 19.1 Cg_endo -78.77 42.18 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.127 1.885 . . . . 0.0 111.54 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 4.1 t-20 -66.48 161.31 23.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.508 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.5 m95 -55.44 -27.17 46.36 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.53 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HD3' ' HG2' ' A' ' 171' ' ' ARG . 2.3 tpt180 -86.61 -22.96 25.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.754 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -31.45 63.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 109.945 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.2 t -62.55 -50.3 80.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.307 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.44 -32.49 73.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.754 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.6 m-85 -55.01 -53.89 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.267 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.8 m-85 -78.55 -37.58 42.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.24 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.16 -37.67 74.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.349 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.1 -51.19 68.77 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.91 -39.19 33.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.055 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.26 -42.57 86.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.122 0.461 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.91 -43.78 64.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.774 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.3 -48.18 77.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.614 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.811 ' HB3' HD21 ' A' ' 22' ' ' LEU . 54.7 m -61.08 -43.34 99.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.678 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.64 -36.92 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 111.114 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.513 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 3.5 tt0 -81.35 -25.08 36.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -79.03 -28.95 43.31 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.051 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 107' ' ' CYS . 59.7 t -70.4 -36.39 66.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -84.35 0.83 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -124.89 -170.78 2.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.226 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -89.52 55.35 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.37 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.472 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.32 36.87 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.066 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.9 mp0 -56.13 -53.79 59.73 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.21 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.43 -26.96 83.94 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.05 1.833 . . . . 0.0 112.614 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.801 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.4 mp -70.64 -25.82 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.62 -52.74 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.67 87.87 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.728 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 6.5 mm100 -62.61 -53.97 46.66 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.504 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 92.7 t -56.46 -37.12 49.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.941 0.401 . . . . 0.0 110.166 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -61.84 -47.45 84.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.807 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.833 ' HA ' HG12 ' A' ' 127' ' ' VAL . 9.7 pt-20 -74.81 -35.63 62.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.035 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.69 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.4 m0 -57.55 -37.55 73.28 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 27.6 ttm -74.9 -53.35 9.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.601 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.833 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -61.93 -33.31 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.51 -48.41 55.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.207 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.4 t80 -57.81 -37.96 74.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.28 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.938 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.91 -53.34 13.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.086 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.33 -29.29 69.79 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 m -84.62 -37.15 21.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -126.08 -43.39 1.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.852 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.938 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.6 mm? -59.67 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.081 0.401 . . . . 0.0 111.678 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.47 -36.62 55.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 123.237 0.336 . . . . 0.0 111.199 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -63.13 -52.63 61.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 63.1 t90 -57.78 -48.27 80.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.247 0.546 . . . . 0.0 109.545 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.556 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.6 mt -57.77 -46.64 86.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.322 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -65.83 -31.12 71.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.695 0.283 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -85.29 -24.84 27.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -56.37 4.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.17 -10.05 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.43 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.69 167.18 40.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.958 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.517 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 97.6 m95 -60.9 -26.46 67.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.25 -32.53 73.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.756 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -40.68 93.73 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.409 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 11.0 t80 -65.84 -36.58 83.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.405 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.872 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -64.32 -31.52 72.76 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.192 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.65 -19.01 31.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.357 0.599 . . . . 0.0 110.105 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 163' ' ' ARG . 9.1 mt -79.92 -40.65 27.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.146 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 1.6 m-85 -125.53 28.95 6.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -118.86 -146.7 8.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.668 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -32.77 61.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -91.76 40.31 2.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.106 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.13 77.17 8.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -62.37 162.02 10.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.857 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.88 -31.3 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' HD12 ' A' ' 156' ' ' LEU . 17.9 mt-10 -72.15 -42.37 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -66.14 -39.59 89.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.54 -52.07 66.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -71.11 -21.73 62.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -75.27 -48.52 22.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.451 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -65.32 -43.61 90.46 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.66 -42.81 90.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.456 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.19 -28.93 72.29 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.473 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 m-20 -66.53 -56.07 12.54 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.252 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.698 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 13.6 p-90 -63.04 -26.12 68.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.016 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.023 0.44 . . . . 0.0 110.325 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.6 m -87.13 -32.2 20.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.698 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 19.0 m -88.66 -33.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG2' ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -73.85 -29.74 62.29 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.656 -0.653 . . . . 0.0 110.541 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.605 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 1.8 m -85.33 -33.87 21.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.673 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.653 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.7 p -65.89 -31.29 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.653 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -110.66 33.12 4.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.087 0.47 . . . . 0.0 110.395 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 172' ' ' THR . 8.4 m -67.68 -32.82 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.124 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.83 50.31 3.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.085 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.449 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -118.01 13.24 13.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.844 HG11 HH21 ' A' ' 59' ' ' ARG . 2.1 t -83.34 61.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.573 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.93 56.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.391 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--O 1.232 0.216 0 CA-C-O 121.081 0.367 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -170.89 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.917 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -37.15 68.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.819 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.05 -35.71 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.722 0.296 . . . . 0.0 110.563 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.2 -36.47 58.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.695 ' HB2' HD13 ' A' ' 42' ' ' LEU . 8.0 tp -70.3 -41.78 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.987 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.27 -34.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.08 -20.84 60.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.453 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -64.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 3.9 t80 -56.21 -52.66 63.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.38 -37.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.227 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.22 -52.59 48.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.253 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.691 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -62.29 -44.58 96.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 2.7 mmtt -62.36 -41.46 98.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -73.28 -43.86 60.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -57.56 -33.85 68.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.558 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 24' ' ' GLN . 1.1 pt20 -86.61 -8.61 57.34 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -121.19 -58.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.92 -48.24 0.5 Allowed Glycine 0 C--O 1.23 -0.149 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.854 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 2.4 t80 -81.44 49.44 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.21 0.528 . . . . 0.0 110.963 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.44 -27.55 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -42.6 72.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 58.98 3.8 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.029 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -62.1 115.64 4.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 179.55 -53.88 0.09 OUTLIER Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.356 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 32.7 Cg_exo -60.55 -50.19 7.35 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.836 1.69 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.06 30.29 5.18 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.438 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -65.69 -38.59 89.66 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.067 0.434 . . . . 0.0 110.981 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . -110.69 132.96 11.27 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.9 Cg_endo -89.31 -143.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.505 2.137 . . . . 0.0 113.785 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -67.42 106.92 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.022 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.59 -33.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 0.0 111.406 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.2 m-20 -79.2 163.49 59.47 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.373 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 29.6 Cg_endo -77.83 48.7 2.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.378 2.718 . . . . 0.0 111.549 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.998 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.3 m170 -62.29 -58.21 8.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.85 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.682 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.97 -28.18 66.07 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.349 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.08 -55.03 11.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.77 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.617 ' HE2' HD11 ' A' ' 13' ' ' LEU . 2.7 tpp -67.4 -36.7 81.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.807 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 3.8 ttp180 -61.92 -37.57 85.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.891 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.6 23.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.793 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.26 -53.74 54.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.84 -48.51 44.48 Favored Glycine 0 C--O 1.215 -1.08 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.25 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.13 -49.6 75.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.87 -44.08 97.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.06 -33.42 65.65 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.986 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.47 -26.65 68.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.0 109.267 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 m -88.61 -25.61 22.35 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.556 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -99.83 -55.25 2.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 111.952 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.57 73.43 10.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.92 0.488 . . . . 0.0 110.567 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 58' ' ' ARG . 3.1 mpt_? -73.82 -18.49 60.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.011 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -79.35 58.55 2.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.45 . . . . 0.0 111.259 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.07 -48.95 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.056 ' HA ' HD22 ' A' ' 64' ' ' LEU . 86.0 m-85 -64.17 -28.28 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.197 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -34.29 76.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -74.54 -18.47 60.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.964 0.411 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.056 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -73.01 -39.05 66.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.16 -48.02 25.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.28 -43.64 61.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.902 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.498 ' NE2' HD22 ' A' ' 180' ' ' LEU . 45.8 mt-30 -69.54 -58.12 4.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.702 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.7 OUTLIER -82.02 16.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.778 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -78.17 -33.78 50.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 71' ' ' THR . 2.2 p -92.26 -67.9 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.342 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.669 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -163.43 154.95 14.68 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.36 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.935 2.423 . . . . 0.0 112.108 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.25 -78.73 1.89 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.41 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.94 47.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.357 0.599 . . . . 0.0 112.209 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.29 -18.21 22.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.262 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 13.2 pt20 -61.86 -38.35 87.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.6 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.474 ' H ' ' HG2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -66.7 -40.44 88.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.533 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 180' ' ' LEU . 17.5 mtt180 -67.22 -45.8 75.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.0 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.17 -49.76 76.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.853 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 p -57.6 -34.56 69.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -60.55 -57.74 11.44 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 ' HG ' ' A' ' 180' ' ' LEU . 31.3 t -58.65 -38.44 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.877 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -65.73 -46.08 80.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.48 -36.82 81.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.789 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 24.8 mt-10 -72.98 -23.57 60.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.395 . . . . 0.0 110.582 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -81.74 -37.69 26.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.659 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -83.93 -8.23 59.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.574 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -42.01 14.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.095 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.19 48.38 0.13 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.723 -1.227 . . . . 0.0 113.13 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.451 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.12 53.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.442 -1.361 . . . . 0.0 114.747 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.2 Cg_endo -80.09 41.36 1.11 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.12 1.88 . . . . 0.0 111.441 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.776 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.34 163.95 23.97 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.618 -178.822 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.584 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.5 m95 -54.2 -29.05 44.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.61 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.22 -37.74 95.37 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -87.68 -24.89 23.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.703 178.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -54.96 -31.52 60.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.7 t -62.89 -52.95 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.472 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.18 72.27 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.331 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.2 m-85 -56.55 -54.6 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.037 0.446 . . . . 0.0 110.231 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.472 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 15.3 m-85 -74.94 -39.48 61.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.002 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.39 -36.76 75.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.254 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -53.18 -59.77 4.13 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.821 0.343 . . . . 0.0 111.562 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.57 -38.67 78.89 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.28 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.8 94.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.192 0.496 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.33 -41.24 73.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.747 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.42 -47.37 84.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.403 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.674 ' HB3' HD21 ' A' ' 22' ' ' LEU . 60.6 m -65.18 -45.39 85.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.206 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.05 70.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.772 0.32 . . . . 0.0 111.601 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.6 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -85.05 -8.77 58.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.683 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -89.92 -29.03 18.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.791 0.329 . . . . 0.0 110.16 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' CYS . 51.9 t -68.65 -32.42 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.6 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 14.5 p30 -85.32 0.96 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 0.0 111.151 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -125.72 -170.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.395 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.21 53.24 2.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.029 0.443 . . . . 0.0 110.633 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.439 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.16 46.44 2.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.408 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.73 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 15.5 mp0 -64.17 -56.19 25.8 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.424 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.1 Cg_exo -64.31 -26.52 63.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.051 1.834 . . . . 0.0 112.614 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 12.4 tp -66.4 -29.11 69.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.3 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.24 -52.54 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.284 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.42 -32.27 83.59 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.296 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 19.1 mm100 -65.95 -52.33 50.71 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.492 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 48.6 t -58.28 -35.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.009 0.433 . . . . 0.0 109.91 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.19 -47.02 86.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.26 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.688 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.0 pt-20 -72.69 -39.63 66.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.934 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 38.9 m0 -55.75 -37.81 68.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.3 ttm -74.11 -53.67 9.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.638 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.6 p -62.81 -34.07 63.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.62 -46.3 66.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 10.0 t80 -61.51 -35.1 76.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.582 0.706 . . . . 0.0 110.123 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.006 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.93 -56.6 5.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.132 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.84 -31.76 72.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.8 m -82.9 -36.86 24.96 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.86 -42.5 1.9 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.006 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -60.85 -46.31 91.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.371 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.21 54.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.444 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.08 -54.95 22.14 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.776 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.7 t90 -56.66 -48.3 77.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.527 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -57.36 -47.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.569 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -68.27 -30.11 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -89.09 -9.02 52.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.52 -57.07 2.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.0 111.609 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.97 -13.3 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.6 168.4 39.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.117 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.468 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.9 m95 -61.75 -29.47 70.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.43 80.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.14 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -63.6 -47.49 81.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 109.55 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.525 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 15.7 t80 -63.27 -38.25 90.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.078 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.736 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 7.5 m -65.98 -27.24 68.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 111.282 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.73 -34.92 27.08 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.655 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -66.15 -39.95 90.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.615 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -116.47 20.39 14.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -107.13 -140.33 9.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.444 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.21 -34.67 23.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.16 42.23 2.98 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.022 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.23 68.19 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.985 0.422 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.575 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.89 173.23 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.272 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -49.84 -39.3 38.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -179.575 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mm-40 -63.56 -52.3 61.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.38 -38.78 88.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -59.65 -57.1 14.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -67.8 -29.24 68.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.684 0.278 . . . . 0.0 111.581 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 4.3 tp -69.02 -46.68 67.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.47 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.8 ptt180 -68.87 -37.2 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.357 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.575 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 3.9 mt-10 -70.67 -43.2 69.58 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.141 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.7 -14.17 72.37 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.3 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 15.4 t-20 -73.25 -65.46 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.017 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.61 ' HE3' ' HD3' ' A' ' 171' ' ' ARG . 48.0 p-90 -61.54 -24.7 66.81 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.576 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.35 -64.11 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.116 0.26 . . . . 0.0 110.734 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -21.46 25.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 2.1 t -81.01 -36.32 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HD3' ' HE3' ' A' ' 167' ' ' TRP . 0.9 OUTLIER -82.87 -13.35 56.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.516 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.907 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.1 p -88.49 -31.62 18.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.76 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.749 HG13 ' HG ' ' A' ' 174' ' ' LEU . 5.7 p -67.07 -24.51 32.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.476 0.655 . . . . 0.0 110.136 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.749 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.81 42.91 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.231 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.907 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.6 OUTLIER -69.28 -43.23 74.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.912 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.62 27.19 1.89 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -89.69 2.07 55.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.225 0.513 . . . . 0.0 111.046 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' VAL . . . . . 0.443 HG12 ' OD2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -80.02 68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.925 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.03 9.65 32.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.785 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.54 ' HG ' HG21 ' A' ' 82' ' ' VAL . 12.4 mt . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.914 0.388 . . . . 0.0 110.509 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.53 0.321 0 CA-C-O 121.285 0.452 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.11 -164.48 1.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.617 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -37.93 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.204 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -62.1 -35.4 78.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.93 -36.13 49.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.0 109.886 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.4 tp -70.44 -43.28 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.657 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -65.87 -35.35 74.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.23 -22.59 61.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.7 -64.24 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.569 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.8 t80 -54.95 -52.71 62.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.829 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . 46.5 t -72.29 -40.0 64.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.32 -54.3 37.39 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.847 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.768 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 48.9 t80 -62.8 -39.69 95.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 0.186 . . . . 0.0 111.271 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.46 -42.99 98.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.645 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -70.42 -44.79 67.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.618 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.825 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -62.47 -20.69 64.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.058 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.641 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.93 -35.38 26.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.47 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.641 ' HD3' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -151.08 76.25 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.96 0.409 . . . . 0.0 112.025 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.67 -70.43 0.3 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.123 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -90.26 56.43 3.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.389 0.614 . . . . 0.0 109.537 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.21 -34.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.757 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -41.65 72.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.386 0.612 . . . . 0.0 109.605 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.45 56.71 4.9 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.913 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.825 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.83 120.99 13.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 172.31 -58.36 0.16 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.173 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.517 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.4 Cg_exo -60.35 -48.45 11.6 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.785 1.657 . . . . 0.0 111.014 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.768 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.91 40.04 2.71 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.898 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 10.1 pt-20 -93.76 -8.09 41.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.77 164.49 12.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.724 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -99.31 -164.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.606 2.871 . . . . 0.0 113.191 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -89.01 73.11 8.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.931 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.11 34.01 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.099 0.476 . . . . 0.0 111.589 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 5.4 m-20 -130.11 161.1 62.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.408 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 6.8 Cg_exo -70.76 28.77 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.912 3.075 . . . . 0.0 113.055 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -166.78 -23.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.0 m170 -55.52 -64.78 0.74 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -58.4 -23.9 58.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.536 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.37 -46.5 40.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 15.2 ttm -72.25 -39.78 68.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.819 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -60.81 -36.14 78.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.569 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -31.34 42.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 109.98 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -65.19 -56.7 11.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.62 -48.47 42.95 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.61 -46.45 80.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.479 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -46.23 91.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.838 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.61 -31.78 65.43 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.871 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.86 -24.9 67.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.651 0.738 . . . . 0.0 109.211 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -89.38 -36.54 15.43 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.913 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -84.44 -64.43 1.16 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.93 72.01 8.98 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.843 0.857 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -82.8 -0.03 45.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.04 23.82 4.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.245 -0.284 . . . . 0.0 111.361 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.53 -1.24 30.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.758 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.4 m-85 -92.6 -19.77 21.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.63 80.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.755 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 3.2 m-20 -62.76 -22.86 66.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.102 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.758 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -68.69 -39.62 80.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.064 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -79.56 -44.72 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.141 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.66 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.386 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.456 ' NE2' HD22 ' A' ' 180' ' ' LEU . 45.7 mt-30 -73.16 -53.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -83.26 14.74 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.32 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 82.6 t60 -77.98 -32.64 51.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.266 0.555 . . . . 0.0 109.631 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -73.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.195 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.35 153.74 16.91 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.512 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -86.64 -167.27 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.199 2.599 . . . . 0.0 111.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.78 -63.41 4.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.998 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.99 24.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.088 0.471 . . . . 0.0 111.85 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -80.23 -23.32 40.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.622 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.599 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 1.8 pt20 -62.01 -43.42 98.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.618 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -62.15 -42.43 99.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -63.23 -44.98 93.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.88 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.84 -50.78 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.496 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 p -56.1 -33.68 65.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.419 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -60.27 -66.58 0.5 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.0 m -56.52 -32.73 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.681 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.1 m -65.85 -43.82 87.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.353 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.57 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.8 -37.02 73.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 109.694 179.098 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -29.05 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.884 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -80.84 -31.79 35.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.309 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 91' ' ' PRO . 37.3 t80 -93.27 1.89 56.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -24.99 36.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.256 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 60.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.344 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.25 59.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.607 -1.282 . . . . 0.0 114.648 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -82.78 39.06 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.275 1.983 . . . . 0.0 111.642 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.833 ' HB2' HG11 ' A' ' 170' ' ' VAL . 3.3 t-20 -66.86 164.36 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.606 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -54.49 -27.15 35.84 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.235 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.34 -38.62 95.2 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.649 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.7 mmp_? -87.53 -26.61 23.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.974 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.61 -31.57 57.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.421 0.629 . . . . 0.0 109.969 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 49' ' ' ALA . 22.0 t -62.09 -55.87 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.82 -29.22 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.47 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.816 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -55.79 -54.65 41.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.095 0.474 . . . . 0.0 110.191 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.657 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.5 m-85 -77.83 -35.54 51.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -60.73 -39.86 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.4 m-85 -55.11 -51.11 67.43 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.23 -38.77 38.53 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.138 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.33 99.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.131 0.465 . . . . 0.0 110.927 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -37.91 74.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.571 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.29 -44.48 97.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.156 179.151 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 94.8 m -63.92 -45.79 87.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.284 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.96 64.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.726 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -77.34 -12.25 59.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.806 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -88.53 -24.96 22.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.941 0.401 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 107' ' ' CYS . 57.4 t -75.64 -35.77 32.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.622 HD21 ' HA ' ' A' ' 109' ' ' GLU . 22.8 p30 -81.44 0.56 37.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.408 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.48 -167.51 1.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -91.27 62.66 4.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.471 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.577 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.66 37.75 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.946 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.3 mp0 -55.84 -55.86 36.47 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.307 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.7 Cg_exo -65.02 -18.55 62.37 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.082 1.855 . . . . 0.0 112.341 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.2 mm? -74.77 -35.22 62.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 107' ' ' CYS . 90.3 t -54.91 -57.72 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.491 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.51 79.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.965 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 5.5 mm-40 -66.35 -49.78 65.75 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 118' ' ' LEU . 59.8 t -57.35 -36.12 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.24 -45.61 92.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.4 pt-20 -76.2 -36.86 58.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.114 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.599 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 39.4 m0 -56.69 -38.62 72.51 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.6 ttm -72.85 -54.94 7.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.685 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.5 p -60.97 -32.49 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.9 -50.41 56.38 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.306 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 13.3 t80 -58.74 -35.21 72.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.642 0.734 . . . . 0.0 110.284 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.038 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.93 -48.5 30.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.956 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.04 -42.22 84.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 m -80.78 -40.57 24.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -42.1 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -63.2 -46.71 85.77 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.418 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.85 55.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.613 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.66 -53.06 30.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.571 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.806 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 55.6 t90 -55.3 -47.51 75.46 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.263 0.554 . . . . 0.0 109.567 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.6 HG13 ' HE3' ' A' ' 137' ' ' TRP . 4.3 mt -57.85 -49.17 81.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.402 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -60.62 -39.69 89.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m -78.0 -26.89 48.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -56.04 5.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.28 -15.75 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.655 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.32 170.85 41.1 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.183 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.82 -26.09 67.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.24 -33.91 77.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.449 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -66.74 -38.71 87.18 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.79 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.5 t80 -65.79 -38.88 90.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.659 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.73 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -67.46 -27.69 67.24 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.8 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.96 -18.06 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.094 0.474 . . . . 0.0 110.349 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -75.78 -49.42 18.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.673 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.45 31.51 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -93.3 -113.85 2.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.359 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.43 -62.94 1.43 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.14 0.495 . . . . 0.0 109.691 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.7 64.11 4.34 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.348 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.74 74.99 7.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.54 153.81 22.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.153 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.661 ' HA ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -57.99 -27.36 63.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.753 -179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.679 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.2 mm-40 -73.83 -32.43 63.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -78.33 -41.56 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -66.61 -37.89 85.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.579 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 158' ' ' GLU . 9.8 ptp85 -72.65 -29.11 63.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.088 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -38.3 81.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.716 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.665 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.3 ttp180 -65.89 -41.9 90.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.585 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -61.62 -48.25 81.76 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.346 0.404 . . . . 0.0 110.295 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.13 -28.52 73.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.408 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.06 -58.66 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.253 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.657 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.2 p-90 -62.08 -27.42 68.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.416 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.17 76.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.446 . . . . 0.0 110.344 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.21 -28.73 20.98 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.833 HG11 ' HB2' ' A' ' 92' ' ' ASN . 8.1 m -95.3 -36.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.604 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -81.34 -15.71 54.54 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.46 -0.775 . . . . 0.0 111.138 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 m -96.08 -17.04 21.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.156 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 1.012 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -81.2 -26.5 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.529 0.68 . . . . 0.0 109.521 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 1.012 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -120.88 39.54 3.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.692 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -30.49 71.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.15 1.93 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.541 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -99.42 6.54 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.56 60.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.99 -11.14 60.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.277 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 121.049 0.354 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -163.32 0.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.652 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.53 -38.59 69.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.959 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -63.12 -35.47 80.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.294 . . . . 0.0 110.729 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.99 60.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.208 0.528 . . . . 0.0 109.756 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -71.91 -42.73 66.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.056 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.4 p -65.11 -36.0 76.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.131 0.491 . . . . 0.0 109.703 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.25 -21.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.375 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 -63.95 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.903 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.505 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.45 -54.04 46.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.51 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.0 t -67.75 -39.55 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -59.47 -54.71 35.5 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.246 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.677 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 34.5 t80 -61.86 -43.21 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.563 0.345 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 12.7 mmtt -61.13 -40.27 93.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -79.16 -46.65 17.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.078 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 39.6 ttp85 -63.75 -17.25 62.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.397 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -85.02 -24.05 28.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.971 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -160.1 76.14 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.81 -68.78 0.37 Allowed Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.271 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.59 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 2.0 t80 -84.85 52.08 2.32 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.008 0.523 . . . . 0.0 109.785 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.63 -40.05 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.59 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -40.42 96.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.409 0.623 . . . . 0.0 109.626 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.25 52.06 4.04 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.043 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.69 124.49 22.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 35' ' ' GLU . . . 176.92 -54.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.603 -1.284 . . . . 0.0 113.637 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 13.0 Cg_exo -72.26 -49.88 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.406 2.071 . . . . 0.0 112.284 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -86.04 28.12 5.22 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.774 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' CA ' ' A' ' 32' ' ' GLY . 3.1 mt-10 -88.04 -26.22 22.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.387 0.613 . . . . 0.0 110.241 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.3 147.86 23.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.301 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -94.79 -155.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.062 2.508 . . . . 0.0 112.833 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.628 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -88.82 85.94 6.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.524 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.29 21.93 5.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 110.333 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.5 m-20 -125.58 159.35 61.1 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.29 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 61.2 Cg_endo -81.32 47.2 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 111.576 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -177.94 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.515 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -57.25 -62.11 2.0 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.735 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.628 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 44.4 tt0 -55.8 -30.84 62.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.56 -51.49 28.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.999 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.1 ttm -67.9 -41.83 82.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -61.77 -35.18 77.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.89 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.46 -41.31 27.84 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.614 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.791 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.49 -54.25 48.74 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.72 -47.24 58.76 Favored Glycine 0 C--O 1.219 -0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.441 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.43 -46.83 87.63 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE2' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -62.95 -45.2 93.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.743 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.858 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -72.57 -33.0 66.46 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.143 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.87 -26.7 68.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 109.706 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -87.43 -29.21 21.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.479 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 6.5 mtp180 -91.68 -46.34 7.97 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.69 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.16 86.68 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.19 0.596 . . . . 0.0 110.207 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -68.52 -23.45 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -86.06 65.97 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.72 -38.12 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.507 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HA ' HD22 ' A' ' 64' ' ' LEU . 42.1 m-85 -91.15 -3.4 57.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 -47.47 55.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.313 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -59.84 -32.11 70.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.469 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 4.8 mp -56.84 -44.89 82.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.589 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -80.46 -42.2 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.6 -41.82 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.258 179.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.683 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.8 mt-30 -79.31 -53.47 6.91 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -82.37 13.1 3.79 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.708 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.658 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 2.0 p-80 -79.6 -25.87 41.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.458 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -71.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.04 151.66 16.52 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.387 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.79 -177.52 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.065 2.51 . . . . 0.0 111.599 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.721 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.27 -71.5 2.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.972 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 45.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.226 0.536 . . . . 0.0 112.026 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.17 -21.1 16.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.682 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -63.77 -40.25 96.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.795 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 18.2 mp0 -63.79 -44.4 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.176 0.297 . . . . 0.0 111.104 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 42.8 mtt180 -65.52 -38.21 89.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.04 0.448 . . . . 0.0 110.033 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t80 -66.17 -51.25 59.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.421 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -56.66 -35.39 68.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 38.4 mm-40 -59.88 -54.66 43.56 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 180' ' ' LEU . 9.9 m -66.89 -32.15 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.097 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 m -66.2 -46.8 76.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.755 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -67.2 -35.62 79.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 110.323 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.49 -27.03 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.259 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -28.15 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.694 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -95.24 -6.4 41.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.07 -50.18 6.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.429 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.56 66.35 0.22 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.4 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.471 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 150.48 62.05 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.677 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.5 Cg_endo -81.74 41.66 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.49 2.127 . . . . 0.0 111.582 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.792 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.2 t-20 -66.71 164.3 17.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' O ' HG23 ' A' ' 97' ' ' VAL . 20.4 m95 -53.88 -29.15 40.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -64.84 -36.05 92.64 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.721 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.3 mmp_? -87.23 -27.18 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.447 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -55.93 -30.55 61.83 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.941 179.388 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 53' ' ' PHE . 18.0 t -63.84 -55.04 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.525 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.22 -29.74 70.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.927 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 7.8 m-85 -57.01 -59.87 4.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.094 0.474 . . . . 0.0 110.354 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.579 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -72.88 -37.91 67.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.348 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.16 -38.76 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.303 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -59.27 -46.17 89.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.379 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.97 -40.32 17.3 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.064 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.92 96.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.37 80.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.838 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -57.99 -45.45 86.77 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.645 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.689 ' HB3' HD21 ' A' ' 22' ' ' LEU . 88.6 m -59.55 -41.73 90.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.74 76.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.968 0.413 . . . . 0.0 110.825 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -78.27 -24.25 46.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.767 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -24.62 41.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.953 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 107' ' ' CYS . 50.6 t -72.07 -37.57 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.976 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 1.4 p-10 -85.78 -0.06 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.335 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -123.66 -173.53 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.903 0.382 . . . . 0.0 110.935 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.8 53.31 2.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.81 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.518 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.23 48.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.484 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -60.24 -54.99 49.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.52 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 16.9 Cg_exo -68.71 -12.81 35.6 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.147 1.898 . . . . 0.0 112.96 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.721 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -78.77 -27.97 44.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.183 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.56 -57.44 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 111.365 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.21 -29.65 71.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.265 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.4 mm-40 -67.68 -52.67 35.13 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 118' ' ' LEU . 63.8 t -56.34 -34.57 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -62.62 -47.89 81.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.342 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.667 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.3 pt-20 -74.48 -37.49 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.84 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.682 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.5 m0 -54.68 -36.75 64.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 1.6 mtm -73.95 -57.57 3.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.518 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.5 p -60.36 -32.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.25 -47.35 57.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.038 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.7 t80 -59.72 -37.21 78.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.708 0.765 . . . . 0.0 110.161 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.004 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.89 -52.74 15.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.85 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -58.73 -35.2 72.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.789 0.328 . . . . 0.0 111.784 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.5 m -79.54 -43.25 23.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -123.64 -38.13 2.56 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.31 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.004 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -64.04 -49.1 73.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.358 0.526 . . . . 0.0 111.571 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.28 -33.32 52.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.111 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.31 -56.26 17.95 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.792 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.6 t90 -56.59 -46.59 80.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.126 0.488 . . . . 0.0 109.863 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.566 HG13 ' HE3' ' A' ' 137' ' ' TRP . 15.1 mt -58.88 -47.02 90.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.251 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -68.06 -31.66 71.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.64 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.2 m -90.14 -4.83 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.68 -51.67 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.62 -10.66 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.475 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.84 166.55 42.66 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.101 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.444 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.5 m95 -60.93 -27.79 68.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.18 86.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.814 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.76 -41.83 99.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.58 -34.68 78.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.517 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -67.04 -28.15 67.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.53 -27.41 25.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.376 0.608 . . . . 0.0 109.811 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 163' ' ' ARG . 2.2 mt -74.24 -38.68 63.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.353 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 6.2 m-85 -122.29 26.67 8.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -117.9 -141.3 6.75 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.914 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -41.79 36.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.299 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.48 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.49 41.55 2.94 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.479 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.24 72.85 10.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 110.268 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.568 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -66.83 170.09 7.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.006 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 157' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 5.6 mm-40 -52.97 -37.93 61.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.746 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 3.9 mp0 -63.64 -47.63 80.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.437 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -65.34 -37.05 85.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.71 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 77.5 mtt180 -58.18 -58.53 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 3.6 ptt180 -67.4 -28.77 68.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -67.22 -49.77 63.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.489 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.662 ' HB3' HD22 ' A' ' 150' ' ' LEU . 0.9 OUTLIER -64.79 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.142 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 5.5 mt-10 -69.08 -47.01 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.632 0.253 . . . . 0.0 110.442 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.84 -24.51 72.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.169 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.04 -60.86 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.697 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.3 p-90 -61.72 -26.32 67.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.742 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.94 93.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.241 0.543 . . . . 0.0 110.228 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 m -86.87 -24.44 24.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.834 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 92' ' ' ASN . 5.3 m -97.07 -38.93 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -73.83 -26.18 60.46 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.625 -0.672 . . . . 0.0 111.396 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -86.28 -25.71 25.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.43 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.765 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -73.7 -22.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.367 0.604 . . . . 0.0 109.763 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.765 ' HG ' HG13 ' A' ' 173' ' ' VAL . 2.9 mt -120.33 40.42 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.178 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -62.77 -22.27 66.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.806 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.36 9.46 61.33 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.714 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.59 28.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.875 0.338 . . . . 0.0 111.744 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.11 69.8 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 82' ' ' VAL . . . -81.1 -9.41 59.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.055 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.832 HD22 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 121.0 0.429 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.462 -0.36 0 CA-C-O 121.123 0.384 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.33 -173.95 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.57 -33.83 66.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -66.36 -33.37 75.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.393 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.83 -47.47 18.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 46' ' ' MET . 1.2 tp -59.4 -41.26 89.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.682 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -65.64 -42.55 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.284 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.07 -29.73 67.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.987 0.422 . . . . 0.0 110.379 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.38 -57.28 4.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.101 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.63 -52.32 65.91 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.509 ' O ' HD13 ' A' ' 22' ' ' LEU . 60.6 t -63.49 -42.68 97.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.2 -46.12 94.81 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.013 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.782 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 63.5 t80 -64.38 -42.43 96.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.979 0.419 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.27 -41.34 94.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.542 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.1 mp -71.7 -43.49 65.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.773 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.685 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -62.99 -20.04 64.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.113 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -78.93 -42.42 27.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.927 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -153.95 79.93 1.13 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.964 0.411 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.25 -65.79 0.32 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.88 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.421 ' HD1' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.35 60.3 1.16 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.296 0.57 . . . . 0.0 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.6 -24.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.633 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -40.97 60.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.608 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 59.83 4.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.357 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.685 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -69.96 116.01 9.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.474 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 173.71 -57.7 0.14 Allowed Glycine 0 C--O 1.226 -0.405 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.501 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 52.0 Cg_exo -57.46 -46.04 30.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.337 2.024 . . . . 0.0 111.698 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.79 31.13 7.52 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.574 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -80.97 -23.75 38.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 109.879 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.44 135.67 13.01 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.534 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 86.3 Cg_endo -89.31 -138.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.965 2.443 . . . . 0.0 113.121 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -96.75 94.33 7.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.0 21.67 2.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.943 0.402 . . . . 0.0 110.846 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 6.2 m-20 -132.83 159.73 71.42 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.761 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.4 Cg_endo -79.96 51.87 4.07 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 111.685 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.16 -33.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.058 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -58.95 -59.82 4.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.907 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.555 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 29.9 tt0 -58.21 -29.1 65.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.693 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.83 -51.44 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.308 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 13' ' ' LEU . 4.0 ttm -64.98 -36.58 84.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.524 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -38.26 87.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.688 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.9 31.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.76 0.314 . . . . 0.0 110.322 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.05 -57.39 13.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.369 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.64 -47.21 37.82 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.598 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.05 -48.94 79.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.016 0.408 . . . . 0.0 111.22 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -43.25 92.97 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.187 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.778 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.46 -38.6 68.2 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.624 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.88 -22.59 62.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.739 0.781 . . . . 0.0 109.725 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -94.91 -37.23 11.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.672 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -84.96 -26.36 27.21 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.453 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.83 98.78 11.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.161 0.505 . . . . 0.0 110.717 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -64.18 -34.09 77.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.662 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 93.61 4.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.125 0.488 . . . . 0.0 110.289 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.1 -59.16 1.81 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.477 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 1.019 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.7 m-85 -87.79 -10.51 50.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -41.4 88.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.948 0.404 . . . . 0.0 111.518 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.9 m-20 -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.076 0.465 . . . . 0.0 110.663 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 1.019 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -75.99 -40.04 54.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.006 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -73.7 -45.54 51.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.747 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.84 63.5 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.492 ' NE2' HD22 ' A' ' 180' ' ' LEU . 45.0 mt-30 -68.79 -56.43 8.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -88.25 16.66 5.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.853 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.63 -24.82 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.025 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.68 -64.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.578 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.1 t -170.02 150.88 3.82 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 1.9 Cg_endo -81.83 -165.19 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.03 2.487 . . . . 0.0 112.083 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.24 -70.73 3.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.018 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.92 39.81 0.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.059 0.457 . . . . 0.0 112.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.59 -23.24 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.087 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.672 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.3 pt20 -62.81 -39.2 93.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -63.07 -44.63 95.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.747 0.308 . . . . 0.0 110.304 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -63.34 -43.39 97.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.984 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -62.77 -50.94 69.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.362 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.77 -33.1 66.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -62.1 -64.23 1.0 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.489 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.687 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.6 m -58.61 -32.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -66.02 -43.15 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.31 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.579 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -69.45 -36.36 76.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.244 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 3.2 mm-40 -70.33 -29.68 66.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.067 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -34.99 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -88.42 -5.51 58.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.655 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -45.62 -46.61 14.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.118 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.23 62.64 0.12 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.758 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.591 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 163.46 53.6 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.6 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 39.37 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.183 1.922 . . . . 0.0 111.555 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HB2' HG11 ' A' ' 170' ' ' VAL . 2.4 t-20 -67.04 162.9 21.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.401 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.486 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 23.1 m95 -55.98 -27.48 52.96 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.299 0.375 . . . . 0.0 111.177 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.31 92.41 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 95' ' ' ARG . 1.3 tpt180 -86.29 -26.63 24.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.291 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -30.17 61.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.309 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 t -62.89 -52.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.38 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.64 69.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.398 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.1 m-85 -57.75 -57.01 14.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.215 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.679 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 10.9 m-85 -74.97 -39.9 61.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.941 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.9 -38.85 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.441 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -57.15 -51.1 70.65 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.639 0.257 . . . . 0.0 111.211 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.21 -38.15 40.41 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.266 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.11 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.174 0.487 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.57 -38.91 81.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.769 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.09 -43.31 91.81 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.128 179.016 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.604 ' HB3' HD21 ' A' ' 22' ' ' LEU . 90.0 m -65.51 -42.92 91.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.74 77.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.3 OUTLIER -80.7 -9.54 59.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.81 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.2 m -91.16 -23.28 20.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.926 0.393 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 107' ' ' CYS . 71.9 t -74.44 -34.35 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.641 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 109' ' ' GLU . 24.1 p30 -85.3 0.81 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.302 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.85 -174.81 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -82.99 62.31 6.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 0.0 110.522 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.29 45.55 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.479 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.6 mt-10 -52.12 -59.38 8.51 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.609 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 7.4 Cg_exo -74.26 -22.09 16.95 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.134 1.889 . . . . 0.0 112.627 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 115' ' ' MET . 3.0 mm? -64.57 -37.47 87.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.302 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' MET . 90.4 t -57.22 -54.55 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.56 -32.37 83.98 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.95 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.574 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.6 mt-30 -65.59 -52.22 53.74 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 118' ' ' LEU . 82.8 t -56.16 -35.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.29 -47.34 82.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.365 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.76 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.2 pt-20 -72.58 -38.19 67.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.672 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.9 m0 -58.1 -40.58 81.52 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 6.2 ttm -73.22 -51.28 18.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.9 p -63.23 -34.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.35 -39.5 65.14 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 12.6 t80 -66.6 -34.53 78.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.647 0.736 . . . . 0.0 110.129 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.972 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.46 -53.0 8.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.828 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -31.6 71.55 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.6 m -85.46 -37.92 19.2 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -119.75 -43.66 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.972 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -61.49 -46.57 89.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.377 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.09 62.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.47 -50.3 70.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.693 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 51.9 t90 -59.28 -46.82 87.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.498 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.6 mt -57.34 -48.44 82.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.995 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -65.04 -32.06 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.2 m -82.43 -17.48 45.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.0 t -85.45 -54.74 4.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.845 0.355 . . . . 0.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -177.37 -19.31 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 100.41 170.93 29.35 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.425 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.1 m95 -59.41 -30.23 68.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.31 84.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -41.55 98.57 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.5 t80 -64.88 -38.23 90.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.485 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.932 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -63.1 -28.12 69.86 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.19 -26.75 26.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.668 . . . . 0.0 109.71 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -75.46 -39.88 58.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.45 28.11 7.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.972 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -119.2 -141.44 6.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.239 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.52 -40.0 44.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.862 0.363 . . . . 0.0 111.42 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.92 46.13 3.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.157 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.57 72.32 10.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 110.631 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -65.28 168.54 6.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.84 -34.77 63.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.67 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.1 mm-40 -73.17 -32.72 65.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 111.187 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -74.6 -42.83 57.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.911 0.386 . . . . 0.0 111.386 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -66.68 -39.54 88.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.219 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -72.01 -28.53 63.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.896 0.379 . . . . 0.0 110.581 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.68 -47.07 33.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.522 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.1 ptt180 -64.27 -37.57 87.96 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.7 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 2.4 tt0 -68.24 -45.81 72.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.93 0.395 . . . . 0.0 110.109 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.91 -25.82 75.05 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.552 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.9 m-20 -66.1 -58.86 4.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.656 0.265 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.71 -27.52 68.76 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.067 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -43.9 74.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -86.84 -33.61 19.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 92' ' ' ASN . 17.0 m -85.05 -26.14 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -79.07 -30.46 43.97 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.821 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -89.21 -27.98 20.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.448 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 174' ' ' LEU . 4.2 p -66.34 -27.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.161 0.505 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.24 44.35 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.0 110.242 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.821 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.42 -29.05 69.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.901 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.97 9.93 43.18 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.397 0.519 . . . . 0.0 114.397 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.33 11.12 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.134 0.467 . . . . 0.0 111.719 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.94 70.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.242 0.544 . . . . 0.0 110.372 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.19 13.55 32.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.087 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.687 ' HG ' HG11 ' A' ' 82' ' ' VAL . 18.4 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.154 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.462 -0.324 0 CA-C-O 121.131 0.388 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.48 -168.35 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -38.27 60.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -62.35 -38.85 91.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.09 62.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.0 109.977 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.5 tp -72.32 -42.07 65.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.138 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.713 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.9 p -65.87 -36.0 76.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -23.66 60.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -65.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.02 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.1 t80 -53.41 -51.57 62.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.933 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -69.5 -43.67 80.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.42 -50.86 62.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.23 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.739 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 4.6 t80 -58.23 -49.66 76.3 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.976 0.51 . . . . 0.0 111.33 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.41 -35.98 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.546 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.0 mp -76.33 -48.36 20.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -63.92 -18.4 64.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -84.63 -14.25 49.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -146.26 -52.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.97 -68.77 1.22 Allowed Glycine 0 C--O 1.229 -0.167 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.741 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.1 t80 -82.61 53.15 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.529 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.94 -30.54 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -42.51 77.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.35 59.24 4.86 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.834 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.21 117.9 7.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.632 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 175.57 -49.38 0.12 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.725 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.52 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 21.1 Cg_exo -67.15 -50.0 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 121.894 1.729 . . . . 0.0 111.548 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.14 34.0 4.8 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.84 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 14.6 pt-20 -88.76 -13.48 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.44 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.98 144.27 17.54 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.847 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -92.87 -175.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.832 2.355 . . . . 0.0 113.137 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -82.49 80.95 8.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.065 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.39 -11.55 7.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.41 . . . . 0.0 111.949 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.1 m-20 -86.45 160.35 51.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 148' ' ' THR . 30.2 Cg_endo -77.96 50.12 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.263 2.642 . . . . 0.0 111.423 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.53 -31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.783 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -58.67 -61.28 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.765 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.94 -25.01 63.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.939 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.99 -50.23 17.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.61 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.49 ' HE1' HD21 ' A' ' 13' ' ' LEU . 6.3 ttm -67.15 -41.93 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -33.23 73.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.059 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.63 -40.05 26.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.284 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.81 -54.93 40.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLY . . . . . 0.433 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.46 -46.21 45.62 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.112 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.44 -56.16 24.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.122 0.486 . . . . 0.0 111.423 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -44.4 90.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.748 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -72.45 -34.84 68.06 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.611 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -62.9 -28.06 69.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.755 0.788 . . . . 0.0 109.556 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 m -83.47 -31.12 26.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.455 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -92.3 -45.23 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 87.38 7.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.149 0.579 . . . . 0.0 111.077 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -81.19 -15.47 55.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -90.38 61.47 5.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.116 0.484 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.55 -55.82 1.91 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.277 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.968 ' HA ' HD22 ' A' ' 64' ' ' LEU . 58.5 m-85 -66.16 -18.89 65.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.403 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -44.12 86.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.698 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -68.09 -26.89 66.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.96 -45.29 28.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.337 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.94 -43.08 63.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.416 ' NE2' HD22 ' A' ' 180' ' ' LEU . 42.4 mt-30 -69.75 -54.36 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.474 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.44 18.99 3.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 2.1 t-160 -78.46 -38.66 40.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 71' ' ' THR . 2.9 p -92.01 -63.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.155 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.587 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.6 149.19 10.66 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 122.371 -0.206 . . . . 0.0 110.742 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.32 -163.19 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.896 2.397 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 84.52 -72.77 2.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.897 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.45 47.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.719 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -94.66 -21.98 18.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.1 pt20 -62.11 -38.03 87.38 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.878 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.91 -39.06 90.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.701 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -68.5 -43.78 76.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -63.39 -50.2 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.756 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -57.69 -34.12 69.09 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.93 -61.09 2.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.908 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.2 m -58.57 -31.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.8 -43.95 82.52 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -68.93 -31.48 70.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 109.738 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -73.09 -31.24 64.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.35 -36.26 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.611 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -86.67 -8.02 57.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -48.77 5.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.39 58.25 0.2 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.225 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.492 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 161.43 57.14 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.705 -1.235 . . . . 0.0 114.726 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.643 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.1 Cg_endo -79.43 44.94 1.81 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.085 1.856 . . . . 0.0 111.4 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.898 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -69.29 164.98 21.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.673 -178.84 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.0 m95 -56.22 -29.64 61.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.35 -37.3 94.31 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HG3' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -86.13 -26.53 25.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.63 179.058 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.37 -30.7 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.435 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.2 t -64.17 -54.57 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.504 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.24 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.237 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.685 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -57.54 -56.87 16.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.98 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 7.4 m-85 -75.85 -36.96 59.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.34 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.75 -36.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -56.75 -53.97 51.7 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 111.363 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -75.11 -36.89 44.56 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.362 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.93 99.73 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.254 0.527 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -40.91 73.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.8 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.71 -51.19 69.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.062 179.037 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 93.7 m -57.02 -47.06 81.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.619 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.24 -37.74 64.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 1.9 mt-10 -83.98 -25.37 30.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 1.4 p -79.07 -24.01 43.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' CYS . 89.5 t -71.16 -35.19 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.966 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -84.41 1.09 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.401 . . . . 0.0 110.765 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -119.67 -168.29 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.668 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.86 58.43 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.086 0.47 . . . . 0.0 110.562 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.434 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.91 47.01 2.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.392 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 6.9 mt-10 -57.33 -55.62 42.46 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.7 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.8 Cg_exo -63.17 -31.6 74.85 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.958 1.772 . . . . 0.0 112.584 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.6 mp -60.16 -34.33 73.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.79 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.2 -52.27 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 111.368 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.04 85.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.208 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.0 mm-40 -67.0 -47.0 72.81 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.9 t -59.82 -35.55 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.27 -46.35 89.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.412 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.654 ' HA ' HG12 ' A' ' 127' ' ' VAL . 19.3 pt-20 -71.5 -40.47 70.16 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.824 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.4 m0 -57.3 -40.42 77.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.419 0.628 . . . . 0.0 109.371 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.404 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.6 ttp -71.07 -53.62 14.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.641 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 5.6 p -62.46 -38.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.54 -46.49 85.72 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 14.6 t80 -62.47 -33.42 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.479 0.657 . . . . 0.0 110.597 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.93 -58.76 3.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.174 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 131' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 6.2 pt-20 -64.95 -20.75 66.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -89.32 -32.05 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 -42.91 0.99 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.989 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.77 -47.38 85.93 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.268 -178.6 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.93 -39.97 60.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.544 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.01 -47.12 87.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.744 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.781 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 56.5 t90 -60.47 -50.18 74.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.624 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.8 mt -57.11 -47.47 83.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.266 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -62.97 -34.25 77.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -90.9 -9.85 44.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -91.35 -45.09 8.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.493 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.62 -15.09 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.55 165.78 39.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.397 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.4 m95 -60.53 -29.62 69.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.93 82.42 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.005 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.02 -41.85 98.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.43 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 17.9 t80 -67.93 -33.41 74.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.627 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.939 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -66.6 -26.54 67.15 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.055 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.89 -36.89 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.656 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -63.56 -41.15 98.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.004 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.417 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 2.4 m-85 -122.83 26.77 8.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.83 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -127.46 -138.55 4.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.493 -1.336 . . . . 0.0 114.043 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -62.46 1.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -0.721 . . . . 0.0 112.347 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -79.42 54.0 4.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.341 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.34 69.12 10.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.556 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.22 167.01 13.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.297 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -51.6 -35.83 43.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.371 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 4.2 mm-40 -65.48 -48.07 73.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.926 0.393 . . . . 0.0 110.308 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -62.8 -34.54 77.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.731 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -59.55 -57.2 14.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -70.4 -27.66 64.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 35.3 tp -66.69 -47.29 72.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.287 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.534 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -69.88 -33.15 71.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.297 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.436 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.29 -43.7 66.62 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.103 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.11 -26.37 74.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.722 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.548 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 7.2 t-20 -59.9 -61.03 2.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.265 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.763 ' HA ' HG12 ' A' ' 170' ' ' VAL . 32.4 p-90 -69.48 -22.82 63.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.84 -58.72 5.26 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.994 0.184 . . . . 0.0 110.745 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.6 m -88.93 -24.04 22.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -81.62 -28.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.398 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 95' ' ' ARG . 1.3 ttt180 -82.16 -22.34 36.13 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.847 -0.533 . . . . 0.0 109.614 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -83.61 -43.01 16.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.97 HG13 ' HG ' ' A' ' 174' ' ' LEU . 14.4 p -57.89 -37.0 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.12 0.486 . . . . 0.0 110.861 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.97 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -110.61 36.26 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.208 0.527 . . . . 0.0 110.16 178.969 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.9 t -77.66 -9.71 59.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 7.27 80.55 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.732 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.97 25.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.26 51.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.913 0.387 . . . . 0.0 110.514 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.81 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.908 ' HG ' HG11 ' A' ' 82' ' ' VAL . 15.8 mt . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 120.816 0.341 . . . . 0.0 110.29 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 C--O 1.233 0.261 0 CA-C-O 120.806 0.252 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.31 -176.58 5.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -32.19 67.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -68.23 -32.66 73.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.396 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.26 -43.59 32.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 42' ' ' LEU . 1.4 tp -62.01 -43.55 98.59 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 127' ' ' VAL . 4.4 p -66.14 -37.65 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.512 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.9 70.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 110.422 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -70.28 -52.55 22.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.045 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.7 t80 -58.1 -52.99 63.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.409 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.1 t -64.15 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.75 -51.81 56.8 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.745 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.732 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.9 t80 -61.98 -38.84 90.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.638 0.375 . . . . 0.0 110.926 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 7.4 mmtt -66.35 -43.56 85.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -75.94 -46.35 30.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -62.22 -21.19 64.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -85.74 -24.03 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.326 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.36 75.34 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 111.456 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.34 -74.62 0.26 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.645 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 2.0 t80 -85.74 58.14 4.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.957 0.408 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.39 -33.87 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.182 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.72 -14.15 61.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.182 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -109.8 40.27 2.61 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -60.27 130.48 46.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.93 -48.43 0.19 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.819 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.604 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 3.2 Cg_exo -84.11 -48.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -78.38 22.57 3.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.989 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -79.84 -26.75 40.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.72 0.76 . . . . 0.0 109.46 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.43 132.44 11.14 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.356 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 90.2 Cg_endo -89.05 -148.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.985 2.457 . . . . 0.0 113.275 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.89 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -86.33 97.79 10.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.7 -34.78 1.01 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.7 m-20 -78.97 160.43 71.4 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.686 0.279 . . . . 0.0 111.617 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.6 Cg_endo -74.43 51.75 2.65 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.525 2.816 . . . . 0.0 112.44 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.59 -34.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.881 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -59.64 -58.0 10.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.089 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.89 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -59.72 -28.0 66.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.693 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.88 -49.66 50.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -63.55 -31.02 72.06 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.976 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 15.2 ttp180 -62.6 -42.37 99.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.413 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.3 -23.62 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.844 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.32 -64.88 0.81 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.301 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.31 -46.18 35.51 Favored Glycine 0 C--O 1.216 -1.013 0 O-C-N 124.107 0.879 . . . . 0.0 112.397 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -51.64 -51.87 52.28 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.382 0.61 . . . . 0.0 111.425 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.45 -45.69 93.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.047 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -75.53 -33.74 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.922 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.46 -26.85 68.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.2 m -88.58 -41.84 12.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.485 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -87.27 -64.43 1.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 112.205 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -80.41 61.26 4.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.121 0.486 . . . . 0.0 111.338 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -85.24 0.38 52.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -89.11 18.21 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -104.38 -0.07 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.754 ' HA ' HD22 ' A' ' 64' ' ' LEU . 80.3 m-85 -84.89 -23.25 29.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.112 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -35.61 81.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 1.013 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 1.4 m-20 -62.0 -33.49 74.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.299 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.84 -41.76 87.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.529 0.681 . . . . 0.0 109.325 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -80.39 -40.56 26.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.579 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.13 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.522 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.569 HE22 HD11 ' A' ' 106' ' ' LEU . 35.2 mt-30 -76.52 -49.16 17.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.448 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.28 6.35 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -176.671 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.1 t60 -82.64 -31.99 28.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.872 0.368 . . . . 0.0 110.66 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 71' ' ' THR . 2.3 p -91.76 -54.77 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 70' ' ' VAL . 5.0 t -171.97 144.51 1.5 Allowed Pre-proline 0 C--O 1.237 0.437 0 CA-C-O 120.91 0.386 . . . . 0.0 111.007 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 3.6 Cg_endo -84.36 -171.81 1.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.258 2.639 . . . . 0.0 111.258 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.27 -67.4 3.7 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.74 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 48.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.385 0.612 . . . . 0.0 111.674 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . . . -104.39 -17.16 14.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 13.1 pt20 -64.27 -35.69 81.66 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.251 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -67.58 -39.63 84.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.891 0.377 . . . . 0.0 110.428 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ARG . . . . . 0.729 ' HD2' ' HA ' ' A' ' 75' ' ' ALA . 23.1 mtt180 -68.59 -45.87 70.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -61.34 -47.84 84.06 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.906 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -58.28 -33.75 69.77 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -60.09 -64.07 1.08 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 9.1 p -57.87 -34.58 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -68.21 -45.63 72.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.667 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -71.36 -38.02 71.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.851 0.358 . . . . 0.0 110.519 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -19.38 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.269 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -85.28 -39.47 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.833 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 32.9 t80 -79.24 -7.67 58.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.243 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -48.59 -35.97 14.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.431 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.51 62.46 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.834 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.62 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 164.05 51.35 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.541 -1.314 . . . . 0.0 115.04 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.62 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 18.3 Cg_endo -81.37 37.01 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 119.762 1.781 . . . . 0.0 111.542 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.2 t-20 -68.04 164.87 19.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.903 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.588 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 26.0 m95 -53.97 -28.2 36.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.458 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.16 -41.14 97.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.117 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -86.09 -23.67 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.654 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.862 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -56.21 -31.59 63.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.479 0.657 . . . . 0.0 109.852 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.766 HG22 ' HB1' ' A' ' 49' ' ' ALA . 38.7 t -61.26 -54.15 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.391 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.33 69.45 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.351 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.862 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.17 -57.27 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 110.509 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 40.9 m-85 -74.56 -38.74 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.4 -40.16 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.793 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.589 ' HE2' HD22 ' A' ' 180' ' ' LEU . 0.6 OUTLIER -54.79 -52.68 61.88 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.21 -38.11 47.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.078 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.11 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.12 0.46 . . . . 0.0 110.756 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -67.54 -39.12 85.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.719 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.97 -42.41 94.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.456 179.282 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.719 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.0 m -69.19 -39.37 78.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.455 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.75 79.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.395 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.7 OUTLIER -84.67 -15.0 46.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.479 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -82.81 -24.64 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.354 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 107' ' ' CYS . 91.4 t -69.23 -33.22 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.318 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.558 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.6 p30 -84.99 1.06 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -126.94 -173.26 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.435 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -84.61 56.37 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.703 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.448 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.06 43.31 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.8 mt-10 -57.33 -53.55 64.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.396 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 17.3 Cg_exo -67.7 -27.52 38.12 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.072 1.848 . . . . 0.0 112.636 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 tp -62.78 -35.66 80.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.74 -51.28 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.56 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.34 -33.52 87.46 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.53 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.2 mm-40 -67.18 -50.35 61.33 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 45.1 t -58.68 -33.71 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -63.04 -46.58 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.263 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.799 ' HA ' HG12 ' A' ' 127' ' ' VAL . 15.4 pt-20 -74.03 -39.31 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.664 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.2 m0 -56.41 -37.88 70.76 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 8.9 ttm -73.61 -55.43 6.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.506 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 124' ' ' GLU . 9.8 p -60.32 -36.19 67.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -67.54 -48.76 66.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.823 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 8.7 t80 -59.01 -34.72 72.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.63 0.729 . . . . 0.0 110.148 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.995 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -73.07 -56.93 4.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.573 -179.173 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -77.43 -38.52 49.37 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -42.61 2.04 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.995 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.82 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.321 0.509 . . . . 0.0 111.676 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.94 61.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -49.52 67.21 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.0 t90 -57.96 -48.08 81.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.566 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.65 -49.55 77.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.944 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.65 -39.51 73.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.1 m -86.79 -11.27 51.5 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.2 -22.02 16.4 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.35 -24.99 0.97 Allowed Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.499 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.566 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 95.86 169.55 35.26 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.011 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 96.2 m95 -60.06 -29.4 68.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.87 79.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.571 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.46 -42.0 96.2 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.844 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -61.95 -39.47 92.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.318 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.682 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -66.07 -27.16 67.87 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 110.75 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -15.31 41.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 0.0 109.856 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.677 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -79.03 -48.87 13.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.22 179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.5 m-85 -138.99 30.75 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -95.09 -132.17 6.75 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.189 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.48 -31.42 70.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -115.5 65.85 0.3 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.77 76.33 10.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.207 0.527 . . . . 0.0 110.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.7 153.59 23.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.324 -179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.66 -28.03 53.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.308 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -74.75 -42.14 58.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 110.801 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.79 -34.66 75.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.242 0.544 . . . . 0.0 110.541 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.58 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 8.3 mtm-85 -63.97 -50.45 68.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.074 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -68.9 -30.11 68.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.569 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -64.77 -37.38 87.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.254 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -69.48 -42.21 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.555 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 3.4 tt0 -65.46 -44.62 86.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.403 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 -22.45 75.63 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.632 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.488 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -74.66 -52.96 10.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.0 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HA ' HG22 ' A' ' 170' ' ' VAL . 14.7 p-90 -66.97 -23.8 65.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.274 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.07 77.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.15 0.5 . . . . 0.0 110.382 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 -32.59 19.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.516 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.845 HG22 ' HA ' ' A' ' 167' ' ' TRP . 34.3 m -86.12 -25.57 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.4 ttp180 -80.84 -25.38 37.76 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.588 -0.695 . . . . 0.0 109.938 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.826 ' HA ' HG23 ' A' ' 175' ' ' THR . 2.2 m -90.09 -28.6 18.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.763 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.94 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -65.32 -29.05 46.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.388 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.94 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -120.07 46.15 2.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.185 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -64.99 -42.33 94.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.94 25.18 1.53 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.499 0.56 . . . . 0.0 114.499 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.96 -2.21 58.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.323 0.561 . . . . 0.0 110.457 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.36 66.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.805 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.03 12.03 37.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.433 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 1.013 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 5.6 mp . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.656 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 CA--C 1.527 0.173 0 CA-C-O 121.176 0.407 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 10' ' ' THR . 1.5 m-20 -84.75 -159.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -56.47 -35.04 67.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.15 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -63.58 -39.59 94.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.689 0.28 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -32.95 57.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.814 0.34 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.749 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.4 tp -74.74 -42.22 58.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.427 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -66.37 -37.93 80.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.834 0.349 . . . . 0.0 110.23 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.72 60.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.75 0.31 . . . . 0.0 110.588 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.082 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 6.7 t80 -56.63 -50.11 73.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.49 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.4 t -66.83 -42.18 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.19 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.47 -52.75 49.23 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.888 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.802 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 23.6 t80 -57.19 -46.55 82.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.073 0.549 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.52 -45.46 90.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 111.059 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.7 mp -66.85 -47.24 72.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 23.7 ttp85 -60.77 -25.81 66.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.3 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.94 -21.79 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.952 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -157.43 72.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.759 0.314 . . . . 0.0 111.654 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.68 -75.99 0.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.2 t80 -84.37 56.13 3.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.05 -28.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.087 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.36 -15.16 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.478 0.656 . . . . 0.0 109.962 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -111.85 53.9 0.57 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.963 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB1' ' OE2' ' A' ' 35' ' ' GLU . . . -63.49 144.59 56.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.204 -0.498 . . . . 0.0 110.408 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' CA ' ' HG2' ' A' ' 35' ' ' GLU . . . 142.77 -57.25 0.56 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.979 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.5 Cg_exo -61.7 -45.36 17.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.579 2.186 . . . . 0.0 112.403 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.43 39.44 2.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.743 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 74.4 mm-40 -79.31 -59.92 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.349 0.574 . . . . 0.0 109.95 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.05 128.96 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.3 Cg_endo -88.28 -132.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.835 2.357 . . . . 0.0 113.476 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HB1' ' HG2' ' A' ' 44' ' ' GLN . . . -73.79 92.4 2.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.493 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.93 39.9 1.04 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -156.41 164.9 19.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.654 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.9 Cg_endo -82.39 49.63 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.135 2.557 . . . . 0.0 112.275 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.749 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.8 -27.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.485 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' HD2' HD12 ' A' ' 42' ' ' LEU . 4.4 m170 -62.55 -56.03 21.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.929 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.98 -23.81 67.48 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.044 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -67.63 -54.1 22.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.465 ' HE3' HD21 ' A' ' 13' ' ' LEU . 3.8 tpp -70.13 -30.07 67.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.338 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -39.87 95.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.572 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.22 -28.52 47.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 109.685 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.5 -61.08 1.99 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.643 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.12 -45.9 42.72 Favored Glycine 0 C--O 1.215 -1.081 0 O-C-N 124.108 0.88 . . . . 0.0 112.292 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.28 -52.75 51.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.588 0.355 . . . . 0.0 111.884 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -44.0 95.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.404 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.678 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -72.56 -35.0 67.87 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.366 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.25 -27.15 68.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.323 0.583 . . . . 0.0 109.518 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -88.01 -39.24 14.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -90.37 -57.23 2.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -81.4 69.21 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 58' ' ' ARG . 17.7 mtt180 -72.89 0.59 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.88 51.69 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 110.198 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.0 0.15 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.412 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.895 ' HA ' HD22 ' A' ' 64' ' ' LEU . 36.6 m-85 -110.51 -25.91 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 0.0 111.592 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -41.11 97.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.74 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.99 -18.95 64.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.748 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -66.87 -45.41 78.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -75.67 -47.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.77 -41.63 23.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.18 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.571 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 42.1 mt-30 -71.83 -65.65 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' A' ' 115' ' ' MET . 0.7 OUTLIER -78.49 14.48 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.339 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 1.6 p-80 -79.15 -20.56 48.23 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.533 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.87 -72.69 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.825 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -157.15 135.64 7.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 21.2 Cg_exo -66.44 170.14 12.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.115 2.543 . . . . 0.0 112.378 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' GLY . . . . . 0.715 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 92.18 -58.49 2.76 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.67 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.55 50.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.43 0.634 . . . . 0.0 110.848 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.67 -25.08 10.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.739 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.626 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -63.03 -42.1 99.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.848 -179.02 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.95 -44.71 95.33 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.383 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -61.7 -42.68 99.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.246 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -62.47 -51.0 69.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.469 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -59.07 -32.2 69.57 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.725 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -61.07 -60.52 3.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.72 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.7 m -60.29 -32.53 51.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.6 m -65.61 -42.42 91.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.16 -40.44 86.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 178.938 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -67.13 -31.79 72.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.486 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.01 -36.59 59.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -85.83 -5.81 59.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -34.46 25.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.018 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.83 62.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.352 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.88 56.64 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.544 -1.313 . . . . 0.0 115.014 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 11.8 Cg_endo -82.13 29.37 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.396 2.064 . . . . 0.0 111.194 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.857 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.9 m120 -61.63 162.06 8.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.889 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 27.7 m95 -52.68 -25.77 11.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.864 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.98 90.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.522 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.674 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.0 mmp_? -87.09 -22.43 25.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.926 -0.161 . . . . 0.0 110.758 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -54.71 -31.08 57.61 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.728 0.643 . . . . 0.0 110.229 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.935 HG22 ' HB1' ' A' ' 49' ' ' ALA . 17.6 t -59.77 -56.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.95 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -27.32 69.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.84 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.0 m-85 -58.49 -55.12 39.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 110.123 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 12.8 m-85 -76.16 -37.86 57.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.73 -37.88 80.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.801 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -54.5 -53.86 48.67 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.13 -35.66 52.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.444 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.61 99.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.136 0.468 . . . . 0.0 110.513 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.43 -40.17 77.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.823 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -59.65 -42.11 92.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.704 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.666 ' HB3' HD21 ' A' ' 22' ' ' LEU . 96.9 m -69.06 -41.16 77.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.024 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.86 -48.46 69.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.983 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -74.13 -20.22 60.31 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.874 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.579 ' HB3' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -78.78 -35.94 43.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.482 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 107' ' ' CYS . 24.6 t -67.81 -16.3 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.829 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 12.3 m-20 -45.73 -70.25 0.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.487 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -175.55 37.45 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.886 179.375 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 17.2 mt-10 -159.68 122.1 3.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.878 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.552 ' HE1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 mtm 70.31 114.84 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.777 0.673 . . . . 0.0 112.106 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.701 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -102.05 -55.34 0.13 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.146 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.701 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 36.2 Cg_exo -59.85 -27.79 85.73 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.487 2.125 . . . . 0.0 113.967 -178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.715 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -62.3 -31.57 72.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.915 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 110' ' ' SER . 94.6 t -60.36 -55.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.623 0.249 . . . . 0.0 111.371 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.51 -28.88 72.0 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.016 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.9 mt-30 -68.52 -49.21 61.32 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 99.6 t -56.64 -36.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.64 -47.05 87.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.859 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' A' ' 127' ' ' VAL . 20.8 pt-20 -73.93 -36.72 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.626 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.1 m0 -57.12 -38.34 73.29 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.9 ttm -73.61 -54.28 8.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.22 -30.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.772 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.32 -50.0 50.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.263 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 11.8 t80 -61.76 -34.4 75.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.0 110.599 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 0.869 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -72.12 -56.01 6.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.133 -178.854 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.99 -34.3 74.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.5 m -79.04 -40.92 30.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -121.61 -42.73 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.869 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.7 mm? -59.6 -46.0 90.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.227 0.467 . . . . 0.0 111.166 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.18 -39.5 56.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.376 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.5 -55.78 29.36 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.449 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.857 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 62.2 t90 -55.79 -46.34 77.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.117 0.484 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.406 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -58.24 -48.19 85.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.721 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -66.07 -32.22 73.56 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.372 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -84.0 -11.85 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -49.61 5.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.3 -18.08 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.406 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 96.15 170.6 35.06 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.017 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.48 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 92.9 m95 -60.48 -30.62 69.8 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.52 76.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -65.38 -42.19 92.95 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.754 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -66.05 -33.85 76.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.548 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -71.07 -24.49 62.34 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.468 178.754 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.35 -31.68 21.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -60.39 -51.38 69.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.581 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 -132.55 33.85 3.75 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.04 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -103.54 -127.79 6.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.431 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.42 -37.61 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 111.078 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.32 61.81 0.3 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.56 72.85 9.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.136 0.493 . . . . 0.0 110.637 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.2 164.16 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.837 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -59.72 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.574 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.5 mt-10 -71.47 -35.78 70.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.26 62.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 0.0 109.73 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' ARG . . . . . 0.647 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 4.0 mtp180 -61.75 -51.64 67.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.294 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' GLU . 1.3 ptm180 -67.64 -28.39 67.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.652 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -66.85 -45.3 78.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.529 ' NH2' ' HA ' ' A' ' 49' ' ' ALA . 13.0 ttp180 -67.26 -38.04 84.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.1 OUTLIER -67.66 -47.12 70.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.214 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.75 -21.79 75.11 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.503 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.6 ' O ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -68.96 -54.04 17.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.277 . . . . 0.0 110.827 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.649 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 15.0 p-90 -67.76 -25.08 65.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.985 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.14 74.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 110.262 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.59 -28.75 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 27.8 m -93.04 -31.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -41.0 67.54 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.544 -0.722 . . . . 0.0 110.29 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 175' ' ' THR . 3.7 m -74.66 -28.47 60.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.809 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -70.44 -26.09 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.569 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.809 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -120.72 39.73 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.726 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -68.5 -16.2 63.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -87.96 14.08 59.65 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.184 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.34 8.2 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.942 0.371 . . . . 0.0 111.806 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 58.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.925 0.393 . . . . 0.0 110.475 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.09 51.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.967 0.32 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.63 -161.4 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.458 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -43.33 74.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.385 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -58.65 -39.33 80.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.631 0.253 . . . . 0.0 110.726 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -47.91 51.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 46' ' ' MET . 4.2 tp -58.78 -45.09 90.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.377 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -65.9 -39.29 84.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.87 76.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.87 -48.85 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.908 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -59.31 -51.06 71.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' O ' HD13 ' A' ' 22' ' ' LEU . 53.5 t -65.24 -40.99 90.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.96 -48.02 87.83 Favored Glycine 0 C--O 1.222 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.94 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' TYR . . . . . 0.721 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.2 t80 -58.12 -47.75 82.34 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.821 0.448 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.68 85.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.175 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -67.15 -46.93 72.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.416 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 35.4 ttp85 -62.96 -20.34 65.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.841 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.7 tt0 -82.19 -36.41 27.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.926 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.44 77.89 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.49 -68.3 0.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.09 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.1 t80 -92.57 59.67 3.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.0 110.701 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.16 -26.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.92 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -36.86 77.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.791 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -96.46 50.6 1.61 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.955 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -67.75 131.28 45.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.01 -53.75 0.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.612 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 18.0 Cg_exo -68.56 -49.22 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.217 1.945 . . . . 0.0 111.643 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.721 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.5 31.88 4.69 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.517 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.83 -59.44 2.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.437 0.637 . . . . 0.0 109.314 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.19 124.88 7.23 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.422 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.82 -112.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.998 2.465 . . . . 0.0 112.955 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.44 97.15 1.24 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.7 20.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.067 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 30.8 m-20 -146.26 162.35 35.18 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -79.22 52.33 4.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.366 2.711 . . . . 0.0 111.468 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.29 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.03 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -62.66 -50.4 71.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.575 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -64.06 -25.23 68.01 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.94 -54.22 7.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.465 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' MET . . . . . 0.46 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.3 ttm -61.97 -38.29 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.976 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -61.32 -37.91 84.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.075 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.51 34.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.519 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.56 -55.88 28.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.308 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.67 -49.45 40.37 Favored Glycine 0 C--O 1.217 -0.963 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.206 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.74 -53.15 58.8 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.906 0.384 . . . . 0.0 111.929 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.1 -46.6 86.6 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.355 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.845 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -69.77 -36.72 75.98 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.778 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -61.04 -32.86 72.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.503 0.668 . . . . 0.0 109.742 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 m -79.34 -28.92 42.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.351 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -92.44 -31.89 15.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.44 93.39 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.191 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -71.64 -25.42 62.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.875 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -94.27 77.31 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.122 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.85 -62.51 1.44 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.097 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PHE . . . . . 0.947 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.0 m-85 -76.79 -10.81 59.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -47.61 80.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -68.41 -21.23 64.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.201 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -68.86 -42.01 77.66 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.77 -43.38 37.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.567 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.22 67.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 44.6 mt-30 -71.33 -58.05 3.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 3.8 6.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 65.5 t60 -78.81 -26.89 44.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.873 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -71.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.13 147.58 11.47 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -89.54 -169.81 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.138 2.559 . . . . 0.0 111.917 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.76 -70.24 2.91 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.343 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.41 37.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 111.905 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' HD11 ' A' ' 118' ' ' LEU . . . -85.84 -16.42 38.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.368 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' GLN . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 9.9 pt20 -60.95 -42.0 97.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.588 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.3 -39.57 94.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.36 . . . . 0.0 110.499 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -67.58 -43.58 80.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.021 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.06 -48.9 76.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -57.73 -31.88 66.87 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.394 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -62.43 -63.27 1.28 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.891 0.376 . . . . 0.0 110.636 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 ' HG ' ' A' ' 180' ' ' LEU . 20.9 m -58.78 -32.12 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.512 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 m -65.91 -43.48 88.01 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -69.26 -40.6 77.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.638 178.708 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -64.14 -28.3 69.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.412 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HG ' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -83.62 -28.5 28.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 110.088 179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -91.08 0.5 57.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 9.1 mm100 -49.0 -33.27 10.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.003 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.67 55.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.962 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.443 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 172.61 54.95 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 C-N-CA 119.953 -1.118 . . . . 0.0 114.324 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -80.87 43.06 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.169 1.913 . . . . 0.0 111.977 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.3 t-20 -67.71 161.74 25.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.896 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' TRP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.3 m95 -55.33 -26.98 44.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.76 98.47 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.689 HH11 ' HG ' ' A' ' 86' ' ' LEU . 5.2 mmt180 -86.31 -18.77 31.1 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.819 -0.224 . . . . 0.0 110.716 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.752 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.86 -31.66 65.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.329 0.585 . . . . 0.0 110.218 179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 53' ' ' PHE . 5.9 t -61.3 -53.73 44.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.521 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.64 -26.85 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.395 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.42 -57.53 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.068 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' PHE . . . . . 0.67 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.6 m-85 -74.79 -40.07 61.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.724 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.02 -38.91 69.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.71 -49.49 75.01 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.729 0.3 . . . . 0.0 111.317 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.36 -37.91 30.37 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.003 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.04 97.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.025 0.413 . . . . 0.0 110.688 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.56 -40.07 80.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.772 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.79 -43.66 90.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.281 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 107' ' ' CYS . . . . . 0.641 ' HB2' HD11 ' A' ' 22' ' ' LEU . 88.5 m -63.57 -44.37 94.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.071 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.03 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.569 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -75.09 -23.06 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.658 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 110' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 119' ' ' VAL . 49.1 m -79.56 -22.24 44.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.116 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.3 t -75.97 -35.44 29.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 1.1 p-10 -85.04 1.13 49.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 8.9 mtmt -123.6 -174.6 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.5 48.74 1.56 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -129.94 37.84 3.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.536 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -54.68 -53.73 57.09 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 23.4 Cg_exo -65.15 -32.12 53.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.005 1.804 . . . . 0.0 112.299 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -59.61 -31.06 69.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.609 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 110' ' ' SER . 87.2 t -58.17 -51.2 73.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.903 0.382 . . . . 0.0 111.256 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.06 -31.58 81.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.089 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 14.3 mm100 -66.27 -51.81 53.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 61.2 t -58.15 -33.71 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.16 -47.57 82.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.325 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' GLU . . . . . 0.66 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.4 pt-20 -72.4 -39.44 67.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' TRP . . . . . 0.62 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.7 m0 -57.61 -38.61 75.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.0 ttm -73.77 -52.83 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.795 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.5 p -62.15 -33.32 58.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.55 -52.07 35.97 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.605 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.49 -33.32 67.89 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.467 0.651 . . . . 0.0 110.568 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' LEU . . . . . 1.045 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.07 -55.81 5.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.748 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -32.02 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.7 m -82.61 -34.7 27.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -126.97 -44.91 1.6 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 1.045 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.05 -46.54 87.98 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.429 -178.394 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.64 -38.85 61.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.259 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -60.03 -52.59 64.73 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.418 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 52.8 t90 -56.62 -48.69 76.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ILE . . . . . 0.507 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.7 mt -57.09 -47.77 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.016 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -66.39 -29.17 69.28 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -88.04 -16.13 34.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.56 -54.39 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.78 -9.74 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.545 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.03 166.88 40.98 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.009 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TRP . . . . . 0.46 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 91.6 m95 -60.67 -29.15 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.22 80.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.89 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.78 -42.77 99.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' PHE . . . . . 0.473 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.3 t80 -66.1 -33.17 75.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.137 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.39 -27.7 68.06 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.738 0.304 . . . . 0.0 111.02 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.0 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 163' ' ' ARG . 5.0 mt -63.61 -42.95 98.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.536 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.4 m-85 -123.39 31.29 5.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.814 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -122.94 -138.37 5.26 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.752 -1.214 . . . . 0.0 113.107 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -42.77 36.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.785 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 154' ' ' GLY . . . . . 0.432 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.52 53.43 4.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.44 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.5 71.76 10.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -63.02 157.68 21.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.39 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -53.07 -33.68 53.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.209 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLU . . . . . 0.681 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.2 mt-10 -72.8 -39.41 66.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.919 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.36 72.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.993 0.425 . . . . 0.0 110.83 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -60.66 -51.46 69.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.037 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -69.16 -26.12 64.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.019 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.68 -46.02 55.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ARG . . . . . 0.62 ' HB3' HD22 ' A' ' 150' ' ' LEU . 3.8 ptt180 -65.1 -38.62 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLU . . . . . 0.587 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -71.02 -43.54 67.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.204 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.81 -28.46 73.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.647 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.3 t-20 -67.1 -57.76 6.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' TRP . . . . . 0.791 ' HA ' HG22 ' A' ' 170' ' ' VAL . 15.7 p-90 -62.12 -25.34 67.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.491 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.4 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.051 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 -29.19 22.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 167' ' ' TRP . 26.8 m -79.4 -23.9 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.265 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 3.7 ttp180 -83.09 -14.43 53.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' THR . . . . . 0.661 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -98.52 -33.21 11.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.471 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' VAL . . . . . 0.964 HG13 ' HG ' ' A' ' 174' ' ' LEU . 11.7 p -63.19 -33.14 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.57 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.964 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -112.34 39.4 2.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.77 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -54.37 -42.86 70.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.372 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.72 59.55 4.43 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.131 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -120.14 6.69 10.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.413 0.625 . . . . 0.0 109.62 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.65 61.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.455 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -82.41 -8.11 59.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.568 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' LEU . . . . . 0.636 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.802 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.34 -50.12 1.56 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.865 2.376 . . . . 0.0 112.003 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 2' ' ' ALA . 9.4 mt -122.88 -149.77 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.247 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' -1' ' ' GLY . . . . . 0.491 ' H ' ' HB3' ' A' ' -2' ' ' LEU . . . 99.68 -77.51 0.48 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.111 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -18.03 65.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.09 23.8 12.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.506 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.501 ' HB2' HD22 ' A' ' -2' ' ' LEU . . . -140.41 121.55 14.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.152 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 p -102.62 149.24 36.55 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.308 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.33 134.16 50.43 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.676 2.251 . . . . 0.0 111.64 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.18 147.91 32.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.035 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 m 59.23 88.65 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.944 0.777 . . . . 0.0 112.225 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.61 161.84 65.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.702 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.13 52.38 0.78 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.322 2.681 . . . . 0.0 113.238 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -166.0 1.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.883 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -39.45 82.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.393 0.139 . . . . 0.0 111.158 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -62.2 -38.01 87.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.84 66.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.6 tp -72.4 -42.28 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.519 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -66.49 -36.07 76.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 109.969 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.23 -22.96 60.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.322 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -73.16 -66.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -53.44 -50.66 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.798 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.453 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.4 t -67.64 -42.31 86.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.429 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.48 -52.29 52.2 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.211 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -55.57 -45.33 77.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.148 0.579 . . . . 0.0 111.223 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -48.37 66.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -63.38 -45.31 91.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.578 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -62.17 -26.98 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.026 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -85.99 -23.97 26.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.57 66.12 1.12 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.9 -72.17 0.29 Allowed Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.833 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.2 t80 -91.2 52.96 2.22 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.163 0.506 . . . . 0.0 110.332 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.15 -31.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.668 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -35.35 79.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.392 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.77 57.39 2.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.659 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -60.18 128.26 35.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.61 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 165.6 -60.91 0.24 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.278 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 32.1 Cg_exo -58.8 -52.51 5.12 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 121.96 1.773 . . . . 0.0 111.024 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -92.57 42.48 2.68 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.51 -18.32 31.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 110.313 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -110.55 147.5 17.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.622 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.5 Cg_endo -93.94 -158.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.964 2.443 . . . . 0.0 113.135 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.909 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.3 96.77 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.31 -24.44 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.737 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 20.6 m-20 -79.5 163.25 59.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.105 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.3 Cg_endo -78.0 50.39 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.42 2.746 . . . . 0.0 112.102 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.78 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.49 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.345 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.3 m170 -59.23 -60.48 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.09 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.909 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.4 -24.88 61.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.045 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -73.82 -50.71 19.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.92 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttm -66.74 -37.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.43 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.98 84.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.542 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.62 -27.69 51.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.348 0.595 . . . . 0.0 110.678 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.98 -62.65 1.29 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.563 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.659 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.94 -45.85 41.1 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.72 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.34 -50.11 72.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.054 0.455 . . . . 0.0 111.697 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -46.37 84.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.198 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.846 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -68.73 -36.33 78.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.274 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.21 -32.5 71.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.302 0.572 . . . . 0.0 109.547 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -83.12 -25.76 31.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.414 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -91.47 -29.43 17.02 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.21 96.86 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 110.992 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt-85 -72.54 -3.69 26.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.601 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.422 HH12 HG11 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -132.2 87.89 2.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.761 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -120.05 -61.02 1.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.658 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.953 ' HA ' HD22 ' A' ' 64' ' ' LEU . 6.9 m-85 -79.67 0.44 30.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.471 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 p -73.42 -53.99 9.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.33 -24.27 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.919 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.953 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -63.15 -44.77 94.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.862 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.65 51.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.898 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.66 -44.28 62.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.201 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.509 ' NE2' HD22 ' A' ' 180' ' ' LEU . 34.3 mt-30 -69.2 -51.24 39.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.716 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.553 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -86.17 20.22 2.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.097 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.74 -40.88 32.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' H ' ' A' ' 71' ' ' THR . 1.5 p -90.88 -60.83 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -172.7 145.7 1.41 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.11 -158.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.075 2.516 . . . . 0.0 112.623 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.99 -71.07 2.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.77 50.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.54 0.686 . . . . 0.0 111.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.61 -20.51 14.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.646 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.5 pt20 -65.13 -38.06 89.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.674 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 26.1 mp0 -67.43 -42.05 83.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -64.06 -45.57 88.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.39 -51.86 65.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.712 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -58.33 -32.62 68.68 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 22.8 mm-40 -64.15 -56.74 12.67 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.3 m -63.84 -31.88 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.315 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.0 m -65.56 -43.41 89.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.356 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -66.96 -36.67 82.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.244 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.46 -26.25 64.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.894 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -30.91 40.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.087 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -95.96 1.48 52.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -50.15 21.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.747 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.14 61.71 0.15 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.844 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.13 58.67 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.004 -1.093 . . . . 0.0 114.129 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.5 Cg_endo -81.08 41.89 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.43 2.087 . . . . 0.0 111.741 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.2 t-20 -64.47 162.89 14.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -56.05 -26.28 48.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.698 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.02 94.14 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.54 -27.23 22.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.952 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.05 -30.88 49.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.388 0.614 . . . . 0.0 110.149 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.846 HG11 ' HB2' ' A' ' 53' ' ' PHE . 13.3 t -63.18 -55.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.66 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.56 -28.66 69.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.322 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.79 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 8.1 m-85 -57.46 -57.62 11.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 109.956 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.568 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 13.6 m-85 -74.88 -37.68 62.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.2 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.74 -37.5 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.157 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -57.15 -52.33 65.72 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.697 0.284 . . . . 0.0 111.202 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.41 -40.85 38.89 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.225 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.29 89.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.189 0.495 . . . . 0.0 111.016 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.594 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.36 -41.04 70.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.765 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.7 -48.74 80.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.584 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.677 ' HB3' HD21 ' A' ' 22' ' ' LEU . 67.0 m -59.66 -42.26 92.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.316 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.89 -55.96 24.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 0.0 110.855 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.4 -17.87 64.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -77.88 -32.97 52.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' CYS . 35.0 t -75.21 -22.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.658 0.742 . . . . 0.0 109.356 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -4.89 59.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.609 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.2 tttt -132.06 -162.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.585 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.18 55.19 3.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.553 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.52 43.64 2.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.023 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.7 mp0 -60.54 -55.32 46.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.962 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.4 Cg_exo -64.72 -26.84 60.43 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.956 1.771 . . . . 0.0 112.198 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.6 mm? -65.72 -28.11 68.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.313 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 111' ' ' VAL . 79.3 t -59.23 -50.69 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.956 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.87 -32.58 84.36 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.838 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 53.3 mm-40 -64.63 -52.88 55.09 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 118' ' ' LEU . 44.8 t -58.3 -33.49 47.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.958 0.408 . . . . 0.0 110.115 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.21 -46.92 81.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.427 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HA ' HG12 ' A' ' 127' ' ' VAL . 19.0 pt-20 -72.31 -39.43 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.064 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.9 m0 -57.8 -38.7 75.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.483 0.658 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 4.7 ttm -71.96 -56.07 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.69 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.2 p -61.19 -33.21 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -73.09 -45.79 55.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.6 t80 -59.88 -37.39 79.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.704 0.764 . . . . 0.0 109.894 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.51 -54.98 8.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.822 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.17 -32.6 70.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -82.43 -35.11 27.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.87 -43.5 1.22 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.51 -48.49 81.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.595 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.8 -38.92 57.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.603 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.15 -50.02 73.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.796 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.8 t90 -58.17 -49.28 77.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 109.525 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.65 HG13 ' HE3' ' A' ' 137' ' ' TRP . 11.3 mt -58.08 -47.14 87.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.152 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.4 m80 -61.12 -40.0 92.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -30.54 43.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -60.03 3.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.947 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.3 -11.07 0.02 OUTLIER Glycine 0 C--N 1.319 -0.367 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.32 169.16 41.89 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.612 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.0 m95 -62.2 -29.03 70.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.51 78.66 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.578 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.81 -44.06 94.4 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 t80 -64.83 -34.21 77.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.579 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.761 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -70.55 -25.55 63.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.37 -32.66 20.84 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.521 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -57.95 -51.49 69.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.643 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -130.32 30.23 4.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.85 -133.13 8.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.927 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -68.59 -45.45 71.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.568 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.68 48.78 2.3 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.12 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.23 73.26 8.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.12 0.486 . . . . 0.0 110.734 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -65.77 160.05 23.85 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.575 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -57.01 -32.18 65.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.281 -178.874 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -69.62 -39.41 77.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.651 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.38 -36.31 78.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.42 ' HA ' ' HE1' ' A' ' 151' ' ' TYR . 61.9 mtt180 -67.56 -50.57 57.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -64.47 -27.32 68.91 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.019 0.438 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -63.34 -47.52 81.81 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.47 178.557 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.458 HH11 ' HE1' ' A' ' 147' ' ' PHE . 11.0 ttp180 -63.4 -39.2 93.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.636 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.19 -49.12 70.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.888 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.54 -27.23 73.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.585 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.648 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.7 m-20 -70.11 -56.63 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.464 -0.368 . . . . 0.0 111.532 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.645 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 9.8 p-90 -60.34 -27.87 67.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.453 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.73 74.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.688 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -24.09 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 166' ' ' ASN . 28.7 m -96.38 -41.15 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.575 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -75.35 -27.4 59.17 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.411 -0.805 . . . . 0.0 111.079 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 1.4 m -81.51 -29.92 33.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.414 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.593 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.2 p -71.57 -28.24 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 110.398 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.593 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -114.44 33.91 5.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.209 0.528 . . . . 0.0 109.628 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.3 t -81.52 -4.72 56.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.242 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -89.39 6.13 83.52 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.647 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 29.29 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.422 HG11 HH12 ' A' ' 59' ' ' ARG . 0.7 OUTLIER -87.23 50.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.054 0.454 . . . . 0.0 110.731 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.14 -1.85 53.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 82' ' ' VAL . 10.4 mt -92.22 -7.28 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.159 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.9 84.57 1.22 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.896 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.748 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -109.85 -168.2 1.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.643 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.3 -19.02 34.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.899 2.4 . . . . 0.0 112.523 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 5.7 mt -104.15 109.45 21.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.889 0.376 . . . . 0.0 111.071 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -68.56 103.26 1.0 Allowed Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.715 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.34 -28.42 29.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -4.77 20.6 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.75 128.26 34.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.801 0.334 . . . . 0.0 111.003 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.519 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 p -99.87 119.93 58.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.804 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.2 Cg_endo -82.7 37.18 0.65 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.344 2.696 . . . . 0.0 112.912 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.47 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -98.76 116.43 30.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 143.02 58.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.34 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.37 102.24 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.251 2.634 . . . . 0.0 111.899 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -72.49 -174.12 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.095 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -37.8 52.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.292 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -64.13 -38.67 91.89 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.49 -35.25 68.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 42' ' ' LEU . 3.0 tp -71.66 -43.19 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.85 -33.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.971 0.415 . . . . 0.0 110.159 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.15 -24.77 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.456 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.36 -63.16 1.39 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -55.54 -51.77 65.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.619 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -68.62 -38.94 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.789 0.328 . . . . 0.0 110.281 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.63 -51.78 55.3 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.477 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.791 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.3 t80 -61.38 -42.27 98.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 0.0 110.847 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -62.61 -46.81 86.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -68.24 -44.72 75.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.737 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.6 -29.14 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.2 pt20 -85.84 -22.94 27.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.84 65.75 1.11 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.26 -70.45 0.31 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.965 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -89.83 51.14 2.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.213 0.53 . . . . 0.0 110.155 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.88 -28.24 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.545 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.63 -29.26 64.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.94 57.87 1.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.737 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.51 112.5 3.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.855 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 178.57 -58.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.403 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -57.86 -48.95 14.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.227 1.951 . . . . 0.0 111.992 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.791 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.16 32.69 5.96 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.709 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.3 -20.63 29.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.908 0.385 . . . . 0.0 110.109 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -94.86 145.6 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 65.8 Cg_endo -97.55 -159.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.199 2.599 . . . . 0.0 113.647 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -81.59 84.41 6.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.05 1.19 7.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.034 0.445 . . . . 0.0 111.273 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 40.6 m-20 -104.98 163.0 18.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.58 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -80.12 47.03 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.443 2.762 . . . . 0.0 111.85 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -175.07 -31.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.755 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.3 m170 -58.0 -58.82 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.342 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.54 ' CA ' ' HB1' ' A' ' 38' ' ' ALA . 4.0 tt0 -58.18 -25.02 61.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.867 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.27 -50.31 16.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.266 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HE1' HD21 ' A' ' 13' ' ' LEU . 3.2 ttm -66.89 -37.6 84.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.577 HH11 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HB2' HH11 ' A' ' 47' ' ' ARG . . . -80.33 -42.01 23.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.324 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.862 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.16 -54.89 41.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.523 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.6 -50.58 41.93 Favored Glycine 0 C--O 1.22 -0.726 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.294 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.36 -50.05 68.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -48.48 80.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -71.28 -33.46 69.77 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.212 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.76 -25.34 67.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.55 0.691 . . . . 0.0 109.327 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -84.82 -37.32 20.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.327 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -92.92 -61.22 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.073 0.463 . . . . 0.0 112.165 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.9 69.7 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.402 0.681 . . . . 0.0 111.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -77.82 -16.97 57.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -81.39 46.43 0.94 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.36 . . . . 0.0 111.476 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 t -120.98 -6.45 9.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.819 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.8 m-85 -92.98 -26.31 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -39.3 93.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.538 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.55 -24.99 66.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -66.16 -41.29 90.57 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -76.67 -46.65 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.678 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -50.26 -43.03 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.551 ' NE2' HD22 ' A' ' 180' ' ' LEU . 42.6 mt-30 -67.57 -59.32 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.938 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.35 16.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.654 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.62 -26.8 45.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 0.0 110.529 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 71' ' ' THR . 3.4 p -93.01 -60.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.449 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.551 ' H ' HG13 ' A' ' 70' ' ' VAL . 8.6 t -174.69 146.96 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.58 178.12 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.714 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 101.91 -76.62 0.35 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.947 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.81 48.96 0.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.176 0.512 . . . . 0.0 111.77 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -95.37 -24.01 16.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.68 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 5.9 pt20 -60.66 -42.0 96.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.845 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.24 87.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.719 0.295 . . . . 0.0 110.54 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -62.83 -42.2 99.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.07 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.12 -51.62 65.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.282 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 p -55.86 -32.93 64.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.383 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -60.18 -65.0 0.75 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.118 0.485 . . . . 0.0 110.611 179.16 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.82 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.4 m -58.45 -32.2 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.594 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -65.79 -43.6 88.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 0.0 110.106 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -71.28 -33.73 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.46 -29.82 65.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.338 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -34.82 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -87.65 -8.64 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.099 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -44.22 -45.15 8.34 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.66 63.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.218 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.8 55.83 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.792 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.7 Cg_endo -80.47 38.38 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.116 1.877 . . . . 0.0 111.569 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.839 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.4 t-20 -68.3 162.76 24.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.089 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.481 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 25.8 m95 -53.53 -26.98 23.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.71 -42.3 98.69 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.71 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.9 mtp180 -86.72 -22.47 26.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.82 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.31 -31.69 54.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 110.25 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.862 HG22 ' HB1' ' A' ' 49' ' ' ALA . 9.5 t -61.62 -56.84 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.5 -27.56 69.36 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.618 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.824 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.3 m-85 -57.07 -55.82 29.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.054 0.454 . . . . 0.0 109.942 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.585 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 12.5 m-85 -75.96 -38.68 57.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.938 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 5.8 t -60.85 -37.66 77.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -55.74 -50.5 70.2 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.77 0.319 . . . . 0.0 111.219 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.21 -38.44 34.41 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.056 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.5 96.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.081 0.44 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.546 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.74 -38.27 80.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.13 -45.19 95.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.186 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.603 ' HB2' HD11 ' A' ' 22' ' ' LEU . 85.2 m -63.86 -42.51 97.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.034 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.43 31.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 110.843 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.97 -16.12 63.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 m -77.98 -33.83 51.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 107' ' ' CYS . 22.2 t -77.08 -20.85 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.708 0.766 . . . . 0.0 109.019 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -82.09 -2.33 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.235 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -138.27 -155.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.16 53.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.698 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.506 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -127.66 44.87 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 8.7 mt-10 -54.08 -56.2 28.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 22.0 Cg_exo -66.54 -32.13 40.02 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.018 1.812 . . . . 0.0 112.954 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.714 HD21 ' H ' ' A' ' 73' ' ' GLY . 3.9 mp -59.57 -31.93 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.11 -53.74 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.42 86.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.084 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 14.0 mm-40 -65.09 -50.81 64.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.8 t -57.87 -35.07 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -63.02 -47.07 84.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.703 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.9 pt-20 -71.49 -39.04 71.12 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.008 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.68 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 35.7 m0 -58.1 -38.08 75.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 109.128 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.6 ttm -73.1 -55.6 6.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.67 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.7 p -60.3 -33.34 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.12 -50.89 36.04 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.598 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.458 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 9.5 t80 -58.2 -33.59 69.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.465 0.65 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.846 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.89 -52.51 9.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.116 -178.376 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -34.76 76.57 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 m -81.72 -39.21 24.57 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -43.32 2.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.9 mm? -61.61 -44.08 97.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.295 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.62 61.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.62 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.69 -53.7 30.84 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.839 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.1 t90 -56.68 -46.69 81.01 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.51 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.29 -49.05 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.418 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -64.07 -34.97 79.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -80.97 -13.28 59.02 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -43.38 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.851 0.358 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.9 -26.86 0.11 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 102.99 171.29 26.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.061 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -58.78 -29.47 66.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.87 79.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.821 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.29 -41.01 97.08 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.648 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.524 ' HE1' HH21 ' A' ' 163' ' ' ARG . 9.7 t80 -66.01 -35.27 80.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.499 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.867 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -67.02 -29.1 68.83 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.127 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -26.72 24.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.186 0.517 . . . . 0.0 109.976 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 8.6 mt -71.2 -40.98 70.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.773 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -130.65 31.79 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.153 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.29 -133.18 7.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.527 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.14 -43.27 17.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.162 0.506 . . . . 0.0 110.302 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.455 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -87.71 52.27 4.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.454 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.31 73.62 10.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.154 0.502 . . . . 0.0 110.077 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -62.79 169.97 2.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.425 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.47 -33.93 66.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.403 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.714 ' HB2' HD12 ' A' ' 156' ' ' LEU . 23.1 mt-10 -72.15 -45.22 61.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.69 0.281 . . . . 0.0 110.524 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.97 -42.68 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -62.48 -50.7 70.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.795 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.62 -35.4 80.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 2.9 mt -67.94 -29.89 69.07 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.361 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.524 HH21 ' HE1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.22 -48.27 62.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.554 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.545 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.4 OUTLIER -67.43 -44.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.587 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.87 -25.32 73.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.989 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -69.13 -51.22 40.56 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.571 0.224 . . . . 0.0 111.379 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.871 ' HA ' HG22 ' A' ' 170' ' ' VAL . 19.5 p-90 -71.98 -21.23 61.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.239 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.71 82.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.309 0.576 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -86.26 -32.84 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.572 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.871 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.5 m -86.99 -31.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -73.13 -32.97 65.26 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.938 -0.477 . . . . 0.0 110.413 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.837 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.6 OUTLIER -85.63 -27.6 25.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.095 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.5 p -71.0 -26.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 0.0 110.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 1.1 mt -120.46 39.54 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.298 0.571 . . . . 0.0 110.388 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.837 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.3 OUTLIER -62.42 -29.93 70.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.794 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.67 40.88 2.99 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.496 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -105.0 10.56 34.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 109.896 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.86 57.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -85.47 -4.7 59.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.694 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.82 ' HG ' HG11 ' A' ' 82' ' ' VAL . 9.2 mt -87.11 -17.78 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.3 89.18 0.8 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.752 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.678 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -95.86 142.0 28.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.066 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.33 95.27 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.013 2.475 . . . . 0.0 112.141 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' -2' ' ' LEU . 0.6 OUTLIER -68.12 -37.45 81.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.438 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 161.64 -129.15 2.04 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.0 134.65 40.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.813 0.34 . . . . 0.0 110.887 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttm -112.03 137.55 49.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.82 125.38 45.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 p -99.8 123.92 45.82 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 23.6 Cg_exo -63.98 124.52 13.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.673 2.249 . . . . 0.0 112.127 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.64 -43.08 57.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -160.18 156.72 27.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -148.96 136.38 10.99 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -78.28 55.17 5.28 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.362 2.708 . . . . 0.0 112.003 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -162.85 0.56 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -36.88 71.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.997 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -37.84 87.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.79 -35.62 62.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.297 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.2 tp -73.69 -40.47 63.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.333 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.714 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 6.7 p -65.19 -37.71 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 110.06 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -24.65 59.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -60.33 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.698 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -59.12 -56.04 27.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.684 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.429 ' O ' HD13 ' A' ' 22' ' ' LEU . 95.9 t -64.32 -38.99 83.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.82 -52.22 53.72 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.795 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 41.2 t80 -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.696 0.284 . . . . 0.0 110.869 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.93 -42.03 97.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.782 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.5 mp -71.21 -45.17 63.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.855 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 26.5 ttp85 -65.56 -15.56 62.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.659 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.36 -36.07 24.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -153.6 78.43 1.14 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 111.836 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.95 -68.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.444 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.6 t80 -91.85 56.52 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.165 0.507 . . . . 0.0 110.01 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.56 -32.36 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.87 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.54 -33.31 71.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -91.09 56.25 3.26 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.399 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -68.21 112.26 5.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.416 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.23 -51.73 0.12 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 119.88 -1.153 . . . . 0.0 113.849 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 38.4 Cg_exo -63.47 -43.71 16.74 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.093 1.862 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.95 32.36 7.54 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.107 -0.952 . . . . 0.0 112.659 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.87 -14.26 39.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.242 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.0 142.18 15.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.781 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.39 -154.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.033 2.489 . . . . 0.0 113.242 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -85.23 80.15 9.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.628 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.51 16.31 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.809 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 13.1 m-20 -126.57 157.81 69.64 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 Cg_exo -71.36 36.58 0.3 Allowed 'Trans proline' 0 N--CA 1.474 0.34 0 C-N-CA 124.251 3.3 . . . . 0.0 113.12 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -167.81 -27.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.2 m170 -59.66 -55.25 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.959 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.502 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.1 -22.42 66.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.942 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.728 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -76.76 -48.73 17.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.994 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.406 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 1.0 OUTLIER -68.98 -32.91 72.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.368 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.25 -43.02 96.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.13 50.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 110.174 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.861 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -62.64 -62.19 1.91 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.278 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.698 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.15 -48.34 32.33 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.834 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.96 -45.5 82.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.124 0.462 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.9 96.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.695 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -76.93 -28.19 55.17 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.097 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.98 -23.09 66.52 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 m -94.85 -39.19 10.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.101 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 56' ' ' ARG . 2.7 mtt180 -84.81 -57.71 3.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 73.6 9.85 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.986 0.514 . . . . 0.0 111.383 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 58' ' ' ARG . 12.6 mtt180 -76.5 -10.28 59.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.522 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 54.43 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -57.43 1.84 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.052 0.453 . . . . 0.0 111.875 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 70.5 m-85 -55.17 -31.74 61.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -39.04 87.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.8 m-20 -70.69 -20.56 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 110.267 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 61' ' ' PHE . 25.0 mt -70.13 -41.43 73.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.99 -43.97 61.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.09 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.664 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -54.84 -43.63 73.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.616 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 41.7 mt-30 -63.22 -58.07 8.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.448 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.43 8.02 8.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 11.9 t60 -79.0 -23.06 44.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -63.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t -172.88 144.47 1.22 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.182 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.85 171.71 16.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.88 2.387 . . . . 0.0 111.598 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 97.54 -60.8 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.342 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 19.19 0.13 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.9 -22.37 56.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.606 0.241 . . . . 0.0 111.185 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.632 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -62.06 -39.5 92.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 3.9 mt-30 -67.62 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.86 -45.12 93.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.813 0.34 . . . . 0.0 110.154 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -62.35 -51.74 66.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.928 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -59.24 -33.81 71.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 74.4 mm-40 -63.56 -50.67 68.59 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.126 0.489 . . . . 0.0 109.991 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 86' ' ' LEU . 65.5 t -63.7 -37.34 79.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.461 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 m -61.64 -46.73 88.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.756 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.646 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.37 -39.45 93.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 110.243 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.0 mm-40 -67.91 -28.68 67.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.28 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -76.61 -38.57 54.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.405 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 26.9 t80 -82.29 -8.79 59.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.5 tt0 -47.16 -38.58 12.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.807 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.4 57.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.131 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.554 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 173.7 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.498 -1.334 . . . . 0.0 115.098 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 9.4 Cg_endo -82.35 23.89 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.454 2.102 . . . . 0.0 111.249 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.793 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 m-20 -63.94 158.0 23.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.078 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.668 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 5.8 m95 -50.35 -24.97 3.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.23 -49.94 66.95 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.467 -0.873 . . . . 0.0 110.955 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.736 ' HD2' HD12 ' A' ' 174' ' ' LEU . 8.4 mtt180 -86.66 -18.67 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.052 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.13 -31.51 63.38 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.471 0.653 . . . . 0.0 110.259 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.861 HG22 ' HB1' ' A' ' 49' ' ' ALA . 28.8 t -60.99 -52.63 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.49 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.64 69.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.312 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.31 -55.11 39.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.714 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 m-85 -76.65 -38.26 54.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.06 -35.69 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -52.75 -60.76 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 111.551 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.23 -34.54 69.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.143 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.288 0.544 . . . . 0.0 110.517 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.05 -39.94 82.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -60.59 -44.92 95.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.663 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.65 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.7 m -66.51 -40.73 89.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.203 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.68 -54.6 42.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.82 -15.46 62.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.1 m -78.31 -33.07 49.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' CYS . 47.3 t -75.45 -31.67 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.347 0.594 . . . . 0.0 109.556 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -77.12 0.7 20.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.208 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.695 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -132.53 -151.45 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.813 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 1.3 mt-10 -108.69 51.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.83 0.348 . . . . 0.0 111.353 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -146.87 42.24 1.13 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.69 -45.84 97.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.344 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -58.13 -16.98 29.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.279 1.986 . . . . 0.0 113.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.4 OUTLIER -82.42 -22.51 35.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.606 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 107' ' ' CYS . 49.9 t -56.02 -54.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.43 77.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.438 -0.886 . . . . 0.0 111.968 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.5 mm-40 -67.34 -50.92 58.0 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' LEU . 30.5 t -57.84 -33.86 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 0.0 109.767 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.33 -46.8 78.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.293 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.79 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.9 pt-20 -73.55 -35.12 65.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.021 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.632 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.5 m0 -58.92 -40.71 85.37 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.5 ttm -72.45 -52.79 14.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.849 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -62.01 -32.22 53.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -52.64 33.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.994 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 6.4 t80 -56.6 -34.72 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 110.81 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.061 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.45 -53.37 8.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.454 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 127' ' ' VAL . 10.9 mt-10 -62.6 -32.01 72.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.1 m -86.75 -43.61 12.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -44.5 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.061 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -59.97 -42.27 93.76 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.348 0.522 . . . . 0.0 111.632 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.32 -31.1 53.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -53.4 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.793 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 57.9 t90 -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.492 HG13 ' HE3' ' A' ' 137' ' ' TRP . 3.5 mt -57.07 -46.86 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.959 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -67.55 -29.28 68.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -94.52 -2.06 52.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -126.37 48.62 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 111.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.78 -67.41 0.92 Allowed Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.554 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.79 177.23 14.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 96.5 m95 -60.93 -28.84 69.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.07 69.67 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.794 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.668 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -68.6 -38.96 81.05 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.791 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.59 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 7.7 t80 -63.14 -41.44 99.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.363 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.728 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -64.22 -30.85 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.01 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 -16.22 35.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.761 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.46 HD22 ' HA ' ' A' ' 150' ' ' LEU . 0.3 OUTLIER -77.93 -45.15 24.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.736 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 30.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -99.85 -119.86 4.38 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -74.22 -51.07 16.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -94.13 64.53 1.68 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.204 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.62 71.78 10.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.315 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.904 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -64.24 158.16 23.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.88 -31.71 50.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.141 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.904 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.9 mm-40 -68.19 -48.92 63.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.497 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.31 83.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.417 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -59.86 -56.1 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.928 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 158' ' ' GLU . 19.5 ptt180 -69.44 -29.1 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -63.82 -39.93 95.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.335 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.843 HH22 ' HA ' ' A' ' 49' ' ' ALA . 4.0 ttp180 -70.06 -38.72 75.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.324 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.589 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.5 OUTLIER -62.85 -46.06 89.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.237 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.33 75.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.195 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.442 ' O ' HG22 ' A' ' 170' ' ' VAL . 4.7 t-20 -67.67 -56.69 8.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.972 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.938 ' HA ' HG22 ' A' ' 170' ' ' VAL . 21.4 p-90 -67.73 -21.44 65.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.412 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.8 52.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.215 0.322 . . . . 0.0 110.766 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 m -88.02 -26.91 22.35 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.938 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.1 m -80.03 -24.64 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.017 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.697 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 13.0 ttp85 -81.09 -23.06 38.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.726 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -90.19 -35.54 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.162 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.953 HG13 ' HG ' ' A' ' 174' ' ' LEU . 7.1 p -62.77 -30.15 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.163 0.506 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.953 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -118.54 40.13 3.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.992 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.726 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.69 -25.84 67.66 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.34 9.34 55.12 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.712 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -72.43 -7.64 50.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.011 0.405 . . . . 0.0 111.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.37 66.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.027 0.441 . . . . 0.0 110.513 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.45 12.65 34.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.236 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 102' ' ' PHE . 7.9 mt -100.27 -13.67 18.76 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.18 86.75 0.58 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.941 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.664 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -95.49 114.74 26.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.784 0.326 . . . . 0.0 110.355 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -4' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' -3' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' -4' ' ' GLY . 16.0 Cg_exo -69.17 -28.8 27.67 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 67.84 92.38 0.08 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.965 0.791 . . . . 0.0 111.785 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -143.62 75.59 0.31 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.636 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.8 m -153.04 164.21 38.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.645 0.259 . . . . 0.0 110.364 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttm -123.68 128.57 49.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.645 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.63 123.11 47.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -99.5 140.5 21.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.63 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.7 Cg_exo -77.42 4.15 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.153 2.568 . . . . 0.0 112.436 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.84 -28.89 8.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.745 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -152.23 129.48 11.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 0.0 110.728 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -149.74 119.22 3.84 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.638 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.7 Cg_exo -78.26 53.55 4.56 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.338 2.692 . . . . 0.0 112.106 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.34 -157.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -41.45 72.75 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.922 0.489 . . . . 0.0 112.279 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -61.12 -37.78 83.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.13 -35.76 61.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.178 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.592 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -73.63 -42.24 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.477 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.0 p -64.6 -36.11 76.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.42 60.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.318 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -65.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.94 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.2 t80 -55.13 -54.77 39.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.61 -38.34 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -62.75 -55.39 27.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.91 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.697 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 t80 -60.1 -42.64 95.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.783 0.433 . . . . 0.0 110.852 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.86 -44.8 95.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.259 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -71.13 -44.26 65.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 16.6 ttp85 -67.64 -13.01 61.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 2.5 mt-30 -84.36 -37.44 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.229 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -154.56 83.4 1.11 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.45 -69.13 0.35 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.664 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.68 54.79 1.04 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.236 0.541 . . . . 0.0 110.201 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -78.67 -27.12 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.179 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -39.16 80.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.87 57.34 4.64 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.169 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -65.98 110.97 3.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.413 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.5 -53.54 0.09 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.878 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 24.8 Cg_exo -65.12 -48.72 3.3 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.016 1.81 . . . . 0.0 111.27 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.03 31.46 6.26 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.301 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.33 -19.81 35.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 0.0 109.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.51 132.84 11.25 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -91.33 -147.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.617 2.211 . . . . 0.0 113.882 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -75.31 76.3 2.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.73 31.84 5.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.793 0.33 . . . . 0.0 111.291 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 12.7 m-20 -142.04 163.29 41.05 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.74 48.46 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.247 2.631 . . . . 0.0 112.331 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.924 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.2 m170 -59.35 -56.47 21.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.944 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.03 -24.65 64.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.906 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.31 -51.49 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.23 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.456 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 5.2 ttm -68.92 -39.36 79.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.673 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -61.95 -35.53 78.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.785 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.45 -43.76 18.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.518 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.57 -54.32 48.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.2 -47.8 54.65 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.667 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.01 -48.51 81.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 110.898 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 56' ' ' ARG . 4.1 tp10 -60.03 -48.74 80.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.926 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -68.87 -35.24 76.66 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.927 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.98 -28.0 68.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.65 0.738 . . . . 0.0 109.409 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.1 m -85.81 -32.16 21.92 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.397 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 52' ' ' GLU . 7.6 mtt180 -88.73 -21.21 23.97 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.548 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -85.16 95.9 9.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.375 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -60.67 -32.94 72.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.482 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.564 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -108.62 94.64 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.126 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.41 -70.94 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 64' ' ' LEU . 48.9 m-85 -78.51 -7.3 57.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -46.99 58.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.564 ' OD1' ' HD3' ' A' ' 59' ' ' ARG . 2.5 m-20 -68.71 -18.32 64.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.199 0.524 . . . . 0.0 110.472 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 61' ' ' PHE . 31.8 mt -72.78 -40.41 65.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.45 -45.88 51.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -53.67 -43.17 68.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.4 mt-30 -64.06 -54.77 28.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.041 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.09 16.06 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 -177.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -26.53 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 0.0 110.691 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -68.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.668 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t -165.92 145.72 5.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.501 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 8.2 Cg_exo -72.11 176.1 8.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.964 2.443 . . . . 0.0 111.974 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.775 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 90.64 -60.09 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -77.07 52.85 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 0.0 110.967 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.85 -25.52 10.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.714 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.3 pt20 -62.72 -35.36 79.5 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.856 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 24.4 mp0 -67.35 -45.14 77.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -63.56 -44.19 94.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.892 0.377 . . . . 0.0 110.086 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.26 -49.27 76.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.789 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 p -59.68 -32.95 70.96 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.849 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 14.9 mm100 -64.82 -54.95 23.09 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' HB1' ' A' ' 177' ' ' ALA . 7.4 p -61.58 -35.3 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.914 0.387 . . . . 0.0 110.406 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.4 m -66.99 -43.1 83.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.83 -44.52 92.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.232 0.539 . . . . 0.0 110.015 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 40.1 mt-10 -69.7 -18.21 63.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.782 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.88 -39.74 19.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.146 0.498 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.63 -4.86 58.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -44.33 -43.32 7.42 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.876 0.735 . . . . 0.0 111.666 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.48 57.34 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.93 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.444 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 168.0 56.85 0.03 OUTLIER Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.775 -1.203 . . . . 0.0 114.655 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.1 Cg_endo -80.5 39.8 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.326 2.017 . . . . 0.0 111.646 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.81 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 11.5 t-20 -65.56 158.93 25.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.414 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.4 m95 -54.97 -27.44 43.82 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.321 0.388 . . . . 0.0 110.297 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.75 -39.56 97.59 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.3 -24.64 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.551 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -55.26 -30.62 60.43 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 53' ' ' PHE . 9.4 t -63.07 -53.34 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.374 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.445 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -64.63 -28.09 69.38 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.282 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.5 m-85 -56.83 -56.82 16.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.131 0.491 . . . . 0.0 109.928 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 8.0 m-85 -76.1 -36.33 58.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.838 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 1.7 t -60.15 -38.05 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -58.13 -47.47 83.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.68 0.276 . . . . 0.0 111.061 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 -40.0 23.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.51 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.072 0.436 . . . . 0.0 110.608 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.43 -41.38 80.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -58.75 -47.5 84.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.76 ' HB3' HD21 ' A' ' 22' ' ' LEU . 63.3 m -60.93 -41.45 96.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.23 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.58 -55.79 25.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.53 -18.18 64.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.604 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -77.94 -27.99 49.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 43.6 t -81.77 -23.03 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -78.97 -15.26 58.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.9 -169.25 2.0 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.02 60.99 6.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.512 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.66 32.19 3.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.005 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.6 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 5.9 mp0 -54.86 -51.96 74.7 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.194 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 35.3 Cg_exo -61.14 -27.45 84.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.92 1.747 . . . . 0.0 112.433 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.775 HD21 ' H ' ' A' ' 73' ' ' GLY . 2.6 mp -71.44 -26.67 62.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.52 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.14 -53.6 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.687 0.279 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.71 83.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.79 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 117' ' ' PRO . 28.4 mt-30 -63.36 -53.68 48.73 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 118' ' ' LEU . 48.2 t -57.54 -33.9 45.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.05 0.452 . . . . 0.0 110.156 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.5 -46.48 82.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.553 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.2 pt-20 -74.09 -37.72 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.906 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.714 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.3 m0 -56.79 -37.43 71.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.9 ttm -72.36 -57.91 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.888 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -61.36 -30.36 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.975 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.8 -50.55 49.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -62.26 -31.18 71.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 111.107 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.918 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.3 -54.04 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.481 -178.762 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.02 -35.85 77.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.892 0.377 . . . . 0.0 111.876 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.1 m -78.18 -36.21 47.75 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -43.8 1.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.2 mm? -58.27 -46.51 85.88 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.394 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.82 -35.82 45.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.19 -52.05 51.86 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.81 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.5 t90 -58.13 -47.65 82.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.5 HG23 ' HH2' ' A' ' 93' ' ' TRP . 9.2 mt -56.94 -48.1 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.755 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -63.31 -32.98 74.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 m -81.88 -18.38 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 t -84.24 -55.03 4.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 111.544 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.46 -17.32 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.63 171.58 29.18 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.615 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.456 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 95.4 m95 -59.51 -28.0 66.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.95 0.405 . . . . 0.0 109.99 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.59 78.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.788 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -41.58 98.36 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.515 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.8 t80 -66.46 -34.07 77.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.49 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.926 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.06 -29.18 70.05 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.804 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.13 -26.07 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.188 0.518 . . . . 0.0 110.043 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 163' ' ' ARG . 3.5 mt -73.96 -39.14 63.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.628 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.517 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 26.7 m-85 -126.83 29.24 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.666 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.16 -140.49 5.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.557 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -54.76 12.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.075 -0.563 . . . . 0.0 111.414 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -81.25 53.59 4.66 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.72 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.94 72.02 10.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.0 109.71 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.09 165.47 3.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.627 -179.061 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HG3' ' NH1' ' A' ' 160' ' ' ARG . 2.7 mt-10 -56.99 -33.66 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.327 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.922 ' HB2' HD12 ' A' ' 156' ' ' LEU . 15.8 mm-40 -71.17 -45.57 63.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.951 0.405 . . . . 0.0 110.305 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -59.96 -47.1 87.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.777 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.4 ' NH1' ' HG3' ' A' ' 157' ' ' GLU . 6.0 ptp180 -63.72 -43.37 96.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.11 -22.37 61.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.277 0.56 . . . . 0.0 110.57 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 -47.05 17.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -62.42 -46.52 88.22 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.419 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.664 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.19 -44.3 95.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.07 -10.22 72.97 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.757 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.655 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -85.28 -58.05 2.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.861 -0.169 . . . . 0.0 110.82 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.716 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.37 -24.91 66.81 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 123.163 0.289 . . . . 0.0 111.311 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.34 84.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.407 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.9 OUTLIER -88.02 -28.02 21.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.716 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 3.2 m -91.16 -42.71 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.65 ' HD3' ' CE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -70.31 -24.83 63.08 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.534 -0.729 . . . . 0.0 111.007 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.744 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.2 OUTLIER -93.21 -9.96 37.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.913 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 170' ' ' VAL . 3.6 p -85.62 -23.22 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 0.0 109.373 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.35 40.33 3.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.802 178.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -69.52 -22.37 63.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.104 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.45 9.8 53.23 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.937 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -76.82 7.41 4.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.095 0.448 . . . . 0.0 111.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.12 65.18 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.357 0.598 . . . . 0.0 111.09 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.32 13.87 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.212 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.12 -46.65 5.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.721 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.421 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -77.54 103.43 1.85 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.123 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.631 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -94.51 -3.4 49.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.142 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.6 152.72 70.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.808 2.338 . . . . 0.0 111.888 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.65 136.79 46.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.954 0.407 . . . . 0.0 110.824 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -149.96 -160.17 9.11 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.548 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.9 t -75.95 135.16 40.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt -100.04 -4.51 29.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.65 154.43 42.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 p -114.1 140.09 24.5 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 4.7 Cg_exo -75.42 155.1 40.98 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.963 2.442 . . . . 0.0 111.874 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 135.26 29.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.61 119.32 37.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.07 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.69 133.17 59.44 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.002 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 7.4 Cg_exo -73.33 55.96 3.14 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.358 2.705 . . . . 0.0 112.12 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -85.58 -167.45 1.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.461 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -37.6 65.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.544 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.07 -37.04 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.734 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.72 62.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.849 0.357 . . . . 0.0 110.097 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.484 ' HB2' HD13 ' A' ' 42' ' ' LEU . 10.5 tp -70.32 -42.15 72.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.629 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 4.8 p -65.9 -35.39 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.939 0.4 . . . . 0.0 110.061 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -20.48 60.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.659 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.06 -63.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.72 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 3.1 t80 -55.35 -51.28 67.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.579 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 99.0 t -70.14 -41.14 78.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 110.365 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.38 -54.25 38.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.576 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.736 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 58.3 t80 -60.64 -42.91 97.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.537 0.335 . . . . 0.0 110.979 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.2 -49.09 77.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.8 mp -65.78 -48.78 70.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.604 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.62 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 6.1 ttp180 -62.6 -20.34 64.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.446 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.3 mt-30 -85.39 -32.58 22.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.311 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -148.52 75.86 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.849 0.356 . . . . 0.0 111.856 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.37 -69.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.624 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.7 t80 -92.21 51.15 1.74 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.19 -26.52 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.09 -16.01 59.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.412 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.39 49.28 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.332 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -63.67 114.36 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.08 -48.23 0.05 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.692 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 6.1 Cg_exo -77.03 -48.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.201 1.934 . . . . 0.0 111.867 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -83.77 22.76 7.39 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.557 -0.747 . . . . 0.0 114.229 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mm-40 -76.03 -32.69 59.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.37 0.585 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.61 111.95 4.23 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 84.1 Cg_endo -84.54 -139.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.563 2.175 . . . . 0.0 114.264 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -70.03 80.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.821 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.58 -0.41 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 8.0 m-20 -110.82 161.11 26.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.447 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -77.08 45.61 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.529 2.819 . . . . 0.0 112.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -173.93 -27.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.331 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.733 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.4 m170 -62.89 -51.26 67.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.559 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.525 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -64.01 -21.68 66.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.27 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.97 -52.32 11.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.544 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.0 OUTLIER -64.86 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.297 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -60.27 -40.33 89.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.206 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.94 -28.44 43.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 110.192 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.826 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -67.71 -60.47 2.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.407 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -48.91 -49.01 29.96 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.46 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.96 -53.0 58.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 111.764 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' HE ' ' A' ' 56' ' ' ARG . 8.2 tt0 -63.16 -45.66 90.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.656 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.75 -30.99 66.19 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.549 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -65.13 -30.9 71.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -86.14 -19.16 30.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.342 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HE ' ' HG3' ' A' ' 52' ' ' GLU . 16.1 mtt-85 -98.09 -49.25 4.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.187 0.518 . . . . 0.0 112.209 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.2 90.13 7.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.236 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -67.48 -21.97 65.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.166 0.508 . . . . 0.0 110.881 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -88.67 66.53 8.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 -14.43 8.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.013 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.52 -0.06 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.28 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -51.84 23.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.257 0.551 . . . . 0.0 111.088 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -57.04 -33.82 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.806 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 7.5 mp -56.93 -43.25 81.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.49 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -81.47 -42.77 19.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.63 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.33 33.69 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.639 0.587 . . . . 0.0 111.799 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.431 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.9 mt-30 -80.65 -47.71 13.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 115' ' ' MET . 0.6 OUTLIER -90.28 20.89 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.1 t60 -80.2 -38.13 31.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.222 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.553 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -90.56 -62.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.553 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -158.66 152.77 19.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 2.9 Cg_endo -79.66 178.17 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.847 2.365 . . . . 0.0 111.497 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.17 -56.52 4.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.759 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.44 34.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.129 0.49 . . . . 0.0 111.61 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.93 -24.66 16.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.648 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 12.5 pt20 -58.45 -47.15 84.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.953 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.26 -45.0 88.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.034 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.95 ' HB3' HD11 ' A' ' 180' ' ' LEU . 11.0 mtt180 -64.91 -40.82 95.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.0 t80 -67.21 -48.04 69.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.459 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -59.11 -28.64 66.72 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -68.14 -60.43 2.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.799 0.333 . . . . 0.0 110.29 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 177' ' ' ALA . 10.6 p -54.52 -36.05 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.594 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -68.81 -41.85 78.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.767 0.318 . . . . 0.0 110.475 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -69.83 -38.6 76.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.55 -26.34 64.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -82.54 -33.09 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.176 0.512 . . . . 0.0 110.392 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -85.35 -10.07 56.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -41.3 -48.73 3.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.507 -179.298 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.78 54.38 0.23 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.185 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.7 57.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 119.376 -1.392 . . . . 0.0 114.683 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 41.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.072 1.848 . . . . 0.0 111.377 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.813 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -70.65 163.14 27.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.069 -178.542 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.669 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.3 m95 -53.59 -27.54 27.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.37 97.88 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.767 HH11 ' HB2' ' A' ' 174' ' ' LEU . 5.0 mtp180 -87.46 -19.99 27.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.579 -0.31 . . . . 0.0 111.353 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.789 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -54.97 -31.87 61.04 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 110.326 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.883 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.8 t -61.52 -54.01 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.89 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.42 70.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.272 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.789 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.0 m-85 -56.72 -55.18 37.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.374 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.629 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 6.8 m-85 -76.93 -37.91 54.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.179 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.29 -37.99 78.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -51.54 63.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.696 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.24 -37.54 36.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.996 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.68 95.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.126 0.463 . . . . 0.0 110.745 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.96 -43.85 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.85 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -59.65 -42.34 92.56 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.279 0.561 . . . . 0.0 110.832 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.8 m -63.74 -44.99 91.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.047 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.2 76.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.572 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.608 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.0 OUTLIER -76.8 -17.75 58.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.8 m -82.63 -26.43 32.23 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.715 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.2 t -70.06 -38.27 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.837 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.608 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.1 p30 -82.48 1.79 35.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -120.69 -172.65 2.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.267 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.95 46.92 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.243 0.544 . . . . 0.0 111.202 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.758 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -142.22 37.15 1.54 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.199 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.3 OUTLIER -56.13 -50.12 89.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.045 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 42.8 Cg_exo -57.77 -25.94 71.09 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.163 1.909 . . . . 0.0 112.841 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.4 mm? -69.05 -25.47 64.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.42 -45.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.96 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.34 -34.75 86.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.712 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -66.0 -50.25 64.92 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 118' ' ' LEU . 29.0 t -58.17 -32.61 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.164 0.507 . . . . 0.0 109.78 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.0 -45.86 80.03 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.429 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.763 ' HA ' HG12 ' A' ' 127' ' ' VAL . 14.4 pt-20 -74.51 -36.53 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.648 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 43.3 m0 -57.4 -39.4 76.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.1 ttm -73.74 -54.96 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.784 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.3 p -61.58 -33.03 55.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -46.73 66.0 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.304 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.602 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 21.0 t80 -61.6 -36.45 80.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.564 0.697 . . . . 0.0 110.336 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.943 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.65 -54.14 15.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.254 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.59 -37.27 80.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -74.72 -36.28 62.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -130.59 -41.36 1.2 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -60.89 -49.02 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.334 0.515 . . . . 0.0 111.813 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.73 60.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.292 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.4 -55.7 19.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.192 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.813 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 42.5 t90 -53.68 -48.48 69.45 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.126 0.488 . . . . 0.0 109.797 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.2 mt -56.27 -48.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.724 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 18.6 m80 -64.53 -36.34 83.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 p -80.82 -14.93 57.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.927 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -55.65 3.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.87 -10.91 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.577 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.28 169.28 44.21 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.698 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.544 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.4 m95 -60.52 -30.52 69.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.84 73.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.106 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.515 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -64.99 -41.31 95.53 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.641 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.9 t80 -64.93 -40.83 95.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.601 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.655 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.24 -26.23 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 110.947 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.23 -29.02 22.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.439 . . . . 0.0 110.306 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -62.67 -51.84 65.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.338 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -132.43 32.93 3.87 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.26 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.84 -129.61 6.75 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.864 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -51.61 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.249 0.547 . . . . 0.0 110.642 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.13 55.89 2.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.394 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.78 73.84 7.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 110.042 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.54 161.04 15.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.81 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 3.2 mt-10 -59.21 -30.37 68.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.061 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.789 ' HB2' HD12 ' A' ' 156' ' ' LEU . 9.1 mm-40 -72.88 -36.26 67.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.79 73.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.013 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.81 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 25.3 mtt-85 -63.09 -55.24 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.386 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 158' ' ' GLU . 2.9 ptm180 -65.0 -25.15 67.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -68.47 -43.42 77.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.93 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.647 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.4 ttp180 -70.95 -34.52 71.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.521 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.521 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER -69.49 -45.6 68.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.172 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.19 -22.14 77.32 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.632 ' O ' HG22 ' A' ' 170' ' ' VAL . 18.8 t-20 -64.13 -66.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.406 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.631 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 26.7 p-90 -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.931 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.47 75.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.99 -29.46 20.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 166' ' ' ASN . 8.4 m -92.13 -35.64 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -70.23 -34.36 72.78 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.925 -0.484 . . . . 0.0 110.595 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.95 -13.39 50.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.905 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.736 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -86.22 -23.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 109.893 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.767 ' HB2' HH11 ' A' ' 95' ' ' ARG . 0.8 OUTLIER -121.07 34.29 5.26 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.012 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -65.33 -18.1 65.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.823 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.69 -4.58 76.38 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.185 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.94 -5.12 23.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 175' ' ' THR . 2.9 t -80.02 65.54 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 110.994 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.28 -10.11 58.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.95 HD11 ' HB3' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -101.04 63.93 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.752 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.97 -55.33 4.9 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.591 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 183' ' ' LEU . . . -161.45 -4.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 0.0 111.244 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' LEU . . . . . 0.404 ' H ' ' H ' ' A' ' 182' ' ' ALA . 1.1 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.733 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -4' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' -3' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' -4' ' ' GLY . 13.4 Cg_exo -69.91 -19.6 35.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.891 2.394 . . . . 0.0 112.077 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' -2' ' ' LEU . 2.3 mm? -93.96 122.01 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.41 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 173.33 179.18 43.83 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.17 -45.27 4.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.168 0.484 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.53 -171.0 0.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.21 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 124.15 7.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.5 p -99.4 126.63 36.96 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 14.2 Cg_exo -69.54 117.16 4.9 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.866 2.377 . . . . 0.0 111.772 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.98 122.16 36.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.576 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m -113.15 34.1 4.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 110.409 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -143.42 141.85 20.0 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 6.9 Cg_exo -73.71 84.96 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.07 2.513 . . . . 0.0 112.103 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.18 -162.27 0.33 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.219 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -47.64 64.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -59.07 -37.74 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.491 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.14 -36.6 61.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.989 0.424 . . . . 0.0 109.966 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.44 -42.37 71.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.249 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.9 p -63.57 -37.38 79.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.06 0.457 . . . . 0.0 109.775 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.03 -23.87 61.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.88 -63.42 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.255 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.62 -50.06 66.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.5 t -69.06 -41.14 81.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.107 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.17 -49.2 81.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.79 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 65.2 t80 -62.32 -47.17 85.45 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.594 0.358 . . . . 0.0 111.475 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -40.9 96.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.285 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -72.15 -46.9 54.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.808 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.455 HH11 ' HB1' ' A' ' 31' ' ' ALA . 18.6 ttp85 -63.5 -17.06 62.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.804 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -80.87 -36.2 31.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.71 78.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.101 0.476 . . . . 0.0 112.082 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.35 -63.12 0.41 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.449 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 1.4 t80 -90.59 50.5 1.83 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.199 0.523 . . . . 0.0 109.915 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.3 -34.16 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.161 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -22.83 63.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.666 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.29 49.83 0.85 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.614 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -65.79 126.81 29.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.524 ' HA2' ' HG3' ' A' ' 35' ' ' GLU . . . 168.36 -54.23 0.22 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.736 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.62 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 17.4 Cg_exo -68.83 -49.22 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.312 2.008 . . . . 0.0 112.21 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -90.1 31.53 5.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.521 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 mm-40 -79.14 -43.05 24.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.608 . . . . 0.0 109.758 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.92 147.17 33.18 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.892 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.7 Cg_endo -98.41 -151.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.196 2.598 . . . . 0.0 113.579 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -80.7 87.33 5.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.52 -14.09 5.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 47.7 m-20 -94.41 158.74 35.18 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.076 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 148' ' ' THR . 3.2 Cg_endo -75.17 50.7 2.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.721 2.947 . . . . 0.0 111.816 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' HD2' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -178.97 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.345 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.6 m170 -60.58 -56.57 19.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.119 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.675 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -59.37 -24.73 63.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.041 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -77.81 -51.48 10.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.45 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.6 ttm -64.72 -41.75 95.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -62.83 -31.55 72.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.665 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.16 -44.68 19.43 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.737 0.304 . . . . 0.0 110.468 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.73 -54.19 49.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.09 -49.18 50.63 Favored Glycine 0 C--O 1.213 -1.165 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.238 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -56.4 -51.61 67.72 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.841 0.456 . . . . 0.0 111.627 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -48.25 82.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB2' HG11 ' A' ' 97' ' ' VAL . 6.4 m-85 -69.97 -32.83 71.26 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.391 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.02 -27.05 68.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.706 0.765 . . . . 0.0 109.029 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -79.65 -31.94 41.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.617 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.1 mtt180 -89.84 -54.01 4.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.187 0.517 . . . . 0.0 111.376 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 68.81 10.6 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.555 0.742 . . . . 0.0 111.099 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -74.47 -26.19 59.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.955 0.407 . . . . 0.0 111.912 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -82.11 61.82 5.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.26 -31.14 4.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 111.516 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HA ' HD22 ' A' ' 64' ' ' LEU . 50.2 m-85 -72.78 -17.0 61.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.163 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.804 0.335 . . . . 0.0 111.499 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -71.97 -23.44 61.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.014 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.02 -41.82 85.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.85 -48.74 35.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.156 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.54 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -52.24 -42.16 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.458 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.653 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 42.6 mt-30 -65.92 -58.5 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.304 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 14.1 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 30.2 t60 -79.24 -27.25 42.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.862 0.363 . . . . 0.0 110.495 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.85 -70.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.675 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -163.64 150.83 10.57 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.908 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 4.1 Cg_exo -80.49 175.8 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.052 2.502 . . . . 0.0 112.404 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.659 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 93.33 -65.11 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.852 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.39 46.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.316 0.579 . . . . 0.0 111.907 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.91 -18.41 14.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.433 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.671 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.3 pt20 -64.15 -38.54 91.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.695 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 10.2 mp0 -69.44 -36.05 76.27 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.865 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.653 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 1.5 ttt180 -67.15 -47.19 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.62 -48.94 78.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 p -60.2 -33.55 72.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 89.9 mm-40 -63.3 -57.37 10.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 110.812 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.762 HG11 ' HG ' ' A' ' 180' ' ' LEU . 4.1 m -62.73 -33.06 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.366 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -65.78 -43.41 88.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.724 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.58 -37.27 87.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.98 -30.35 63.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.628 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.649 ' HG ' HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -75.05 -35.33 61.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.806 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 91' ' ' PRO . 33.7 t80 -89.51 -13.27 37.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.567 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -33.55 -61.01 0.34 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.506 1.123 . . . . 0.0 113.891 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.2 62.81 0.49 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.163 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.79 70.53 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.944 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 87' ' ' PHE . 6.8 Cg_endo -75.87 46.95 1.82 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 111.505 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.749 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -66.29 165.23 14.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.149 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 26.9 m95 -55.33 -28.36 53.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.402 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.4 89.8 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.778 HH11 ' HB ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -85.85 -28.4 24.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.317 178.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.817 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.39 -30.9 61.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.301 0.572 . . . . 0.0 110.57 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.7 t -66.49 -56.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.818 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.34 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.119 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.817 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.8 m-85 -56.35 -58.19 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 110.473 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 9.6 m-85 -75.07 -35.45 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.228 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.79 -39.05 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -56.38 -51.86 66.74 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.7 0.286 . . . . 0.0 111.286 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.58 -41.11 44.95 Favored Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.285 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.54 88.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.347 0.573 . . . . 0.0 110.905 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.34 -40.95 70.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.74 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.32 -46.85 87.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.465 179.187 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.727 ' HB3' HD21 ' A' ' 22' ' ' LEU . 68.9 m -62.17 -41.63 98.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.5 -54.94 37.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.14 66.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.578 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.425 ' HB2' HG22 ' A' ' 119' ' ' VAL . 67.1 m -76.74 -31.61 57.22 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 14.1 t -79.06 -23.34 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.451 0.643 . . . . 0.0 109.295 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -84.06 -5.03 59.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.189 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 13.3 mttt -125.72 -152.44 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.432 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 2.0 mt-10 -108.19 50.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.205 0.526 . . . . 0.0 110.106 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.32 56.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.445 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.5 mp0 -62.38 -52.71 64.11 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.2 Cg_exo -65.41 -25.44 56.13 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.356 2.037 . . . . 0.0 113.112 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 73' ' ' GLY . 4.5 mp -67.5 -30.68 70.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.425 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 110' ' ' SER . 91.6 t -57.61 -55.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.186 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.89 85.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.061 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.535 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.5 mt-30 -65.18 -51.42 61.2 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 118' ' ' LEU . 86.2 t -57.05 -35.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 109.867 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.16 -47.52 82.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.588 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.8 pt-20 -72.8 -37.1 67.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.085 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.671 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 42.8 m0 -58.89 -39.41 81.34 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.409 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 9.8 ttm -72.6 -53.94 10.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.852 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.97 -33.16 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.592 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.1 OUTLIER -67.26 -51.02 58.08 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.077 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 23.9 t80 -58.36 -35.69 72.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.542 0.687 . . . . 0.0 110.742 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.29 -56.05 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.559 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.75 -24.04 67.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.0 m -82.2 -43.13 18.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.93 -37.29 2.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -61.41 -48.17 82.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.229 0.468 . . . . 0.0 111.377 -178.585 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -37.54 62.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.257 0.348 . . . . 0.0 110.952 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.99 -53.53 52.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.413 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 59.4 t90 -57.31 -48.99 77.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.546 HG13 ' HE3' ' A' ' 137' ' ' TRP . 26.6 mt -57.77 -47.46 85.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.812 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.5 m80 -68.05 -26.93 66.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 m -96.23 -3.48 44.12 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.75 -53.16 3.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 111.724 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.97 -13.09 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.76 166.24 42.04 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.45 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 92.9 m95 -59.36 -30.24 68.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.5 81.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.1 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -62.69 -42.95 99.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.17 -34.14 77.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.504 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.923 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.57 -26.38 67.09 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.723 0.297 . . . . 0.0 110.836 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.79 -47.1 12.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.52 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -54.09 -42.67 69.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.35 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -119.19 24.91 10.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.41 -135.89 4.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.647 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.64 -45.33 59.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.189 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -82.0 52.43 4.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.608 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.11 70.18 10.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.054 0.454 . . . . 0.0 110.381 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -64.89 158.92 23.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.902 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.1 tp10 -57.01 -33.86 67.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.072 0.463 . . . . 0.0 110.82 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.9 mp0 -68.12 -38.3 82.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -75.62 -37.31 59.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 110.613 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.4 mtm180 -58.56 -53.36 59.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 7.8 ptm180 -69.11 -23.54 64.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.595 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.3 mt -71.95 -41.87 67.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.364 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -70.57 -35.86 73.29 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.111 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.95 -43.76 64.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.797 178.865 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.29 -20.27 74.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.904 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 8.3 t-20 -65.3 -63.9 0.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.684 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.829 ' HA ' HG22 ' A' ' 170' ' ' VAL . 28.1 p-90 -64.72 -22.91 67.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.777 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.15 57.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 0.0 110.591 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -16.43 33.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.9 m -101.79 -35.75 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 167' ' ' TRP . 3.0 ttp180 -78.16 -27.84 48.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 122.229 -0.294 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 m -82.8 -15.07 53.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.86 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.08 -9.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 ' HG ' ' A' ' 86' ' ' LEU . 81.5 mt -79.74 -8.59 59.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.75 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 p -57.01 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.42 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.0 -24.02 2.58 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.39 13.84 0.87 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.98 0.419 . . . . 0.0 111.154 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.25 68.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.73 0.92 42.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.022 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.762 ' HG ' HG11 ' A' ' 82' ' ' VAL . 8.9 mt -86.78 -38.5 16.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -75.26 95.49 0.96 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.469 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -81.06 98.87 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.663 179.581 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.7 130.59 30.14 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 112.075 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -49.82 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -170.29 -122.18 0.62 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.374 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -40.16 63.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.036 0.446 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -133.98 159.05 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.67 145.17 18.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 p -108.23 134.7 20.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.359 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.4 Cg_exo -76.76 1.99 7.96 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.993 2.462 . . . . 0.0 112.6 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.73 84.27 0.96 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.646 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.39 112.03 24.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -100.75 131.67 23.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 9.5 Cg_endo -89.31 76.78 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.361 2.707 . . . . 0.0 111.743 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.64 -160.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.674 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.19 -45.95 44.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -61.8 -33.29 73.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.569 0.223 . . . . 0.0 111.281 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.51 -34.03 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.5 tp -73.33 -41.7 63.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.05 -36.24 76.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.55 59.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.7 -66.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.607 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.73 -50.71 67.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.922 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.1 t -67.34 -42.53 87.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.255 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.27 -52.55 52.01 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.2 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.695 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.5 t80 -55.82 -46.18 78.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.992 0.517 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -66.24 -41.31 90.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.2 mp -70.16 -47.37 61.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.118 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 27.1 ttp85 -64.17 -18.83 64.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.541 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -78.86 -34.63 44.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -156.31 77.7 0.93 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 111.667 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.22 -70.12 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.732 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -87.31 52.31 2.47 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.144 0.497 . . . . 0.0 110.352 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.35 -34.09 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.078 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -39.62 93.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.06 57.48 2.11 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.449 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.71 130.97 45.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.309 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.42 -51.61 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.665 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 36.6 Cg_exo -62.05 -46.45 13.03 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.82 1.68 . . . . 0.0 111.446 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.48 38.01 3.32 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.194 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -89.01 -23.11 22.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.111 0.481 . . . . 0.0 109.965 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -98.86 142.2 15.95 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 86.8 Cg_endo -93.5 -155.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.772 2.315 . . . . 0.0 113.71 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -79.18 83.16 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.333 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.82 33.44 3.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 111.087 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.8 m-20 -139.91 165.79 28.42 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.063 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 148' ' ' THR . 60.5 Cg_endo -81.54 49.39 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.266 2.644 . . . . 0.0 111.8 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.68 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.85 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.0 m170 -60.47 -57.52 12.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.698 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 3.8 mt-30 -59.32 -25.99 64.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.751 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.9 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.07 -52.59 10.66 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.184 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.0 ttm -66.53 -38.53 87.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.88 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.92 -38.29 85.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.885 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 -42.25 29.19 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.415 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.784 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.28 -56.73 18.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.96 -48.06 46.6 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.643 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.01 -47.6 84.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.056 0.428 . . . . 0.0 110.994 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -45.67 91.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.835 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.34 -34.91 70.95 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -24.43 67.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.532 0.682 . . . . 0.0 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -95.45 -18.59 20.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -98.67 -38.37 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.848 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.99 104.03 15.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.528 0.68 . . . . 0.0 110.467 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 58' ' ' ARG . 9.9 mtt180 -87.81 -0.19 56.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.501 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -125.48 58.07 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.863 0.363 . . . . 0.0 111.18 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 0.55 10.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.936 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.878 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.9 m-85 -118.65 -28.75 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.716 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -31.56 72.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.653 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -72.8 -20.06 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.878 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.25 -40.5 70.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.28 -43.62 50.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -54.59 -43.01 71.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.886 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' NE2' HD22 ' A' ' 180' ' ' LEU . 41.3 mt-30 -64.66 -56.92 10.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.005 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.85 12.25 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 3.4 t-80 -77.7 -24.86 49.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.05 0.452 . . . . 0.0 109.96 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -76.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -160.65 145.47 10.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 9.5 Cg_exo -71.46 174.88 10.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.825 2.35 . . . . 0.0 111.722 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.742 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 85.84 -57.81 4.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.249 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.14 50.83 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 111.346 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.6 -25.05 9.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -64.79 -32.78 74.63 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.307 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -72.38 -35.0 68.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.06 0.457 . . . . 0.0 109.885 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 11.7 mtt-85 -70.19 -44.53 68.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.41 -48.61 78.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -57.92 -34.55 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.248 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -59.75 -63.03 1.45 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 110.501 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 ' HG ' ' A' ' 180' ' ' LEU . 10.8 m -59.31 -31.85 47.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.775 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -66.51 -41.96 88.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 109.982 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -38.71 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.857 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 72.0 mt-10 -70.27 -31.99 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.902 179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -35.69 44.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.955 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -88.83 -4.19 58.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.0 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -45.55 -43.2 11.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.03 -179.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.88 63.09 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.56 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.06 54.36 0.02 OUTLIER Glycine 0 CA--C 1.524 0.595 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.752 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 28.0 Cg_endo -80.65 42.07 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.964 1.776 . . . . 0.0 111.785 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -69.36 161.12 30.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.407 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.495 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 14.2 m95 -54.33 -26.89 32.3 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -40.69 96.99 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.622 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.0 mmp_? -87.49 -22.22 25.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.281 . . . . 0.0 110.786 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.806 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -55.5 -31.38 61.98 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.407 0.622 . . . . 0.0 110.151 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.9 t -61.43 -53.97 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.678 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.59 -29.0 70.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.315 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.806 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.4 m-85 -56.87 -56.56 20.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.016 0.436 . . . . 0.0 110.078 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -76.52 -36.53 57.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.362 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 t -61.8 -36.44 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -56.31 -55.71 30.09 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 111.321 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.3 59.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.367 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.64 99.1 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.344 0.572 . . . . 0.0 110.709 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.8 -40.61 75.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.751 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.12 -47.14 81.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.442 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 22' ' ' LEU . 87.9 m -61.98 -44.64 96.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.787 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.43 69.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.417 . . . . 0.0 111.363 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.633 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -82.73 -23.41 34.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -27.95 40.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.951 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 53.8 t -69.8 -37.03 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 12.6 p30 -84.82 1.68 45.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -121.42 -152.79 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.483 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 6.1 mt-10 -108.68 47.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.538 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -136.81 39.13 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -57.82 -51.0 84.97 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.109 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.7 Cg_exo -63.92 -12.01 29.86 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.169 1.913 . . . . 0.0 112.908 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.742 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.7 mp -85.05 -24.05 28.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.012 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.41 -54.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.93 72.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.129 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 74.5 mt-30 -67.84 -53.47 26.53 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 54.8 t -56.02 -34.81 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 0.0 109.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.47 -46.49 85.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.47 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 16.6 pt-20 -73.69 -38.01 65.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.952 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.8 m0 -58.39 -38.95 78.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.713 0.768 . . . . 0.0 109.091 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.2 ttp -72.58 -55.2 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.988 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.3 p -62.89 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.554 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 2.9 tt0 -67.78 -53.32 28.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.155 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -59.36 -33.28 70.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.377 0.608 . . . . 0.0 110.746 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.95 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.35 -56.43 5.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.153 -178.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.52 -29.05 68.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 m -84.62 -36.53 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -125.51 -44.88 1.82 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.95 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -59.12 -46.9 87.13 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.37 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.77 65.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.263 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.44 -48.36 73.02 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.196 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.6 t90 -58.31 -50.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -56.19 -48.91 78.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.405 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -60.73 -34.17 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.754 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 m -86.3 -16.15 38.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.15 -58.81 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.405 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -174.94 -5.3 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 86.1 171.65 48.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.955 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -62.48 -26.48 68.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.2 -35.99 82.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.443 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.5 tt0 -63.52 -44.02 95.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 12.9 t80 -64.86 -36.43 84.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.684 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.9 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 m -66.34 -27.18 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.201 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.34 25.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.684 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -72.05 -42.65 66.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.338 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -118.65 25.43 10.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.931 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -109.48 -143.09 9.89 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.12 -22.4 28.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.263 0.554 . . . . 0.0 110.567 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -95.14 33.26 5.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.615 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.56 70.62 4.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.666 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.515 ' H ' HD23 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -63.5 170.55 3.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.163 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.18 -35.84 60.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.241 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 40.2 mt-10 -68.12 -40.27 82.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.759 0.314 . . . . 0.0 110.706 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.68 -36.66 76.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 163' ' ' ARG . 7.4 mtm180 -60.28 -56.62 19.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.3 -23.81 65.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -70.75 -47.92 57.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.229 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 3.5 ptt85 -66.94 -36.76 82.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.309 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 1.7 mt-10 -70.26 -44.21 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.298 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.84 75.1 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 170' ' ' VAL . 9.7 t-20 -59.94 -66.13 0.57 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.577 -0.812 . . . . 0.0 111.111 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 32.2 p-90 -61.56 -27.8 68.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.342 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.38 -41.32 69.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 110.79 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -30.1 20.27 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 92' ' ' ASN . 2.7 m -92.18 -36.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -66.22 -29.47 69.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.927 0.394 . . . . 0.0 110.596 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -15.16 29.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.848 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.814 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.4 p -86.11 -25.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.557 . . . . 0.0 110.365 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.9 OUTLIER -120.66 32.95 5.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.016 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.71 70.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.409 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.35 48.23 3.77 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.277 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -111.36 15.53 21.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.489 0.661 . . . . 0.0 109.272 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.17 67.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.271 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -100.8 10.4 41.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.914 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.739 ' HG ' HG11 ' A' ' 82' ' ' VAL . 19.1 mt -99.81 -52.63 3.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.683 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -65.51 95.77 0.23 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.088 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.553 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -102.73 148.75 25.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.096 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.39 -31.72 21.59 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.904 2.403 . . . . 0.0 111.974 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.14 132.4 34.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.321 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -168.5 44.21 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.544 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.2 m -106.93 122.21 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.774 0.321 . . . . 0.0 110.456 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtm -106.8 6.67 29.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.22 146.05 26.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 p -106.16 134.55 19.72 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 6.7 Cg_exo -73.34 102.87 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 111.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.64 141.8 33.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.33 65.51 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.19 0.519 . . . . 0.0 110.938 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -118.23 150.43 47.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.658 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 6.6 Cg_exo -74.43 62.27 5.31 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.155 2.57 . . . . 0.0 112.374 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.3 -151.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -45.09 72.58 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.267 0.627 . . . . 0.0 112.682 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -36.25 79.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.727 0.298 . . . . 0.0 111.133 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . . . -76.55 -35.68 58.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 110.057 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.69 -40.21 66.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.0 p -65.69 -39.2 84.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.074 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.29 60.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.504 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -59.31 2.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.185 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.669 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.3 t80 -57.13 -53.91 52.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.749 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.6 t -66.62 -40.18 85.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.36 -51.3 59.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.011 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.787 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.4 t80 -63.2 -41.7 99.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.711 0.291 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.63 -40.77 97.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.649 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.4 mp -73.36 -42.7 61.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 8.2 ttp85 -65.69 -15.52 62.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.272 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.03 -35.29 25.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.04 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -158.16 79.4 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.553 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.58 -70.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.665 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -88.84 58.98 4.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.13 0.49 . . . . 0.0 110.537 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.48 -29.82 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.036 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -42.87 78.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.577 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.35 59.37 3.79 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.076 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.6 127.34 32.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.26 -54.51 0.36 Allowed Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.793 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.569 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 45.0 Cg_exo -58.53 -42.92 49.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.026 1.818 . . . . 0.0 111.407 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.94 37.65 3.65 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.478 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.84 -6.91 53.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.139 0.495 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.28 144.9 15.84 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.78 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 88.2 Cg_endo -96.06 -150.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.995 2.463 . . . . 0.0 113.118 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -88.59 86.48 7.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.62 1.93 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 55.0 m-20 -107.03 160.4 26.48 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -78.27 41.12 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.23 2.62 . . . . 0.0 111.991 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.44 -28.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.932 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.7 m170 -59.02 -56.5 21.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.848 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.491 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.67 -27.06 67.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.99 -49.58 36.0 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.421 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.9 OUTLIER -67.8 -31.57 71.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -40.99 97.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.45 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -23.27 43.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 109.851 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.808 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -70.27 -63.88 1.0 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.099 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.35 -48.41 41.08 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.864 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -42.65 79.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.089 0.471 . . . . 0.0 111.262 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -62.88 -44.32 96.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -75.64 -29.33 59.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.919 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.18 -24.09 66.57 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -40.48 10.15 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.634 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -88.96 -54.36 4.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -85.3 68.64 10.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.75 0.42 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -75.93 -22.99 55.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.358 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.19 37.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.035 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -120.79 -5.01 9.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.863 ' HA ' HD22 ' A' ' 64' ' ' LEU . 4.9 m-85 -93.6 -31.05 14.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.891 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.18 67.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.831 0.348 . . . . 0.0 111.425 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 2.0 m-20 -77.79 -18.02 56.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.892 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.863 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -72.83 -39.63 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.36 -46.0 35.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.979 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.87 -42.87 63.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.955 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.525 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 47.8 mt-30 -67.8 -61.61 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.656 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -79.61 13.33 2.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 47.0 t60 -79.13 -26.45 42.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -74.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.998 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -159.84 142.77 10.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.075 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.8 Cg_exo -75.6 -175.34 2.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.009 2.473 . . . . 0.0 112.069 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.713 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.74 -65.81 2.94 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.027 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.24 41.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.833 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -97.11 -21.17 17.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.663 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 8.3 pt20 -63.83 -37.97 89.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.607 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 4.4 mm100 -68.95 -35.22 76.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.32 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.49 -48.15 61.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.14 0.495 . . . . 0.0 109.769 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.53 -47.62 84.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.068 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -58.66 -34.98 71.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.429 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 73.4 mm-40 -60.23 -56.63 19.25 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.177 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.3 t -59.0 -37.86 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.081 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.2 m -62.47 -46.37 88.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.551 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.8 OUTLIER -69.46 -36.32 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 33.4 mm-40 -67.53 -32.87 73.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.872 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' HA ' HD13 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -77.17 -36.73 54.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.23 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' HB2' ' HE2' ' A' ' 129' ' ' TYR . 55.2 t80 -85.21 -5.61 59.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -53.79 -37.09 63.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.563 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.46 59.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.813 -1.184 . . . . 0.0 113.384 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.625 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 167.27 49.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.605 -1.284 . . . . 0.0 115.17 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -80.7 38.98 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 119.913 1.856 . . . . 0.0 111.715 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.761 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -70.15 162.61 27.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.529 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 15.1 m95 -53.22 -27.86 24.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.03 -43.49 97.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -85.65 -23.15 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.675 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.765 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.35 -30.85 61.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 110.036 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.808 HG22 ' HB1' ' A' ' 49' ' ' ALA . 41.2 t -60.93 -56.3 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.41 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' A' ' 53' ' ' PHE . . . -62.93 -28.44 70.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.406 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.765 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.45 -51.84 66.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.201 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.8 m-85 -81.53 -35.05 30.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 15.2 t -63.75 -34.53 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.758 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.615 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -54.23 -59.08 5.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 111.496 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -69.78 -35.91 74.02 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.226 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.19 90.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.2 0.5 . . . . 0.0 110.602 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.19 -39.1 82.59 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.7 -45.3 94.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.759 ' HB3' HD21 ' A' ' 22' ' ' LEU . 82.5 m -64.14 -41.69 97.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.86 -53.7 52.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.293 . . . . 0.0 111.041 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -19.95 65.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -78.71 -33.78 46.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.594 0.235 . . . . 0.0 110.716 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 32.1 t -74.52 -25.88 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.481 0.658 . . . . 0.0 109.669 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.55 1.42 45.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.147 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -133.93 -169.78 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.649 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.78 57.84 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 110.025 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.485 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.54 46.44 2.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.716 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.53 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.4 mp0 -62.47 -54.25 50.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 26.3 Cg_exo -63.58 -20.19 68.95 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.077 1.852 . . . . 0.0 112.864 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -71.98 -29.49 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.62 -51.25 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.03 -31.5 80.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.608 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 23.8 mm-40 -68.06 -49.82 59.01 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 118' ' ' LEU . 42.0 t -58.72 -33.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -63.33 -46.49 86.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 12.2 pt-20 -71.55 -40.44 69.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.702 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.663 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 32.3 m0 -57.99 -39.98 79.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.555 0.693 . . . . 0.0 109.337 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.408 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.4 ttp -73.56 -53.0 11.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.956 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -63.66 -31.87 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.92 -50.52 41.29 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.068 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 7.0 t80 -58.92 -33.15 70.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 110.983 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.009 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.15 -52.27 9.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.89 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -35.32 79.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 m -81.15 -39.22 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.72 -41.33 2.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.009 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -63.36 -47.09 83.59 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.545 -178.501 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.58 -34.53 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.275 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.4 -50.0 67.16 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.219 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.761 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 45.6 t90 -59.08 -49.05 79.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 14.8 mt -56.92 -48.41 81.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.074 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -65.59 -30.52 71.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.2 m -83.55 -30.37 27.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -57.69 4.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -170.83 -10.86 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.559 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 92.3 170.24 40.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.626 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.7 m95 -62.84 -30.77 71.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.75 72.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.204 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -65.44 -41.12 93.82 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.707 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 8.2 t80 -65.85 -39.04 90.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.514 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.738 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.78 -25.73 67.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.024 0.44 . . . . 0.0 110.815 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.4 -28.04 23.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.083 0.468 . . . . 0.0 109.849 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.712 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.15 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.27 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -134.3 30.26 3.58 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.62 -111.03 3.56 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 119.84 -1.172 . . . . 0.0 112.862 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.6 -67.27 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.041 0.448 . . . . 0.0 110.973 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.94 69.88 1.86 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.553 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.54 71.38 9.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 110.343 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.1 165.04 14.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.039 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -58.91 -36.27 74.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.1 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.621 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -68.63 -38.96 80.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.344 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.712 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.98 -40.14 75.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -68.04 -49.55 60.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 157' ' ' GLU . 9.7 ptm180 -62.3 -28.57 69.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 110.385 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -67.42 -42.32 83.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.833 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.619 HH22 ' HA ' ' A' ' 49' ' ' ALA . 5.2 ttp180 -67.08 -44.04 81.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.23 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.648 ' HG3' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.11 -47.29 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.41 -23.63 75.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.739 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 2.9 t-20 -74.43 -54.53 7.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.532 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.976 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.7 p-90 -64.25 -24.29 67.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.055 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -51.36 -52.97 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.215 0.322 . . . . 0.0 110.811 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -27.72 22.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.976 HG22 ' HA ' ' A' ' 167' ' ' TRP . 25.0 m -80.02 -25.98 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.273 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.4 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.7 ttp180 -83.13 -15.11 52.04 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.809 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -96.22 -39.16 9.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 13.2 p -59.39 -33.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.403 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -115.7 44.5 1.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.634 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.16 -43.08 92.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.294 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.21 41.42 1.32 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.724 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.554 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -100.77 -4.24 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.264 0.554 . . . . 0.0 109.878 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.41 67.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.397 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.35 8.2 45.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.446 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 102' ' ' PHE . 8.7 mt -90.94 -45.24 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.64 101.58 0.31 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.183 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.579 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -104.21 157.04 17.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.7 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.994 -0.527 . . . . 0.0 109.847 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.75 151.77 36.6 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.122 2.548 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.22 14.97 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 122.08 124.2 2.99 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.471 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 128.19 43.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.795 0.331 . . . . 0.0 110.67 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.71 -52.51 17.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.3 0.571 . . . . 0.0 110.153 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.47 121.79 34.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.032 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.9 p -99.84 117.27 63.79 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 120.909 0.385 . . . . 0.0 110.96 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 21.8 Cg_exo -65.19 127.47 18.42 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.9 2.4 . . . . 0.0 111.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.77 136.53 34.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.504 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.55 138.24 17.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.769 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -86.55 127.41 60.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.439 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 8.7 Cg_exo -72.99 40.75 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.618 2.878 . . . . 0.0 112.894 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -156.65 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.42 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.22 72.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -42.8 99.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.15 -35.03 66.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.654 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.6 tp -72.91 -42.18 63.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.486 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.8 p -66.47 -37.42 79.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.0 -21.05 61.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' CE1' ' A' ' 43' ' ' HIS . 1.2 t70 -77.81 -68.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 t80 -52.3 -50.33 62.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.206 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 19.3 t -75.93 -39.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.935 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' ALA . . . -61.22 -53.69 42.53 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.527 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.735 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 85.9 t80 -60.8 -45.47 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.029 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -61.04 -47.73 85.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -67.93 -47.85 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 29.6 ttp85 -58.75 -30.95 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.554 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 -86.63 -12.03 49.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -156.47 63.09 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.46 -71.21 0.33 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.73 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -82.2 56.62 3.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.15 0.5 . . . . 0.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 t -78.31 -32.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 m -66.27 -35.38 80.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.774 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.23 51.62 2.46 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.639 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 116.16 9.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.746 0.308 . . . . 0.0 110.668 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.22 -51.05 0.13 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.599 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.7 -48.46 2.12 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.187 1.925 . . . . 0.0 111.667 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.735 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -89.47 27.48 7.76 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.94 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.25 -58.54 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.604 0.716 . . . . 0.0 109.388 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.94 139.22 30.91 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.699 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -90.53 -133.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.722 2.281 . . . . 0.0 113.567 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -83.63 92.02 7.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.452 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.84 10.63 5.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.489 0.661 . . . . 0.0 109.576 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.8 m-20 -121.11 160.51 44.95 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.365 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -81.36 37.03 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.246 2.631 . . . . 0.0 112.4 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -165.61 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.414 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 16' ' ' ASP . 2.5 m170 -56.21 -56.98 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.586 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 9.1 tt0 -57.67 -23.4 51.23 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.557 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.948 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -82.52 -49.62 9.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.434 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 4.5 ttm -66.42 -42.14 88.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -30.74 71.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.498 0.19 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.87 33.57 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.78 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.51 -55.76 30.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.097 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.98 -44.75 41.57 Favored Glycine 0 C--O 1.217 -0.93 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.613 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.01 -54.14 50.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.453 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -43.43 97.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.965 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.88 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.87 -30.24 62.53 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.495 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.97 -30.35 71.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.78 0.8 . . . . 0.0 108.864 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.1 m -79.54 -33.69 41.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.297 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 56' ' ' ARG . 19.0 mtt180 -89.56 -52.12 5.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.174 0.512 . . . . 0.0 111.716 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.27 64.13 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.303 0.641 . . . . 0.0 110.958 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -18.29 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.768 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.59 58.43 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -51.07 2.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 111.746 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 5.1 m-85 -62.17 -19.73 63.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -38.79 66.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.835 0.35 . . . . 0.0 111.311 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 3.3 m-20 -67.03 -28.41 68.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.491 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.1 mt -61.19 -43.63 98.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.338 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.8 -40.49 47.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.02 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.59 -45.52 63.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.699 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.497 ' CD ' ' HG ' ' A' ' 180' ' ' LEU . 44.0 mt-30 -67.64 -54.73 17.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.255 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -84.38 17.52 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.9 t60 -78.17 -30.28 49.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.635 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -91.5 -65.25 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.635 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -162.3 145.95 9.15 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 122.138 0.175 . . . . 0.0 110.708 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.9 Cg_exo -76.45 172.18 16.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.818 2.345 . . . . 0.0 111.355 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.92 -60.99 1.13 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.625 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.17 50.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.418 0.628 . . . . 0.0 110.93 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.76 -22.12 13.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.684 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 7.4 pt20 -64.32 -39.94 94.91 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.509 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.82 -47.71 82.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.998 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -47.66 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.81 -50.02 75.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.774 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' THR . . . . . 0.411 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 18.5 p -60.61 -30.01 69.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -68.01 -53.11 28.34 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.002 0.43 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 180' ' ' LEU . 34.2 m -65.77 -32.3 57.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.089 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 80' ' ' THR . 1.3 p -69.13 -39.94 78.59 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.892 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -46.5 82.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.239 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -68.87 -25.03 64.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -79.82 -26.15 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.501 . . . . 0.0 109.952 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -97.37 -4.24 38.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.395 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -39.04 -50.47 1.81 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.542 0.737 . . . . 0.0 112.378 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.3 48.99 0.16 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.901 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.12 56.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.221 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.6 Cg_endo -77.8 45.78 1.87 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.21 1.94 . . . . 0.0 111.817 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.8 162.92 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.598 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 17.6 m95 -54.01 -28.85 40.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.639 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.86 -40.78 98.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.204 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.607 ' HE ' ' HA ' ' A' ' 171' ' ' ARG . 6.9 mmt180 -86.35 -21.56 27.16 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.812 -0.228 . . . . 0.0 110.551 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.774 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -57.66 -30.62 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.346 0.593 . . . . 0.0 110.132 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.5 t -62.9 -55.16 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -61.61 -29.06 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.053 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.774 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 3.6 m-85 -56.42 -54.21 48.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.082 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.524 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 6.6 m-85 -79.03 -36.33 41.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.02 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 t -59.99 -38.45 76.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -57.41 -50.0 74.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.71 0.291 . . . . 0.0 111.613 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.68 -37.65 34.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.261 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.63 98.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.245 0.523 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -69.22 -38.88 78.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.549 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -60.31 -44.9 95.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.749 ' HB3' HD21 ' A' ' 22' ' ' LEU . 86.6 m -64.06 -41.01 97.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.172 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.25 -54.7 40.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -17.72 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.516 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB2' HG22 ' A' ' 119' ' ' VAL . 74.2 m -77.97 -31.0 50.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.6 t -80.95 -13.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.905 0.859 . . . . 0.0 109.163 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -85.02 0.07 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -144.64 -170.38 3.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.519 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.84 55.59 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 110.034 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.85 29.69 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.513 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -53.51 -51.07 79.29 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 116' ' ' GLU . 19.1 Cg_endo -59.84 -23.19 71.39 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.238 1.959 . . . . 0.0 113.243 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 mm? -76.04 -26.68 56.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.591 0.234 . . . . 0.0 110.777 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 110' ' ' SER . 88.9 t -59.25 -54.3 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.193 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.29 71.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.446 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 9.0 mm-40 -69.45 -49.77 51.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 46.1 t -58.52 -35.16 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.15 -50.38 73.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.359 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.666 ' HA ' HG12 ' A' ' 127' ' ' VAL . 10.7 pt-20 -69.27 -39.78 78.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.684 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.9 m0 -57.3 -40.93 78.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.391 0.615 . . . . 0.0 109.524 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.532 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.04 -44.53 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.376 -178.323 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.0 p -71.45 -31.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.741 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.57 -48.14 61.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -59.34 -35.16 73.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.692 . . . . 0.0 110.473 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.926 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.39 -53.19 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.908 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -62.36 -28.78 70.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.9 m -85.1 -36.11 21.37 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -128.14 -40.77 1.64 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.926 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.67 -45.83 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.129 0.422 . . . . 0.0 111.325 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.04 61.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.356 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -65.71 -53.96 33.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 47.8 t90 -57.12 -47.31 81.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.471 HG13 ' HE3' ' A' ' 137' ' ' TRP . 8.3 mt -57.02 -49.18 80.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -65.1 -32.71 74.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.97 -4.41 58.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -99.31 -50.71 4.03 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.871 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.462 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -176.35 -19.97 0.02 OUTLIER Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.81 168.36 35.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.434 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 89.3 m95 -60.14 -31.15 69.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.3 75.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.012 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.462 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.8 tt0 -65.74 -38.15 88.34 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.35 -38.94 81.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.747 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.948 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -61.91 -33.84 74.96 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.686 0.279 . . . . 0.0 111.401 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.78 32.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.813 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -61.74 -44.65 96.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.084 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -111.27 16.45 20.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -108.24 -137.88 8.34 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.9 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -29.66 26.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 111.217 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.84 37.9 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.092 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.13 68.81 9.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.5 OUTLIER -67.46 176.78 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.206 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -53.54 -38.42 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -68.47 -46.56 69.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.91 73.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -56.78 9.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.009 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -65.36 -34.1 77.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.351 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.0 OUTLIER -67.86 -31.47 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.652 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 150' ' ' LEU . 6.2 mtp180 -70.14 -51.59 30.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 12.8 mt-10 -67.57 -38.63 84.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.36 76.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.122 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.6 t-20 -69.4 -71.39 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.545 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 164' ' ' GLU . 35.8 p-90 -58.36 -25.4 61.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.854 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.56 -63.14 1.25 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 110.883 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.75 -23.4 24.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 8.3 t -77.99 -39.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 111.682 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.607 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 16.2 ttp180 -74.15 -24.1 59.36 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.091 -0.381 . . . . 0.0 110.699 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.732 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -84.24 -27.75 27.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.659 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 174' ' ' LEU . 0.7 OUTLIER -68.27 -22.98 27.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.983 0.421 . . . . 0.0 110.497 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.567 ' HG ' ' CG1' ' A' ' 173' ' ' VAL . 0.4 OUTLIER -120.38 38.49 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.634 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.37 -23.24 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.297 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 6.86 67.91 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.465 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.652 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -80.08 7.03 9.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.83 65.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.27 0.557 . . . . 0.0 110.713 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -102.48 13.67 33.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.19 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -100.34 -28.5 12.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.846 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -83.21 94.76 1.8 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.831 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.727 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -93.9 -168.08 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.064 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.96 126.01 15.15 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.809 2.339 . . . . 0.0 112.253 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.44 -63.21 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 171.56 -178.77 43.7 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.836 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -85.12 137.94 32.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.492 0.146 . . . . 0.0 110.659 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 0' ' ' SER . 0.0 OUTLIER 73.81 146.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.012 0.82 . . . . 0.0 111.648 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.71 138.08 35.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.365 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 p -99.42 134.58 21.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.236 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.0 Cg_exo -75.04 132.27 15.18 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.027 2.485 . . . . 0.0 112.094 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.46 122.18 27.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 111.003 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.99 115.51 28.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.6 151.36 38.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.95 108.81 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.156 2.571 . . . . 0.0 112.079 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.83 -172.04 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.81 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -28.04 50.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 111.929 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.78 -39.98 88.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 110.093 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -34.3 62.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.606 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.1 tp -72.82 -41.58 64.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.2 p -64.98 -36.96 79.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.71 62.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -66.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.0 t80 -54.21 -52.07 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.07 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.8 t -65.5 -42.02 92.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.462 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.97 -51.83 56.09 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.18 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.758 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 42.8 t80 -58.32 -45.45 88.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.009 0.524 . . . . 0.0 111.292 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -64.52 -47.87 77.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.301 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -65.23 -46.71 79.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 12.6 ttp85 -62.84 -20.42 65.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.87 -31.16 23.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.798 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.32 71.97 1.14 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.163 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.16 -69.83 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.756 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.114 0.483 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.42 -33.94 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -37.9 89.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.29 52.42 1.37 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.716 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -65.47 141.7 58.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.51 -45.71 0.53 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.111 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 11.5 Cg_exo -73.37 -47.62 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.138 1.892 . . . . 0.0 111.869 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.95 27.22 7.54 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.216 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 19.9 mm-40 -80.57 -41.96 23.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.504 0.652 . . . . 0.0 109.403 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.3 142.66 46.2 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.006 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -93.49 -166.27 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.784 2.323 . . . . 0.0 113.806 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.22 85.51 7.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.392 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.04 -23.44 4.96 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 4.2 m-20 -79.32 160.28 70.79 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.472 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' HG21 ' A' ' 148' ' ' THR . 27.8 Cg_endo -77.61 50.16 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.279 2.653 . . . . 0.0 111.568 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -178.96 -31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.287 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.68 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.8 m170 -60.42 -59.58 5.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.963 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.932 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -57.54 -27.1 62.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.732 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.88 -52.78 15.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.423 ' HE1' HD21 ' A' ' 13' ' ' LEU . 2.9 ttm -65.58 -38.3 89.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.639 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -38.63 80.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.402 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.67 45.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.22 0.533 . . . . 0.0 110.107 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.877 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -63.73 -63.21 1.23 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.48 -47.41 36.25 Favored Glycine 0 C--O 1.215 -1.038 0 O-C-N 124.137 0.898 . . . . 0.0 112.502 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -51.74 -51.62 54.84 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.855 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.06 -46.9 79.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -68.88 -35.7 77.19 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.74 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.27 -32.77 73.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 109.468 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -85.35 -18.24 34.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.606 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.06 -65.62 1.03 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.097 0.475 . . . . 0.0 111.861 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.8 67.63 8.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.243 0.617 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.26 -8.95 59.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.952 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 40.9 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -120.35 0.06 10.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.766 ' HA ' HD22 ' A' ' 64' ' ' LEU . 30.3 m-85 -89.65 -17.11 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.172 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -41.05 93.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.7 m-20 -63.18 -27.2 69.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.821 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -63.74 -42.55 97.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.722 0.773 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.51 -44.05 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.409 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -52.33 -42.24 63.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.441 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -73.01 -52.44 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.326 -179.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.34 19.91 3.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t60 -79.34 -35.3 41.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.234 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -91.42 -68.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.275 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.7 145.66 8.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.416 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.45 -178.01 4.16 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.623 2.215 . . . . 0.0 112.185 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.718 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.28 -71.3 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.879 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.68 44.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.97 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.15 -19.25 18.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.947 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 8.0 pt20 -63.78 -36.22 83.17 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.728 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -70.43 -38.73 74.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.398 . . . . 0.0 110.164 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -68.13 -44.47 76.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.946 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.45 -45.84 91.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.92 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -60.2 -33.5 72.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.195 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -61.63 -60.14 4.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.759 0.314 . . . . 0.0 111.109 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.8 p -58.61 -36.57 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -65.59 -41.97 92.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.091 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -43.3 81.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -70.21 -21.21 63.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -84.42 -34.88 23.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 110.291 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -85.43 -7.64 58.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.484 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.48 -50.54 2.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.019 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.3 56.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.861 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.31 51.28 0.05 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.599 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 13.3 Cg_endo -80.44 40.81 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.149 1.9 . . . . 0.0 111.842 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.819 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.9 OUTLIER -70.35 166.12 20.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.684 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 30.6 m95 -53.19 -30.32 36.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.437 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.49 99.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.283 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -87.12 -25.76 23.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.839 -0.181 . . . . 0.0 110.931 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.77 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.74 -31.86 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.45 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 53' ' ' PHE . 16.4 t -62.65 -56.12 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.6 -28.38 69.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.77 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.9 m-85 -55.73 -54.59 42.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.198 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.2 m-85 -78.27 -35.13 48.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.223 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 t -62.66 -36.36 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -55.2 -55.68 28.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.466 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.89 56.1 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.41 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.135 0.468 . . . . 0.0 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.07 -39.33 72.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.0 -49.92 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.672 ' HB3' HD21 ' A' ' 22' ' ' LEU . 79.8 m -60.17 -40.13 88.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.097 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.53 30.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.1 -15.96 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 119' ' ' VAL . 66.8 m -77.88 -29.02 50.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 107' ' ' CYS . 16.9 t -82.1 -17.01 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.685 0.755 . . . . 0.0 109.057 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -79.69 -8.57 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.892 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -166.16 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.511 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.25 67.64 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.02 0.438 . . . . 0.0 110.036 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.401 ' O ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -140.95 37.23 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.223 -179.05 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 3.3 mp0 -57.9 -51.7 79.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 34.1 Cg_exo -58.53 -30.73 92.69 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.044 1.829 . . . . 0.0 112.32 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -71.35 -30.95 66.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 111' ' ' VAL . 73.4 t -57.68 -52.02 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.77 -31.73 79.18 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.9 mm-40 -66.05 -50.7 63.24 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 96.3 t -56.56 -36.46 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.02 -48.32 80.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.488 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.1 pt-20 -72.46 -36.42 68.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.195 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.644 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.7 m0 -58.16 -39.77 79.71 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.8 ttp -72.89 -53.4 11.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.581 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.4 p -60.45 -32.54 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.783 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -67.12 -54.7 18.9 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.061 0.458 . . . . 0.0 110.24 179.221 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.78 -30.2 67.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.902 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.38 -52.9 8.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.526 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.29 77.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.8 m -80.83 -33.86 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 -46.31 1.95 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.902 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.31 -42.1 90.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.645 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.28 64.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.05 -51.17 60.62 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.819 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 69.8 t90 -57.81 -47.5 82.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -58.23 -47.53 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.555 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -63.52 -25.59 68.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 111.567 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -100.37 -5.64 26.96 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -122.17 44.76 2.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.722 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.33 -65.97 0.89 Allowed Glycine 0 CA--C 1.506 -0.484 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.25 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 123.59 173.45 13.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.906 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 98.5 m95 -56.04 -36.75 68.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.04 77.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.52 -43.01 98.41 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.877 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 13.7 t80 -67.48 -31.63 71.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.699 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -69.47 -25.0 63.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.155 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.57 -34.4 19.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.779 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -56.21 -51.81 66.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.929 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.423 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.7 m-85 -130.35 31.76 4.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -98.52 -134.85 8.58 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.177 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.26 -53.42 44.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 110.334 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.477 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.61 64.06 1.87 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.708 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.24 73.3 7.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.391 0.615 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -59.22 153.39 18.53 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.114 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 2.6 mm-40 -56.66 -27.64 59.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.099 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -73.37 -42.39 62.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 110.643 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -66.89 -37.56 84.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.271 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 160' ' ' ARG . 25.4 mtm-85 -65.64 -52.81 48.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.24 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 17.8 ptt180 -63.65 -31.36 72.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -65.74 -39.33 90.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.818 HH22 ' HA ' ' A' ' 49' ' ' ALA . 2.5 ttp180 -68.13 -43.65 77.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 29.2 mt-10 -62.44 -47.38 84.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.398 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.8 -23.76 75.66 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.953 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -74.04 -52.25 13.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.759 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.9 p-90 -65.28 -24.3 67.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.855 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.23 77.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.341 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -31.26 20.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 167' ' ' TRP . 27.4 m -89.51 -37.04 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -68.77 -30.91 69.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.804 -0.56 . . . . 0.0 110.939 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.29 -37.47 21.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.663 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -66.35 -27.08 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.952 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.7 OUTLIER -115.8 32.94 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.323 0.582 . . . . 0.0 109.875 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.8 -9.99 59.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.107 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.55 15.03 62.4 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.703 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.38 6.53 36.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.569 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.61 71.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.531 0.682 . . . . 0.0 109.979 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.44 8.08 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.483 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -98.46 -39.25 8.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.656 0.265 . . . . 0.0 110.849 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.443 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.69 89.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.275 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.515 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -97.05 9.43 42.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.991 0.424 . . . . 0.0 111.018 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -87.85 157.43 7.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.373 2.715 . . . . 0.0 111.999 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.09 128.1 9.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.104 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 167.88 -165.6 38.83 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.721 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.93 156.53 37.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm -117.53 -41.7 2.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.53 149.69 33.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 p -104.63 144.87 29.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.783 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 1.2 Cg_endo -84.23 82.23 1.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.077 2.518 . . . . 0.0 111.873 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.2 4.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.61 141.47 41.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 111.841 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -142.24 138.93 17.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.975 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.1 Cg_exo -77.03 57.79 5.92 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.249 2.632 . . . . 0.0 112.953 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 -160.25 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -43.19 66.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -61.18 -38.23 85.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.292 . . . . 0.0 111.213 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.72 -34.91 60.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.1 0.476 . . . . 0.0 110.137 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -72.28 -42.86 65.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.3 p -65.98 -35.8 75.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.21 61.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.333 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -66.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.5 t80 -55.08 -53.78 51.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.968 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.4 t -67.16 -37.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.221 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.68 -51.79 53.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.059 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 1.1 t80 -63.32 -47.06 83.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.44 0.296 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 1.9 tmtm? -57.84 -37.3 73.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 111.222 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -78.44 -47.34 17.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.533 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.747 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -59.35 -27.16 65.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.853 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 14.0 pt20 -85.65 -11.09 54.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.16 -56.19 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.53 -57.43 0.66 Allowed Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.665 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -78.32 46.06 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 122.782 0.433 . . . . 0.0 111.101 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.1 -31.95 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.001 0.429 . . . . 0.0 110.222 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -39.04 83.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.39 0.614 . . . . 0.0 109.356 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.61 58.43 3.75 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.575 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.747 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.26 109.76 1.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.474 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -172.56 -57.46 0.05 OUTLIER Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 35.8 Cg_exo -62.33 -50.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.235 1.956 . . . . 0.0 111.482 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -85.94 27.23 5.55 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.404 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -77.4 -31.15 53.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.079 0.466 . . . . 0.0 109.891 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.43 124.82 8.05 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 92.7 Cg_endo -87.5 -150.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.591 2.194 . . . . 0.0 113.657 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -78.22 82.81 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.78 26.82 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.439 . . . . 0.0 110.627 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 9.7 m-20 -135.76 161.63 61.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.098 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 47.1 Cg_endo -78.83 50.78 3.57 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.274 2.649 . . . . 0.0 112.279 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER 179.82 -32.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.579 179.294 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.7 m170 -60.02 -56.49 21.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 2.5 mt-30 -61.27 -25.19 66.93 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.637 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -72.82 -50.45 24.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.966 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.6 ttm -66.88 -37.37 84.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.667 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -60.93 -40.66 94.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.53 -29.38 56.72 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 110.054 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -66.19 -62.15 1.64 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.39 -45.97 28.77 Favored Glycine 0 C--O 1.216 -0.981 0 O-C-N 124.224 0.953 . . . . 0.0 112.572 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.6 -53.82 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.51 -45.87 81.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.837 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -65.16 -38.56 90.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.27 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.65 -36.53 78.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.621 . . . . 0.0 109.967 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -83.2 -12.78 56.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.352 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.88 -24.88 12.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.78 92.22 8.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.49 -31.32 70.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.421 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -119.65 79.11 1.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -120.81 -7.59 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.889 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.88 -29.62 4.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -32.84 71.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -71.58 -20.59 61.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.925 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.889 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.06 -41.06 71.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -74.34 -42.26 59.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.626 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -56.46 -43.31 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.785 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.491 ' NE2' HD22 ' A' ' 180' ' ' LEU . 40.8 mt-30 -63.42 -52.78 60.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.464 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.21 7.43 22.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.267 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 4.2 t60 -78.85 -23.27 45.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -68.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.391 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -164.67 143.12 5.55 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.1 Cg_exo -81.05 -175.96 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.412 2.741 . . . . 0.0 111.897 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 80.9 -62.3 4.44 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.82 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.83 28.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.472 . . . . 0.0 111.897 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -81.4 -23.43 37.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.662 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 12.4 pt20 -59.91 -40.83 90.16 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.927 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.28 -49.07 77.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.115 0.259 . . . . 0.0 110.757 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -59.76 -43.56 94.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.966 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.81 -52.26 64.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.646 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.59 -33.6 66.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -61.92 -51.66 67.23 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.306 0.574 . . . . 0.0 109.988 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG13 ' HB1' ' A' ' 177' ' ' ALA . 31.2 t -64.51 -35.82 75.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.711 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.998 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.84 -34.21 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.377 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.5 mm-40 -65.99 -30.41 70.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.53 . . . . 0.0 109.948 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.1 mp -78.38 -36.92 45.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.21 -2.03 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.731 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -36.9 61.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.475 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.8 59.69 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.898 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.582 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.31 53.36 0.02 OUTLIER Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.835 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 14.2 Cg_endo -81.37 36.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.325 2.017 . . . . 0.0 111.551 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.77 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -68.47 163.9 22.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.907 -178.772 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m95 -53.67 -27.73 29.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.53 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.32 98.48 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER -86.61 -23.83 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.69 -0.255 . . . . 0.0 110.918 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -54.25 -32.07 55.13 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.381 0.61 . . . . 0.0 110.488 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.1 t -61.95 -54.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.571 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -62.11 -30.69 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.247 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.1 m-85 -55.5 -51.82 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -82.48 -32.72 28.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.412 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.95 -34.0 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.813 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.33 -60.05 3.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.63 61.42 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.206 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.21 83.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.157 0.479 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -72.92 -42.49 63.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.785 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.03 -51.85 67.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.603 179.272 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.655 ' HB3' HD21 ' A' ' 22' ' ' LEU . 87.1 m -60.55 -43.8 96.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.22 67.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.811 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -78.63 -25.63 45.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG22 ' A' ' 119' ' ' VAL . 50.6 m -78.25 -37.02 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.676 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.9 t -66.51 -32.96 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.207 -0.308 . . . . 0.0 111.523 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -79.3 -30.99 43.15 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.411 -0.516 . . . . 0.0 112.253 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.15 113.99 2.74 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 115' ' ' MET . 23.0 mt-10 65.35 143.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 7.5 mtm 76.86 126.47 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.772 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 1.7 tt0 -120.53 -58.11 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.425 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.34 -29.23 88.4 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.218 1.946 . . . . 0.0 113.09 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -60.0 -31.65 70.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.597 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 110' ' ' SER . 89.3 t -60.86 -51.22 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.85 -30.48 72.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.461 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -64.83 -52.57 56.0 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.542 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 89.0 t -55.6 -37.55 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.025 0.44 . . . . 0.0 109.915 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -61.69 -47.04 87.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.643 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.67 ' HA ' HG12 ' A' ' 127' ' ' VAL . 23.2 pt-20 -74.1 -35.88 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.662 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.0 m0 -56.24 -37.98 70.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.2 mtp -73.34 -56.45 5.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.462 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.4 p -60.64 -32.83 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.7 -47.6 62.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.185 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.5 t80 -61.45 -36.14 79.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.545 0.688 . . . . 0.0 110.421 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.007 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.47 -55.57 7.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.196 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.95 -32.75 72.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.1 m -78.68 -40.78 32.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -41.05 1.88 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -60.53 -48.3 82.39 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.337 0.517 . . . . 0.0 111.709 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -35.9 41.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.238 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.75 -51.92 65.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.373 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.77 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.0 t90 -58.65 -47.58 83.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.602 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.7 mt -57.44 -48.05 83.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.389 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -68.97 -26.45 65.04 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.666 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -92.04 -9.08 44.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.13 -53.8 3.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.91 -15.64 0.02 OUTLIER Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.423 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.63 168.75 36.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.6 m95 -63.46 -30.26 71.41 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.58 75.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.741 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.417 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -64.27 -42.8 96.28 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.704 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 11.1 t80 -66.2 -33.93 76.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.631 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -68.25 -27.07 66.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.706 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.78 -26.5 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.123 0.487 . . . . 0.0 109.936 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.64 -50.78 65.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.39 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.5 m-85 -133.05 33.24 3.67 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.991 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -102.05 -137.28 9.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.98 -39.31 79.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.166 0.507 . . . . 0.0 110.716 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -102.47 53.98 0.75 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.766 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.88 76.13 3.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.331 0.586 . . . . 0.0 110.288 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.761 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -64.37 162.59 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.24 -32.98 64.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.242 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.761 ' HB2' HD12 ' A' ' 156' ' ' LEU . 45.8 mt-10 -74.06 -35.31 64.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.716 0.294 . . . . 0.0 111.291 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -71.04 -39.18 72.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 mtm-85 -62.18 -56.36 19.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.735 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.43 -33.13 73.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -64.18 -42.64 96.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.68 HH22 ' HA ' ' A' ' 49' ' ' ALA . 3.2 ttp180 -68.2 -41.19 81.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.994 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.716 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -64.92 -40.99 95.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.43 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.75 -31.22 67.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.963 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.5 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -67.03 -55.65 13.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.214 -0.493 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.772 ' HA ' HG22 ' A' ' 170' ' ' VAL . 12.0 p-90 -61.98 -28.94 69.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.193 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.54 -42.88 79.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 110.75 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.86 -30.56 20.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.3 m -87.03 -29.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.531 ' HD2' ' HZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -77.12 -34.72 56.63 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.804 -0.56 . . . . 0.0 110.153 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 -8.78 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.045 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.9 p -85.19 -26.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.26 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -121.35 43.22 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.139 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -22.61 62.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.765 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.82 8.48 49.72 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.339 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.424 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -78.17 -0.29 27.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.7 69.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.344 0.592 . . . . 0.0 110.546 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -103.56 16.11 27.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.12 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.491 HD22 ' NE2' ' A' ' 67' ' ' GLN . 35.4 mt -100.06 -43.34 6.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 92.49 0.27 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.626 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -101.77 139.11 37.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.978 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.71 117.27 5.06 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.895 2.397 . . . . 0.0 111.693 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -25.2 58.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 158.14 159.98 9.95 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.995 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.0 m -155.32 140.92 17.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt -104.57 8.82 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.807 0.337 . . . . 0.0 111.025 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.29 132.48 23.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.807 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p -110.01 131.38 22.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.691 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 15.6 Cg_exo -68.55 151.11 75.51 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.955 2.437 . . . . 0.0 112.959 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.11 50.92 14.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.009 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.42 88.74 7.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.87 112.25 65.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 2.8 Cg_exo -76.33 54.32 4.23 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.451 2.767 . . . . 0.0 112.238 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.63 -167.17 1.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.578 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.55 75.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -39.47 93.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.679 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.43 69.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.007 0.432 . . . . 0.0 110.018 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.3 tp -70.66 -43.14 69.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.84 -34.9 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.011 0.434 . . . . 0.0 110.009 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.19 60.94 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.448 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -66.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.917 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.671 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -55.08 -50.73 68.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . 44.2 t -72.59 -39.01 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.665 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.8 -55.92 25.7 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.271 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.702 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 13.0 t80 -56.45 -44.77 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.856 0.462 . . . . 0.0 110.798 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.42 -45.58 90.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.525 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.3 mp -68.7 -43.3 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 24.3 ttp85 -66.76 -15.31 63.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.597 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -84.14 -38.61 20.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.71 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.04 79.9 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.765 0.317 . . . . 0.0 111.841 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.14 -66.33 0.38 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.911 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -96.68 55.57 1.41 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.306 0.574 . . . . 0.0 110.333 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.04 -27.75 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.977 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -41.07 78.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 58.69 4.02 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.772 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.26 118.13 10.22 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.81 -54.16 0.16 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.348 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.8 Cg_exo -60.55 -46.94 15.26 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 121.936 1.757 . . . . 0.0 111.021 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.702 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -97.93 36.76 3.77 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.218 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -18.24 43.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.26 140.78 16.34 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 83.2 Cg_endo -94.58 -141.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.98 2.454 . . . . 0.0 113.283 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -76.29 86.96 3.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.359 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.69 20.8 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.067 0.461 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 3.8 m-20 -131.69 161.67 60.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.938 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.31 45.51 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.253 2.635 . . . . 0.0 111.964 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -174.27 -30.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.13 179.674 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.8 m170 -57.84 -57.13 14.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.819 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 25.1 tt0 -58.58 -26.81 64.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.872 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.45 -50.71 17.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.381 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 13' ' ' LEU . 3.7 ttm -67.11 -41.72 85.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.613 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -62.87 -33.76 75.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.759 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.23 -41.87 27.26 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.234 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -60.59 -55.66 30.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.649 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.671 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.3 -46.55 57.23 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.742 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.64 -49.0 79.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 111.502 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -65.17 -46.29 81.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.38 0.61 . . . . 0.0 110.257 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.458 ' HB2' HG11 ' A' ' 97' ' ' VAL . 45.7 t80 -63.34 -40.46 97.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.635 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.25 -33.03 70.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.341 0.591 . . . . 0.0 109.973 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 m -78.02 -24.8 47.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.278 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -98.71 -18.86 17.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.26 93.74 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.926 0.393 . . . . 0.0 111.409 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -61.22 -46.64 89.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.25 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.844 HH21 HG11 ' A' ' 178' ' ' VAL . 3.2 mtm-85 -91.17 86.71 6.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.106 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -57.08 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.001 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.913 ' HA ' HD22 ' A' ' 64' ' ' LEU . 7.8 m-85 -90.96 0.98 57.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 59' ' ' ARG . 2.1 p -70.17 -56.49 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 111.33 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -63.92 -23.52 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.169 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 ' HA ' ' A' ' 61' ' ' PHE . 1.8 mp -64.69 -43.24 94.17 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.86 -41.6 29.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.503 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -55.38 -36.47 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.879 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.751 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 48.0 mt-30 -75.32 -58.86 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.033 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.472 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -76.6 9.17 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -177.512 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.581 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.8 t60 -79.01 -18.42 53.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.957 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.34 -77.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -160.1 144.57 10.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.306 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 5.4 Cg_exo -74.84 162.96 36.54 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.811 2.341 . . . . 0.0 112.04 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.48 -64.06 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.643 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.57 42.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.259 0.552 . . . . 0.0 111.867 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.59 -23.23 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.69 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.9 pt20 -60.86 -41.89 96.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 1.1 mt-30 -63.45 -39.68 95.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.76 0.314 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.751 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 56.0 mtt-85 -68.24 -43.56 77.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.986 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -62.98 -47.96 80.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -58.45 -31.28 67.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.332 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.0 mm100 -63.77 -65.43 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' HB1' ' A' ' 177' ' ' ALA . 4.8 p -54.93 -36.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.3 m -65.81 -46.62 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.821 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.657 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.1 -37.73 86.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.163 0.506 . . . . 0.0 109.862 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 4.9 mt-10 -68.55 -25.92 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.557 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 1.8 mp -78.96 -38.31 37.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.549 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -84.9 -6.54 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.386 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mt-30 -47.06 -43.16 19.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.309 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.16 56.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.529 -1.32 . . . . 0.0 113.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.512 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 158.43 57.66 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.643 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.675 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 19.1 Cg_endo -78.77 42.18 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.127 1.885 . . . . 0.0 111.54 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 4.1 t-20 -66.48 161.31 23.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.508 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.5 m95 -55.44 -27.17 46.36 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.53 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HD3' ' HG2' ' A' ' 171' ' ' ARG . 2.3 tpt180 -86.61 -22.96 25.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.754 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -31.45 63.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 109.945 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.2 t -62.55 -50.3 80.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.307 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.44 -32.49 73.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.754 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.6 m-85 -55.01 -53.89 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.267 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.8 m-85 -78.55 -37.58 42.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.24 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.16 -37.67 74.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.349 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.1 -51.19 68.77 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.91 -39.19 33.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.055 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.26 -42.57 86.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.122 0.461 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.91 -43.78 64.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.774 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.3 -48.18 77.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.614 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.811 ' HB3' HD21 ' A' ' 22' ' ' LEU . 54.7 m -61.08 -43.34 99.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.678 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.64 -36.92 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 111.114 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.513 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 3.5 tt0 -81.35 -25.08 36.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -79.03 -28.95 43.31 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.051 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 107' ' ' CYS . 59.7 t -70.4 -36.39 66.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.513 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 0.8 OUTLIER -84.35 0.83 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 -179.923 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -124.89 -170.78 2.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.226 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -89.52 55.35 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.37 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.472 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.32 36.87 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.066 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.9 mp0 -56.13 -53.79 59.73 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.21 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.43 -26.96 83.94 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.05 1.833 . . . . 0.0 112.614 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.801 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.4 mp -70.64 -25.82 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.62 -52.74 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.67 87.87 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.728 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 6.5 mm100 -62.61 -53.97 46.66 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.504 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 92.7 t -56.46 -37.12 49.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.941 0.401 . . . . 0.0 110.166 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -61.84 -47.45 84.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.807 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.833 ' HA ' HG12 ' A' ' 127' ' ' VAL . 9.7 pt-20 -74.81 -35.63 62.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.035 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.69 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.4 m0 -57.55 -37.55 73.28 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 27.6 ttm -74.9 -53.35 9.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.601 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.833 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -61.93 -33.31 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.51 -48.41 55.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.207 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.4 t80 -57.81 -37.96 74.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.28 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.938 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.91 -53.34 13.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.086 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.33 -29.29 69.79 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 m -84.62 -37.15 21.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -126.08 -43.39 1.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.852 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.938 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.6 mm? -59.67 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.081 0.401 . . . . 0.0 111.678 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.47 -36.62 55.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 123.237 0.336 . . . . 0.0 111.199 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -63.13 -52.63 61.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 63.1 t90 -57.78 -48.27 80.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.247 0.546 . . . . 0.0 109.545 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.556 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.6 mt -57.77 -46.64 86.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.322 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.0 m80 -65.83 -31.12 71.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.695 0.283 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -85.29 -24.84 27.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -56.37 4.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.17 -10.05 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.43 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.69 167.18 40.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.958 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.517 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 97.6 m95 -60.9 -26.46 67.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.25 -32.53 73.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.756 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -40.68 93.73 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.409 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 11.0 t80 -65.84 -36.58 83.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.405 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.872 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -64.32 -31.52 72.76 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.192 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.65 -19.01 31.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.357 0.599 . . . . 0.0 110.105 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 163' ' ' ARG . 9.1 mt -79.92 -40.65 27.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.146 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 1.6 m-85 -125.53 28.95 6.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -118.86 -146.7 8.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.668 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -32.77 61.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -91.76 40.31 2.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.106 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.13 77.17 8.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -62.37 162.02 10.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.857 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.88 -31.3 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' HD12 ' A' ' 156' ' ' LEU . 17.9 mt-10 -72.15 -42.37 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -66.14 -39.59 89.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.54 -52.07 66.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -71.11 -21.73 62.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -75.27 -48.52 22.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.451 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -65.32 -43.61 90.46 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.66 -42.81 90.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.456 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.19 -28.93 72.29 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.473 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 m-20 -66.53 -56.07 12.54 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.252 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.698 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 13.6 p-90 -63.04 -26.12 68.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.016 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.023 0.44 . . . . 0.0 110.325 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.6 m -87.13 -32.2 20.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.698 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 19.0 m -88.66 -33.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG2' ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -73.85 -29.74 62.29 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.656 -0.653 . . . . 0.0 110.541 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.605 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 1.8 m -85.33 -33.87 21.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.673 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.653 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.7 p -65.89 -31.29 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.653 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -110.66 33.12 4.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.087 0.47 . . . . 0.0 110.395 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 172' ' ' THR . 8.4 m -67.68 -32.82 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.124 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.83 50.31 3.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.085 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.449 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -118.01 13.24 13.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.844 HG11 HH21 ' A' ' 59' ' ' ARG . 2.1 t -83.34 61.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.573 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.93 56.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.391 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -92.69 -45.49 8.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.69 98.63 0.42 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.984 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.624 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -83.37 -160.41 0.42 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.788 0.327 . . . . 0.0 110.631 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.19 151.08 81.37 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.984 2.456 . . . . 0.0 112.14 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -117.75 -47.0 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.638 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.71 -176.66 48.35 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.087 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.08 63.69 2.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.189 0.518 . . . . 0.0 111.391 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt -90.68 141.57 28.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.807 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.97 151.04 40.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.385 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p -105.57 135.93 19.31 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.3 Cg_endo -85.52 125.64 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.328 2.686 . . . . 0.0 112.405 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.55 129.35 38.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.56 159.3 42.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.513 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -91.48 143.39 28.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.597 0.236 . . . . 0.0 111.155 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.3 Cg_exo -74.92 77.62 3.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.135 2.557 . . . . 0.0 111.858 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -170.89 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.917 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -37.15 68.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.819 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.05 -35.71 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.722 0.296 . . . . 0.0 110.563 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.2 -36.47 58.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.695 ' HB2' HD13 ' A' ' 42' ' ' LEU . 8.0 tp -70.3 -41.78 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.987 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.27 -34.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.08 -20.84 60.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.453 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -64.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 3.9 t80 -56.21 -52.66 63.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.38 -37.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.227 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.22 -52.59 48.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.253 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.691 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -62.29 -44.58 96.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 2.7 mmtt -62.36 -41.46 98.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -73.28 -43.86 60.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -57.56 -33.85 68.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.558 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 24' ' ' GLN . 1.1 pt20 -86.61 -8.61 57.34 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -121.19 -58.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.92 -48.24 0.5 Allowed Glycine 0 C--O 1.23 -0.149 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.854 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 2.4 t80 -81.44 49.44 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.21 0.528 . . . . 0.0 110.963 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.44 -27.55 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -42.6 72.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 58.98 3.8 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.029 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -62.1 115.64 4.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 179.55 -53.88 0.09 OUTLIER Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.356 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 32.7 Cg_exo -60.55 -50.19 7.35 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.836 1.69 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.06 30.29 5.18 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.438 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -65.69 -38.59 89.66 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.067 0.434 . . . . 0.0 110.981 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . -110.69 132.96 11.27 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.9 Cg_endo -89.31 -143.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.505 2.137 . . . . 0.0 113.785 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -67.42 106.92 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.022 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.59 -33.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 0.0 111.406 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.2 m-20 -79.2 163.49 59.47 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.373 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 29.6 Cg_endo -77.83 48.7 2.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.378 2.718 . . . . 0.0 111.549 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.998 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.3 m170 -62.29 -58.21 8.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.85 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.682 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.97 -28.18 66.07 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.349 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.08 -55.03 11.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.77 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.617 ' HE2' HD11 ' A' ' 13' ' ' LEU . 2.7 tpp -67.4 -36.7 81.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.807 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 3.8 ttp180 -61.92 -37.57 85.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.891 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.6 23.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.793 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.26 -53.74 54.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.84 -48.51 44.48 Favored Glycine 0 C--O 1.215 -1.08 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.25 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.13 -49.6 75.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.87 -44.08 97.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.06 -33.42 65.65 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.986 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.47 -26.65 68.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.0 109.267 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 m -88.61 -25.61 22.35 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.556 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -99.83 -55.25 2.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 111.952 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.57 73.43 10.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.92 0.488 . . . . 0.0 110.567 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 58' ' ' ARG . 3.1 mpt_? -73.82 -18.49 60.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.011 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -79.35 58.55 2.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.45 . . . . 0.0 111.259 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.07 -48.95 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.056 ' HA ' HD22 ' A' ' 64' ' ' LEU . 86.0 m-85 -64.17 -28.28 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.197 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -34.29 76.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -74.54 -18.47 60.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.964 0.411 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.056 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -73.01 -39.05 66.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.16 -48.02 25.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.28 -43.64 61.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.902 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.498 ' NE2' HD22 ' A' ' 180' ' ' LEU . 45.8 mt-30 -69.54 -58.12 4.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.702 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.7 OUTLIER -82.02 16.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.778 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -78.17 -33.78 50.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 71' ' ' THR . 2.2 p -92.26 -67.9 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.342 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.669 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -163.43 154.95 14.68 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.36 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.935 2.423 . . . . 0.0 112.108 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.25 -78.73 1.89 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.41 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.94 47.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.357 0.599 . . . . 0.0 112.209 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.29 -18.21 22.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.262 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 13.2 pt20 -61.86 -38.35 87.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.6 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.474 ' H ' ' HG2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -66.7 -40.44 88.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.533 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 180' ' ' LEU . 17.5 mtt180 -67.22 -45.8 75.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.0 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.17 -49.76 76.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.853 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 p -57.6 -34.56 69.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -60.55 -57.74 11.44 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 ' HG ' ' A' ' 180' ' ' LEU . 31.3 t -58.65 -38.44 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.877 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -65.73 -46.08 80.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.48 -36.82 81.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.789 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 24.8 mt-10 -72.98 -23.57 60.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.395 . . . . 0.0 110.582 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -81.74 -37.69 26.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.659 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -83.93 -8.23 59.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.574 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -42.01 14.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.095 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.19 48.38 0.13 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.723 -1.227 . . . . 0.0 113.13 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.451 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.12 53.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.442 -1.361 . . . . 0.0 114.747 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.2 Cg_endo -80.09 41.36 1.11 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.12 1.88 . . . . 0.0 111.441 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.776 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.34 163.95 23.97 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.618 -178.822 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.584 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.5 m95 -54.2 -29.05 44.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.61 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.22 -37.74 95.37 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -87.68 -24.89 23.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.703 178.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -54.96 -31.52 60.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.7 t -62.89 -52.95 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.472 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.18 72.27 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.331 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.2 m-85 -56.55 -54.6 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.037 0.446 . . . . 0.0 110.231 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.472 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 15.3 m-85 -74.94 -39.48 61.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.002 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.39 -36.76 75.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.254 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -53.18 -59.77 4.13 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.821 0.343 . . . . 0.0 111.562 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.57 -38.67 78.89 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.28 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.8 94.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.192 0.496 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.33 -41.24 73.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.747 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.42 -47.37 84.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.403 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.674 ' HB3' HD21 ' A' ' 22' ' ' LEU . 60.6 m -65.18 -45.39 85.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.206 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.05 70.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.772 0.32 . . . . 0.0 111.601 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.6 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -85.05 -8.77 58.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.683 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -89.92 -29.03 18.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.791 0.329 . . . . 0.0 110.16 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' CYS . 51.9 t -68.65 -32.42 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.6 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 14.5 p30 -85.32 0.96 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 0.0 111.151 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -125.72 -170.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.395 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.21 53.24 2.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.029 0.443 . . . . 0.0 110.633 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.439 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.16 46.44 2.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.408 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.73 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 15.5 mp0 -64.17 -56.19 25.8 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.424 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.1 Cg_exo -64.31 -26.52 63.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.051 1.834 . . . . 0.0 112.614 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 12.4 tp -66.4 -29.11 69.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.3 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.24 -52.54 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.284 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.42 -32.27 83.59 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.296 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 19.1 mm100 -65.95 -52.33 50.71 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.492 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 48.6 t -58.28 -35.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.009 0.433 . . . . 0.0 109.91 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.19 -47.02 86.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.26 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.688 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.0 pt-20 -72.69 -39.63 66.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.934 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 38.9 m0 -55.75 -37.81 68.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.3 ttm -74.11 -53.67 9.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.638 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.6 p -62.81 -34.07 63.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.62 -46.3 66.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 10.0 t80 -61.51 -35.1 76.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.582 0.706 . . . . 0.0 110.123 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.006 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.93 -56.6 5.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.132 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.84 -31.76 72.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.8 m -82.9 -36.86 24.96 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.86 -42.5 1.9 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.006 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -60.85 -46.31 91.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.371 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.21 54.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.444 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.08 -54.95 22.14 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.776 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.7 t90 -56.66 -48.3 77.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.527 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -57.36 -47.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.569 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -68.27 -30.11 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -89.09 -9.02 52.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.52 -57.07 2.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.0 111.609 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.97 -13.3 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.6 168.4 39.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.117 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.468 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.9 m95 -61.75 -29.47 70.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.43 80.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.14 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -63.6 -47.49 81.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 109.55 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.525 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 15.7 t80 -63.27 -38.25 90.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.078 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.736 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 7.5 m -65.98 -27.24 68.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 111.282 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.73 -34.92 27.08 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.655 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -66.15 -39.95 90.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.615 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -116.47 20.39 14.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -107.13 -140.33 9.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.444 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.21 -34.67 23.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.16 42.23 2.98 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.022 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.23 68.19 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.985 0.422 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.575 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.89 173.23 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.272 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -49.84 -39.3 38.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -179.575 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mm-40 -63.56 -52.3 61.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.38 -38.78 88.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -59.65 -57.1 14.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -67.8 -29.24 68.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.684 0.278 . . . . 0.0 111.581 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 4.3 tp -69.02 -46.68 67.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.47 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.8 ptt180 -68.87 -37.2 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.357 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.575 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 3.9 mt-10 -70.67 -43.2 69.58 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.141 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.7 -14.17 72.37 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.3 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 15.4 t-20 -73.25 -65.46 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.017 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.61 ' HE3' ' HD3' ' A' ' 171' ' ' ARG . 48.0 p-90 -61.54 -24.7 66.81 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.576 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.35 -64.11 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.116 0.26 . . . . 0.0 110.734 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -21.46 25.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 2.1 t -81.01 -36.32 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HD3' ' HE3' ' A' ' 167' ' ' TRP . 0.9 OUTLIER -82.87 -13.35 56.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.516 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.907 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.1 p -88.49 -31.62 18.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.76 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.749 HG13 ' HG ' ' A' ' 174' ' ' LEU . 5.7 p -67.07 -24.51 32.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.476 0.655 . . . . 0.0 110.136 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.749 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.81 42.91 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.231 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.907 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.6 OUTLIER -69.28 -43.23 74.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.912 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.62 27.19 1.89 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -89.69 2.07 55.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.225 0.513 . . . . 0.0 111.046 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' VAL . . . . . 0.443 HG12 ' OD2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -80.02 68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.925 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.03 9.65 32.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.785 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.54 ' HG ' HG21 ' A' ' 82' ' ' VAL . 12.4 mt -95.84 -43.6 7.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.914 0.388 . . . . 0.0 110.509 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.437 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.09 94.62 0.46 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.733 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.612 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -86.68 149.2 25.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.055 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.09 -36.52 88.81 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.155 2.57 . . . . 0.0 113.07 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.454 ' HA ' HD13 ' A' ' -2' ' ' LEU . 0.4 OUTLIER 65.36 77.15 0.31 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.475 0.484 . . . . 0.0 111.489 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -122.46 36.57 3.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.423 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.34 116.21 16.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.292 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.24 167.92 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.741 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.47 150.85 40.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.528 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.6 p -114.27 130.49 23.92 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 110.851 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 7.8 Cg_exo -73.47 158.01 48.47 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.207 2.605 . . . . 0.0 112.267 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.38 129.14 56.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.16 110.46 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.187 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.07 132.74 62.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.409 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 7.9 Cg_exo -73.56 49.32 1.76 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.662 2.908 . . . . 0.0 112.453 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.11 -164.48 1.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.617 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -37.93 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.204 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -62.1 -35.4 78.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.93 -36.13 49.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.0 109.886 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.4 tp -70.44 -43.28 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.657 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -65.87 -35.35 74.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.23 -22.59 61.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.7 -64.24 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.569 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.8 t80 -54.95 -52.71 62.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.829 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . 46.5 t -72.29 -40.0 64.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.32 -54.3 37.39 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.847 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.768 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 48.9 t80 -62.8 -39.69 95.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 0.186 . . . . 0.0 111.271 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.46 -42.99 98.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.645 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -70.42 -44.79 67.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.618 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.825 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -62.47 -20.69 64.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.058 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.641 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.93 -35.38 26.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.47 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.641 ' HD3' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -151.08 76.25 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.96 0.409 . . . . 0.0 112.025 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.67 -70.43 0.3 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.123 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -90.26 56.43 3.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.389 0.614 . . . . 0.0 109.537 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.21 -34.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.757 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -41.65 72.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.386 0.612 . . . . 0.0 109.605 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.45 56.71 4.9 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.913 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.825 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.83 120.99 13.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 172.31 -58.36 0.16 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.173 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.517 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.4 Cg_exo -60.35 -48.45 11.6 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.785 1.657 . . . . 0.0 111.014 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.768 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.91 40.04 2.71 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.898 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 10.1 pt-20 -93.76 -8.09 41.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.77 164.49 12.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.724 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -99.31 -164.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.606 2.871 . . . . 0.0 113.191 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -89.01 73.11 8.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.931 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.11 34.01 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.099 0.476 . . . . 0.0 111.589 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 5.4 m-20 -130.11 161.1 62.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 6.8 Cg_exo -70.76 28.77 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.912 3.075 . . . . 0.0 113.055 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -166.78 -23.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.0 m170 -55.52 -64.78 0.74 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -58.4 -23.9 58.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.536 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.37 -46.5 40.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 15.2 ttm -72.25 -39.78 68.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.819 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -60.81 -36.14 78.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.569 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -31.34 42.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 109.98 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -65.19 -56.7 11.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.62 -48.47 42.95 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.61 -46.45 80.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.479 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -46.23 91.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.838 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.61 -31.78 65.43 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.871 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.86 -24.9 67.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.651 0.738 . . . . 0.0 109.211 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -89.38 -36.54 15.43 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.913 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -84.44 -64.43 1.16 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.93 72.01 8.98 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.843 0.857 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -82.8 -0.03 45.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.04 23.82 4.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.245 -0.284 . . . . 0.0 111.361 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.53 -1.24 30.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.758 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.4 m-85 -92.6 -19.77 21.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.63 80.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.755 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 3.2 m-20 -62.76 -22.86 66.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.102 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.758 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -68.69 -39.62 80.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.064 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -79.56 -44.72 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.141 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.554 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.3 -42.66 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.386 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.456 ' NE2' HD22 ' A' ' 180' ' ' LEU . 45.7 mt-30 -73.16 -53.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -83.26 14.74 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.32 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 82.6 t60 -77.98 -32.64 51.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.266 0.555 . . . . 0.0 109.631 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -73.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.195 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.35 153.74 16.91 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.512 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -86.64 -167.27 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.199 2.599 . . . . 0.0 111.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.78 -63.41 4.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.998 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.99 24.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.088 0.471 . . . . 0.0 111.85 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -80.23 -23.32 40.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.622 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.599 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 1.8 pt20 -62.01 -43.42 98.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.618 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -62.15 -42.43 99.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -63.23 -44.98 93.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.88 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.84 -50.78 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.496 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 p -56.1 -33.68 65.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.419 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 32.4 mm-40 -60.27 -66.58 0.5 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.175 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.0 m -56.52 -32.73 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.681 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.1 m -65.85 -43.82 87.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.353 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.57 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.8 -37.02 73.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 109.694 179.098 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -29.05 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.884 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -80.84 -31.79 35.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.309 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 91' ' ' PRO . 37.3 t80 -93.27 1.89 56.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -24.99 36.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.256 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 60.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.344 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.25 59.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.607 -1.282 . . . . 0.0 114.648 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -82.78 39.06 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.275 1.983 . . . . 0.0 111.642 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.833 ' HB2' HG11 ' A' ' 170' ' ' VAL . 3.3 t-20 -66.86 164.36 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.606 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -54.49 -27.15 35.84 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.235 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.34 -38.62 95.2 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.649 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.7 mmp_? -87.53 -26.61 23.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.974 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.61 -31.57 57.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.421 0.629 . . . . 0.0 109.969 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 49' ' ' ALA . 22.0 t -62.09 -55.87 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.82 -29.22 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.47 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.816 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -55.79 -54.65 41.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.095 0.474 . . . . 0.0 110.191 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.657 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.5 m-85 -77.83 -35.54 51.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -60.73 -39.86 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.4 m-85 -55.11 -51.11 67.43 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.23 -38.77 38.53 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.138 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.33 99.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.131 0.465 . . . . 0.0 110.927 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -37.91 74.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.571 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.29 -44.48 97.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.156 179.151 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 94.8 m -63.92 -45.79 87.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.284 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.96 64.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.726 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -77.34 -12.25 59.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.806 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -88.53 -24.96 22.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.941 0.401 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 107' ' ' CYS . 57.4 t -75.64 -35.77 32.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.622 HD21 ' HA ' ' A' ' 109' ' ' GLU . 22.8 p30 -81.44 0.56 37.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.408 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.48 -167.51 1.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -91.27 62.66 4.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.471 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.577 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.66 37.75 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.946 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.3 mp0 -55.84 -55.86 36.47 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.307 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.7 Cg_exo -65.02 -18.55 62.37 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.082 1.855 . . . . 0.0 112.341 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.2 mm? -74.77 -35.22 62.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 107' ' ' CYS . 90.3 t -54.91 -57.72 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.491 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.51 79.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.965 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 5.5 mm-40 -66.35 -49.78 65.75 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 118' ' ' LEU . 59.8 t -57.35 -36.12 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.24 -45.61 92.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.4 pt-20 -76.2 -36.86 58.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.114 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.599 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 39.4 m0 -56.69 -38.62 72.51 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.6 ttm -72.85 -54.94 7.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.685 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.5 p -60.97 -32.49 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.9 -50.41 56.38 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.306 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 13.3 t80 -58.74 -35.21 72.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.642 0.734 . . . . 0.0 110.284 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.038 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.93 -48.5 30.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.956 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.04 -42.22 84.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 m -80.78 -40.57 24.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -42.1 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -63.2 -46.71 85.77 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.418 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.85 55.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.613 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.66 -53.06 30.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.571 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.806 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 55.6 t90 -55.3 -47.51 75.46 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.263 0.554 . . . . 0.0 109.567 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.6 HG13 ' HE3' ' A' ' 137' ' ' TRP . 4.3 mt -57.85 -49.17 81.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.402 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -60.62 -39.69 89.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m -78.0 -26.89 48.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -56.04 5.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.28 -15.75 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.655 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.32 170.85 41.1 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.183 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.82 -26.09 67.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.24 -33.91 77.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.449 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -66.74 -38.71 87.18 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.79 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.5 t80 -65.79 -38.88 90.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.659 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.73 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -67.46 -27.69 67.24 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.8 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.96 -18.06 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.094 0.474 . . . . 0.0 110.349 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -75.78 -49.42 18.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.673 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.45 31.51 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -93.3 -113.85 2.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.359 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.43 -62.94 1.43 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.14 0.495 . . . . 0.0 109.691 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.7 64.11 4.34 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.348 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.74 74.99 7.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.54 153.81 22.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.153 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.661 ' HA ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -57.99 -27.36 63.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.753 -179.438 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.679 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.2 mm-40 -73.83 -32.43 63.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -78.33 -41.56 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -66.61 -37.89 85.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.579 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 158' ' ' GLU . 9.8 ptp85 -72.65 -29.11 63.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.088 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -38.3 81.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.716 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.665 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.3 ttp180 -65.89 -41.9 90.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.585 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -61.62 -48.25 81.76 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.346 0.404 . . . . 0.0 110.295 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.13 -28.52 73.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.408 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.06 -58.66 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.253 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.657 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.2 p-90 -62.08 -27.42 68.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.416 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.17 76.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.446 . . . . 0.0 110.344 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.21 -28.73 20.98 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.833 HG11 ' HB2' ' A' ' 92' ' ' ASN . 8.1 m -95.3 -36.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.604 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -81.34 -15.71 54.54 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.46 -0.775 . . . . 0.0 111.138 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 m -96.08 -17.04 21.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.156 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 1.012 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -81.2 -26.5 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.529 0.68 . . . . 0.0 109.521 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 1.012 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -120.88 39.54 3.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.692 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -30.49 71.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.15 1.93 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.541 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -99.42 6.54 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.56 60.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.99 -11.14 60.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.277 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -96.39 -9.38 30.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.848 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.87 89.7 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.651 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.554 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -108.87 171.46 7.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.64 0.257 . . . . 0.0 110.4 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.84 -39.79 49.4 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.726 2.284 . . . . 0.0 111.643 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.06 176.78 5.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.479 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 141.4 -25.74 2.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.581 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 58.9 m -157.27 151.58 25.0 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.22 160.65 43.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 118.15 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.368 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 p -99.78 118.41 61.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.359 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.8 Cg_exo -77.5 139.09 17.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.316 2.677 . . . . 0.0 112.02 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.22 133.36 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.666 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 m -77.17 157.87 30.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -84.67 128.37 61.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 11.4 Cg_exo -71.52 99.87 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.103 2.536 . . . . 0.0 111.704 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -163.32 0.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.652 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.53 -38.59 69.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.959 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -63.12 -35.47 80.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.294 . . . . 0.0 110.729 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.99 60.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.208 0.528 . . . . 0.0 109.756 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -71.91 -42.73 66.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.056 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.4 p -65.11 -36.0 76.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.131 0.491 . . . . 0.0 109.703 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.25 -21.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.375 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 -63.95 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.903 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.505 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.45 -54.04 46.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.51 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.0 t -67.75 -39.55 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -59.47 -54.71 35.5 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.246 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.677 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 34.5 t80 -61.86 -43.21 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.563 0.345 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 12.7 mmtt -61.13 -40.27 93.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -79.16 -46.65 17.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.078 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 39.6 ttp85 -63.75 -17.25 62.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.397 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -85.02 -24.05 28.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.971 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -160.1 76.14 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.81 -68.78 0.37 Allowed Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.271 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.59 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 2.0 t80 -84.85 52.08 2.32 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.008 0.523 . . . . 0.0 109.785 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.63 -40.05 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.59 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -40.42 96.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.409 0.623 . . . . 0.0 109.626 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.25 52.06 4.04 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.043 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.69 124.49 22.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 35' ' ' GLU . . . 176.92 -54.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.603 -1.284 . . . . 0.0 113.637 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 13.0 Cg_exo -72.26 -49.88 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.406 2.071 . . . . 0.0 112.284 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -86.04 28.12 5.22 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.774 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' CA ' ' A' ' 32' ' ' GLY . 3.1 mt-10 -88.04 -26.22 22.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.387 0.613 . . . . 0.0 110.241 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.3 147.86 23.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.301 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -94.79 -155.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.062 2.508 . . . . 0.0 112.833 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.628 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -88.82 85.94 6.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.524 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.29 21.93 5.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 110.333 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.5 m-20 -125.58 159.35 61.1 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.29 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 61.2 Cg_endo -81.32 47.2 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 111.576 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -177.94 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.515 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -57.25 -62.11 2.0 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.735 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.628 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 44.4 tt0 -55.8 -30.84 62.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.56 -51.49 28.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.999 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.1 ttm -67.9 -41.83 82.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -61.77 -35.18 77.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.89 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.46 -41.31 27.84 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.614 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.791 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.49 -54.25 48.74 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.72 -47.24 58.76 Favored Glycine 0 C--O 1.219 -0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.441 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.43 -46.83 87.63 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE2' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -62.95 -45.2 93.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.743 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.858 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -72.57 -33.0 66.46 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.143 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.87 -26.7 68.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 109.706 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -87.43 -29.21 21.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.479 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 6.5 mtp180 -91.68 -46.34 7.97 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.69 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.16 86.68 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.19 0.596 . . . . 0.0 110.207 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -68.52 -23.45 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -86.06 65.97 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.72 -38.12 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.507 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HA ' HD22 ' A' ' 64' ' ' LEU . 42.1 m-85 -91.15 -3.4 57.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 -47.47 55.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.313 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -59.84 -32.11 70.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.469 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 4.8 mp -56.84 -44.89 82.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.589 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -80.46 -42.2 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 182' ' ' ALA . . . -50.6 -41.82 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.683 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.8 mt-30 -79.31 -53.47 6.91 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -82.37 13.1 3.79 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.708 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.658 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 2.0 p-80 -79.6 -25.87 41.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.458 179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -71.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.04 151.66 16.52 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.387 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.79 -177.52 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.065 2.51 . . . . 0.0 111.599 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.721 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.27 -71.5 2.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.972 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 45.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.226 0.536 . . . . 0.0 112.026 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.17 -21.1 16.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.682 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -63.77 -40.25 96.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.795 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 18.2 mp0 -63.79 -44.4 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.176 0.297 . . . . 0.0 111.104 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 42.8 mtt180 -65.52 -38.21 89.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.04 0.448 . . . . 0.0 110.033 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t80 -66.17 -51.25 59.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.421 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -56.66 -35.39 68.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 38.4 mm-40 -59.88 -54.66 43.56 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 180' ' ' LEU . 9.9 m -66.89 -32.15 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.097 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 m -66.2 -46.8 76.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.755 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -67.2 -35.62 79.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 110.323 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.49 -27.03 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.259 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -28.15 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.694 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -95.24 -6.4 41.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.07 -50.18 6.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.429 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.56 66.35 0.22 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.4 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.471 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 150.48 62.05 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.677 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.5 Cg_endo -81.74 41.66 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.49 2.127 . . . . 0.0 111.582 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.792 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.2 t-20 -66.71 164.3 17.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' O ' HG23 ' A' ' 97' ' ' VAL . 20.4 m95 -53.88 -29.15 40.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -64.84 -36.05 92.64 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.721 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.3 mmp_? -87.23 -27.18 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.447 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -55.93 -30.55 61.83 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.941 179.388 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 53' ' ' PHE . 18.0 t -63.84 -55.04 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.525 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.22 -29.74 70.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.927 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 7.8 m-85 -57.01 -59.87 4.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.094 0.474 . . . . 0.0 110.354 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.579 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -72.88 -37.91 67.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.348 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.16 -38.76 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.303 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -59.27 -46.17 89.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.379 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.97 -40.32 17.3 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.064 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.92 96.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.37 80.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.838 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -57.99 -45.45 86.77 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.645 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.689 ' HB3' HD21 ' A' ' 22' ' ' LEU . 88.6 m -59.55 -41.73 90.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.74 76.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.968 0.413 . . . . 0.0 110.825 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.433 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -78.27 -24.25 46.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.767 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -24.62 41.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.953 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 107' ' ' CYS . 50.6 t -72.07 -37.57 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.976 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.433 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 1.4 p-10 -85.78 -0.06 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.335 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -123.66 -173.53 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.903 0.382 . . . . 0.0 110.935 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.8 53.31 2.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.81 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.518 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.23 48.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.484 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -60.24 -54.99 49.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.52 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 16.9 Cg_exo -68.71 -12.81 35.6 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.147 1.898 . . . . 0.0 112.96 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.721 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -78.77 -27.97 44.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.183 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.56 -57.44 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 111.365 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.21 -29.65 71.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.265 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.4 mm-40 -67.68 -52.67 35.13 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 118' ' ' LEU . 63.8 t -56.34 -34.57 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -62.62 -47.89 81.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.342 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.667 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.3 pt-20 -74.48 -37.49 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.84 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.682 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.5 m0 -54.68 -36.75 64.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 1.6 mtm -73.95 -57.57 3.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.518 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.5 p -60.36 -32.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.25 -47.35 57.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.038 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.7 t80 -59.72 -37.21 78.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.708 0.765 . . . . 0.0 110.161 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.004 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.89 -52.74 15.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.85 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -58.73 -35.2 72.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.789 0.328 . . . . 0.0 111.784 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.5 m -79.54 -43.25 23.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -123.64 -38.13 2.56 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.31 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.004 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -64.04 -49.1 73.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.358 0.526 . . . . 0.0 111.571 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.28 -33.32 52.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.111 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.31 -56.26 17.95 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.792 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.6 t90 -56.59 -46.59 80.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.126 0.488 . . . . 0.0 109.863 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG13 ' HE3' ' A' ' 137' ' ' TRP . 15.1 mt -58.88 -47.02 90.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.251 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.1 m80 -68.06 -31.66 71.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.64 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.2 m -90.14 -4.83 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.68 -51.67 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.62 -10.66 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.475 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.84 166.55 42.66 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.101 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.444 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.5 m95 -60.93 -27.79 68.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.18 86.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.814 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.76 -41.83 99.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.58 -34.68 78.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.517 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -67.04 -28.15 67.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.53 -27.41 25.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.376 0.608 . . . . 0.0 109.811 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 163' ' ' ARG . 2.2 mt -74.24 -38.68 63.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.353 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 6.2 m-85 -122.29 26.67 8.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -117.9 -141.3 6.75 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.914 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -41.79 36.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.299 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.48 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.49 41.55 2.94 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.479 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.24 72.85 10.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 110.268 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.568 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -66.83 170.09 7.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.006 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 157' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 5.6 mm-40 -52.97 -37.93 61.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.746 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 3.9 mp0 -63.64 -47.63 80.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.437 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -65.34 -37.05 85.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.71 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 77.5 mtt180 -58.18 -58.53 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 3.6 ptt180 -67.4 -28.77 68.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -67.22 -49.77 63.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.489 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.662 ' HB3' HD22 ' A' ' 150' ' ' LEU . 0.9 OUTLIER -64.79 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.142 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 5.5 mt-10 -69.08 -47.01 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.632 0.253 . . . . 0.0 110.442 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.84 -24.51 72.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.169 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.04 -60.86 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.697 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.3 p-90 -61.72 -26.32 67.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.742 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.94 93.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.241 0.543 . . . . 0.0 110.228 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 m -86.87 -24.44 24.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.834 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 92' ' ' ASN . 5.3 m -97.07 -38.93 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -73.83 -26.18 60.46 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.625 -0.672 . . . . 0.0 111.396 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -86.28 -25.71 25.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.43 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.765 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -73.7 -22.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.367 0.604 . . . . 0.0 109.763 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.765 ' HG ' HG13 ' A' ' 173' ' ' VAL . 2.9 mt -120.33 40.42 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.178 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -62.77 -22.27 66.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.806 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.36 9.46 61.33 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.714 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.59 28.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.875 0.338 . . . . 0.0 111.744 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.11 69.8 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 82' ' ' VAL . . . -81.1 -9.41 59.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.055 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.832 HD22 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -92.98 36.03 1.04 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.0 0.429 . . . . 0.0 111.319 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.37 76.23 2.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.168 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.512 ' HB3' ' HB1' ' A' ' 66' ' ' ALA . . . -117.48 150.83 38.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.794 0.297 . . . . 0.0 110.555 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.031 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.89 136.15 51.59 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.83 2.353 . . . . 0.0 112.263 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 5.9 mt -110.33 160.24 16.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.457 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -175.97 118.73 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 0' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.9 OUTLIER -98.25 85.21 3.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.488 0.185 . . . . 0.0 110.763 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 0' ' ' SER . 25.8 mtm 76.65 123.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.108 0.88 . . . . 0.0 111.491 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.26 132.24 21.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.964 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.0 p -99.54 138.77 20.52 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.401 . . . . 0.0 110.907 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 4.0 Cg_endo -85.59 25.46 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.178 2.585 . . . . 0.0 112.219 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.35 -10.75 14.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.65 127.68 46.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -134.41 132.97 21.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.559 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.8 Cg_exo -74.38 80.9 2.15 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.144 2.563 . . . . 0.0 111.739 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.33 -173.95 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.57 -33.83 66.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -66.36 -33.37 75.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.393 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.83 -47.47 18.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 46' ' ' MET . 1.2 tp -59.4 -41.26 89.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.682 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -65.64 -42.55 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.284 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.07 -29.73 67.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.987 0.422 . . . . 0.0 110.379 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.38 -57.28 4.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.101 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.63 -52.32 65.91 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.509 ' O ' HD13 ' A' ' 22' ' ' LEU . 60.6 t -63.49 -42.68 97.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.2 -46.12 94.81 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.013 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.782 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 63.5 t80 -64.38 -42.43 96.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.979 0.419 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.27 -41.34 94.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.542 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.1 mp -71.7 -43.49 65.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.773 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.685 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -62.99 -20.04 64.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.113 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -78.93 -42.42 27.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.927 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -153.95 79.93 1.13 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.964 0.411 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.25 -65.79 0.32 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.88 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.421 ' HD1' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.35 60.3 1.16 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.296 0.57 . . . . 0.0 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.6 -24.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.633 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -40.97 60.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.608 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 59.83 4.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.357 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.685 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -69.96 116.01 9.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.474 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 173.71 -57.7 0.14 Allowed Glycine 0 C--O 1.226 -0.405 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.501 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 52.0 Cg_exo -57.46 -46.04 30.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.337 2.024 . . . . 0.0 111.698 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.79 31.13 7.52 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.574 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -80.97 -23.75 38.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 109.879 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.44 135.67 13.01 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.534 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 86.3 Cg_endo -89.31 -138.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.965 2.443 . . . . 0.0 113.121 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -96.75 94.33 7.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.0 21.67 2.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.943 0.402 . . . . 0.0 110.846 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 6.2 m-20 -132.83 159.73 71.42 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.761 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.4 Cg_endo -79.96 51.87 4.07 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 111.685 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.421 HD13 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.16 -33.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.058 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -58.95 -59.82 4.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.907 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.555 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 29.9 tt0 -58.21 -29.1 65.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.693 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.83 -51.44 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.308 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 13' ' ' LEU . 4.0 ttm -64.98 -36.58 84.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.524 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -38.26 87.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.688 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.9 31.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.76 0.314 . . . . 0.0 110.322 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.05 -57.39 13.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.369 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.64 -47.21 37.82 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.598 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.05 -48.94 79.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.016 0.408 . . . . 0.0 111.22 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -43.25 92.97 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.187 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.778 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.46 -38.6 68.2 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.624 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.88 -22.59 62.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.739 0.781 . . . . 0.0 109.725 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -94.91 -37.23 11.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.672 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -84.96 -26.36 27.21 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.453 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.83 98.78 11.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.161 0.505 . . . . 0.0 110.717 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -64.18 -34.09 77.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.662 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 93.61 4.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.125 0.488 . . . . 0.0 110.289 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.1 -59.16 1.81 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.477 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 1.019 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.7 m-85 -87.79 -10.51 50.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -41.4 88.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.948 0.404 . . . . 0.0 111.518 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.9 m-20 -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.076 0.465 . . . . 0.0 110.663 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 1.019 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -75.99 -40.04 54.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.006 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -73.7 -45.54 51.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.747 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -51.89 -43.84 63.5 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.492 ' NE2' HD22 ' A' ' 180' ' ' LEU . 45.0 mt-30 -68.79 -56.43 8.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -88.25 16.66 5.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.853 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.63 -24.82 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.025 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.68 -64.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.578 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.1 t -170.02 150.88 3.82 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 1.9 Cg_endo -81.83 -165.19 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.03 2.487 . . . . 0.0 112.083 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.24 -70.73 3.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.018 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.92 39.81 0.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.059 0.457 . . . . 0.0 112.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.59 -23.24 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.087 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.672 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.3 pt20 -62.81 -39.2 93.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -63.07 -44.63 95.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.747 0.308 . . . . 0.0 110.304 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -63.34 -43.39 97.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.984 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -62.77 -50.94 69.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.362 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.77 -33.1 66.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -62.1 -64.23 1.0 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.489 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.687 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.6 m -58.61 -32.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -66.02 -43.15 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.31 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.579 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -69.45 -36.36 76.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.244 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 3.2 mm-40 -70.33 -29.68 66.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.067 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -34.99 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -88.42 -5.51 58.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.655 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -45.62 -46.61 14.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.118 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.23 62.64 0.12 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.758 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.591 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 163.46 53.6 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.6 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 39.37 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.183 1.922 . . . . 0.0 111.555 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HB2' HG11 ' A' ' 170' ' ' VAL . 2.4 t-20 -67.04 162.9 21.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.401 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.486 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 23.1 m95 -55.98 -27.48 52.96 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.299 0.375 . . . . 0.0 111.177 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.31 92.41 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 95' ' ' ARG . 1.3 tpt180 -86.29 -26.63 24.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.291 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -30.17 61.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.309 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 t -62.89 -52.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.38 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.64 69.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.398 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.1 m-85 -57.75 -57.01 14.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.215 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.679 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 10.9 m-85 -74.97 -39.9 61.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.941 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.9 -38.85 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.441 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -57.15 -51.1 70.65 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.639 0.257 . . . . 0.0 111.211 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.21 -38.15 40.41 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.266 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.11 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.174 0.487 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.57 -38.91 81.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.769 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.09 -43.31 91.81 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.128 179.016 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.604 ' HB3' HD21 ' A' ' 22' ' ' LEU . 90.0 m -65.51 -42.92 91.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.74 77.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.3 OUTLIER -80.7 -9.54 59.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.81 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.2 m -91.16 -23.28 20.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.926 0.393 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 107' ' ' CYS . 71.9 t -74.44 -34.35 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.641 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 109' ' ' GLU . 24.1 p30 -85.3 0.81 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.302 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.85 -174.81 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -82.99 62.31 6.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 0.0 110.522 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.29 45.55 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.479 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.6 mt-10 -52.12 -59.38 8.51 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.609 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 7.4 Cg_exo -74.26 -22.09 16.95 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.134 1.889 . . . . 0.0 112.627 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 115' ' ' MET . 3.0 mm? -64.57 -37.47 87.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.302 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' MET . 90.4 t -57.22 -54.55 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.56 -32.37 83.98 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.95 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.574 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.6 mt-30 -65.59 -52.22 53.74 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 118' ' ' LEU . 82.8 t -56.16 -35.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.29 -47.34 82.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.365 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.76 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.2 pt-20 -72.58 -38.19 67.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.672 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.9 m0 -58.1 -40.58 81.52 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 6.2 ttm -73.22 -51.28 18.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.9 p -63.23 -34.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.35 -39.5 65.14 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 12.6 t80 -66.6 -34.53 78.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.647 0.736 . . . . 0.0 110.129 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.972 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.46 -53.0 8.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.828 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -31.6 71.55 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.6 m -85.46 -37.92 19.2 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -119.75 -43.66 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.972 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -61.49 -46.57 89.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.377 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.09 62.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.47 -50.3 70.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.693 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 51.9 t90 -59.28 -46.82 87.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.498 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.6 mt -57.34 -48.44 82.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.995 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 28.7 m80 -65.04 -32.06 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.2 m -82.43 -17.48 45.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.0 t -85.45 -54.74 4.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.845 0.355 . . . . 0.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -177.37 -19.31 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 100.41 170.93 29.35 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.425 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.1 m95 -59.41 -30.23 68.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.31 84.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -41.55 98.57 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.5 t80 -64.88 -38.23 90.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.485 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.932 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -63.1 -28.12 69.86 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.19 -26.75 26.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.668 . . . . 0.0 109.71 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -75.46 -39.88 58.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.45 28.11 7.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.972 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -119.2 -141.44 6.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.239 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.52 -40.0 44.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.862 0.363 . . . . 0.0 111.42 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.92 46.13 3.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.157 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.57 72.32 10.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 110.631 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -65.28 168.54 6.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.84 -34.77 63.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.67 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.1 mm-40 -73.17 -32.72 65.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 111.187 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -74.6 -42.83 57.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.911 0.386 . . . . 0.0 111.386 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -66.68 -39.54 88.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.219 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -72.01 -28.53 63.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.896 0.379 . . . . 0.0 110.581 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.68 -47.07 33.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.522 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.1 ptt180 -64.27 -37.57 87.96 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.7 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 2.4 tt0 -68.24 -45.81 72.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.93 0.395 . . . . 0.0 110.109 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.91 -25.82 75.05 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.552 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.9 m-20 -66.1 -58.86 4.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.656 0.265 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.71 -27.52 68.76 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.067 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -43.9 74.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -86.84 -33.61 19.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 92' ' ' ASN . 17.0 m -85.05 -26.14 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -79.07 -30.46 43.97 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.821 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -89.21 -27.98 20.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.448 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 174' ' ' LEU . 4.2 p -66.34 -27.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.161 0.505 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.24 44.35 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.0 110.242 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.821 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.42 -29.05 69.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.901 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.97 9.93 43.18 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.397 0.519 . . . . 0.0 114.397 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.33 11.12 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.134 0.467 . . . . 0.0 111.719 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.94 70.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.242 0.544 . . . . 0.0 110.372 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.19 13.55 32.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.087 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.687 ' HG ' HG11 ' A' ' 82' ' ' VAL . 18.4 mt -99.52 -51.55 3.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.154 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.585 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -72.07 96.68 0.71 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.794 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.493 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -92.57 152.43 19.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.912 0.386 . . . . 0.0 111.088 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.754 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.4 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.19 134.24 58.06 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.876 2.384 . . . . 0.0 111.634 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.464 HD13 ' HA ' ' A' ' -2' ' ' LEU . 0.6 OUTLIER 72.51 -55.36 0.67 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.978 0.799 . . . . 0.0 111.38 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -176.35 -131.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.134 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 33.9 m -124.31 173.85 8.11 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.68 125.1 31.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.018 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.24 144.86 28.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.615 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.2 p -105.5 139.5 20.24 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.6 Cg_exo -77.26 1.92 8.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.968 2.445 . . . . 0.0 112.355 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.04 133.98 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.184 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -148.35 172.12 14.91 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -124.47 138.08 30.41 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.616 0.246 . . . . 0.0 111.029 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.1 Cg_exo -77.58 70.4 6.9 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.201 2.6 . . . . 0.0 111.571 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.48 -168.35 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -38.27 60.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -62.35 -38.85 91.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.09 62.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.0 109.977 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.5 tp -72.32 -42.07 65.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.138 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.713 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.9 p -65.87 -36.0 76.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -23.66 60.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -65.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.02 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.1 t80 -53.41 -51.57 62.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.933 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -69.5 -43.67 80.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.42 -50.86 62.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.23 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.739 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 4.6 t80 -58.23 -49.66 76.3 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.976 0.51 . . . . 0.0 111.33 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.41 -35.98 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.546 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.0 mp -76.33 -48.36 20.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -63.92 -18.4 64.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -84.63 -14.25 49.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -146.26 -52.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.97 -68.77 1.22 Allowed Glycine 0 C--O 1.229 -0.167 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.741 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.1 t80 -82.61 53.15 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.529 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.94 -30.54 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -42.51 77.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.35 59.24 4.86 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.834 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.21 117.9 7.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.632 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 175.57 -49.38 0.12 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.725 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.52 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 21.1 Cg_exo -67.15 -50.0 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 121.894 1.729 . . . . 0.0 111.548 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.14 34.0 4.8 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.84 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 14.6 pt-20 -88.76 -13.48 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.44 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.98 144.27 17.54 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.847 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -92.87 -175.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.832 2.355 . . . . 0.0 113.137 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -82.49 80.95 8.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.065 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.39 -11.55 7.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.41 . . . . 0.0 111.949 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.1 m-20 -86.45 160.35 51.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 148' ' ' THR . 30.2 Cg_endo -77.96 50.12 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.263 2.642 . . . . 0.0 111.423 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.53 -31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.783 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -58.67 -61.28 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.765 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.94 -25.01 63.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.939 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.99 -50.23 17.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.61 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HE1' HD21 ' A' ' 13' ' ' LEU . 6.3 ttm -67.15 -41.93 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -33.23 73.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.059 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.63 -40.05 26.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.284 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.81 -54.93 40.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLY . . . . . 0.433 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.46 -46.21 45.62 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.112 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.44 -56.16 24.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.122 0.486 . . . . 0.0 111.423 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -44.4 90.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.748 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -72.45 -34.84 68.06 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.611 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -62.9 -28.06 69.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.755 0.788 . . . . 0.0 109.556 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 m -83.47 -31.12 26.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.455 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -92.3 -45.23 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 87.38 7.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.149 0.579 . . . . 0.0 111.077 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -81.19 -15.47 55.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -90.38 61.47 5.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.116 0.484 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.55 -55.82 1.91 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.277 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.968 ' HA ' HD22 ' A' ' 64' ' ' LEU . 58.5 m-85 -66.16 -18.89 65.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.403 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -44.12 86.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.698 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -68.09 -26.89 66.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.96 -45.29 28.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.337 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.94 -43.08 63.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.416 ' NE2' HD22 ' A' ' 180' ' ' LEU . 42.4 mt-30 -69.75 -54.36 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.474 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.44 18.99 3.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 2.1 t-160 -78.46 -38.66 40.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 71' ' ' THR . 2.9 p -92.01 -63.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.155 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.587 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.6 149.19 10.66 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 122.371 -0.206 . . . . 0.0 110.742 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.32 -163.19 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.896 2.397 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 84.52 -72.77 2.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.897 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.45 47.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.719 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -94.66 -21.98 18.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.1 pt20 -62.11 -38.03 87.38 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.878 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.91 -39.06 90.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.701 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -68.5 -43.78 76.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -63.39 -50.2 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.756 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -57.69 -34.12 69.09 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 14.4 mm100 -63.93 -61.09 2.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.908 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.2 m -58.57 -31.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.8 -43.95 82.52 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -68.93 -31.48 70.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 109.738 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -73.09 -31.24 64.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.127 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.35 -36.26 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.611 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -86.67 -8.02 57.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -42.54 -48.77 5.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.622 -179.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.39 58.25 0.2 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.225 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.492 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 161.43 57.14 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.705 -1.235 . . . . 0.0 114.726 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.643 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.1 Cg_endo -79.43 44.94 1.81 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.085 1.856 . . . . 0.0 111.4 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.898 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -69.29 164.98 21.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.673 -178.84 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.0 m95 -56.22 -29.64 61.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.35 -37.3 94.31 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HG3' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -86.13 -26.53 25.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.63 179.058 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.37 -30.7 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.435 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.2 t -64.17 -54.57 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.504 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.24 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.237 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.685 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -57.54 -56.87 16.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.98 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 7.4 m-85 -75.85 -36.96 59.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.34 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.75 -36.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -56.75 -53.97 51.7 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 111.363 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -75.11 -36.89 44.56 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.362 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.93 99.73 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.254 0.527 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -40.91 73.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.8 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.71 -51.19 69.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.062 179.037 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 93.7 m -57.02 -47.06 81.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.619 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.24 -37.74 64.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.448 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 1.9 mt-10 -83.98 -25.37 30.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 1.4 p -79.07 -24.01 43.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' CYS . 89.5 t -71.16 -35.19 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.966 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.448 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -84.41 1.09 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.401 . . . . 0.0 110.765 179.736 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -119.67 -168.29 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.668 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.86 58.43 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.086 0.47 . . . . 0.0 110.562 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.434 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.91 47.01 2.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.392 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 6.9 mt-10 -57.33 -55.62 42.46 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.7 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.8 Cg_exo -63.17 -31.6 74.85 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.958 1.772 . . . . 0.0 112.584 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.6 mp -60.16 -34.33 73.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.79 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.2 -52.27 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 111.368 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.04 85.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.208 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.0 mm-40 -67.0 -47.0 72.81 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.9 t -59.82 -35.55 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.27 -46.35 89.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.412 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.654 ' HA ' HG12 ' A' ' 127' ' ' VAL . 19.3 pt-20 -71.5 -40.47 70.16 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.824 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.4 m0 -57.3 -40.42 77.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.419 0.628 . . . . 0.0 109.371 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.404 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.6 ttp -71.07 -53.62 14.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.641 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 5.6 p -62.46 -38.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.54 -46.49 85.72 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 14.6 t80 -62.47 -33.42 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.479 0.657 . . . . 0.0 110.597 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.93 -58.76 3.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.174 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 131' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 6.2 pt-20 -64.95 -20.75 66.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -89.32 -32.05 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 -42.91 0.99 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.989 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.77 -47.38 85.93 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.268 -178.6 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.93 -39.97 60.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.544 179.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.01 -47.12 87.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.744 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.781 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 56.5 t90 -60.47 -50.18 74.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.624 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.8 mt -57.11 -47.47 83.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.266 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.0 m80 -62.97 -34.25 77.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -90.9 -9.85 44.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -91.35 -45.09 8.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.493 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.62 -15.09 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.55 165.78 39.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.397 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.4 m95 -60.53 -29.62 69.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.93 82.42 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.005 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.02 -41.85 98.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.43 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 17.9 t80 -67.93 -33.41 74.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.627 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.939 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -66.6 -26.54 67.15 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.055 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.89 -36.89 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.656 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -63.56 -41.15 98.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.004 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.417 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 2.4 m-85 -122.83 26.77 8.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.83 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -127.46 -138.55 4.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.493 -1.336 . . . . 0.0 114.043 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -62.46 1.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -0.721 . . . . 0.0 112.347 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -79.42 54.0 4.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.341 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.34 69.12 10.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.556 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.22 167.01 13.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.297 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -51.6 -35.83 43.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.371 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 4.2 mm-40 -65.48 -48.07 73.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.926 0.393 . . . . 0.0 110.308 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -62.8 -34.54 77.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.731 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -59.55 -57.2 14.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -70.4 -27.66 64.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 35.3 tp -66.69 -47.29 72.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.287 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.534 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -69.88 -33.15 71.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.297 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.436 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.29 -43.7 66.62 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.103 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.11 -26.37 74.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.722 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.548 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 7.2 t-20 -59.9 -61.03 2.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.265 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.763 ' HA ' HG12 ' A' ' 170' ' ' VAL . 32.4 p-90 -69.48 -22.82 63.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.84 -58.72 5.26 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.994 0.184 . . . . 0.0 110.745 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.6 m -88.93 -24.04 22.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -81.62 -28.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.398 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 95' ' ' ARG . 1.3 ttt180 -82.16 -22.34 36.13 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.847 -0.533 . . . . 0.0 109.614 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -83.61 -43.01 16.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.97 HG13 ' HG ' ' A' ' 174' ' ' LEU . 14.4 p -57.89 -37.0 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.12 0.486 . . . . 0.0 110.861 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.97 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -110.61 36.26 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.208 0.527 . . . . 0.0 110.16 178.969 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.9 t -77.66 -9.71 59.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 7.27 80.55 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.732 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.97 25.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.26 51.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.913 0.387 . . . . 0.0 110.514 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.81 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.908 ' HG ' HG11 ' A' ' 82' ' ' VAL . 15.8 mt -86.67 -30.71 21.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.816 0.341 . . . . 0.0 110.29 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -77.75 91.05 1.07 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.685 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.585 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -79.93 136.4 36.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 111.632 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.915 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -4' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' -3' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' -2' ' ' LEU . 13.8 Cg_exo -69.0 128.34 16.57 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.807 2.338 . . . . 0.0 111.705 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' -2' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' -3' ' ' PRO . 0.4 OUTLIER 73.54 -55.17 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.85 0.719 . . . . 0.0 111.128 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -158.94 -168.48 21.07 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.6 m -151.48 143.71 24.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.88 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.33 136.92 51.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.8 p -99.36 131.1 25.63 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 16.9 Cg_exo -67.54 98.04 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.948 2.432 . . . . 0.0 112.341 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.65 42.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 111.246 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.6 m -158.13 124.3 4.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.56 149.13 25.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.339 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 11.9 Cg_exo -70.74 108.0 2.17 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.051 2.501 . . . . 0.0 112.112 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.31 -176.58 5.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -32.19 67.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -68.23 -32.66 73.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.396 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.26 -43.59 32.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 42' ' ' LEU . 1.4 tp -62.01 -43.55 98.59 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 127' ' ' VAL . 4.4 p -66.14 -37.65 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.512 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.9 70.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 110.422 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -70.28 -52.55 22.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.045 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.7 t80 -58.1 -52.99 63.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.409 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.1 t -64.15 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.75 -51.81 56.8 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.745 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.732 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.9 t80 -61.98 -38.84 90.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.638 0.375 . . . . 0.0 110.926 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 7.4 mmtt -66.35 -43.56 85.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -75.94 -46.35 30.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -62.22 -21.19 64.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -85.74 -24.03 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.326 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.36 75.34 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 111.456 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.34 -74.62 0.26 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.645 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 2.0 t80 -85.74 58.14 4.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.957 0.408 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.39 -33.87 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.182 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.72 -14.15 61.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.182 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -109.8 40.27 2.61 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -60.27 130.48 46.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.93 -48.43 0.19 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.819 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.604 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 3.2 Cg_exo -84.11 -48.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -78.38 22.57 3.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.989 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -79.84 -26.75 40.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.72 0.76 . . . . 0.0 109.46 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.43 132.44 11.14 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.356 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 90.2 Cg_endo -89.05 -148.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.985 2.457 . . . . 0.0 113.275 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.89 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -86.33 97.79 10.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.7 -34.78 1.01 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.7 m-20 -78.97 160.43 71.4 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.686 0.279 . . . . 0.0 111.617 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.6 Cg_endo -74.43 51.75 2.65 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.525 2.816 . . . . 0.0 112.44 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.59 -34.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.881 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -59.64 -58.0 10.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.089 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.89 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -59.72 -28.0 66.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.693 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.88 -49.66 50.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -63.55 -31.02 72.06 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.976 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 15.2 ttp180 -62.6 -42.37 99.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.413 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.3 -23.62 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.844 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.32 -64.88 0.81 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.301 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.31 -46.18 35.51 Favored Glycine 0 C--O 1.216 -1.013 0 O-C-N 124.107 0.879 . . . . 0.0 112.397 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -51.64 -51.87 52.28 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.382 0.61 . . . . 0.0 111.425 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.45 -45.69 93.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.047 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -75.53 -33.74 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.922 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.46 -26.85 68.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.2 m -88.58 -41.84 12.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.485 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -87.27 -64.43 1.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 112.205 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -80.41 61.26 4.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.121 0.486 . . . . 0.0 111.338 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -85.24 0.38 52.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -89.11 18.21 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -104.38 -0.07 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.754 ' HA ' HD22 ' A' ' 64' ' ' LEU . 80.3 m-85 -84.89 -23.25 29.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.112 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -35.61 81.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 1.013 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 1.4 m-20 -62.0 -33.49 74.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.299 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.84 -41.76 87.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.529 0.681 . . . . 0.0 109.325 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -80.39 -40.56 26.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.579 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.628 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.21 -46.13 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.522 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.569 HE22 HD11 ' A' ' 106' ' ' LEU . 35.2 mt-30 -76.52 -49.16 17.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.448 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.28 6.35 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -176.671 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.1 t60 -82.64 -31.99 28.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.872 0.368 . . . . 0.0 110.66 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 71' ' ' THR . 2.3 p -91.76 -54.77 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 70' ' ' VAL . 5.0 t -171.97 144.51 1.5 Allowed Pre-proline 0 C--O 1.237 0.437 0 CA-C-O 120.91 0.386 . . . . 0.0 111.007 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 3.6 Cg_endo -84.36 -171.81 1.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.258 2.639 . . . . 0.0 111.258 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.27 -67.4 3.7 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.74 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 48.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.385 0.612 . . . . 0.0 111.674 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . . . -104.39 -17.16 14.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 13.1 pt20 -64.27 -35.69 81.66 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.251 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -67.58 -39.63 84.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.891 0.377 . . . . 0.0 110.428 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ARG . . . . . 0.729 ' HD2' ' HA ' ' A' ' 75' ' ' ALA . 23.1 mtt180 -68.59 -45.87 70.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -61.34 -47.84 84.06 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.906 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -58.28 -33.75 69.77 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 38.0 mm-40 -60.09 -64.07 1.08 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 9.1 p -57.87 -34.58 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -68.21 -45.63 72.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.667 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -71.36 -38.02 71.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.851 0.358 . . . . 0.0 110.519 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -19.38 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.269 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -85.28 -39.47 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.833 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 32.9 t80 -79.24 -7.67 58.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.243 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -48.59 -35.97 14.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.431 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.51 62.46 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.834 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.62 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 164.05 51.35 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.541 -1.314 . . . . 0.0 115.04 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.62 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 18.3 Cg_endo -81.37 37.01 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 119.762 1.781 . . . . 0.0 111.542 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.2 t-20 -68.04 164.87 19.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.903 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.588 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 26.0 m95 -53.97 -28.2 36.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.458 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.16 -41.14 97.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.117 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -86.09 -23.67 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.654 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.862 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -56.21 -31.59 63.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.479 0.657 . . . . 0.0 109.852 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.766 HG22 ' HB1' ' A' ' 49' ' ' ALA . 38.7 t -61.26 -54.15 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.391 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.33 69.45 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.351 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.862 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.17 -57.27 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 110.509 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 40.9 m-85 -74.56 -38.74 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.4 -40.16 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.793 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.589 ' HE2' HD22 ' A' ' 180' ' ' LEU . 0.6 OUTLIER -54.79 -52.68 61.88 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.21 -38.11 47.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.078 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.11 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.12 0.46 . . . . 0.0 110.756 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -67.54 -39.12 85.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.719 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.97 -42.41 94.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.456 179.282 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.719 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.0 m -69.19 -39.37 78.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.455 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.75 79.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.395 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.7 OUTLIER -84.67 -15.0 46.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.479 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -82.81 -24.64 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.354 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 107' ' ' CYS . 91.4 t -69.23 -33.22 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.318 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.558 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.6 p30 -84.99 1.06 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -126.94 -173.26 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.435 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -84.61 56.37 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.703 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.448 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.06 43.31 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.8 mt-10 -57.33 -53.55 64.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.396 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 17.3 Cg_exo -67.7 -27.52 38.12 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.072 1.848 . . . . 0.0 112.636 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 tp -62.78 -35.66 80.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.74 -51.28 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.56 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.34 -33.52 87.46 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.53 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.2 mm-40 -67.18 -50.35 61.33 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 45.1 t -58.68 -33.71 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -63.04 -46.58 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.263 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.799 ' HA ' HG12 ' A' ' 127' ' ' VAL . 15.4 pt-20 -74.03 -39.31 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.664 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.2 m0 -56.41 -37.88 70.76 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 8.9 ttm -73.61 -55.43 6.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.506 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 124' ' ' GLU . 9.8 p -60.32 -36.19 67.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -67.54 -48.76 66.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.823 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 8.7 t80 -59.01 -34.72 72.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.63 0.729 . . . . 0.0 110.148 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.995 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -73.07 -56.93 4.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.573 -179.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -77.43 -38.52 49.37 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -42.61 2.04 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -177.607 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.995 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.82 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.321 0.509 . . . . 0.0 111.676 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.94 61.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -49.52 67.21 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.0 t90 -57.96 -48.08 81.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.65 -49.55 77.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.944 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.65 -39.51 73.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.1 m -86.79 -11.27 51.5 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.2 -22.02 16.4 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.35 -24.99 0.97 Allowed Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.499 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.566 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 95.86 169.55 35.26 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.011 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 96.2 m95 -60.06 -29.4 68.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.87 79.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.571 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.46 -42.0 96.2 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.844 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -61.95 -39.47 92.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.318 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.682 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -66.07 -27.16 67.87 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 110.75 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -15.31 41.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 0.0 109.856 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.677 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -79.03 -48.87 13.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.22 179.497 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.5 m-85 -138.99 30.75 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -95.09 -132.17 6.75 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.189 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.48 -31.42 70.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -115.5 65.85 0.3 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.77 76.33 10.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.207 0.527 . . . . 0.0 110.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.7 153.59 23.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.324 -179.588 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.66 -28.03 53.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.308 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -74.75 -42.14 58.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 110.801 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.79 -34.66 75.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.242 0.544 . . . . 0.0 110.541 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.58 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 8.3 mtm-85 -63.97 -50.45 68.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.074 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -68.9 -30.11 68.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.569 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -64.77 -37.38 87.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.254 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -69.48 -42.21 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.555 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 3.4 tt0 -65.46 -44.62 86.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.403 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 -22.45 75.63 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.632 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.488 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -74.66 -52.96 10.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.0 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HA ' HG22 ' A' ' 170' ' ' VAL . 14.7 p-90 -66.97 -23.8 65.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.274 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.07 77.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.15 0.5 . . . . 0.0 110.382 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 -32.59 19.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.516 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.845 HG22 ' HA ' ' A' ' 167' ' ' TRP . 34.3 m -86.12 -25.57 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.4 ttp180 -80.84 -25.38 37.76 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.588 -0.695 . . . . 0.0 109.938 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.826 ' HA ' HG23 ' A' ' 175' ' ' THR . 2.2 m -90.09 -28.6 18.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.763 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.94 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -65.32 -29.05 46.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.388 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.94 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -120.07 46.15 2.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.185 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -64.99 -42.33 94.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.94 25.18 1.53 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.499 0.56 . . . . 0.0 114.499 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.96 -2.21 58.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.323 0.561 . . . . 0.0 110.457 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.36 66.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.805 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.03 12.03 37.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.433 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 1.013 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 5.6 mp -91.41 -47.06 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.656 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . 0.401 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.02 92.77 0.39 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.628 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -89.6 100.48 13.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.53 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.75 133.77 30.55 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.842 2.361 . . . . 0.0 111.478 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.5 mp -78.7 -83.71 0.09 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.997 0.427 . . . . 0.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -147.14 140.07 8.34 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -47.3 14.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 110.541 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.83 152.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.787 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.31 160.49 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.892 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.559 HG21 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -102.48 141.38 22.41 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 5.9 Cg_exo -78.9 -7.62 15.48 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.022 2.481 . . . . 0.0 112.967 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.59 -47.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.702 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 m -153.92 148.32 26.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.644 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -88.37 137.61 30.7 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 3.6 Cg_exo -75.13 34.93 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.589 2.86 . . . . 0.0 112.303 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 10' ' ' THR . 1.5 m-20 -84.75 -159.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -56.47 -35.04 67.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.15 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -63.58 -39.59 94.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.689 0.28 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -32.95 57.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.814 0.34 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.749 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.4 tp -74.74 -42.22 58.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.427 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -66.37 -37.93 80.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.834 0.349 . . . . 0.0 110.23 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.72 60.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.75 0.31 . . . . 0.0 110.588 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.082 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 6.7 t80 -56.63 -50.11 73.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.4 t -66.83 -42.18 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.19 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.47 -52.75 49.23 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.888 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.802 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 23.6 t80 -57.19 -46.55 82.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.073 0.549 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.52 -45.46 90.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 111.059 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.7 mp -66.85 -47.24 72.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 23.7 ttp85 -60.77 -25.81 66.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.3 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.94 -21.79 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.952 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -157.43 72.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.759 0.314 . . . . 0.0 111.654 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.68 -75.99 0.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.2 t80 -84.37 56.13 3.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.05 -28.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.087 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.36 -15.16 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.478 0.656 . . . . 0.0 109.962 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -111.85 53.9 0.57 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.963 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB1' ' OE2' ' A' ' 35' ' ' GLU . . . -63.49 144.59 56.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.204 -0.498 . . . . 0.0 110.408 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' CA ' ' HG2' ' A' ' 35' ' ' GLU . . . 142.77 -57.25 0.56 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.979 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.5 Cg_exo -61.7 -45.36 17.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.579 2.186 . . . . 0.0 112.403 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.43 39.44 2.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.743 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 74.4 mm-40 -79.31 -59.92 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.349 0.574 . . . . 0.0 109.95 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.05 128.96 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.3 Cg_endo -88.28 -132.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.835 2.357 . . . . 0.0 113.476 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HB1' ' HG2' ' A' ' 44' ' ' GLN . . . -73.79 92.4 2.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.493 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.93 39.9 1.04 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -156.41 164.9 19.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.654 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.9 Cg_endo -82.39 49.63 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.135 2.557 . . . . 0.0 112.275 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.749 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.8 -27.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.485 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' HD2' HD12 ' A' ' 42' ' ' LEU . 4.4 m170 -62.55 -56.03 21.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.929 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.98 -23.81 67.48 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.044 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -67.63 -54.1 22.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.465 ' HE3' HD21 ' A' ' 13' ' ' LEU . 3.8 tpp -70.13 -30.07 67.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.338 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -39.87 95.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.572 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.22 -28.52 47.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 109.685 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.5 -61.08 1.99 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.643 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.12 -45.9 42.72 Favored Glycine 0 C--O 1.215 -1.081 0 O-C-N 124.108 0.88 . . . . 0.0 112.292 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.28 -52.75 51.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.588 0.355 . . . . 0.0 111.884 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -44.0 95.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.404 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.678 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -72.56 -35.0 67.87 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.366 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.25 -27.15 68.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.323 0.583 . . . . 0.0 109.518 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -88.01 -39.24 14.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -90.37 -57.23 2.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -81.4 69.21 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 58' ' ' ARG . 17.7 mtt180 -72.89 0.59 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.88 51.69 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 110.198 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.0 0.15 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.412 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.895 ' HA ' HD22 ' A' ' 64' ' ' LEU . 36.6 m-85 -110.51 -25.91 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 0.0 111.592 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -41.11 97.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.74 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.99 -18.95 64.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.748 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -66.87 -45.41 78.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -75.67 -47.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -47.77 -41.63 23.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.18 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.571 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 42.1 mt-30 -71.83 -65.65 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' A' ' 115' ' ' MET . 0.7 OUTLIER -78.49 14.48 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.339 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 1.6 p-80 -79.15 -20.56 48.23 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.533 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.87 -72.69 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.825 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -157.15 135.64 7.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 21.2 Cg_exo -66.44 170.14 12.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.115 2.543 . . . . 0.0 112.378 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . 0.715 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 92.18 -58.49 2.76 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.67 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.55 50.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.43 0.634 . . . . 0.0 110.848 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.67 -25.08 10.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.739 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.626 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -63.03 -42.1 99.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.848 -179.02 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.95 -44.71 95.33 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.383 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -61.7 -42.68 99.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.246 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -62.47 -51.0 69.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.469 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -59.07 -32.2 69.57 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.725 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -61.07 -60.52 3.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.72 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.7 m -60.29 -32.53 51.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.6 m -65.61 -42.42 91.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.16 -40.44 86.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 178.938 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -67.13 -31.79 72.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.486 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.01 -36.59 59.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -85.83 -5.81 59.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -34.46 25.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.018 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.83 62.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.352 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.88 56.64 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.544 -1.313 . . . . 0.0 115.014 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 11.8 Cg_endo -82.13 29.37 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.396 2.064 . . . . 0.0 111.194 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.857 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.9 m120 -61.63 162.06 8.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.889 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 27.7 m95 -52.68 -25.77 11.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.864 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.98 90.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.522 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.674 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.0 mmp_? -87.09 -22.43 25.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.926 -0.161 . . . . 0.0 110.758 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -54.71 -31.08 57.61 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.728 0.643 . . . . 0.0 110.229 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.935 HG22 ' HB1' ' A' ' 49' ' ' ALA . 17.6 t -59.77 -56.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.95 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -27.32 69.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.84 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.0 m-85 -58.49 -55.12 39.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 110.123 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 12.8 m-85 -76.16 -37.86 57.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.73 -37.88 80.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.801 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -54.5 -53.86 48.67 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.13 -35.66 52.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.444 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.61 99.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.136 0.468 . . . . 0.0 110.513 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.43 -40.17 77.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.823 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -59.65 -42.11 92.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.704 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.666 ' HB3' HD21 ' A' ' 22' ' ' LEU . 96.9 m -69.06 -41.16 77.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.024 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.86 -48.46 69.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.983 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -74.13 -20.22 60.31 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.874 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.579 ' HB3' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -78.78 -35.94 43.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.482 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 107' ' ' CYS . 24.6 t -67.81 -16.3 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.829 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 12.3 m-20 -45.73 -70.25 0.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.487 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -175.55 37.45 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.886 179.375 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 17.2 mt-10 -159.68 122.1 3.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.878 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.552 ' HE1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 mtm 70.31 114.84 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.777 0.673 . . . . 0.0 112.106 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.701 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -102.05 -55.34 0.13 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.146 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.701 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 36.2 Cg_exo -59.85 -27.79 85.73 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.487 2.125 . . . . 0.0 113.967 -178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.715 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -62.3 -31.57 72.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.915 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 110' ' ' SER . 94.6 t -60.36 -55.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.623 0.249 . . . . 0.0 111.371 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.51 -28.88 72.0 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.016 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.9 mt-30 -68.52 -49.21 61.32 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 99.6 t -56.64 -36.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.64 -47.05 87.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.859 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' A' ' 127' ' ' VAL . 20.8 pt-20 -73.93 -36.72 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.626 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.1 m0 -57.12 -38.34 73.29 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.9 ttm -73.61 -54.28 8.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.22 -30.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.772 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.32 -50.0 50.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.263 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 11.8 t80 -61.76 -34.4 75.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.0 110.599 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 0.869 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -72.12 -56.01 6.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.133 -178.854 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.99 -34.3 74.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.5 m -79.04 -40.92 30.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -121.61 -42.73 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.869 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.7 mm? -59.6 -46.0 90.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.227 0.467 . . . . 0.0 111.166 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.18 -39.5 56.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.376 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.5 -55.78 29.36 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.449 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.857 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 62.2 t90 -55.79 -46.34 77.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.117 0.484 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.406 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -58.24 -48.19 85.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.721 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.2 m80 -66.07 -32.22 73.56 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.372 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -84.0 -11.85 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -49.61 5.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.3 -18.08 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.406 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 96.15 170.6 35.06 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.017 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.48 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 92.9 m95 -60.48 -30.62 69.8 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.52 76.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -65.38 -42.19 92.95 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.754 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -66.05 -33.85 76.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.548 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -71.07 -24.49 62.34 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.468 178.754 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.35 -31.68 21.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -60.39 -51.38 69.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.581 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 -132.55 33.85 3.75 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.04 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -103.54 -127.79 6.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.431 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.42 -37.61 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 111.078 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.32 61.81 0.3 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.56 72.85 9.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.136 0.493 . . . . 0.0 110.637 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.2 164.16 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.837 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -59.72 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.574 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.5 mt-10 -71.47 -35.78 70.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.26 62.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 0.0 109.73 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' ARG . . . . . 0.647 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 4.0 mtp180 -61.75 -51.64 67.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.294 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' GLU . 1.3 ptm180 -67.64 -28.39 67.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.652 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -66.85 -45.3 78.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.529 ' NH2' ' HA ' ' A' ' 49' ' ' ALA . 13.0 ttp180 -67.26 -38.04 84.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.1 OUTLIER -67.66 -47.12 70.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.214 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.75 -21.79 75.11 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.503 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.6 ' O ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -68.96 -54.04 17.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.277 . . . . 0.0 110.827 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.649 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 15.0 p-90 -67.76 -25.08 65.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.985 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.14 74.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 110.262 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.59 -28.75 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 27.8 m -93.04 -31.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -41.0 67.54 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.544 -0.722 . . . . 0.0 110.29 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 175' ' ' THR . 3.7 m -74.66 -28.47 60.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.809 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -70.44 -26.09 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.569 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.809 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -120.72 39.73 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.726 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -68.5 -16.2 63.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -87.96 14.08 59.65 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.184 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.34 8.2 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.942 0.371 . . . . 0.0 111.806 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 58.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.925 0.393 . . . . 0.0 110.475 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.09 51.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -100.7 -7.84 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.03 89.48 0.2 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.141 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.589 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -127.98 -172.44 2.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.89 133.1 34.71 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.969 2.446 . . . . 0.0 112.348 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -3.44 35.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 109.04 -78.42 0.24 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -56.98 4.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.726 0.298 . . . . 0.0 110.697 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpp? 70.86 -56.41 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.234 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.7 138.66 36.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.68 0.276 . . . . 0.0 110.906 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -99.74 140.87 21.89 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.63 160.46 49.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.747 2.298 . . . . 0.0 111.765 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.57 141.5 51.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.521 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m 62.68 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.11 138.26 20.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 15.3 Cg_exo -68.88 101.95 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.984 2.456 . . . . 0.0 111.872 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.63 -161.4 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.458 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -43.33 74.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.385 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -58.65 -39.33 80.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.631 0.253 . . . . 0.0 110.726 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -47.91 51.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 46' ' ' MET . 4.2 tp -58.78 -45.09 90.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.377 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -65.9 -39.29 84.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.87 76.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.87 -48.85 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.908 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -59.31 -51.06 71.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' O ' HD13 ' A' ' 22' ' ' LEU . 53.5 t -65.24 -40.99 90.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.96 -48.02 87.83 Favored Glycine 0 C--O 1.222 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.94 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' TYR . . . . . 0.721 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.2 t80 -58.12 -47.75 82.34 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.821 0.448 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.68 85.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.175 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -67.15 -46.93 72.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.416 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 35.4 ttp85 -62.96 -20.34 65.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.841 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.7 tt0 -82.19 -36.41 27.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.926 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.44 77.89 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.49 -68.3 0.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.09 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.1 t80 -92.57 59.67 3.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.0 110.701 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.16 -26.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.92 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -36.86 77.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.791 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -96.46 50.6 1.61 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.955 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -67.75 131.28 45.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.01 -53.75 0.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.612 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 18.0 Cg_exo -68.56 -49.22 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.217 1.945 . . . . 0.0 111.643 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.721 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.5 31.88 4.69 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.517 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.83 -59.44 2.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.437 0.637 . . . . 0.0 109.314 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.19 124.88 7.23 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.422 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.82 -112.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.998 2.465 . . . . 0.0 112.955 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.44 97.15 1.24 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.7 20.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.067 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 30.8 m-20 -146.26 162.35 35.18 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -79.22 52.33 4.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.366 2.711 . . . . 0.0 111.468 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.29 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.03 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -62.66 -50.4 71.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.575 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -64.06 -25.23 68.01 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.94 -54.22 7.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.465 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' MET . . . . . 0.46 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.3 ttm -61.97 -38.29 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.976 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -61.32 -37.91 84.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.075 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.51 34.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.519 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.56 -55.88 28.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.308 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.67 -49.45 40.37 Favored Glycine 0 C--O 1.217 -0.963 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.206 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.74 -53.15 58.8 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.906 0.384 . . . . 0.0 111.929 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.1 -46.6 86.6 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.355 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.845 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -69.77 -36.72 75.98 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.778 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -61.04 -32.86 72.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.503 0.668 . . . . 0.0 109.742 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 m -79.34 -28.92 42.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.351 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -92.44 -31.89 15.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.44 93.39 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.191 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -71.64 -25.42 62.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.875 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -94.27 77.31 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.122 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.85 -62.51 1.44 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.097 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PHE . . . . . 0.947 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.0 m-85 -76.79 -10.81 59.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -47.61 80.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -68.41 -21.23 64.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.201 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -68.86 -42.01 77.66 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.77 -43.38 37.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.567 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -53.48 -43.22 67.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.466 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 44.6 mt-30 -71.33 -58.05 3.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 3.8 6.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 65.5 t60 -78.81 -26.89 44.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.873 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -71.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.13 147.58 11.47 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -89.54 -169.81 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.138 2.559 . . . . 0.0 111.917 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.76 -70.24 2.91 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.343 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.41 37.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 111.905 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' HD11 ' A' ' 118' ' ' LEU . . . -85.84 -16.42 38.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.368 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' GLN . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 9.9 pt20 -60.95 -42.0 97.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.588 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.3 -39.57 94.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.36 . . . . 0.0 110.499 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -67.58 -43.58 80.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.021 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.06 -48.9 76.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -57.73 -31.88 66.87 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.394 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -62.43 -63.27 1.28 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.891 0.376 . . . . 0.0 110.636 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 ' HG ' ' A' ' 180' ' ' LEU . 20.9 m -58.78 -32.12 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.512 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 m -65.91 -43.48 88.01 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -69.26 -40.6 77.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.638 178.708 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -64.14 -28.3 69.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.412 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HG ' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -83.62 -28.5 28.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 110.088 179.075 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -91.08 0.5 57.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 9.1 mm100 -49.0 -33.27 10.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.003 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.67 55.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.962 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.443 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 172.61 54.95 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 C-N-CA 119.953 -1.118 . . . . 0.0 114.324 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -80.87 43.06 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.169 1.913 . . . . 0.0 111.977 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.3 t-20 -67.71 161.74 25.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.896 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' TRP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.3 m95 -55.33 -26.98 44.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.76 98.47 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.689 HH11 ' HG ' ' A' ' 86' ' ' LEU . 5.2 mmt180 -86.31 -18.77 31.1 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.819 -0.224 . . . . 0.0 110.716 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.752 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.86 -31.66 65.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.329 0.585 . . . . 0.0 110.218 179.574 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 53' ' ' PHE . 5.9 t -61.3 -53.73 44.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.521 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.64 -26.85 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.395 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.42 -57.53 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.068 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.67 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.6 m-85 -74.79 -40.07 61.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.724 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.02 -38.91 69.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.71 -49.49 75.01 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.729 0.3 . . . . 0.0 111.317 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.36 -37.91 30.37 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.003 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.04 97.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.025 0.413 . . . . 0.0 110.688 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.56 -40.07 80.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.772 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.79 -43.66 90.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.281 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 107' ' ' CYS . . . . . 0.641 ' HB2' HD11 ' A' ' 22' ' ' LEU . 88.5 m -63.57 -44.37 94.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.071 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.03 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.569 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . 0.443 ' HA ' ' OD1' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -75.09 -23.06 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.658 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 110' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 119' ' ' VAL . 49.1 m -79.56 -22.24 44.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.116 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.3 t -75.97 -35.44 29.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' ASN . . . . . 0.443 ' OD1' ' HA ' ' A' ' 109' ' ' GLU . 1.1 p-10 -85.04 1.13 49.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 8.9 mtmt -123.6 -174.6 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.5 48.74 1.56 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -129.94 37.84 3.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.536 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -54.68 -53.73 57.09 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 23.4 Cg_exo -65.15 -32.12 53.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.005 1.804 . . . . 0.0 112.299 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -59.61 -31.06 69.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.609 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 110' ' ' SER . 87.2 t -58.17 -51.2 73.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.903 0.382 . . . . 0.0 111.256 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.06 -31.58 81.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.089 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 14.3 mm100 -66.27 -51.81 53.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 61.2 t -58.15 -33.71 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.16 -47.57 82.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.325 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLU . . . . . 0.66 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.4 pt-20 -72.4 -39.44 67.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' TRP . . . . . 0.62 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.7 m0 -57.61 -38.61 75.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.0 ttm -73.77 -52.83 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.795 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.5 p -62.15 -33.32 58.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.55 -52.07 35.97 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.605 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.49 -33.32 67.89 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.467 0.651 . . . . 0.0 110.568 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' LEU . . . . . 1.045 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.07 -55.81 5.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.748 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -32.02 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.7 m -82.61 -34.7 27.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -126.97 -44.91 1.6 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 1.045 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.05 -46.54 87.98 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.429 -178.394 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.64 -38.85 61.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.259 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -60.03 -52.59 64.73 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.418 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 52.8 t90 -56.62 -48.69 76.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ILE . . . . . 0.507 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.7 mt -57.09 -47.77 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.016 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 43.4 m80 -66.39 -29.17 69.28 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -88.04 -16.13 34.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.56 -54.39 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.78 -9.74 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.545 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.03 166.88 40.98 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.009 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TRP . . . . . 0.46 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 91.6 m95 -60.67 -29.15 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.22 80.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.89 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.78 -42.77 99.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' PHE . . . . . 0.473 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.3 t80 -66.1 -33.17 75.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.137 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.39 -27.7 68.06 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.738 0.304 . . . . 0.0 111.02 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.0 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 163' ' ' ARG . 5.0 mt -63.61 -42.95 98.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.536 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.4 m-85 -123.39 31.29 5.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.814 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -122.94 -138.37 5.26 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.752 -1.214 . . . . 0.0 113.107 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -42.77 36.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.785 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' GLY . . . . . 0.432 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.52 53.43 4.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.44 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.5 71.76 10.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -63.02 157.68 21.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.39 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -53.07 -33.68 53.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.209 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLU . . . . . 0.681 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.2 mt-10 -72.8 -39.41 66.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.919 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.36 72.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.993 0.425 . . . . 0.0 110.83 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -60.66 -51.46 69.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.037 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -69.16 -26.12 64.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.019 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.68 -46.02 55.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ARG . . . . . 0.62 ' HB3' HD22 ' A' ' 150' ' ' LEU . 3.8 ptt180 -65.1 -38.62 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLU . . . . . 0.587 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -71.02 -43.54 67.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.204 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.81 -28.46 73.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.647 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.3 t-20 -67.1 -57.76 6.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' TRP . . . . . 0.791 ' HA ' HG22 ' A' ' 170' ' ' VAL . 15.7 p-90 -62.12 -25.34 67.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.491 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.4 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.051 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 -29.19 22.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 167' ' ' TRP . 26.8 m -79.4 -23.9 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.265 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 3.7 ttp180 -83.09 -14.43 53.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' THR . . . . . 0.661 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -98.52 -33.21 11.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.471 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' VAL . . . . . 0.964 HG13 ' HG ' ' A' ' 174' ' ' LEU . 11.7 p -63.19 -33.14 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.57 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.964 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -112.34 39.4 2.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.77 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -54.37 -42.86 70.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.372 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.72 59.55 4.43 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.131 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -120.14 6.69 10.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.413 0.625 . . . . 0.0 109.62 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.65 61.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.455 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -82.41 -8.11 59.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.568 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' LEU . . . . . 0.636 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -94.43 -33.76 13.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.802 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.14 96.62 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.627 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.588 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -110.81 43.25 1.46 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.835 0.35 . . . . 0.0 110.588 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.755 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo . . . . . 0 N--CA 1.478 0.562 0 CA-C-O 121.26 0.442 . . . . 0.0 113.238 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -166.0 1.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.883 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -39.45 82.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.393 0.139 . . . . 0.0 111.158 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -62.2 -38.01 87.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.84 66.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.6 tp -72.4 -42.28 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.519 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -66.49 -36.07 76.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 109.969 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.23 -22.96 60.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.322 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -73.16 -66.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -53.44 -50.66 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.798 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.453 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.4 t -67.64 -42.31 86.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.429 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.48 -52.29 52.2 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.211 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -55.57 -45.33 77.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.148 0.579 . . . . 0.0 111.223 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -48.37 66.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -63.38 -45.31 91.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.578 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -62.17 -26.98 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.026 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -85.99 -23.97 26.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.57 66.12 1.12 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.9 -72.17 0.29 Allowed Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.833 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.2 t80 -91.2 52.96 2.22 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.163 0.506 . . . . 0.0 110.332 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.15 -31.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.668 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -35.35 79.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.392 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.77 57.39 2.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.659 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -60.18 128.26 35.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.61 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 165.6 -60.91 0.24 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.278 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 32.1 Cg_exo -58.8 -52.51 5.12 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 121.96 1.773 . . . . 0.0 111.024 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -92.57 42.48 2.68 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.51 -18.32 31.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 110.313 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -110.55 147.5 17.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.622 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.5 Cg_endo -93.94 -158.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.964 2.443 . . . . 0.0 113.135 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.909 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.3 96.77 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.31 -24.44 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.737 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 20.6 m-20 -79.5 163.25 59.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.105 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.3 Cg_endo -78.0 50.39 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.42 2.746 . . . . 0.0 112.102 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.78 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.49 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.345 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.3 m170 -59.23 -60.48 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.09 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.909 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.4 -24.88 61.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.045 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -73.82 -50.71 19.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.92 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttm -66.74 -37.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.43 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.98 84.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.542 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.62 -27.69 51.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.348 0.595 . . . . 0.0 110.678 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.98 -62.65 1.29 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.563 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.659 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.94 -45.85 41.1 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.72 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.34 -50.11 72.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.054 0.455 . . . . 0.0 111.697 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -46.37 84.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.198 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.846 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -68.73 -36.33 78.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.274 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.21 -32.5 71.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.302 0.572 . . . . 0.0 109.547 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -83.12 -25.76 31.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.414 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -91.47 -29.43 17.02 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.21 96.86 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 110.992 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt-85 -72.54 -3.69 26.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.601 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.422 HH12 HG11 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -132.2 87.89 2.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.761 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -120.05 -61.02 1.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.658 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.953 ' HA ' HD22 ' A' ' 64' ' ' LEU . 6.9 m-85 -79.67 0.44 30.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.471 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 p -73.42 -53.99 9.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.33 -24.27 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.919 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.953 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -63.15 -44.77 94.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.862 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.65 51.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.898 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.66 -44.28 62.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.201 179.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.457 HE22 HD11 ' A' ' 106' ' ' LEU . 19.7 mt-30 -69.2 -51.24 39.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.716 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.553 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -86.17 20.22 2.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.097 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.74 -40.88 32.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' H ' ' A' ' 71' ' ' THR . 1.5 p -90.88 -60.83 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -172.7 145.7 1.41 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.11 -158.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.075 2.516 . . . . 0.0 112.623 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.99 -71.07 2.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.77 50.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.54 0.686 . . . . 0.0 111.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.61 -20.51 14.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.646 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -65.13 -38.06 89.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.674 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 26.1 mp0 -67.43 -42.05 83.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -64.06 -45.57 88.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.39 -51.86 65.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.712 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -58.33 -32.62 68.68 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 22.8 mm-40 -64.15 -56.74 12.67 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.3 m -63.84 -31.88 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.315 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.0 m -65.56 -43.41 89.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.356 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -66.96 -36.67 82.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.244 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.46 -26.25 64.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.894 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -30.91 40.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.087 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -95.96 1.48 52.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -50.15 21.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.747 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.14 61.71 0.15 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.844 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.13 58.67 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.004 -1.093 . . . . 0.0 114.129 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.5 Cg_endo -81.08 41.89 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.43 2.087 . . . . 0.0 111.741 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.2 t-20 -64.47 162.89 14.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -56.05 -26.28 48.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.698 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.02 94.14 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.54 -27.23 22.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.952 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.05 -30.88 49.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.388 0.614 . . . . 0.0 110.149 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.846 HG11 ' HB2' ' A' ' 53' ' ' PHE . 13.3 t -63.18 -55.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.66 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.56 -28.66 69.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.322 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.79 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 8.1 m-85 -57.46 -57.62 11.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 109.956 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.568 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 13.6 m-85 -74.88 -37.68 62.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.2 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.74 -37.5 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.157 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -57.15 -52.33 65.72 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.697 0.284 . . . . 0.0 111.202 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.41 -40.85 38.89 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.225 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.29 89.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.189 0.495 . . . . 0.0 111.016 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.594 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.36 -41.04 70.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.765 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.7 -48.74 80.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.584 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.677 ' HB3' HD21 ' A' ' 22' ' ' LEU . 67.0 m -59.66 -42.26 92.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.316 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.89 -55.96 24.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 0.0 110.855 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.4 -17.87 64.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -77.88 -32.97 52.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' CYS . 35.0 t -75.21 -22.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.658 0.742 . . . . 0.0 109.356 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -4.89 59.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.609 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.2 tttt -132.06 -162.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.585 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.18 55.19 3.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.553 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.52 43.64 2.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.023 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.7 mp0 -60.54 -55.32 46.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.962 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.4 Cg_exo -64.72 -26.84 60.43 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.956 1.771 . . . . 0.0 112.198 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.6 mm? -65.72 -28.11 68.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.313 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 111' ' ' VAL . 79.3 t -59.23 -50.69 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.956 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.87 -32.58 84.36 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.838 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 7.9 mm100 -64.63 -52.88 55.09 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 118' ' ' LEU . 44.8 t -58.3 -33.49 47.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.958 0.408 . . . . 0.0 110.115 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.21 -46.92 81.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.427 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HA ' HG12 ' A' ' 127' ' ' VAL . 19.0 pt-20 -72.31 -39.43 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.064 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.9 m0 -57.8 -38.7 75.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.483 0.658 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 4.7 ttm -71.96 -56.07 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.69 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.2 p -61.19 -33.21 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -73.09 -45.79 55.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.6 t80 -59.88 -37.39 79.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.704 0.764 . . . . 0.0 109.894 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.51 -54.98 8.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.822 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.17 -32.6 70.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -82.43 -35.11 27.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.87 -43.5 1.22 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.51 -48.49 81.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.595 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.8 -38.92 57.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.603 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.15 -50.02 73.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.796 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.8 t90 -58.17 -49.28 77.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 109.525 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.65 HG13 ' HE3' ' A' ' 137' ' ' TRP . 11.3 mt -58.08 -47.14 87.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.152 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -61.12 -40.0 92.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -30.54 43.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -60.03 3.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.947 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.3 -11.07 0.02 OUTLIER Glycine 0 C--N 1.319 -0.367 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.32 169.16 41.89 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.612 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.0 m95 -62.2 -29.03 70.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.51 78.66 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.578 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.81 -44.06 94.4 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 t80 -64.83 -34.21 77.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.579 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.761 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -70.55 -25.55 63.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.37 -32.66 20.84 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.521 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -57.95 -51.49 69.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.643 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -130.32 30.23 4.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.85 -133.13 8.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.927 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -68.59 -45.45 71.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.568 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.68 48.78 2.3 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.12 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.23 73.26 8.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.12 0.486 . . . . 0.0 110.734 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -65.77 160.05 23.85 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.575 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -57.01 -32.18 65.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.281 -178.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -69.62 -39.41 77.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.651 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.38 -36.31 78.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.42 ' HA ' ' HE1' ' A' ' 151' ' ' TYR . 61.9 mtt180 -67.56 -50.57 57.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -64.47 -27.32 68.91 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.019 0.438 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -63.34 -47.52 81.81 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.47 178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.458 HH11 ' HE1' ' A' ' 147' ' ' PHE . 11.0 ttp180 -63.4 -39.2 93.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.636 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.19 -49.12 70.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.888 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.54 -27.23 73.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.585 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.648 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.7 m-20 -70.11 -56.63 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.464 -0.368 . . . . 0.0 111.532 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.645 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 9.8 p-90 -60.34 -27.87 67.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.453 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.73 74.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.688 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -24.09 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 166' ' ' ASN . 28.7 m -96.38 -41.15 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.575 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -75.35 -27.4 59.17 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.411 -0.805 . . . . 0.0 111.079 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 1.4 m -81.51 -29.92 33.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.414 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.593 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.2 p -71.57 -28.24 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 110.398 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.593 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -114.44 33.91 5.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.209 0.528 . . . . 0.0 109.628 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.3 t -81.52 -4.72 56.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.242 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -89.39 6.13 83.52 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.647 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 29.29 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.422 HG11 HH12 ' A' ' 59' ' ' ARG . 0.7 OUTLIER -87.23 50.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.054 0.454 . . . . 0.0 110.731 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.14 -1.85 53.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 82' ' ' VAL . 10.4 mt . . . . . 0 C--N 1.328 -0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.159 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo . . . . . 0 C--O 1.233 0.259 0 CA-C-O 121.047 0.353 . . . . 0.0 111.899 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -72.49 -174.12 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.095 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -37.8 52.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.292 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -64.13 -38.67 91.89 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.49 -35.25 68.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 42' ' ' LEU . 3.0 tp -71.66 -43.19 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.85 -33.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.971 0.415 . . . . 0.0 110.159 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.15 -24.77 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.456 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.36 -63.16 1.39 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -55.54 -51.77 65.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.619 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -68.62 -38.94 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.789 0.328 . . . . 0.0 110.281 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.63 -51.78 55.3 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.477 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.791 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.3 t80 -61.38 -42.27 98.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 0.0 110.847 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -62.61 -46.81 86.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -68.24 -44.72 75.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.737 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.6 -29.14 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.2 pt20 -85.84 -22.94 27.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.84 65.75 1.11 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.26 -70.45 0.31 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.965 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -89.83 51.14 2.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.213 0.53 . . . . 0.0 110.155 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.88 -28.24 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.545 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.63 -29.26 64.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.94 57.87 1.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.737 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.51 112.5 3.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.855 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.491 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 178.57 -58.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.403 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -57.86 -48.95 14.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.227 1.951 . . . . 0.0 111.992 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.791 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.16 32.69 5.96 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.709 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.3 -20.63 29.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.908 0.385 . . . . 0.0 110.109 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -94.86 145.6 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 65.8 Cg_endo -97.55 -159.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.199 2.599 . . . . 0.0 113.647 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -81.59 84.41 6.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.05 1.19 7.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.034 0.445 . . . . 0.0 111.273 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 40.6 m-20 -104.98 163.0 18.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.58 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -80.12 47.03 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.443 2.762 . . . . 0.0 111.85 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -175.07 -31.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.755 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.3 m170 -58.0 -58.82 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.342 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.54 ' CA ' ' HB1' ' A' ' 38' ' ' ALA . 4.0 tt0 -58.18 -25.02 61.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.867 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.27 -50.31 16.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.266 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.462 ' HE1' HD21 ' A' ' 13' ' ' LEU . 3.2 ttm -66.89 -37.6 84.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.577 HH11 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HB2' HH11 ' A' ' 47' ' ' ARG . . . -80.33 -42.01 23.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.324 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.862 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.16 -54.89 41.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.523 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.6 -50.58 41.93 Favored Glycine 0 C--O 1.22 -0.726 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.294 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.36 -50.05 68.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -48.48 80.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -71.28 -33.46 69.77 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.212 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.76 -25.34 67.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.55 0.691 . . . . 0.0 109.327 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -84.82 -37.32 20.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.327 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -92.92 -61.22 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.073 0.463 . . . . 0.0 112.165 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.9 69.7 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.402 0.681 . . . . 0.0 111.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -77.82 -16.97 57.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -81.39 46.43 0.94 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.36 . . . . 0.0 111.476 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 t -120.98 -6.45 9.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.819 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.8 m-85 -92.98 -26.31 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -39.3 93.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.538 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.55 -24.99 66.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -66.16 -41.29 90.57 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -76.67 -46.65 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -50.26 -43.03 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 179.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.65 HE22 HD11 ' A' ' 106' ' ' LEU . 25.0 mt-30 -67.57 -59.32 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.938 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.35 16.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.62 -26.8 45.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 0.0 110.529 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 71' ' ' THR . 3.4 p -93.01 -60.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.449 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.551 ' H ' HG13 ' A' ' 70' ' ' VAL . 8.6 t -174.69 146.96 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.58 178.12 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.714 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 101.91 -76.62 0.35 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.947 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.81 48.96 0.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.176 0.512 . . . . 0.0 111.77 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -95.37 -24.01 16.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.68 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 5.9 pt20 -60.66 -42.0 96.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.845 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.24 87.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.719 0.295 . . . . 0.0 110.54 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -62.83 -42.2 99.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.07 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.12 -51.62 65.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.282 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 p -55.86 -32.93 64.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.383 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' A' ' 81' ' ' GLN . 0.8 OUTLIER -60.18 -65.0 0.75 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.118 0.485 . . . . 0.0 110.611 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.82 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.4 m -58.45 -32.2 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.594 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -65.79 -43.6 88.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 0.0 110.106 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -71.28 -33.73 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.46 -29.82 65.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.338 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -34.82 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -87.65 -8.64 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.099 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -44.22 -45.15 8.34 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.66 63.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.218 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.8 55.83 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.792 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.7 Cg_endo -80.47 38.38 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.116 1.877 . . . . 0.0 111.569 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.839 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.4 t-20 -68.3 162.76 24.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.089 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.481 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 25.8 m95 -53.53 -26.98 23.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.71 -42.3 98.69 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.71 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.9 mtp180 -86.72 -22.47 26.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.82 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.31 -31.69 54.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 110.25 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.862 HG22 ' HB1' ' A' ' 49' ' ' ALA . 9.5 t -61.62 -56.84 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.5 -27.56 69.36 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.618 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.824 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.3 m-85 -57.07 -55.82 29.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.054 0.454 . . . . 0.0 109.942 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.585 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 12.5 m-85 -75.96 -38.68 57.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.938 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 5.8 t -60.85 -37.66 77.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.547 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -55.74 -50.5 70.2 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.77 0.319 . . . . 0.0 111.219 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.21 -38.44 34.41 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.056 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.5 96.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.081 0.44 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.546 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.74 -38.27 80.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.13 -45.19 95.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.186 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.603 ' HB2' HD11 ' A' ' 22' ' ' LEU . 85.2 m -63.86 -42.51 97.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.034 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.43 31.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 110.843 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.97 -16.12 63.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 m -77.98 -33.83 51.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 107' ' ' CYS . 22.2 t -77.08 -20.85 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.708 0.766 . . . . 0.0 109.019 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -82.09 -2.33 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.235 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -138.27 -155.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.16 53.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.698 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.506 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -127.66 44.87 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 8.7 mt-10 -54.08 -56.2 28.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 22.0 Cg_exo -66.54 -32.13 40.02 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.018 1.812 . . . . 0.0 112.954 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.714 HD21 ' H ' ' A' ' 73' ' ' GLY . 3.9 mp -59.57 -31.93 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.11 -53.74 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.42 86.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.084 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 4.5 mm100 -65.09 -50.81 64.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.8 t -57.87 -35.07 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -63.02 -47.07 84.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.703 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.9 pt-20 -71.49 -39.04 71.12 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.008 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.68 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 35.7 m0 -58.1 -38.08 75.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 109.128 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.6 ttm -73.1 -55.6 6.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.67 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.7 p -60.3 -33.34 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.12 -50.89 36.04 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.598 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.458 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 9.5 t80 -58.2 -33.59 69.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.465 0.65 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.846 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.89 -52.51 9.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.116 -178.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -34.76 76.57 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 m -81.72 -39.21 24.57 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -43.32 2.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.9 mm? -61.61 -44.08 97.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.295 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.62 61.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.62 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.69 -53.7 30.84 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.839 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.1 t90 -56.68 -46.69 81.01 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.51 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.29 -49.05 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.418 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -64.07 -34.97 79.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -80.97 -13.28 59.02 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -43.38 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.851 0.358 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.9 -26.86 0.11 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 102.99 171.29 26.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.061 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -58.78 -29.47 66.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.87 79.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.821 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.29 -41.01 97.08 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.524 ' HE1' HH21 ' A' ' 163' ' ' ARG . 9.7 t80 -66.01 -35.27 80.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.499 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.867 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -67.02 -29.1 68.83 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.127 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -26.72 24.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.186 0.517 . . . . 0.0 109.976 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 8.6 mt -71.2 -40.98 70.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.773 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -130.65 31.79 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.153 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.29 -133.18 7.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.527 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.14 -43.27 17.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.162 0.506 . . . . 0.0 110.302 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.455 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -87.71 52.27 4.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.454 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.31 73.62 10.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.154 0.502 . . . . 0.0 110.077 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -62.79 169.97 2.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.425 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.47 -33.93 66.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.403 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.714 ' HB2' HD12 ' A' ' 156' ' ' LEU . 23.1 mt-10 -72.15 -45.22 61.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.69 0.281 . . . . 0.0 110.524 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.97 -42.68 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -62.48 -50.7 70.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.795 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.62 -35.4 80.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 2.9 mt -67.94 -29.89 69.07 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.361 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.524 HH21 ' HE1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.22 -48.27 62.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.554 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.545 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.4 OUTLIER -67.43 -44.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.587 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.87 -25.32 73.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.989 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -69.13 -51.22 40.56 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.571 0.224 . . . . 0.0 111.379 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.871 ' HA ' HG22 ' A' ' 170' ' ' VAL . 19.5 p-90 -71.98 -21.23 61.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.239 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.71 82.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.309 0.576 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -86.26 -32.84 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.572 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.871 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.5 m -86.99 -31.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -73.13 -32.97 65.26 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.938 -0.477 . . . . 0.0 110.413 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.837 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.6 OUTLIER -85.63 -27.6 25.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.095 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.5 p -71.0 -26.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 0.0 110.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 1.1 mt -120.46 39.54 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.298 0.571 . . . . 0.0 110.388 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.837 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.3 OUTLIER -62.42 -29.93 70.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.794 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.67 40.88 2.99 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.496 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -105.0 10.56 34.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 109.896 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.86 57.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -85.47 -4.7 59.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.694 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.82 ' HG ' HG11 ' A' ' 82' ' ' VAL . 9.2 mt . . . . . 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo . . . . . 0 CA--C 1.529 0.258 0 CA-C-O 120.932 0.305 . . . . 0.0 112.003 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -162.85 0.56 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -36.88 71.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.997 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -37.84 87.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.79 -35.62 62.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.297 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.2 tp -73.69 -40.47 63.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.333 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.714 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 6.7 p -65.19 -37.71 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 110.06 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -24.65 59.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -60.33 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.698 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -59.12 -56.04 27.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.684 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.429 ' O ' HD13 ' A' ' 22' ' ' LEU . 95.9 t -64.32 -38.99 83.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.82 -52.22 53.72 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.795 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 41.2 t80 -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.696 0.284 . . . . 0.0 110.869 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.93 -42.03 97.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.782 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.5 mp -71.21 -45.17 63.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.855 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 26.5 ttp85 -65.56 -15.56 62.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.659 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.36 -36.07 24.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -153.6 78.43 1.14 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 111.836 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.95 -68.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.444 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.6 t80 -91.85 56.52 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.165 0.507 . . . . 0.0 110.01 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.56 -32.36 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.87 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.54 -33.31 71.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -91.09 56.25 3.26 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.399 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -68.21 112.26 5.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.416 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.23 -51.73 0.12 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 119.88 -1.153 . . . . 0.0 113.849 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 38.4 Cg_exo -63.47 -43.71 16.74 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.093 1.862 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.95 32.36 7.54 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.107 -0.952 . . . . 0.0 112.659 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.87 -14.26 39.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.242 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.0 142.18 15.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.781 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.39 -154.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.033 2.489 . . . . 0.0 113.242 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -85.23 80.15 9.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.628 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.51 16.31 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.809 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 13.1 m-20 -126.57 157.81 69.64 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 Cg_exo -71.36 36.58 0.3 Allowed 'Trans proline' 0 N--CA 1.474 0.34 0 C-N-CA 124.251 3.3 . . . . 0.0 113.12 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -167.81 -27.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.2 m170 -59.66 -55.25 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.959 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.502 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.1 -22.42 66.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.942 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.728 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -76.76 -48.73 17.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.994 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.406 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 1.0 OUTLIER -68.98 -32.91 72.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.368 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.25 -43.02 96.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.13 50.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 110.174 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.861 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -62.64 -62.19 1.91 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.278 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.698 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.15 -48.34 32.33 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.834 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.96 -45.5 82.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.124 0.462 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.9 96.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.695 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -76.93 -28.19 55.17 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.097 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.98 -23.09 66.52 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 m -94.85 -39.19 10.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.101 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 56' ' ' ARG . 2.7 mtt180 -84.81 -57.71 3.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 73.6 9.85 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.986 0.514 . . . . 0.0 111.383 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 58' ' ' ARG . 12.6 mtt180 -76.5 -10.28 59.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.522 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 54.43 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -57.43 1.84 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.052 0.453 . . . . 0.0 111.875 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 70.5 m-85 -55.17 -31.74 61.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -39.04 87.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.8 m-20 -70.69 -20.56 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 110.267 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 61' ' ' PHE . 25.0 mt -70.13 -41.43 73.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.99 -43.97 61.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.09 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.84 -43.63 73.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.616 179.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 26.9 mt-30 -63.22 -58.07 8.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.448 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.43 8.02 8.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 11.9 t60 -79.0 -23.06 44.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -63.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t -172.88 144.47 1.22 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.182 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.85 171.71 16.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.88 2.387 . . . . 0.0 111.598 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 97.54 -60.8 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.342 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 19.19 0.13 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.9 -22.37 56.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.606 0.241 . . . . 0.0 111.185 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.632 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -62.06 -39.5 92.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 3.9 mt-30 -67.62 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.86 -45.12 93.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.813 0.34 . . . . 0.0 110.154 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -62.35 -51.74 66.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.928 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -59.24 -33.81 71.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 74.4 mm-40 -63.56 -50.67 68.59 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.126 0.489 . . . . 0.0 109.991 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 86' ' ' LEU . 65.5 t -63.7 -37.34 79.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.461 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 m -61.64 -46.73 88.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.756 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.646 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.37 -39.45 93.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 110.243 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.456 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.0 mm-40 -67.91 -28.68 67.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.28 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -76.61 -38.57 54.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.405 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 26.9 t80 -82.29 -8.79 59.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -38.58 12.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.807 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.4 57.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.131 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.554 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 173.7 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.498 -1.334 . . . . 0.0 115.098 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 9.4 Cg_endo -82.35 23.89 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.454 2.102 . . . . 0.0 111.249 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.793 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 m-20 -63.94 158.0 23.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.078 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.668 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 5.8 m95 -50.35 -24.97 3.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.23 -49.94 66.95 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.467 -0.873 . . . . 0.0 110.955 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.736 ' HD2' HD12 ' A' ' 174' ' ' LEU . 8.4 mtt180 -86.66 -18.67 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.052 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.13 -31.51 63.38 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.471 0.653 . . . . 0.0 110.259 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.861 HG22 ' HB1' ' A' ' 49' ' ' ALA . 28.8 t -60.99 -52.63 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.49 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.64 69.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.312 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.31 -55.11 39.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.714 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 m-85 -76.65 -38.26 54.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.06 -35.69 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -52.75 -60.76 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 111.551 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.23 -34.54 69.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.143 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.288 0.544 . . . . 0.0 110.517 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.05 -39.94 82.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -60.59 -44.92 95.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.663 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.65 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.7 m -66.51 -40.73 89.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.203 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.68 -54.6 42.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.82 -15.46 62.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.1 m -78.31 -33.07 49.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' CYS . 47.3 t -75.45 -31.67 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.347 0.594 . . . . 0.0 109.556 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -77.12 0.7 20.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.208 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.695 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -132.53 -151.45 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.813 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 1.3 mt-10 -108.69 51.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.83 0.348 . . . . 0.0 111.353 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -146.87 42.24 1.13 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.69 -45.84 97.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.344 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -58.13 -16.98 29.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.279 1.986 . . . . 0.0 113.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.4 OUTLIER -82.42 -22.51 35.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.606 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 107' ' ' CYS . 49.9 t -56.02 -54.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.43 77.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.438 -0.886 . . . . 0.0 111.968 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.5 mm-40 -67.34 -50.92 58.0 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' LEU . 30.5 t -57.84 -33.86 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 0.0 109.767 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.33 -46.8 78.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.293 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.79 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.9 pt-20 -73.55 -35.12 65.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.021 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.632 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.5 m0 -58.92 -40.71 85.37 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.5 ttm -72.45 -52.79 14.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.849 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -62.01 -32.22 53.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -52.64 33.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.994 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 6.4 t80 -56.6 -34.72 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 110.81 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.061 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.45 -53.37 8.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.454 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 127' ' ' VAL . 10.9 mt-10 -62.6 -32.01 72.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.1 m -86.75 -43.61 12.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -44.5 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.061 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -59.97 -42.27 93.76 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.348 0.522 . . . . 0.0 111.632 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.32 -31.1 53.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -53.4 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.793 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 57.9 t90 -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.492 HG13 ' HE3' ' A' ' 137' ' ' TRP . 3.5 mt -57.07 -46.86 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.959 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -67.55 -29.28 68.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -94.52 -2.06 52.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -126.37 48.62 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 111.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.78 -67.41 0.92 Allowed Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.554 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.79 177.23 14.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 96.5 m95 -60.93 -28.84 69.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.07 69.67 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.794 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.668 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -68.6 -38.96 81.05 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.59 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 7.7 t80 -63.14 -41.44 99.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.363 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.728 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -64.22 -30.85 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.01 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 -16.22 35.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.761 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -77.93 -45.15 24.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.736 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 30.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -99.85 -119.86 4.38 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -74.22 -51.07 16.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -94.13 64.53 1.68 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.204 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.62 71.78 10.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.315 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.904 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -64.24 158.16 23.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.88 -31.71 50.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.141 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.904 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.9 mm-40 -68.19 -48.92 63.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.497 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.31 83.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.417 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -59.86 -56.1 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.928 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 158' ' ' GLU . 19.5 ptt180 -69.44 -29.1 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -63.82 -39.93 95.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.335 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.843 HH22 ' HA ' ' A' ' 49' ' ' ALA . 4.0 ttp180 -70.06 -38.72 75.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.324 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.589 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.5 OUTLIER -62.85 -46.06 89.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.237 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.33 75.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.195 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.442 ' O ' HG22 ' A' ' 170' ' ' VAL . 4.7 t-20 -67.67 -56.69 8.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.972 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.938 ' HA ' HG22 ' A' ' 170' ' ' VAL . 21.4 p-90 -67.73 -21.44 65.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.412 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.8 52.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.215 0.322 . . . . 0.0 110.766 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 m -88.02 -26.91 22.35 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.938 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.1 m -80.03 -24.64 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.017 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.697 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 13.0 ttp85 -81.09 -23.06 38.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.726 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -90.19 -35.54 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.162 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.953 HG13 ' HG ' ' A' ' 174' ' ' LEU . 7.1 p -62.77 -30.15 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.163 0.506 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.953 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -118.54 40.13 3.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.992 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.726 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.69 -25.84 67.66 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.34 9.34 55.12 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.712 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -72.43 -7.64 50.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.011 0.405 . . . . 0.0 111.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.37 66.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.027 0.441 . . . . 0.0 110.513 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.45 12.65 34.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.236 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 102' ' ' PHE . 7.9 mt . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.114 -179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo . . . . . 0 CA--C 1.529 0.274 0 CA-C-O 121.051 0.355 . . . . 0.0 112.106 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.34 -157.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -41.45 72.75 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.922 0.489 . . . . 0.0 112.279 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -61.12 -37.78 83.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.13 -35.76 61.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.178 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.592 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -73.63 -42.24 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.477 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.0 p -64.6 -36.11 76.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.42 60.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.318 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -65.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.94 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.2 t80 -55.13 -54.77 39.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.61 -38.34 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -62.75 -55.39 27.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.91 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.697 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 t80 -60.1 -42.64 95.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.783 0.433 . . . . 0.0 110.852 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.86 -44.8 95.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.259 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -71.13 -44.26 65.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 16.6 ttp85 -67.64 -13.01 61.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 2.5 mt-30 -84.36 -37.44 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.229 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -154.56 83.4 1.11 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.45 -69.13 0.35 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.664 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.68 54.79 1.04 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.236 0.541 . . . . 0.0 110.201 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -78.67 -27.12 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.179 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -39.16 80.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.87 57.34 4.64 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.169 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -65.98 110.97 3.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.413 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.5 -53.54 0.09 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.878 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 24.8 Cg_exo -65.12 -48.72 3.3 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.016 1.81 . . . . 0.0 111.27 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.03 31.46 6.26 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.301 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.33 -19.81 35.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 0.0 109.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.51 132.84 11.25 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -91.33 -147.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.617 2.211 . . . . 0.0 113.882 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -75.31 76.3 2.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.73 31.84 5.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.793 0.33 . . . . 0.0 111.291 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 12.7 m-20 -142.04 163.29 41.05 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.74 48.46 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.247 2.631 . . . . 0.0 112.331 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.924 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.2 m170 -59.35 -56.47 21.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.944 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.03 -24.65 64.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.906 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.31 -51.49 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.23 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.456 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 5.2 ttm -68.92 -39.36 79.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.673 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -61.95 -35.53 78.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.785 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.45 -43.76 18.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.518 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.57 -54.32 48.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.2 -47.8 54.65 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.667 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.01 -48.51 81.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 110.898 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 56' ' ' ARG . 4.1 tp10 -60.03 -48.74 80.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.926 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -68.87 -35.24 76.66 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.927 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.98 -28.0 68.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.65 0.738 . . . . 0.0 109.409 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.1 m -85.81 -32.16 21.92 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.397 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 52' ' ' GLU . 7.6 mtt180 -88.73 -21.21 23.97 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.548 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -85.16 95.9 9.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.375 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -60.67 -32.94 72.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.482 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.564 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -108.62 94.64 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.126 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.41 -70.94 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 64' ' ' LEU . 48.9 m-85 -78.51 -7.3 57.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -46.99 58.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.564 ' OD1' ' HD3' ' A' ' 59' ' ' ARG . 2.5 m-20 -68.71 -18.32 64.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.199 0.524 . . . . 0.0 110.472 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 61' ' ' PHE . 31.8 mt -72.78 -40.41 65.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.45 -45.88 51.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.67 -43.17 68.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.435 HE22 HD11 ' A' ' 106' ' ' LEU . 22.9 mt-30 -64.06 -54.77 28.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.041 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.09 16.06 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 -177.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -26.53 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 0.0 110.691 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -68.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.668 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t -165.92 145.72 5.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.501 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 8.2 Cg_exo -72.11 176.1 8.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.964 2.443 . . . . 0.0 111.974 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.775 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 90.64 -60.09 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -77.07 52.85 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 0.0 110.967 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.85 -25.52 10.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.714 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.3 pt20 -62.72 -35.36 79.5 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.856 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 24.4 mp0 -67.35 -45.14 77.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -63.56 -44.19 94.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.892 0.377 . . . . 0.0 110.086 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.26 -49.27 76.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.789 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 p -59.68 -32.95 70.96 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.849 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.3 mm-40 -64.82 -54.95 23.09 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' HB1' ' A' ' 177' ' ' ALA . 7.4 p -61.58 -35.3 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.914 0.387 . . . . 0.0 110.406 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.4 m -66.99 -43.1 83.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.83 -44.52 92.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.232 0.539 . . . . 0.0 110.015 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 40.1 mt-10 -69.7 -18.21 63.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.782 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.88 -39.74 19.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.146 0.498 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.63 -4.86 58.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -44.33 -43.32 7.42 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.876 0.735 . . . . 0.0 111.666 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.48 57.34 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.93 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.444 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 168.0 56.85 0.03 OUTLIER Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.775 -1.203 . . . . 0.0 114.655 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.1 Cg_endo -80.5 39.8 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.326 2.017 . . . . 0.0 111.646 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.81 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 11.5 t-20 -65.56 158.93 25.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.414 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.4 m95 -54.97 -27.44 43.82 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.321 0.388 . . . . 0.0 110.297 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.75 -39.56 97.59 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.3 -24.64 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.551 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -55.26 -30.62 60.43 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 53' ' ' PHE . 9.4 t -63.07 -53.34 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.374 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.445 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -64.63 -28.09 69.38 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.282 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.5 m-85 -56.83 -56.82 16.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.131 0.491 . . . . 0.0 109.928 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 8.0 m-85 -76.1 -36.33 58.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.838 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 1.7 t -60.15 -38.05 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -58.13 -47.47 83.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.68 0.276 . . . . 0.0 111.061 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 -40.0 23.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.51 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.072 0.436 . . . . 0.0 110.608 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.43 -41.38 80.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -58.75 -47.5 84.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.76 ' HB3' HD21 ' A' ' 22' ' ' LEU . 63.3 m -60.93 -41.45 96.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.23 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.58 -55.79 25.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.53 -18.18 64.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.604 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -77.94 -27.99 49.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 43.6 t -81.77 -23.03 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -78.97 -15.26 58.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.9 -169.25 2.0 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.02 60.99 6.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.512 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.66 32.19 3.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.005 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.6 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 5.9 mp0 -54.86 -51.96 74.7 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.194 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 35.3 Cg_exo -61.14 -27.45 84.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.92 1.747 . . . . 0.0 112.433 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.775 HD21 ' H ' ' A' ' 73' ' ' GLY . 2.6 mp -71.44 -26.67 62.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.52 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.14 -53.6 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.687 0.279 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.71 83.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.79 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 117' ' ' PRO . 28.4 mt-30 -63.36 -53.68 48.73 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 118' ' ' LEU . 48.2 t -57.54 -33.9 45.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.05 0.452 . . . . 0.0 110.156 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.5 -46.48 82.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.553 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.2 pt-20 -74.09 -37.72 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.906 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.714 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.3 m0 -56.79 -37.43 71.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.9 ttm -72.36 -57.91 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.888 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -61.36 -30.36 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.975 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.8 -50.55 49.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -62.26 -31.18 71.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 111.107 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.918 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.3 -54.04 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.481 -178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.02 -35.85 77.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.892 0.377 . . . . 0.0 111.876 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.1 m -78.18 -36.21 47.75 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -43.8 1.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.2 mm? -58.27 -46.51 85.88 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.394 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.82 -35.82 45.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.19 -52.05 51.86 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.81 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.5 t90 -58.13 -47.65 82.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.5 HG23 ' HH2' ' A' ' 93' ' ' TRP . 9.2 mt -56.94 -48.1 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.755 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -63.31 -32.98 74.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 m -81.88 -18.38 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 t -84.24 -55.03 4.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 111.544 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.46 -17.32 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.63 171.58 29.18 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.615 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.456 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 95.4 m95 -59.51 -28.0 66.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.95 0.405 . . . . 0.0 109.99 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.59 78.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.788 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -41.58 98.36 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.515 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.8 t80 -66.46 -34.07 77.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.49 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.926 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.06 -29.18 70.05 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.804 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.13 -26.07 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.188 0.518 . . . . 0.0 110.043 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 163' ' ' ARG . 3.5 mt -73.96 -39.14 63.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.628 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.517 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 26.7 m-85 -126.83 29.24 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.666 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.16 -140.49 5.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.557 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -54.76 12.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.075 -0.563 . . . . 0.0 111.414 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -81.25 53.59 4.66 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.72 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.94 72.02 10.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.0 109.71 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.09 165.47 3.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.627 -179.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HG3' ' NH1' ' A' ' 160' ' ' ARG . 2.7 mt-10 -56.99 -33.66 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.327 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.922 ' HB2' HD12 ' A' ' 156' ' ' LEU . 15.8 mm-40 -71.17 -45.57 63.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.951 0.405 . . . . 0.0 110.305 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -59.96 -47.1 87.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.777 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.4 ' NH1' ' HG3' ' A' ' 157' ' ' GLU . 6.0 ptp180 -63.72 -43.37 96.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.11 -22.37 61.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.277 0.56 . . . . 0.0 110.57 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 -47.05 17.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -62.42 -46.52 88.22 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.419 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.664 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.19 -44.3 95.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.07 -10.22 72.97 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.757 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.655 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -85.28 -58.05 2.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.861 -0.169 . . . . 0.0 110.82 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.716 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.37 -24.91 66.81 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 123.163 0.289 . . . . 0.0 111.311 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.34 84.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.407 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.9 OUTLIER -88.02 -28.02 21.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.716 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 3.2 m -91.16 -42.71 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.65 ' HD3' ' CE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -70.31 -24.83 63.08 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.534 -0.729 . . . . 0.0 111.007 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.744 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.2 OUTLIER -93.21 -9.96 37.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.913 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 170' ' ' VAL . 3.6 p -85.62 -23.22 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 0.0 109.373 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.35 40.33 3.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.802 178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -69.52 -22.37 63.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.104 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.45 9.8 53.23 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.937 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -76.82 7.41 4.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.095 0.448 . . . . 0.0 111.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.12 65.18 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.357 0.598 . . . . 0.0 111.09 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.32 13.87 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.212 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.9 mp . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.721 -178.741 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.4 Cg_exo . . . . . 0 CA--C 1.529 0.269 0 CA-C-O 121.37 0.488 . . . . 0.0 112.12 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -85.58 -167.45 1.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.461 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -37.6 65.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.544 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.07 -37.04 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.734 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.72 62.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.849 0.357 . . . . 0.0 110.097 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.484 ' HB2' HD13 ' A' ' 42' ' ' LEU . 10.5 tp -70.32 -42.15 72.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.629 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 4.8 p -65.9 -35.39 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.939 0.4 . . . . 0.0 110.061 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -20.48 60.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.659 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.06 -63.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.72 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 3.1 t80 -55.35 -51.28 67.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.579 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 99.0 t -70.14 -41.14 78.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 110.365 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.38 -54.25 38.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.576 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.736 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 58.3 t80 -60.64 -42.91 97.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.537 0.335 . . . . 0.0 110.979 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.2 -49.09 77.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.8 mp -65.78 -48.78 70.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.604 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.62 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 6.1 ttp180 -62.6 -20.34 64.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.446 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.3 mt-30 -85.39 -32.58 22.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.311 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -148.52 75.86 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.849 0.356 . . . . 0.0 111.856 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.37 -69.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.624 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.7 t80 -92.21 51.15 1.74 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.19 -26.52 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.09 -16.01 59.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.412 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.39 49.28 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.332 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -63.67 114.36 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.08 -48.23 0.05 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.692 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 6.1 Cg_exo -77.03 -48.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.201 1.934 . . . . 0.0 111.867 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -83.77 22.76 7.39 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.557 -0.747 . . . . 0.0 114.229 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.418 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mm-40 -76.03 -32.69 59.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.37 0.585 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.61 111.95 4.23 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 84.1 Cg_endo -84.54 -139.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.563 2.175 . . . . 0.0 114.264 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -70.03 80.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.821 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.58 -0.41 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.499 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 8.0 m-20 -110.82 161.11 26.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.447 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -77.08 45.61 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.529 2.819 . . . . 0.0 112.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -173.93 -27.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.331 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.733 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.4 m170 -62.89 -51.26 67.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.559 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.525 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -64.01 -21.68 66.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.27 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.97 -52.32 11.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.544 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.0 OUTLIER -64.86 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.297 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -60.27 -40.33 89.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.206 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.94 -28.44 43.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 110.192 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.826 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -67.71 -60.47 2.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.407 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.427 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -48.91 -49.01 29.96 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.46 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.96 -53.0 58.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 111.764 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' HE ' ' A' ' 56' ' ' ARG . 8.2 tt0 -63.16 -45.66 90.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.656 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.75 -30.99 66.19 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.549 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -65.13 -30.9 71.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -86.14 -19.16 30.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.342 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HE ' ' HG3' ' A' ' 52' ' ' GLU . 16.1 mtt-85 -98.09 -49.25 4.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.187 0.518 . . . . 0.0 112.209 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.2 90.13 7.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.236 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -67.48 -21.97 65.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.166 0.508 . . . . 0.0 110.881 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -88.67 66.53 8.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 -14.43 8.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.013 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.52 -0.06 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.28 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -51.84 23.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.257 0.551 . . . . 0.0 111.088 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -57.04 -33.82 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.806 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 7.5 mp -56.93 -43.25 81.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.49 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -81.47 -42.77 19.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.63 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.33 33.69 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.639 0.587 . . . . 0.0 111.799 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.506 ' NE2' ' HG ' ' A' ' 180' ' ' LEU . 65.0 mt-30 -80.65 -47.71 13.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 115' ' ' MET . 0.6 OUTLIER -90.28 20.89 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -80.2 -38.13 31.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.222 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.553 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -90.56 -62.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.553 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -158.66 152.77 19.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 2.9 Cg_endo -79.66 178.17 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.847 2.365 . . . . 0.0 111.497 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.17 -56.52 4.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.759 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.44 34.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.129 0.49 . . . . 0.0 111.61 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.93 -24.66 16.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.648 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -58.45 -47.15 84.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.953 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.26 -45.0 88.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.034 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.95 ' HB3' HD11 ' A' ' 180' ' ' LEU . 11.0 mtt180 -64.91 -40.82 95.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.0 t80 -67.21 -48.04 69.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.459 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -59.11 -28.64 66.72 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -68.14 -60.43 2.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.799 0.333 . . . . 0.0 110.29 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 177' ' ' ALA . 10.6 p -54.52 -36.05 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.594 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -68.81 -41.85 78.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.767 0.318 . . . . 0.0 110.475 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -69.83 -38.6 76.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.55 -26.34 64.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -82.54 -33.09 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.176 0.512 . . . . 0.0 110.392 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -85.35 -10.07 56.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -41.3 -48.73 3.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.507 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.78 54.38 0.23 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.185 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.7 57.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 119.376 -1.392 . . . . 0.0 114.683 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 41.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.072 1.848 . . . . 0.0 111.377 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.813 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -70.65 163.14 27.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.069 -178.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.669 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.3 m95 -53.59 -27.54 27.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.37 97.88 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.767 HH11 ' HB2' ' A' ' 174' ' ' LEU . 5.0 mtp180 -87.46 -19.99 27.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.579 -0.31 . . . . 0.0 111.353 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.789 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -54.97 -31.87 61.04 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 110.326 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.883 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.8 t -61.52 -54.01 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.89 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.42 70.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.272 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.789 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.0 m-85 -56.72 -55.18 37.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.374 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.629 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 6.8 m-85 -76.93 -37.91 54.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.179 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.29 -37.99 78.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -51.54 63.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.696 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.24 -37.54 36.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.996 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.68 95.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.126 0.463 . . . . 0.0 110.745 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.96 -43.85 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.85 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -59.65 -42.34 92.56 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.279 0.561 . . . . 0.0 110.832 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.8 m -63.74 -44.99 91.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.047 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.2 76.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.572 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.608 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.0 OUTLIER -76.8 -17.75 58.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.8 m -82.63 -26.43 32.23 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.715 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.2 t -70.06 -38.27 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.837 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.608 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.1 p30 -82.48 1.79 35.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -120.69 -172.65 2.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.267 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.95 46.92 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.243 0.544 . . . . 0.0 111.202 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.758 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -142.22 37.15 1.54 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.199 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.3 OUTLIER -56.13 -50.12 89.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.045 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 42.8 Cg_exo -57.77 -25.94 71.09 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.163 1.909 . . . . 0.0 112.841 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.4 mm? -69.05 -25.47 64.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.42 -45.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.96 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.34 -34.75 86.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.712 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -66.0 -50.25 64.92 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 118' ' ' LEU . 29.0 t -58.17 -32.61 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.164 0.507 . . . . 0.0 109.78 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.0 -45.86 80.03 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.429 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.763 ' HA ' HG12 ' A' ' 127' ' ' VAL . 14.4 pt-20 -74.51 -36.53 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.648 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 43.3 m0 -57.4 -39.4 76.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.1 ttm -73.74 -54.96 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.784 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.3 p -61.58 -33.03 55.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -46.73 66.0 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.304 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.602 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 21.0 t80 -61.6 -36.45 80.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.564 0.697 . . . . 0.0 110.336 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.943 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.65 -54.14 15.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.254 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.59 -37.27 80.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -74.72 -36.28 62.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -130.59 -41.36 1.2 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -60.89 -49.02 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.334 0.515 . . . . 0.0 111.813 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.73 60.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.292 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.4 -55.7 19.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.192 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.813 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 42.5 t90 -53.68 -48.48 69.45 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.126 0.488 . . . . 0.0 109.797 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.2 mt -56.27 -48.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.724 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -64.53 -36.34 83.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 p -80.82 -14.93 57.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.927 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -55.65 3.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.87 -10.91 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.577 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.28 169.28 44.21 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.698 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.544 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.4 m95 -60.52 -30.52 69.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.84 73.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.106 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.515 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -64.99 -41.31 95.53 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.641 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.9 t80 -64.93 -40.83 95.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.601 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.655 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.24 -26.23 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 110.947 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.23 -29.02 22.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.439 . . . . 0.0 110.306 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -62.67 -51.84 65.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.338 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -132.43 32.93 3.87 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.26 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.84 -129.61 6.75 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.864 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -51.61 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.249 0.547 . . . . 0.0 110.642 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.13 55.89 2.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.394 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.78 73.84 7.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 110.042 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.54 161.04 15.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.81 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 3.2 mt-10 -59.21 -30.37 68.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.061 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.789 ' HB2' HD12 ' A' ' 156' ' ' LEU . 9.1 mm-40 -72.88 -36.26 67.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.79 73.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.013 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.81 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 25.3 mtt-85 -63.09 -55.24 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.386 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 158' ' ' GLU . 2.9 ptm180 -65.0 -25.15 67.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -68.47 -43.42 77.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.93 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.647 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.4 ttp180 -70.95 -34.52 71.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.521 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.521 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER -69.49 -45.6 68.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.172 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.19 -22.14 77.32 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.632 ' O ' HG22 ' A' ' 170' ' ' VAL . 18.8 t-20 -64.13 -66.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.406 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.631 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 26.7 p-90 -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.931 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.47 75.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.99 -29.46 20.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 166' ' ' ASN . 8.4 m -92.13 -35.64 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -70.23 -34.36 72.78 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.925 -0.484 . . . . 0.0 110.595 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.95 -13.39 50.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.905 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.736 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -86.22 -23.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 109.893 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.767 ' HB2' HH11 ' A' ' 95' ' ' ARG . 0.8 OUTLIER -121.07 34.29 5.26 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.012 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -65.33 -18.1 65.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.823 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.69 -4.58 76.38 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.185 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.94 -5.12 23.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 175' ' ' THR . 2.9 t -80.02 65.54 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 110.994 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.28 -10.11 58.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.95 HD11 ' HB3' ' A' ' 78' ' ' ARG . 0.6 OUTLIER . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.752 -179.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 6.9 Cg_exo . . . . . 0 N--CA 1.463 -0.279 0 CA-C-O 120.832 0.263 . . . . 0.0 112.103 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.18 -162.27 0.33 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.219 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -47.64 64.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -59.07 -37.74 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.491 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.14 -36.6 61.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.989 0.424 . . . . 0.0 109.966 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.44 -42.37 71.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.249 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.9 p -63.57 -37.38 79.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.06 0.457 . . . . 0.0 109.775 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.03 -23.87 61.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.88 -63.42 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.255 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.62 -50.06 66.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.5 t -69.06 -41.14 81.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.107 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.17 -49.2 81.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.79 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 65.2 t80 -62.32 -47.17 85.45 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.594 0.358 . . . . 0.0 111.475 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -40.9 96.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.285 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -72.15 -46.9 54.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.808 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.455 HH11 ' HB1' ' A' ' 31' ' ' ALA . 18.6 ttp85 -63.5 -17.06 62.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.804 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -80.87 -36.2 31.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.71 78.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.101 0.476 . . . . 0.0 112.082 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.35 -63.12 0.41 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.449 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 1.4 t80 -90.59 50.5 1.83 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.199 0.523 . . . . 0.0 109.915 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.3 -34.16 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.161 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -22.83 63.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.666 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.29 49.83 0.85 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.614 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -65.79 126.81 29.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.524 ' HA2' ' HG3' ' A' ' 35' ' ' GLU . . . 168.36 -54.23 0.22 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.736 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.62 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 17.4 Cg_exo -68.83 -49.22 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.312 2.008 . . . . 0.0 112.21 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -90.1 31.53 5.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.521 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 mm-40 -79.14 -43.05 24.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.608 . . . . 0.0 109.758 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.92 147.17 33.18 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.892 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.7 Cg_endo -98.41 -151.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.196 2.598 . . . . 0.0 113.579 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -80.7 87.33 5.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.52 -14.09 5.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 47.7 m-20 -94.41 158.74 35.18 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.076 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 148' ' ' THR . 3.2 Cg_endo -75.17 50.7 2.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.721 2.947 . . . . 0.0 111.816 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' HD2' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -178.97 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.345 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.6 m170 -60.58 -56.57 19.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.119 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.675 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -59.37 -24.73 63.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.041 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -77.81 -51.48 10.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.45 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.6 ttm -64.72 -41.75 95.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -62.83 -31.55 72.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.665 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.16 -44.68 19.43 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.737 0.304 . . . . 0.0 110.468 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.73 -54.19 49.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.09 -49.18 50.63 Favored Glycine 0 C--O 1.213 -1.165 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.238 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -56.4 -51.61 67.72 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.841 0.456 . . . . 0.0 111.627 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -48.25 82.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB2' HG11 ' A' ' 97' ' ' VAL . 6.4 m-85 -69.97 -32.83 71.26 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.391 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.02 -27.05 68.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.706 0.765 . . . . 0.0 109.029 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -79.65 -31.94 41.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.617 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.1 mtt180 -89.84 -54.01 4.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.187 0.517 . . . . 0.0 111.376 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 68.81 10.6 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.555 0.742 . . . . 0.0 111.099 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -74.47 -26.19 59.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.955 0.407 . . . . 0.0 111.912 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -82.11 61.82 5.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.26 -31.14 4.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 111.516 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HA ' HD22 ' A' ' 64' ' ' LEU . 50.2 m-85 -72.78 -17.0 61.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.163 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.804 0.335 . . . . 0.0 111.499 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -71.97 -23.44 61.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.014 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.02 -41.82 85.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.85 -48.74 35.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.156 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.24 -42.16 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.458 179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.653 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 25.3 mt-30 -65.92 -58.5 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.304 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 14.1 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 30.2 t60 -79.24 -27.25 42.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.862 0.363 . . . . 0.0 110.495 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.85 -70.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.675 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -163.64 150.83 10.57 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.908 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 4.1 Cg_exo -80.49 175.8 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.052 2.502 . . . . 0.0 112.404 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.659 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 93.33 -65.11 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.852 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.39 46.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.316 0.579 . . . . 0.0 111.907 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.91 -18.41 14.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.433 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.671 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.3 pt20 -64.15 -38.54 91.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.695 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 10.2 mp0 -69.44 -36.05 76.27 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.865 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.653 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 1.5 ttt180 -67.15 -47.19 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.62 -48.94 78.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 p -60.2 -33.55 72.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 89.9 mm-40 -63.3 -57.37 10.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 110.812 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.762 HG11 ' HG ' ' A' ' 180' ' ' LEU . 4.1 m -62.73 -33.06 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.366 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -65.78 -43.41 88.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.724 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.58 -37.27 87.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.98 -30.35 63.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.628 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.649 ' HG ' HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -75.05 -35.33 61.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.806 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 91' ' ' PRO . 33.7 t80 -89.51 -13.27 37.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.567 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -33.55 -61.01 0.34 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.506 1.123 . . . . 0.0 113.891 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.2 62.81 0.49 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.163 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.79 70.53 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.944 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 87' ' ' PHE . 6.8 Cg_endo -75.87 46.95 1.82 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 111.505 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.749 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -66.29 165.23 14.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.149 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 26.9 m95 -55.33 -28.36 53.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.402 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.4 89.8 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.778 HH11 ' HB ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -85.85 -28.4 24.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.317 178.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.817 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.39 -30.9 61.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.301 0.572 . . . . 0.0 110.57 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.7 t -66.49 -56.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.818 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.34 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.119 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.817 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.8 m-85 -56.35 -58.19 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 110.473 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 9.6 m-85 -75.07 -35.45 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.228 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.79 -39.05 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -56.38 -51.86 66.74 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.7 0.286 . . . . 0.0 111.286 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.58 -41.11 44.95 Favored Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.285 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.54 88.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.347 0.573 . . . . 0.0 110.905 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.34 -40.95 70.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.74 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.32 -46.85 87.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.465 179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.727 ' HB3' HD21 ' A' ' 22' ' ' LEU . 68.9 m -62.17 -41.63 98.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.5 -54.94 37.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.14 66.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.578 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.425 ' HB2' HG22 ' A' ' 119' ' ' VAL . 67.1 m -76.74 -31.61 57.22 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 14.1 t -79.06 -23.34 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.451 0.643 . . . . 0.0 109.295 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -84.06 -5.03 59.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.189 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 13.3 mttt -125.72 -152.44 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.432 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 2.0 mt-10 -108.19 50.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.205 0.526 . . . . 0.0 110.106 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.32 56.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.445 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.5 mp0 -62.38 -52.71 64.11 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.2 Cg_exo -65.41 -25.44 56.13 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.356 2.037 . . . . 0.0 113.112 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 73' ' ' GLY . 4.5 mp -67.5 -30.68 70.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.425 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 110' ' ' SER . 91.6 t -57.61 -55.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.186 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.89 85.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.061 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.535 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.5 mt-30 -65.18 -51.42 61.2 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 118' ' ' LEU . 86.2 t -57.05 -35.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 109.867 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.16 -47.52 82.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.588 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.8 pt-20 -72.8 -37.1 67.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.085 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.671 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 42.8 m0 -58.89 -39.41 81.34 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.409 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 9.8 ttm -72.6 -53.94 10.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.852 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.97 -33.16 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.592 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.1 OUTLIER -67.26 -51.02 58.08 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.077 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 23.9 t80 -58.36 -35.69 72.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.542 0.687 . . . . 0.0 110.742 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.29 -56.05 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.559 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.75 -24.04 67.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.0 m -82.2 -43.13 18.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.93 -37.29 2.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -61.41 -48.17 82.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.229 0.468 . . . . 0.0 111.377 -178.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -37.54 62.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.257 0.348 . . . . 0.0 110.952 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.99 -53.53 52.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.413 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 59.4 t90 -57.31 -48.99 77.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.546 HG13 ' HE3' ' A' ' 137' ' ' TRP . 26.6 mt -57.77 -47.46 85.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.812 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -68.05 -26.93 66.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 m -96.23 -3.48 44.12 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.75 -53.16 3.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 111.724 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.97 -13.09 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.76 166.24 42.04 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.45 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 92.9 m95 -59.36 -30.24 68.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.5 81.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.1 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.52 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -62.69 -42.95 99.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.17 -34.14 77.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.504 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.923 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.57 -26.38 67.09 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.723 0.297 . . . . 0.0 110.836 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.79 -47.1 12.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.52 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -54.09 -42.67 69.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.35 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -119.19 24.91 10.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.41 -135.89 4.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.647 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.64 -45.33 59.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.189 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -82.0 52.43 4.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.608 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.11 70.18 10.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.054 0.454 . . . . 0.0 110.381 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -64.89 158.92 23.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.902 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.1 tp10 -57.01 -33.86 67.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.072 0.463 . . . . 0.0 110.82 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.9 mp0 -68.12 -38.3 82.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -75.62 -37.31 59.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 110.613 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.4 mtm180 -58.56 -53.36 59.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 7.8 ptm180 -69.11 -23.54 64.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.595 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.3 mt -71.95 -41.87 67.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.364 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -70.57 -35.86 73.29 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.111 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.95 -43.76 64.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.797 178.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.29 -20.27 74.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.904 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 8.3 t-20 -65.3 -63.9 0.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.684 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.829 ' HA ' HG22 ' A' ' 170' ' ' VAL . 28.1 p-90 -64.72 -22.91 67.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.777 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.15 57.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 0.0 110.591 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -16.43 33.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.9 m -101.79 -35.75 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 167' ' ' TRP . 3.0 ttp180 -78.16 -27.84 48.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 122.229 -0.294 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 m -82.8 -15.07 53.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.86 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.08 -9.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 ' HG ' ' A' ' 86' ' ' LEU . 81.5 mt -79.74 -8.59 59.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.75 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 p -57.01 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.42 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.0 -24.02 2.58 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.39 13.84 0.87 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.98 0.419 . . . . 0.0 111.154 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.25 68.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.73 0.92 42.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.022 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.762 ' HG ' HG11 ' A' ' 82' ' ' VAL . 8.9 mt . . . . . 0 C--N 1.325 -0.46 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 9.5 Cg_endo . . . . . 0 N--CA 1.456 -0.711 0 CA-C-O 120.895 0.289 . . . . 0.0 111.743 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.64 -160.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.674 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.19 -45.95 44.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -61.8 -33.29 73.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.569 0.223 . . . . 0.0 111.281 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.51 -34.03 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.5 tp -73.33 -41.7 63.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.05 -36.24 76.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.55 59.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.7 -66.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.607 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.73 -50.71 67.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.922 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.1 t -67.34 -42.53 87.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.255 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.27 -52.55 52.01 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.2 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.695 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.5 t80 -55.82 -46.18 78.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.992 0.517 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -66.24 -41.31 90.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.2 mp -70.16 -47.37 61.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.118 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 27.1 ttp85 -64.17 -18.83 64.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.541 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -78.86 -34.63 44.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -156.31 77.7 0.93 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 111.667 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.22 -70.12 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.732 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -87.31 52.31 2.47 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.144 0.497 . . . . 0.0 110.352 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.35 -34.09 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.078 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -39.62 93.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.06 57.48 2.11 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.449 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.71 130.97 45.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.309 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.42 -51.61 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.665 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 36.6 Cg_exo -62.05 -46.45 13.03 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.82 1.68 . . . . 0.0 111.446 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.48 38.01 3.32 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.194 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -89.01 -23.11 22.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.111 0.481 . . . . 0.0 109.965 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -98.86 142.2 15.95 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 86.8 Cg_endo -93.5 -155.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.772 2.315 . . . . 0.0 113.71 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -79.18 83.16 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.333 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.82 33.44 3.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 111.087 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.8 m-20 -139.91 165.79 28.42 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.063 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 148' ' ' THR . 60.5 Cg_endo -81.54 49.39 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.266 2.644 . . . . 0.0 111.8 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.68 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.85 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.0 m170 -60.47 -57.52 12.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.698 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 3.8 mt-30 -59.32 -25.99 64.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.751 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.9 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.07 -52.59 10.66 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.184 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.0 ttm -66.53 -38.53 87.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.88 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.92 -38.29 85.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.885 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 -42.25 29.19 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.415 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.784 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.28 -56.73 18.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.96 -48.06 46.6 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.643 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.01 -47.6 84.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.056 0.428 . . . . 0.0 110.994 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -45.67 91.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.835 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.34 -34.91 70.95 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -24.43 67.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.532 0.682 . . . . 0.0 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -95.45 -18.59 20.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -98.67 -38.37 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.848 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.99 104.03 15.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.528 0.68 . . . . 0.0 110.467 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 58' ' ' ARG . 9.9 mtt180 -87.81 -0.19 56.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.501 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -125.48 58.07 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.863 0.363 . . . . 0.0 111.18 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 0.55 10.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.936 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.878 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.9 m-85 -118.65 -28.75 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.716 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -31.56 72.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.653 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -72.8 -20.06 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.878 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.25 -40.5 70.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.28 -43.62 50.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -54.59 -43.01 71.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.886 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.646 HE22 HD11 ' A' ' 106' ' ' LEU . 26.9 mt-30 -64.66 -56.92 10.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.005 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.85 12.25 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 3.4 t-80 -77.7 -24.86 49.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.05 0.452 . . . . 0.0 109.96 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -76.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -160.65 145.47 10.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 9.5 Cg_exo -71.46 174.88 10.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.825 2.35 . . . . 0.0 111.722 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.742 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 85.84 -57.81 4.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.249 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.14 50.83 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 111.346 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.6 -25.05 9.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -64.79 -32.78 74.63 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.307 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -72.38 -35.0 68.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.06 0.457 . . . . 0.0 109.885 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 11.7 mtt-85 -70.19 -44.53 68.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.41 -48.61 78.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -57.92 -34.55 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.248 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -59.75 -63.03 1.45 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 110.501 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 ' HG ' ' A' ' 180' ' ' LEU . 10.8 m -59.31 -31.85 47.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.775 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -66.51 -41.96 88.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 109.982 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -38.71 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.857 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 72.0 mt-10 -70.27 -31.99 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -35.69 44.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.955 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -88.83 -4.19 58.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.0 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -45.55 -43.2 11.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.03 -179.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.88 63.09 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.56 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.06 54.36 0.02 OUTLIER Glycine 0 CA--C 1.524 0.595 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.752 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 28.0 Cg_endo -80.65 42.07 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.964 1.776 . . . . 0.0 111.785 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -69.36 161.12 30.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.407 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.495 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 14.2 m95 -54.33 -26.89 32.3 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -40.69 96.99 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.622 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.0 mmp_? -87.49 -22.22 25.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.281 . . . . 0.0 110.786 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.806 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -55.5 -31.38 61.98 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.407 0.622 . . . . 0.0 110.151 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.9 t -61.43 -53.97 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.678 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.59 -29.0 70.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.315 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.806 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.4 m-85 -56.87 -56.56 20.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.016 0.436 . . . . 0.0 110.078 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -76.52 -36.53 57.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.362 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 t -61.8 -36.44 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -56.31 -55.71 30.09 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 111.321 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.3 59.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.367 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.64 99.1 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.344 0.572 . . . . 0.0 110.709 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.8 -40.61 75.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.751 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.12 -47.14 81.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.442 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 22' ' ' LEU . 87.9 m -61.98 -44.64 96.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.787 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.43 69.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.417 . . . . 0.0 111.363 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.633 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -82.73 -23.41 34.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -27.95 40.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.951 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 53.8 t -69.8 -37.03 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 12.6 p30 -84.82 1.68 45.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -121.42 -152.79 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.483 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 6.1 mt-10 -108.68 47.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.538 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -136.81 39.13 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.419 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -57.82 -51.0 84.97 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.109 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.7 Cg_exo -63.92 -12.01 29.86 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.169 1.913 . . . . 0.0 112.908 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.742 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.7 mp -85.05 -24.05 28.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.012 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.41 -54.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.93 72.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.129 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 74.5 mt-30 -67.84 -53.47 26.53 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 54.8 t -56.02 -34.81 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 0.0 109.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.47 -46.49 85.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.47 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 16.6 pt-20 -73.69 -38.01 65.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.952 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.8 m0 -58.39 -38.95 78.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.713 0.768 . . . . 0.0 109.091 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.2 ttp -72.58 -55.2 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.988 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.3 p -62.89 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.554 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 2.9 tt0 -67.78 -53.32 28.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.155 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -59.36 -33.28 70.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.377 0.608 . . . . 0.0 110.746 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.95 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.35 -56.43 5.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.153 -178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.52 -29.05 68.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 m -84.62 -36.53 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -125.51 -44.88 1.82 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.95 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -59.12 -46.9 87.13 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.37 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.77 65.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.263 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.44 -48.36 73.02 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.196 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.6 t90 -58.31 -50.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -56.19 -48.91 78.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.405 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -60.73 -34.17 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.754 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 m -86.3 -16.15 38.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.15 -58.81 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.405 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -174.94 -5.3 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 86.1 171.65 48.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.955 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -62.48 -26.48 68.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.2 -35.99 82.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.443 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.405 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.5 tt0 -63.52 -44.02 95.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.495 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 12.9 t80 -64.86 -36.43 84.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.684 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.9 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 m -66.34 -27.18 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.201 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.34 25.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.684 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -72.05 -42.65 66.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.338 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -118.65 25.43 10.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.931 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -109.48 -143.09 9.89 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.12 -22.4 28.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.263 0.554 . . . . 0.0 110.567 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -95.14 33.26 5.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.615 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.56 70.62 4.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.666 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 156' ' ' LEU . 0.6 OUTLIER -63.5 170.55 3.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.163 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.18 -35.84 60.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.241 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 40.2 mt-10 -68.12 -40.27 82.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.759 0.314 . . . . 0.0 110.706 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.68 -36.66 76.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 163' ' ' ARG . 7.4 mtm180 -60.28 -56.62 19.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.3 -23.81 65.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -70.75 -47.92 57.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.229 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 3.5 ptt85 -66.94 -36.76 82.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.309 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 1.7 mt-10 -70.26 -44.21 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.298 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.84 75.1 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 170' ' ' VAL . 9.7 t-20 -59.94 -66.13 0.57 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.577 -0.812 . . . . 0.0 111.111 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 32.2 p-90 -61.56 -27.8 68.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.342 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.38 -41.32 69.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 110.79 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -30.1 20.27 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 92' ' ' ASN . 2.7 m -92.18 -36.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -66.22 -29.47 69.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.927 0.394 . . . . 0.0 110.596 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -15.16 29.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.848 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.814 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.4 p -86.11 -25.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.557 . . . . 0.0 110.365 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.9 OUTLIER -120.66 32.95 5.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.016 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.71 70.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.409 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.35 48.23 3.77 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.277 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -111.36 15.53 21.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.489 0.661 . . . . 0.0 109.272 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.17 67.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.271 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.4 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -100.8 10.4 41.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.914 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.739 ' HG ' HG11 ' A' ' 82' ' ' VAL . 19.1 mt . . . . . 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.683 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 6.6 Cg_exo . . . . . 0 CA--C 1.531 0.331 0 CA-C-O 120.833 0.264 . . . . 0.0 112.374 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.3 -151.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -45.09 72.58 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.267 0.627 . . . . 0.0 112.682 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -36.25 79.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.727 0.298 . . . . 0.0 111.133 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . . . -76.55 -35.68 58.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 110.057 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.69 -40.21 66.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.0 p -65.69 -39.2 84.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.074 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.29 60.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.504 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -59.31 2.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.185 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.669 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.3 t80 -57.13 -53.91 52.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.749 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.466 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.6 t -66.62 -40.18 85.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.36 -51.3 59.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.011 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.787 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.4 t80 -63.2 -41.7 99.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.711 0.291 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.63 -40.77 97.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.649 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.4 mp -73.36 -42.7 61.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 8.2 ttp85 -65.69 -15.52 62.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.272 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.03 -35.29 25.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.04 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -158.16 79.4 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.553 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.58 -70.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.665 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -88.84 58.98 4.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.13 0.49 . . . . 0.0 110.537 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.48 -29.82 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.036 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -42.87 78.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.577 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.35 59.37 3.79 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.076 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.6 127.34 32.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.26 -54.51 0.36 Allowed Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.793 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.569 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 45.0 Cg_exo -58.53 -42.92 49.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.026 1.818 . . . . 0.0 111.407 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.94 37.65 3.65 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.478 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.84 -6.91 53.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.139 0.495 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.28 144.9 15.84 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.78 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 88.2 Cg_endo -96.06 -150.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.995 2.463 . . . . 0.0 113.118 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -88.59 86.48 7.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.62 1.93 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 55.0 m-20 -107.03 160.4 26.48 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -78.27 41.12 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.23 2.62 . . . . 0.0 111.991 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.44 -28.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.932 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.7 m170 -59.02 -56.5 21.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.848 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.491 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.67 -27.06 67.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.99 -49.58 36.0 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.421 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.9 OUTLIER -67.8 -31.57 71.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -40.99 97.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.45 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -23.27 43.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 109.851 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.808 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -70.27 -63.88 1.0 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.099 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.35 -48.41 41.08 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.864 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -42.65 79.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.089 0.471 . . . . 0.0 111.262 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -62.88 -44.32 96.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -75.64 -29.33 59.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.919 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.18 -24.09 66.57 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -40.48 10.15 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.634 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -88.96 -54.36 4.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -85.3 68.64 10.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.75 0.42 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -75.93 -22.99 55.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.358 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.19 37.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.035 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -120.79 -5.01 9.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.863 ' HA ' HD22 ' A' ' 64' ' ' LEU . 4.9 m-85 -93.6 -31.05 14.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.891 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.18 67.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.831 0.348 . . . . 0.0 111.425 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 2.0 m-20 -77.79 -18.02 56.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.892 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.863 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -72.83 -39.63 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.36 -46.0 35.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.979 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.87 -42.87 63.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.955 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.575 HE22 HD11 ' A' ' 106' ' ' LEU . 25.2 mt-30 -67.8 -61.61 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.656 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -79.61 13.33 2.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 47.0 t60 -79.13 -26.45 42.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -74.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.998 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -159.84 142.77 10.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.075 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.8 Cg_exo -75.6 -175.34 2.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.009 2.473 . . . . 0.0 112.069 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.713 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.74 -65.81 2.94 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.027 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.24 41.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.833 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -97.11 -21.17 17.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.663 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -63.83 -37.97 89.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.607 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 4.4 mm100 -68.95 -35.22 76.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.32 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.49 -48.15 61.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.14 0.495 . . . . 0.0 109.769 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.53 -47.62 84.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.068 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -58.66 -34.98 71.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.429 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 73.4 mm-40 -60.23 -56.63 19.25 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.177 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.3 t -59.0 -37.86 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.081 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.2 m -62.47 -46.37 88.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.551 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.8 OUTLIER -69.46 -36.32 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 33.4 mm-40 -67.53 -32.87 73.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.872 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.562 ' HA ' HD13 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -77.17 -36.73 54.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.23 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.486 ' HB2' ' HE2' ' A' ' 129' ' ' TYR . 55.2 t80 -85.21 -5.61 59.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -53.79 -37.09 63.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.563 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.46 59.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.813 -1.184 . . . . 0.0 113.384 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.625 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 167.27 49.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.605 -1.284 . . . . 0.0 115.17 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -80.7 38.98 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 119.913 1.856 . . . . 0.0 111.715 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.761 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -70.15 162.61 27.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.529 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 15.1 m95 -53.22 -27.86 24.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.03 -43.49 97.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -85.65 -23.15 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.675 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.765 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.35 -30.85 61.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 110.036 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.808 HG22 ' HB1' ' A' ' 49' ' ' ALA . 41.2 t -60.93 -56.3 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.41 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' A' ' 53' ' ' PHE . . . -62.93 -28.44 70.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.406 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.765 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.45 -51.84 66.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.201 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.8 m-85 -81.53 -35.05 30.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 15.2 t -63.75 -34.53 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.758 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.615 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -54.23 -59.08 5.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 111.496 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -69.78 -35.91 74.02 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.226 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.19 90.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.2 0.5 . . . . 0.0 110.602 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.19 -39.1 82.59 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.7 -45.3 94.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.759 ' HB3' HD21 ' A' ' 22' ' ' LEU . 82.5 m -64.14 -41.69 97.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.86 -53.7 52.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.293 . . . . 0.0 111.041 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -19.95 65.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -78.71 -33.78 46.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.594 0.235 . . . . 0.0 110.716 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 32.1 t -74.52 -25.88 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.481 0.658 . . . . 0.0 109.669 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.55 1.42 45.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.147 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -133.93 -169.78 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.649 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.78 57.84 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 110.025 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.485 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.54 46.44 2.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.716 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.53 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.4 mp0 -62.47 -54.25 50.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 26.3 Cg_exo -63.58 -20.19 68.95 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.077 1.852 . . . . 0.0 112.864 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -71.98 -29.49 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.62 -51.25 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.03 -31.5 80.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.608 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 5.8 mm100 -68.06 -49.82 59.01 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 118' ' ' LEU . 42.0 t -58.72 -33.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -63.33 -46.49 86.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 12.2 pt-20 -71.55 -40.44 69.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.702 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.663 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 32.3 m0 -57.99 -39.98 79.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.555 0.693 . . . . 0.0 109.337 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.408 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.4 ttp -73.56 -53.0 11.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.956 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -63.66 -31.87 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.92 -50.52 41.29 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.068 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 7.0 t80 -58.92 -33.15 70.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 110.983 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.009 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.15 -52.27 9.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.89 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -35.32 79.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 m -81.15 -39.22 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.72 -41.33 2.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.009 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -63.36 -47.09 83.59 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.545 -178.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.58 -34.53 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.275 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.4 -50.0 67.16 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.219 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.761 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 45.6 t90 -59.08 -49.05 79.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 14.8 mt -56.92 -48.41 81.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.074 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -65.59 -30.52 71.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.2 m -83.55 -30.37 27.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -57.69 4.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -170.83 -10.86 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.559 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 92.3 170.24 40.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.626 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.7 m95 -62.84 -30.77 71.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.75 72.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.204 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -65.44 -41.12 93.82 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.707 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 8.2 t80 -65.85 -39.04 90.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.514 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.738 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.78 -25.73 67.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.024 0.44 . . . . 0.0 110.815 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.4 -28.04 23.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.083 0.468 . . . . 0.0 109.849 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.712 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.15 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.27 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -134.3 30.26 3.58 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.62 -111.03 3.56 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 119.84 -1.172 . . . . 0.0 112.862 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.6 -67.27 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.041 0.448 . . . . 0.0 110.973 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.94 69.88 1.86 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.553 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.54 71.38 9.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 110.343 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.1 165.04 14.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.039 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -58.91 -36.27 74.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.1 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.621 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -68.63 -38.96 80.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.344 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.712 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.98 -40.14 75.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -68.04 -49.55 60.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 157' ' ' GLU . 9.7 ptm180 -62.3 -28.57 69.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 110.385 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -67.42 -42.32 83.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.833 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.619 HH22 ' HA ' ' A' ' 49' ' ' ALA . 5.2 ttp180 -67.08 -44.04 81.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.23 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.648 ' HG3' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.11 -47.29 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.41 -23.63 75.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.739 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 2.9 t-20 -74.43 -54.53 7.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.532 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.976 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.7 p-90 -64.25 -24.29 67.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.055 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -51.36 -52.97 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.215 0.322 . . . . 0.0 110.811 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -27.72 22.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.976 HG22 ' HA ' ' A' ' 167' ' ' TRP . 25.0 m -80.02 -25.98 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.273 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.4 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.7 ttp180 -83.13 -15.11 52.04 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.809 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -96.22 -39.16 9.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 13.2 p -59.39 -33.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.403 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -115.7 44.5 1.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.634 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.16 -43.08 92.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.294 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.21 41.42 1.32 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.724 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.554 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -100.77 -4.24 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.264 0.554 . . . . 0.0 109.878 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.41 67.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.397 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.35 8.2 45.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.446 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 102' ' ' PHE . 8.7 mt . . . . . 0 C--N 1.326 -0.444 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_exo . . . . . 0 CA--C 1.532 0.382 0 CA-C-O 121.047 0.353 . . . . 0.0 112.894 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -156.65 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.42 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.22 72.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -42.8 99.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.15 -35.03 66.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.654 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.6 tp -72.91 -42.18 63.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.486 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.8 p -66.47 -37.42 79.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.0 -21.05 61.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' CE1' ' A' ' 43' ' ' HIS . 1.2 t70 -77.81 -68.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 t80 -52.3 -50.33 62.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.206 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 19.3 t -75.93 -39.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.935 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' ALA . . . -61.22 -53.69 42.53 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.527 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.735 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 85.9 t80 -60.8 -45.47 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.029 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -61.04 -47.73 85.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -67.93 -47.85 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 29.6 ttp85 -58.75 -30.95 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.554 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.63 -12.03 49.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -156.47 63.09 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.46 -71.21 0.33 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.73 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -82.2 56.62 3.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.15 0.5 . . . . 0.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 t -78.31 -32.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 m -66.27 -35.38 80.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.774 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.23 51.62 2.46 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.639 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 116.16 9.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.746 0.308 . . . . 0.0 110.668 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.22 -51.05 0.13 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.599 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.7 -48.46 2.12 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.187 1.925 . . . . 0.0 111.667 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.735 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -89.47 27.48 7.76 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.94 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.25 -58.54 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.604 0.716 . . . . 0.0 109.388 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.94 139.22 30.91 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.699 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -90.53 -133.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.722 2.281 . . . . 0.0 113.567 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -83.63 92.02 7.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.452 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.84 10.63 5.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.489 0.661 . . . . 0.0 109.576 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.8 m-20 -121.11 160.51 44.95 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.365 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -81.36 37.03 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.246 2.631 . . . . 0.0 112.4 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -165.61 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.414 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 16' ' ' ASP . 2.5 m170 -56.21 -56.98 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.586 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 9.1 tt0 -57.67 -23.4 51.23 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.557 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.948 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -82.52 -49.62 9.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.434 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 4.5 ttm -66.42 -42.14 88.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -30.74 71.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.498 0.19 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.87 33.57 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.78 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.51 -55.76 30.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.097 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.445 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.98 -44.75 41.57 Favored Glycine 0 C--O 1.217 -0.93 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.613 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.01 -54.14 50.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.453 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -43.43 97.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.965 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.88 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.87 -30.24 62.53 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.495 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.97 -30.35 71.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.78 0.8 . . . . 0.0 108.864 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.1 m -79.54 -33.69 41.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.297 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 56' ' ' ARG . 19.0 mtt180 -89.56 -52.12 5.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.174 0.512 . . . . 0.0 111.716 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.27 64.13 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.303 0.641 . . . . 0.0 110.958 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -18.29 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.768 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.59 58.43 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -51.07 2.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 111.746 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.508 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 5.1 m-85 -62.17 -19.73 63.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -38.79 66.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.835 0.35 . . . . 0.0 111.311 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 3.3 m-20 -67.03 -28.41 68.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.491 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.1 mt -61.19 -43.63 98.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.338 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.8 -40.49 47.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.02 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.59 -45.52 63.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.699 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.636 ' NE2' ' HG ' ' A' ' 180' ' ' LEU . 36.9 mt-30 -67.64 -54.73 17.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.255 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -84.38 17.52 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.9 t60 -78.17 -30.28 49.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.635 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -91.5 -65.25 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.635 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -162.3 145.95 9.15 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 122.138 0.175 . . . . 0.0 110.708 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.9 Cg_exo -76.45 172.18 16.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.818 2.345 . . . . 0.0 111.355 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.92 -60.99 1.13 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.625 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.17 50.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.418 0.628 . . . . 0.0 110.93 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.76 -22.12 13.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.684 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.32 -39.94 94.91 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.509 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.82 -47.71 82.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.998 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -47.66 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.81 -50.02 75.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.774 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . 0.411 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 18.5 p -60.61 -30.01 69.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -68.01 -53.11 28.34 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.002 0.43 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 180' ' ' LEU . 34.2 m -65.77 -32.3 57.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.089 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 80' ' ' THR . 1.3 p -69.13 -39.94 78.59 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.892 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -46.5 82.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.239 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -68.87 -25.03 64.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -79.82 -26.15 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.501 . . . . 0.0 109.952 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -97.37 -4.24 38.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.395 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -39.04 -50.47 1.81 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.542 0.737 . . . . 0.0 112.378 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.3 48.99 0.16 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.901 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.12 56.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.221 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.6 Cg_endo -77.8 45.78 1.87 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.21 1.94 . . . . 0.0 111.817 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.8 162.92 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.598 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 17.6 m95 -54.01 -28.85 40.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.639 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.86 -40.78 98.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.204 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.607 ' HE ' ' HA ' ' A' ' 171' ' ' ARG . 6.9 mmt180 -86.35 -21.56 27.16 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.812 -0.228 . . . . 0.0 110.551 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.774 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -57.66 -30.62 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.346 0.593 . . . . 0.0 110.132 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.5 t -62.9 -55.16 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -61.61 -29.06 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.053 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.774 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 3.6 m-85 -56.42 -54.21 48.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.082 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.524 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 6.6 m-85 -79.03 -36.33 41.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.02 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 t -59.99 -38.45 76.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -57.41 -50.0 74.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.71 0.291 . . . . 0.0 111.613 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.68 -37.65 34.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.261 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.63 98.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.245 0.523 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -69.22 -38.88 78.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.549 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -60.31 -44.9 95.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.749 ' HB3' HD21 ' A' ' 22' ' ' LEU . 86.6 m -64.06 -41.01 97.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.172 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.25 -54.7 40.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -17.72 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.516 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB2' HG22 ' A' ' 119' ' ' VAL . 74.2 m -77.97 -31.0 50.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.6 t -80.95 -13.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.905 0.859 . . . . 0.0 109.163 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -85.02 0.07 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -144.64 -170.38 3.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.519 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.84 55.59 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 110.034 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.85 29.69 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.513 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -53.51 -51.07 79.29 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 116' ' ' GLU . 19.1 Cg_endo -59.84 -23.19 71.39 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.238 1.959 . . . . 0.0 113.243 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 mm? -76.04 -26.68 56.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.591 0.234 . . . . 0.0 110.777 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 110' ' ' SER . 88.9 t -59.25 -54.3 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.193 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.29 71.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.446 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 mm100 -69.45 -49.77 51.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 46.1 t -58.52 -35.16 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.15 -50.38 73.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.359 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.666 ' HA ' HG12 ' A' ' 127' ' ' VAL . 10.7 pt-20 -69.27 -39.78 78.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.684 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.9 m0 -57.3 -40.93 78.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.391 0.615 . . . . 0.0 109.524 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.532 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.04 -44.53 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.376 -178.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.0 p -71.45 -31.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.741 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.57 -48.14 61.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -59.34 -35.16 73.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.692 . . . . 0.0 110.473 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.926 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.39 -53.19 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.908 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -62.36 -28.78 70.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.9 m -85.1 -36.11 21.37 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -128.14 -40.77 1.64 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.926 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.67 -45.83 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.129 0.422 . . . . 0.0 111.325 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.04 61.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.356 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -65.71 -53.96 33.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 47.8 t90 -57.12 -47.31 81.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.471 HG13 ' HE3' ' A' ' 137' ' ' TRP . 8.3 mt -57.02 -49.18 80.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -65.1 -32.71 74.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.97 -4.41 58.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -99.31 -50.71 4.03 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.871 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.462 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -176.35 -19.97 0.02 OUTLIER Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.81 168.36 35.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.434 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 89.3 m95 -60.14 -31.15 69.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.3 75.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.012 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.462 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.8 tt0 -65.74 -38.15 88.34 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.35 -38.94 81.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.747 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.948 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -61.91 -33.84 74.96 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.686 0.279 . . . . 0.0 111.401 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.78 32.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.813 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -61.74 -44.65 96.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.084 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -111.27 16.45 20.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -108.24 -137.88 8.34 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.9 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -29.66 26.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 111.217 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.84 37.9 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.092 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.13 68.81 9.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.5 OUTLIER -67.46 176.78 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.206 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -53.54 -38.42 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -68.47 -46.56 69.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.91 73.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -56.78 9.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.009 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -65.36 -34.1 77.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.351 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.0 OUTLIER -67.86 -31.47 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.652 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 150' ' ' LEU . 6.2 mtp180 -70.14 -51.59 30.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 12.8 mt-10 -67.57 -38.63 84.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.36 76.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.122 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.6 t-20 -69.4 -71.39 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.545 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 164' ' ' GLU . 35.8 p-90 -58.36 -25.4 61.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.854 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.56 -63.14 1.25 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 110.883 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.75 -23.4 24.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 8.3 t -77.99 -39.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 111.682 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.607 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 16.2 ttp180 -74.15 -24.1 59.36 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.091 -0.381 . . . . 0.0 110.699 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.732 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -84.24 -27.75 27.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.659 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 174' ' ' LEU . 0.7 OUTLIER -68.27 -22.98 27.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.983 0.421 . . . . 0.0 110.497 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.567 ' HG ' ' CG1' ' A' ' 173' ' ' VAL . 0.4 OUTLIER -120.38 38.49 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.634 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.37 -23.24 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.297 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 6.86 67.91 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.465 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.652 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -80.08 7.03 9.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.83 65.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.27 0.557 . . . . 0.0 110.713 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -102.48 13.67 33.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.19 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.591 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.846 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo . . . . . 0 C--O 1.231 0.172 0 CA-C-O 120.974 0.322 . . . . 0.0 112.079 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.83 -172.04 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.81 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -28.04 50.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 111.929 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.78 -39.98 88.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 110.093 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -34.3 62.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.606 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.1 tp -72.82 -41.58 64.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.2 p -64.98 -36.96 79.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.71 62.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -66.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.0 t80 -54.21 -52.07 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.07 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.462 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.8 t -65.5 -42.02 92.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.462 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.97 -51.83 56.09 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.18 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.758 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 42.8 t80 -58.32 -45.45 88.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.009 0.524 . . . . 0.0 111.292 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -64.52 -47.87 77.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.301 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -65.23 -46.71 79.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 12.6 ttp85 -62.84 -20.42 65.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.87 -31.16 23.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.798 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.32 71.97 1.14 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.163 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.16 -69.83 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.756 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.114 0.483 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.42 -33.94 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -37.9 89.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.29 52.42 1.37 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.716 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -65.47 141.7 58.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.51 -45.71 0.53 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.111 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 11.5 Cg_exo -73.37 -47.62 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.138 1.892 . . . . 0.0 111.869 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.95 27.22 7.54 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.216 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 19.9 mm-40 -80.57 -41.96 23.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.504 0.652 . . . . 0.0 109.403 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.3 142.66 46.2 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.006 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -93.49 -166.27 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.784 2.323 . . . . 0.0 113.806 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.22 85.51 7.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.392 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.04 -23.44 4.96 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 4.2 m-20 -79.32 160.28 70.79 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.472 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' HG21 ' A' ' 148' ' ' THR . 27.8 Cg_endo -77.61 50.16 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.279 2.653 . . . . 0.0 111.568 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -178.96 -31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.287 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.68 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.8 m170 -60.42 -59.58 5.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.963 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.932 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -57.54 -27.1 62.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.732 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.88 -52.78 15.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.423 ' HE1' HD21 ' A' ' 13' ' ' LEU . 2.9 ttm -65.58 -38.3 89.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.639 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -38.63 80.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.402 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.67 45.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.22 0.533 . . . . 0.0 110.107 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.877 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -63.73 -63.21 1.23 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.438 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.48 -47.41 36.25 Favored Glycine 0 C--O 1.215 -1.038 0 O-C-N 124.137 0.898 . . . . 0.0 112.502 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -51.74 -51.62 54.84 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.855 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.06 -46.9 79.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.71 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -68.88 -35.7 77.19 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.74 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.27 -32.77 73.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 109.468 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -85.35 -18.24 34.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.606 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.06 -65.62 1.03 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.097 0.475 . . . . 0.0 111.861 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.8 67.63 8.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.243 0.617 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.26 -8.95 59.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.952 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 40.9 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -120.35 0.06 10.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.766 ' HA ' HD22 ' A' ' 64' ' ' LEU . 30.3 m-85 -89.65 -17.11 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.172 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -41.05 93.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.7 m-20 -63.18 -27.2 69.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.821 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -63.74 -42.55 97.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.722 0.773 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.51 -44.05 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.409 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -52.33 -42.24 63.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.441 179.883 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.723 HE22 HD11 ' A' ' 106' ' ' LEU . 21.0 mt-30 -73.01 -52.44 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.326 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.34 19.91 3.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t60 -79.34 -35.3 41.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.234 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -91.42 -68.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.275 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.7 145.66 8.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.416 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.45 -178.01 4.16 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.623 2.215 . . . . 0.0 112.185 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.718 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.28 -71.3 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.879 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.68 44.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.97 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.15 -19.25 18.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.947 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.3 pt20 -63.78 -36.22 83.17 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.728 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -70.43 -38.73 74.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.398 . . . . 0.0 110.164 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -68.13 -44.47 76.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.946 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.45 -45.84 91.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.92 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -60.2 -33.5 72.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.195 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -61.63 -60.14 4.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.759 0.314 . . . . 0.0 111.109 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.8 p -58.61 -36.57 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -65.59 -41.97 92.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.091 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -43.3 81.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -70.21 -21.21 63.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -84.42 -34.88 23.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 110.291 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -85.43 -7.64 58.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.484 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.48 -50.54 2.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.019 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.3 56.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.861 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.534 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.31 51.28 0.05 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.599 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 13.3 Cg_endo -80.44 40.81 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.149 1.9 . . . . 0.0 111.842 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.819 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.9 OUTLIER -70.35 166.12 20.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.684 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 30.6 m95 -53.19 -30.32 36.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.437 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.49 99.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.283 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -87.12 -25.76 23.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.839 -0.181 . . . . 0.0 110.931 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.77 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.74 -31.86 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.45 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 53' ' ' PHE . 16.4 t -62.65 -56.12 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.6 -28.38 69.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.77 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.9 m-85 -55.73 -54.59 42.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.198 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.2 m-85 -78.27 -35.13 48.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.223 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 t -62.66 -36.36 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -55.2 -55.68 28.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.466 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.89 56.1 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.41 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.135 0.468 . . . . 0.0 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.07 -39.33 72.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.0 -49.92 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.672 ' HB3' HD21 ' A' ' 22' ' ' LEU . 79.8 m -60.17 -40.13 88.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.097 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.53 30.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.1 -15.96 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 119' ' ' VAL . 66.8 m -77.88 -29.02 50.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 107' ' ' CYS . 16.9 t -82.1 -17.01 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.685 0.755 . . . . 0.0 109.057 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -79.69 -8.57 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.892 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -166.16 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.511 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.25 67.64 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.02 0.438 . . . . 0.0 110.036 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.401 ' O ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -140.95 37.23 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.223 -179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 3.3 mp0 -57.9 -51.7 79.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 34.1 Cg_exo -58.53 -30.73 92.69 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.044 1.829 . . . . 0.0 112.32 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -71.35 -30.95 66.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 111' ' ' VAL . 73.4 t -57.68 -52.02 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.77 -31.73 79.18 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.9 mm-40 -66.05 -50.7 63.24 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 96.3 t -56.56 -36.46 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.02 -48.32 80.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.488 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.1 pt-20 -72.46 -36.42 68.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.195 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.644 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.7 m0 -58.16 -39.77 79.71 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.8 ttp -72.89 -53.4 11.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.581 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.4 p -60.45 -32.54 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.783 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -67.12 -54.7 18.9 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.061 0.458 . . . . 0.0 110.24 179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.78 -30.2 67.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.902 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.38 -52.9 8.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.526 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.29 77.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.8 m -80.83 -33.86 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 -46.31 1.95 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.902 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.31 -42.1 90.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.645 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.28 64.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.05 -51.17 60.62 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.819 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 69.8 t90 -57.81 -47.5 82.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -58.23 -47.53 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.555 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -63.52 -25.59 68.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 111.567 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -100.37 -5.64 26.96 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -122.17 44.76 2.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.722 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.33 -65.97 0.89 Allowed Glycine 0 CA--C 1.506 -0.484 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.25 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 123.59 173.45 13.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.906 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 98.5 m95 -56.04 -36.75 68.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.04 77.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.52 -43.01 98.41 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.877 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 13.7 t80 -67.48 -31.63 71.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.699 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -69.47 -25.0 63.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.155 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.57 -34.4 19.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.779 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -56.21 -51.81 66.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.929 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.423 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.7 m-85 -130.35 31.76 4.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -98.52 -134.85 8.58 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.177 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.26 -53.42 44.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 110.334 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.477 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.61 64.06 1.87 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.708 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.24 73.3 7.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.391 0.615 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -59.22 153.39 18.53 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.114 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 2.6 mm-40 -56.66 -27.64 59.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.099 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -73.37 -42.39 62.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 110.643 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -66.89 -37.56 84.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.271 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 160' ' ' ARG . 25.4 mtm-85 -65.64 -52.81 48.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.24 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 17.8 ptt180 -63.65 -31.36 72.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -65.74 -39.33 90.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.818 HH22 ' HA ' ' A' ' 49' ' ' ALA . 2.5 ttp180 -68.13 -43.65 77.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 29.2 mt-10 -62.44 -47.38 84.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.398 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.8 -23.76 75.66 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.953 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -74.04 -52.25 13.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.759 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.9 p-90 -65.28 -24.3 67.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.855 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.23 77.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.341 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -31.26 20.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 167' ' ' TRP . 27.4 m -89.51 -37.04 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -68.77 -30.91 69.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.804 -0.56 . . . . 0.0 110.939 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.29 -37.47 21.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.663 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -66.35 -27.08 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.952 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.7 OUTLIER -115.8 32.94 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.323 0.582 . . . . 0.0 109.875 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.8 -9.99 59.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.107 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.55 15.03 62.4 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.703 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.38 6.53 36.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.569 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.61 71.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.531 0.682 . . . . 0.0 109.979 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.44 8.08 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.483 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.656 0.265 . . . . 0.0 110.849 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo . . . . . 0 CA--C 1.53 0.305 0 N-CA-C 112.953 0.328 . . . . 0.0 112.953 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 -160.25 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -43.19 66.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -61.18 -38.23 85.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.292 . . . . 0.0 111.213 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.72 -34.91 60.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.1 0.476 . . . . 0.0 110.137 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -72.28 -42.86 65.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.3 p -65.98 -35.8 75.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.21 61.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.333 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -66.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.5 t80 -55.08 -53.78 51.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.968 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.4 t -67.16 -37.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.221 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.68 -51.79 53.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.059 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 1.1 t80 -63.32 -47.06 83.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.44 0.296 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 1.9 tmtm? -57.84 -37.3 73.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 111.222 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -78.44 -47.34 17.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.533 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.747 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -59.35 -27.16 65.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.853 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 14.0 pt20 -85.65 -11.09 54.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.16 -56.19 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.53 -57.43 0.66 Allowed Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.665 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -78.32 46.06 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 122.782 0.433 . . . . 0.0 111.101 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.1 -31.95 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.001 0.429 . . . . 0.0 110.222 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -39.04 83.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.39 0.614 . . . . 0.0 109.356 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.61 58.43 3.75 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.575 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.747 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.26 109.76 1.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.474 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -172.56 -57.46 0.05 OUTLIER Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 35.8 Cg_exo -62.33 -50.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.235 1.956 . . . . 0.0 111.482 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -85.94 27.23 5.55 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.404 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -77.4 -31.15 53.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.079 0.466 . . . . 0.0 109.891 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.43 124.82 8.05 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 92.7 Cg_endo -87.5 -150.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.591 2.194 . . . . 0.0 113.657 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -78.22 82.81 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.78 26.82 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.439 . . . . 0.0 110.627 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 9.7 m-20 -135.76 161.63 61.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.098 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 47.1 Cg_endo -78.83 50.78 3.57 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.274 2.649 . . . . 0.0 112.279 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER 179.82 -32.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.579 179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.7 m170 -60.02 -56.49 21.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 2.5 mt-30 -61.27 -25.19 66.93 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.637 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -72.82 -50.45 24.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.966 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.6 ttm -66.88 -37.37 84.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.667 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -60.93 -40.66 94.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.53 -29.38 56.72 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 110.054 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -66.19 -62.15 1.64 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.39 -45.97 28.77 Favored Glycine 0 C--O 1.216 -0.981 0 O-C-N 124.224 0.953 . . . . 0.0 112.572 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.6 -53.82 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.51 -45.87 81.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.837 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -65.16 -38.56 90.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.27 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.65 -36.53 78.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.621 . . . . 0.0 109.967 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -83.2 -12.78 56.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.352 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.88 -24.88 12.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.78 92.22 8.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.49 -31.32 70.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.421 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -119.65 79.11 1.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -120.81 -7.59 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.889 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.88 -29.62 4.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -32.84 71.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -71.58 -20.59 61.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.925 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.889 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.06 -41.06 71.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -74.34 -42.26 59.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -56.46 -43.31 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.785 179.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.494 HE22 HD11 ' A' ' 106' ' ' LEU . 28.1 mt-30 -63.42 -52.78 60.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.464 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.21 7.43 22.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 4.2 t60 -78.85 -23.27 45.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -68.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.391 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -164.67 143.12 5.55 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.1 Cg_exo -81.05 -175.96 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.412 2.741 . . . . 0.0 111.897 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 80.9 -62.3 4.44 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.82 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.83 28.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.472 . . . . 0.0 111.897 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -81.4 -23.43 37.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.662 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -59.91 -40.83 90.16 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.927 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.28 -49.07 77.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.115 0.259 . . . . 0.0 110.757 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -59.76 -43.56 94.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.966 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.81 -52.26 64.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.646 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.59 -33.6 66.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -61.92 -51.66 67.23 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.306 0.574 . . . . 0.0 109.988 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.424 HG21 ' HG ' ' A' ' 180' ' ' LEU . 31.2 t -64.51 -35.82 75.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.711 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.998 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.84 -34.21 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.377 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.5 mm-40 -65.99 -30.41 70.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.53 . . . . 0.0 109.948 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.1 mp -78.38 -36.92 45.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.21 -2.03 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.731 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -36.9 61.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.475 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.8 59.69 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.898 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.582 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.31 53.36 0.02 OUTLIER Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.835 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 14.2 Cg_endo -81.37 36.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.325 2.017 . . . . 0.0 111.551 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.77 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -68.47 163.9 22.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.907 -178.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m95 -53.67 -27.73 29.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.53 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.32 98.48 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER -86.61 -23.83 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.69 -0.255 . . . . 0.0 110.918 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -54.25 -32.07 55.13 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.381 0.61 . . . . 0.0 110.488 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.837 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.1 t -61.95 -54.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.571 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -62.11 -30.69 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.247 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.1 m-85 -55.5 -51.82 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.548 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -82.48 -32.72 28.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.412 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.95 -34.0 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.813 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.33 -60.05 3.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.63 61.42 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.206 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.21 83.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.157 0.479 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -72.92 -42.49 63.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.785 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.03 -51.85 67.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.603 179.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.655 ' HB3' HD21 ' A' ' 22' ' ' LEU . 87.1 m -60.55 -43.8 96.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.22 67.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.811 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.635 ' HA ' HD22 ' A' ' 112' ' ' ASN . 1.7 tt0 -78.63 -25.63 45.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG22 ' A' ' 119' ' ' VAL . 50.6 m -78.25 -37.02 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.676 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.9 t -66.51 -32.96 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.207 -0.308 . . . . 0.0 111.523 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.635 HD22 ' HA ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -79.3 -30.99 43.15 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.411 -0.516 . . . . 0.0 112.253 -178.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.15 113.99 2.74 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 115' ' ' MET . 23.0 mt-10 65.35 143.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 7.5 mtm 76.86 126.47 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.772 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 1.7 tt0 -120.53 -58.11 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.425 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.34 -29.23 88.4 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.218 1.946 . . . . 0.0 113.09 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -60.0 -31.65 70.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.597 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 110' ' ' SER . 89.3 t -60.86 -51.22 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.85 -30.48 72.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.461 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -64.83 -52.57 56.0 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.542 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 89.0 t -55.6 -37.55 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.025 0.44 . . . . 0.0 109.915 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -61.69 -47.04 87.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.643 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.67 ' HA ' HG12 ' A' ' 127' ' ' VAL . 23.2 pt-20 -74.1 -35.88 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.662 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.0 m0 -56.24 -37.98 70.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.2 mtp -73.34 -56.45 5.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.462 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.4 p -60.64 -32.83 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.7 -47.6 62.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.185 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.5 t80 -61.45 -36.14 79.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.545 0.688 . . . . 0.0 110.421 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.007 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.47 -55.57 7.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.196 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.95 -32.75 72.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.1 m -78.68 -40.78 32.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -41.05 1.88 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -60.53 -48.3 82.39 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.337 0.517 . . . . 0.0 111.709 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -35.9 41.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.238 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.75 -51.92 65.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.373 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.77 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.0 t90 -58.65 -47.58 83.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.602 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.7 mt -57.44 -48.05 83.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.389 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -68.97 -26.45 65.04 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.666 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -92.04 -9.08 44.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.13 -53.8 3.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.91 -15.64 0.02 OUTLIER Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.423 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.63 168.75 36.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.6 m95 -63.46 -30.26 71.41 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.58 75.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.741 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.417 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -64.27 -42.8 96.28 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.704 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 11.1 t80 -66.2 -33.93 76.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.631 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -68.25 -27.07 66.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.706 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.78 -26.5 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.123 0.487 . . . . 0.0 109.936 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.64 -50.78 65.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.39 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.5 m-85 -133.05 33.24 3.67 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.991 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -102.05 -137.28 9.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.98 -39.31 79.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.166 0.507 . . . . 0.0 110.716 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -102.47 53.98 0.75 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.766 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.88 76.13 3.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.331 0.586 . . . . 0.0 110.288 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.761 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -64.37 162.59 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.24 -32.98 64.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.242 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.761 ' HB2' HD12 ' A' ' 156' ' ' LEU . 45.8 mt-10 -74.06 -35.31 64.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.716 0.294 . . . . 0.0 111.291 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -71.04 -39.18 72.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 mtm-85 -62.18 -56.36 19.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.735 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.43 -33.13 73.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -64.18 -42.64 96.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.68 HH22 ' HA ' ' A' ' 49' ' ' ALA . 3.2 ttp180 -68.2 -41.19 81.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.994 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.716 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -64.92 -40.99 95.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.43 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.75 -31.22 67.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.963 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.5 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -67.03 -55.65 13.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.214 -0.493 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.772 ' HA ' HG22 ' A' ' 170' ' ' VAL . 12.0 p-90 -61.98 -28.94 69.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.193 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.54 -42.88 79.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 110.75 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.86 -30.56 20.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.3 m -87.03 -29.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.531 ' HD2' ' HZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -77.12 -34.72 56.63 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.804 -0.56 . . . . 0.0 110.153 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 -8.78 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.045 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.9 p -85.19 -26.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.26 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -121.35 43.22 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.139 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -22.61 62.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.765 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.82 8.48 49.72 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.339 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.424 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -78.17 -0.29 27.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.7 69.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.344 0.592 . . . . 0.0 110.546 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -103.56 16.11 27.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.12 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 82' ' ' VAL . 35.4 mt . . . . . 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.805 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo . . . . . 0 CA--C 1.527 0.16 0 CA-C-O 121.177 0.407 . . . . 0.0 112.238 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.63 -167.17 1.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.578 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.55 75.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -39.47 93.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.679 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.43 69.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.007 0.432 . . . . 0.0 110.018 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.3 tp -70.66 -43.14 69.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.84 -34.9 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.011 0.434 . . . . 0.0 110.009 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.19 60.94 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.448 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -66.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.917 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.671 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -55.08 -50.73 68.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . 44.2 t -72.59 -39.01 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.665 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.8 -55.92 25.7 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.271 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.702 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 13.0 t80 -56.45 -44.77 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.856 0.462 . . . . 0.0 110.798 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.42 -45.58 90.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.525 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.3 mp -68.7 -43.3 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 24.3 ttp85 -66.76 -15.31 63.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.597 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -84.14 -38.61 20.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.71 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.04 79.9 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.765 0.317 . . . . 0.0 111.841 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.14 -66.33 0.38 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.911 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -96.68 55.57 1.41 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.306 0.574 . . . . 0.0 110.333 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.04 -27.75 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.977 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -41.07 78.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 58.69 4.02 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.772 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.26 118.13 10.22 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.81 -54.16 0.16 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.348 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.8 Cg_exo -60.55 -46.94 15.26 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 121.936 1.757 . . . . 0.0 111.021 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.702 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -97.93 36.76 3.77 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.218 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -18.24 43.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.26 140.78 16.34 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 83.2 Cg_endo -94.58 -141.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.98 2.454 . . . . 0.0 113.283 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -76.29 86.96 3.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.359 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.69 20.8 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.067 0.461 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 3.8 m-20 -131.69 161.67 60.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.938 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.31 45.51 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.253 2.635 . . . . 0.0 111.964 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -174.27 -30.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.13 179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.8 m170 -57.84 -57.13 14.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.819 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 25.1 tt0 -58.58 -26.81 64.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.872 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.45 -50.71 17.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.381 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 13' ' ' LEU . 3.7 ttm -67.11 -41.72 85.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.613 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -62.87 -33.76 75.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.759 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.23 -41.87 27.26 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.234 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -60.59 -55.66 30.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.649 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.671 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.3 -46.55 57.23 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.742 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.64 -49.0 79.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 111.502 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -65.17 -46.29 81.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.38 0.61 . . . . 0.0 110.257 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.458 ' HB2' HG11 ' A' ' 97' ' ' VAL . 45.7 t80 -63.34 -40.46 97.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.635 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.25 -33.03 70.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.341 0.591 . . . . 0.0 109.973 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 m -78.02 -24.8 47.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.278 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -98.71 -18.86 17.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.26 93.74 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.926 0.393 . . . . 0.0 111.409 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -61.22 -46.64 89.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.25 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.844 HH21 HG11 ' A' ' 178' ' ' VAL . 3.2 mtm-85 -91.17 86.71 6.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.106 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -57.08 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.001 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.913 ' HA ' HD22 ' A' ' 64' ' ' LEU . 7.8 m-85 -90.96 0.98 57.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 59' ' ' ARG . 2.1 p -70.17 -56.49 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 111.33 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -63.92 -23.52 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.169 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 ' HA ' ' A' ' 61' ' ' PHE . 1.8 mp -64.69 -43.24 94.17 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.86 -41.6 29.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.503 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -55.38 -36.47 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.879 179.667 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.751 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 23.5 mt-30 -75.32 -58.86 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.033 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.472 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -76.6 9.17 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -177.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.581 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.8 t60 -79.01 -18.42 53.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.957 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.34 -77.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -160.1 144.57 10.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.306 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 5.4 Cg_exo -74.84 162.96 36.54 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.811 2.341 . . . . 0.0 112.04 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.48 -64.06 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.643 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.57 42.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.259 0.552 . . . . 0.0 111.867 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.59 -23.23 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.69 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.9 pt20 -60.86 -41.89 96.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 1.1 mt-30 -63.45 -39.68 95.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.76 0.314 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.751 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 56.0 mtt-85 -68.24 -43.56 77.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.986 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -62.98 -47.96 80.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -58.45 -31.28 67.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.332 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.0 mm100 -63.77 -65.43 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' HB1' ' A' ' 177' ' ' ALA . 4.8 p -54.93 -36.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.3 m -65.81 -46.62 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.821 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.657 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.1 -37.73 86.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.163 0.506 . . . . 0.0 109.862 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 4.9 mt-10 -68.55 -25.92 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.557 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 1.8 mp -78.96 -38.31 37.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.549 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -84.9 -6.54 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.386 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mt-30 -47.06 -43.16 19.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.309 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.16 56.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.529 -1.32 . . . . 0.0 113.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.512 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 158.43 57.66 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.643 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.675 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 19.1 Cg_endo -78.77 42.18 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.127 1.885 . . . . 0.0 111.54 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 4.1 t-20 -66.48 161.31 23.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.508 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.5 m95 -55.44 -27.17 46.36 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.53 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HD3' ' HG2' ' A' ' 171' ' ' ARG . 2.3 tpt180 -86.61 -22.96 25.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.754 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -31.45 63.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 109.945 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.2 t -62.55 -50.3 80.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.307 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.44 -32.49 73.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.754 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.6 m-85 -55.01 -53.89 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.267 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.8 m-85 -78.55 -37.58 42.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.24 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.16 -37.67 74.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.349 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.1 -51.19 68.77 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.91 -39.19 33.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.055 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.26 -42.57 86.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.122 0.461 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.91 -43.78 64.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.774 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.3 -48.18 77.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.614 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.811 ' HB3' HD21 ' A' ' 22' ' ' LEU . 54.7 m -61.08 -43.34 99.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.678 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.64 -36.92 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 111.114 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.659 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 3.5 tt0 -81.35 -25.08 36.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -79.03 -28.95 43.31 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.051 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 107' ' ' CYS . 59.7 t -70.4 -36.39 66.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.659 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.4 p30 -84.35 0.83 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -124.89 -170.78 2.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.226 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -89.52 55.35 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.37 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.472 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.32 36.87 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.066 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.9 mp0 -56.13 -53.79 59.73 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.21 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.43 -26.96 83.94 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.05 1.833 . . . . 0.0 112.614 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.801 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.4 mp -70.64 -25.82 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.62 -52.74 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.67 87.87 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.728 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 6.5 mm100 -62.61 -53.97 46.66 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.504 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 92.7 t -56.46 -37.12 49.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.941 0.401 . . . . 0.0 110.166 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -61.84 -47.45 84.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.807 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.833 ' HA ' HG12 ' A' ' 127' ' ' VAL . 9.7 pt-20 -74.81 -35.63 62.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.035 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.69 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.4 m0 -57.55 -37.55 73.28 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 27.6 ttm -74.9 -53.35 9.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.601 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.833 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -61.93 -33.31 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.51 -48.41 55.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.207 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.4 t80 -57.81 -37.96 74.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.28 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.938 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.91 -53.34 13.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.086 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.33 -29.29 69.79 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 m -84.62 -37.15 21.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -126.08 -43.39 1.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.938 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.6 mm? -59.67 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.081 0.401 . . . . 0.0 111.678 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.47 -36.62 55.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 123.237 0.336 . . . . 0.0 111.199 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -63.13 -52.63 61.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 63.1 t90 -57.78 -48.27 80.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.247 0.546 . . . . 0.0 109.545 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.556 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.6 mt -57.77 -46.64 86.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.322 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -65.83 -31.12 71.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.695 0.283 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -85.29 -24.84 27.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -56.37 4.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.17 -10.05 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.43 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.69 167.18 40.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.958 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.517 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 97.6 m95 -60.9 -26.46 67.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.25 -32.53 73.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.756 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -40.68 93.73 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.409 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 11.0 t80 -65.84 -36.58 83.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.405 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.872 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -64.32 -31.52 72.76 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.192 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.65 -19.01 31.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.357 0.599 . . . . 0.0 110.105 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 163' ' ' ARG . 9.1 mt -79.92 -40.65 27.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.146 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 1.6 m-85 -125.53 28.95 6.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -118.86 -146.7 8.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.668 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -32.77 61.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -91.76 40.31 2.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.106 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.13 77.17 8.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -62.37 162.02 10.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.857 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.88 -31.3 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' HD12 ' A' ' 156' ' ' LEU . 17.9 mt-10 -72.15 -42.37 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -66.14 -39.59 89.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.54 -52.07 66.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -71.11 -21.73 62.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -75.27 -48.52 22.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.451 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -65.32 -43.61 90.46 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.66 -42.81 90.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.456 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.19 -28.93 72.29 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.473 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 m-20 -66.53 -56.07 12.54 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.252 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.698 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 13.6 p-90 -63.04 -26.12 68.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.016 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.023 0.44 . . . . 0.0 110.325 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.6 m -87.13 -32.2 20.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.698 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 19.0 m -88.66 -33.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG2' ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -73.85 -29.74 62.29 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.656 -0.653 . . . . 0.0 110.541 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.605 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 1.8 m -85.33 -33.87 21.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.673 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.653 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.7 p -65.89 -31.29 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.653 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -110.66 33.12 4.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.087 0.47 . . . . 0.0 110.395 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 172' ' ' THR . 8.4 m -67.68 -32.82 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.124 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.83 50.31 3.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.085 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.449 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -118.01 13.24 13.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.844 HG11 HH21 ' A' ' 59' ' ' ARG . 2.1 t -83.34 61.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.573 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.93 56.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.391 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt . . . . . 0 C--N 1.324 -0.54 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo . . . . . 0 C--O 1.232 0.216 0 CA-C-O 121.081 0.367 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -170.89 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.917 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -37.15 68.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.819 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.05 -35.71 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.722 0.296 . . . . 0.0 110.563 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.2 -36.47 58.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.695 ' HB2' HD13 ' A' ' 42' ' ' LEU . 8.0 tp -70.3 -41.78 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.987 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.27 -34.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.08 -20.84 60.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.453 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -64.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 3.9 t80 -56.21 -52.66 63.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.38 -37.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.227 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.22 -52.59 48.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.253 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.691 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -62.29 -44.58 96.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 2.7 mmtt -62.36 -41.46 98.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -73.28 -43.86 60.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -57.56 -33.85 68.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.558 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 24' ' ' GLN . 1.1 pt20 -86.61 -8.61 57.34 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -121.19 -58.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.92 -48.24 0.5 Allowed Glycine 0 C--O 1.23 -0.149 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.854 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 2.4 t80 -81.44 49.44 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.21 0.528 . . . . 0.0 110.963 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.44 -27.55 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -42.6 72.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 58.98 3.8 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.029 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -62.1 115.64 4.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.476 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 179.55 -53.88 0.09 OUTLIER Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.356 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 32.7 Cg_exo -60.55 -50.19 7.35 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.836 1.69 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.06 30.29 5.18 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.438 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -65.69 -38.59 89.66 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.067 0.434 . . . . 0.0 110.981 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . -110.69 132.96 11.27 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.9 Cg_endo -89.31 -143.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.505 2.137 . . . . 0.0 113.785 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -67.42 106.92 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.022 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.59 -33.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 0.0 111.406 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.2 m-20 -79.2 163.49 59.47 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.373 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 29.6 Cg_endo -77.83 48.7 2.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.378 2.718 . . . . 0.0 111.549 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.998 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.3 m170 -62.29 -58.21 8.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.85 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.682 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.97 -28.18 66.07 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.349 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.08 -55.03 11.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.77 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.617 ' HE2' HD11 ' A' ' 13' ' ' LEU . 2.7 tpp -67.4 -36.7 81.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.807 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 3.8 ttp180 -61.92 -37.57 85.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.891 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.6 23.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.793 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.26 -53.74 54.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.84 -48.51 44.48 Favored Glycine 0 C--O 1.215 -1.08 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.25 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.13 -49.6 75.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.87 -44.08 97.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.06 -33.42 65.65 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.986 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.47 -26.65 68.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.0 109.267 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 m -88.61 -25.61 22.35 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.556 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -99.83 -55.25 2.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 111.952 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.57 73.43 10.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.92 0.488 . . . . 0.0 110.567 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 58' ' ' ARG . 3.1 mpt_? -73.82 -18.49 60.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.011 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -79.35 58.55 2.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.45 . . . . 0.0 111.259 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.07 -48.95 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.056 ' HA ' HD22 ' A' ' 64' ' ' LEU . 86.0 m-85 -64.17 -28.28 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.197 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -34.29 76.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -74.54 -18.47 60.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.964 0.411 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.056 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -73.01 -39.05 66.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.16 -48.02 25.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.28 -43.64 61.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.902 179.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.655 HE22 HD11 ' A' ' 106' ' ' LEU . 24.8 mt-30 -69.54 -58.12 4.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.702 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.7 OUTLIER -82.02 16.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -78.17 -33.78 50.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 71' ' ' THR . 2.2 p -92.26 -67.9 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.342 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.669 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -163.43 154.95 14.68 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.36 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.935 2.423 . . . . 0.0 112.108 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.25 -78.73 1.89 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.41 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.94 47.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.357 0.599 . . . . 0.0 112.209 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.29 -18.21 22.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.262 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.8 pt20 -61.86 -38.35 87.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.6 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.474 ' H ' ' HG2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -66.7 -40.44 88.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.533 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 180' ' ' LEU . 17.5 mtt180 -67.22 -45.8 75.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.0 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.17 -49.76 76.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.853 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 p -57.6 -34.56 69.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -60.55 -57.74 11.44 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 ' HG ' ' A' ' 180' ' ' LEU . 31.3 t -58.65 -38.44 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.877 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -65.73 -46.08 80.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.48 -36.82 81.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.789 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 24.8 mt-10 -72.98 -23.57 60.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.395 . . . . 0.0 110.582 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -81.74 -37.69 26.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.659 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -83.93 -8.23 59.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.574 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -42.01 14.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.095 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.19 48.38 0.13 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.723 -1.227 . . . . 0.0 113.13 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.451 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.12 53.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.442 -1.361 . . . . 0.0 114.747 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.2 Cg_endo -80.09 41.36 1.11 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.12 1.88 . . . . 0.0 111.441 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.776 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.34 163.95 23.97 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.618 -178.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.584 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.5 m95 -54.2 -29.05 44.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.61 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.22 -37.74 95.37 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -87.68 -24.89 23.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.703 178.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -54.96 -31.52 60.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.7 t -62.89 -52.95 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.472 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.18 72.27 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.331 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.2 m-85 -56.55 -54.6 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.037 0.446 . . . . 0.0 110.231 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.472 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 15.3 m-85 -74.94 -39.48 61.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.002 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.39 -36.76 75.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.254 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -53.18 -59.77 4.13 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.821 0.343 . . . . 0.0 111.562 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.57 -38.67 78.89 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.28 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.8 94.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.192 0.496 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.33 -41.24 73.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.747 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.42 -47.37 84.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.403 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.674 ' HB3' HD21 ' A' ' 22' ' ' LEU . 60.6 m -65.18 -45.39 85.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.206 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.05 70.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.772 0.32 . . . . 0.0 111.601 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.6 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -85.05 -8.77 58.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.683 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -89.92 -29.03 18.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.791 0.329 . . . . 0.0 110.16 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' CYS . 51.9 t -68.65 -32.42 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.6 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 14.5 p30 -85.32 0.96 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 0.0 111.151 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -125.72 -170.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.395 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.21 53.24 2.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.029 0.443 . . . . 0.0 110.633 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.439 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.16 46.44 2.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.408 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.73 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 15.5 mp0 -64.17 -56.19 25.8 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.424 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.1 Cg_exo -64.31 -26.52 63.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.051 1.834 . . . . 0.0 112.614 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 12.4 tp -66.4 -29.11 69.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.3 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.24 -52.54 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.284 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.42 -32.27 83.59 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.296 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 19.1 mm100 -65.95 -52.33 50.71 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.492 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 48.6 t -58.28 -35.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.009 0.433 . . . . 0.0 109.91 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.19 -47.02 86.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.26 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.688 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.0 pt-20 -72.69 -39.63 66.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.934 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 38.9 m0 -55.75 -37.81 68.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.3 ttm -74.11 -53.67 9.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.638 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.6 p -62.81 -34.07 63.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.62 -46.3 66.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 10.0 t80 -61.51 -35.1 76.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.582 0.706 . . . . 0.0 110.123 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.006 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.93 -56.6 5.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.132 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.84 -31.76 72.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.8 m -82.9 -36.86 24.96 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.86 -42.5 1.9 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.006 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -60.85 -46.31 91.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.371 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.21 54.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.444 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.08 -54.95 22.14 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.776 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.7 t90 -56.66 -48.3 77.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.527 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -57.36 -47.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.569 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.27 -30.11 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -89.09 -9.02 52.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.52 -57.07 2.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.0 111.609 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.97 -13.3 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.6 168.4 39.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.117 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.468 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.9 m95 -61.75 -29.47 70.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.43 80.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.14 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -63.6 -47.49 81.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 109.55 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.525 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 15.7 t80 -63.27 -38.25 90.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.078 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.736 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 7.5 m -65.98 -27.24 68.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 111.282 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.73 -34.92 27.08 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.655 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -66.15 -39.95 90.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.615 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -116.47 20.39 14.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -107.13 -140.33 9.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.444 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.21 -34.67 23.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.16 42.23 2.98 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.022 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.23 68.19 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.985 0.422 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.575 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.89 173.23 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.272 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -49.84 -39.3 38.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mm-40 -63.56 -52.3 61.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.38 -38.78 88.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -59.65 -57.1 14.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -67.8 -29.24 68.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.684 0.278 . . . . 0.0 111.581 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 4.3 tp -69.02 -46.68 67.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.47 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.8 ptt180 -68.87 -37.2 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.357 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.575 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 3.9 mt-10 -70.67 -43.2 69.58 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.141 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.7 -14.17 72.37 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.3 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 15.4 t-20 -73.25 -65.46 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.017 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.61 ' HE3' ' HD3' ' A' ' 171' ' ' ARG . 48.0 p-90 -61.54 -24.7 66.81 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.576 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.35 -64.11 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.116 0.26 . . . . 0.0 110.734 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -21.46 25.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 2.1 t -81.01 -36.32 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HD3' ' HE3' ' A' ' 167' ' ' TRP . 0.9 OUTLIER -82.87 -13.35 56.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.516 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.907 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.1 p -88.49 -31.62 18.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.76 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.749 HG13 ' HG ' ' A' ' 174' ' ' LEU . 5.7 p -67.07 -24.51 32.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.476 0.655 . . . . 0.0 110.136 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.749 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.81 42.91 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.231 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.907 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.6 OUTLIER -69.28 -43.23 74.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.912 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.62 27.19 1.89 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -89.69 2.07 55.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.225 0.513 . . . . 0.0 111.046 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . 0.443 HG12 ' OD2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -80.02 68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.925 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.03 9.65 32.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.785 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.54 ' HG ' HG21 ' A' ' 82' ' ' VAL . 12.4 mt . . . . . 0 C--N 1.326 -0.432 0 CA-C-O 120.914 0.388 . . . . 0.0 110.509 179.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 7.9 Cg_exo . . . . . 0 CA--C 1.53 0.321 0 CA-C-O 121.285 0.452 . . . . 0.0 112.453 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.11 -164.48 1.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.617 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -37.93 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.204 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -62.1 -35.4 78.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.93 -36.13 49.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.0 109.886 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.4 tp -70.44 -43.28 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.657 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -65.87 -35.35 74.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.23 -22.59 61.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.7 -64.24 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.569 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.8 t80 -54.95 -52.71 62.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.829 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . 46.5 t -72.29 -40.0 64.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.32 -54.3 37.39 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.847 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.768 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 48.9 t80 -62.8 -39.69 95.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 0.186 . . . . 0.0 111.271 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.46 -42.99 98.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.645 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -70.42 -44.79 67.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.618 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.825 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -62.47 -20.69 64.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.058 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.641 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.93 -35.38 26.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.47 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.641 ' HD3' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -151.08 76.25 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.96 0.409 . . . . 0.0 112.025 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.67 -70.43 0.3 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.123 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -90.26 56.43 3.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.389 0.614 . . . . 0.0 109.537 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.21 -34.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.757 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -41.65 72.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.386 0.612 . . . . 0.0 109.605 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.45 56.71 4.9 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.913 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.825 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.83 120.99 13.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 172.31 -58.36 0.16 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.173 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.517 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.4 Cg_exo -60.35 -48.45 11.6 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.785 1.657 . . . . 0.0 111.014 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.768 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.91 40.04 2.71 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.898 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.473 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 10.1 pt-20 -93.76 -8.09 41.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.77 164.49 12.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.724 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -99.31 -164.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.606 2.871 . . . . 0.0 113.191 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -89.01 73.11 8.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.931 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.11 34.01 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.099 0.476 . . . . 0.0 111.589 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.518 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 5.4 m-20 -130.11 161.1 62.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.408 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 6.8 Cg_exo -70.76 28.77 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.912 3.075 . . . . 0.0 113.055 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -166.78 -23.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.0 m170 -55.52 -64.78 0.74 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -58.4 -23.9 58.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.536 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.37 -46.5 40.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 15.2 ttm -72.25 -39.78 68.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.819 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -60.81 -36.14 78.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.569 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -31.34 42.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 109.98 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -65.19 -56.7 11.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.62 -48.47 42.95 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.61 -46.45 80.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.479 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -46.23 91.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.838 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.61 -31.78 65.43 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.871 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.86 -24.9 67.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.651 0.738 . . . . 0.0 109.211 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -89.38 -36.54 15.43 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.913 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -84.44 -64.43 1.16 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.93 72.01 8.98 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.843 0.857 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -82.8 -0.03 45.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.04 23.82 4.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.245 -0.284 . . . . 0.0 111.361 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.53 -1.24 30.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.758 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.4 m-85 -92.6 -19.77 21.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.63 80.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.755 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 3.2 m-20 -62.76 -22.86 66.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.102 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.758 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -68.69 -39.62 80.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -79.56 -44.72 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.141 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.3 -42.66 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.386 179.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.634 HE22 HD11 ' A' ' 106' ' ' LEU . 27.2 mt-30 -73.16 -53.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -83.26 14.74 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 82.6 t60 -77.98 -32.64 51.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.266 0.555 . . . . 0.0 109.631 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -73.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.195 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.35 153.74 16.91 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.512 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -86.64 -167.27 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.199 2.599 . . . . 0.0 111.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.78 -63.41 4.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.998 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.99 24.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.088 0.471 . . . . 0.0 111.85 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -80.23 -23.32 40.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.622 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.599 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 1.8 pt20 -62.01 -43.42 98.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.618 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -62.15 -42.43 99.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -63.23 -44.98 93.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.88 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.84 -50.78 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.496 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 p -56.1 -33.68 65.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.419 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.442 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.3 mm100 -60.27 -66.58 0.5 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.0 m -56.52 -32.73 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.681 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.1 m -65.85 -43.82 87.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.353 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.57 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.8 -37.02 73.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 109.694 179.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -29.05 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.884 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -80.84 -31.79 35.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.309 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 91' ' ' PRO . 37.3 t80 -93.27 1.89 56.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -24.99 36.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.256 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 60.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.344 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.25 59.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.607 -1.282 . . . . 0.0 114.648 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -82.78 39.06 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.275 1.983 . . . . 0.0 111.642 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.833 ' HB2' HG11 ' A' ' 170' ' ' VAL . 3.3 t-20 -66.86 164.36 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.606 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -54.49 -27.15 35.84 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.235 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.34 -38.62 95.2 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.649 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.7 mmp_? -87.53 -26.61 23.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.974 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.61 -31.57 57.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.421 0.629 . . . . 0.0 109.969 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 49' ' ' ALA . 22.0 t -62.09 -55.87 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.82 -29.22 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.47 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.816 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -55.79 -54.65 41.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.095 0.474 . . . . 0.0 110.191 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.657 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.5 m-85 -77.83 -35.54 51.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -60.73 -39.86 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.4 m-85 -55.11 -51.11 67.43 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.23 -38.77 38.53 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.138 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.33 99.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.131 0.465 . . . . 0.0 110.927 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -37.91 74.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.634 HD11 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.29 -44.48 97.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.156 179.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 94.8 m -63.92 -45.79 87.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.284 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.96 64.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.726 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -77.34 -12.25 59.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.806 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -88.53 -24.96 22.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.941 0.401 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 107' ' ' CYS . 57.4 t -75.64 -35.77 32.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.622 HD21 ' HA ' ' A' ' 109' ' ' GLU . 22.8 p30 -81.44 0.56 37.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.408 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.48 -167.51 1.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -91.27 62.66 4.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.471 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.577 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.66 37.75 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.946 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.3 mp0 -55.84 -55.86 36.47 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.307 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.7 Cg_exo -65.02 -18.55 62.37 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.082 1.855 . . . . 0.0 112.341 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.2 mm? -74.77 -35.22 62.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 107' ' ' CYS . 90.3 t -54.91 -57.72 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.491 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.51 79.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.965 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 5.5 mm-40 -66.35 -49.78 65.75 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 118' ' ' LEU . 59.8 t -57.35 -36.12 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.24 -45.61 92.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.4 pt-20 -76.2 -36.86 58.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.114 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.599 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 39.4 m0 -56.69 -38.62 72.51 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.6 ttm -72.85 -54.94 7.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.685 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.5 p -60.97 -32.49 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.9 -50.41 56.38 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.306 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 13.3 t80 -58.74 -35.21 72.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.642 0.734 . . . . 0.0 110.284 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.038 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.93 -48.5 30.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.956 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.04 -42.22 84.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 m -80.78 -40.57 24.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -42.1 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -63.2 -46.71 85.77 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.418 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.85 55.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.613 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.66 -53.06 30.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.571 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.806 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 55.6 t90 -55.3 -47.51 75.46 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.263 0.554 . . . . 0.0 109.567 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.6 HG13 ' HE3' ' A' ' 137' ' ' TRP . 4.3 mt -57.85 -49.17 81.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.402 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -60.62 -39.69 89.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m -78.0 -26.89 48.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -56.04 5.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.28 -15.75 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.655 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.32 170.85 41.1 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.183 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.82 -26.09 67.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.24 -33.91 77.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.449 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -66.74 -38.71 87.18 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.5 t80 -65.79 -38.88 90.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.659 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.73 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -67.46 -27.69 67.24 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.8 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.96 -18.06 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.094 0.474 . . . . 0.0 110.349 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -75.78 -49.42 18.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.673 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.45 31.51 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -93.3 -113.85 2.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.359 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.43 -62.94 1.43 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.14 0.495 . . . . 0.0 109.691 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.7 64.11 4.34 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.348 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.74 74.99 7.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.54 153.81 22.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.153 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.661 ' HA ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -57.99 -27.36 63.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.753 -179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.679 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.2 mm-40 -73.83 -32.43 63.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -78.33 -41.56 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -66.61 -37.89 85.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.579 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 158' ' ' GLU . 9.8 ptp85 -72.65 -29.11 63.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.088 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -38.3 81.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.716 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.665 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.3 ttp180 -65.89 -41.9 90.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.585 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -61.62 -48.25 81.76 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.346 0.404 . . . . 0.0 110.295 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.13 -28.52 73.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.408 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.06 -58.66 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.253 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.657 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.2 p-90 -62.08 -27.42 68.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.416 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.17 76.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.446 . . . . 0.0 110.344 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.21 -28.73 20.98 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.833 HG11 ' HB2' ' A' ' 92' ' ' ASN . 8.1 m -95.3 -36.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.604 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -81.34 -15.71 54.54 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.46 -0.775 . . . . 0.0 111.138 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 m -96.08 -17.04 21.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.156 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 1.012 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -81.2 -26.5 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.529 0.68 . . . . 0.0 109.521 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 1.012 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -120.88 39.54 3.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.692 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -30.49 71.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.15 1.93 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.541 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -99.42 6.54 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.56 60.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.99 -11.14 60.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.277 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.848 179.953 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_exo . . . . . 0 C--O 1.231 0.148 0 CA-C-O 121.049 0.354 . . . . 0.0 111.704 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -163.32 0.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.652 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.53 -38.59 69.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.959 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -63.12 -35.47 80.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.294 . . . . 0.0 110.729 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.99 60.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.208 0.528 . . . . 0.0 109.756 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -71.91 -42.73 66.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.056 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.4 p -65.11 -36.0 76.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.131 0.491 . . . . 0.0 109.703 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.25 -21.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.375 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 -63.95 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.903 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.505 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.45 -54.04 46.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.51 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.0 t -67.75 -39.55 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -59.47 -54.71 35.5 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.246 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.677 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 34.5 t80 -61.86 -43.21 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.563 0.345 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 12.7 mmtt -61.13 -40.27 93.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -79.16 -46.65 17.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.078 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 39.6 ttp85 -63.75 -17.25 62.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.397 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -85.02 -24.05 28.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.971 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -160.1 76.14 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.81 -68.78 0.37 Allowed Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.271 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.59 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 2.0 t80 -84.85 52.08 2.32 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.008 0.523 . . . . 0.0 109.785 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.63 -40.05 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.59 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -40.42 96.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.409 0.623 . . . . 0.0 109.626 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.25 52.06 4.04 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.043 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.69 124.49 22.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 35' ' ' GLU . . . 176.92 -54.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.603 -1.284 . . . . 0.0 113.637 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 13.0 Cg_exo -72.26 -49.88 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.406 2.071 . . . . 0.0 112.284 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -86.04 28.12 5.22 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.774 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' CA ' ' A' ' 32' ' ' GLY . 3.1 mt-10 -88.04 -26.22 22.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.387 0.613 . . . . 0.0 110.241 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.3 147.86 23.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.301 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -94.79 -155.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.062 2.508 . . . . 0.0 112.833 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.628 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -88.82 85.94 6.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.524 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.29 21.93 5.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 110.333 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.5 m-20 -125.58 159.35 61.1 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.29 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.425 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 61.2 Cg_endo -81.32 47.2 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 111.576 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -177.94 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.515 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -57.25 -62.11 2.0 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.735 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.628 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 44.4 tt0 -55.8 -30.84 62.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.56 -51.49 28.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.999 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.1 ttm -67.9 -41.83 82.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -61.77 -35.18 77.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.89 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.46 -41.31 27.84 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.614 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.791 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.49 -54.25 48.74 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.72 -47.24 58.76 Favored Glycine 0 C--O 1.219 -0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.441 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.43 -46.83 87.63 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE2' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -62.95 -45.2 93.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.743 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.858 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -72.57 -33.0 66.46 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.143 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.87 -26.7 68.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 109.706 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -87.43 -29.21 21.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.479 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 6.5 mtp180 -91.68 -46.34 7.97 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.69 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.16 86.68 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.19 0.596 . . . . 0.0 110.207 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -68.52 -23.45 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -86.06 65.97 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.72 -38.12 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.507 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HA ' HD22 ' A' ' 64' ' ' LEU . 42.1 m-85 -91.15 -3.4 57.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 -47.47 55.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.313 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -59.84 -32.11 70.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.469 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 4.8 mp -56.84 -44.89 82.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.589 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -80.46 -42.2 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . 0.426 ' O ' ' HD2' ' A' ' 69' ' ' HIS . . . -50.6 -41.82 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.683 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.8 mt-30 -79.31 -53.47 6.91 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -82.37 13.1 3.79 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.658 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.6 -25.87 41.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.458 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -71.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.04 151.66 16.52 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.387 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.79 -177.52 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.065 2.51 . . . . 0.0 111.599 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.721 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.27 -71.5 2.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.972 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 45.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.226 0.536 . . . . 0.0 112.026 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.17 -21.1 16.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.682 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -63.77 -40.25 96.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.795 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 18.2 mp0 -63.79 -44.4 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.176 0.297 . . . . 0.0 111.104 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 42.8 mtt180 -65.52 -38.21 89.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.04 0.448 . . . . 0.0 110.033 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t80 -66.17 -51.25 59.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.421 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -56.66 -35.39 68.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 38.4 mm-40 -59.88 -54.66 43.56 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 180' ' ' LEU . 9.9 m -66.89 -32.15 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.097 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 m -66.2 -46.8 76.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.755 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -67.2 -35.62 79.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 110.323 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.49 -27.03 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.259 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -28.15 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.694 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -95.24 -6.4 41.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.07 -50.18 6.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.429 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.56 66.35 0.22 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.4 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.471 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 150.48 62.05 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.677 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.5 Cg_endo -81.74 41.66 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.49 2.127 . . . . 0.0 111.582 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.792 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.2 t-20 -66.71 164.3 17.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.453 ' O ' HG23 ' A' ' 97' ' ' VAL . 20.4 m95 -53.88 -29.15 40.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -64.84 -36.05 92.64 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.721 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.3 mmp_? -87.23 -27.18 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.447 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -55.93 -30.55 61.83 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.941 179.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 53' ' ' PHE . 18.0 t -63.84 -55.04 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.525 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.22 -29.74 70.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.927 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 7.8 m-85 -57.01 -59.87 4.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.094 0.474 . . . . 0.0 110.354 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.579 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -72.88 -37.91 67.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.348 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.16 -38.76 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.303 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -59.27 -46.17 89.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.379 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.97 -40.32 17.3 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.064 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.92 96.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.37 80.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.838 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -57.99 -45.45 86.77 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.645 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.689 ' HB3' HD21 ' A' ' 22' ' ' LEU . 88.6 m -59.55 -41.73 90.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.74 76.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.968 0.413 . . . . 0.0 110.825 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.585 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -78.27 -24.25 46.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.767 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -24.62 41.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.953 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 107' ' ' CYS . 50.6 t -72.07 -37.57 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.976 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.585 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.7 p30 -85.78 -0.06 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.335 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -123.66 -173.53 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.903 0.382 . . . . 0.0 110.935 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.8 53.31 2.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.81 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.518 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.23 48.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.484 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -60.24 -54.99 49.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.52 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 16.9 Cg_exo -68.71 -12.81 35.6 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.147 1.898 . . . . 0.0 112.96 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.721 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -78.77 -27.97 44.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.183 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.56 -57.44 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 111.365 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.21 -29.65 71.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.265 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.4 mm-40 -67.68 -52.67 35.13 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 118' ' ' LEU . 63.8 t -56.34 -34.57 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -62.62 -47.89 81.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.342 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.667 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.3 pt-20 -74.48 -37.49 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.84 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.682 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.5 m0 -54.68 -36.75 64.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 1.6 mtm -73.95 -57.57 3.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.518 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.5 p -60.36 -32.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.25 -47.35 57.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.038 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.7 t80 -59.72 -37.21 78.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.708 0.765 . . . . 0.0 110.161 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.004 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.89 -52.74 15.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.85 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -58.73 -35.2 72.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.789 0.328 . . . . 0.0 111.784 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.5 m -79.54 -43.25 23.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -123.64 -38.13 2.56 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.004 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -64.04 -49.1 73.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.358 0.526 . . . . 0.0 111.571 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.28 -33.32 52.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.111 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.31 -56.26 17.95 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.792 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.6 t90 -56.59 -46.59 80.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.126 0.488 . . . . 0.0 109.863 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.566 HG13 ' HE3' ' A' ' 137' ' ' TRP . 15.1 mt -58.88 -47.02 90.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.251 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -68.06 -31.66 71.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.64 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.2 m -90.14 -4.83 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.68 -51.67 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.62 -10.66 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.475 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.84 166.55 42.66 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.101 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.444 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.5 m95 -60.93 -27.79 68.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.18 86.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.814 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.76 -41.83 99.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.58 -34.68 78.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.517 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -67.04 -28.15 67.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.53 -27.41 25.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.376 0.608 . . . . 0.0 109.811 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 163' ' ' ARG . 2.2 mt -74.24 -38.68 63.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.353 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 6.2 m-85 -122.29 26.67 8.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -117.9 -141.3 6.75 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.914 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -41.79 36.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.299 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.48 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.49 41.55 2.94 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.479 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.24 72.85 10.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 110.268 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.568 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -66.83 170.09 7.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.006 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 5.6 mm-40 -52.97 -37.93 61.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.746 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 3.9 mp0 -63.64 -47.63 80.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.437 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -65.34 -37.05 85.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.71 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 77.5 mtt180 -58.18 -58.53 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 3.6 ptt180 -67.4 -28.77 68.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -67.22 -49.77 63.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.489 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.662 ' HB3' HD22 ' A' ' 150' ' ' LEU . 0.9 OUTLIER -64.79 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.142 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 5.5 mt-10 -69.08 -47.01 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.632 0.253 . . . . 0.0 110.442 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.84 -24.51 72.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.169 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.04 -60.86 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.697 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.3 p-90 -61.72 -26.32 67.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.742 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.94 93.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.241 0.543 . . . . 0.0 110.228 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 m -86.87 -24.44 24.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.834 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 92' ' ' ASN . 5.3 m -97.07 -38.93 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -73.83 -26.18 60.46 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.625 -0.672 . . . . 0.0 111.396 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -86.28 -25.71 25.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.43 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.765 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -73.7 -22.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.367 0.604 . . . . 0.0 109.763 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.765 ' HG ' HG13 ' A' ' 173' ' ' VAL . 2.9 mt -120.33 40.42 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.178 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -62.77 -22.27 66.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.806 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.36 9.46 61.33 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.714 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.59 28.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.875 0.338 . . . . 0.0 111.744 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.11 69.8 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 82' ' ' VAL . . . -81.1 -9.41 59.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.055 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.832 HD22 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.416 0 CA-C-O 121.0 0.429 . . . . 0.0 111.319 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo . . . . . 0 N--CA 1.462 -0.36 0 CA-C-O 121.123 0.384 . . . . 0.0 111.739 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.33 -173.95 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.57 -33.83 66.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -66.36 -33.37 75.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.393 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.83 -47.47 18.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 46' ' ' MET . 1.2 tp -59.4 -41.26 89.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.682 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -65.64 -42.55 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.284 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.07 -29.73 67.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.987 0.422 . . . . 0.0 110.379 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.38 -57.28 4.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.101 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.63 -52.32 65.91 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.509 ' O ' HD13 ' A' ' 22' ' ' LEU . 60.6 t -63.49 -42.68 97.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.2 -46.12 94.81 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.013 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.782 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 63.5 t80 -64.38 -42.43 96.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.979 0.419 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.27 -41.34 94.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.542 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.1 mp -71.7 -43.49 65.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.773 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.685 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -62.99 -20.04 64.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.113 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -78.93 -42.42 27.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.927 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -153.95 79.93 1.13 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.964 0.411 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.25 -65.79 0.32 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.88 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.421 ' HD1' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.35 60.3 1.16 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.296 0.57 . . . . 0.0 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.6 -24.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.633 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -40.97 60.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.608 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 59.83 4.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.357 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.685 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -69.96 116.01 9.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.474 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 173.71 -57.7 0.14 Allowed Glycine 0 C--O 1.226 -0.405 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.501 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 52.0 Cg_exo -57.46 -46.04 30.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.337 2.024 . . . . 0.0 111.698 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.79 31.13 7.52 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.574 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -80.97 -23.75 38.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 109.879 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.44 135.67 13.01 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.534 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 86.3 Cg_endo -89.31 -138.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.965 2.443 . . . . 0.0 113.121 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -96.75 94.33 7.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.0 21.67 2.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.943 0.402 . . . . 0.0 110.846 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 6.2 m-20 -132.83 159.73 71.42 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.761 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.4 Cg_endo -79.96 51.87 4.07 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 111.685 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 144' ' ' TRP . 0.2 OUTLIER 179.16 -33.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.058 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -58.95 -59.82 4.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.907 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.555 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 29.9 tt0 -58.21 -29.1 65.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.693 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.83 -51.44 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.308 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 13' ' ' LEU . 4.0 ttm -64.98 -36.58 84.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.524 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -38.26 87.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.688 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.9 31.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.76 0.314 . . . . 0.0 110.322 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.05 -57.39 13.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.369 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.64 -47.21 37.82 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.598 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.05 -48.94 79.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.016 0.408 . . . . 0.0 111.22 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -43.25 92.97 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.187 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.778 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.46 -38.6 68.2 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.624 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.88 -22.59 62.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.739 0.781 . . . . 0.0 109.725 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -94.91 -37.23 11.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.672 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -84.96 -26.36 27.21 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.453 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.83 98.78 11.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.161 0.505 . . . . 0.0 110.717 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -64.18 -34.09 77.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.662 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 93.61 4.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.125 0.488 . . . . 0.0 110.289 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.1 -59.16 1.81 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.477 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 1.019 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.7 m-85 -87.79 -10.51 50.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -41.4 88.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.948 0.404 . . . . 0.0 111.518 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.9 m-20 -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.076 0.465 . . . . 0.0 110.663 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 1.019 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -75.99 -40.04 54.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -73.7 -45.54 51.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.747 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.89 -43.84 63.5 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 179.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.579 HE22 HD11 ' A' ' 106' ' ' LEU . 27.6 mt-30 -68.79 -56.43 8.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -88.25 16.66 5.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.63 -24.82 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.025 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.68 -64.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.578 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.1 t -170.02 150.88 3.82 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 1.9 Cg_endo -81.83 -165.19 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.03 2.487 . . . . 0.0 112.083 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.24 -70.73 3.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.018 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.92 39.81 0.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.059 0.457 . . . . 0.0 112.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.59 -23.24 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.087 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.672 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.3 pt20 -62.81 -39.2 93.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -63.07 -44.63 95.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.747 0.308 . . . . 0.0 110.304 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -63.34 -43.39 97.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.984 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -62.77 -50.94 69.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.362 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.77 -33.1 66.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -62.1 -64.23 1.0 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.489 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.687 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.6 m -58.61 -32.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -66.02 -43.15 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.31 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.579 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -69.45 -36.36 76.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.244 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 3.2 mm-40 -70.33 -29.68 66.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.067 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -34.99 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -88.42 -5.51 58.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.655 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -45.62 -46.61 14.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.118 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.23 62.64 0.12 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.758 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.591 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 163.46 53.6 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.6 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 39.37 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.183 1.922 . . . . 0.0 111.555 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HB2' HG11 ' A' ' 170' ' ' VAL . 2.4 t-20 -67.04 162.9 21.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.401 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.486 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 23.1 m95 -55.98 -27.48 52.96 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.299 0.375 . . . . 0.0 111.177 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.31 92.41 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 95' ' ' ARG . 1.3 tpt180 -86.29 -26.63 24.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.291 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -30.17 61.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.309 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 t -62.89 -52.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.38 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.64 69.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.398 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.1 m-85 -57.75 -57.01 14.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.215 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.679 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 10.9 m-85 -74.97 -39.9 61.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.941 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.9 -38.85 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.441 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -57.15 -51.1 70.65 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.639 0.257 . . . . 0.0 111.211 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.21 -38.15 40.41 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.266 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.11 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.174 0.487 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.57 -38.91 81.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.769 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.09 -43.31 91.81 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.128 179.016 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.604 ' HB3' HD21 ' A' ' 22' ' ' LEU . 90.0 m -65.51 -42.92 91.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.74 77.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.3 OUTLIER -80.7 -9.54 59.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.81 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.2 m -91.16 -23.28 20.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.926 0.393 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 107' ' ' CYS . 71.9 t -74.44 -34.35 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.641 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 109' ' ' GLU . 24.1 p30 -85.3 0.81 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.302 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.85 -174.81 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -82.99 62.31 6.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 0.0 110.522 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.29 45.55 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.479 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.6 mt-10 -52.12 -59.38 8.51 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.609 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 7.4 Cg_exo -74.26 -22.09 16.95 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.134 1.889 . . . . 0.0 112.627 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 115' ' ' MET . 3.0 mm? -64.57 -37.47 87.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.302 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' MET . 90.4 t -57.22 -54.55 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.56 -32.37 83.98 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.95 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.574 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.6 mt-30 -65.59 -52.22 53.74 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 118' ' ' LEU . 82.8 t -56.16 -35.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.29 -47.34 82.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.365 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.76 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.2 pt-20 -72.58 -38.19 67.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.672 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.9 m0 -58.1 -40.58 81.52 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 6.2 ttm -73.22 -51.28 18.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.9 p -63.23 -34.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.35 -39.5 65.14 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 12.6 t80 -66.6 -34.53 78.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.647 0.736 . . . . 0.0 110.129 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.972 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.46 -53.0 8.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.828 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -31.6 71.55 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.6 m -85.46 -37.92 19.2 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -119.75 -43.66 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.972 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -61.49 -46.57 89.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.377 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.09 62.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.47 -50.3 70.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.693 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 51.9 t90 -59.28 -46.82 87.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.498 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.6 mt -57.34 -48.44 82.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.995 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -65.04 -32.06 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.2 m -82.43 -17.48 45.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.0 t -85.45 -54.74 4.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.845 0.355 . . . . 0.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -177.37 -19.31 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 100.41 170.93 29.35 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.425 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.1 m95 -59.41 -30.23 68.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.31 84.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -41.55 98.57 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.5 t80 -64.88 -38.23 90.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.485 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.932 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -63.1 -28.12 69.86 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.19 -26.75 26.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.668 . . . . 0.0 109.71 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -75.46 -39.88 58.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.45 28.11 7.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.972 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -119.2 -141.44 6.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.239 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.52 -40.0 44.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.862 0.363 . . . . 0.0 111.42 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.92 46.13 3.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.157 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.57 72.32 10.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 110.631 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -65.28 168.54 6.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.84 -34.77 63.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.67 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.1 mm-40 -73.17 -32.72 65.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 111.187 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -74.6 -42.83 57.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.911 0.386 . . . . 0.0 111.386 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -66.68 -39.54 88.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.219 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -72.01 -28.53 63.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.896 0.379 . . . . 0.0 110.581 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.68 -47.07 33.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.522 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.1 ptt180 -64.27 -37.57 87.96 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.7 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 2.4 tt0 -68.24 -45.81 72.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.93 0.395 . . . . 0.0 110.109 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.91 -25.82 75.05 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.552 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.9 m-20 -66.1 -58.86 4.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.656 0.265 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.71 -27.52 68.76 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.067 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -43.9 74.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -86.84 -33.61 19.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 92' ' ' ASN . 17.0 m -85.05 -26.14 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -79.07 -30.46 43.97 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.821 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -89.21 -27.98 20.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.448 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 174' ' ' LEU . 4.2 p -66.34 -27.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.161 0.505 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.24 44.35 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.0 110.242 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.821 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.42 -29.05 69.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.901 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.97 9.93 43.18 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.397 0.519 . . . . 0.0 114.397 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.33 11.12 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.134 0.467 . . . . 0.0 111.719 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.94 70.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.242 0.544 . . . . 0.0 110.372 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.19 13.55 32.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.087 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.687 ' HG ' HG11 ' A' ' 82' ' ' VAL . 18.4 mt . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.154 179.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo . . . . . 0 N--CA 1.462 -0.324 0 CA-C-O 121.131 0.388 . . . . 0.0 111.571 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.48 -168.35 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -38.27 60.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -62.35 -38.85 91.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.09 62.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.0 109.977 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.5 tp -72.32 -42.07 65.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.138 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.713 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.9 p -65.87 -36.0 76.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -23.66 60.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -65.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.02 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.1 t80 -53.41 -51.57 62.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.933 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -69.5 -43.67 80.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.42 -50.86 62.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.23 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.739 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 4.6 t80 -58.23 -49.66 76.3 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.976 0.51 . . . . 0.0 111.33 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.41 -35.98 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.546 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.0 mp -76.33 -48.36 20.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -63.92 -18.4 64.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -84.63 -14.25 49.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -146.26 -52.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.97 -68.77 1.22 Allowed Glycine 0 C--O 1.229 -0.167 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.741 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.1 t80 -82.61 53.15 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.529 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.94 -30.54 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -42.51 77.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.35 59.24 4.86 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.834 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.21 117.9 7.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.632 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 175.57 -49.38 0.12 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.725 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.52 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 21.1 Cg_exo -67.15 -50.0 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 121.894 1.729 . . . . 0.0 111.548 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.14 34.0 4.8 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.84 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 14.6 pt-20 -88.76 -13.48 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.44 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.98 144.27 17.54 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.847 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -92.87 -175.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.832 2.355 . . . . 0.0 113.137 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -82.49 80.95 8.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.065 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.39 -11.55 7.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.41 . . . . 0.0 111.949 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.1 m-20 -86.45 160.35 51.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 148' ' ' THR . 30.2 Cg_endo -77.96 50.12 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.263 2.642 . . . . 0.0 111.423 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.53 -31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.783 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -58.67 -61.28 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.765 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.94 -25.01 63.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.939 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.99 -50.23 17.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.61 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.49 ' HE1' HD21 ' A' ' 13' ' ' LEU . 6.3 ttm -67.15 -41.93 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -33.23 73.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.059 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.63 -40.05 26.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.284 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.81 -54.93 40.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . 0.433 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.46 -46.21 45.62 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.112 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.44 -56.16 24.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.122 0.486 . . . . 0.0 111.423 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -44.4 90.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.748 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -72.45 -34.84 68.06 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.611 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -62.9 -28.06 69.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.755 0.788 . . . . 0.0 109.556 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 m -83.47 -31.12 26.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.455 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -92.3 -45.23 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 87.38 7.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.149 0.579 . . . . 0.0 111.077 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -81.19 -15.47 55.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -90.38 61.47 5.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.116 0.484 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.55 -55.82 1.91 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.277 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.968 ' HA ' HD22 ' A' ' 64' ' ' LEU . 58.5 m-85 -66.16 -18.89 65.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.403 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -44.12 86.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.698 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -68.09 -26.89 66.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.96 -45.29 28.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.337 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.94 -43.08 63.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.653 HE22 HD11 ' A' ' 106' ' ' LEU . 23.8 mt-30 -69.75 -54.36 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.474 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.44 18.99 3.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 2.1 t-160 -78.46 -38.66 40.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 71' ' ' THR . 2.9 p -92.01 -63.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.155 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.587 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.6 149.19 10.66 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 122.371 -0.206 . . . . 0.0 110.742 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.32 -163.19 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.896 2.397 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 84.52 -72.77 2.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.897 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.45 47.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.719 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -94.66 -21.98 18.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.1 pt20 -62.11 -38.03 87.38 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.878 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.91 -39.06 90.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.701 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -68.5 -43.78 76.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -63.39 -50.2 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.756 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -57.69 -34.12 69.09 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -63.93 -61.09 2.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.908 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.2 m -58.57 -31.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.8 -43.95 82.52 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -68.93 -31.48 70.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 109.738 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.43 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 74.5 mt-10 -73.09 -31.24 64.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.35 -36.26 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.611 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -86.67 -8.02 57.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -42.54 -48.77 5.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.622 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.39 58.25 0.2 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.225 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.492 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 161.43 57.14 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.705 -1.235 . . . . 0.0 114.726 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.643 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.1 Cg_endo -79.43 44.94 1.81 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.085 1.856 . . . . 0.0 111.4 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.898 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -69.29 164.98 21.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.673 -178.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.0 m95 -56.22 -29.64 61.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.35 -37.3 94.31 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HG3' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -86.13 -26.53 25.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.63 179.058 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.37 -30.7 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.435 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.2 t -64.17 -54.57 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.504 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.24 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.237 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.685 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -57.54 -56.87 16.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.98 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 7.4 m-85 -75.85 -36.96 59.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.34 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.75 -36.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -56.75 -53.97 51.7 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 111.363 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -75.11 -36.89 44.56 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.362 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.93 99.73 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.254 0.527 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -40.91 73.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.8 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.71 -51.19 69.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.062 179.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 93.7 m -57.02 -47.06 81.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.619 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.24 -37.74 64.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.643 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.9 mt-10 -83.98 -25.37 30.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 1.4 p -79.07 -24.01 43.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' CYS . 89.5 t -71.16 -35.19 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.966 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.643 HD21 ' HA ' ' A' ' 109' ' ' GLU . 15.6 p30 -84.41 1.09 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.401 . . . . 0.0 110.765 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -119.67 -168.29 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.668 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.86 58.43 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.086 0.47 . . . . 0.0 110.562 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.434 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.91 47.01 2.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.392 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 6.9 mt-10 -57.33 -55.62 42.46 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.7 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.8 Cg_exo -63.17 -31.6 74.85 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.958 1.772 . . . . 0.0 112.584 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.6 mp -60.16 -34.33 73.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.79 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.2 -52.27 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 111.368 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.04 85.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.208 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.2 mm100 -67.0 -47.0 72.81 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.9 t -59.82 -35.55 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.27 -46.35 89.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.412 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.654 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 19.3 pt-20 -71.5 -40.47 70.16 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.824 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.4 m0 -57.3 -40.42 77.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.419 0.628 . . . . 0.0 109.371 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.404 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.6 ttp -71.07 -53.62 14.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.641 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 5.6 p -62.46 -38.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.54 -46.49 85.72 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 14.6 t80 -62.47 -33.42 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.479 0.657 . . . . 0.0 110.597 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.93 -58.76 3.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 6.2 pt-20 -64.95 -20.75 66.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -89.32 -32.05 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 -42.91 0.99 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.989 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.77 -47.38 85.93 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.268 -178.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 139' ' ' HIS . . . -51.93 -39.97 60.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.544 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.01 -47.12 87.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.744 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.781 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 56.5 t90 -60.47 -50.18 74.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.624 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.8 mt -57.11 -47.47 83.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.266 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . 0.401 ' HD2' ' O ' ' A' ' 135' ' ' ALA . 43.3 m-70 -62.97 -34.25 77.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -90.9 -9.85 44.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -91.35 -45.09 8.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.62 -15.09 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.55 165.78 39.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.397 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.4 m95 -60.53 -29.62 69.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.93 82.42 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.005 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.02 -41.85 98.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.43 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 17.9 t80 -67.93 -33.41 74.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.627 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.939 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -66.6 -26.54 67.15 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.055 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.89 -36.89 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.656 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -63.56 -41.15 98.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.004 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.417 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 2.4 m-85 -122.83 26.77 8.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.83 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -127.46 -138.55 4.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.493 -1.336 . . . . 0.0 114.043 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -62.46 1.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -0.721 . . . . 0.0 112.347 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -79.42 54.0 4.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.341 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.34 69.12 10.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.556 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.22 167.01 13.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.297 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -51.6 -35.83 43.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.371 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 4.2 mm-40 -65.48 -48.07 73.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.926 0.393 . . . . 0.0 110.308 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -62.8 -34.54 77.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.731 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -59.55 -57.2 14.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -70.4 -27.66 64.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 35.3 tp -66.69 -47.29 72.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.287 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.534 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -69.88 -33.15 71.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.297 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.436 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.29 -43.7 66.62 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.103 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.11 -26.37 74.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.722 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.548 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 7.2 t-20 -59.9 -61.03 2.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.265 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.763 ' HA ' HG12 ' A' ' 170' ' ' VAL . 32.4 p-90 -69.48 -22.82 63.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.84 -58.72 5.26 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.994 0.184 . . . . 0.0 110.745 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.6 m -88.93 -24.04 22.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -81.62 -28.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 95' ' ' ARG . 1.3 ttt180 -82.16 -22.34 36.13 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.847 -0.533 . . . . 0.0 109.614 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -83.61 -43.01 16.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.97 HG13 ' HG ' ' A' ' 174' ' ' LEU . 14.4 p -57.89 -37.0 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.12 0.486 . . . . 0.0 110.861 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.97 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -110.61 36.26 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.208 0.527 . . . . 0.0 110.16 178.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.9 t -77.66 -9.71 59.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 7.27 80.55 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.732 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.97 25.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.26 51.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.913 0.387 . . . . 0.0 110.514 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.81 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.908 ' HG ' HG11 ' A' ' 82' ' ' VAL . 15.8 mt . . . . . 0 C--N 1.324 -0.516 0 CA-C-O 120.816 0.341 . . . . 0.0 110.29 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_exo . . . . . 0 C--O 1.233 0.261 0 CA-C-O 120.806 0.252 . . . . 0.0 112.112 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.31 -176.58 5.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -32.19 67.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -68.23 -32.66 73.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.396 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.26 -43.59 32.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 42' ' ' LEU . 1.4 tp -62.01 -43.55 98.59 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 127' ' ' VAL . 4.4 p -66.14 -37.65 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.512 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.9 70.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 110.422 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -70.28 -52.55 22.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.045 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.7 t80 -58.1 -52.99 63.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.409 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.1 t -64.15 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.75 -51.81 56.8 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.745 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.732 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.9 t80 -61.98 -38.84 90.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.638 0.375 . . . . 0.0 110.926 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 7.4 mmtt -66.35 -43.56 85.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -75.94 -46.35 30.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -62.22 -21.19 64.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -85.74 -24.03 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.326 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.36 75.34 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 111.456 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.34 -74.62 0.26 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.645 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 2.0 t80 -85.74 58.14 4.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.957 0.408 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.39 -33.87 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.182 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.72 -14.15 61.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.182 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -109.8 40.27 2.61 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -60.27 130.48 46.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.93 -48.43 0.19 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.819 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.604 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 3.2 Cg_exo -84.11 -48.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -78.38 22.57 3.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.989 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -79.84 -26.75 40.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.72 0.76 . . . . 0.0 109.46 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.43 132.44 11.14 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.356 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 90.2 Cg_endo -89.05 -148.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.985 2.457 . . . . 0.0 113.275 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.89 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -86.33 97.79 10.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.7 -34.78 1.01 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.7 m-20 -78.97 160.43 71.4 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.686 0.279 . . . . 0.0 111.617 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.6 Cg_endo -74.43 51.75 2.65 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.525 2.816 . . . . 0.0 112.44 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.59 -34.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.881 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -59.64 -58.0 10.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.089 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.89 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -59.72 -28.0 66.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.693 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.88 -49.66 50.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -63.55 -31.02 72.06 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.976 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 15.2 ttp180 -62.6 -42.37 99.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.413 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.3 -23.62 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.844 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.32 -64.88 0.81 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.301 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.31 -46.18 35.51 Favored Glycine 0 C--O 1.216 -1.013 0 O-C-N 124.107 0.879 . . . . 0.0 112.397 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -51.64 -51.87 52.28 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.382 0.61 . . . . 0.0 111.425 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.45 -45.69 93.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.047 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -75.53 -33.74 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.922 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.46 -26.85 68.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.2 m -88.58 -41.84 12.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.485 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -87.27 -64.43 1.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 112.205 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -80.41 61.26 4.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.121 0.486 . . . . 0.0 111.338 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -85.24 0.38 52.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -89.11 18.21 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -104.38 -0.07 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.754 ' HA ' HD22 ' A' ' 64' ' ' LEU . 80.3 m-85 -84.89 -23.25 29.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.112 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -35.61 81.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 1.013 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 1.4 m-20 -62.0 -33.49 74.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.299 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.84 -41.76 87.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.529 0.681 . . . . 0.0 109.325 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -80.39 -40.56 26.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.579 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -51.21 -46.13 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.522 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.569 HE22 HD11 ' A' ' 106' ' ' LEU . 35.2 mt-30 -76.52 -49.16 17.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.448 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.28 6.35 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -176.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.1 t60 -82.64 -31.99 28.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.872 0.368 . . . . 0.0 110.66 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 71' ' ' THR . 2.3 p -91.76 -54.77 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 70' ' ' VAL . 5.0 t -171.97 144.51 1.5 Allowed Pre-proline 0 C--O 1.237 0.437 0 CA-C-O 120.91 0.386 . . . . 0.0 111.007 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 3.6 Cg_endo -84.36 -171.81 1.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.258 2.639 . . . . 0.0 111.258 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.27 -67.4 3.7 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.74 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 48.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.385 0.612 . . . . 0.0 111.674 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . . . -104.39 -17.16 14.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.27 -35.69 81.66 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.251 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -67.58 -39.63 84.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.891 0.377 . . . . 0.0 110.428 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . 0.729 ' HD2' ' HA ' ' A' ' 75' ' ' ALA . 23.1 mtt180 -68.59 -45.87 70.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -61.34 -47.84 84.06 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.906 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -58.28 -33.75 69.77 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.09 -64.07 1.08 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 9.1 p -57.87 -34.58 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -68.21 -45.63 72.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.667 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -71.36 -38.02 71.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.851 0.358 . . . . 0.0 110.519 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -19.38 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.269 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -85.28 -39.47 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.833 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 32.9 t80 -79.24 -7.67 58.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.243 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -48.59 -35.97 14.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.431 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.51 62.46 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.834 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.62 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 164.05 51.35 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.541 -1.314 . . . . 0.0 115.04 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.62 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 18.3 Cg_endo -81.37 37.01 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 119.762 1.781 . . . . 0.0 111.542 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.2 t-20 -68.04 164.87 19.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.903 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.588 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 26.0 m95 -53.97 -28.2 36.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.458 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.16 -41.14 97.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.117 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -86.09 -23.67 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.654 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.862 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -56.21 -31.59 63.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.479 0.657 . . . . 0.0 109.852 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.766 HG22 ' HB1' ' A' ' 49' ' ' ALA . 38.7 t -61.26 -54.15 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.391 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.33 69.45 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.351 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.862 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.17 -57.27 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 110.509 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 40.9 m-85 -74.56 -38.74 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.4 -40.16 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.793 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.589 ' HE2' HD22 ' A' ' 180' ' ' LEU . 0.6 OUTLIER -54.79 -52.68 61.88 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.21 -38.11 47.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.078 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.11 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.12 0.46 . . . . 0.0 110.756 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -67.54 -39.12 85.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.719 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.97 -42.41 94.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.456 179.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.719 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.0 m -69.19 -39.37 78.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.455 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.75 79.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.395 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.7 OUTLIER -84.67 -15.0 46.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.479 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -82.81 -24.64 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.354 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 107' ' ' CYS . 91.4 t -69.23 -33.22 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.318 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.558 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.6 p30 -84.99 1.06 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -126.94 -173.26 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.435 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -84.61 56.37 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.703 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.448 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.06 43.31 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.8 mt-10 -57.33 -53.55 64.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.396 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 17.3 Cg_exo -67.7 -27.52 38.12 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.072 1.848 . . . . 0.0 112.636 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 tp -62.78 -35.66 80.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.74 -51.28 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.56 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.34 -33.52 87.46 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.53 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.4 mm100 -67.18 -50.35 61.33 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 118' ' ' LEU . 45.1 t -58.68 -33.71 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -63.04 -46.58 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.263 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.799 ' HA ' HG12 ' A' ' 127' ' ' VAL . 15.4 pt-20 -74.03 -39.31 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.664 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.2 m0 -56.41 -37.88 70.76 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 8.9 ttm -73.61 -55.43 6.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.506 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 124' ' ' GLU . 9.8 p -60.32 -36.19 67.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -67.54 -48.76 66.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.823 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 8.7 t80 -59.01 -34.72 72.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.63 0.729 . . . . 0.0 110.148 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.995 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -73.07 -56.93 4.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.573 -179.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -77.43 -38.52 49.37 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -42.61 2.04 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.995 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.82 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.321 0.509 . . . . 0.0 111.676 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.94 61.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -49.52 67.21 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.0 t90 -57.96 -48.08 81.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.566 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.65 -49.55 77.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.944 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.65 -39.51 73.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.1 m -86.79 -11.27 51.5 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.2 -22.02 16.4 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.35 -24.99 0.97 Allowed Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.499 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.566 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 95.86 169.55 35.26 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.011 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 96.2 m95 -60.06 -29.4 68.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.87 79.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.571 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.46 -42.0 96.2 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.844 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -61.95 -39.47 92.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.318 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.682 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -66.07 -27.16 67.87 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 110.75 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -15.31 41.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 0.0 109.856 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.677 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -79.03 -48.87 13.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.22 179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.5 m-85 -138.99 30.75 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -95.09 -132.17 6.75 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.189 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.48 -31.42 70.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -115.5 65.85 0.3 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.77 76.33 10.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.207 0.527 . . . . 0.0 110.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.7 153.59 23.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.324 -179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.66 -28.03 53.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.308 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -74.75 -42.14 58.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 110.801 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.79 -34.66 75.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.242 0.544 . . . . 0.0 110.541 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.58 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 8.3 mtm-85 -63.97 -50.45 68.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.074 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -68.9 -30.11 68.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.569 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -64.77 -37.38 87.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.254 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -69.48 -42.21 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.555 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 3.4 tt0 -65.46 -44.62 86.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.403 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 -22.45 75.63 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.632 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.488 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -74.66 -52.96 10.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.0 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HA ' HG22 ' A' ' 170' ' ' VAL . 14.7 p-90 -66.97 -23.8 65.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.274 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.07 77.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.15 0.5 . . . . 0.0 110.382 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 -32.59 19.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.516 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.845 HG22 ' HA ' ' A' ' 167' ' ' TRP . 34.3 m -86.12 -25.57 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.4 ttp180 -80.84 -25.38 37.76 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.588 -0.695 . . . . 0.0 109.938 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.826 ' HA ' HG23 ' A' ' 175' ' ' THR . 2.2 m -90.09 -28.6 18.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.763 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.94 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -65.32 -29.05 46.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.388 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.94 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -120.07 46.15 2.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.185 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -64.99 -42.33 94.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.94 25.18 1.53 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.499 0.56 . . . . 0.0 114.499 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.96 -2.21 58.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.323 0.561 . . . . 0.0 110.457 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.36 66.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.805 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.03 12.03 37.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.433 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 1.013 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 5.6 mp . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.656 -179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo . . . . . 0 CA--C 1.527 0.173 0 CA-C-O 121.176 0.407 . . . . 0.0 112.303 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 10' ' ' THR . 1.5 m-20 -84.75 -159.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -56.47 -35.04 67.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.15 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -63.58 -39.59 94.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.689 0.28 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -32.95 57.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.814 0.34 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.749 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.4 tp -74.74 -42.22 58.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.427 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -66.37 -37.93 80.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.834 0.349 . . . . 0.0 110.23 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.72 60.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.75 0.31 . . . . 0.0 110.588 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.082 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 6.7 t80 -56.63 -50.11 73.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.49 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.4 t -66.83 -42.18 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.19 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.47 -52.75 49.23 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.888 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.802 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 23.6 t80 -57.19 -46.55 82.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.073 0.549 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.52 -45.46 90.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 111.059 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.7 mp -66.85 -47.24 72.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 23.7 ttp85 -60.77 -25.81 66.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.3 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.94 -21.79 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.952 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -157.43 72.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.759 0.314 . . . . 0.0 111.654 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.68 -75.99 0.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.2 t80 -84.37 56.13 3.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.05 -28.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.087 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.36 -15.16 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.478 0.656 . . . . 0.0 109.962 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -111.85 53.9 0.57 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.963 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB1' ' OE2' ' A' ' 35' ' ' GLU . . . -63.49 144.59 56.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.204 -0.498 . . . . 0.0 110.408 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.421 ' CA ' ' HG2' ' A' ' 35' ' ' GLU . . . 142.77 -57.25 0.56 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.979 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.5 Cg_exo -61.7 -45.36 17.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.579 2.186 . . . . 0.0 112.403 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.43 39.44 2.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.743 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 74.4 mm-40 -79.31 -59.92 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.349 0.574 . . . . 0.0 109.95 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.05 128.96 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.3 Cg_endo -88.28 -132.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.835 2.357 . . . . 0.0 113.476 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HB1' ' HG2' ' A' ' 44' ' ' GLN . . . -73.79 92.4 2.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.493 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.93 39.9 1.04 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -156.41 164.9 19.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.654 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.9 Cg_endo -82.39 49.63 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.135 2.557 . . . . 0.0 112.275 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.749 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.8 -27.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.485 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.514 ' HD2' HD12 ' A' ' 42' ' ' LEU . 4.4 m170 -62.55 -56.03 21.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.929 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.98 -23.81 67.48 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.044 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -67.63 -54.1 22.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.465 ' HE3' HD21 ' A' ' 13' ' ' LEU . 3.8 tpp -70.13 -30.07 67.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.338 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -39.87 95.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.572 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.22 -28.52 47.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 109.685 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.5 -61.08 1.99 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.643 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.12 -45.9 42.72 Favored Glycine 0 C--O 1.215 -1.081 0 O-C-N 124.108 0.88 . . . . 0.0 112.292 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.28 -52.75 51.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.588 0.355 . . . . 0.0 111.884 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -44.0 95.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.404 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.678 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -72.56 -35.0 67.87 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.25 -27.15 68.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.323 0.583 . . . . 0.0 109.518 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -88.01 -39.24 14.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -90.37 -57.23 2.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -81.4 69.21 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 58' ' ' ARG . 17.7 mtt180 -72.89 0.59 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.88 51.69 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 110.198 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.0 0.15 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.412 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.895 ' HA ' HD22 ' A' ' 64' ' ' LEU . 36.6 m-85 -110.51 -25.91 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 0.0 111.592 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -41.11 97.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.74 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.99 -18.95 64.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.748 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -66.87 -45.41 78.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.674 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -75.67 -47.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -47.77 -41.63 23.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.18 179.517 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.571 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 27.9 mt-30 -71.83 -65.65 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' A' ' 115' ' ' MET . 0.7 OUTLIER -78.49 14.48 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 1.6 p-80 -79.15 -20.56 48.23 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.533 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.87 -72.69 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.825 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -157.15 135.64 7.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 21.2 Cg_exo -66.44 170.14 12.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.115 2.543 . . . . 0.0 112.378 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . 0.715 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 92.18 -58.49 2.76 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.67 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.55 50.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.43 0.634 . . . . 0.0 110.848 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.67 -25.08 10.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.739 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.626 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -63.03 -42.1 99.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.848 -179.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.95 -44.71 95.33 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.383 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -61.7 -42.68 99.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.246 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -62.47 -51.0 69.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.469 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -59.07 -32.2 69.57 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.725 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -61.07 -60.52 3.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.72 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.7 m -60.29 -32.53 51.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.6 m -65.61 -42.42 91.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.16 -40.44 86.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 178.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -67.13 -31.79 72.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.486 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.01 -36.59 59.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -85.83 -5.81 59.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -34.46 25.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.018 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.83 62.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.352 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.88 56.64 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.544 -1.313 . . . . 0.0 115.014 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 11.8 Cg_endo -82.13 29.37 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.396 2.064 . . . . 0.0 111.194 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.857 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.9 m120 -61.63 162.06 8.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.889 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 27.7 m95 -52.68 -25.77 11.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.864 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.98 90.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.522 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.674 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.0 mmp_? -87.09 -22.43 25.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.926 -0.161 . . . . 0.0 110.758 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -54.71 -31.08 57.61 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.728 0.643 . . . . 0.0 110.229 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.935 HG22 ' HB1' ' A' ' 49' ' ' ALA . 17.6 t -59.77 -56.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.95 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -27.32 69.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.84 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.0 m-85 -58.49 -55.12 39.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 110.123 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 12.8 m-85 -76.16 -37.86 57.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.73 -37.88 80.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.801 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -54.5 -53.86 48.67 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.13 -35.66 52.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.444 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.61 99.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.136 0.468 . . . . 0.0 110.513 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.43 -40.17 77.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.823 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -59.65 -42.11 92.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.704 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.666 ' HB3' HD21 ' A' ' 22' ' ' LEU . 96.9 m -69.06 -41.16 77.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.024 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.86 -48.46 69.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.983 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -74.13 -20.22 60.31 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.874 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.579 ' HB3' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -78.78 -35.94 43.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.482 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 107' ' ' CYS . 24.6 t -67.81 -16.3 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.829 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 12.3 m-20 -45.73 -70.25 0.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.487 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -175.55 37.45 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.886 179.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 17.2 mt-10 -159.68 122.1 3.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.878 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.552 ' HE1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 mtm 70.31 114.84 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.777 0.673 . . . . 0.0 112.106 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.701 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -102.05 -55.34 0.13 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.146 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.701 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 36.2 Cg_exo -59.85 -27.79 85.73 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.487 2.125 . . . . 0.0 113.967 -178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.715 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -62.3 -31.57 72.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 110' ' ' SER . 94.6 t -60.36 -55.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.623 0.249 . . . . 0.0 111.371 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.51 -28.88 72.0 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.016 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.9 mt-30 -68.52 -49.21 61.32 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 99.6 t -56.64 -36.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.64 -47.05 87.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.859 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' A' ' 127' ' ' VAL . 20.8 pt-20 -73.93 -36.72 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.626 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.1 m0 -57.12 -38.34 73.29 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.9 ttm -73.61 -54.28 8.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.22 -30.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.772 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.32 -50.0 50.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.263 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 11.8 t80 -61.76 -34.4 75.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.0 110.599 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 0.869 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -72.12 -56.01 6.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.133 -178.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.99 -34.3 74.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.5 m -79.04 -40.92 30.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -121.61 -42.73 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.869 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.7 mm? -59.6 -46.0 90.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.227 0.467 . . . . 0.0 111.166 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.18 -39.5 56.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.376 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.5 -55.78 29.36 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.449 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.857 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 62.2 t90 -55.79 -46.34 77.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.117 0.484 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.406 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -58.24 -48.19 85.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.721 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -66.07 -32.22 73.56 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.372 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -84.0 -11.85 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -49.61 5.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.3 -18.08 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.406 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 96.15 170.6 35.06 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.017 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.48 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 92.9 m95 -60.48 -30.62 69.8 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.52 76.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -65.38 -42.19 92.95 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.754 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -66.05 -33.85 76.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.548 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -71.07 -24.49 62.34 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.468 178.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.35 -31.68 21.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -60.39 -51.38 69.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.581 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 -132.55 33.85 3.75 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.04 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -103.54 -127.79 6.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.431 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.42 -37.61 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 111.078 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.32 61.81 0.3 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.56 72.85 9.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.136 0.493 . . . . 0.0 110.637 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.2 164.16 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.837 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -59.72 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.574 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.5 mt-10 -71.47 -35.78 70.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.26 62.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 0.0 109.73 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . 0.647 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 4.0 mtp180 -61.75 -51.64 67.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.294 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' GLU . 1.3 ptm180 -67.64 -28.39 67.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.652 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -66.85 -45.3 78.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.529 ' NH2' ' HA ' ' A' ' 49' ' ' ALA . 13.0 ttp180 -67.26 -38.04 84.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.1 OUTLIER -67.66 -47.12 70.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.214 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.75 -21.79 75.11 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.503 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.6 ' O ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -68.96 -54.04 17.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.277 . . . . 0.0 110.827 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.649 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 15.0 p-90 -67.76 -25.08 65.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.985 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.14 74.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 110.262 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.59 -28.75 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 27.8 m -93.04 -31.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -41.0 67.54 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.544 -0.722 . . . . 0.0 110.29 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 175' ' ' THR . 3.7 m -74.66 -28.47 60.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.809 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -70.44 -26.09 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.569 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.809 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -120.72 39.73 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.726 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -68.5 -16.2 63.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -87.96 14.08 59.65 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.184 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.34 8.2 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.942 0.371 . . . . 0.0 111.806 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 58.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.925 0.393 . . . . 0.0 110.475 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.09 51.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.3 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_exo . . . . . 0 C--O 1.231 0.16 0 CA-C-O 120.967 0.32 . . . . 0.0 111.872 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.63 -161.4 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.458 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -43.33 74.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.385 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -58.65 -39.33 80.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.631 0.253 . . . . 0.0 110.726 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -47.91 51.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 46' ' ' MET . 4.2 tp -58.78 -45.09 90.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.377 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -65.9 -39.29 84.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.87 76.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.87 -48.85 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.908 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -59.31 -51.06 71.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.402 ' O ' HD13 ' A' ' 22' ' ' LEU . 53.5 t -65.24 -40.99 90.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.96 -48.02 87.83 Favored Glycine 0 C--O 1.222 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.94 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' TYR . . . . . 0.721 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.2 t80 -58.12 -47.75 82.34 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.821 0.448 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.68 85.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.175 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -67.15 -46.93 72.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.416 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 35.4 ttp85 -62.96 -20.34 65.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.841 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.7 tt0 -82.19 -36.41 27.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.926 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.44 77.89 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.49 -68.3 0.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.09 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.1 t80 -92.57 59.67 3.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.0 110.701 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.16 -26.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.92 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -36.86 77.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.791 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -96.46 50.6 1.61 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.955 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -67.75 131.28 45.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.01 -53.75 0.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.612 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 18.0 Cg_exo -68.56 -49.22 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.217 1.945 . . . . 0.0 111.643 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.721 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.5 31.88 4.69 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.517 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.83 -59.44 2.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.437 0.637 . . . . 0.0 109.314 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.19 124.88 7.23 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.422 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.82 -112.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.998 2.465 . . . . 0.0 112.955 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.44 97.15 1.24 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.7 20.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.067 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 30.8 m-20 -146.26 162.35 35.18 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -79.22 52.33 4.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.366 2.711 . . . . 0.0 111.468 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.29 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.03 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -62.66 -50.4 71.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.575 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -64.06 -25.23 68.01 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.94 -54.22 7.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.465 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' MET . . . . . 0.46 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.3 ttm -61.97 -38.29 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.976 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -61.32 -37.91 84.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.075 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.51 34.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.519 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.56 -55.88 28.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.308 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.67 -49.45 40.37 Favored Glycine 0 C--O 1.217 -0.963 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.206 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.74 -53.15 58.8 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.906 0.384 . . . . 0.0 111.929 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.1 -46.6 86.6 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.355 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.845 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -69.77 -36.72 75.98 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.778 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -61.04 -32.86 72.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.503 0.668 . . . . 0.0 109.742 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 m -79.34 -28.92 42.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.351 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -92.44 -31.89 15.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.44 93.39 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.191 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -71.64 -25.42 62.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.875 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -94.27 77.31 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.122 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.85 -62.51 1.44 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.097 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PHE . . . . . 0.947 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.0 m-85 -76.79 -10.81 59.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -47.61 80.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -68.41 -21.23 64.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.201 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -68.86 -42.01 77.66 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.77 -43.38 37.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.567 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -53.48 -43.22 67.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.72 HE22 HD11 ' A' ' 106' ' ' LEU . 26.6 mt-30 -71.33 -58.05 3.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 3.8 6.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 65.5 t60 -78.81 -26.89 44.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.873 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -71.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.13 147.58 11.47 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -89.54 -169.81 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.138 2.559 . . . . 0.0 111.917 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.76 -70.24 2.91 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.343 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.41 37.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 111.905 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' HD11 ' A' ' 118' ' ' LEU . . . -85.84 -16.42 38.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.368 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' GLN . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.0 pt20 -60.95 -42.0 97.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.588 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.3 -39.57 94.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.36 . . . . 0.0 110.499 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -67.58 -43.58 80.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.021 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.06 -48.9 76.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -57.73 -31.88 66.87 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.394 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -62.43 -63.27 1.28 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.891 0.376 . . . . 0.0 110.636 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 ' HG ' ' A' ' 180' ' ' LEU . 20.9 m -58.78 -32.12 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.512 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 m -65.91 -43.48 88.01 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -69.26 -40.6 77.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.638 178.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -64.14 -28.3 69.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.412 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HG ' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -83.62 -28.5 28.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 110.088 179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -91.08 0.5 57.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 9.1 mm100 -49.0 -33.27 10.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.003 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.67 55.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.962 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.443 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 172.61 54.95 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 C-N-CA 119.953 -1.118 . . . . 0.0 114.324 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -80.87 43.06 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.169 1.913 . . . . 0.0 111.977 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.3 t-20 -67.71 161.74 25.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.896 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' TRP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.3 m95 -55.33 -26.98 44.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.76 98.47 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.689 HH11 ' HG ' ' A' ' 86' ' ' LEU . 5.2 mmt180 -86.31 -18.77 31.1 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.819 -0.224 . . . . 0.0 110.716 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.752 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.86 -31.66 65.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.329 0.585 . . . . 0.0 110.218 179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 53' ' ' PHE . 5.9 t -61.3 -53.73 44.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.521 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.64 -26.85 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.395 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.42 -57.53 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.068 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' PHE . . . . . 0.67 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.6 m-85 -74.79 -40.07 61.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.724 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.02 -38.91 69.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.71 -49.49 75.01 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.729 0.3 . . . . 0.0 111.317 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.36 -37.91 30.37 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.003 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.04 97.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.025 0.413 . . . . 0.0 110.688 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.56 -40.07 80.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.772 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.79 -43.66 90.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.281 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' CYS . . . . . 0.641 ' HB2' HD11 ' A' ' 22' ' ' LEU . 88.5 m -63.57 -44.37 94.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.071 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.03 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.569 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . 0.64 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.4 OUTLIER -75.09 -23.06 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.658 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 119' ' ' VAL . 49.1 m -79.56 -22.24 44.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.116 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.3 t -75.97 -35.44 29.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' ASN . . . . . 0.64 HD21 ' HA ' ' A' ' 109' ' ' GLU . 14.7 p30 -85.04 1.13 49.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 8.9 mtmt -123.6 -174.6 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.5 48.74 1.56 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -129.94 37.84 3.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.536 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -54.68 -53.73 57.09 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 23.4 Cg_exo -65.15 -32.12 53.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.005 1.804 . . . . 0.0 112.299 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -59.61 -31.06 69.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.609 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 110' ' ' SER . 87.2 t -58.17 -51.2 73.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.903 0.382 . . . . 0.0 111.256 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.06 -31.58 81.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.089 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 14.3 mm100 -66.27 -51.81 53.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' VAL . . . . . 0.434 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 61.2 t -58.15 -33.71 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.16 -47.57 82.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.325 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' GLU . . . . . 0.66 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.4 pt-20 -72.4 -39.44 67.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' TRP . . . . . 0.62 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.7 m0 -57.61 -38.61 75.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.0 ttm -73.77 -52.83 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.795 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.5 p -62.15 -33.32 58.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.55 -52.07 35.97 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.605 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.49 -33.32 67.89 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.467 0.651 . . . . 0.0 110.568 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' LEU . . . . . 1.045 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.07 -55.81 5.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.748 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -32.02 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.7 m -82.61 -34.7 27.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -126.97 -44.91 1.6 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 1.045 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.05 -46.54 87.98 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.429 -178.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.64 -38.85 61.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.259 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -60.03 -52.59 64.73 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.418 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 52.8 t90 -56.62 -48.69 76.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ILE . . . . . 0.507 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.7 mt -57.09 -47.77 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.016 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -66.39 -29.17 69.28 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -88.04 -16.13 34.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.56 -54.39 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.78 -9.74 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.545 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.03 166.88 40.98 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.009 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TRP . . . . . 0.46 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 91.6 m95 -60.67 -29.15 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.22 80.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.89 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.78 -42.77 99.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' PHE . . . . . 0.473 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.3 t80 -66.1 -33.17 75.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.137 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.39 -27.7 68.06 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.738 0.304 . . . . 0.0 111.02 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.0 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 163' ' ' ARG . 5.0 mt -63.61 -42.95 98.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.536 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.4 m-85 -123.39 31.29 5.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.814 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -122.94 -138.37 5.26 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.752 -1.214 . . . . 0.0 113.107 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -42.77 36.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.785 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' GLY . . . . . 0.432 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.52 53.43 4.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.44 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.5 71.76 10.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -63.02 157.68 21.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.39 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -53.07 -33.68 53.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.209 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLU . . . . . 0.681 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.2 mt-10 -72.8 -39.41 66.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.919 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.36 72.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.993 0.425 . . . . 0.0 110.83 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -60.66 -51.46 69.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.037 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -69.16 -26.12 64.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.019 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.68 -46.02 55.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ARG . . . . . 0.62 ' HB3' HD22 ' A' ' 150' ' ' LEU . 3.8 ptt180 -65.1 -38.62 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLU . . . . . 0.587 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -71.02 -43.54 67.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.204 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.81 -28.46 73.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.647 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.3 t-20 -67.1 -57.76 6.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' TRP . . . . . 0.791 ' HA ' HG22 ' A' ' 170' ' ' VAL . 15.7 p-90 -62.12 -25.34 67.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.491 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.4 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.051 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 -29.19 22.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 167' ' ' TRP . 26.8 m -79.4 -23.9 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.265 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 3.7 ttp180 -83.09 -14.43 53.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' THR . . . . . 0.661 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -98.52 -33.21 11.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.471 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' VAL . . . . . 0.964 HG13 ' HG ' ' A' ' 174' ' ' LEU . 11.7 p -63.19 -33.14 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.57 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.964 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -112.34 39.4 2.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.77 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -54.37 -42.86 70.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.372 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.72 59.55 4.43 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.131 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -120.14 6.69 10.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.413 0.625 . . . . 0.0 109.62 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.65 61.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.455 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -82.41 -8.11 59.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.568 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' LEU . . . . . 0.636 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.8 OUTLIER . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.802 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.735 0 N-CA-C 111.867 -0.493 . . . . 0.0 111.867 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_exo -66.34 -50.12 1.56 Allowed 'Trans proline' 0 C--N 1.343 0.248 0 C-N-CA 122.865 2.376 . . . . 0.0 112.003 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 2' ' ' ALA . 9.4 mt -122.88 -149.77 0.43 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.247 179.773 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . 0.491 ' H ' ' HB3' ' A' ' -2' ' ' LEU . . . 99.68 -77.51 0.48 Allowed Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 120.68 -0.771 . . . . 0.0 112.111 179.776 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.79 -18.03 65.17 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.053 0.454 . . . . 0.0 111.41 -179.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -114.09 23.8 12.59 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.506 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.501 ' HB2' HD22 ' A' ' -2' ' ' LEU . . . -140.41 121.55 14.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.929 0.395 . . . . 0.0 111.152 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.3 p -102.62 149.24 36.55 Favored Pre-proline 0 C--N 1.323 -0.566 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.308 179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -61.33 134.16 50.43 Favored 'Trans proline' 0 C--O 1.234 0.285 0 C-N-CA 122.676 2.251 . . . . 0.0 111.64 179.734 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -110.18 147.91 32.82 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.035 -179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 19.3 m 59.23 88.65 0.07 Allowed 'General case' 0 CA--C 1.532 0.282 0 O-C-N 123.944 0.777 . . . . 0.0 112.225 179.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.61 161.84 65.34 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.702 178.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -69.13 52.38 0.78 Allowed 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 123.322 2.681 . . . . 0.0 113.238 -179.359 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -90.75 -166.0 1.48 Allowed 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.692 -0.686 . . . . 0.0 109.883 179.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.21 -39.45 82.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.393 0.139 . . . . 0.0 111.158 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.1 ttp180 -62.2 -38.01 87.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.736 0.303 . . . . 0.0 110.716 179.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.22 -34.84 66.14 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.075 0.464 . . . . 0.0 110.089 179.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.78 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.6 tp -72.4 -42.28 65.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.87 -0.605 . . . . 0.0 111.017 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.519 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -66.49 -36.07 76.42 Favored 'Isoleucine or valine' 0 C--O 1.232 0.164 0 CA-C-O 121.014 0.435 . . . . 0.0 109.969 179.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.23 -22.96 60.31 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.322 178.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -73.16 -66.93 0.62 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.865 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.659 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -53.44 -50.66 64.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.798 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.453 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.4 t -67.64 -42.31 86.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.429 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.538 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.48 -52.29 52.2 Favored Glycine 0 C--O 1.226 -0.402 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.211 179.273 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.56 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.1 OUTLIER -55.57 -45.33 77.36 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 123.148 0.579 . . . . 0.0 111.223 179.961 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.61 -48.37 66.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.084 -179.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.677 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -63.38 -45.31 91.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.578 -179.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.74 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.4 OUTLIER -62.17 -26.98 68.64 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.026 -179.923 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.6 mt-30 -85.99 -23.97 26.66 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 112.404 0.52 . . . . 0.0 112.404 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.57 66.12 1.12 Allowed 'General case' 0 C--O 1.234 0.289 0 N-CA-C 112.541 0.571 . . . . 0.0 112.541 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.9 -72.17 0.29 Allowed Glycine 0 CA--C 1.508 -0.347 0 C-N-CA 120.108 -1.044 . . . . 0.0 112.833 179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.434 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.2 t80 -91.2 52.96 2.22 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.163 0.506 . . . . 0.0 110.332 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.4 p -79.15 -31.79 14.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 115.843 -0.617 . . . . 0.0 109.668 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -67.01 -35.35 79.72 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.343 -0.844 . . . . 0.0 109.392 178.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -91.77 57.39 2.97 Favored Glycine 0 N--CA 1.444 -0.816 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.659 178.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.74 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -60.18 128.26 35.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.608 -0.296 . . . . 0.0 110.32 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.61 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 165.6 -60.91 0.24 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 119.702 -1.237 . . . . 0.0 113.278 -179.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.498 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 32.1 Cg_exo -58.8 -52.51 5.12 Favored 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 121.96 1.773 . . . . 0.0 111.024 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.56 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -92.57 42.48 2.68 Favored Glycine 0 N--CA 1.445 -0.746 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.879 178.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -86.51 -18.32 31.87 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.94 0.4 . . . . 0.0 110.313 -179.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.409 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -110.55 147.5 17.53 Favored Glycine 0 N--CA 1.447 -0.603 0 C-N-CA 120.868 -0.682 . . . . 0.0 111.622 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.5 Cg_endo -93.94 -158.07 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.964 2.443 . . . . 0.0 113.135 -179.233 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.909 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.3 96.77 8.59 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.18 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -135.31 -24.44 1.4 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.737 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.424 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 20.6 m-20 -79.5 163.25 59.99 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.105 -179.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.499 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.3 Cg_endo -78.0 50.39 3.28 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 123.42 2.746 . . . . 0.0 112.102 179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.78 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.49 -32.32 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 114.395 -1.275 . . . . 0.0 108.345 179.434 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.673 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.3 m170 -59.23 -60.48 3.79 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.177 -0.92 . . . . 0.0 110.09 179.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.909 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.4 -24.88 61.27 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.045 179.856 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -73.82 -50.71 19.12 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.739 -0.664 . . . . 0.0 110.92 179.689 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.8 ttm -66.74 -37.91 85.6 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.43 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.45 -40.98 84.12 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.542 -179.558 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.62 -27.69 51.24 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.348 0.595 . . . . 0.0 110.678 -179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.802 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.98 -62.65 1.29 Allowed 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.523 -0.762 . . . . 0.0 109.563 179.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.659 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.94 -45.85 41.1 Favored Glycine 0 C--O 1.218 -0.859 0 CA-C-N 115.388 -0.824 . . . . 0.0 112.72 179.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -56.34 -50.11 72.44 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-O 121.054 0.455 . . . . 0.0 111.697 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.02 -46.37 84.79 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.198 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.846 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.3 OUTLIER -68.73 -36.33 78.26 Favored 'General case' 0 C--O 1.22 -0.451 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.274 -179.52 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -60.21 -32.5 71.16 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.302 0.572 . . . . 0.0 109.547 179.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 54.6 m -83.12 -25.76 31.64 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.414 179.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 10.0 mtt180 -91.47 -29.43 17.02 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 112.444 0.535 . . . . 0.0 112.444 -178.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.493 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.21 96.86 9.62 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.308 0.575 . . . . 0.0 110.992 -178.793 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt-85 -72.54 -3.69 26.1 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.601 -179.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.422 HH12 HG11 ' A' ' 178' ' ' VAL . 0.1 OUTLIER -132.2 87.89 2.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.074 0.464 . . . . 0.0 109.761 179.602 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.454 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -120.05 -61.02 1.64 Allowed 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.658 -178.486 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.953 ' HA ' HD22 ' A' ' 64' ' ' LEU . 6.9 m-85 -79.67 0.44 30.32 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.892 -0.595 . . . . 0.0 112.471 -178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 1.4 p -73.42 -53.99 9.37 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 121.224 0.535 . . . . 0.0 110.876 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.505 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.33 -24.27 66.5 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.919 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.953 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.6 OUTLIER -63.15 -44.77 94.56 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.433 -0.803 . . . . 0.0 108.862 178.036 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -75.55 -42.65 51.75 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.898 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.748 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.66 -44.28 62.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.201 179.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.457 HE22 HD11 ' A' ' 106' ' ' LEU . 19.7 mt-30 -69.2 -51.24 39.93 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.716 179.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.553 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -86.17 20.22 2.4 Favored 'General case' 0 C--O 1.237 0.405 0 CA-C-N 116.271 -0.422 . . . . 0.0 112.097 -178.312 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.74 -40.88 32.27 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.718 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.507 HG13 ' H ' ' A' ' 71' ' ' THR . 1.5 p -90.88 -60.83 2.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 CA-C-N 115.897 -0.592 . . . . 0.0 111.563 -179.361 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.507 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.9 OUTLIER -172.7 145.7 1.41 Allowed Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 110.358 -0.238 . . . . 0.0 110.358 -179.057 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -78.11 -158.33 0.09 OUTLIER 'Trans proline' 0 C--N 1.348 0.51 0 C-N-CA 123.075 2.516 . . . . 0.0 112.623 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 80.99 -71.07 2.96 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.722 -0.751 . . . . 0.0 112.466 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -76.77 50.93 0.73 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.54 0.686 . . . . 0.0 111.121 179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -102.61 -20.51 14.41 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.646 179.684 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -65.13 -38.06 89.43 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.437 -179.334 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.674 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 26.1 mp0 -67.43 -42.05 83.8 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.9 mtt180 -64.06 -45.57 88.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.971 0.415 . . . . 0.0 109.952 178.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -62.39 -51.86 65.91 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.674 -0.693 . . . . 0.0 110.712 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 9.7 p -58.33 -32.62 68.68 Favored 'General case' 0 N--CA 1.464 0.266 0 N-CA-C 112.239 0.459 . . . . 0.0 112.239 -179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.674 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 22.8 mm-40 -64.15 -56.74 12.67 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-O 120.987 0.422 . . . . 0.0 110.652 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.782 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.3 m -63.84 -31.88 54.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.947 -0.57 . . . . 0.0 111.315 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.0 m -65.56 -43.41 89.93 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.608 -0.269 . . . . 0.0 110.356 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -66.96 -36.67 82.72 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.947 0.403 . . . . 0.0 110.244 179.439 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -69.46 -26.25 64.49 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.894 178.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -79.81 -30.91 40.62 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.087 179.239 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 38.0 t80 -95.96 1.48 52.84 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.703 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.23 -50.15 21.71 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.747 -179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.14 61.71 0.15 Allowed Glycine 0 N--CA 1.445 -0.729 0 C-N-CA 120.047 -1.073 . . . . 0.0 112.844 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.13 58.67 0.02 OUTLIER Glycine 0 CA--C 1.522 0.498 0 C-N-CA 120.004 -1.093 . . . . 0.0 114.129 179.206 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.5 Cg_endo -81.08 41.89 1.24 Allowed 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 122.43 2.087 . . . . 0.0 111.741 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 2.2 t-20 -64.47 162.89 14.37 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.637 -179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.6 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -56.05 -26.28 48.55 Favored 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.698 179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.65 -38.02 94.14 Favored Glycine 0 N--CA 1.445 -0.728 0 N-CA-C 110.754 -0.938 . . . . 0.0 110.754 178.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.516 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.54 -27.23 22.72 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.952 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.79 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.05 -30.88 49.69 Favored 'General case' 0 C--O 1.235 0.312 0 CA-C-O 121.388 0.614 . . . . 0.0 110.149 179.848 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.846 HG11 ' HB2' ' A' ' 53' ' ' PHE . 13.3 t -63.18 -55.55 22.68 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.66 178.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.56 -28.66 69.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.128 -0.942 . . . . 0.0 111.322 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.79 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 8.1 m-85 -57.46 -57.62 11.88 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 121.213 0.53 . . . . 0.0 109.956 179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.568 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 13.6 m-85 -74.88 -37.68 62.08 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.51 -0.768 . . . . 0.0 111.2 -179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.74 -37.5 71.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.157 -179.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.504 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -57.15 -52.33 65.72 Favored 'General case' 0 C--N 1.334 -0.106 0 CA-C-O 120.697 0.284 . . . . 0.0 111.202 -179.947 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.41 -40.85 38.89 Favored Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.416 -0.897 . . . . 0.0 113.225 -179.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.96 -42.29 89.52 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 117.189 0.495 . . . . 0.0 111.016 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.594 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.36 -41.04 70.25 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.565 -0.532 . . . . 0.0 109.565 178.861 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.765 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.7 -48.74 80.08 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.584 179.302 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.677 ' HB3' HD21 ' A' ' 22' ' ' LEU . 67.0 m -59.66 -42.26 92.43 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.138 -0.937 . . . . 0.0 111.316 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.89 -55.96 24.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.823 0.344 . . . . 0.0 110.855 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -67.4 -17.87 64.9 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.901 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 71.2 m -77.88 -32.97 52.22 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.537 HG23 ' O ' ' A' ' 107' ' ' CYS . 35.0 t -75.21 -22.21 16.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 121.658 0.742 . . . . 0.0 109.356 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 37.8 m-80 -85.27 -4.89 59.31 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.067 -0.97 . . . . 0.0 110.609 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.454 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.2 tttt -132.06 -162.92 1.27 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.585 -179.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -89.18 55.19 3.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.513 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.553 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.52 43.64 2.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.023 -179.086 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.7 mp0 -60.54 -55.32 46.2 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.962 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.4 Cg_exo -64.72 -26.84 60.43 Favored 'Trans proline' 0 C--N 1.354 0.853 0 C-N-CA 121.956 1.771 . . . . 0.0 112.198 179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.439 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.6 mm? -65.72 -28.11 68.82 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.313 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.429 HG21 HG22 ' A' ' 111' ' ' VAL . 79.3 t -59.23 -50.69 78.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.956 179.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.87 -32.58 84.36 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.838 179.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.579 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 7.9 mm100 -64.63 -52.88 55.09 Favored 'General case' 0 C--O 1.219 -0.548 0 N-CA-C 109.708 -0.478 . . . . 0.0 109.708 178.684 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.439 HG23 ' O ' ' A' ' 118' ' ' LEU . 44.8 t -58.3 -33.49 47.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.958 0.408 . . . . 0.0 110.115 178.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -64.21 -46.92 81.77 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.877 -0.602 . . . . 0.0 110.427 178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.631 ' HA ' HG12 ' A' ' 127' ' ' VAL . 19.0 pt-20 -72.31 -39.43 68.25 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.064 179.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.9 m0 -57.8 -38.7 75.98 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-O 121.483 0.658 . . . . 0.0 109.25 178.954 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.568 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 4.7 ttm -71.96 -56.07 6.34 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.853 -1.067 . . . . 0.0 111.69 -179.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.631 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.2 p -61.19 -33.21 55.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 112.249 0.462 . . . . 0.0 112.249 -178.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -73.09 -45.79 55.15 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.368 -0.533 . . . . 0.0 110.853 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.6 t80 -59.88 -37.39 79.23 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.704 0.764 . . . . 0.0 109.894 178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.032 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.51 -54.98 8.77 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.034 -0.985 . . . . 0.0 111.822 -179.632 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.17 -32.6 70.05 Favored 'General case' 0 C--N 1.323 -0.549 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -178.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -82.43 -35.11 27.91 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 113.461 0.911 . . . . 0.0 113.461 -178.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.87 -43.5 1.22 Allowed 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 114.049 1.129 . . . . 0.0 114.049 -178.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.032 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.51 -48.49 81.43 Favored 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 120.682 -0.407 . . . . 0.0 111.595 -178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.8 -38.92 57.62 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.603 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -62.15 -50.02 73.55 Favored 'General case' 0 C--N 1.332 -0.16 0 C-N-CA 120.824 -0.35 . . . . 0.0 110.796 179.821 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.8 t90 -58.17 -49.28 77.55 Favored 'General case' 0 N--CA 1.454 -0.272 0 CA-C-O 121.34 0.59 . . . . 0.0 109.525 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.65 HG13 ' HE3' ' A' ' 137' ' ' TRP . 11.3 mt -58.08 -47.14 87.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.152 -178.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 37.8 m-70 -61.12 -40.0 92.13 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.867 0.321 . . . . 0.0 111.867 -178.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.2 m -79.23 -30.54 43.27 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.343 0.497 . . . . 0.0 112.343 -179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.39 -60.03 3.14 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.84 0.352 . . . . 0.0 111.947 -179.182 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.3 -11.07 0.02 OUTLIER Glycine 0 C--N 1.319 -0.367 0 N-CA-C 111.366 -0.694 . . . . 0.0 111.366 -179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.32 169.16 41.89 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.612 179.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.484 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.0 m95 -62.2 -29.03 70.09 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.103 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.94 -35.51 78.66 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.578 178.601 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.6 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.81 -44.06 94.4 Favored 'General case' 0 N--CA 1.462 0.152 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.977 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.702 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 9.2 t80 -64.83 -34.21 77.83 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.579 179.118 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.761 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.7 OUTLIER -70.55 -25.55 63.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.013 0.435 . . . . 0.0 110.403 179.08 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.37 -32.66 20.84 Favored 'General case' 0 C--N 1.321 -0.64 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 178.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.521 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -57.95 -51.49 69.41 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.404 -0.816 . . . . 0.0 111.643 -179.628 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.42 ' HE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -130.32 30.23 4.77 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 112.642 0.608 . . . . 0.0 112.642 -178.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.488 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.85 -133.13 8.02 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.227 -0.987 . . . . 0.0 111.927 179.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 34.1 t0 -68.59 -45.45 71.96 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.07 0.462 . . . . 0.0 110.397 179.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.568 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.68 48.78 2.3 Favored Glycine 0 N--CA 1.449 -0.459 0 C-N-CA 120.743 -0.741 . . . . 0.0 112.12 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -81.23 73.26 8.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.12 0.486 . . . . 0.0 110.734 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.626 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -65.77 160.05 23.85 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.575 179.93 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.521 ' HG3' ' N ' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -57.01 -32.18 65.88 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.887 -0.597 . . . . 0.0 112.281 -178.874 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.626 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.2 OUTLIER -69.62 -39.41 77.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.901 0.381 . . . . 0.0 110.651 -179.858 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.521 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.38 -36.31 78.98 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.084 0.469 . . . . 0.0 110.532 179.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.42 ' HA ' ' HE1' ' A' ' 151' ' ' TYR . 61.9 mtt180 -67.56 -50.57 57.9 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.013 179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.3 ptp180 -64.47 -27.32 68.91 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-O 121.019 0.438 . . . . 0.0 110.11 179.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.449 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.7 OUTLIER -63.34 -47.52 81.81 Favored 'General case' 0 N--CA 1.454 -0.268 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.47 178.557 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.458 HH11 ' HE1' ' A' ' 147' ' ' PHE . 11.0 ttp180 -63.4 -39.2 93.86 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.461 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.636 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.19 -49.12 70.99 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.888 179.86 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.54 -27.23 73.04 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.469 -0.872 . . . . 0.0 111.585 179.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.648 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.7 m-20 -70.11 -56.63 6.41 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.464 -0.368 . . . . 0.0 111.532 -179.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.645 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 9.8 p-90 -60.34 -27.87 67.71 Favored 'General case' 0 CA--C 1.52 -0.182 0 C-N-CA 121.092 -0.243 . . . . 0.0 111.453 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.81 -46.73 74.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.952 0.406 . . . . 0.0 110.688 179.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -87.9 -24.09 23.73 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.648 HG22 ' O ' ' A' ' 166' ' ' ASN . 28.7 m -96.38 -41.15 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.447 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 -177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.575 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -75.35 -27.4 59.17 Favored 'General case' 0 C--N 1.318 -0.786 0 O-C-N 121.411 -0.805 . . . . 0.0 111.079 -178.244 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.439 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 1.4 m -81.51 -29.92 33.42 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.414 179.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.593 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.2 p -71.57 -28.24 30.8 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 CA-C-O 121.12 0.486 . . . . 0.0 110.398 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.593 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -114.44 33.91 5.04 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.209 0.528 . . . . 0.0 109.628 178.378 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.439 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.3 t -81.52 -4.72 56.75 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.242 -179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -89.39 6.13 83.52 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.856 -0.688 . . . . 0.0 112.647 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.67 29.29 0.25 Allowed 'General case' 0 N--CA 1.466 0.344 0 N-CA-C 112.005 0.372 . . . . 0.0 112.005 -179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.422 HG11 HH12 ' A' ' 59' ' ' ARG . 0.7 OUTLIER -87.23 50.62 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 121.054 0.454 . . . . 0.0 110.731 179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.14 -1.85 53.96 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.923 0.392 . . . . 0.0 111.056 -179.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.782 ' HG ' HG11 ' A' ' 82' ' ' VAL . 10.4 mt -92.22 -7.28 48.67 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.06 0.457 . . . . 0.0 110.159 179.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -78.9 84.57 1.22 Allowed Glycine 0 N--CA 1.446 -0.689 0 CA-C-N 115.637 -0.711 . . . . 0.0 112.896 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.748 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -109.85 -168.2 1.29 Allowed 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.908 -0.405 . . . . 0.0 109.908 179.275 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.009 -0.996 . . . . 0.0 109.643 179.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.718 0 N-CA-C 111.674 -0.571 . . . . 0.0 111.674 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_exo -70.3 -19.02 34.09 Favored 'Trans proline' 0 C--N 1.342 0.231 0 C-N-CA 122.899 2.4 . . . . 0.0 112.523 -179.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 5.7 mt -104.15 109.45 21.25 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.889 0.376 . . . . 0.0 111.071 -179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -68.56 103.26 1.0 Allowed Glycine 0 N--CA 1.451 -0.328 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.715 179.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -83.34 -28.42 29.01 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 111.962 0.356 . . . . 0.0 111.962 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -105.7 -4.77 20.6 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 111.637 0.236 . . . . 0.0 111.637 -179.297 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -133.75 128.26 34.49 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.801 0.334 . . . . 0.0 111.003 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.519 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 p -99.87 119.93 58.41 Favored Pre-proline 0 C--N 1.324 -0.503 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.804 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.519 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.2 Cg_endo -82.7 37.18 0.65 Allowed 'Trans proline' 0 CA--C 1.53 0.292 0 C-N-CA 123.344 2.696 . . . . 0.0 112.912 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -147.8 150.47 34.28 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.182 179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.0 m -98.76 116.43 30.98 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 179.619 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -79.65 143.02 58.03 Favored Pre-proline 0 C--N 1.325 -0.475 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.34 -179.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.37 102.24 0.46 Allowed 'Trans proline' 0 C--N 1.343 0.278 0 C-N-CA 123.251 2.634 . . . . 0.0 111.899 179.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -72.49 -174.12 1.29 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.416 -0.811 . . . . 0.0 111.095 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -51.69 -37.8 52.25 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.104 -0.953 . . . . 0.0 112.292 -179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -64.13 -38.67 91.89 Favored 'General case' 0 C--N 1.332 -0.168 0 C-N-CA 121.102 -0.239 . . . . 0.0 110.939 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.49 -35.25 68.13 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 178.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.519 ' HB2' HD13 ' A' ' 42' ' ' LEU . 3.0 tp -71.66 -43.19 66.5 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.874 -0.603 . . . . 0.0 111.149 179.782 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 4.3 p -65.85 -33.23 62.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 120.971 0.415 . . . . 0.0 110.159 179.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.15 -24.77 59.45 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.456 179.04 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -76.36 -63.16 1.39 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.141 179.897 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -55.54 -51.77 65.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.619 -179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.43 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -68.62 -38.94 79.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.789 0.328 . . . . 0.0 110.281 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.63 -51.78 55.3 Favored Glycine 0 N--CA 1.447 -0.58 0 C-N-CA 120.902 -0.666 . . . . 0.0 112.477 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.791 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.3 t80 -61.38 -42.27 98.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.906 0.384 . . . . 0.0 110.847 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.475 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 0.1 OUTLIER -62.61 -46.81 86.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.732 179.975 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.603 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -68.24 -44.72 75.04 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.069 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.737 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -59.6 -29.14 67.76 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.734 -179.698 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.475 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 2.2 pt20 -85.84 -22.94 27.33 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -179.217 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -147.84 65.75 1.11 Allowed 'General case' 0 C--O 1.234 0.276 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 -178.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.26 -70.45 0.31 Allowed Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.102 -1.047 . . . . 0.0 112.965 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.432 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -89.83 51.14 2.01 Favored 'General case' 0 C--N 1.317 -0.843 0 CA-C-O 121.213 0.53 . . . . 0.0 110.155 179.811 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.5 p -78.88 -28.24 13.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.545 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 2.0 m -71.63 -29.26 64.46 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.451 0.643 . . . . 0.0 109.465 178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -95.94 57.87 1.52 Allowed Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.603 -0.999 . . . . 0.0 110.603 178.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.737 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.51 112.5 3.17 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.276 -0.462 . . . . 0.0 110.855 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.491 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 178.57 -58.84 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.08 -1.057 . . . . 0.0 113.403 -179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_exo -57.86 -48.95 14.42 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 122.227 1.951 . . . . 0.0 111.992 -179.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.791 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.16 32.69 5.96 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.819 -0.628 . . . . 0.0 112.709 179.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -85.3 -20.63 29.72 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.908 0.385 . . . . 0.0 110.109 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.405 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -94.86 145.6 17.79 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.914 179.362 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.405 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 65.8 Cg_endo -97.55 -159.87 0.05 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.995 0 C-N-CA 123.199 2.599 . . . . 0.0 113.647 -178.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.702 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -81.59 84.41 6.77 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.125 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -125.05 1.19 7.95 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.034 0.445 . . . . 0.0 111.273 -179.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.451 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 40.6 m-20 -104.98 163.0 18.05 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.58 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -80.12 47.03 2.4 Favored 'Trans proline' 0 N--CA 1.461 -0.405 0 C-N-CA 123.443 2.762 . . . . 0.0 111.85 179.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.519 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -175.07 -31.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.71 -1.132 . . . . 0.0 108.755 179.437 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.702 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.3 m170 -58.0 -58.82 6.71 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.386 -0.824 . . . . 0.0 110.342 179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.54 ' CA ' ' HB1' ' A' ' 38' ' ' ALA . 4.0 tt0 -58.18 -25.02 61.03 Favored 'General case' 0 N--CA 1.463 0.212 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.867 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.867 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.27 -50.31 16.49 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.266 179.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.462 ' HE1' HD21 ' A' ' 13' ' ' LEU . 3.2 ttm -66.89 -37.6 84.7 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 111.993 0.368 . . . . 0.0 111.993 -179.105 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.577 HH11 ' HB2' ' A' ' 48' ' ' ALA . 0.0 OUTLIER -60.82 -33.8 73.57 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.89 0.33 . . . . 0.0 111.89 -179.044 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . 0.577 ' HB2' HH11 ' A' ' 47' ' ' ARG . . . -80.33 -42.01 23.74 Favored 'General case' 0 CA--C 1.514 -0.422 0 C-N-CA 120.789 -0.365 . . . . 0.0 110.324 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.862 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.16 -54.89 41.82 Favored 'General case' 0 N--CA 1.45 -0.427 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.523 178.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -51.6 -50.58 41.93 Favored Glycine 0 C--O 1.22 -0.726 0 CA-C-N 115.469 -0.787 . . . . 0.0 112.294 179.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -54.36 -50.05 68.36 Favored 'General case' 0 N--CA 1.467 0.405 0 CA-C-O 121.177 0.513 . . . . 0.0 110.96 179.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -58.39 -48.48 80.49 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.136 -179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.747 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -71.28 -33.46 69.77 Favored 'General case' 0 C--O 1.22 -0.457 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.212 -179.957 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.76 -25.34 67.88 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.55 0.691 . . . . 0.0 109.327 179.104 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 28.0 m -84.82 -37.32 20.87 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.327 178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.0 mtt180 -92.92 -61.22 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 121.073 0.463 . . . . 0.0 112.165 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -76.9 69.7 3.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.402 0.681 . . . . 0.0 111.235 -179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 8.4 mtm180 -77.82 -16.97 57.93 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.494 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.2 ttt85 -81.39 46.43 0.94 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.857 0.36 . . . . 0.0 111.476 -179.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 13.7 t -120.98 -6.45 9.53 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.885 0.374 . . . . 0.0 111.047 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.819 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.8 m-85 -92.98 -26.31 17.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.874 0.369 . . . . 0.0 111.401 -179.413 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.51 -39.3 93.08 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.538 -179.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -66.55 -24.99 66.44 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.621 -178.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.819 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -66.16 -41.29 90.57 Favored 'General case' 0 C--N 1.32 -0.699 0 N-CA-C 108.824 -0.806 . . . . 0.0 108.824 178.803 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.46 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -76.67 -46.65 24.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 114.948 -1.024 . . . . 0.0 110.086 179.085 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.678 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -50.26 -43.03 53.0 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.193 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.65 HE22 HD11 ' A' ' 106' ' ' LEU . 25.0 mt-30 -67.57 -59.32 3.45 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.877 -0.602 . . . . 0.0 111.938 179.545 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.506 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.35 16.06 1.42 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -177.654 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.46 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.4 OUTLIER -78.62 -26.8 45.37 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.778 0.323 . . . . 0.0 110.529 179.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.551 HG13 ' H ' ' A' ' 71' ' ' THR . 3.4 p -93.01 -60.11 2.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.449 179.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.551 ' H ' HG13 ' A' ' 70' ' ' VAL . 8.6 t -174.69 146.96 1.07 Allowed Pre-proline 0 N--CA 1.454 -0.249 0 N-CA-C 110.246 -0.279 . . . . 0.0 110.246 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -77.58 178.12 8.0 Favored 'Trans proline' 0 N--CA 1.46 -0.472 0 C-N-CA 122.771 2.314 . . . . 0.0 111.534 179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.714 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 101.91 -76.62 0.35 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.463 -0.875 . . . . 0.0 112.947 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -73.81 48.96 0.3 Allowed 'General case' 0 N--CA 1.465 0.299 0 CA-C-O 121.176 0.512 . . . . 0.0 111.77 -179.384 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.417 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -95.37 -24.01 16.91 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.771 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.68 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 5.9 pt20 -60.66 -42.0 96.15 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.845 -178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -60.84 -47.24 87.26 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.719 0.295 . . . . 0.0 110.54 179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 10.8 mtt180 -62.83 -42.2 99.63 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.07 178.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.3 t80 -63.12 -51.62 65.82 Favored 'General case' 0 N--CA 1.454 -0.225 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.282 179.324 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.1 p -55.86 -32.93 64.08 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.709 -0.223 . . . . 0.0 111.383 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.452 HE21 ' HB3' ' A' ' 81' ' ' GLN . 0.8 OUTLIER -60.18 -65.0 0.75 Allowed 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.118 0.485 . . . . 0.0 110.611 179.16 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.82 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.4 m -58.45 -32.2 44.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-N 114.991 -1.004 . . . . 0.0 111.594 -179.337 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 40.9 m -65.79 -43.6 88.26 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.857 0.361 . . . . 0.0 110.106 179.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.458 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.4 OUTLIER -71.28 -33.73 70.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.946 179.087 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -71.46 -29.82 65.3 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.338 179.054 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.37 -34.82 31.48 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.909 -179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -87.65 -8.64 55.92 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.099 -179.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -44.22 -45.15 8.34 Favored 'General case' 0 N--CA 1.464 0.273 0 N-CA-C 112.492 0.553 . . . . 0.0 112.492 -179.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -170.66 63.37 0.17 Allowed Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.218 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.557 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.8 55.83 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.718 -1.23 . . . . 0.0 114.792 178.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.567 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 15.7 Cg_endo -80.47 38.38 0.75 Allowed 'Trans proline' 0 C--N 1.349 0.571 0 C-N-CA 122.116 1.877 . . . . 0.0 111.569 177.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.839 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.4 t-20 -68.3 162.76 24.46 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.668 -0.696 . . . . 0.0 112.089 -178.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.481 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 25.8 m95 -53.53 -26.98 23.28 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.372 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.491 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.71 -42.3 98.69 Favored Glycine 0 N--CA 1.445 -0.76 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 178.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.71 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.9 mtp180 -86.72 -22.47 26.0 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.696 -0.252 . . . . 0.0 110.82 179.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.824 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -54.31 -31.69 54.69 Favored 'General case' 0 C--O 1.235 0.299 0 CA-C-O 121.247 0.546 . . . . 0.0 110.25 179.601 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.862 HG22 ' HB1' ' A' ' 49' ' ' ALA . 9.5 t -61.62 -56.84 15.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.2 -0.909 . . . . 0.0 109.399 178.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.41 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.5 -27.56 69.36 Favored 'General case' 0 C--O 1.222 -0.38 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.618 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.824 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.3 m-85 -57.07 -55.82 29.75 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.054 0.454 . . . . 0.0 109.942 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.585 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 12.5 m-85 -75.96 -38.68 57.28 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.938 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.41 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 5.8 t -60.85 -37.66 77.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.356 -179.41 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.547 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -55.74 -50.5 70.2 Favored 'General case' 0 CA--C 1.523 -0.083 0 CA-C-O 120.77 0.319 . . . . 0.0 111.219 179.973 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.21 -38.44 34.41 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.272 -0.966 . . . . 0.0 113.056 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.75 -44.5 96.78 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.081 0.44 . . . . 0.0 110.902 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.546 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.74 -38.27 80.01 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.724 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.13 -45.19 95.7 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.186 179.048 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.603 ' HB2' HD11 ' A' ' 22' ' ' LEU . 85.2 m -63.86 -42.51 97.53 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.2 -0.909 . . . . 0.0 111.034 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.15 -55.43 31.21 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.733 0.302 . . . . 0.0 110.843 179.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -67.97 -16.12 63.91 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 111.978 0.362 . . . . 0.0 111.978 179.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 57.7 m -77.98 -33.83 51.18 Favored 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 179.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.501 HG23 ' O ' ' A' ' 107' ' ' CYS . 22.2 t -77.08 -20.85 14.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.708 0.766 . . . . 0.0 109.019 177.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 13.3 m-80 -82.09 -2.33 51.59 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.235 179.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 12.3 mtmt -138.27 -155.13 0.57 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.279 -179.684 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -99.16 53.64 0.97 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.908 0.385 . . . . 0.0 110.698 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.506 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -127.66 44.87 2.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.934 0.397 . . . . 0.0 110.693 -179.676 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.582 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 8.7 mt-10 -54.08 -56.2 28.44 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -179.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.582 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 22.0 Cg_exo -66.54 -32.13 40.02 Favored 'Trans proline' 0 C--N 1.356 0.96 0 C-N-CA 122.018 1.812 . . . . 0.0 112.954 -179.043 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.714 HD21 ' H ' ' A' ' 73' ' ' GLY . 3.9 mp -59.57 -31.93 69.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.588 -179.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 90.4 t -57.11 -53.74 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.736 0.303 . . . . 0.0 111.392 179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.6 -33.42 86.17 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.084 -179.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.589 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 4.5 mm100 -65.09 -50.81 64.69 Favored 'General case' 0 C--O 1.219 -0.54 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.8 t -57.87 -35.07 50.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 178.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -63.02 -47.07 84.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.315 178.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.703 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.9 pt-20 -71.49 -39.04 71.12 Favored 'General case' 0 N--CA 1.455 -0.177 0 CA-C-N 116.549 -0.296 . . . . 0.0 111.008 179.779 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.68 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 35.7 m0 -58.1 -38.08 75.76 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-O 121.709 0.766 . . . . 0.0 109.128 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.585 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.6 ttm -73.1 -55.6 6.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.646 -1.161 . . . . 0.0 111.67 -179.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.703 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.7 p -60.3 -33.34 53.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 -178.621 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -70.12 -50.89 36.04 Favored 'General case' 0 CA--C 1.52 -0.179 0 C-N-CA 120.772 -0.371 . . . . 0.0 110.598 179.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.458 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 9.5 t80 -58.2 -33.59 69.44 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.465 0.65 . . . . 0.0 110.85 179.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.846 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.89 -52.51 9.33 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.36 -0.837 . . . . 0.0 113.116 -178.376 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 -34.76 76.57 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.7 m -81.72 -39.21 24.57 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 113.729 1.011 . . . . 0.0 113.729 -178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -116.87 -43.32 2.89 Favored 'General case' 0 N--CA 1.466 0.351 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 -177.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.846 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.9 mm? -61.61 -44.08 97.67 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.295 -178.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.27 -34.62 61.22 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-N 116.491 -0.322 . . . . 0.0 111.62 179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -66.69 -53.7 30.84 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.839 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.1 t90 -56.68 -46.69 81.01 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 109.437 -0.579 . . . . 0.0 109.437 178.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.51 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.29 -49.05 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.418 -179.366 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 20.1 m170 -64.07 -34.97 79.23 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 111.468 0.173 . . . . 0.0 111.468 -179.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 16.1 m -80.97 -13.28 59.02 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 112.312 0.486 . . . . 0.0 112.312 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.05 -43.38 8.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.851 0.358 . . . . 0.0 111.959 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 169.9 -26.86 0.11 Allowed Glycine 0 CA--C 1.502 -0.721 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.51 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 102.99 171.29 26.27 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 120.844 -0.693 . . . . 0.0 113.061 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.0 m95 -58.78 -29.47 66.84 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 110.049 -0.352 . . . . 0.0 110.049 179.557 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.65 -34.87 79.23 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 115.587 -0.733 . . . . 0.0 110.821 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.481 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.29 -41.01 97.08 Favored 'General case' 0 N--CA 1.461 0.1 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 178.648 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.524 ' HE1' HH21 ' A' ' 163' ' ' ARG . 9.7 t80 -66.01 -35.27 80.11 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 114.843 -1.071 . . . . 0.0 110.499 178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.867 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -67.02 -29.1 68.83 Favored 'General case' 0 C--O 1.223 -0.339 0 CA-C-O 120.663 0.268 . . . . 0.0 111.127 179.571 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -26.72 24.91 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.186 0.517 . . . . 0.0 109.976 179.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.442 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 8.6 mt -71.2 -40.98 70.85 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.773 -179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.503 ' HD1' ' HA ' ' A' ' 151' ' ' TYR . 0.1 OUTLIER -130.65 31.79 4.49 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.002 0.429 . . . . 0.0 111.153 -179.461 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.545 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.29 -133.18 7.57 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.111 -1.042 . . . . 0.0 112.527 -179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -82.14 -43.27 17.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.162 0.506 . . . . 0.0 110.302 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.455 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -87.71 52.27 4.2 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.454 179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.31 73.62 10.44 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.154 0.502 . . . . 0.0 110.077 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.714 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.3 OUTLIER -62.79 169.97 2.88 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.484 -0.78 . . . . 0.0 111.425 -179.26 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -56.47 -33.93 66.41 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.403 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.714 ' HB2' HD12 ' A' ' 156' ' ' LEU . 23.1 mt-10 -72.15 -45.22 61.37 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.69 0.281 . . . . 0.0 110.524 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.97 -42.68 99.4 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.242 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 11.7 mtm180 -62.48 -50.7 70.37 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.795 -179.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.9 ptp180 -66.62 -35.4 80.08 Favored 'General case' 0 C--N 1.331 -0.212 0 C-N-CA 121.12 -0.232 . . . . 0.0 110.999 -179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 2.9 mt -67.94 -29.89 69.07 Favored 'General case' 0 C--O 1.224 -0.28 0 CA-C-N 116.533 -0.303 . . . . 0.0 110.361 179.447 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.524 HH21 ' HE1' ' A' ' 147' ' ' PHE . 0.0 OUTLIER -69.22 -48.27 62.43 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.554 179.781 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.545 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.4 OUTLIER -67.43 -44.33 79.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.587 179.807 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.87 -25.32 73.13 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.667 -0.777 . . . . 0.0 111.989 179.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.611 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -69.13 -51.22 40.56 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-O 120.571 0.224 . . . . 0.0 111.379 -179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.871 ' HA ' HG22 ' A' ' 170' ' ' VAL . 19.5 p-90 -71.98 -21.23 61.61 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.519 -0.472 . . . . 0.0 111.239 -179.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.69 -41.71 82.17 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.309 0.576 . . . . 0.0 110.142 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.417 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.1 OUTLIER -86.26 -32.84 20.9 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.62 -0.718 . . . . 0.0 112.572 -179.717 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.871 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.5 m -86.99 -31.22 5.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.443 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 -177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 5.8 ttt180 -73.13 -32.97 65.26 Favored 'General case' 0 C--N 1.321 -0.673 0 O-C-N 121.938 -0.477 . . . . 0.0 110.413 -179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.837 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.6 OUTLIER -85.63 -27.6 25.31 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.095 -179.515 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.5 p -71.0 -26.4 27.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-O 121.007 0.432 . . . . 0.0 110.644 179.638 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 1.1 mt -120.46 39.54 3.71 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.298 0.571 . . . . 0.0 110.388 179.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.837 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.3 OUTLIER -62.42 -29.93 70.85 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.431 -0.804 . . . . 0.0 111.794 -179.696 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -84.67 40.88 2.99 Favored Glycine 0 CA--C 1.518 0.268 0 C-N-CA 121.179 -0.534 . . . . 0.0 113.496 -179.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -105.0 10.56 34.09 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.355 0.598 . . . . 0.0 109.896 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -86.86 57.98 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.668 179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.413 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -85.47 -4.7 59.24 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.366 -0.379 . . . . 0.0 111.694 -179.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.82 ' HG ' HG11 ' A' ' 82' ' ' VAL . 9.2 mt -87.11 -17.78 32.0 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.937 0.398 . . . . 0.0 110.865 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.3 89.18 0.8 Allowed Glycine 0 N--CA 1.448 -0.537 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.752 -179.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.678 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -95.86 142.0 28.64 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.248 1.02 0 CA-C-O 118.719 -0.658 . . . . 0.0 110.066 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.825 0 N-CA-C 111.799 -0.52 . . . . 0.0 111.799 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_exo -71.33 95.27 0.68 Allowed 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 123.013 2.475 . . . . 0.0 112.141 -179.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' -2' ' ' LEU . 0.6 OUTLIER -68.12 -37.45 81.12 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.438 179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 161.64 -129.15 2.04 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 110.776 -0.929 . . . . 0.0 110.776 -179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -76.0 134.65 40.09 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.813 0.34 . . . . 0.0 110.887 179.336 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.1 ttm -112.03 137.55 49.9 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.307 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.82 125.38 45.75 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.935 -179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.446 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.1 p -99.8 123.92 45.82 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.671 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 23.6 Cg_exo -63.98 124.52 13.67 Favored 'Trans proline' 0 C--N 1.343 0.267 0 C-N-CA 122.673 2.249 . . . . 0.0 112.127 -179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -74.64 -43.08 57.16 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.978 -179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 37.7 m -160.18 156.72 27.1 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.497 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -148.96 136.38 10.99 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.251 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.497 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.8 Cg_exo -78.28 55.17 5.28 Favored 'Trans proline' 0 CA--C 1.529 0.258 0 C-N-CA 123.362 2.708 . . . . 0.0 112.003 -179.751 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -81.58 -162.85 0.56 Allowed 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.628 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.28 -36.88 71.56 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.997 -179.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.51 -37.84 87.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.804 0.335 . . . . 0.0 110.637 179.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.79 -35.62 62.51 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.297 179.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.408 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.2 tp -73.69 -40.47 63.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.333 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.714 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 6.7 p -65.19 -37.71 80.85 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.146 0 CA-C-O 120.839 0.352 . . . . 0.0 110.06 179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.7 -24.65 59.96 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 178.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -75.69 -60.33 2.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.698 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -59.12 -56.04 27.3 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.684 -179.346 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.429 ' O ' HD13 ' A' ' 22' ' ' LEU . 95.9 t -64.32 -38.99 83.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 -179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.504 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.82 -52.22 53.72 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.735 -0.745 . . . . 0.0 111.886 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.795 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 41.2 t80 -62.1 -41.57 98.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.696 0.284 . . . . 0.0 110.869 -179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.93 -42.03 97.47 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.782 -179.806 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.5 mp -71.21 -45.17 63.91 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.855 179.202 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.555 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 26.5 ttp85 -65.56 -15.56 62.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.659 179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -83.36 -36.07 24.64 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.87 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 3.1 pttt -153.6 78.43 1.14 Allowed 'General case' 0 C--O 1.235 0.294 0 CA-C-O 120.961 0.41 . . . . 0.0 111.836 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.95 -68.38 0.33 Allowed Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.444 179.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.44 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.6 t80 -91.85 56.52 2.95 Favored 'General case' 0 C--N 1.317 -0.839 0 CA-C-O 121.165 0.507 . . . . 0.0 110.01 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 8.7 p -78.56 -32.36 16.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.87 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 34.7 m -70.54 -33.31 71.01 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.401 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -91.09 56.25 3.26 Favored Glycine 0 N--CA 1.445 -0.756 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.399 178.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.555 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -68.21 112.26 5.02 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-N 115.527 -0.336 . . . . 0.0 110.416 -179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.23 -51.73 0.12 Allowed Glycine 0 CA--C 1.521 0.446 0 C-N-CA 119.88 -1.153 . . . . 0.0 113.849 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.504 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 38.4 Cg_exo -63.47 -43.71 16.74 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 122.093 1.862 . . . . 0.0 111.586 -179.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.795 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.95 32.36 7.54 Favored Glycine 0 N--CA 1.443 -0.887 0 CA-C-N 115.107 -0.952 . . . . 0.0 112.659 179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -87.87 -14.26 39.86 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.135 0.493 . . . . 0.0 110.242 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.0 142.18 15.89 Favored Glycine 0 N--CA 1.447 -0.57 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.781 179.18 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.2 Cg_endo -94.39 -154.63 0.04 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.033 2.489 . . . . 0.0 113.242 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.611 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -85.23 80.15 9.29 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.628 179.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.51 16.31 8.89 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.783 0.325 . . . . 0.0 111.809 -178.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.441 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 13.1 m-20 -126.57 157.81 69.64 Favored Pre-proline 0 N--CA 1.449 -0.509 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 40' ' ' ASP . 2.9 Cg_exo -71.36 36.58 0.3 Allowed 'Trans proline' 0 N--CA 1.474 0.34 0 C-N-CA 124.251 3.3 . . . . 0.0 113.12 179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.408 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -167.81 -27.78 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.398 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.611 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.2 m170 -59.66 -55.25 36.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.959 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.502 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.1 -22.42 66.85 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.942 -179.879 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.728 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -76.76 -48.73 17.81 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.994 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.406 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 1.0 OUTLIER -68.98 -32.91 72.82 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.368 -179.62 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.417 HH11 ' HD3' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.25 -43.02 96.48 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.843 -179.499 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.97 -31.13 50.64 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-O 121.23 0.538 . . . . 0.0 110.174 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.861 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -62.64 -62.19 1.91 Allowed 'General case' 0 N--CA 1.447 -0.619 0 CA-C-N 115.546 -0.752 . . . . 0.0 109.278 178.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.698 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.15 -48.34 32.33 Favored Glycine 0 C--O 1.219 -0.8 0 CA-C-N 115.117 -0.947 . . . . 0.0 112.834 179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -56.96 -45.5 82.82 Favored 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 117.124 0.462 . . . . 0.0 111.537 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.99 -44.9 96.72 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.936 179.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.695 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -76.93 -28.19 55.17 Favored 'General case' 0 C--O 1.222 -0.368 0 C-N-CA 120.76 -0.376 . . . . 0.0 111.097 -179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -65.98 -23.09 66.52 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 108.364 -0.976 . . . . 0.0 108.364 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 17.5 m -94.85 -39.19 10.37 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-N 114.726 -1.124 . . . . 0.0 111.101 178.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.401 HH11 ' HD3' ' A' ' 56' ' ' ARG . 2.7 mtt180 -84.81 -57.71 3.0 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.385 0.513 . . . . 0.0 112.385 -179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -82.83 73.6 9.85 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 122.986 0.514 . . . . 0.0 111.383 -179.058 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.41 HH11 ' HD3' ' A' ' 58' ' ' ARG . 12.6 mtt180 -76.5 -10.28 59.27 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.522 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.65 54.43 3.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.866 0.365 . . . . 0.0 110.838 -179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -121.33 -57.43 1.84 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.052 0.453 . . . . 0.0 111.875 -178.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.56 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 70.5 m-85 -55.17 -31.74 61.61 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 113.18 0.807 . . . . 0.0 113.18 -178.265 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.91 -39.04 87.3 Favored 'General case' 0 C--N 1.321 -0.671 0 N-CA-C 112.18 0.437 . . . . 0.0 112.18 -179.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.8 m-20 -70.69 -20.56 62.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.055 0.455 . . . . 0.0 110.267 179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.56 ' CD1' ' HA ' ' A' ' 61' ' ' PHE . 25.0 mt -70.13 -41.43 73.94 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 177.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.569 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.99 -43.97 61.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.073 -0.967 . . . . 0.0 110.09 179.424 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.664 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -54.84 -43.63 73.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.905 -0.589 . . . . 0.0 110.616 179.008 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.48 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 26.9 mt-30 -63.22 -58.07 8.38 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.448 179.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -80.43 8.02 8.53 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 -177.178 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.569 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 11.9 t60 -79.0 -23.06 44.64 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.825 0.345 . . . . 0.0 110.6 179.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.37 -63.47 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.767 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.41 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 9.0 t -172.88 144.47 1.22 Allowed Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.182 -179.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.449 ' HG3' ' HE3' ' A' ' 115' ' ' MET . 5.8 Cg_exo -77.85 171.71 16.85 Favored 'Trans proline' 0 N--CA 1.46 -0.471 0 C-N-CA 122.88 2.387 . . . . 0.0 111.598 179.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.641 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 97.54 -60.8 1.04 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.579 -0.819 . . . . 0.0 113.342 179.218 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.28 19.19 0.13 Allowed 'General case' 0 CA--C 1.534 0.344 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -179.104 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -75.9 -22.37 56.16 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.606 0.241 . . . . 0.0 111.185 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.632 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -62.06 -39.5 92.62 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 112.079 0.4 . . . . 0.0 112.079 -179.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.623 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 3.9 mt-30 -67.62 -46.29 72.92 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.477 179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -59.86 -45.12 93.47 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.813 0.34 . . . . 0.0 110.154 179.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 21.2 t80 -62.35 -51.74 66.42 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.928 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.7 p -59.24 -33.81 71.46 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 111.666 0.247 . . . . 0.0 111.666 -179.774 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.623 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 74.4 mm-40 -63.56 -50.67 68.59 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-O 121.126 0.489 . . . . 0.0 109.991 179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.727 HG12 HD12 ' A' ' 86' ' ' LEU . 65.5 t -63.7 -37.34 79.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.461 179.209 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 25.7 m -61.64 -46.73 88.52 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.756 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.646 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.37 -39.45 93.9 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.113 0.482 . . . . 0.0 110.243 179.435 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.456 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.0 mm-40 -67.91 -28.68 67.71 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.28 179.043 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.727 HD12 HG12 ' A' ' 82' ' ' VAL . 0.3 OUTLIER -76.61 -38.57 54.55 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.734 179.673 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.405 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 26.9 t80 -82.29 -8.79 59.64 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.02 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -47.16 -38.58 12.03 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.807 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.4 57.1 0.06 OUTLIER Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.171 -1.014 . . . . 0.0 113.131 179.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.554 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 173.7 50.93 0.05 OUTLIER Glycine 0 CA--C 1.523 0.551 0 C-N-CA 119.498 -1.334 . . . . 0.0 115.098 178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.554 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 9.4 Cg_endo -82.35 23.89 0.76 Allowed 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.454 2.102 . . . . 0.0 111.249 177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.793 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.3 m-20 -63.94 158.0 23.44 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.254 -0.885 . . . . 0.0 111.078 -178.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.668 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 5.8 m95 -50.35 -24.97 3.33 Favored 'General case' 0 N--CA 1.47 0.561 0 N-CA-C 112.49 0.552 . . . . 0.0 112.49 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.23 -49.94 66.95 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.467 -0.873 . . . . 0.0 110.955 178.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.736 ' HD2' HD12 ' A' ' 174' ' ' LEU . 8.4 mtt180 -86.66 -18.67 30.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.629 -0.285 . . . . 0.0 111.052 179.18 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.672 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.13 -31.51 63.38 Favored 'General case' 0 C--O 1.238 0.499 0 CA-C-O 121.471 0.653 . . . . 0.0 110.259 179.794 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.861 HG22 ' HB1' ' A' ' 49' ' ' ALA . 28.8 t -60.99 -52.63 59.44 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 CA-C-N 115.176 -0.92 . . . . 0.0 109.49 178.282 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.26 -27.64 69.18 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 114.988 -1.005 . . . . 0.0 111.312 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.672 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.31 -55.11 39.07 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 110.046 179.429 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.714 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 4.3 m-85 -76.65 -38.26 54.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.119 -179.875 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.06 -35.69 62.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.767 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.678 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -52.75 -60.76 2.86 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.011 0.434 . . . . 0.0 111.551 179.844 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -70.23 -34.54 69.54 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 120.536 -0.84 . . . . 0.0 113.143 -179.299 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.31 -46.0 90.72 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.288 0.544 . . . . 0.0 110.517 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.526 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.05 -39.94 82.94 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.459 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.2 OUTLIER -60.59 -44.92 95.7 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.663 179.382 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.65 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.7 m -66.51 -40.73 89.35 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.133 -0.94 . . . . 0.0 111.203 179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.68 -54.6 42.21 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.185 -179.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -70.82 -15.46 62.65 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.139 0.422 . . . . 0.0 112.139 -179.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 56.1 m -78.31 -33.07 49.55 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.786 -0.45 . . . . 0.0 109.786 178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 107' ' ' CYS . 47.3 t -75.45 -31.67 24.06 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.166 0 CA-C-O 121.347 0.594 . . . . 0.0 109.556 178.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 59.3 m-80 -77.12 0.7 20.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.165 -0.925 . . . . 0.0 111.208 179.829 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.695 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -132.53 -151.45 0.46 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.554 -0.294 . . . . 0.0 110.813 -179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.418 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 1.3 mt-10 -108.69 51.09 0.75 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.83 0.348 . . . . 0.0 111.353 -179.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.695 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -146.87 42.24 1.13 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.215 0.531 . . . . 0.0 110.593 179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -60.69 -45.84 97.05 Favored Pre-proline 0 CA--C 1.54 0.579 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.344 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -58.13 -16.98 29.71 Favored 'Trans proline' 0 C--N 1.358 1.078 0 C-N-CA 122.279 1.986 . . . . 0.0 113.298 -179.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.641 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.4 OUTLIER -82.42 -22.51 35.3 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.757 -0.201 . . . . 0.0 110.606 179.666 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.458 HG13 ' HB3' ' A' ' 107' ' ' CYS . 49.9 t -56.02 -54.76 23.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.243 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.58 -31.43 77.69 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.438 -0.886 . . . . 0.0 111.968 179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.548 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.5 mm-40 -67.34 -50.92 58.0 Favored 'General case' 0 C--O 1.217 -0.615 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.588 HG23 ' O ' ' A' ' 118' ' ' LEU . 30.5 t -57.84 -33.86 46.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 121.118 0.485 . . . . 0.0 109.767 178.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.7 tt0 -65.33 -46.8 78.82 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.574 -0.739 . . . . 0.0 110.293 178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.79 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.9 pt-20 -73.55 -35.12 65.47 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.021 179.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.632 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.5 m0 -58.92 -40.71 85.37 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 178.435 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.5 ttm -72.45 -52.79 14.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.194 -1.366 . . . . 0.0 111.849 -179.036 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.79 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -62.01 -32.22 53.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 N-CA-C 111.776 0.287 . . . . 0.0 111.776 -178.847 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -68.02 -52.64 33.26 Favored 'General case' 0 CA--C 1.518 -0.261 0 C-N-CA 120.371 -0.532 . . . . 0.0 109.994 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.646 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 6.4 t80 -56.6 -34.72 67.47 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.56 0.695 . . . . 0.0 110.81 179.292 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.061 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -76.45 -53.37 8.22 Favored 'General case' 0 C--N 1.317 -0.841 0 CA-C-N 115.429 -0.805 . . . . 0.0 112.454 -178.963 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.447 ' HG3' HG22 ' A' ' 127' ' ' VAL . 10.9 mt-10 -62.6 -32.01 72.94 Favored 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 111.835 0.309 . . . . 0.0 111.835 -178.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 12.1 m -86.75 -43.61 12.42 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 113.339 0.866 . . . . 0.0 113.339 -178.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.33 -44.5 3.11 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 114.16 1.17 . . . . 0.0 114.16 -177.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.061 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.7 OUTLIER -59.97 -42.27 93.76 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 118.348 0.522 . . . . 0.0 111.632 -178.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.32 -31.1 53.42 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.591 179.821 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -66.7 -53.4 34.02 Favored 'General case' 0 C--O 1.234 0.255 0 N-CA-C 110.016 -0.365 . . . . 0.0 110.016 179.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.793 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 57.9 t90 -59.09 -46.93 87.02 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 178.422 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.492 HG13 ' HE3' ' A' ' 137' ' ' TRP . 3.5 mt -57.07 -46.86 84.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.959 -179.153 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 36.3 m170 -67.55 -29.28 68.63 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.9 m -94.52 -2.06 52.32 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 120.8 0.333 . . . . 0.0 111.434 -179.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.51 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.2 OUTLIER -126.37 48.62 2.11 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.141 0.496 . . . . 0.0 111.176 -179.74 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 96.78 -67.41 0.92 Allowed Glycine 0 CA--C 1.505 -0.585 0 C-N-CA 120.432 -0.889 . . . . 0.0 112.554 179.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 124.79 177.23 14.85 Favored Glycine 0 N--CA 1.445 -0.764 0 C-N-CA 120.908 -0.663 . . . . 0.0 111.974 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.406 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 96.5 m95 -60.93 -28.84 69.24 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 110.023 -0.362 . . . . 0.0 110.023 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.48 -30.07 69.67 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.794 178.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.668 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -68.6 -38.96 81.05 Favored 'General case' 0 C--N 1.333 -0.149 0 N-CA-C 108.742 -0.836 . . . . 0.0 108.742 178.791 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.59 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 7.7 t80 -63.14 -41.44 99.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.243 -0.889 . . . . 0.0 110.363 178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.728 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -64.22 -30.85 71.88 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.067 0.46 . . . . 0.0 111.01 179.175 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.27 -16.22 35.8 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-O 121.052 0.453 . . . . 0.0 110.761 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.46 ' HA ' HD22 ' A' ' 150' ' ' LEU . 0.3 OUTLIER -77.93 -45.15 24.85 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.736 -179.568 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.35 30.3 1.57 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 112.05 0.389 . . . . 0.0 112.05 -179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -99.85 -119.86 4.38 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.083 -1.056 . . . . 0.0 112.315 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 27.0 t0 -74.22 -51.07 16.51 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.11 0.481 . . . . 0.0 110.607 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.415 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -94.13 64.53 1.68 Allowed Glycine 0 C--O 1.226 -0.379 0 C-N-CA 120.929 -0.653 . . . . 0.0 112.204 179.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.62 71.78 10.68 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.199 0.523 . . . . 0.0 110.315 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.904 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -64.24 158.16 23.95 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.846 -179.489 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -53.88 -31.71 50.77 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.141 -179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.904 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.9 mm-40 -68.19 -48.92 63.95 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.716 0.293 . . . . 0.0 110.497 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -64.15 -36.31 83.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.417 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 4.1 mtm180 -59.86 -56.1 25.97 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.928 179.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.414 HH21 ' CD ' ' A' ' 158' ' ' GLU . 19.5 ptt180 -69.44 -29.1 66.73 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 120.881 -0.327 . . . . 0.0 111.143 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.491 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -63.82 -39.93 95.4 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.506 -0.315 . . . . 0.0 110.335 179.217 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.843 HH22 ' HA ' ' A' ' 49' ' ' ALA . 4.0 ttp180 -70.06 -38.72 75.84 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.939 -0.304 . . . . 0.0 110.324 179.405 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.589 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.5 OUTLIER -62.85 -46.06 89.65 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.237 179.296 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.18 -25.33 75.53 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 120.59 -0.814 . . . . 0.0 111.195 178.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.442 ' O ' HG22 ' A' ' 170' ' ' VAL . 4.7 t-20 -67.67 -56.69 8.35 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.96 0.409 . . . . 0.0 110.972 179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.938 ' HA ' HG22 ' A' ' 170' ' ' VAL . 21.4 p-90 -67.73 -21.44 65.29 Favored 'General case' 0 N--CA 1.451 -0.389 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.412 -179.086 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.52 -52.8 52.94 Favored 'General case' 0 C--N 1.326 -0.453 0 O-C-N 123.215 0.322 . . . . 0.0 110.766 179.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 2.3 m -88.02 -26.91 22.35 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 113.114 0.783 . . . . 0.0 113.114 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.938 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.1 m -80.03 -24.64 11.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 C-N-CA 119.599 -0.84 . . . . 0.0 112.017 -178.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.697 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 13.0 ttp85 -81.09 -23.06 38.71 Favored 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 179.149 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.726 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -90.19 -35.54 15.3 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.162 -179.652 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.953 HG13 ' HG ' ' A' ' 174' ' ' LEU . 7.1 p -62.77 -30.15 48.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 121.163 0.506 . . . . 0.0 110.989 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.953 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -118.54 40.13 3.3 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.992 179.374 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.726 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.69 -25.84 67.66 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.417 0.525 . . . . 0.0 112.417 -179.828 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.34 9.34 55.12 Favored Glycine 0 CA--C 1.52 0.352 0 C-N-CA 121.026 -0.607 . . . . 0.0 113.712 -178.831 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.446 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -72.43 -7.64 50.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.011 0.405 . . . . 0.0 111.896 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -79.37 66.99 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-O 121.027 0.441 . . . . 0.0 110.513 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.45 12.65 34.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.806 -0.634 . . . . 0.0 112.236 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.517 HD11 ' CE2' ' A' ' 102' ' ' PHE . 7.9 mt -100.27 -13.67 18.76 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 120.779 -0.368 . . . . 0.0 111.114 -179.732 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -73.18 86.75 0.58 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 116.018 -0.537 . . . . 0.0 112.941 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.664 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -95.49 114.74 26.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.784 0.326 . . . . 0.0 110.355 179.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.04 -179.841 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.482 1.719 0 N-CA-C 111.751 -0.54 . . . . 0.0 111.751 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' -4' ' ' GLY . 16.0 Cg_exo -69.17 -28.8 27.67 Favored 'Trans proline' 0 C--N 1.344 0.314 0 C-N-CA 122.951 2.434 . . . . 0.0 112.209 -179.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 67.84 92.38 0.08 Allowed 'General case' 0 N--CA 1.465 0.312 0 O-C-N 123.965 0.791 . . . . 0.0 111.785 179.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -143.62 75.59 0.31 Allowed Glycine 0 N--CA 1.447 -0.591 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.636 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 44.8 m -153.04 164.21 38.42 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.645 0.259 . . . . 0.0 110.364 -179.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ttm -123.68 128.57 49.82 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.645 -179.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -104.63 123.11 47.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.278 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 1.0 OUTLIER -99.5 140.5 21.67 Favored Pre-proline 0 C--N 1.325 -0.494 0 CA-C-N 116.396 -0.365 . . . . 0.0 110.63 -179.542 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.7 Cg_exo -77.42 4.15 6.17 Favored 'Trans proline' 0 N--CA 1.464 -0.243 0 C-N-CA 123.153 2.568 . . . . 0.0 112.436 -179.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -109.84 -28.89 8.55 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.745 -179.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 49.5 m -152.23 129.48 11.24 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.889 0.376 . . . . 0.0 110.728 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.486 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -149.74 119.22 3.84 Favored Pre-proline 0 C--N 1.326 -0.448 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.638 179.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.7 Cg_exo -78.26 53.55 4.56 Favored 'Trans proline' 0 CA--C 1.529 0.274 0 C-N-CA 123.338 2.692 . . . . 0.0 112.106 -179.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.34 -157.58 0.49 Allowed 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.942 -179.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.41 -41.45 72.75 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 122.922 0.489 . . . . 0.0 112.279 -179.322 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -61.12 -37.78 83.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.793 0.33 . . . . 0.0 110.712 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.13 -35.76 61.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.178 179.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.592 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -73.63 -42.24 61.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.477 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.559 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.0 p -64.6 -36.11 76.53 Favored 'Isoleucine or valine' 0 C--O 1.231 0.128 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.28 -25.42 60.67 Favored 'General case' 0 N--CA 1.454 -0.23 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.318 178.4 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -74.75 -65.86 0.82 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.94 179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.619 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.2 t80 -55.13 -54.77 39.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.248 0.462 . . . . 0.0 112.248 -179.202 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 59.9 t -67.61 -38.34 80.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 120.699 0.285 . . . . 0.0 110.512 -179.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -62.75 -55.39 27.25 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.723 -0.751 . . . . 0.0 111.91 179.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.697 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 5.6 t80 -60.1 -42.64 95.1 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 122.783 0.433 . . . . 0.0 110.852 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.533 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.86 -44.8 95.14 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.259 -179.635 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.76 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -71.13 -44.26 65.95 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.018 179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.675 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 16.6 ttp85 -67.64 -13.01 61.72 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.52 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.403 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 2.5 mt-30 -84.36 -37.44 21.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.229 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 6.0 pttt -154.56 83.4 1.11 Allowed 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.146 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.45 -69.13 0.35 Allowed Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.529 -0.843 . . . . 0.0 112.664 179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.3 t80 -98.68 54.79 1.04 Allowed 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.236 0.541 . . . . 0.0 110.201 179.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 9.1 p -78.67 -27.12 13.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.179 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.73 -39.16 80.52 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 178.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -86.87 57.34 4.64 Favored Glycine 0 N--CA 1.447 -0.623 0 CA-C-N 115.182 -0.917 . . . . 0.0 111.169 178.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.675 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -65.98 110.97 3.11 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.327 -0.437 . . . . 0.0 110.413 -179.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.5 -53.54 0.09 OUTLIER Glycine 0 CA--C 1.521 0.414 0 C-N-CA 119.849 -1.167 . . . . 0.0 113.878 -178.965 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.465 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 24.8 Cg_exo -65.12 -48.72 3.3 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 122.016 1.81 . . . . 0.0 111.27 -179.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.697 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.03 31.46 6.26 Favored Glycine 0 N--CA 1.444 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 112.301 179.303 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 -83.33 -19.81 35.49 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.062 0.458 . . . . 0.0 109.961 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -104.51 132.84 11.25 Favored Glycine 0 N--CA 1.445 -0.726 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.459 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -91.33 -147.34 0.03 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.617 2.211 . . . . 0.0 113.882 -178.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.66 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -75.31 76.3 2.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.839 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -124.73 31.84 5.59 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.793 0.33 . . . . 0.0 111.291 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.486 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 12.7 m-20 -142.04 163.29 41.05 Favored Pre-proline 0 C--N 1.328 -0.358 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -80.74 48.46 2.9 Favored 'Trans proline' 0 N--CA 1.463 -0.267 0 C-N-CA 123.247 2.631 . . . . 0.0 112.331 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.592 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -30.18 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.924 179.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.66 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.2 m170 -59.35 -56.47 21.64 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.322 -0.853 . . . . 0.0 110.944 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.03 -24.65 64.69 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.906 -179.727 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.926 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.31 -51.49 13.1 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.23 -179.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.456 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 5.2 ttm -68.92 -39.36 79.67 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.673 -179.249 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.8 mmm180 -61.95 -35.53 78.72 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.785 -179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -81.45 -43.76 18.42 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 120.891 -0.324 . . . . 0.0 110.518 -179.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.667 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.57 -54.32 48.35 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 178.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.619 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.2 -47.8 54.65 Favored Glycine 0 C--O 1.22 -0.762 0 CA-C-N 115.406 -0.816 . . . . 0.0 112.667 179.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -59.01 -48.51 81.33 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.213 0.53 . . . . 0.0 110.898 179.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.485 ' CD ' HH21 ' A' ' 56' ' ' ARG . 4.1 tp10 -60.03 -48.74 80.44 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.926 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.847 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -68.87 -35.24 76.66 Favored 'General case' 0 C--O 1.219 -0.509 0 CA-C-N 116.662 -0.245 . . . . 0.0 110.927 179.541 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.6 tt0 -60.98 -28.0 68.69 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.65 0.738 . . . . 0.0 109.409 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 21.1 m -85.81 -32.16 21.92 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-N 115.12 -0.945 . . . . 0.0 111.397 178.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.485 HH21 ' CD ' ' A' ' 52' ' ' GLU . 7.6 mtt180 -88.73 -21.21 23.97 Favored 'General case' 0 CA--C 1.539 0.524 0 N-CA-C 112.715 0.635 . . . . 0.0 112.715 -178.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.548 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -85.16 95.9 9.3 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.257 0.551 . . . . 0.0 111.375 -178.879 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.6 mtt180 -60.67 -32.94 72.12 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.212 -0.904 . . . . 0.0 111.482 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.564 ' HD3' ' OD1' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -108.62 94.64 5.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.126 179.746 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.548 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.41 -70.94 0.76 Allowed 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.812 -178.749 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.585 ' HA ' HD12 ' A' ' 64' ' ' LEU . 48.9 m-85 -78.51 -7.3 57.34 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 -178.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -71.43 -46.99 58.66 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 111.973 0.36 . . . . 0.0 111.973 -179.093 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.564 ' OD1' ' HD3' ' A' ' 59' ' ' ARG . 2.5 m-20 -68.71 -18.32 64.22 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 121.199 0.524 . . . . 0.0 110.472 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.585 HD12 ' HA ' ' A' ' 61' ' ' PHE . 31.8 mt -72.78 -40.41 65.96 Favored 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 108.901 -0.777 . . . . 0.0 108.901 178.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -73.45 -45.88 51.67 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.274 179.447 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.631 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -53.67 -43.17 68.64 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.325 179.204 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.435 HE22 HD11 ' A' ' 106' ' ' LEU . 22.9 mt-30 -64.06 -54.77 28.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.041 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.512 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.09 16.06 3.74 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 112.872 0.694 . . . . 0.0 112.872 -177.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -78.38 -26.53 46.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.906 0.384 . . . . 0.0 110.691 -179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.86 -68.37 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 115.782 -0.645 . . . . 0.0 111.668 -179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.423 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 6.2 t -165.92 145.72 5.32 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.501 -179.177 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.423 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 8.2 Cg_exo -72.11 176.1 8.93 Favored 'Trans proline' 0 C--N 1.345 0.352 0 C-N-CA 122.964 2.443 . . . . 0.0 111.974 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.775 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 90.64 -60.09 3.25 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.496 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -77.07 52.85 0.91 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.575 0.702 . . . . 0.0 110.967 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -108.85 -25.52 10.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.45 -0.795 . . . . 0.0 110.737 179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.714 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.3 pt20 -62.72 -35.36 79.5 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.856 -179.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.609 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 24.4 mp0 -67.35 -45.14 77.23 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 179.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 3.5 mtt180 -63.56 -44.19 94.86 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.892 0.377 . . . . 0.0 110.086 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 10.9 t80 -62.26 -49.27 76.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.789 179.634 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.5 p -59.68 -32.95 70.96 Favored 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.792 -0.363 . . . . 0.0 111.849 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.609 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 9.3 mm-40 -64.82 -54.95 23.09 Favored 'General case' 0 N--CA 1.463 0.196 0 C-N-CA 121.049 -0.26 . . . . 0.0 111.048 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.607 HG23 ' HB1' ' A' ' 177' ' ' ALA . 7.4 p -61.58 -35.3 66.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 CA-C-O 120.914 0.387 . . . . 0.0 110.406 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 22.4 m -66.99 -43.1 83.83 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.554 179.038 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -63.83 -44.52 92.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.232 0.539 . . . . 0.0 110.015 179.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.503 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 40.1 mt-10 -69.7 -18.21 63.53 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.782 179.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.1 mp -83.88 -39.74 19.49 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.146 0.498 . . . . 0.0 109.913 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 23.2 t80 -83.63 -4.86 58.94 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.257 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -44.33 -43.32 7.42 Favored 'General case' 0 N--CA 1.464 0.249 0 O-C-N 123.876 0.735 . . . . 0.0 111.666 179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 179.48 57.34 0.08 OUTLIER Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.307 -0.949 . . . . 0.0 112.93 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.444 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 168.0 56.85 0.03 OUTLIER Glycine 0 CA--C 1.522 0.486 0 C-N-CA 119.775 -1.203 . . . . 0.0 114.655 179.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.564 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.1 Cg_endo -80.5 39.8 0.9 Allowed 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.326 2.017 . . . . 0.0 111.646 177.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.81 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 11.5 t-20 -65.56 158.93 25.75 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.414 -179.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.703 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.4 m95 -54.97 -27.44 43.82 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 123.321 0.388 . . . . 0.0 110.297 179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.621 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -63.75 -39.56 97.59 Favored Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 110.736 -0.945 . . . . 0.0 110.736 178.421 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.527 ' NH1' ' HB2' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -87.3 -24.64 24.25 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.465 -0.367 . . . . 0.0 110.551 178.768 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.703 ' HB2' ' HA ' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -55.26 -30.62 60.43 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-O 121.278 0.561 . . . . 0.0 110.206 179.797 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.847 HG11 ' HB2' ' A' ' 53' ' ' PHE . 9.4 t -63.07 -53.34 47.63 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 CA-C-N 115.231 -0.895 . . . . 0.0 109.374 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.445 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -64.63 -28.09 69.38 Favored 'General case' 0 C--O 1.224 -0.286 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.282 179.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.667 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.5 m-85 -56.83 -56.82 16.73 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.131 0.491 . . . . 0.0 109.928 179.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.643 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 8.0 m-85 -76.1 -36.33 58.95 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.553 -0.748 . . . . 0.0 110.838 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.445 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 1.7 t -60.15 -38.05 75.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.095 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.544 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -58.13 -47.47 83.22 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-O 120.68 0.276 . . . . 0.0 111.061 179.942 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.6 -40.0 23.9 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.36 -0.924 . . . . 0.0 112.905 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.65 -44.51 93.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.072 0.436 . . . . 0.0 110.608 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.559 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -68.43 -41.38 80.44 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' PHE . 0.2 OUTLIER -58.75 -47.5 84.44 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.37 179.258 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.76 ' HB3' HD21 ' A' ' 22' ' ' LEU . 63.3 m -60.93 -41.45 96.23 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.256 -0.884 . . . . 0.0 111.23 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.58 -55.79 25.69 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.753 0.311 . . . . 0.0 111.144 179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -68.53 -18.18 64.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.604 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 70.8 m -77.94 -27.99 49.49 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 179.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 43.6 t -81.77 -23.03 9.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 178.143 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 25.2 m-80 -78.97 -15.26 58.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.221 -0.9 . . . . 0.0 110.632 179.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -126.9 -169.25 2.0 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.173 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -86.02 60.99 6.57 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 110.155 179.468 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.512 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.66 32.19 3.04 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.005 -179.411 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.6 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 5.9 mp0 -54.86 -51.96 74.7 Favored Pre-proline 0 CA--C 1.537 0.473 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.194 -179.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.6 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 35.3 Cg_exo -61.14 -27.45 84.07 Favored 'Trans proline' 0 C--N 1.353 0.791 0 C-N-CA 121.92 1.747 . . . . 0.0 112.433 -179.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.775 HD21 ' H ' ' A' ' 73' ' ' GLY . 2.6 mp -71.44 -26.67 62.83 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.52 -179.678 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 87.6 t -58.14 -53.6 43.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.687 0.279 . . . . 0.0 110.978 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.21 -32.71 83.56 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.621 -0.799 . . . . 0.0 111.79 179.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 117' ' ' PRO . 28.4 mt-30 -63.36 -53.68 48.73 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.492 HG23 ' O ' ' A' ' 118' ' ' LEU . 48.2 t -57.54 -33.9 45.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.05 0.452 . . . . 0.0 110.156 179.123 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.3 tt0 -64.5 -46.48 82.8 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.553 178.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.582 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.2 pt-20 -74.09 -37.72 64.09 Favored 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.975 -0.29 . . . . 0.0 110.906 179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.714 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.3 m0 -56.79 -37.43 71.13 Favored 'General case' 0 N--CA 1.469 0.509 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.487 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.643 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 3.9 ttm -72.36 -57.91 3.82 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.543 -1.208 . . . . 0.0 111.888 -179.253 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.582 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -61.36 -30.36 47.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.352 -0.386 . . . . 0.0 111.975 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -68.8 -50.55 49.29 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.148 178.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -62.26 -31.18 71.72 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.274 0.559 . . . . 0.0 111.107 179.564 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.918 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -76.3 -54.04 7.35 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.481 -178.762 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 20.9 mm-40 -61.02 -35.85 77.97 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 120.892 0.377 . . . . 0.0 111.876 -178.897 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.1 m -78.18 -36.21 47.75 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 -178.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -43.8 1.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 114.22 1.193 . . . . 0.0 114.22 -177.657 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.918 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.2 mm? -58.27 -46.51 85.88 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.394 -178.475 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.82 -35.82 45.77 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 116.144 -0.48 . . . . 0.0 112.011 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -66.19 -52.05 51.86 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 121.062 -0.255 . . . . 0.0 110.514 179.284 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.81 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 58.5 t90 -58.13 -47.65 82.65 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 178.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.5 HG23 ' HH2' ' A' ' 93' ' ' TRP . 9.2 mt -56.94 -48.1 82.13 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.438 -0.801 . . . . 0.0 111.755 -179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.2 m170 -63.31 -32.98 74.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.491 -179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.0 m -81.88 -18.38 44.0 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 112.135 0.42 . . . . 0.0 112.135 -179.245 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.0 t -84.24 -55.03 4.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.014 0.435 . . . . 0.0 111.544 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 179.46 -17.32 0.03 OUTLIER Glycine 0 CA--C 1.501 -0.794 0 N-CA-C 110.875 -0.89 . . . . 0.0 110.875 -179.217 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 100.63 171.58 29.18 Favored Glycine 0 N--CA 1.442 -0.954 0 CA-C-N 114.991 -0.604 . . . . 0.0 112.615 179.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.456 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 95.4 m95 -59.51 -28.0 66.66 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.95 0.405 . . . . 0.0 109.99 179.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.95 -34.59 78.47 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 115.499 -0.773 . . . . 0.0 110.788 178.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.58 -41.58 98.36 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.563 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.515 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.8 t80 -66.46 -34.07 77.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.49 178.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.926 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.06 -29.18 70.05 Favored 'General case' 0 C--O 1.224 -0.288 0 CA-C-O 120.768 0.318 . . . . 0.0 110.804 179.239 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.13 -26.07 27.09 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.188 0.518 . . . . 0.0 110.043 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.471 HD22 ' HB3' ' A' ' 163' ' ' ARG . 3.5 mt -73.96 -39.14 63.93 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.628 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.517 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 26.7 m-85 -126.83 29.24 5.7 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.666 -178.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.16 -140.49 5.68 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 119.614 -1.279 . . . . 0.0 113.557 -179.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.59 -54.76 12.5 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.075 -0.563 . . . . 0.0 111.414 -179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.498 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -81.25 53.59 4.66 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 121.04 -0.6 . . . . 0.0 112.72 -179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.94 72.02 10.85 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.185 0.517 . . . . 0.0 109.71 179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.922 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.09 165.47 3.35 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 115.314 -0.857 . . . . 0.0 111.627 -179.061 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.4 ' HG3' ' NH1' ' A' ' 160' ' ' ARG . 2.7 mt-10 -56.99 -33.66 67.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.327 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.922 ' HB2' HD12 ' A' ' 156' ' ' LEU . 15.8 mm-40 -71.17 -45.57 63.19 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.951 0.405 . . . . 0.0 110.305 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.695 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -59.96 -47.1 87.17 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.82 -0.627 . . . . 0.0 111.777 -179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.4 ' NH1' ' HG3' ' A' ' 157' ' ' GLU . 6.0 ptp180 -63.72 -43.37 96.73 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 112.364 0.505 . . . . 0.0 112.364 -178.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.2 ptt180 -72.11 -22.37 61.34 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.277 0.56 . . . . 0.0 110.57 179.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -78.87 -47.05 17.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.383 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.695 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -62.42 -46.52 88.22 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 120.959 -0.296 . . . . 0.0 111.419 -179.483 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.664 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.19 -44.3 95.75 Favored 'General case' 0 C--O 1.237 0.437 0 CA-C-O 120.806 0.336 . . . . 0.0 110.295 179.488 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -72.07 -10.22 72.97 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.478 -0.868 . . . . 0.0 111.757 178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.655 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -85.28 -58.05 2.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.861 -0.169 . . . . 0.0 110.82 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.716 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.37 -24.91 66.81 Favored 'General case' 0 CA--C 1.518 -0.255 0 O-C-N 123.163 0.289 . . . . 0.0 111.311 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -58.25 -41.34 84.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.092 0.472 . . . . 0.0 110.407 179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.436 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.9 OUTLIER -88.02 -28.02 21.66 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.879 0.696 . . . . 0.0 112.879 -179.726 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.716 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 3.2 m -91.16 -42.71 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.48 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -177.429 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.65 ' HD3' ' CE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -70.31 -24.83 63.08 Favored 'General case' 0 C--N 1.321 -0.655 0 O-C-N 121.534 -0.729 . . . . 0.0 111.007 -178.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.744 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.2 OUTLIER -93.21 -9.96 37.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.913 -179.877 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.537 HG12 ' O ' ' A' ' 170' ' ' VAL . 3.6 p -85.62 -23.22 7.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 121.668 0.747 . . . . 0.0 109.373 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.527 ' HB2' ' NH1' ' A' ' 95' ' ' ARG . 0.0 OUTLIER -120.35 40.33 3.5 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.232 -0.895 . . . . 0.0 109.802 178.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.744 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -69.52 -22.37 63.58 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.104 -179.292 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.45 9.8 53.23 Favored Glycine 0 CA--C 1.518 0.269 0 C-N-CA 121.027 -0.606 . . . . 0.0 113.937 -178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.607 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -76.82 7.41 4.76 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 117.095 0.448 . . . . 0.0 111.843 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -81.12 65.18 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.357 0.598 . . . . 0.0 111.09 -179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.32 13.87 33.73 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.212 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . . . . . . . . . 6.9 mp -100.12 -46.65 5.25 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.527 -0.76 . . . . 0.0 110.721 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.421 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -77.54 103.43 1.85 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.831 -0.622 . . . . 0.0 113.123 -179.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.631 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -94.51 -3.4 49.95 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.696 -0.252 . . . . 0.0 111.524 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.167 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.142 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 111.271 -0.732 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -69.6 152.72 70.17 Favored 'Trans proline' 0 C--N 1.342 0.208 0 C-N-CA 122.808 2.338 . . . . 0.0 111.888 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -107.65 136.79 46.81 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.954 0.407 . . . . 0.0 110.824 -179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -149.96 -160.17 9.11 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.548 179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 1.9 t -75.95 135.16 40.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.018 0.437 . . . . 0.0 110.821 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.1 mtt -100.04 -4.51 29.78 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.283 179.767 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -145.65 154.43 42.1 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.15 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.468 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 p -114.1 140.09 24.5 Favored Pre-proline 0 N--CA 1.447 -0.584 0 CA-C-O 120.8 0.333 . . . . 0.0 110.856 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 4.7 Cg_exo -75.42 155.1 40.98 Favored 'Trans proline' 0 C--O 1.234 0.321 0 C-N-CA 122.963 2.442 . . . . 0.0 111.874 -179.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -141.67 135.26 29.72 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 120.939 0.399 . . . . 0.0 111.162 -179.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.61 119.32 37.88 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.07 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.459 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.69 133.17 59.44 Favored Pre-proline 0 C--N 1.326 -0.454 0 CA-C-N 116.547 -0.297 . . . . 0.0 111.002 -179.584 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 7.4 Cg_exo -73.33 55.96 3.14 Favored 'Trans proline' 0 C--N 1.345 0.354 0 C-N-CA 123.358 2.705 . . . . 0.0 112.12 179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.2 t0 -85.58 -167.45 1.85 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.461 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -54.45 -37.6 65.38 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.544 179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 1.5 tpm_? -63.07 -37.04 85.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.497 -0.32 . . . . 0.0 110.734 179.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -37.72 62.15 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.849 0.357 . . . . 0.0 110.097 179.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.484 ' HB2' HD13 ' A' ' 42' ' ' LEU . 10.5 tp -70.32 -42.15 72.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.375 -0.375 . . . . 0.0 110.996 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.629 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 4.8 p -65.9 -35.39 74.99 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 CA-C-O 120.939 0.4 . . . . 0.0 110.061 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.31 -20.48 60.1 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.659 178.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -79.06 -63.65 1.37 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.72 179.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.53 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 3.1 t80 -55.35 -51.28 67.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.579 -179.357 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 99.0 t -70.14 -41.14 78.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 120.826 0.346 . . . . 0.0 110.365 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.628 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.38 -54.25 38.81 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.576 179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.736 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 58.3 t80 -60.64 -42.91 97.88 Favored 'General case' 0 C--N 1.324 -0.501 0 C-N-CA 122.537 0.335 . . . . 0.0 110.979 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.53 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -62.2 -49.09 77.16 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.337 -0.392 . . . . 0.0 110.894 179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.688 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.8 mp -65.78 -48.78 70.64 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.604 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.62 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 6.1 ttp180 -62.6 -20.34 64.64 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.827 -0.624 . . . . 0.0 111.446 -179.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.3 mt-30 -85.39 -32.58 22.31 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.311 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 18.2 tttt -148.52 75.86 1.33 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.849 0.356 . . . . 0.0 111.856 -179.088 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 148.37 -69.4 0.35 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.569 -0.824 . . . . 0.0 112.624 179.412 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.451 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.7 t80 -92.21 51.15 1.74 Allowed 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.101 0.477 . . . . 0.0 110.328 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.19 -26.52 14.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.158 -179.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 4.1 t -76.09 -16.01 59.99 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.412 178.411 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -111.39 49.28 0.86 Allowed Glycine 0 N--CA 1.446 -0.644 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.332 179.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.62 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -63.67 114.36 3.93 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.419 -0.39 . . . . 0.0 110.335 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -174.08 -48.23 0.05 OUTLIER Glycine 0 CA--C 1.522 0.5 0 C-N-CA 120.441 -0.885 . . . . 0.0 113.692 -178.641 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.628 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 6.1 Cg_exo -77.03 -48.83 0.11 Allowed 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 122.201 1.934 . . . . 0.0 111.867 -179.292 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.736 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -83.77 22.76 7.39 Favored Glycine 0 N--CA 1.449 -0.441 0 CA-C-N 115.557 -0.747 . . . . 0.0 114.229 -179.161 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.418 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 1.2 mm-40 -76.03 -32.69 59.47 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 117.37 0.585 . . . . 0.0 109.86 179.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -101.61 111.95 4.23 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.634 -0.986 . . . . 0.0 110.634 178.787 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.489 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 84.1 Cg_endo -84.54 -139.15 0.02 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 122.563 2.175 . . . . 0.0 114.264 -177.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.733 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -70.03 80.32 0.49 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.137 -0.938 . . . . 0.0 112.821 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -127.58 -0.41 6.18 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.996 0.427 . . . . 0.0 110.973 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.499 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 8.0 m-20 -110.82 161.11 26.21 Favored Pre-proline 0 C--N 1.326 -0.428 0 CA-C-N 116.026 -0.533 . . . . 0.0 110.447 -179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -77.08 45.61 1.74 Allowed 'Trans proline' 0 C--N 1.345 0.39 0 C-N-CA 123.529 2.819 . . . . 0.0 112.86 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -173.93 -27.47 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.822 -1.081 . . . . 0.0 108.331 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.733 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.4 m170 -62.89 -51.26 67.64 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 114.966 -1.016 . . . . 0.0 110.559 179.72 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.525 ' HG3' ' H ' ' A' ' 44' ' ' GLN . 0.0 OUTLIER -64.01 -21.68 66.61 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.27 179.698 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.655 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.97 -52.32 11.46 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.358 -0.837 . . . . 0.0 110.898 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.544 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.0 OUTLIER -64.86 -38.09 89.82 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.297 -179.822 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -60.27 -40.33 89.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.925 -0.58 . . . . 0.0 112.206 -179.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.94 -28.44 43.76 Favored 'General case' 0 CA--C 1.514 -0.409 0 CA-C-O 121.327 0.584 . . . . 0.0 110.192 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.826 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -67.71 -60.47 2.51 Favored 'General case' 0 N--CA 1.443 -0.788 0 CA-C-N 115.602 -0.726 . . . . 0.0 109.407 178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.427 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -48.91 -49.01 29.96 Favored Glycine 0 C--O 1.216 -0.975 0 CA-C-N 115.216 -0.902 . . . . 0.0 112.46 179.517 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -53.96 -53.0 58.84 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 120.928 0.394 . . . . 0.0 111.764 179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.452 ' HG3' ' HE ' ' A' ' 56' ' ' ARG . 8.2 tt0 -63.16 -45.66 90.85 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.656 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.883 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.75 -30.99 66.19 Favored 'General case' 0 C--O 1.217 -0.625 0 C-N-CA 120.702 -0.399 . . . . 0.0 111.549 -179.266 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -65.13 -30.9 71.86 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 7.3 m -86.14 -19.16 30.55 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.342 178.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.452 ' HE ' ' HG3' ' A' ' 52' ' ' GLU . 16.1 mtt-85 -98.09 -49.25 4.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-O 121.187 0.518 . . . . 0.0 112.209 -179.215 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.43 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -85.2 90.13 7.81 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.236 -179.037 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 51.1 mtt180 -67.48 -21.97 65.49 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.166 0.508 . . . . 0.0 110.881 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 31.4 mtm180 -88.67 66.53 8.14 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.941 179.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -120.38 -14.43 8.72 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.111 -0.495 . . . . 0.0 112.013 -178.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . . . . . . . . . 7.9 m-85 -114.52 -0.06 13.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.855 0.36 . . . . 0.0 111.28 -178.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.9 -51.84 23.68 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 121.257 0.551 . . . . 0.0 111.088 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.478 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -57.04 -33.82 67.61 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.926 -1.034 . . . . 0.0 111.806 -179.298 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.85 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 7.5 mp -56.93 -43.25 81.27 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-N 115.372 -0.831 . . . . 0.0 109.49 179.201 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.548 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -81.47 -42.77 19.8 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.141 -0.936 . . . . 0.0 110.63 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -48.09 -46.33 33.69 Favored 'General case' 0 C--N 1.328 -0.339 0 O-C-N 123.639 0.587 . . . . 0.0 111.799 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.506 ' NE2' ' HG ' ' A' ' 180' ' ' LEU . 65.0 mt-30 -80.65 -47.71 13.68 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.977 0.732 . . . . 0.0 112.977 -178.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.446 ' HB3' ' HE2' ' A' ' 115' ' ' MET . 0.6 OUTLIER -90.28 20.89 4.11 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 -177.117 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.548 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -80.2 -38.13 31.82 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.766 -0.373 . . . . 0.0 111.222 179.824 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.553 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -90.56 -62.37 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.792 -178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.553 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.2 OUTLIER -158.66 152.77 19.87 Favored Pre-proline 0 C--N 1.33 -0.252 0 N-CA-C 110.631 -0.137 . . . . 0.0 110.631 -179.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HG3' ' HE1' ' A' ' 115' ' ' MET . 2.9 Cg_endo -79.66 178.17 7.62 Favored 'Trans proline' 0 N--CA 1.458 -0.584 0 C-N-CA 122.847 2.365 . . . . 0.0 111.497 179.26 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 85.17 -56.52 4.98 Favored Glycine 0 CA--C 1.518 0.262 0 C-N-CA 120.831 -0.699 . . . . 0.0 112.759 179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.44 34.87 0.14 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.129 0.49 . . . . 0.0 111.61 -179.906 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.93 -24.66 16.87 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.66 179.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.648 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -58.45 -47.15 84.95 Favored 'General case' 0 C--O 1.221 -0.407 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.953 -179.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 7.0 mt-30 -58.26 -45.0 88.64 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.749 0.309 . . . . 0.0 111.034 -179.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.95 ' HB3' HD11 ' A' ' 180' ' ' LEU . 11.0 mtt180 -64.91 -40.82 95.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.58 179.649 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.416 ' O ' HG12 ' A' ' 82' ' ' VAL . 13.0 t80 -67.21 -48.04 69.05 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.459 179.522 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 4.0 p -59.11 -28.64 66.72 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.444 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 15.4 mm100 -68.14 -60.43 2.48 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 120.799 0.333 . . . . 0.0 110.29 179.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 177' ' ' ALA . 10.6 p -54.52 -36.05 33.72 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.594 -179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.4 p -68.81 -41.85 78.1 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.767 0.318 . . . . 0.0 110.475 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.602 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -69.83 -38.6 76.57 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.018 0.437 . . . . 0.0 110.311 179.579 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.0 mt-10 -69.55 -26.34 64.44 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.707 179.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.0 OUTLIER -82.54 -33.09 28.3 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.176 0.512 . . . . 0.0 110.392 179.408 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.4 t80 -85.35 -10.07 56.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.664 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -41.3 -48.73 3.67 Favored 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.738 -0.664 . . . . 0.0 112.507 -179.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -167.78 54.38 0.23 Allowed Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 119.92 -1.133 . . . . 0.0 113.185 179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.452 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.7 57.15 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 119.376 -1.392 . . . . 0.0 114.683 179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.615 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 41.19 1.07 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.072 1.848 . . . . 0.0 111.377 177.896 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.813 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -70.65 163.14 27.68 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.491 -0.777 . . . . 0.0 112.069 -178.542 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.669 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.3 m95 -53.59 -27.54 27.24 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.849 -179.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.02 -44.37 97.88 Favored Glycine 0 N--CA 1.447 -0.585 0 N-CA-C 110.947 -0.861 . . . . 0.0 110.947 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.767 HH11 ' HB2' ' A' ' 174' ' ' LEU . 5.0 mtp180 -87.46 -19.99 27.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.579 -0.31 . . . . 0.0 111.353 179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.789 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -54.97 -31.87 61.04 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-O 121.379 0.609 . . . . 0.0 110.326 179.723 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.883 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.8 t -61.52 -54.01 40.75 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.89 178.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.62 -29.42 70.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.272 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.789 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.0 m-85 -56.72 -55.18 37.4 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.984 0.421 . . . . 0.0 110.374 179.49 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.629 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 6.8 m-85 -76.93 -37.91 54.42 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.179 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.29 -37.99 78.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.595 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -54.13 -51.54 63.94 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-O 120.742 0.306 . . . . 0.0 111.696 -179.534 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.24 -37.54 36.67 Favored Glycine 0 N--CA 1.446 -0.674 0 C-N-CA 120.076 -1.059 . . . . 0.0 112.996 -179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.21 -42.68 95.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 117.126 0.463 . . . . 0.0 110.745 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -69.96 -43.85 70.68 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.079 179.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.85 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -59.65 -42.34 92.56 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.279 0.561 . . . . 0.0 110.832 179.836 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.688 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.8 m -63.74 -44.99 91.87 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.047 179.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.42 -45.2 76.76 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.572 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.608 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.0 OUTLIER -76.8 -17.75 58.84 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.03 0.382 . . . . 0.0 112.03 -179.646 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 69.8 m -82.63 -26.43 32.23 Favored 'General case' 0 C--N 1.323 -0.545 0 C-N-CA 121.007 -0.277 . . . . 0.0 110.715 179.665 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.2 t -70.06 -38.27 74.61 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.2 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.837 179.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.608 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.1 p30 -82.48 1.79 35.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.892 0.377 . . . . 0.0 111.234 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.758 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 0.0 OUTLIER -120.69 -172.65 2.42 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.267 179.613 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -90.95 46.92 1.36 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.243 0.544 . . . . 0.0 111.202 -179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.758 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -142.22 37.15 1.54 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.199 179.627 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.486 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.3 OUTLIER -56.13 -50.12 89.26 Favored Pre-proline 0 CA--C 1.539 0.539 0 CA-C-N 115.557 -0.747 . . . . 0.0 112.045 179.567 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.486 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 42.8 Cg_exo -57.77 -25.94 71.09 Favored 'Trans proline' 0 C--N 1.358 1.043 0 C-N-CA 122.163 1.909 . . . . 0.0 112.841 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.569 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.4 mm? -69.05 -25.47 64.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.931 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 43.1 t -57.42 -45.44 85.58 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.96 179.724 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -67.34 -34.75 86.15 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.332 -0.937 . . . . 0.0 111.712 179.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.541 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.5 OUTLIER -66.0 -50.25 64.92 Favored 'General case' 0 C--O 1.217 -0.61 0 N-CA-C 109.791 -0.448 . . . . 0.0 109.791 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.569 HG23 ' O ' ' A' ' 118' ' ' LEU . 29.0 t -58.17 -32.61 44.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.164 0.507 . . . . 0.0 109.78 178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -66.0 -45.86 80.03 Favored 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.429 178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.763 ' HA ' HG12 ' A' ' 127' ' ' VAL . 14.4 pt-20 -74.51 -36.53 63.22 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.858 179.63 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.648 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 43.3 m0 -57.4 -39.4 76.03 Favored 'General case' 0 N--CA 1.465 0.276 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 178.524 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 9.1 ttm -73.74 -54.96 6.89 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.428 -1.26 . . . . 0.0 111.784 -179.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.763 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.3 p -61.58 -33.03 55.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 111.939 0.348 . . . . 0.0 111.939 -178.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -69.46 -46.73 66.0 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.304 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.602 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 21.0 t80 -61.6 -36.45 80.73 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.564 0.697 . . . . 0.0 110.336 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.943 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -69.65 -54.14 15.34 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-N 115.032 -0.985 . . . . 0.0 112.254 -178.86 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -60.59 -37.27 80.8 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 120.948 0.404 . . . . 0.0 112.016 -178.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 7.3 m -74.72 -36.28 62.67 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 113.536 0.939 . . . . 0.0 113.536 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 mtt180 -130.59 -41.36 1.2 Allowed 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 114.388 1.255 . . . . 0.0 114.388 -177.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.943 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -60.89 -49.02 79.14 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 118.334 0.515 . . . . 0.0 111.813 -178.365 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.38 -35.73 60.65 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.292 179.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -64.4 -55.7 19.27 Favored 'General case' 0 CA--C 1.514 -0.406 0 C-N-CA 120.729 -0.388 . . . . 0.0 110.192 179.005 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.813 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 42.5 t90 -53.68 -48.48 69.45 Favored 'General case' 0 C--O 1.234 0.265 0 CA-C-O 121.126 0.488 . . . . 0.0 109.797 178.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.612 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.2 mt -56.27 -48.14 79.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.272 -0.876 . . . . 0.0 111.724 -178.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -64.53 -36.34 83.91 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.144 0.424 . . . . 0.0 112.144 -179.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.2 p -80.82 -14.93 57.62 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.685 -0.406 . . . . 0.0 111.927 -179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.42 -55.65 3.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.805 0.336 . . . . 0.0 111.644 -179.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.87 -10.91 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.577 0 N-CA-C 111.241 -0.743 . . . . 0.0 111.241 -179.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 89.28 169.28 44.21 Favored Glycine 0 N--CA 1.44 -1.051 0 C-N-CA 120.773 -0.727 . . . . 0.0 112.698 179.599 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.544 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.4 m95 -60.52 -30.52 69.79 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.735 -0.468 . . . . 0.0 109.735 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.67 -32.84 73.97 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.517 -0.765 . . . . 0.0 111.106 178.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.515 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -64.99 -41.31 95.53 Favored 'General case' 0 N--CA 1.462 0.132 0 N-CA-C 109.033 -0.728 . . . . 0.0 109.033 179.027 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.641 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.9 t80 -64.93 -40.83 95.65 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.023 -0.989 . . . . 0.0 110.601 178.929 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.655 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.24 -26.23 68.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.962 0.41 . . . . 0.0 110.947 179.15 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -87.23 -29.02 22.0 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.023 0.439 . . . . 0.0 110.306 179.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.515 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -62.67 -51.84 65.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.338 -179.548 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.521 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.4 m-85 -132.43 32.93 3.87 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.296 -0.562 . . . . 0.0 112.26 -179.015 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.53 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -100.84 -129.61 6.75 Favored Glycine 0 C--N 1.316 -0.534 0 C-N-CA 120.235 -0.983 . . . . 0.0 111.864 179.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -66.24 -51.61 55.89 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 121.249 0.547 . . . . 0.0 110.642 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.13 55.89 2.49 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.394 179.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.78 73.84 7.76 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.122 0.487 . . . . 0.0 110.042 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.789 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.54 161.04 15.3 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.362 -179.325 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.81 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 3.2 mt-10 -59.21 -30.37 68.18 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.7 -0.682 . . . . 0.0 112.061 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.789 ' HB2' HD12 ' A' ' 156' ' ' LEU . 9.1 mm-40 -72.88 -36.26 67.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.789 0.328 . . . . 0.0 110.477 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.32 -34.79 73.11 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.013 178.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.81 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 25.3 mtt-85 -63.09 -55.24 27.04 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.386 179.178 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.465 ' HD3' ' OE1' ' A' ' 158' ' ' GLU . 2.9 ptm180 -65.0 -25.15 67.74 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.614 179.608 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.55 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -68.47 -43.42 77.01 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.309 -0.405 . . . . 0.0 109.93 178.754 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.647 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.4 ttp180 -70.95 -34.52 71.54 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.521 179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.521 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.8 OUTLIER -69.49 -45.6 68.56 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.172 179.522 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.19 -22.14 77.32 Favored Glycine 0 N--CA 1.452 -0.294 0 N-CA-C 110.358 -1.097 . . . . 0.0 110.358 177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.632 ' O ' HG22 ' A' ' 170' ' ' VAL . 18.8 t-20 -64.13 -66.1 0.59 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.406 179.085 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.631 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 26.7 p-90 -61.06 -29.04 69.5 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.931 -179.067 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.08 -41.47 75.2 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.163 0.506 . . . . 0.0 110.582 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.446 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.99 -29.46 20.73 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 113.116 0.784 . . . . 0.0 113.116 -179.805 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.632 HG22 ' O ' ' A' ' 166' ' ' ASN . 8.4 m -92.13 -35.64 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 -177.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -70.23 -34.36 72.78 Favored 'General case' 0 C--N 1.318 -0.789 0 O-C-N 121.925 -0.484 . . . . 0.0 110.595 -179.213 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.95 -13.39 50.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.905 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.736 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -86.22 -23.73 6.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-O 121.24 0.543 . . . . 0.0 109.893 178.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.767 ' HB2' HH11 ' A' ' 95' ' ' ARG . 0.8 OUTLIER -121.07 34.29 5.26 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.012 179.33 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.419 ' O ' HG23 ' A' ' 178' ' ' VAL . 0.0 OUTLIER -65.33 -18.1 65.05 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.823 -179.853 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.69 -4.58 76.38 Favored Glycine 0 C--O 1.226 -0.379 0 C-N-CA 121.053 -0.594 . . . . 0.0 113.185 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.449 ' O ' HG23 ' A' ' 82' ' ' VAL . . . -69.94 -5.12 23.97 Favored 'General case' 0 N--CA 1.466 0.372 0 N-CA-C 112.491 0.552 . . . . 0.0 112.491 -179.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 175' ' ' THR . 2.9 t -80.02 65.54 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.285 0.564 . . . . 0.0 110.994 179.871 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -83.28 -10.11 58.72 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.33 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.95 HD11 ' HB3' ' A' ' 78' ' ' ARG . 0.6 OUTLIER -101.04 63.93 1.03 Allowed 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.752 -179.203 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -75.97 -55.33 4.9 Favored Glycine 0 C--N 1.316 -0.554 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.591 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.404 ' H ' ' H ' ' A' ' 183' ' ' LEU . . . -161.45 -4.76 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.789 0.328 . . . . 0.0 111.244 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . 0.404 ' H ' ' H ' ' A' ' 182' ' ' ALA . 1.1 mp . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.01 -0.995 . . . . 0.0 109.733 -179.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . 0.419 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.699 0 N-CA-C 111.888 -0.485 . . . . 0.0 111.888 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . 0.419 ' HD3' ' HA2' ' A' ' -4' ' ' GLY . 13.4 Cg_exo -69.91 -19.6 35.2 Favored 'Trans proline' 0 C--N 1.344 0.332 0 C-N-CA 122.891 2.394 . . . . 0.0 112.077 -179.81 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.419 HD13 ' HA ' ' A' ' -2' ' ' LEU . 2.3 mm? -93.96 122.01 36.02 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.41 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 173.33 179.18 43.83 Favored Glycine 0 N--CA 1.448 -0.561 0 N-CA-C 111.175 -0.77 . . . . 0.0 111.175 -179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.17 -45.27 4.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 117.168 0.484 . . . . 0.0 110.912 -179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 63.53 -171.0 0.18 Allowed 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 115.659 -0.7 . . . . 0.0 111.21 -179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -153.28 124.15 7.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.417 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.475 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.5 p -99.4 126.63 36.96 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.786 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.475 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 14.2 Cg_exo -69.54 117.16 4.9 Favored 'Trans proline' 0 C--O 1.233 0.255 0 C-N-CA 122.866 2.377 . . . . 0.0 111.772 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -124.98 122.16 36.51 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.576 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 66.9 m -113.15 34.1 4.68 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 121.29 0.567 . . . . 0.0 110.409 -179.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.438 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -143.42 141.85 20.0 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.399 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 6.9 Cg_exo -73.71 84.96 1.36 Allowed 'Trans proline' 0 N--CA 1.463 -0.279 0 C-N-CA 123.07 2.513 . . . . 0.0 112.103 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.18 -162.27 0.33 Allowed 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.219 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -51.84 -47.64 64.31 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 15.4 ttp180 -59.07 -37.74 77.78 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.73 0.3 . . . . 0.0 111.491 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.14 -36.6 61.57 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 120.989 0.424 . . . . 0.0 109.966 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 2.1 tp -70.44 -42.37 71.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.249 179.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.631 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.9 p -63.57 -37.38 79.46 Favored 'Isoleucine or valine' 0 C--O 1.231 0.119 0 CA-C-O 121.06 0.457 . . . . 0.0 109.775 179.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.03 -23.87 61.45 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.336 178.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.88 -63.42 1.39 Allowed 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 115.914 -0.585 . . . . 0.0 111.255 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -53.62 -50.06 66.49 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.66 -179.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.492 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.5 t -69.06 -41.14 81.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.107 179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.62 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.17 -49.2 81.18 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.449 179.278 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.79 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 65.2 t80 -62.32 -47.17 85.45 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 122.594 0.358 . . . . 0.0 111.475 -179.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -61.76 -40.9 96.76 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.285 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.727 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -72.15 -46.9 54.67 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.808 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.455 HH11 ' HB1' ' A' ' 31' ' ' ALA . 18.6 ttp85 -63.5 -17.06 62.37 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.804 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.3 mt-30 -80.87 -36.2 31.66 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.967 179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.71 78.17 1.06 Allowed 'General case' 0 N--CA 1.465 0.315 0 CA-C-O 121.101 0.476 . . . . 0.0 112.082 -179.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.35 -63.12 0.41 Allowed Glycine 0 N--CA 1.453 -0.196 0 C-N-CA 120.622 -0.799 . . . . 0.0 112.449 179.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.577 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 1.4 t80 -90.59 50.5 1.83 Allowed 'General case' 0 C--N 1.314 -0.939 0 CA-C-O 121.199 0.523 . . . . 0.0 109.915 179.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -78.3 -34.16 18.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.161 -179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -69.78 -22.83 63.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.666 178.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -106.29 49.83 0.85 Allowed Glycine 0 N--CA 1.444 -0.794 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.614 179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.455 ' HB1' HH11 ' A' ' 23' ' ' ARG . . . -65.79 126.81 29.63 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 110.12 -0.326 . . . . 0.0 110.12 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.524 ' HA2' ' HG3' ' A' ' 35' ' ' GLU . . . 168.36 -54.23 0.22 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 119.747 -1.216 . . . . 0.0 113.736 -179.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.62 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 17.4 Cg_exo -68.83 -49.22 0.76 Allowed 'Trans proline' 0 C--N 1.346 0.405 0 C-N-CA 122.312 2.008 . . . . 0.0 112.21 -179.208 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.79 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -90.1 31.53 5.32 Favored Glycine 0 N--CA 1.449 -0.46 0 C-N-CA 120.909 -0.662 . . . . 0.0 113.521 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HG3' ' HA2' ' A' ' 32' ' ' GLY . 3.2 mm-40 -79.14 -43.05 24.78 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.378 0.608 . . . . 0.0 109.758 179.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.431 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -76.92 147.17 33.18 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.892 179.544 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.431 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 96.7 Cg_endo -98.41 -151.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.129 0 C-N-CA 123.196 2.598 . . . . 0.0 113.579 -178.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -80.7 87.33 5.83 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.075 -0.966 . . . . 0.0 110.878 179.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -126.52 -14.09 5.86 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.945 0.35 . . . . 0.0 111.945 -179.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.402 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 47.7 m-20 -94.41 158.74 35.18 Favored Pre-proline 0 C--N 1.324 -0.532 0 CA-C-N 116.609 -0.269 . . . . 0.0 111.076 -179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.405 ' HA ' HG21 ' A' ' 148' ' ' THR . 3.2 Cg_endo -75.17 50.7 2.64 Favored 'Trans proline' 0 C--N 1.343 0.271 0 C-N-CA 123.721 2.947 . . . . 0.0 111.816 178.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.434 HD12 ' HD2' ' A' ' 43' ' ' HIS . 0.1 OUTLIER -178.97 -32.23 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 114.779 -1.101 . . . . 0.0 108.345 179.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.596 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.6 m170 -60.58 -56.57 19.79 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.119 179.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.675 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.7 OUTLIER -59.37 -24.73 63.66 Favored 'General case' 0 CA--C 1.519 -0.23 0 CA-C-N 115.35 -0.841 . . . . 0.0 111.041 -179.99 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.923 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -77.81 -51.48 10.43 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.31 -179.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.45 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.6 ttm -64.72 -41.75 95.75 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.621 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 11.8 ttt-85 -62.83 -31.55 72.58 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.665 -179.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.16 -44.68 19.43 Favored 'General case' 0 CA--C 1.516 -0.364 0 CA-C-O 120.737 0.304 . . . . 0.0 110.468 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.71 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.73 -54.19 49.93 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -52.09 -49.18 50.63 Favored Glycine 0 C--O 1.213 -1.165 0 CA-C-N 115.304 -0.862 . . . . 0.0 112.238 179.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.8 t0 -56.4 -51.61 67.72 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 122.841 0.456 . . . . 0.0 111.627 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -61.13 -48.25 82.48 Favored 'General case' 0 C--O 1.238 0.45 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.989 179.998 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.668 ' HB2' HG11 ' A' ' 97' ' ' VAL . 6.4 m-85 -69.97 -32.83 71.26 Favored 'General case' 0 C--O 1.219 -0.553 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.391 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -65.02 -27.05 68.54 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.706 0.765 . . . . 0.0 109.029 178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 89.8 m -79.65 -31.94 41.56 Favored 'General case' 0 N--CA 1.447 -0.617 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.617 178.639 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.408 HH11 ' HD3' ' A' ' 56' ' ' ARG . 34.1 mtt180 -89.84 -54.01 4.24 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.187 0.517 . . . . 0.0 111.376 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.36 68.81 10.6 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 123.555 0.742 . . . . 0.0 111.099 -179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 6.0 mtt-85 -74.47 -26.19 59.87 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.955 0.407 . . . . 0.0 111.912 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 12.7 mtt180 -82.11 61.82 5.55 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.17 -179.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.26 -31.14 4.45 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.198 0.523 . . . . 0.0 111.516 -179.397 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.014 ' HA ' HD22 ' A' ' 64' ' ' LEU . 50.2 m-85 -72.78 -17.0 61.62 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.943 -0.572 . . . . 0.0 112.163 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.68 -39.38 93.57 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.804 0.335 . . . . 0.0 111.499 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.679 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 0.9 OUTLIER -71.97 -23.44 61.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.883 -179.644 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.014 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -67.02 -41.82 85.98 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 178.535 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.544 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -72.85 -48.74 35.06 Favored 'General case' 0 N--CA 1.45 -0.472 0 CA-C-N 114.868 -1.06 . . . . 0.0 110.156 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.54 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -52.24 -42.16 63.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.458 179.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.653 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 25.3 mt-30 -65.92 -58.5 5.43 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.092 -0.503 . . . . 0.0 112.304 -179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -83.24 14.1 3.76 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 113.105 0.78 . . . . 0.0 113.105 -177.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.544 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 30.2 t60 -79.24 -27.25 42.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.862 0.363 . . . . 0.0 110.495 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.85 -70.61 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.013 -0.539 . . . . 0.0 110.675 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.431 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -163.64 150.83 10.57 Favored Pre-proline 0 C--N 1.325 -0.458 0 CA-C-N 116.175 -0.466 . . . . 0.0 109.908 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 4.1 Cg_exo -80.49 175.8 9.79 Favored 'Trans proline' 0 N--CA 1.46 -0.476 0 C-N-CA 123.052 2.502 . . . . 0.0 112.404 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.659 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 93.33 -65.11 1.88 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.852 179.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.39 46.39 0.26 Allowed 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.316 0.579 . . . . 0.0 111.907 -179.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.91 -18.41 14.05 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.956 -0.566 . . . . 0.0 110.433 179.26 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.671 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.3 pt20 -64.15 -38.54 91.43 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.695 -179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.501 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 10.2 mp0 -69.44 -36.05 76.27 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 120.628 -0.429 . . . . 0.0 109.865 179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.653 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 1.5 ttt180 -67.15 -47.19 71.78 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.019 179.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -61.62 -48.94 78.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.023 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.6 p -60.2 -33.55 72.4 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 112.177 0.436 . . . . 0.0 112.177 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.501 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 89.9 mm-40 -63.3 -57.37 10.63 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 121.136 0.493 . . . . 0.0 110.812 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.762 HG11 ' HG ' ' A' ' 180' ' ' LEU . 4.1 m -62.73 -33.06 57.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.366 -179.407 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 64.8 m -65.78 -43.41 88.88 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.724 179.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.516 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -64.58 -37.27 87.0 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.666 179.864 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -72.98 -30.35 63.76 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.099 0.476 . . . . 0.0 110.628 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.649 ' HG ' HD22 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -75.05 -35.33 61.88 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.806 179.944 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.496 ' CD1' ' HG3' ' A' ' 91' ' ' PRO . 33.7 t80 -89.51 -13.27 37.79 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.567 -179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 -33.55 -61.01 0.34 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.506 1.123 . . . . 0.0 113.891 -178.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -144.2 62.81 0.49 Allowed Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 119.268 -1.444 . . . . 0.0 114.163 -178.79 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 139.79 70.53 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.509 0 C-N-CA 119.4 -1.381 . . . . 0.0 114.944 178.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.496 ' HG3' ' CD1' ' A' ' 87' ' ' PHE . 6.8 Cg_endo -75.87 46.95 1.82 Allowed 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 122.409 2.073 . . . . 0.0 111.505 177.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.749 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -66.29 165.23 14.36 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.706 -0.679 . . . . 0.0 112.149 -178.601 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.536 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 26.9 m95 -55.33 -28.36 53.2 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 115.905 -0.589 . . . . 0.0 111.402 -179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.69 -34.4 89.8 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 178.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.778 HH11 ' HB ' ' A' ' 170' ' ' VAL . 0.3 OUTLIER -85.85 -28.4 24.45 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.465 -0.368 . . . . 0.0 110.317 178.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.817 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.39 -30.9 61.27 Favored 'General case' 0 C--O 1.236 0.373 0 CA-C-O 121.301 0.572 . . . . 0.0 110.57 179.792 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.7 t -66.49 -56.24 15.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.818 178.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -61.3 -30.34 70.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.119 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.817 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.8 m-85 -56.35 -58.19 9.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.041 0.448 . . . . 0.0 110.473 179.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.631 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 9.6 m-85 -75.07 -35.45 61.82 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.922 -0.581 . . . . 0.0 111.228 -179.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -61.79 -39.05 81.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.059 -179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.9 OUTLIER -56.38 -51.86 66.74 Favored 'General case' 0 CA--C 1.523 -0.087 0 CA-C-O 120.7 0.286 . . . . 0.0 111.286 -179.925 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -73.58 -41.11 44.95 Favored Glycine 0 C--O 1.224 -0.51 0 C-N-CA 120.418 -0.896 . . . . 0.0 113.285 -179.643 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.54 88.81 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 117.347 0.573 . . . . 0.0 110.905 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.505 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.34 -40.95 70.39 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.74 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.32 -46.85 87.46 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.465 179.187 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.727 ' HB3' HD21 ' A' ' 22' ' ' LEU . 68.9 m -62.17 -41.63 98.5 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.158 -0.928 . . . . 0.0 111.125 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.5 -54.94 37.63 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 110.682 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.01 -22.14 66.8 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.578 179.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.425 ' HB2' HG22 ' A' ' 119' ' ' VAL . 67.1 m -76.74 -31.61 57.22 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.561 -179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 14.1 t -79.06 -23.34 12.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 CA-C-O 121.451 0.643 . . . . 0.0 109.295 178.166 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -84.06 -5.03 59.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.266 -0.879 . . . . 0.0 110.189 179.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.432 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 13.3 mttt -125.72 -152.44 0.52 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.295 179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.432 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 2.0 mt-10 -108.19 50.81 0.76 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.205 0.526 . . . . 0.0 110.106 179.434 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.443 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -130.32 56.11 1.77 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.831 -0.622 . . . . 0.0 110.445 -179.395 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.5 mp0 -62.38 -52.71 64.11 Favored Pre-proline 0 CA--C 1.541 0.628 0 N-CA-C 112.863 0.69 . . . . 0.0 112.863 -179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.501 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.2 Cg_exo -65.41 -25.44 56.13 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 122.356 2.037 . . . . 0.0 113.112 -179.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.659 HD21 ' H ' ' A' ' 73' ' ' GLY . 4.5 mp -67.5 -30.68 70.43 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.389 -0.369 . . . . 0.0 111.425 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.425 HG22 ' HB2' ' A' ' 110' ' ' SER . 91.6 t -57.61 -55.47 21.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.517 -0.311 . . . . 0.0 111.186 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.14 -32.89 85.69 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.403 -0.903 . . . . 0.0 112.061 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.535 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.5 mt-30 -65.18 -51.42 61.2 Favored 'General case' 0 C--O 1.216 -0.689 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 118' ' ' LEU . 86.2 t -57.05 -35.33 47.42 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.02 0.438 . . . . 0.0 109.867 178.783 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.16 -47.52 82.34 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.738 -0.665 . . . . 0.0 110.447 178.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.588 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.8 pt-20 -72.8 -37.1 67.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.085 179.598 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.671 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 42.8 m0 -58.89 -39.41 81.34 Favored 'General case' 0 N--CA 1.464 0.244 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 178.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.409 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 9.8 ttm -72.6 -53.94 10.5 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 114.712 -1.131 . . . . 0.0 111.852 -179.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.588 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.97 -33.16 56.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 121.001 -0.279 . . . . 0.0 111.592 -179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.442 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.1 OUTLIER -67.26 -51.02 58.08 Favored 'General case' 0 CA--C 1.518 -0.251 0 C-N-CA 120.681 -0.407 . . . . 0.0 110.077 179.146 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.516 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 23.9 t80 -58.36 -35.69 72.34 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.542 0.687 . . . . 0.0 110.742 179.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.957 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.29 -56.05 5.6 Favored 'General case' 0 C--N 1.318 -0.765 0 CA-C-N 115.059 -0.973 . . . . 0.0 112.559 -178.873 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 38.9 mt-10 -62.75 -24.04 67.5 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 112.077 0.399 . . . . 0.0 112.077 -178.489 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 27.0 m -82.2 -43.13 18.06 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.441 0.534 . . . . 0.0 112.441 -179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.4 mtp180 -126.93 -37.29 2.12 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 113.994 1.109 . . . . 0.0 113.994 -178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.957 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -61.41 -48.17 82.44 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 118.229 0.468 . . . . 0.0 111.377 -178.585 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.25 -37.54 62.2 Favored 'General case' 0 N--CA 1.453 -0.277 0 O-C-N 123.257 0.348 . . . . 0.0 110.952 179.483 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.99 -53.53 52.54 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.413 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.749 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 59.4 t90 -57.31 -48.99 77.51 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-O 121.091 0.472 . . . . 0.0 109.791 178.46 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.546 HG13 ' HE3' ' A' ' 137' ' ' TRP . 26.6 mt -57.77 -47.46 85.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.812 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 34.9 m-70 -68.05 -26.93 66.1 Favored 'General case' 0 C--N 1.327 -0.399 0 N-CA-C 111.948 0.351 . . . . 0.0 111.948 -179.104 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.7 m -96.23 -3.48 44.12 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.362 0.504 . . . . 0.0 112.362 -179.537 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.75 -53.16 3.37 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.861 0.362 . . . . 0.0 111.724 -179.794 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -171.97 -13.09 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.422 0 N-CA-C 111.547 -0.621 . . . . 0.0 111.547 -179.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 88.76 166.24 42.04 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.901 -0.666 . . . . 0.0 112.822 179.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.45 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 92.9 m95 -59.36 -30.24 68.25 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.546 -0.538 . . . . 0.0 109.546 179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -36.5 81.86 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.304 -0.862 . . . . 0.0 111.1 178.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.52 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.2 OUTLIER -62.69 -42.95 99.9 Favored 'General case' 0 C--O 1.234 0.264 0 N-CA-C 108.867 -0.79 . . . . 0.0 108.867 179.084 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -66.17 -34.14 77.36 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 114.953 -1.021 . . . . 0.0 110.504 178.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.923 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.57 -26.38 67.09 Favored 'General case' 0 CA--C 1.521 -0.172 0 CA-C-O 120.723 0.297 . . . . 0.0 110.836 179.222 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.79 -47.1 12.29 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 178.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.52 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.3 OUTLIER -54.09 -42.67 69.6 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.35 179.706 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -119.19 24.91 10.49 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 111.906 0.336 . . . . 0.0 111.906 -178.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -123.41 -135.89 4.65 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.596 -1.288 . . . . 0.0 113.647 -179.514 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 2.5 t70 -72.64 -45.33 59.53 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.318 -0.441 . . . . 0.0 111.189 -179.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -82.0 52.43 4.61 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.608 -179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.11 70.18 10.87 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.054 0.454 . . . . 0.0 110.381 179.754 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.699 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.0 OUTLIER -64.89 158.92 23.91 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.902 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.477 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 3.1 tp10 -57.01 -33.86 67.59 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.072 0.463 . . . . 0.0 110.82 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.699 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.9 mp0 -68.12 -38.3 82.1 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.508 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.42 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -75.62 -37.31 59.86 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.988 0.423 . . . . 0.0 110.613 179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.43 HH11 ' HD3' ' A' ' 160' ' ' ARG . 8.4 mtm180 -58.56 -53.36 59.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.906 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 7.8 ptm180 -69.11 -23.54 64.01 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.595 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.549 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.3 mt -71.95 -41.87 67.26 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.364 179.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.42 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -70.57 -35.86 73.29 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.486 -0.486 . . . . 0.0 111.111 -179.609 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.405 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.95 -43.76 64.7 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.495 -0.482 . . . . 0.0 109.797 178.865 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.29 -20.27 74.99 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.374 -0.917 . . . . 0.0 110.904 178.219 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.549 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 8.3 t-20 -65.3 -63.9 0.99 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.001 -0.599 . . . . 0.0 110.684 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.829 ' HA ' HG22 ' A' ' 170' ' ' VAL . 28.1 p-90 -64.72 -22.91 67.09 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.777 -179.051 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -52.66 -52.15 57.01 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.065 0.46 . . . . 0.0 110.591 179.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -88.31 -16.43 33.11 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 113.261 0.837 . . . . 0.0 113.261 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.829 HG22 ' HA ' ' A' ' 167' ' ' TRP . 29.9 m -101.79 -35.75 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 N-CA-C 114.258 1.206 . . . . 0.0 114.258 -177.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.444 ' HB2' ' HB2' ' A' ' 167' ' ' TRP . 3.0 ttp180 -78.16 -27.84 48.19 Favored 'General case' 0 C--N 1.316 -0.87 0 O-C-N 122.229 -0.294 . . . . 0.0 111.146 -178.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.3 m -82.8 -15.07 53.08 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.86 179.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -82.08 -9.29 11.76 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.649 HD22 ' HG ' ' A' ' 86' ' ' LEU . 81.5 mt -79.74 -8.59 59.34 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-N 114.961 -1.018 . . . . 0.0 111.75 179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 5.4 p -57.01 96.91 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 121.029 0.442 . . . . 0.0 110.42 179.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . 141.0 -24.02 2.58 Favored Glycine 0 N--CA 1.449 -0.46 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 -178.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.39 13.84 0.87 Allowed 'General case' 0 N--CA 1.465 0.304 0 CA-C-O 120.98 0.419 . . . . 0.0 111.154 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.2 t -84.25 68.91 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 179.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.73 0.92 42.75 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.795 -0.639 . . . . 0.0 111.022 -178.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.762 ' HG ' HG11 ' A' ' 82' ' ' VAL . 8.9 mt -86.78 -38.5 16.82 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.369 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.54 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -75.26 95.49 0.96 Allowed Glycine 0 N--CA 1.446 -0.674 0 CA-C-N 115.585 -0.734 . . . . 0.0 111.873 179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.469 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -81.06 98.87 8.18 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.972 0.415 . . . . 0.0 111.396 -179.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.9 mt . . . . . 0 C--O 1.253 1.254 0 CA-C-O 118.038 -0.982 . . . . 0.0 109.663 179.581 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.728 0 N-CA-C 111.95 -0.46 . . . . 0.0 111.95 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_exo -62.7 130.59 30.14 Favored 'Trans proline' 0 C--O 1.234 0.294 0 C-N-CA 122.821 2.347 . . . . 0.0 112.075 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -68.57 -49.82 56.5 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.095 -179.482 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -170.29 -122.18 0.62 Allowed Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.429 -0.891 . . . . 0.0 112.374 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.64 -40.16 63.95 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.036 0.446 . . . . 0.0 110.949 -179.68 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.8 ptt? -133.98 159.05 41.91 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.947 -0.569 . . . . 0.0 110.41 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -157.67 145.17 18.52 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.635 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.486 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 p -108.23 134.7 20.09 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.359 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.486 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.4 Cg_exo -76.76 1.99 7.96 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.993 2.462 . . . . 0.0 112.6 -179.46 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -156.73 84.27 0.96 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.646 179.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.39 112.03 24.43 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.924 -179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.432 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -100.75 131.67 23.25 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.045 -179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 9.5 Cg_endo -89.31 76.78 1.22 Allowed 'Trans proline' 0 N--CA 1.456 -0.711 0 C-N-CA 123.361 2.707 . . . . 0.0 111.743 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -86.64 -160.72 0.59 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.674 -179.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -49.19 -45.95 44.88 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 -178.622 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -61.8 -33.29 73.85 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.569 0.223 . . . . 0.0 111.281 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -78.51 -34.03 47.64 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.175 0.512 . . . . 0.0 109.825 178.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.713 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.5 tp -73.33 -41.7 63.17 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.919 179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.475 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.05 -36.24 76.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.216 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.75 -23.55 59.76 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.275 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -73.7 -66.13 0.74 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.971 179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.607 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.73 -50.71 67.7 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.922 -179.39 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.474 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.1 t -67.34 -42.53 87.66 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-N 116.288 -0.414 . . . . 0.0 110.255 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.598 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.27 -52.55 52.01 Favored Glycine 0 C--O 1.225 -0.468 0 C-N-CA 120.705 -0.76 . . . . 0.0 112.2 179.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.695 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 2.5 t80 -55.82 -46.18 78.16 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 122.992 0.517 . . . . 0.0 111.476 -179.808 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.5 tttp -66.24 -41.31 90.2 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.316 -179.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.629 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.2 mp -70.16 -47.37 61.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.118 -179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.468 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 27.1 ttp85 -64.17 -18.83 64.85 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.541 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.429 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.1 OUTLIER -78.86 -34.63 44.83 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.151 179.527 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.3 pttt -156.31 77.7 0.93 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.949 0.404 . . . . 0.0 111.667 -179.137 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.22 -70.12 0.31 Allowed Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.44 -0.886 . . . . 0.0 112.732 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.493 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.5 OUTLIER -87.31 52.31 2.47 Favored 'General case' 0 C--N 1.315 -0.907 0 CA-C-O 121.144 0.497 . . . . 0.0 110.352 179.755 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.9 t -79.35 -34.09 15.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 115.775 -0.648 . . . . 0.0 110.078 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -39.62 93.53 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.551 179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -94.06 57.48 2.11 Favored Glycine 0 N--CA 1.447 -0.59 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.449 178.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.468 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.71 130.97 45.55 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.536 -0.332 . . . . 0.0 110.309 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.42 -51.61 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 C-N-CA 119.811 -1.185 . . . . 0.0 113.665 -179.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.598 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 36.6 Cg_exo -62.05 -46.45 13.03 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 121.82 1.68 . . . . 0.0 111.446 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.695 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -100.48 38.01 3.32 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 112.194 179.284 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -89.01 -23.11 22.68 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.111 0.481 . . . . 0.0 109.965 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.41 ' HA2' ' HD3' ' A' ' 37' ' ' PRO . . . -98.86 142.2 15.95 Favored Glycine 0 N--CA 1.448 -0.528 0 N-CA-C 111.41 -0.676 . . . . 0.0 111.41 179.035 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.41 ' HD3' ' HA2' ' A' ' 36' ' ' GLY . 86.8 Cg_endo -93.5 -155.74 0.04 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.772 2.315 . . . . 0.0 113.71 -178.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.698 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -79.18 83.16 5.27 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.333 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.82 33.44 3.72 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 121.001 0.429 . . . . 0.0 111.087 -179.709 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.439 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 5.8 m-20 -139.91 165.79 28.42 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.063 179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.486 ' HA ' HG21 ' A' ' 148' ' ' THR . 60.5 Cg_endo -81.54 49.39 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.495 0 C-N-CA 123.266 2.644 . . . . 0.0 111.8 179.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.713 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -179.68 -33.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 114.624 -1.171 . . . . 0.0 108.85 179.636 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 4.0 m170 -60.47 -57.52 12.4 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.392 -0.822 . . . . 0.0 110.44 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.698 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 3.8 mt-30 -59.32 -25.99 64.64 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 115.452 -0.795 . . . . 0.0 110.751 -179.908 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.9 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.07 -52.59 10.66 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.479 -0.782 . . . . 0.0 111.184 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 7.0 ttm -66.53 -38.53 87.37 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.88 -179.214 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.469 ' HA ' ' HD2' ' A' ' 47' ' ' ARG . 0.0 OUTLIER -60.92 -38.29 85.28 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.441 -0.345 . . . . 0.0 111.885 -179.137 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.65 -42.25 29.19 Favored 'General case' 0 CA--C 1.514 -0.432 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.415 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.784 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -58.28 -56.73 18.32 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 109.325 -0.62 . . . . 0.0 109.325 178.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.607 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.96 -48.06 46.6 Favored Glycine 0 C--O 1.219 -0.838 0 CA-C-N 115.397 -0.819 . . . . 0.0 112.643 179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -59.01 -47.6 84.63 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 117.056 0.428 . . . . 0.0 110.994 179.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -59.69 -45.67 91.39 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.748 179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.835 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -71.34 -34.91 70.95 Favored 'General case' 0 C--O 1.221 -0.415 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.55 179.444 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.95 -24.43 67.87 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 121.532 0.682 . . . . 0.0 109.703 179.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 5.9 m -95.45 -18.59 20.56 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-N 115.435 -0.802 . . . . 0.0 111.495 179.354 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.0 mtt180 -98.67 -38.37 9.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.88 0.371 . . . . 0.0 111.848 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -85.99 104.03 15.24 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.528 0.68 . . . . 0.0 110.467 -179.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.441 HH11 ' HD2' ' A' ' 58' ' ' ARG . 9.9 mtt180 -87.81 -0.19 56.62 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.501 -179.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -125.48 58.07 1.31 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 120.863 0.363 . . . . 0.0 111.18 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.38 0.55 10.59 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.936 -179.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.878 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.9 m-85 -118.65 -28.75 5.57 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.87 0.367 . . . . 0.0 111.716 -179.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -65.1 -31.56 72.82 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.653 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.407 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -72.8 -20.06 61.22 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.984 -179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.878 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.25 -40.5 70.97 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.759 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.28 -43.62 50.18 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.024 -0.989 . . . . 0.0 110.083 179.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.553 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -54.59 -43.01 71.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.774 -0.648 . . . . 0.0 110.886 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.646 HE22 HD11 ' A' ' 106' ' ' LEU . 26.9 mt-30 -64.66 -56.92 10.72 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.851 -0.613 . . . . 0.0 112.005 179.575 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.538 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.85 12.25 3.37 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 112.723 0.638 . . . . 0.0 112.723 -178.081 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 3.4 t-80 -77.7 -24.86 49.12 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.05 0.452 . . . . 0.0 109.96 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -91.49 -76.39 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.659 -0.701 . . . . 0.0 111.102 -179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.442 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -160.65 145.47 10.74 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.541 -179.348 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.442 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 9.5 Cg_exo -71.46 174.88 10.23 Favored 'Trans proline' 0 C--N 1.343 0.285 0 C-N-CA 122.825 2.35 . . . . 0.0 111.722 179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.742 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 85.84 -57.81 4.83 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.572 -0.823 . . . . 0.0 112.249 179.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.14 50.83 0.39 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.321 0.581 . . . . 0.0 111.346 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -112.6 -25.05 9.33 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.983 -179.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.678 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.7 pt20 -64.79 -32.78 74.63 Favored 'General case' 0 CA--C 1.517 -0.324 0 C-N-CA 121.034 -0.267 . . . . 0.0 111.307 -179.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 25.1 mp0 -72.38 -35.0 68.34 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 121.06 0.457 . . . . 0.0 109.885 178.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.467 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 11.7 mtt-85 -70.19 -44.53 68.53 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.833 178.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -62.41 -48.61 78.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.465 -0.789 . . . . 0.0 110.567 179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.4 p -57.92 -34.55 69.98 Favored 'General case' 0 N--CA 1.464 0.259 0 C-N-CA 120.98 -0.288 . . . . 0.0 111.248 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 46.9 mm-40 -59.75 -63.03 1.45 Allowed 'General case' 0 N--CA 1.463 0.189 0 CA-C-O 121.022 0.439 . . . . 0.0 110.501 179.217 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.739 HG11 ' HG ' ' A' ' 180' ' ' LEU . 10.8 m -59.31 -31.85 47.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.347 -0.842 . . . . 0.0 111.775 -179.406 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.4 m -66.51 -41.96 88.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.957 0.408 . . . . 0.0 109.982 179.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.17 -38.71 82.35 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.815 -0.63 . . . . 0.0 109.857 179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.498 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 72.0 mt-10 -70.27 -31.99 69.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.902 179.927 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -78.74 -35.69 44.33 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.955 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -88.83 -4.19 58.55 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.0 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.498 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.2 OUTLIER -45.55 -43.2 11.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.062 -0.517 . . . . 0.0 112.03 -179.295 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -176.88 63.09 0.09 OUTLIER Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 120.168 -1.015 . . . . 0.0 112.961 179.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.56 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 162.06 54.36 0.02 OUTLIER Glycine 0 CA--C 1.524 0.595 0 C-N-CA 119.654 -1.26 . . . . 0.0 114.752 179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.697 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 28.0 Cg_endo -80.65 42.07 1.26 Allowed 'Trans proline' 0 C--N 1.351 0.66 0 C-N-CA 121.964 1.776 . . . . 0.0 111.785 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.78 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -69.36 161.12 30.0 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.617 -0.719 . . . . 0.0 111.407 -179.146 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.495 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 14.2 m95 -54.33 -26.89 32.3 Favored 'General case' 0 N--CA 1.467 0.377 0 N-CA-C 112.056 0.391 . . . . 0.0 112.056 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -65.16 -40.69 96.99 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.448 -0.882 . . . . 0.0 111.002 178.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.622 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.0 mmp_? -87.49 -22.22 25.03 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.638 -0.281 . . . . 0.0 110.786 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.806 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.4 OUTLIER -55.5 -31.38 61.98 Favored 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.407 0.622 . . . . 0.0 110.151 179.607 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.835 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.9 t -61.43 -53.97 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 CA-C-N 115.214 -0.903 . . . . 0.0 109.678 178.412 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.59 -29.0 70.28 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.091 -0.959 . . . . 0.0 111.315 179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.806 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.4 m-85 -56.87 -56.56 20.0 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.016 0.436 . . . . 0.0 110.078 179.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.475 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -76.52 -36.53 57.68 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.362 -179.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.6 t -61.8 -36.44 73.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.127 -179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.432 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.8 OUTLIER -56.31 -55.71 30.09 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 120.76 0.314 . . . . 0.0 111.321 179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.17 -37.3 59.75 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.525 -0.845 . . . . 0.0 113.367 -179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.5 -42.64 99.1 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 117.344 0.572 . . . . 0.0 110.709 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.438 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.8 -40.61 75.87 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 178.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.751 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.12 -47.14 81.86 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 115.207 -0.906 . . . . 0.0 110.442 179.169 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.629 ' HB2' HD11 ' A' ' 22' ' ' LEU . 87.9 m -61.98 -44.64 96.31 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 114.821 -1.081 . . . . 0.0 111.787 -179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -57.6 -34.43 69.25 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.975 0.417 . . . . 0.0 111.363 -179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.633 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.7 OUTLIER -82.73 -23.41 34.05 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.323 0.49 . . . . 0.0 112.323 -179.507 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.68 -27.95 40.73 Favored 'General case' 0 C--N 1.326 -0.44 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.951 -179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.568 HG23 ' O ' ' A' ' 107' ' ' CYS . 53.8 t -69.8 -37.03 72.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.058 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.633 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 12.6 p30 -84.82 1.68 45.82 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.789 0.328 . . . . 0.0 111.149 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.427 ' HB3' ' H ' ' A' ' 114' ' ' GLU . 1.0 OUTLIER -121.42 -152.79 0.52 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.483 179.49 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.427 ' H ' ' HB3' ' A' ' 113' ' ' LYS . 6.1 mt-10 -108.68 47.98 0.88 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.078 0.466 . . . . 0.0 110.357 -179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.538 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.3 OUTLIER -136.81 39.13 2.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.556 -179.22 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.419 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.0 OUTLIER -57.82 -51.0 84.97 Favored Pre-proline 0 CA--C 1.537 0.469 0 CA-C-N 116.097 -0.501 . . . . 0.0 112.109 179.956 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.419 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.7 Cg_exo -63.92 -12.01 29.86 Favored 'Trans proline' 0 C--N 1.356 0.946 0 C-N-CA 122.169 1.913 . . . . 0.0 112.908 -179.813 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.742 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.7 mp -85.05 -24.05 28.32 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.474 -0.33 . . . . 0.0 111.012 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 88.3 t -58.41 -54.42 33.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.13 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.42 -29.93 72.92 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.627 -0.797 . . . . 0.0 112.129 179.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.558 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 74.5 mt-30 -67.84 -53.47 26.53 Favored 'General case' 0 C--O 1.216 -0.666 0 N-CA-C 109.7 -0.482 . . . . 0.0 109.7 178.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 54.8 t -56.02 -34.81 39.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 121.207 0.527 . . . . 0.0 109.798 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -63.47 -46.49 85.96 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.407 -0.815 . . . . 0.0 110.47 178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.578 ' O ' ' HB2' ' A' ' 128' ' ' GLU . 16.6 pt-20 -73.69 -38.01 65.01 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.952 179.638 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.678 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.8 m0 -58.39 -38.95 78.35 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-O 121.713 0.768 . . . . 0.0 109.091 178.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.2 ttp -72.58 -55.2 7.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.635 -1.166 . . . . 0.0 111.988 -178.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.513 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.3 p -62.89 -30.1 48.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 120.914 -0.314 . . . . 0.0 111.554 -178.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 2.9 tt0 -67.78 -53.32 28.12 Favored 'General case' 0 CA--C 1.518 -0.27 0 CA-C-O 120.873 0.368 . . . . 0.0 110.155 178.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 6.5 t80 -59.36 -33.28 70.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.377 0.608 . . . . 0.0 110.746 179.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.95 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.35 -56.43 5.07 Favored 'General case' 0 C--N 1.318 -0.797 0 CA-C-N 115.425 -0.807 . . . . 0.0 112.153 -178.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 -60.52 -29.05 68.87 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 112.41 0.522 . . . . 0.0 112.41 -178.622 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.0 m -84.62 -36.53 21.95 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 -178.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 11.9 mtp180 -125.51 -44.88 1.82 Allowed 'General case' 0 N--CA 1.465 0.275 0 N-CA-C 113.725 1.009 . . . . 0.0 113.725 -178.02 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.95 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.5 mm? -59.12 -46.9 87.13 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 121.016 -0.274 . . . . 0.0 111.37 -178.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.48 -37.77 65.65 Favored 'General case' 0 N--CA 1.452 -0.336 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.263 179.952 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -65.44 -48.36 73.02 Favored 'General case' 0 CA--C 1.517 -0.321 0 C-N-CA 120.928 -0.309 . . . . 0.0 110.196 179.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.78 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.6 t90 -58.31 -50.39 73.8 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -56.19 -48.91 78.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 115.358 -0.837 . . . . 0.0 111.405 -179.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 23.4 m170 -60.73 -34.17 74.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.754 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.5 m -86.3 -16.15 38.41 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -85.15 -58.81 2.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.953 0.406 . . . . 0.0 111.346 -179.424 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.405 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -174.94 -5.3 0.02 OUTLIER Glycine 0 C--N 1.319 -0.394 0 CA-C-N 115.751 -0.659 . . . . 0.0 111.534 -179.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.402 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 86.1 171.65 48.08 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.93 -0.653 . . . . 0.0 112.955 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 90.4 m95 -62.48 -26.48 68.55 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.2 -35.99 82.62 Favored 'General case' 0 N--CA 1.452 -0.327 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.443 178.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.405 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.5 tt0 -63.52 -44.02 95.48 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 178.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.495 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 12.9 t80 -64.86 -36.43 84.31 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.428 -0.805 . . . . 0.0 110.684 178.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.9 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 4.1 m -66.34 -27.18 67.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.861 0.363 . . . . 0.0 111.201 179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.14 -28.34 25.6 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 121.295 0.569 . . . . 0.0 109.684 178.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.434 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.2 OUTLIER -72.05 -42.65 66.03 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.495 -0.775 . . . . 0.0 111.338 179.871 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 12.6 m-85 -118.65 25.43 10.26 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.931 -178.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -109.48 -143.09 9.89 Favored Glycine 0 N--CA 1.442 -0.943 0 C-N-CA 119.829 -1.177 . . . . 0.0 112.462 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -85.12 -22.4 28.89 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.263 0.554 . . . . 0.0 110.567 -179.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.418 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -95.14 33.26 5.53 Favored Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.819 -0.705 . . . . 0.0 111.615 179.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -78.56 70.62 4.94 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.19 0.519 . . . . 0.0 110.666 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.515 HD23 ' H ' ' A' ' 156' ' ' LEU . 0.6 OUTLIER -63.5 170.55 3.07 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 115.264 -0.88 . . . . 0.0 111.163 -179.739 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -53.18 -35.84 60.27 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.717 -0.674 . . . . 0.0 112.241 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.616 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 40.2 mt-10 -68.12 -40.27 82.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.759 0.314 . . . . 0.0 110.706 179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.434 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.68 -36.66 76.2 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.887 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.412 ' O ' ' HG2' ' A' ' 163' ' ' ARG . 7.4 mtm180 -60.28 -56.62 19.3 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.229 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -67.3 -23.81 65.69 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.703 179.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.616 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -70.75 -47.92 57.17 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.246 -0.433 . . . . 0.0 111.229 -179.929 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.412 ' HG2' ' O ' ' A' ' 160' ' ' ARG . 3.5 ptt85 -66.94 -36.76 82.96 Favored 'General case' 0 C--N 1.331 -0.231 0 C-N-CA 120.527 -0.469 . . . . 0.0 111.309 -179.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.442 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 1.7 mt-10 -70.26 -44.21 68.93 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.902 0.382 . . . . 0.0 110.298 179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.57 -25.84 75.1 Favored Glycine 0 N--CA 1.45 -0.431 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 178.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.628 ' O ' HG22 ' A' ' 170' ' ' VAL . 9.7 t-20 -59.94 -66.13 0.57 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.577 -0.812 . . . . 0.0 111.111 179.441 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.596 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 32.2 p-90 -61.56 -27.8 68.88 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.342 -179.251 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.38 -41.32 69.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.061 0.457 . . . . 0.0 110.79 179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.97 -30.1 20.27 Favored 'General case' 0 CA--C 1.538 0.51 0 N-CA-C 113.091 0.775 . . . . 0.0 113.091 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.697 HG11 ' HB2' ' A' ' 92' ' ' ASN . 2.7 m -92.18 -36.79 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 N-CA-C 113.799 1.037 . . . . 0.0 113.799 -177.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 16.5 ttp180 -66.22 -29.47 69.73 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 120.927 0.394 . . . . 0.0 110.596 -179.57 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.45 -15.16 29.28 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.848 -179.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.814 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.4 p -86.11 -25.3 6.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 121.271 0.557 . . . . 0.0 110.365 179.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.814 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.9 OUTLIER -120.66 32.95 5.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.016 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.14 -32.71 70.11 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.035 -0.529 . . . . 0.0 111.409 179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -81.35 48.23 3.77 Favored Glycine 0 N--CA 1.451 -0.356 0 CA-C-N 116.075 -0.511 . . . . 0.0 113.277 -179.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -111.36 15.53 21.3 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.489 0.661 . . . . 0.0 109.272 178.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -86.17 67.15 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.271 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.4 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -100.8 10.4 41.19 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.914 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.739 ' HG ' HG11 ' A' ' 82' ' ' VAL . 19.1 mt -99.81 -52.63 3.39 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.683 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.5 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -65.51 95.77 0.23 Allowed Glycine 0 N--CA 1.449 -0.477 0 CA-C-N 115.668 -0.696 . . . . 0.0 113.088 -179.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.553 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -102.73 148.75 25.21 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 3.4 mt . . . . . 0 C--O 1.247 0.969 0 CA-C-O 118.569 -0.729 . . . . 0.0 110.096 179.999 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.679 0 N-CA-C 111.843 -0.503 . . . . 0.0 111.843 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -69.39 -31.72 21.59 Favored 'Trans proline' 0 C--N 1.345 0.367 0 C-N-CA 122.904 2.403 . . . . 0.0 111.974 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -86.14 132.4 34.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.321 179.63 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -168.5 44.21 0.23 Allowed Glycine 0 N--CA 1.447 -0.568 0 C-N-CA 120.49 -0.862 . . . . 0.0 112.544 -179.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 20.2 m -106.93 122.21 45.98 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.774 0.321 . . . . 0.0 110.456 179.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 25.4 mtm -106.8 6.67 29.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.881 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.22 146.05 26.6 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.852 -179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.438 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.4 p -106.16 134.55 19.72 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.62 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 6.7 Cg_exo -73.34 102.87 1.53 Allowed 'Trans proline' 0 N--CA 1.462 -0.35 0 C-N-CA 122.886 2.391 . . . . 0.0 111.899 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -101.64 141.8 33.95 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.778 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.33 65.51 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.19 0.519 . . . . 0.0 110.938 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.421 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -118.23 150.43 47.65 Favored Pre-proline 0 C--N 1.324 -0.501 0 CA-C-N 115.995 -0.548 . . . . 0.0 110.658 -179.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.439 ' HA ' ' CB ' ' A' ' 12' ' ' ALA . 6.6 Cg_exo -74.43 62.27 5.31 Favored 'Trans proline' 0 CA--C 1.531 0.331 0 C-N-CA 123.155 2.57 . . . . 0.0 112.374 -179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -89.3 -151.7 0.23 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.515 179.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -54.33 -45.09 72.58 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 123.267 0.627 . . . . 0.0 112.682 -179.064 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.49 -36.25 79.95 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.727 0.298 . . . . 0.0 111.133 -179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.439 ' CB ' ' HA ' ' A' ' 8' ' ' PRO . . . -76.55 -35.68 58.1 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.878 0.37 . . . . 0.0 110.057 179.318 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 8.5 tp -72.69 -40.21 66.43 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.153 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.0 p -65.69 -39.2 84.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.216 0 CA-C-O 120.888 0.375 . . . . 0.0 110.074 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.36 -24.29 60.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.504 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -77.61 -59.31 2.83 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.185 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.669 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.3 t80 -57.13 -53.91 52.73 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.749 -179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.466 ' O ' HD13 ' A' ' 22' ' ' LEU . 96.6 t -66.62 -40.18 85.61 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.569 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.36 -51.3 59.62 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.714 -0.755 . . . . 0.0 112.011 179.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.787 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 73.4 t80 -63.2 -41.7 99.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.711 0.291 . . . . 0.0 110.931 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.447 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -63.63 -40.77 97.74 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.649 -179.634 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.759 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.4 mp -73.36 -42.7 61.89 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 179.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 8.2 ttp85 -65.69 -15.52 62.88 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.6 -0.727 . . . . 0.0 110.272 179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -83.03 -35.29 25.91 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.04 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.4 pttt -158.16 79.4 0.83 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.902 0.382 . . . . 0.0 111.553 -179.473 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.58 -70.54 0.3 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.551 -0.833 . . . . 0.0 112.665 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.4 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 0.7 OUTLIER -88.84 58.98 4.85 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.13 0.49 . . . . 0.0 110.537 179.819 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -79.48 -29.82 13.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.036 179.849 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.3 -42.87 78.8 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.272 -0.876 . . . . 0.0 109.577 179.075 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.35 59.37 3.79 Favored Glycine 0 N--CA 1.446 -0.679 0 CA-C-N 115.341 -0.845 . . . . 0.0 112.076 179.298 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.483 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.6 127.34 32.39 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.017 -0.364 . . . . 0.0 110.017 179.478 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.26 -54.51 0.36 Allowed Glycine 0 C--O 1.225 -0.424 0 C-N-CA 119.711 -1.233 . . . . 0.0 113.793 -179.546 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.569 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 45.0 Cg_exo -58.53 -42.92 49.88 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.026 1.818 . . . . 0.0 111.407 -179.629 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.787 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.94 37.65 3.65 Favored Glycine 0 N--CA 1.443 -0.866 0 CA-C-N 114.936 -1.029 . . . . 0.0 112.478 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -90.84 -6.91 53.63 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.139 0.495 . . . . 0.0 110.067 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -105.28 144.9 15.84 Favored Glycine 0 N--CA 1.448 -0.557 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.78 179.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.423 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 88.2 Cg_endo -96.06 -150.27 0.03 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.1 0 C-N-CA 122.995 2.463 . . . . 0.0 113.118 -179.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -88.59 86.48 7.02 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.702 -179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.62 1.93 4.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.909 0.385 . . . . 0.0 111.735 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.457 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 55.0 m-20 -107.03 160.4 26.48 Favored Pre-proline 0 C--N 1.323 -0.562 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -78.27 41.12 0.98 Allowed 'Trans proline' 0 N--CA 1.46 -0.441 0 C-N-CA 123.23 2.62 . . . . 0.0 111.991 179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -170.44 -28.84 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.133 -0.939 . . . . 0.0 108.932 179.273 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.497 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.7 m170 -59.02 -56.5 21.49 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.848 179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.491 ' CB ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -60.67 -27.06 67.55 Favored 'General case' 0 CA--C 1.519 -0.233 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.684 -179.855 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.738 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.99 -49.58 36.0 Favored 'General case' 0 C--N 1.319 -0.717 0 CA-C-N 115.418 -0.81 . . . . 0.0 110.906 -179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.421 ' CE ' ' HZ3' ' A' ' 144' ' ' TRP . 0.9 OUTLIER -67.8 -31.57 71.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.313 -179.707 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.12 -40.99 97.77 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.45 -179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -23.27 43.25 Favored 'General case' 0 CA--C 1.515 -0.392 0 CA-C-O 121.306 0.574 . . . . 0.0 109.851 179.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.808 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -70.27 -63.88 1.0 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.64 -0.709 . . . . 0.0 109.099 178.503 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.669 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.35 -48.41 41.08 Favored Glycine 0 C--O 1.221 -0.686 0 CA-C-N 115.17 -0.923 . . . . 0.0 112.864 179.668 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -56.82 -42.65 79.96 Favored 'General case' 0 C--O 1.237 0.398 0 CA-C-O 121.089 0.471 . . . . 0.0 111.262 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 11.4 tt0 -62.88 -44.32 96.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.846 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.413 ' HE2' ' HB2' ' A' ' 98' ' ' ALA . 0.9 OUTLIER -75.64 -29.33 59.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.919 179.93 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -66.18 -24.09 66.57 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 178.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 96.7 m -93.84 -40.48 10.15 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 115.251 -0.886 . . . . 0.0 111.634 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.1 mtt180 -88.96 -54.36 4.16 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -178.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 2.1 t80 -85.3 68.64 10.56 Favored 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 122.75 0.42 . . . . 0.0 111.324 -179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 21.1 mtt180 -75.93 -22.99 55.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.358 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -78.19 37.84 0.27 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.279 -0.419 . . . . 0.0 112.035 -179.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -120.79 -5.01 9.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.826 0.346 . . . . 0.0 110.72 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.863 ' HA ' HD22 ' A' ' 64' ' ' LEU . 4.9 m-85 -93.6 -31.05 14.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.462 -0.335 . . . . 0.0 111.891 -179.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -64.07 -24.18 67.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.831 0.348 . . . . 0.0 111.425 -179.83 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 2.0 m-20 -77.79 -18.02 56.85 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.892 -179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.863 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -72.83 -39.63 66.42 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.36 -46.0 35.86 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 114.969 -1.014 . . . . 0.0 109.979 178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.579 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.87 -42.87 63.0 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.955 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.575 HE22 HD11 ' A' ' 106' ' ' LEU . 25.2 mt-30 -67.8 -61.61 1.8 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.829 -0.623 . . . . 0.0 112.656 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.485 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -79.61 13.33 2.09 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 -176.8 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 47.0 t60 -79.13 -26.45 42.84 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.631 179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -90.54 -74.99 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.998 -179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.404 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -159.84 142.77 10.17 Favored Pre-proline 0 C--N 1.326 -0.423 0 CA-C-N 116.438 -0.346 . . . . 0.0 110.075 -179.923 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.404 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.8 Cg_exo -75.6 -175.34 2.4 Favored 'Trans proline' 0 N--CA 1.462 -0.345 0 C-N-CA 123.009 2.473 . . . . 0.0 112.069 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.713 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.74 -65.81 2.94 Favored Glycine 0 CA--C 1.518 0.226 0 C-N-CA 120.69 -0.767 . . . . 0.0 113.027 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.24 41.81 0.14 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.234 0.54 . . . . 0.0 111.833 -179.596 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -97.11 -21.17 17.51 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.913 179.782 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.663 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.6 OUTLIER -63.83 -37.97 89.37 Favored 'General case' 0 CA--C 1.515 -0.383 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.763 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.607 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 4.4 mm100 -68.95 -35.22 76.51 Favored 'General case' 0 C--N 1.324 -0.521 0 C-N-CA 120.862 -0.335 . . . . 0.0 110.32 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.525 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -69.49 -48.15 61.55 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.14 0.495 . . . . 0.0 109.769 178.912 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.1 t80 -61.53 -47.62 84.74 Favored 'General case' 0 N--CA 1.451 -0.376 0 CA-C-N 115.558 -0.746 . . . . 0.0 111.068 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 5.3 p -58.66 -34.98 71.83 Favored 'General case' 0 C--O 1.232 0.137 0 C-N-CA 121.029 -0.268 . . . . 0.0 111.429 -179.773 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.607 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 73.4 mm-40 -60.23 -56.63 19.25 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 120.889 0.376 . . . . 0.0 110.177 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.615 HG11 ' CE2' ' A' ' 102' ' ' PHE . 12.3 t -59.0 -37.86 70.24 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.653 -0.703 . . . . 0.0 111.081 179.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 24.2 m -62.47 -46.37 88.79 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.979 -179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.551 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.8 OUTLIER -69.46 -36.32 76.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.862 0.363 . . . . 0.0 110.924 -179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.538 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 33.4 mm-40 -67.53 -32.87 73.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.251 -0.432 . . . . 0.0 109.872 179.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.562 ' HA ' HD13 ' A' ' 174' ' ' LEU . 0.7 OUTLIER -77.17 -36.73 54.85 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.23 179.909 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.486 ' HB2' ' HE2' ' A' ' 129' ' ' TYR . 55.2 t80 -85.21 -5.61 59.32 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.594 -0.275 . . . . 0.0 111.105 -179.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.538 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -53.79 -37.09 63.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.563 -179.486 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -179.46 59.92 0.08 OUTLIER Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 119.813 -1.184 . . . . 0.0 113.384 179.413 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.625 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 167.27 49.5 0.03 OUTLIER Glycine 0 CA--C 1.524 0.625 0 C-N-CA 119.605 -1.284 . . . . 0.0 115.17 178.842 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.63 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.4 Cg_endo -80.7 38.98 0.8 Allowed 'Trans proline' 0 C--N 1.353 0.781 0 CA-C-N 119.913 1.856 . . . . 0.0 111.715 177.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.761 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.6 OUTLIER -70.15 162.61 27.98 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.529 -179.12 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.573 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 15.1 m95 -53.22 -27.86 24.21 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.616 -179.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.03 -43.49 97.26 Favored Glycine 0 N--CA 1.45 -0.401 0 N-CA-C 111.088 -0.805 . . . . 0.0 111.088 179.083 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.4 ' NH1' ' HA ' ' A' ' 171' ' ' ARG . 0.4 OUTLIER -85.65 -23.15 27.59 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.59 -0.305 . . . . 0.0 110.675 178.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.765 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -55.35 -30.85 61.09 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.449 0.642 . . . . 0.0 110.036 179.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.808 HG22 ' HB1' ' A' ' 49' ' ' ALA . 41.2 t -60.93 -56.3 18.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 CA-C-N 114.958 -1.019 . . . . 0.0 109.41 178.435 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB2' ' HE2' ' A' ' 53' ' ' PHE . . . -62.93 -28.44 70.07 Favored 'General case' 0 C--O 1.221 -0.408 0 CA-C-N 115.038 -0.983 . . . . 0.0 111.406 179.463 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.765 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.45 -51.84 66.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.933 0.397 . . . . 0.0 110.201 179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.8 m-85 -81.53 -35.05 30.78 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.0 -0.545 . . . . 0.0 111.373 -179.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 15.2 t -63.75 -34.53 68.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.758 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.615 ' CE2' HG11 ' A' ' 82' ' ' VAL . 0.2 OUTLIER -54.23 -59.08 5.14 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.727 0.299 . . . . 0.0 111.496 179.807 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.408 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -69.78 -35.91 74.02 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.479 -0.867 . . . . 0.0 113.226 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.7 -46.19 90.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 117.2 0.5 . . . . 0.0 110.602 179.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.525 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.19 -39.1 82.59 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 178.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.707 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.7 -45.3 94.57 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.717 -0.674 . . . . 0.0 110.45 179.361 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.759 ' HB3' HD21 ' A' ' 22' ' ' LEU . 82.5 m -64.14 -41.69 97.09 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.108 -0.951 . . . . 0.0 111.298 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.86 -53.7 52.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.714 0.293 . . . . 0.0 111.041 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.5 -19.95 65.39 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.374 -0.376 . . . . 0.0 111.661 179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 68.3 m -78.71 -33.78 46.5 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.594 0.235 . . . . 0.0 110.716 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.554 HG23 ' O ' ' A' ' 107' ' ' CYS . 32.1 t -74.52 -25.88 19.66 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.236 0 CA-C-O 121.481 0.658 . . . . 0.0 109.669 178.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.55 1.42 45.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.147 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 42.7 mttt -133.93 -169.78 2.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.684 -0.689 . . . . 0.0 109.649 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.0 mt-10 -90.78 57.84 3.68 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.036 0.446 . . . . 0.0 110.025 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.485 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -137.54 46.44 2.12 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.716 -179.178 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.53 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.4 mp0 -62.47 -54.25 50.26 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 112.588 0.588 . . . . 0.0 112.588 -179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.53 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 26.3 Cg_exo -63.58 -20.19 68.95 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.077 1.852 . . . . 0.0 112.864 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.713 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -71.98 -29.49 64.29 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.528 -0.305 . . . . 0.0 110.911 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 81.1 t -58.62 -51.25 74.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.109 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.03 -31.5 80.91 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.656 -0.783 . . . . 0.0 112.142 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.608 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 5.8 mm100 -68.06 -49.82 59.01 Favored 'General case' 0 C--O 1.216 -0.663 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 179.068 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 118' ' ' LEU . 42.0 t -58.72 -33.88 50.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 178.615 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -63.33 -46.49 86.38 Favored 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.391 178.505 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 12.2 pt-20 -71.55 -40.44 69.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.702 179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.663 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 32.3 m0 -57.99 -39.98 79.58 Favored 'General case' 0 CA--C 1.519 -0.249 0 CA-C-O 121.555 0.693 . . . . 0.0 109.337 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.408 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.4 ttp -73.56 -53.0 11.55 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.898 -1.046 . . . . 0.0 111.956 -178.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.568 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.9 p -63.66 -31.87 54.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 N-CA-C 112.224 0.453 . . . . 0.0 112.224 -178.587 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -69.92 -50.52 41.29 Favored 'General case' 0 CA--C 1.522 -0.099 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.068 179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.551 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 7.0 t80 -58.92 -33.15 70.25 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.407 0.622 . . . . 0.0 110.983 179.121 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.009 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.15 -52.27 9.57 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.451 -0.795 . . . . 0.0 112.89 -178.698 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -62.6 -35.32 79.16 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 2.5 m -81.15 -39.22 25.9 Favored 'General case' 0 C--N 1.324 -0.511 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -121.72 -41.33 2.48 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 114.514 1.301 . . . . 0.0 114.514 -177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.009 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -63.36 -47.09 83.59 Favored 'General case' 0 C--N 1.327 -0.41 0 C-N-CA 120.332 -0.547 . . . . 0.0 111.545 -178.501 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.58 -34.53 62.07 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.427 -0.351 . . . . 0.0 111.275 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -65.4 -50.0 67.16 Favored 'General case' 0 CA--C 1.519 -0.247 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.219 179.272 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.761 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 45.6 t90 -59.08 -49.05 79.38 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 109.274 -0.639 . . . . 0.0 109.274 178.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.594 HG13 ' HE3' ' A' ' 137' ' ' TRP . 14.8 mt -56.92 -48.41 81.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.163 -0.926 . . . . 0.0 112.074 -178.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 -65.59 -30.52 71.26 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.691 0.256 . . . . 0.0 111.691 -179.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.2 m -83.55 -30.37 27.11 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.1 0.407 . . . . 0.0 112.1 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.26 -57.69 4.24 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.164 0.431 . . . . 0.0 112.164 -178.802 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -170.83 -10.86 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.559 0 N-CA-C 111.354 -0.698 . . . . 0.0 111.354 -179.442 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.407 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 92.3 170.24 40.9 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.626 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.448 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.7 m95 -62.84 -30.77 71.75 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.75 72.86 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.255 -0.884 . . . . 0.0 111.204 178.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.427 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -65.44 -41.12 93.82 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.907 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.707 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 8.2 t80 -65.85 -39.04 90.39 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.514 178.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.738 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -65.78 -25.73 67.38 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.024 0.44 . . . . 0.0 110.815 179.177 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.4 -28.04 23.82 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.083 0.468 . . . . 0.0 109.849 178.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.712 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.15 -50.77 66.88 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.44 -0.8 . . . . 0.0 111.27 -179.83 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -134.3 30.26 3.58 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 112.483 0.549 . . . . 0.0 112.483 -178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -105.62 -111.03 3.56 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 119.84 -1.172 . . . . 0.0 112.862 -179.736 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -70.6 -67.27 0.51 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.041 0.448 . . . . 0.0 110.973 -179.333 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -91.94 69.88 1.86 Allowed Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.553 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.54 71.38 9.62 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.282 0.563 . . . . 0.0 110.343 179.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.621 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.1 165.04 14.27 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.262 -0.881 . . . . 0.0 111.039 -179.539 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.425 ' OE1' ' HD2' ' A' ' 161' ' ' ARG . 0.1 OUTLIER -58.91 -36.27 74.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.1 179.873 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.621 ' HB2' HD12 ' A' ' 156' ' ' LEU . 0.6 OUTLIER -68.63 -38.96 80.94 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.592 -0.276 . . . . 0.0 111.344 -179.512 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.712 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -69.98 -40.14 75.51 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.234 0.54 . . . . 0.0 110.236 179.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 7.5 mtt180 -68.04 -49.55 60.7 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.868 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.425 ' HD2' ' OE1' ' A' ' 157' ' ' GLU . 9.7 ptm180 -62.3 -28.57 69.82 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-O 120.757 0.313 . . . . 0.0 110.385 179.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.621 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -67.42 -42.32 83.39 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.833 179.186 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.619 HH22 ' HA ' ' A' ' 49' ' ' ALA . 5.2 ttp180 -67.08 -44.04 81.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.23 179.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.648 ' HG3' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -63.11 -47.29 83.45 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.735 179.657 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.41 -23.63 75.07 Favored Glycine 0 N--CA 1.449 -0.437 0 C-N-CA 120.522 -0.847 . . . . 0.0 111.739 179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.621 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 2.9 t-20 -74.43 -54.53 7.4 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.662 -0.269 . . . . 0.0 111.532 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.976 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.7 p-90 -64.25 -24.29 67.61 Favored 'General case' 0 N--CA 1.452 -0.347 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.055 -179.183 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -51.36 -52.97 40.95 Favored 'General case' 0 C--N 1.326 -0.449 0 O-C-N 123.215 0.322 . . . . 0.0 110.811 179.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.8 -27.72 22.12 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.986 0.736 . . . . 0.0 112.986 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.976 HG22 ' HA ' ' A' ' 167' ' ' TRP . 25.0 m -80.02 -25.98 11.94 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 C-N-CA 119.906 -0.717 . . . . 0.0 112.273 -178.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.4 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.7 ttp180 -83.13 -15.11 52.04 Favored 'General case' 0 C--N 1.315 -0.904 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 179.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.809 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -96.22 -39.16 9.81 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.003 -0.544 . . . . 0.0 111.33 179.5 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.91 HG13 ' HG ' ' A' ' 174' ' ' LEU . 13.2 p -59.39 -33.4 51.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.126 0.489 . . . . 0.0 110.403 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.91 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.0 OUTLIER -115.7 44.5 1.88 Allowed 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.634 178.836 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.809 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.16 -43.08 92.92 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.294 179.91 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.21 41.42 1.32 Allowed Glycine 0 C--N 1.332 0.349 0 CA-C-N 116.05 -0.523 . . . . 0.0 113.724 -179.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.554 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -100.77 -4.24 28.44 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.264 0.554 . . . . 0.0 109.878 178.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.41 67.4 0.37 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 115.648 -0.706 . . . . 0.0 110.397 179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -98.35 8.2 45.16 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.726 -0.67 . . . . 0.0 111.446 -179.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.542 HD11 ' CE2' ' A' ' 102' ' ' PHE . 8.7 mt -90.94 -45.24 8.87 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.249 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -60.64 101.58 0.31 Allowed Glycine 0 N--CA 1.447 -0.63 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.183 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.579 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -104.21 157.04 17.4 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.523 -0.339 . . . . 0.0 110.7 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.245 0.868 0 CA-C-O 118.994 -0.527 . . . . 0.0 109.847 179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.64 0 N-CA-C 112.11 -0.396 . . . . 0.0 112.11 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -75.75 151.77 36.6 Favored 'Trans proline' 0 N--CA 1.463 -0.285 0 C-N-CA 123.122 2.548 . . . . 0.0 112.08 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -108.22 14.97 24.55 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.915 0.388 . . . . 0.0 110.982 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 122.08 124.2 2.99 Favored Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.471 179.661 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.97 128.19 43.69 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-O 120.795 0.331 . . . . 0.0 110.67 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.4 mmt -71.71 -52.51 17.43 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.3 0.571 . . . . 0.0 110.153 179.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.47 121.79 34.77 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.032 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.9 p -99.84 117.27 63.79 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-O 120.909 0.385 . . . . 0.0 110.96 -179.539 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 21.8 Cg_exo -65.19 127.47 18.42 Favored 'Trans proline' 0 C--N 1.344 0.341 0 C-N-CA 122.9 2.4 . . . . 0.0 111.96 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -83.77 136.53 34.12 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.991 -0.55 . . . . 0.0 111.504 -179.568 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.55 138.24 17.87 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.748 -0.66 . . . . 0.0 109.769 179.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.446 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -86.55 127.41 60.76 Favored Pre-proline 0 C--N 1.324 -0.54 0 CA-C-N 116.469 -0.332 . . . . 0.0 110.439 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 8.7 Cg_exo -72.99 40.75 0.52 Allowed 'Trans proline' 0 CA--C 1.532 0.382 0 C-N-CA 123.618 2.878 . . . . 0.0 112.894 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.89 -156.65 0.45 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.42 179.718 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -57.89 -36.22 72.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.252 179.487 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -61.73 -42.8 99.44 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.884 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.15 -35.03 66.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.907 0.384 . . . . 0.0 110.465 179.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.654 ' HB2' HD13 ' A' ' 42' ' ' LEU . 6.6 tp -72.91 -42.18 63.81 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.486 -179.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.8 p -66.47 -37.42 79.58 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.849 -0.426 . . . . 0.0 109.849 179.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.421 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.0 -21.05 61.61 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.532 178.842 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.537 ' HB2' ' CE1' ' A' ' 43' ' ' HIS . 1.2 t70 -77.81 -68.71 0.6 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.099 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.543 ' O ' ' HB2' ' A' ' 21' ' ' LYS . 4.5 t80 -52.3 -50.33 62.4 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.974 -0.557 . . . . 0.0 112.206 -178.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.4 ' O ' HD13 ' A' ' 22' ' ' LEU . 19.3 t -75.93 -39.18 37.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 C-N-CA 120.855 -0.338 . . . . 0.0 110.935 -179.57 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.421 ' HA3' ' O ' ' A' ' 15' ' ' ALA . . . -61.22 -53.69 42.53 Favored Glycine 0 C--O 1.227 -0.305 0 C-N-CA 120.643 -0.789 . . . . 0.0 112.527 179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.735 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 85.9 t80 -60.8 -45.47 94.29 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 122.527 0.331 . . . . 0.0 111.029 -179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.543 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.1 OUTLIER -61.04 -47.73 85.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.204 -179.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.749 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.3 mp -67.93 -47.85 67.57 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.52 -179.746 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.56 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 29.6 ttp85 -58.75 -30.95 67.89 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.554 -179.631 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 5.4 mm100 -86.63 -12.03 49.66 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.529 0.566 . . . . 0.0 112.529 -179.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.7 tttp -156.47 63.09 0.54 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 -178.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.46 -71.21 0.33 Allowed Glycine 0 CA--C 1.51 -0.231 0 C-N-CA 120.337 -0.935 . . . . 0.0 112.73 179.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.56 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.3 t80 -82.2 56.62 3.26 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.15 0.5 . . . . 0.0 110.149 179.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 5.0 t -78.31 -32.57 16.88 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.219 -179.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 1.7 m -66.27 -35.38 80.24 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.862 -0.608 . . . . 0.0 109.774 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.23 51.62 2.46 Favored Glycine 0 N--CA 1.448 -0.549 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.639 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -69.86 116.16 9.93 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.746 0.308 . . . . 0.0 110.668 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.22 -51.05 0.13 Allowed Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.105 -1.045 . . . . 0.0 113.599 -179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -66.7 -48.46 2.12 Favored 'Trans proline' 0 C--N 1.349 0.558 0 C-N-CA 122.187 1.925 . . . . 0.0 111.667 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.735 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -89.47 27.48 7.76 Favored Glycine 0 N--CA 1.447 -0.588 0 CA-C-N 115.525 -0.761 . . . . 0.0 112.94 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.9 mm-40 -77.25 -58.54 3.22 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.604 0.716 . . . . 0.0 109.388 179.767 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -69.94 139.22 30.91 Favored Glycine 0 N--CA 1.449 -0.469 0 CA-C-N 114.279 -1.328 . . . . 0.0 111.699 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.47 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 87.5 Cg_endo -90.53 -133.83 0.01 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 122.722 2.281 . . . . 0.0 113.567 -178.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.586 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -83.63 92.02 7.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.655 -0.702 . . . . 0.0 111.452 -179.479 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -129.84 10.63 5.54 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.489 0.661 . . . . 0.0 109.576 179.493 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.431 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.8 m-20 -121.11 160.51 44.95 Favored Pre-proline 0 N--CA 1.448 -0.541 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.365 -178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.431 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -81.36 37.03 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.492 0 C-N-CA 123.246 2.631 . . . . 0.0 112.4 179.361 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.0 OUTLIER -165.61 -29.93 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.414 179.439 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.537 ' CE1' ' HB2' ' A' ' 16' ' ' ASP . 2.5 m170 -56.21 -56.98 14.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.49 -0.777 . . . . 0.0 110.697 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.586 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 9.1 tt0 -57.67 -23.4 51.23 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.514 -0.767 . . . . 0.0 111.557 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.948 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -82.52 -49.62 9.71 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.863 -0.608 . . . . 0.0 112.164 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.434 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 4.5 ttm -66.42 -42.14 88.2 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 111.92 0.341 . . . . 0.0 111.92 -178.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.24 -30.74 71.78 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.498 0.19 . . . . 0.0 111.323 -179.638 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.56 -40.87 33.57 Favored 'General case' 0 CA--C 1.515 -0.381 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 179.331 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.78 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.51 -55.76 30.52 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.528 -0.76 . . . . 0.0 109.097 178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.445 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.98 -44.75 41.57 Favored Glycine 0 C--O 1.217 -0.93 0 CA-C-N 115.219 -0.901 . . . . 0.0 112.613 179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -59.01 -54.14 50.52 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-O 121.123 0.487 . . . . 0.0 111.453 179.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.53 -43.43 97.15 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.965 -179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.88 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.87 -30.24 62.53 Favored 'General case' 0 C--O 1.216 -0.7 0 CA-C-N 116.494 -0.321 . . . . 0.0 111.495 -179.751 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -64.97 -30.35 71.33 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-O 121.78 0.8 . . . . 0.0 108.864 179.124 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 56.1 m -79.54 -33.69 41.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 114.915 -1.039 . . . . 0.0 111.297 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 56' ' ' ARG . 19.0 mtt180 -89.56 -52.12 5.18 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 121.174 0.512 . . . . 0.0 111.716 -179.54 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.402 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.3 OUTLIER -86.27 64.13 8.39 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 123.303 0.641 . . . . 0.0 110.958 -179.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -67.98 -18.29 64.68 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.032 0.444 . . . . 0.0 111.768 -179.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.59 58.43 3.72 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.852 179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -121.27 -51.07 2.1 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 121.129 0.49 . . . . 0.0 111.746 -179.227 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.508 ' HA ' ' CD1' ' A' ' 64' ' ' LEU . 5.1 m-85 -62.17 -19.73 63.39 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 112.948 0.722 . . . . 0.0 112.948 -178.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.96 -38.79 66.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.835 0.35 . . . . 0.0 111.311 -179.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.795 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 3.3 m-20 -67.03 -28.41 68.2 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.9 -0.591 . . . . 0.0 110.491 -179.367 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.614 HD11 ' HB1' ' A' ' 105' ' ' ALA . 20.1 mt -61.19 -43.63 98.58 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.696 -0.684 . . . . 0.0 109.338 178.408 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.8 -40.49 47.88 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.02 179.452 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.727 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.59 -45.52 63.17 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.699 179.009 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.636 ' NE2' ' HG ' ' A' ' 180' ' ' LEU . 36.9 mt-30 -67.64 -54.73 17.22 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.683 -0.689 . . . . 0.0 112.255 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.418 HD12 ' HA ' ' A' ' 72' ' ' PRO . 0.5 OUTLIER -84.38 17.52 2.57 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 113.131 0.789 . . . . 0.0 113.131 -177.377 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.486 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.9 t60 -78.17 -30.28 49.04 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 121.012 0.434 . . . . 0.0 110.492 179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.635 HG13 ' H ' ' A' ' 71' ' ' THR . 2.4 p -91.5 -65.25 1.06 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.104 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.635 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.1 OUTLIER -162.3 145.95 9.15 Favored Pre-proline 0 C--N 1.33 -0.25 0 C-N-CA 122.138 0.175 . . . . 0.0 110.708 179.895 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 2.9 Cg_exo -76.45 172.18 16.7 Favored 'Trans proline' 0 N--CA 1.46 -0.497 0 C-N-CA 122.818 2.345 . . . . 0.0 111.355 179.228 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 96.92 -60.99 1.13 Allowed Glycine 0 N--CA 1.452 -0.237 0 C-N-CA 120.381 -0.914 . . . . 0.0 112.625 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.17 50.62 0.5 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.418 0.628 . . . . 0.0 110.93 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -105.76 -22.12 13.02 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.679 -0.691 . . . . 0.0 111.04 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.684 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.32 -39.94 94.91 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 120.8 -0.36 . . . . 0.0 111.509 -179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.82 -47.71 82.26 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.475 -0.49 . . . . 0.0 109.998 179.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.33 -47.66 83.02 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.316 178.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 5.4 t80 -60.81 -50.02 75.14 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.774 179.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . 0.411 ' HA ' ' OG ' ' A' ' 83' ' ' SER . 18.5 p -60.61 -30.01 69.58 Favored 'General case' 0 CA--C 1.532 0.273 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -179.615 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 28.6 mm-40 -68.01 -53.11 28.34 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-O 121.002 0.43 . . . . 0.0 110.591 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.52 ' CG1' HD13 ' A' ' 180' ' ' LEU . 34.2 m -65.77 -32.3 57.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 115.881 -0.599 . . . . 0.0 112.089 -179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.411 ' OG ' ' HA ' ' A' ' 80' ' ' THR . 1.3 p -69.13 -39.94 78.59 Favored 'General case' 0 C--N 1.332 -0.156 0 C-N-CA 120.63 -0.428 . . . . 0.0 109.892 179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -64.65 -46.5 82.23 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.239 179.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -68.87 -25.03 64.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.81 179.695 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.652 HD12 ' HB1' ' A' ' 177' ' ' ALA . 0.0 OUTLIER -79.82 -26.15 40.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.153 0.501 . . . . 0.0 109.952 179.214 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 57.2 t80 -97.37 -4.24 38.82 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.395 179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 4.5 tm0? -39.04 -50.47 1.81 Allowed 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 123.542 0.737 . . . . 0.0 112.378 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -173.3 48.99 0.16 Allowed Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.126 -1.035 . . . . 0.0 112.901 179.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . 174.12 56.82 0.05 OUTLIER Glycine 0 N--CA 1.448 -0.523 0 C-N-CA 119.761 -1.209 . . . . 0.0 114.221 179.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.587 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 14.6 Cg_endo -77.8 45.78 1.87 Allowed 'Trans proline' 0 C--N 1.35 0.652 0 C-N-CA 122.21 1.94 . . . . 0.0 111.817 178.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.8 162.92 26.91 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.598 -178.958 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.637 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 17.6 m95 -54.01 -28.85 40.71 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.639 -179.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.86 -40.78 98.71 Favored Glycine 0 N--CA 1.448 -0.525 0 C-N-CA 120.615 -0.802 . . . . 0.0 111.204 179.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.607 ' HE ' ' HA ' ' A' ' 171' ' ' ARG . 6.9 mmt180 -86.35 -21.56 27.16 Favored 'General case' 0 C--N 1.326 -0.442 0 O-C-N 122.812 -0.228 . . . . 0.0 110.551 178.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.774 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.0 OUTLIER -57.66 -30.62 65.57 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-O 121.346 0.593 . . . . 0.0 110.132 179.38 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.88 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.5 t -62.9 -55.16 25.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 CA-C-N 115.348 -0.842 . . . . 0.0 109.461 178.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.447 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -61.61 -29.06 69.8 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.053 179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.774 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 3.6 m-85 -56.42 -54.21 48.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.142 0.496 . . . . 0.0 110.082 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.524 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 6.6 m-85 -79.03 -36.33 41.26 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.02 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.447 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 3.4 t -59.99 -38.45 76.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.163 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.51 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -57.41 -50.0 74.41 Favored 'General case' 0 C--N 1.333 -0.116 0 CA-C-O 120.71 0.291 . . . . 0.0 111.613 -179.643 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -76.68 -37.65 34.07 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.356 -0.926 . . . . 0.0 113.261 -179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -43.63 98.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 117.245 0.523 . . . . 0.0 110.731 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.614 ' HB1' HD11 ' A' ' 64' ' ' LEU . . . -69.22 -38.88 78.77 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.645 -0.502 . . . . 0.0 109.645 178.837 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.549 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -60.31 -44.9 95.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.385 -0.825 . . . . 0.0 110.292 179.22 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.749 ' HB3' HD21 ' A' ' 22' ' ' LEU . 86.6 m -64.06 -41.01 97.52 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.172 179.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.25 -54.7 40.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.381 179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -69.14 -17.72 63.87 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 121.081 -0.248 . . . . 0.0 111.516 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.421 ' HB2' HG22 ' A' ' 119' ' ' VAL . 74.2 m -77.97 -31.0 50.56 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.077 -0.342 . . . . 0.0 110.077 179.266 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.595 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.6 t -80.95 -13.87 12.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.905 0.859 . . . . 0.0 109.163 177.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 12.8 m-80 -85.02 0.07 52.73 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.119 -0.946 . . . . 0.0 110.267 179.348 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 3.0 mttt -144.64 -170.38 3.38 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.674 -0.693 . . . . 0.0 109.519 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -86.84 55.59 3.63 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.226 0.536 . . . . 0.0 110.034 179.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -129.85 29.69 4.95 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.513 -179.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.509 ' N ' ' HD2' ' A' ' 117' ' ' PRO . 0.0 OUTLIER -53.51 -51.07 79.29 Favored Pre-proline 0 CA--C 1.538 0.517 0 N-CA-C 112.643 0.608 . . . . 0.0 112.643 -179.62 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.509 ' HD2' ' N ' ' A' ' 116' ' ' GLU . 19.1 Cg_endo -59.84 -23.19 71.39 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 122.238 1.959 . . . . 0.0 113.243 -179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.506 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 mm? -76.04 -26.68 56.83 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.591 0.234 . . . . 0.0 110.777 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.421 HG22 ' HB2' ' A' ' 110' ' ' SER . 88.9 t -59.25 -54.3 36.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.193 179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -60.49 -30.29 71.37 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.879 -0.677 . . . . 0.0 112.446 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 3.7 mm100 -69.45 -49.77 51.82 Favored 'General case' 0 C--O 1.217 -0.618 0 N-CA-C 109.35 -0.611 . . . . 0.0 109.35 179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.512 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 46.1 t -58.52 -35.16 53.34 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 N-CA-C 109.635 -0.505 . . . . 0.0 109.635 178.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -61.15 -50.38 73.42 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.527 -0.761 . . . . 0.0 110.359 178.389 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.666 ' HA ' HG12 ' A' ' 127' ' ' VAL . 10.7 pt-20 -69.27 -39.78 78.2 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.915 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.684 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 33.9 m0 -57.3 -40.93 78.84 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-O 121.391 0.615 . . . . 0.0 109.524 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.532 ' HG2' ' N ' ' A' ' 127' ' ' VAL . 0.0 OUTLIER -76.04 -44.53 38.75 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.174 -0.921 . . . . 0.0 112.376 -178.323 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.666 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.0 p -71.45 -31.57 43.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 120.299 -0.56 . . . . 0.0 111.741 -179.137 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.0 mm-40 -69.57 -48.14 61.24 Favored 'General case' 0 CA--C 1.521 -0.165 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.09 179.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 13.7 t80 -59.34 -35.16 73.33 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.552 0.692 . . . . 0.0 110.473 179.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.926 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.39 -53.19 11.32 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.229 -0.896 . . . . 0.0 111.908 -179.504 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 19.8 mt-10 -62.36 -28.78 70.0 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 17.9 m -85.1 -36.11 21.37 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 113.303 0.853 . . . . 0.0 113.303 -178.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.0 mtp180 -128.14 -40.77 1.64 Allowed 'General case' 0 N--CA 1.47 0.542 0 N-CA-C 113.915 1.079 . . . . 0.0 113.915 -178.246 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.926 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.67 -45.83 92.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 118.129 0.422 . . . . 0.0 111.325 -178.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.92 -35.04 61.24 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.367 -0.378 . . . . 0.0 111.356 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -65.71 -53.96 33.75 Favored 'General case' 0 CA--C 1.52 -0.199 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.799 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 47.8 t90 -57.12 -47.31 81.43 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.471 HG13 ' HE3' ' A' ' 137' ' ' TRP . 8.3 mt -57.02 -49.18 80.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.597 -179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 52.8 m170 -65.1 -32.71 74.54 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 111.885 0.328 . . . . 0.0 111.885 -179.36 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -88.97 -4.41 58.44 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.418 0.525 . . . . 0.0 112.418 -179.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.443 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -99.31 -50.71 4.03 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.831 -0.348 . . . . 0.0 111.871 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.462 ' HA3' ' OE1' ' A' ' 146' ' ' GLU . . . -176.35 -19.97 0.02 OUTLIER Glycine 0 CA--C 1.502 -0.768 0 N-CA-C 110.868 -0.893 . . . . 0.0 110.868 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 95.81 168.36 35.07 Favored Glycine 0 N--CA 1.44 -1.067 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.732 179.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.434 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 89.3 m95 -60.14 -31.15 69.81 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.611 -0.514 . . . . 0.0 109.611 179.522 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.49 -33.3 75.28 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.012 178.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.462 ' OE1' ' HA3' ' A' ' 142' ' ' GLY . 2.8 tt0 -65.74 -38.15 88.34 Favored 'General case' 0 C--O 1.235 0.307 0 N-CA-C 108.804 -0.813 . . . . 0.0 108.804 178.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -68.35 -38.94 81.95 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.762 -1.108 . . . . 0.0 110.747 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.948 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.3 OUTLIER -61.91 -33.84 74.96 Favored 'General case' 0 CA--C 1.52 -0.18 0 CA-C-O 120.686 0.279 . . . . 0.0 111.401 179.776 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -79.14 -39.78 32.67 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.182 0.515 . . . . 0.0 109.813 179.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.508 HD22 ' HG3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -61.74 -44.65 96.49 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.428 -0.805 . . . . 0.0 112.084 -179.779 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.569 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -111.27 16.45 20.93 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 112.157 0.428 . . . . 0.0 112.157 -178.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -108.24 -137.88 8.34 Favored Glycine 0 N--CA 1.444 -0.817 0 C-N-CA 119.958 -1.115 . . . . 0.0 112.9 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.0 -29.66 26.79 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 111.217 -179.125 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.505 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.84 37.9 2.82 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.915 -0.659 . . . . 0.0 112.092 179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.13 68.81 9.72 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.184 0.516 . . . . 0.0 110.647 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.505 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.5 OUTLIER -67.46 176.78 2.18 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.206 -179.691 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -53.54 -38.42 63.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.565 -179.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -68.47 -46.56 69.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.433 -0.349 . . . . 0.0 111.02 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -63.43 -31.91 73.2 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.865 0.364 . . . . 0.0 110.731 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -66.27 -56.78 9.57 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.009 179.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 1.6 ptm180 -65.36 -34.1 77.53 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.42 -0.355 . . . . 0.0 111.351 -179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.595 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 1.0 OUTLIER -67.86 -31.47 71.31 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.657 -0.247 . . . . 0.0 110.652 179.817 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.508 ' HG3' HD22 ' A' ' 150' ' ' LEU . 6.2 mtp180 -70.14 -51.59 30.21 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.816 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.453 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 12.8 mt-10 -67.57 -38.63 84.37 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.61 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.83 -21.36 76.6 Favored Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.594 -0.813 . . . . 0.0 111.122 178.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.595 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 9.6 t-20 -69.4 -71.39 0.23 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.295 -0.452 . . . . 0.0 110.545 179.634 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.453 ' CD1' ' HA ' ' A' ' 164' ' ' GLU . 35.8 p-90 -58.36 -25.4 61.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.006 -0.543 . . . . 0.0 111.854 -179.112 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.56 -63.14 1.25 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.61 0.243 . . . . 0.0 110.883 179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.75 -23.4 24.12 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 112.814 0.672 . . . . 0.0 112.814 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.475 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 8.3 t -77.99 -39.01 25.09 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.873 0.368 . . . . 0.0 111.682 -178.534 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.607 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 16.2 ttp180 -74.15 -24.1 59.36 Favored 'General case' 0 C--N 1.323 -0.58 0 O-C-N 122.091 -0.381 . . . . 0.0 110.699 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.732 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.8 OUTLIER -84.24 -27.75 27.72 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.659 -179.931 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.567 ' CG1' ' HG ' ' A' ' 174' ' ' LEU . 0.7 OUTLIER -68.27 -22.98 27.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-O 120.983 0.421 . . . . 0.0 110.497 -179.979 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.567 ' HG ' ' CG1' ' A' ' 173' ' ' VAL . 0.4 OUTLIER -120.38 38.49 3.97 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.634 178.787 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.732 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -61.37 -23.24 65.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.139 -0.482 . . . . 0.0 112.297 -179.402 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -82.76 6.86 67.91 Favored Glycine 0 CA--C 1.52 0.394 0 C-N-CA 120.88 -0.676 . . . . 0.0 113.465 -179.273 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.652 ' HB1' HD12 ' A' ' 86' ' ' LEU . . . -80.08 7.03 9.97 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 111.996 0.369 . . . . 0.0 111.996 -179.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.8 t -85.83 65.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-O 121.27 0.557 . . . . 0.0 110.713 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.47 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -102.48 13.67 33.95 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.284 0.564 . . . . 0.0 110.19 179.841 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.795 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 0.3 OUTLIER -100.34 -28.5 12.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.503 -0.771 . . . . 0.0 110.846 -179.335 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -83.21 94.76 1.8 Allowed Glycine 0 N--CA 1.447 -0.628 0 CA-C-N 115.799 -0.637 . . . . 0.0 112.831 -179.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.727 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -93.9 -168.08 1.81 Allowed 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.249 1.064 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.684 0 N-CA-C 111.601 -0.6 . . . . 0.0 111.601 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -65.96 126.01 15.15 Favored 'Trans proline' 0 C--O 1.232 0.214 0 C-N-CA 122.809 2.339 . . . . 0.0 112.253 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 83.3 mt -84.44 -63.21 1.38 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.911 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 171.56 -178.77 43.7 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.825 -0.702 . . . . 0.0 111.836 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.477 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.0 OUTLIER -85.12 137.94 32.72 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.492 0.146 . . . . 0.0 110.659 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' HB2' ' O ' ' A' ' 0' ' ' SER . 0.0 OUTLIER 73.81 146.01 0.08 Allowed 'General case' 0 N--CA 1.468 0.453 0 O-C-N 124.012 0.82 . . . . 0.0 111.648 179.978 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -139.71 138.08 35.68 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.365 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.444 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.0 p -99.42 134.58 21.1 Favored Pre-proline 0 C--N 1.324 -0.509 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.236 -179.479 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.0 Cg_exo -75.04 132.27 15.18 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 123.027 2.485 . . . . 0.0 112.094 -179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -130.46 122.18 27.22 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.866 0.365 . . . . 0.0 111.003 -179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.99 115.51 28.05 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.761 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . . . . . . . . . . . -102.6 151.36 38.24 Favored Pre-proline 0 C--N 1.327 -0.41 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.031 -179.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -65.95 108.81 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.156 2.571 . . . . 0.0 112.079 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -83.83 -172.04 3.94 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.81 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -55.27 -28.04 50.69 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 123.382 0.673 . . . . 0.0 111.929 179.714 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 6.9 ttp180 -66.78 -39.98 88.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.837 0.351 . . . . 0.0 110.093 179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.85 -34.3 62.26 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.191 0.519 . . . . 0.0 109.727 178.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.606 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.1 tp -72.82 -41.58 64.73 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.315 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.2 p -64.98 -36.96 79.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.158 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.94 -25.71 62.87 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.391 178.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -71.97 -66.52 0.63 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.131 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.438 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.0 t80 -54.21 -52.07 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.268 -0.424 . . . . 0.0 112.07 -179.213 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.462 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.8 t -65.5 -42.02 92.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 116.452 -0.34 . . . . 0.0 110.462 -179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.593 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.97 -51.83 56.09 Favored Glycine 0 C--O 1.225 -0.441 0 C-N-CA 120.718 -0.754 . . . . 0.0 112.18 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.758 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 42.8 t80 -58.32 -45.45 88.02 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 123.009 0.524 . . . . 0.0 111.292 -179.846 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -64.52 -47.87 77.25 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.301 -179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.672 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -65.23 -46.71 79.5 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.437 -179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.553 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 12.6 ttp85 -62.84 -20.42 65.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.952 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.87 -31.16 23.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.798 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -149.32 71.97 1.14 Allowed 'General case' 0 C--O 1.235 0.337 0 C-N-CA 120.618 -0.433 . . . . 0.0 112.163 -179.096 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.16 -69.83 0.32 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.3 -0.952 . . . . 0.0 112.756 179.108 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.42 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -87.5 53.74 2.9 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.114 0.483 . . . . 0.0 110.488 179.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.42 -33.94 15.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-N 115.955 -0.566 . . . . 0.0 109.805 179.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -64.08 -37.9 89.12 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.455 -0.793 . . . . 0.0 110.023 178.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -97.29 52.42 1.37 Allowed Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.307 -0.86 . . . . 0.0 111.716 178.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.553 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -65.47 141.7 58.41 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 155.51 -45.71 0.53 Allowed Glycine 0 CA--C 1.522 0.527 0 C-N-CA 119.757 -1.211 . . . . 0.0 114.111 -179.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.593 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 11.5 Cg_exo -73.37 -47.62 0.29 Allowed 'Trans proline' 0 C--N 1.348 0.54 0 C-N-CA 122.138 1.892 . . . . 0.0 111.869 -179.307 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.758 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.95 27.22 7.54 Favored Glycine 0 N--CA 1.447 -0.6 0 CA-C-N 115.4 -0.818 . . . . 0.0 114.216 -179.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 19.9 mm-40 -80.57 -41.96 23.17 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 117.504 0.652 . . . . 0.0 109.403 179.117 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -64.3 142.66 46.2 Favored Glycine 0 N--CA 1.449 -0.445 0 CA-C-N 114.934 -1.03 . . . . 0.0 112.006 179.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_endo -93.49 -166.27 0.14 Allowed 'Trans proline' 0 N--CA 1.452 -0.915 0 C-N-CA 122.784 2.323 . . . . 0.0 113.806 -178.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.932 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -83.22 85.51 7.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.392 179.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.04 -23.44 4.96 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 112.018 0.377 . . . . 0.0 112.018 -178.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.444 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 4.2 m-20 -79.32 160.28 70.79 Favored Pre-proline 0 C--N 1.322 -0.597 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.472 -178.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.47 ' HA ' HG21 ' A' ' 148' ' ' THR . 27.8 Cg_endo -77.61 50.16 3.13 Favored 'Trans proline' 0 N--CA 1.46 -0.49 0 C-N-CA 123.279 2.653 . . . . 0.0 111.568 178.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.606 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -178.96 -31.55 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.106 -1.407 . . . . 0.0 108.287 179.579 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.68 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.8 m170 -60.42 -59.58 5.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.264 -0.88 . . . . 0.0 109.963 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.932 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -57.54 -27.1 62.33 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.732 179.51 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.748 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -71.88 -52.78 15.63 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.729 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.423 ' HE1' HD21 ' A' ' 13' ' ' LEU . 2.9 ttm -65.58 -38.3 89.13 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.648 -0.251 . . . . 0.0 111.639 -179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -59.25 -38.63 80.51 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.402 -179.681 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.74 -30.67 45.95 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.22 0.533 . . . . 0.0 110.107 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.877 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -63.73 -63.21 1.23 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.657 178.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.438 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -49.48 -47.41 36.25 Favored Glycine 0 C--O 1.215 -1.038 0 O-C-N 124.137 0.898 . . . . 0.0 112.502 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -51.74 -51.62 54.84 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 121.076 0.465 . . . . 0.0 111.855 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -65.06 -46.9 79.3 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.129 -0.487 . . . . 0.0 111.538 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.71 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -68.88 -35.7 77.19 Favored 'General case' 0 C--O 1.219 -0.508 0 C-N-CA 121.0 -0.28 . . . . 0.0 111.74 -179.297 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 -62.27 -32.77 73.52 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 121.439 0.638 . . . . 0.0 109.468 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.0 m -85.35 -18.24 34.37 Favored 'General case' 0 CA--C 1.544 0.727 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.606 179.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -105.06 -65.62 1.03 Allowed 'General case' 0 N--CA 1.466 0.366 0 CA-C-O 121.097 0.475 . . . . 0.0 111.861 -179.761 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 10.0 t80 -82.8 67.63 8.95 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.243 0.617 . . . . 0.0 110.552 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -80.26 -8.95 59.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.952 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.34 40.9 0.95 Allowed 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 111.804 0.298 . . . . 0.0 111.804 -179.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.9 t -120.35 0.06 10.5 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.239 0.542 . . . . 0.0 110.302 179.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.766 ' HA ' HD22 ' A' ' 64' ' ' LEU . 30.3 m-85 -89.65 -17.11 29.03 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.172 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.55 -41.05 93.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.487 -179.593 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.733 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.7 m-20 -63.18 -27.2 69.2 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.821 -178.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.766 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.2 OUTLIER -63.74 -42.55 97.85 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.722 0.773 . . . . 0.0 109.225 179.147 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.539 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.51 -44.05 25.37 Favored 'General case' 0 N--CA 1.45 -0.467 0 CA-C-N 115.011 -0.995 . . . . 0.0 110.409 179.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.515 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -52.33 -42.24 63.68 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.441 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.723 HE22 HD11 ' A' ' 106' ' ' LEU . 21.0 mt-30 -73.01 -52.44 14.4 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.037 -0.529 . . . . 0.0 112.326 -179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.34 19.91 3.56 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.845 0.683 . . . . 0.0 112.845 -177.651 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.539 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t60 -79.34 -35.3 41.19 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.984 0.421 . . . . 0.0 110.234 179.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.405 HG23 ' H ' ' A' ' 71' ' ' THR . 0.0 OUTLIER -91.42 -68.82 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.682 -0.69 . . . . 0.0 111.275 -179.622 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.405 ' H ' HG23 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.7 145.66 8.56 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.416 -179.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_endo -80.45 -178.01 4.16 Favored 'Trans proline' 0 N--CA 1.463 -0.32 0 C-N-CA 122.623 2.215 . . . . 0.0 112.185 179.688 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.718 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.28 -71.3 0.28 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.583 -0.818 . . . . 0.0 112.879 179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.68 44.62 0.29 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.124 0.488 . . . . 0.0 111.97 -179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -97.15 -19.25 18.78 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.42 -0.355 . . . . 0.0 110.947 179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.644 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.3 pt20 -63.78 -36.22 83.17 Favored 'General case' 0 CA--C 1.518 -0.262 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.728 -179.571 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 29.4 mp0 -70.43 -38.73 74.61 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.937 0.398 . . . . 0.0 110.164 179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 32.8 mtt180 -68.13 -44.47 76.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.946 179.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -62.45 -45.84 91.23 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.92 179.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.3 p -60.2 -33.5 72.32 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.736 -0.386 . . . . 0.0 111.195 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 20.6 mm-40 -61.63 -60.14 4.13 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-O 120.759 0.314 . . . . 0.0 111.109 179.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.479 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 2.8 p -58.61 -36.57 60.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.938 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 44.4 m -65.59 -41.97 92.21 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.091 179.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -67.55 -43.3 81.02 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.897 0.38 . . . . 0.0 110.815 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -70.21 -21.21 63.04 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.812 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.508 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -84.42 -34.88 23.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.088 0.47 . . . . 0.0 110.291 179.425 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -85.43 -7.64 58.82 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.484 179.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -40.48 -50.54 2.91 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.628 -0.715 . . . . 0.0 112.019 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.3 56.52 0.12 Allowed Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 120.208 -0.996 . . . . 0.0 112.861 179.719 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.534 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.31 51.28 0.05 OUTLIER Glycine 0 CA--C 1.522 0.518 0 C-N-CA 119.859 -1.162 . . . . 0.0 114.599 179.333 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.534 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 13.3 Cg_endo -80.44 40.81 1.03 Allowed 'Trans proline' 0 C--N 1.349 0.578 0 C-N-CA 122.149 1.9 . . . . 0.0 111.842 178.294 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.819 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.9 OUTLIER -70.35 166.12 20.92 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.684 -178.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.582 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 30.6 m95 -53.19 -30.32 36.9 Favored 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.437 -179.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.99 -40.49 99.37 Favored Glycine 0 N--CA 1.447 -0.619 0 C-N-CA 120.593 -0.813 . . . . 0.0 111.283 179.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 2.2 tpt85 -87.12 -25.76 23.97 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.839 -0.181 . . . . 0.0 110.931 179.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.77 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.74 -31.86 58.99 Favored 'General case' 0 C--O 1.236 0.349 0 CA-C-O 121.249 0.547 . . . . 0.0 110.45 179.836 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.71 HG11 ' HB2' ' A' ' 53' ' ' PHE . 16.4 t -62.65 -56.12 19.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.497 178.608 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.459 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.6 -28.38 69.89 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.114 -0.948 . . . . 0.0 111.258 179.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.77 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 2.9 m-85 -55.73 -54.59 42.41 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.947 0.403 . . . . 0.0 110.198 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.556 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.2 m-85 -78.27 -35.13 48.49 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.223 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.459 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 6.2 t -62.66 -36.36 74.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.053 -179.719 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.419 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -55.2 -55.68 28.46 Favored 'General case' 0 C--O 1.232 0.159 0 CA-C-O 120.773 0.32 . . . . 0.0 111.466 179.941 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -72.38 -39.89 56.1 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.5 -0.857 . . . . 0.0 112.976 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.19 -42.41 90.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 117.135 0.468 . . . . 0.0 111.038 -179.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.642 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.07 -39.33 72.25 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 109.813 -0.44 . . . . 0.0 109.813 178.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.726 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -61.0 -49.92 75.47 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.335 179.17 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.672 ' HB3' HD21 ' A' ' 22' ' ' LEU . 79.8 m -60.17 -40.13 88.86 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.979 -1.01 . . . . 0.0 111.097 179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.59 -55.53 30.92 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 -69.1 -15.96 63.56 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.732 0.271 . . . . 0.0 111.732 179.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.507 ' HB2' HG22 ' A' ' 119' ' ' VAL . 66.8 m -77.88 -29.02 50.06 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.375 -0.602 . . . . 0.0 109.375 178.619 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 107' ' ' CYS . 16.9 t -82.1 -17.01 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.181 0 CA-C-O 121.685 0.755 . . . . 0.0 109.057 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -79.69 -8.57 59.3 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.188 -0.915 . . . . 0.0 109.892 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -136.44 -166.16 1.84 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.511 179.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -88.25 67.64 8.8 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.02 0.438 . . . . 0.0 110.036 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.401 ' O ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -140.95 37.23 1.77 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.223 -179.05 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.567 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 3.3 mp0 -57.9 -51.7 79.86 Favored Pre-proline 0 CA--C 1.538 0.514 0 N-CA-C 112.314 0.487 . . . . 0.0 112.314 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.567 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 34.1 Cg_exo -58.53 -30.73 92.69 Favored 'Trans proline' 0 C--N 1.357 0.98 0 C-N-CA 122.044 1.829 . . . . 0.0 112.32 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.718 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.7 OUTLIER -71.35 -30.95 66.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.844 179.819 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.519 HG21 HG22 ' A' ' 111' ' ' VAL . 73.4 t -57.68 -52.02 62.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.164 179.76 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -66.77 -31.73 79.18 Favored Glycine 0 N--CA 1.447 -0.579 0 C-N-CA 120.511 -0.852 . . . . 0.0 111.837 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.501 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.9 mm-40 -66.05 -50.7 63.24 Favored 'General case' 0 C--O 1.218 -0.593 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.487 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 96.3 t -56.56 -36.46 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 178.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 -62.02 -48.32 80.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.622 -0.717 . . . . 0.0 110.488 178.461 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.735 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.1 pt-20 -72.46 -36.42 68.48 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 121.084 -0.246 . . . . 0.0 111.195 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.644 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 41.7 m0 -58.16 -39.77 79.71 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 178.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 3.8 ttp -72.89 -53.4 11.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.581 -179.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.4 p -60.45 -32.54 51.48 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.783 -178.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . 0.445 ' HB2' ' O ' ' A' ' 124' ' ' GLU . 0.0 OUTLIER -67.12 -54.7 18.9 Favored 'General case' 0 CA--C 1.521 -0.137 0 CA-C-O 121.061 0.458 . . . . 0.0 110.24 179.221 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -58.78 -30.2 67.38 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.111 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.902 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.38 -52.9 8.37 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.526 -179.054 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.73 -34.29 77.85 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.115 0.413 . . . . 0.0 112.115 -178.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.8 m -80.83 -33.86 34.32 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 113.222 0.823 . . . . 0.0 113.222 -178.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.07 -46.31 1.95 Allowed 'General case' 0 N--CA 1.466 0.346 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 -177.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.902 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -59.31 -42.1 90.61 Favored 'General case' 0 C--N 1.327 -0.408 0 C-N-CA 120.706 -0.398 . . . . 0.0 111.645 -177.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -55.95 -33.28 64.62 Favored 'General case' 0 N--CA 1.453 -0.284 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.29 179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -66.05 -51.17 60.62 Favored 'General case' 0 CA--C 1.516 -0.347 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.819 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 69.8 t90 -57.81 -47.5 82.43 Favored 'General case' 0 N--CA 1.448 -0.542 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 178.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.687 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.5 OUTLIER -58.23 -47.53 87.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.555 -179.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 25.8 m170 -63.52 -25.59 68.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.655 0.264 . . . . 0.0 111.567 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.1 m -100.37 -5.64 26.96 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 112.099 0.407 . . . . 0.0 112.099 -179.311 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.42 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -122.17 44.76 2.51 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.856 0.36 . . . . 0.0 111.722 -179.425 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 97.33 -65.97 0.89 Allowed Glycine 0 CA--C 1.506 -0.484 0 C-N-CA 120.588 -0.815 . . . . 0.0 112.25 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.687 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 123.59 173.45 13.97 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.906 179.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.4 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 98.5 m95 -56.04 -36.75 68.36 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -60.75 -36.04 77.9 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.023 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.582 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -63.52 -43.01 98.41 Favored 'General case' 0 C--O 1.231 0.101 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 179.039 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.877 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 13.7 t80 -67.48 -31.63 71.91 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.699 178.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.748 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.6 OUTLIER -69.47 -25.0 63.87 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.007 0.432 . . . . 0.0 110.155 178.96 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.57 -34.4 19.92 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 178.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.779 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -56.21 -51.81 66.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.355 -0.839 . . . . 0.0 111.929 -179.513 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.423 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.7 m-85 -130.35 31.76 4.56 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -178.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.524 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -98.52 -134.85 8.58 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.04 -1.076 . . . . 0.0 112.177 179.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -65.26 -53.42 44.5 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.2 0.524 . . . . 0.0 110.334 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.477 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -93.61 64.06 1.87 Allowed Glycine 0 N--CA 1.446 -0.677 0 C-N-CA 120.891 -0.671 . . . . 0.0 111.708 179.318 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.24 73.3 7.09 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.391 0.615 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.477 HD23 ' O ' ' A' ' 154' ' ' GLY . 0.2 OUTLIER -59.22 153.39 18.53 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.114 -179.444 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.574 ' O ' ' HG2' ' A' ' 161' ' ' ARG . 2.6 mm-40 -56.66 -27.64 59.05 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.513 -0.767 . . . . 0.0 112.099 -179.553 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.499 ' O ' ' HB2' ' A' ' 162' ' ' LEU . 0.4 OUTLIER -73.37 -42.39 62.23 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.808 0.337 . . . . 0.0 110.643 179.672 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.779 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -66.89 -37.56 84.63 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.131 0.491 . . . . 0.0 110.271 179.496 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.414 HH11 ' HD3' ' A' ' 160' ' ' ARG . 25.4 mtm-85 -65.64 -52.81 48.93 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.24 179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.574 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 17.8 ptt180 -63.65 -31.36 72.5 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.854 0.359 . . . . 0.0 110.704 179.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.557 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.2 OUTLIER -65.74 -39.33 90.99 Favored 'General case' 0 N--CA 1.453 -0.277 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.483 179.374 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.818 HH22 ' HA ' ' A' ' 49' ' ' ALA . 2.5 ttp180 -68.13 -43.65 77.87 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.931 -0.308 . . . . 0.0 110.34 179.514 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.578 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 29.2 mt-10 -62.44 -47.38 84.33 Favored 'General case' 0 C--O 1.235 0.339 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.398 179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.8 -23.76 75.66 Favored Glycine 0 N--CA 1.448 -0.524 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.953 179.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.557 ' HB2' ' O ' ' A' ' 162' ' ' LEU . 1.8 t-20 -74.04 -52.25 13.27 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.536 0.208 . . . . 0.0 111.145 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.759 ' HA ' HG22 ' A' ' 170' ' ' VAL . 11.9 p-90 -65.28 -24.3 67.26 Favored 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 120.408 -0.517 . . . . 0.0 110.855 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.37 -42.23 77.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.154 0.502 . . . . 0.0 110.341 178.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 -31.26 20.09 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 112.685 0.624 . . . . 0.0 112.685 179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.759 HG22 ' HA ' ' A' ' 167' ' ' TRP . 27.4 m -89.51 -37.04 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.594 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -68.77 -30.91 69.6 Favored 'General case' 0 C--N 1.322 -0.617 0 O-C-N 121.804 -0.56 . . . . 0.0 110.939 -179.025 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -84.29 -37.47 21.65 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.663 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.584 HG13 ' HG ' ' A' ' 174' ' ' LEU . 1.6 p -66.35 -27.08 39.43 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 CA-C-O 121.047 0.451 . . . . 0.0 110.952 179.851 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.584 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.7 OUTLIER -115.8 32.94 5.77 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.323 0.582 . . . . 0.0 109.875 178.55 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -80.8 -9.99 59.76 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.107 -179.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.55 15.03 62.4 Favored Glycine 0 CA--C 1.517 0.213 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.703 179.717 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.38 6.53 36.92 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.871 0.367 . . . . 0.0 111.569 -179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.8 t -78.61 71.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-O 121.531 0.682 . . . . 0.0 109.979 179.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -101.44 8.08 42.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.483 -178.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.733 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 4.5 mt -98.46 -39.25 8.85 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.656 0.265 . . . . 0.0 110.849 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.443 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.69 89.42 0.37 Allowed Glycine 0 N--CA 1.45 -0.383 0 CA-C-N 116.132 -0.485 . . . . 0.0 112.275 179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.515 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -97.05 9.43 42.09 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.991 0.424 . . . . 0.0 111.018 -179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.248 1.018 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 112.188 -0.365 . . . . 0.0 112.188 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 8.9 Cg_endo -87.85 157.43 7.41 Favored 'Trans proline' 0 N--CA 1.455 -0.788 0 C-N-CA 123.373 2.715 . . . . 0.0 111.999 -179.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -153.09 128.1 9.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.104 179.724 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 167.88 -165.6 38.83 Favored Glycine 0 N--CA 1.445 -0.724 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.721 -179.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -67.93 156.53 37.01 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.021 0.439 . . . . 0.0 111.079 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.6 mtm -117.53 -41.7 2.93 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.85 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -147.53 149.69 33.09 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.544 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.481 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.3 p -104.63 144.87 29.6 Favored Pre-proline 0 C--N 1.325 -0.484 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.783 -179.598 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.481 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 1.2 Cg_endo -84.23 82.23 1.93 Allowed 'Trans proline' 0 N--CA 1.457 -0.626 0 C-N-CA 123.077 2.518 . . . . 0.0 111.873 -179.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -71.2 -57.2 4.72 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.793 -179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -76.61 141.47 41.06 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.064 0.459 . . . . 0.0 111.841 -179.241 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.451 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -142.24 138.93 17.11 Favored Pre-proline 0 C--N 1.328 -0.359 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.975 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.451 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.1 Cg_exo -77.03 57.79 5.92 Favored 'Trans proline' 0 CA--C 1.53 0.305 0 C-N-CA 123.249 2.632 . . . . 0.0 112.953 -179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -90.06 -160.25 0.68 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.406 -0.361 . . . . 0.0 110.736 179.61 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -52.96 -43.19 66.18 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 112.898 0.703 . . . . 0.0 112.898 -178.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 9.9 ttp180 -61.18 -38.23 85.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.714 0.292 . . . . 0.0 111.213 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.72 -34.91 60.37 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.1 0.476 . . . . 0.0 110.137 179.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.609 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.6 tp -72.28 -42.86 65.05 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.296 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.548 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 8.3 p -65.98 -35.8 75.96 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.163 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -71.99 -24.21 61.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.333 178.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -75.24 -66.54 0.75 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.12 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.5 t80 -55.08 -53.78 51.46 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.968 -179.035 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.437 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.4 t -67.16 -37.61 79.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-O 120.82 0.343 . . . . 0.0 110.221 -179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.68 -51.79 53.37 Favored Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 120.726 -0.749 . . . . 0.0 112.059 179.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.665 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 1.1 t80 -63.32 -47.06 83.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 122.44 0.296 . . . . 0.0 111.209 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 1.9 tmtm? -57.84 -37.3 73.62 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.308 0.575 . . . . 0.0 111.222 -179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.655 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.6 mp -78.44 -47.34 17.69 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.533 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.747 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -59.35 -27.16 65.68 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.871 -0.604 . . . . 0.0 111.853 -179.888 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.471 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 14.0 pt20 -85.65 -11.09 54.7 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.486 0.55 . . . . 0.0 112.486 -179.315 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.16 -56.19 0.97 Allowed 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 114.024 1.12 . . . . 0.0 114.024 -178.359 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -105.53 -57.43 0.66 Allowed Glycine 0 C--O 1.23 -0.135 0 C-N-CA 120.46 -0.876 . . . . 0.0 113.665 -178.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.546 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.5 t80 -78.32 46.06 0.6 Allowed 'General case' 0 C--N 1.32 -0.707 0 C-N-CA 122.782 0.433 . . . . 0.0 111.101 -179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.6 p -78.1 -31.95 16.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-O 121.001 0.429 . . . . 0.0 110.222 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.03 -39.04 83.18 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.39 0.614 . . . . 0.0 109.356 178.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.61 58.43 3.75 Favored Glycine 0 N--CA 1.444 -0.773 0 CA-C-N 115.209 -0.905 . . . . 0.0 111.575 178.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.747 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.26 109.76 1.66 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.481 -0.359 . . . . 0.0 110.474 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.588 ' O ' ' HB3' ' A' ' 35' ' ' GLU . . . -172.56 -57.46 0.05 OUTLIER Glycine 0 C--O 1.227 -0.323 0 C-N-CA 120.134 -1.031 . . . . 0.0 113.365 -179.023 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.463 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 35.8 Cg_exo -62.33 -50.66 4.32 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.235 1.956 . . . . 0.0 111.482 -179.592 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.665 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -85.94 27.23 5.55 Favored Glycine 0 N--CA 1.447 -0.572 0 CA-C-N 115.752 -0.658 . . . . 0.0 112.404 178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.588 ' HB3' ' O ' ' A' ' 32' ' ' GLY . 0.0 OUTLIER -77.4 -31.15 53.93 Favored 'General case' 0 N--CA 1.453 -0.299 0 CA-C-O 121.079 0.466 . . . . 0.0 109.891 179.863 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -94.43 124.82 8.05 Favored Glycine 0 N--CA 1.447 -0.601 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 178.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.419 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 92.7 Cg_endo -87.5 -150.49 0.04 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 122.591 2.194 . . . . 0.0 113.657 -178.528 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.675 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -78.22 82.81 4.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.36 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.78 26.82 4.33 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 121.023 0.439 . . . . 0.0 110.627 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.467 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 9.7 m-20 -135.76 161.63 61.73 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.098 -179.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.467 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 47.1 Cg_endo -78.83 50.78 3.57 Favored 'Trans proline' 0 N--CA 1.462 -0.355 0 C-N-CA 123.274 2.649 . . . . 0.0 112.279 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.609 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER 179.82 -32.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 114.696 -1.138 . . . . 0.0 108.579 179.294 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.675 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.7 m170 -60.02 -56.49 21.08 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.102 -0.953 . . . . 0.0 110.413 179.552 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 2.5 mt-30 -61.27 -25.19 66.93 Favored 'General case' 0 CA--C 1.518 -0.258 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.637 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.756 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -72.82 -50.45 24.05 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.966 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 3.6 ttm -66.88 -37.37 84.27 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.667 -179.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 22.8 ttp180 -60.93 -40.66 94.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.324 -0.398 . . . . 0.0 111.734 -179.491 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -76.53 -29.38 56.72 Favored 'General case' 0 CA--C 1.516 -0.346 0 CA-C-O 121.373 0.606 . . . . 0.0 110.054 179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.731 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -66.19 -62.15 1.64 Allowed 'General case' 0 N--CA 1.444 -0.758 0 CA-C-N 115.379 -0.828 . . . . 0.0 109.653 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -48.39 -45.97 28.77 Favored Glycine 0 C--O 1.216 -0.981 0 O-C-N 124.224 0.953 . . . . 0.0 112.572 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -53.6 -53.82 46.32 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 111.981 0.363 . . . . 0.0 111.981 179.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -65.51 -45.87 81.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.889 0.376 . . . . 0.0 111.29 -179.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.837 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.5 OUTLIER -65.16 -38.56 90.97 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.563 -0.289 . . . . 0.0 111.27 -179.807 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -60.65 -36.53 78.9 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.405 0.621 . . . . 0.0 109.967 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 4.8 m -83.2 -12.78 56.54 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.405 -0.816 . . . . 0.0 111.352 179.388 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -104.88 -24.88 12.8 Favored 'General case' 0 CA--C 1.535 0.37 0 N-CA-C 112.203 0.446 . . . . 0.0 112.203 -179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.646 ' HB3' ' HB ' ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.78 92.22 8.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.113 0.482 . . . . 0.0 111.081 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 -60.49 -31.32 70.36 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.421 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 27.1 ttm180 -119.65 79.11 1.39 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.044 0.45 . . . . 0.0 110.506 179.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.646 ' HB ' ' HB3' ' A' ' 57' ' ' PHE . 11.2 t -120.81 -7.59 9.53 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.461 -179.529 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.889 ' HA ' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -120.88 -29.62 4.59 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.261 0.467 . . . . 0.0 112.261 -179.097 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -59.94 -32.84 71.17 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.724 0.297 . . . . 0.0 111.724 -179.3 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.42 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -71.58 -20.59 61.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.925 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.889 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -71.06 -41.06 71.21 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.545 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -74.34 -42.26 59.7 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.028 -0.987 . . . . 0.0 110.046 179.388 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.626 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -56.46 -43.31 79.43 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.785 179.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.494 HE22 HD11 ' A' ' 106' ' ' LEU . 28.1 mt-30 -63.42 -52.78 60.08 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.864 -0.607 . . . . 0.0 112.464 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.548 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -85.21 7.43 22.01 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.868 0.692 . . . . 0.0 112.868 -177.267 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.545 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 4.2 t60 -78.85 -23.27 45.1 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 121.1 0.476 . . . . 0.0 110.318 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -91.62 -68.87 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.391 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.445 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.0 OUTLIER -164.67 143.12 5.55 Favored Pre-proline 0 C--O 1.239 0.52 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.688 179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.574 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 3.1 Cg_exo -81.05 -175.96 2.92 Favored 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.412 2.741 . . . . 0.0 111.897 179.893 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.425 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 80.9 -62.3 4.44 Favored Glycine 0 CA--C 1.519 0.303 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.82 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.83 28.19 0.09 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.09 0.472 . . . . 0.0 111.897 -179.808 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.425 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -81.4 -23.43 37.6 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.235 179.779 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.662 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.2 pt20 -59.91 -40.83 90.16 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.927 -179.01 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 mt-30 -62.28 -49.07 77.14 Favored 'General case' 0 C--N 1.325 -0.488 0 O-C-N 123.115 0.259 . . . . 0.0 110.757 179.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 54.6 mtt180 -59.76 -43.56 94.24 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.269 -0.423 . . . . 0.0 109.966 179.147 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -61.81 -52.26 64.91 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.646 179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.59 -33.6 66.37 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 112.078 0.399 . . . . 0.0 112.078 -179.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.3 mm-40 -61.92 -51.66 67.23 Favored 'General case' 0 CA--C 1.516 -0.358 0 CA-C-O 121.306 0.574 . . . . 0.0 109.988 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.424 HG21 ' HG ' ' A' ' 180' ' ' LEU . 31.2 t -64.51 -35.82 75.58 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.711 179.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 17.6 m -63.78 -47.43 80.95 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.998 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.629 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -68.84 -34.21 75.09 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.789 0.328 . . . . 0.0 110.377 179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.432 ' O ' HD22 ' A' ' 174' ' ' LEU . 3.5 mm-40 -65.99 -30.41 70.96 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.214 0.53 . . . . 0.0 109.948 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.485 ' HA ' HD13 ' A' ' 174' ' ' LEU . 1.1 mp -78.38 -36.92 45.27 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.693 179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -86.21 -2.03 58.0 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.731 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -53.1 -36.9 61.23 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.475 -179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 176.8 59.69 0.06 OUTLIER Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 120.426 -0.892 . . . . 0.0 112.898 179.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.582 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 165.31 53.36 0.02 OUTLIER Glycine 0 CA--C 1.522 0.526 0 C-N-CA 119.656 -1.259 . . . . 0.0 114.835 179.186 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.582 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 14.2 Cg_endo -81.37 36.76 0.64 Allowed 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.325 2.017 . . . . 0.0 111.551 177.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.77 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.5 OUTLIER -68.47 163.9 22.31 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.907 -178.772 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.429 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.6 m95 -53.67 -27.73 29.3 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.53 -179.862 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.85 -42.32 98.48 Favored Glycine 0 N--CA 1.448 -0.502 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 178.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.444 ' HD2' ' HA ' ' A' ' 95' ' ' ARG . 0.4 OUTLIER -86.61 -23.83 25.58 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.69 -0.255 . . . . 0.0 110.918 179.034 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.718 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.5 OUTLIER -54.25 -32.07 55.13 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.381 0.61 . . . . 0.0 110.488 179.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.837 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.1 t -61.95 -54.37 35.5 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 CA-C-N 115.317 -0.856 . . . . 0.0 109.571 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.497 ' HB2' ' CE2' ' A' ' 53' ' ' PHE . . . -62.11 -30.69 71.19 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.247 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.718 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 6.1 m-85 -55.5 -51.82 65.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 110.372 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.548 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -82.48 -32.72 28.7 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.412 -179.53 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.5 t -64.95 -34.0 67.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.424 -0.353 . . . . 0.0 110.813 -179.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -52.33 -60.05 3.68 Favored 'General case' 0 C--O 1.232 0.162 0 N-CA-C 111.896 0.332 . . . . 0.0 111.896 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -71.71 -37.63 61.42 Favored Glycine 0 N--CA 1.447 -0.575 0 C-N-CA 120.419 -0.896 . . . . 0.0 113.206 -179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.8 -40.21 83.4 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 117.157 0.479 . . . . 0.0 110.811 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.532 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -72.92 -42.49 63.45 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.8 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.785 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -57.03 -51.85 67.63 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 115.288 -0.869 . . . . 0.0 110.603 179.272 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.655 ' HB3' HD21 ' A' ' 22' ' ' LEU . 87.1 m -60.55 -43.8 96.82 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 114.683 -1.144 . . . . 0.0 111.531 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.49 -37.22 67.54 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.811 -179.827 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.635 ' HA ' HD22 ' A' ' 112' ' ' ASN . 1.7 tt0 -78.63 -25.63 45.09 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 111.928 0.344 . . . . 0.0 111.928 -179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.432 ' HB2' HG22 ' A' ' 119' ' ' VAL . 50.6 m -78.25 -37.02 46.14 Favored 'General case' 0 C--N 1.324 -0.503 0 C-N-CA 120.427 -0.509 . . . . 0.0 110.676 179.454 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.632 HG23 ' O ' ' A' ' 107' ' ' CYS . 15.9 t -66.51 -32.96 60.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 O-C-N 122.207 -0.308 . . . . 0.0 111.523 179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.635 HD22 ' HA ' ' A' ' 109' ' ' GLU . 1.0 OUTLIER -79.3 -30.99 43.15 Favored 'General case' 0 C--N 1.326 -0.434 0 C-N-CA 120.411 -0.516 . . . . 0.0 112.253 -178.713 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -158.15 113.99 2.74 Favored 'General case' 0 C--N 1.332 -0.154 0 N-CA-C 113.183 0.808 . . . . 0.0 113.183 179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.41 ' O ' ' HB2' ' A' ' 115' ' ' MET . 23.0 mt-10 65.35 143.57 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 114.321 1.23 . . . . 0.0 114.321 177.026 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.574 ' SD ' ' HB3' ' A' ' 72' ' ' PRO . 7.5 mtm 76.86 126.47 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 114.653 -1.158 . . . . 0.0 112.38 178.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.772 ' HB3' ' HD3' ' A' ' 117' ' ' PRO . 1.7 tt0 -120.53 -58.11 0.03 OUTLIER Pre-proline 0 CA--C 1.539 0.554 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.425 179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.772 ' HD3' ' HB3' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.34 -29.23 88.4 Favored 'Trans proline' 0 C--N 1.357 1.006 0 C-N-CA 122.218 1.946 . . . . 0.0 113.09 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.526 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.2 mm? -60.0 -31.65 70.13 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.597 -179.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.432 HG22 ' HB2' ' A' ' 110' ' ' SER . 89.3 t -60.86 -51.22 75.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.253 179.832 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -68.85 -30.48 72.49 Favored Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.137 -1.03 . . . . 0.0 111.533 179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.461 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 0.9 OUTLIER -64.83 -52.57 56.0 Favored 'General case' 0 C--O 1.217 -0.631 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 178.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.542 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 89.0 t -55.6 -37.55 46.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.025 0.44 . . . . 0.0 109.915 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 16.7 tt0 -61.69 -47.04 87.14 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.784 -0.644 . . . . 0.0 110.643 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.67 ' HA ' HG12 ' A' ' 127' ' ' VAL . 23.2 pt-20 -74.1 -35.88 64.21 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.84 -0.344 . . . . 0.0 111.003 179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.662 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.0 m0 -56.24 -37.98 70.48 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 178.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 1.2 mtp -73.34 -56.45 5.05 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.45 -1.25 . . . . 0.0 111.462 -179.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.67 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.4 p -60.64 -32.83 52.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 N-CA-C 112.151 0.426 . . . . 0.0 112.151 -178.827 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 3.7 mt-10 -69.7 -47.6 62.6 Favored 'General case' 0 CA--C 1.518 -0.264 0 C-N-CA 120.636 -0.426 . . . . 0.0 110.185 179.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.629 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 15.5 t80 -61.45 -36.14 79.56 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.545 0.688 . . . . 0.0 110.421 179.172 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.007 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.47 -55.57 7.64 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.109 -0.95 . . . . 0.0 112.196 -178.824 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 54.4 mt-10 -60.95 -32.75 72.26 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 24.1 m -78.68 -40.78 32.97 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 113.095 0.776 . . . . 0.0 113.095 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -126.64 -41.05 1.88 Allowed 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 -177.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.007 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.9 OUTLIER -60.53 -48.3 82.39 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 118.337 0.517 . . . . 0.0 111.709 -178.323 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.44 -35.9 41.6 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.513 -0.312 . . . . 0.0 111.238 179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -62.75 -51.92 65.26 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.982 -0.287 . . . . 0.0 110.373 179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.77 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 53.0 t90 -58.65 -47.58 83.95 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 109.406 -0.59 . . . . 0.0 109.406 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.602 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.7 mt -57.44 -48.05 83.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 115.521 -0.763 . . . . 0.0 112.389 -178.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.0 m-70 -68.97 -26.45 65.04 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 121.035 -0.266 . . . . 0.0 111.666 -178.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.9 m -92.04 -9.08 44.09 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 112.229 0.455 . . . . 0.0 112.229 -179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.13 -53.8 3.82 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.052 0.39 . . . . 0.0 112.052 -179.141 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -174.91 -15.64 0.02 OUTLIER Glycine 0 C--N 1.315 -0.618 0 C-N-CA 120.831 -0.7 . . . . 0.0 111.423 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 94.63 168.75 36.9 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.75 179.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.427 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 94.6 m95 -63.46 -30.26 71.41 Favored 'General case' 0 C--N 1.322 -0.589 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 179.305 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.07 -33.58 75.75 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.195 -0.912 . . . . 0.0 110.741 178.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.417 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.1 OUTLIER -64.27 -42.8 96.28 Favored 'General case' 0 N--CA 1.462 0.154 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.704 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 11.1 t80 -66.2 -33.93 76.87 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.631 178.524 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.756 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -68.25 -27.07 66.02 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.947 0.403 . . . . 0.0 110.706 178.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.78 -26.5 24.1 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 121.123 0.487 . . . . 0.0 109.936 178.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.885 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -64.64 -50.78 65.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.603 -0.726 . . . . 0.0 111.39 -179.672 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.545 ' CD1' ' HD3' ' A' ' 163' ' ' ARG . 1.5 m-85 -133.05 33.24 3.67 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.652 -0.419 . . . . 0.0 111.991 -178.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.518 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -102.05 -137.28 9.57 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 119.849 -1.167 . . . . 0.0 112.443 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -68.98 -39.31 79.47 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.166 0.507 . . . . 0.0 110.716 -179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.559 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -102.47 53.98 0.75 Allowed Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 120.85 -0.69 . . . . 0.0 111.766 179.372 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -76.88 76.13 3.48 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.331 0.586 . . . . 0.0 110.288 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.761 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -64.37 162.59 14.7 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.073 -0.967 . . . . 0.0 111.431 -179.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -56.24 -32.98 64.99 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.419 -0.81 . . . . 0.0 112.242 -179.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.761 ' HB2' HD12 ' A' ' 156' ' ' LEU . 45.8 mt-10 -74.06 -35.31 64.27 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.716 0.294 . . . . 0.0 111.291 -179.417 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.885 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -71.04 -39.18 72.46 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.99 0.424 . . . . 0.0 110.777 -179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.1 mtm-85 -62.18 -56.36 19.45 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.735 179.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 7.2 ptp180 -61.43 -33.13 73.2 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.066 -179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.575 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.1 OUTLIER -64.18 -42.64 96.61 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.075 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.68 HH22 ' HA ' ' A' ' 49' ' ' ALA . 3.2 ttp180 -68.2 -41.19 81.74 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.994 -179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.716 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -64.92 -40.99 95.9 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.014 0.435 . . . . 0.0 110.43 179.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.75 -31.22 67.65 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.215 -0.993 . . . . 0.0 110.963 178.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.5 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -67.03 -55.65 13.45 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.214 -0.493 . . . . 0.0 111.464 -179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.772 ' HA ' HG22 ' A' ' 170' ' ' VAL . 12.0 p-90 -61.98 -28.94 69.91 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 121.056 -0.258 . . . . 0.0 111.193 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.54 -42.88 79.26 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.959 0.409 . . . . 0.0 110.75 179.176 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.59 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -87.86 -30.56 20.07 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 -179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.772 HG22 ' HA ' ' A' ' 167' ' ' TRP . 35.3 m -87.03 -29.94 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 N-CA-C 113.629 0.974 . . . . 0.0 113.629 -177.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.531 ' HD2' ' HZ ' ' A' ' 53' ' ' PHE . 0.9 OUTLIER -77.12 -34.72 56.63 Favored 'General case' 0 C--N 1.316 -0.876 0 O-C-N 121.804 -0.56 . . . . 0.0 110.153 -179.84 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.05 -8.78 55.06 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.837 -0.619 . . . . 0.0 112.045 179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.645 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.9 p -85.19 -26.89 6.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.26 178.453 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.645 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -121.35 43.22 2.87 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.139 178.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.19 -22.61 62.92 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.765 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.82 8.48 49.72 Favored Glycine 0 C--N 1.331 0.25 0 C-N-CA 121.065 -0.588 . . . . 0.0 113.339 -179.551 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.424 ' HB1' HG13 ' A' ' 82' ' ' VAL . . . -78.17 -0.29 27.78 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 3.3 t -79.7 69.12 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.344 0.592 . . . . 0.0 110.546 179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -103.56 16.11 27.25 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.614 -0.721 . . . . 0.0 111.12 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.424 ' HG ' HG21 ' A' ' 82' ' ' VAL . 35.4 mt -100.06 -43.34 6.38 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.312 -0.403 . . . . 0.0 110.805 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.49 92.49 0.27 Allowed Glycine 0 N--CA 1.448 -0.503 0 CA-C-N 115.808 -0.633 . . . . 0.0 112.587 -179.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.626 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -101.77 139.11 37.85 Favored 'General case' 0 C--N 1.322 -0.617 0 N-CA-C 110.228 -0.286 . . . . 0.0 110.228 179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.247 0.951 0 CA-C-O 118.335 -0.841 . . . . 0.0 109.978 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 111.788 -0.525 . . . . 0.0 111.788 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -71.71 117.27 5.06 Favored 'Trans proline' 0 N--CA 1.463 -0.295 0 C-N-CA 122.895 2.397 . . . . 0.0 111.693 179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -25.2 58.5 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.112 -179.488 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 158.14 159.98 9.95 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.863 -0.684 . . . . 0.0 111.995 -179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.0 m -155.32 140.92 17.92 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 179.961 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 mmt -104.57 8.82 35.48 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.807 0.337 . . . . 0.0 111.025 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -143.29 132.48 23.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.807 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.459 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p -110.01 131.38 22.0 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.691 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.459 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 15.6 Cg_exo -68.55 151.11 75.51 Favored 'Trans proline' 0 CA--C 1.529 0.249 0 C-N-CA 122.955 2.437 . . . . 0.0 112.959 -179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . 55.11 50.92 14.26 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.698 -0.683 . . . . 0.0 112.009 179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.42 88.74 7.69 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.878 179.86 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.463 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -103.87 112.25 65.47 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.505 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.463 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 2.8 Cg_exo -76.33 54.32 4.23 Favored 'Trans proline' 0 C--N 1.342 0.225 0 C-N-CA 123.451 2.767 . . . . 0.0 112.238 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -90.63 -167.17 1.76 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.773 -0.648 . . . . 0.0 110.578 -179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -58.99 -36.55 75.07 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.817 179.578 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -62.5 -39.47 93.61 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.679 179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -72.17 -35.43 69.01 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.007 0.432 . . . . 0.0 110.018 179.262 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.439 ' HB2' HD13 ' A' ' 42' ' ' LEU . 4.3 tp -70.66 -43.14 69.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 111.009 179.831 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.716 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -66.84 -34.9 72.99 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-O 121.011 0.434 . . . . 0.0 110.009 179.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.6 -19.19 60.94 Favored 'General case' 0 C--O 1.227 -0.123 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.448 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.9 -66.21 0.87 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.879 -0.601 . . . . 0.0 110.917 179.792 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.671 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.1 t80 -55.08 -50.73 68.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.907 -179.095 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.441 ' O ' HD13 ' A' ' 22' ' ' LEU . 44.2 t -72.59 -39.01 60.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 116.539 -0.301 . . . . 0.0 110.665 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.484 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.8 -55.92 25.7 Favored Glycine 0 N--CA 1.45 -0.412 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.271 179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.702 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 13.0 t80 -56.45 -44.77 80.84 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 122.856 0.462 . . . . 0.0 110.798 179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.49 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.42 -45.58 90.32 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.525 -179.628 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.811 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.3 mp -68.7 -43.3 76.35 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.26 -0.427 . . . . 0.0 109.971 -179.939 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.578 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 24.3 ttp85 -66.76 -15.31 63.47 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.597 179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 4.5 mt-30 -84.14 -38.61 20.49 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.773 -0.649 . . . . 0.0 110.71 179.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.04 79.9 1.36 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.765 0.317 . . . . 0.0 111.841 -179.106 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.14 -66.33 0.38 Allowed Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.269 -0.967 . . . . 0.0 112.911 179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -96.68 55.57 1.41 Allowed 'General case' 0 C--N 1.315 -0.92 0 CA-C-O 121.306 0.574 . . . . 0.0 110.333 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 7.8 p -79.04 -27.75 13.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.39 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.977 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -68.9 -41.07 78.75 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 178.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.84 58.69 4.02 Favored Glycine 0 N--CA 1.444 -0.797 0 CA-C-N 115.215 -0.902 . . . . 0.0 111.772 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.578 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -67.26 118.13 10.22 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 172.81 -54.16 0.16 Allowed Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 119.928 -1.13 . . . . 0.0 113.348 -178.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.484 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.8 Cg_exo -60.55 -46.94 15.26 Favored 'Trans proline' 0 C--N 1.348 0.553 0 C-N-CA 121.936 1.757 . . . . 0.0 111.021 -179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.702 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -97.93 36.76 3.77 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 115.332 -0.849 . . . . 0.0 112.218 178.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -82.09 -18.24 43.72 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.93 0.395 . . . . 0.0 110.541 -179.75 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.26 140.78 16.34 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.42 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 83.2 Cg_endo -94.58 -141.9 0.02 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 122.98 2.454 . . . . 0.0 113.283 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.499 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -76.29 86.96 3.09 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.65 -0.705 . . . . 0.0 111.359 -179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -132.69 20.8 4.23 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.067 0.461 . . . . 0.0 110.498 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 3.8 m-20 -131.69 161.67 60.94 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.938 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 56.8 Cg_endo -81.31 45.51 2.0 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.253 2.635 . . . . 0.0 111.964 179.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.439 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -174.27 -30.44 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.142 -0.935 . . . . 0.0 109.13 179.674 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.499 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 3.8 m170 -57.84 -57.13 14.11 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.819 179.562 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.47 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 25.1 tt0 -58.58 -26.81 64.01 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.846 -179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.872 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.45 -50.71 17.27 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.381 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.408 ' SD ' HD11 ' A' ' 13' ' ' LEU . 3.7 ttm -67.11 -41.72 85.73 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.394 -0.366 . . . . 0.0 111.613 -179.301 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 2.2 mmm180 -62.87 -33.76 75.95 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.759 -179.193 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.23 -41.87 27.26 Favored 'General case' 0 CA--C 1.515 -0.365 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.234 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.573 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -60.59 -55.66 30.64 Favored 'General case' 0 N--CA 1.45 -0.474 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.649 178.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.671 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.3 -46.55 57.23 Favored Glycine 0 C--O 1.219 -0.811 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.742 179.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -58.64 -49.0 79.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.003 0.43 . . . . 0.0 111.502 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 29.8 tp10 -65.17 -46.29 81.44 Favored 'General case' 0 C--O 1.237 0.404 0 CA-C-O 121.38 0.61 . . . . 0.0 110.257 179.474 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.458 ' HB2' HG11 ' A' ' 97' ' ' VAL . 45.7 t80 -63.34 -40.46 97.35 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.635 179.348 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -59.25 -33.03 70.54 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.341 0.591 . . . . 0.0 109.973 179.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.5 m -78.02 -24.8 47.76 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.521 -0.763 . . . . 0.0 111.278 179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.6 mtt180 -98.71 -18.86 17.81 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.415 ' HD1' ' HA ' ' A' ' 57' ' ' PHE . 0.2 OUTLIER -86.26 93.74 9.14 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 120.926 0.393 . . . . 0.0 111.409 -179.204 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -61.22 -46.64 89.58 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.25 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.844 HH21 HG11 ' A' ' 178' ' ' VAL . 3.2 mtm-85 -91.17 86.71 6.27 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.106 179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.22 -57.08 2.33 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.203 -0.453 . . . . 0.0 112.001 -178.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.913 ' HA ' HD22 ' A' ' 64' ' ' LEU . 7.8 m-85 -90.96 0.98 57.39 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 112.027 0.38 . . . . 0.0 112.027 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . 0.409 ' OG ' ' HD2' ' A' ' 59' ' ' ARG . 2.1 p -70.17 -56.49 6.71 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.115 0.483 . . . . 0.0 111.33 -179.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.623 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -63.92 -23.52 67.38 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.169 -178.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.913 HD22 ' HA ' ' A' ' 61' ' ' PHE . 1.8 mp -64.69 -43.24 94.17 Favored 'General case' 0 C--N 1.318 -0.763 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.259 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.581 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -78.86 -41.6 29.53 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 114.906 -1.043 . . . . 0.0 110.503 179.533 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.624 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -55.38 -36.47 66.42 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.572 . . . . 0.0 110.879 179.667 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.751 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 23.5 mt-30 -75.32 -58.86 3.02 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.033 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.472 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -76.6 9.17 2.91 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -177.512 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.581 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.8 t60 -79.01 -18.42 53.64 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.612 -0.435 . . . . 0.0 109.957 179.245 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 1.9 t -91.34 -77.88 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.772 179.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.452 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.1 OUTLIER -160.1 144.57 10.84 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.306 -179.689 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.452 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 5.4 Cg_exo -74.84 162.96 36.54 Favored 'Trans proline' 0 N--CA 1.463 -0.283 0 C-N-CA 122.811 2.341 . . . . 0.0 112.04 -179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.801 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 103.48 -64.06 0.39 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.666 -0.778 . . . . 0.0 112.643 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.57 42.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.259 0.552 . . . . 0.0 111.867 -179.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -96.59 -23.23 16.61 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.849 179.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.69 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.9 pt20 -60.86 -41.89 96.79 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.438 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 1.1 mt-30 -63.45 -39.68 95.13 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 120.76 0.314 . . . . 0.0 110.792 179.884 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.751 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 56.0 mtt-85 -68.24 -43.56 77.61 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.226 -0.443 . . . . 0.0 109.986 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.4 t80 -62.98 -47.96 80.88 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.286 179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 6.4 p -58.45 -31.28 67.63 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 121.141 -0.224 . . . . 0.0 111.332 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 17.0 mm100 -63.77 -65.43 0.68 Allowed 'General case' 0 CA--C 1.518 -0.26 0 CA-C-O 120.783 0.325 . . . . 0.0 110.923 179.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.449 HG23 ' HB1' ' A' ' 177' ' ' ALA . 4.8 p -54.93 -36.37 37.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.678 -0.692 . . . . 0.0 110.896 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 46.3 m -65.81 -46.62 77.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.821 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.657 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.2 OUTLIER -66.1 -37.73 86.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.163 0.506 . . . . 0.0 109.862 179.488 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.427 ' O ' ' HB2' ' A' ' 88' ' ' GLN . 4.9 mt-10 -68.55 -25.92 65.15 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.557 179.174 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.416 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 1.8 mp -78.96 -38.31 37.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.549 179.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 59.9 t80 -84.9 -6.54 59.34 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.386 179.818 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.427 ' HB2' ' O ' ' A' ' 85' ' ' GLU . 3.2 mt-30 -47.06 -43.16 19.75 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 115.772 -0.649 . . . . 0.0 112.309 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -172.16 56.57 0.17 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 119.529 -1.32 . . . . 0.0 113.572 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.512 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 158.43 57.66 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 119.627 -1.273 . . . . 0.0 114.643 178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.675 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 19.1 Cg_endo -78.77 42.18 1.21 Allowed 'Trans proline' 0 C--N 1.35 0.616 0 C-N-CA 122.127 1.885 . . . . 0.0 111.54 177.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.763 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 4.1 t-20 -66.48 161.31 23.13 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.423 -0.808 . . . . 0.0 111.508 -179.179 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.483 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 14.5 m95 -55.44 -27.17 46.36 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.53 179.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.588 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -62.62 -42.63 99.67 Favored Glycine 0 N--CA 1.448 -0.544 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 178.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.68 ' HD3' ' HG2' ' A' ' 171' ' ' ARG . 2.3 tpt180 -86.61 -22.96 25.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.268 -0.466 . . . . 0.0 110.916 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.754 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -31.45 63.05 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-O 121.312 0.577 . . . . 0.0 109.945 179.653 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.573 HG22 ' HB1' ' A' ' 49' ' ' ALA . 4.2 t -62.55 -50.3 80.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.307 178.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.44 -32.49 73.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.125 -0.943 . . . . 0.0 111.229 179.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.754 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.6 m-85 -55.01 -53.89 50.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.122 0.487 . . . . 0.0 110.267 179.714 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.716 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.8 m-85 -78.55 -37.58 42.46 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.778 -0.647 . . . . 0.0 111.24 -179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.1 t -60.16 -37.67 74.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.349 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.1 -51.19 68.77 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.788 0.328 . . . . 0.0 111.303 -179.881 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.91 -39.19 33.93 Favored Glycine 0 N--CA 1.448 -0.531 0 C-N-CA 120.357 -0.925 . . . . 0.0 113.055 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -58.26 -42.57 86.77 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.122 0.461 . . . . 0.0 110.865 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.451 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -71.91 -43.78 64.77 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.615 -0.513 . . . . 0.0 109.615 178.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.774 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.3 -48.18 77.2 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.51 -0.768 . . . . 0.0 110.614 179.476 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.811 ' HB3' HD21 ' A' ' 22' ' ' LEU . 54.7 m -61.08 -43.34 99.04 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 114.957 -1.02 . . . . 0.0 111.678 -179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.64 -36.92 67.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.981 0.42 . . . . 0.0 111.114 179.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.659 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 3.5 tt0 -81.35 -25.08 36.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.182 -0.463 . . . . 0.0 112.138 -179.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.412 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -79.03 -28.95 43.31 Favored 'General case' 0 C--N 1.323 -0.562 0 C-N-CA 120.413 -0.515 . . . . 0.0 111.051 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.557 HG23 ' O ' ' A' ' 107' ' ' CYS . 59.7 t -70.4 -36.39 66.41 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 120.756 0.312 . . . . 0.0 111.131 179.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.659 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.4 p30 -84.35 0.83 47.79 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.906 0.384 . . . . 0.0 110.744 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 9.6 mtmm -124.89 -170.78 2.22 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.226 179.389 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.2 mt-10 -89.52 55.35 3.2 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.205 0.526 . . . . 0.0 110.37 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.472 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -140.32 36.87 1.88 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.066 -179.676 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.575 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.9 mp0 -56.13 -53.79 59.73 Favored Pre-proline 0 CA--C 1.536 0.415 0 CA-C-N 115.685 -0.689 . . . . 0.0 112.21 -179.703 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.575 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 31.2 Cg_exo -60.43 -26.96 83.94 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.05 1.833 . . . . 0.0 112.614 -179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.801 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.4 mp -70.64 -25.82 63.18 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.319 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 85.2 t -59.62 -52.74 57.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.881 0.372 . . . . 0.0 111.041 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.17 -33.67 87.87 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.563 -0.827 . . . . 0.0 111.728 179.787 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.492 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 6.5 mm100 -62.61 -53.97 46.66 Favored 'General case' 0 C--O 1.218 -0.573 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.504 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 92.7 t -56.46 -37.12 49.89 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 120.941 0.401 . . . . 0.0 110.166 178.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -61.84 -47.45 84.98 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.807 179.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.833 ' HA ' HG12 ' A' ' 127' ' ' VAL . 9.7 pt-20 -74.81 -35.63 62.47 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 120.749 -0.381 . . . . 0.0 111.035 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.69 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 45.4 m0 -57.55 -37.55 73.28 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 178.218 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 27.6 ttm -74.9 -53.35 9.19 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 114.427 -1.261 . . . . 0.0 111.601 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.833 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.6 p -61.93 -33.31 57.48 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 N-CA-C 111.924 0.342 . . . . 0.0 111.924 -178.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.51 -48.41 55.74 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 120.629 -0.429 . . . . 0.0 110.207 179.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.657 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.4 t80 -57.81 -37.96 74.71 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.644 0.735 . . . . 0.0 110.28 179.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.938 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -71.91 -53.34 13.44 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.009 -0.996 . . . . 0.0 112.086 -179.171 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 73.5 mt-10 -61.33 -29.29 69.79 Favored 'General case' 0 C--N 1.321 -0.653 0 N-CA-C 112.231 0.456 . . . . 0.0 112.231 -178.622 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.9 m -84.62 -37.15 21.44 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -179.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.426 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.3 OUTLIER -126.08 -43.39 1.81 Allowed 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 114.12 1.156 . . . . 0.0 114.12 -177.852 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.938 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.6 mm? -59.67 -48.62 80.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 118.081 0.401 . . . . 0.0 111.678 -178.31 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.47 -36.62 55.23 Favored 'General case' 0 N--CA 1.455 -0.19 0 O-C-N 123.237 0.336 . . . . 0.0 111.199 179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -63.13 -52.63 61.79 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 110.144 -0.317 . . . . 0.0 110.144 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.763 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 63.1 t90 -57.78 -48.27 80.16 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-O 121.247 0.546 . . . . 0.0 109.545 178.261 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.556 HG13 ' HE3' ' A' ' 137' ' ' TRP . 5.6 mt -57.77 -46.64 86.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.38 -0.827 . . . . 0.0 112.322 -179.108 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 39.6 m-70 -65.83 -31.12 71.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.695 0.283 . . . . 0.0 111.52 -179.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.8 m -85.29 -24.84 27.54 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 112.346 0.499 . . . . 0.0 112.346 -179.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.65 -56.37 4.67 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 112.232 0.456 . . . . 0.0 112.232 -178.857 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -175.17 -10.05 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.47 0 C-N-CA 120.88 -0.676 . . . . 0.0 111.43 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.69 167.18 40.37 Favored Glycine 0 N--CA 1.445 -0.743 0 C-N-CA 120.711 -0.757 . . . . 0.0 112.958 179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.517 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 97.6 m95 -60.9 -26.46 67.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -67.25 -32.53 73.62 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.756 178.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.4 -40.68 93.73 Favored 'General case' 0 N--CA 1.463 0.178 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 178.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.409 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 11.0 t80 -65.84 -36.58 83.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.405 178.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.872 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -64.32 -31.52 72.76 Favored 'General case' 0 C--O 1.225 -0.233 0 CA-C-O 120.828 0.347 . . . . 0.0 111.192 179.563 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.65 -19.01 31.59 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 121.357 0.599 . . . . 0.0 110.105 179.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.536 HD22 ' HB3' ' A' ' 163' ' ' ARG . 9.1 mt -79.92 -40.65 27.73 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.646 -0.707 . . . . 0.0 111.146 -179.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.407 ' CE2' ' HD2' ' A' ' 163' ' ' ARG . 1.6 m-85 -125.53 28.95 6.12 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.708 -178.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.4 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -118.86 -146.7 8.01 Favored Glycine 0 N--CA 1.444 -0.775 0 C-N-CA 119.78 -1.2 . . . . 0.0 112.668 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -75.19 -32.77 61.31 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 120.957 0.408 . . . . 0.0 111.163 -179.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.493 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -91.76 40.31 2.94 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.106 179.776 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.13 77.17 8.97 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.268 0.556 . . . . 0.0 110.867 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.65 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -62.37 162.02 10.68 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.086 -0.961 . . . . 0.0 110.857 179.936 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -57.88 -31.3 66.59 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.819 -179.525 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.65 ' HB2' HD12 ' A' ' 156' ' ' LEU . 17.9 mt-10 -72.15 -42.37 66.02 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.902 0.382 . . . . 0.0 110.167 179.655 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.569 ' O ' ' HG2' ' A' ' 163' ' ' ARG . . . -66.14 -39.59 89.96 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.353 179.443 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 8.0 mtm180 -56.54 -52.07 66.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.561 -179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 10.7 ptm180 -71.11 -21.73 62.18 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.83 0.348 . . . . 0.0 111.105 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 4.1 mt -75.27 -48.52 22.88 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.451 -179.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.569 ' HG2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -65.32 -43.61 90.46 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.901 -0.32 . . . . 0.0 110.903 -179.687 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.588 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -65.66 -42.81 90.92 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.456 179.725 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -69.19 -28.93 72.29 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.436 -0.888 . . . . 0.0 111.473 178.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.626 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 m-20 -66.53 -56.07 12.54 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-N 115.527 -0.336 . . . . 0.0 111.252 -179.818 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.698 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 13.6 p-90 -63.04 -26.12 68.7 Favored 'General case' 0 CA--C 1.516 -0.35 0 C-N-CA 120.539 -0.464 . . . . 0.0 111.016 -179.274 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -56.83 -42.25 79.3 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.023 0.44 . . . . 0.0 110.325 178.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 17.6 m -87.13 -32.2 20.01 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.698 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 19.0 m -88.66 -33.13 6.16 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 N-CA-C 113.854 1.057 . . . . 0.0 113.854 -177.449 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.68 ' HG2' ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -73.85 -29.74 62.29 Favored 'General case' 0 C--N 1.316 -0.851 0 O-C-N 121.656 -0.653 . . . . 0.0 110.541 -179.487 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.605 ' HA ' ' OG1' ' A' ' 175' ' ' THR . 1.8 m -85.33 -33.87 21.97 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.673 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.653 HG13 ' HG ' ' A' ' 174' ' ' LEU . 3.7 p -65.89 -31.29 53.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.221 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.633 179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.653 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -110.66 33.12 4.72 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.087 0.47 . . . . 0.0 110.395 178.706 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.605 ' OG1' ' HA ' ' A' ' 172' ' ' THR . 8.4 m -67.68 -32.82 73.74 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.124 179.558 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.83 50.31 3.28 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 121.223 -0.513 . . . . 0.0 113.085 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.449 ' HB1' HG23 ' A' ' 82' ' ' VAL . . . -118.01 13.24 13.89 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.681 0.753 . . . . 0.0 109.275 179.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.844 HG11 HH21 ' A' ' 59' ' ' ARG . 2.1 t -83.34 61.29 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.573 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -88.92 0.93 56.17 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.243 0.544 . . . . 0.0 110.391 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.623 ' HB2' ' HB3' ' A' ' 63' ' ' ASP . 3.3 mt -92.69 -45.49 8.03 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.69 98.63 0.42 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.984 -179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.624 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -83.37 -160.41 0.42 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.788 0.327 . . . . 0.0 110.631 179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.248 1.009 0 CA-C-O 118.014 -0.993 . . . . 0.0 110.148 179.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.59 0 N-CA-C 111.622 -0.591 . . . . 0.0 111.622 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -61.19 151.08 81.37 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.984 2.456 . . . . 0.0 112.14 179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.0 mp -117.75 -47.0 2.63 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.638 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 74.71 -176.66 48.35 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.009 -0.615 . . . . 0.0 112.087 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 51.08 63.69 2.14 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-O 121.189 0.518 . . . . 0.0 111.391 179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.7 mmt -90.68 141.57 28.65 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.807 -179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -142.97 151.04 40.48 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.385 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.437 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.7 p -105.57 135.93 19.31 Favored Pre-proline 0 N--CA 1.45 -0.474 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.634 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.437 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 2.3 Cg_endo -85.52 125.64 2.94 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.328 2.686 . . . . 0.0 112.405 -179.221 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -70.55 129.35 38.97 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.113 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -137.56 159.3 42.33 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.513 179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.492 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -91.48 143.39 28.06 Favored Pre-proline 0 C--N 1.326 -0.419 0 CA-C-O 120.597 0.236 . . . . 0.0 111.155 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.492 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.3 Cg_exo -74.92 77.62 3.06 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 123.135 2.557 . . . . 0.0 111.858 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.92 -170.89 3.31 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.917 -179.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -55.99 -37.15 68.72 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.819 -179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 5.1 ttp180 -65.05 -35.71 82.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.722 0.296 . . . . 0.0 110.563 179.48 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.2 -36.47 58.6 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 178.868 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.695 ' HB2' HD13 ' A' ' 42' ' ' LEU . 8.0 tp -70.3 -41.78 72.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.987 179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.9 p -66.27 -34.38 69.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 179.114 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -74.08 -20.84 60.14 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.453 178.62 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -78.02 -64.74 1.09 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.929 -0.578 . . . . 0.0 110.808 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.472 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 3.9 t80 -56.21 -52.66 63.61 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.449 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 63.4 t -68.38 -37.71 78.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.227 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -62.22 -52.59 48.57 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.253 179.142 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.691 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 0.6 OUTLIER -62.29 -44.58 96.19 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.855 0.36 . . . . 0.0 110.821 179.79 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 2.7 mmtt -62.36 -41.46 98.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.823 -0.626 . . . . 0.0 111.254 -179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.674 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -73.28 -43.86 60.23 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 109.581 -0.526 . . . . 0.0 109.581 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.696 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.0 OUTLIER -57.56 -33.85 68.56 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.606 -0.725 . . . . 0.0 111.558 -179.949 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.402 HE21 ' HB2' ' A' ' 24' ' ' GLN . 1.1 pt20 -86.61 -8.61 57.34 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.611 0.597 . . . . 0.0 112.611 -179.332 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mtpp -121.19 -58.88 1.76 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.831 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -115.92 -48.24 0.5 Allowed Glycine 0 C--O 1.23 -0.149 0 C-N-CA 120.3 -0.952 . . . . 0.0 113.854 -178.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 2.4 t80 -81.44 49.44 1.3 Allowed 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 121.21 0.528 . . . . 0.0 110.963 -179.491 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 12.0 p -79.44 -27.55 12.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.46 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.15 -42.6 72.31 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.469 0.652 . . . . 0.0 109.526 179.068 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -89.4 58.98 3.8 Favored Glycine 0 N--CA 1.443 -0.85 0 CA-C-N 115.301 -0.863 . . . . 0.0 112.029 179.246 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.696 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -62.1 115.64 4.28 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.581 -0.525 . . . . 0.0 109.581 179.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.476 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 179.55 -53.88 0.09 OUTLIER Glycine 0 C--O 1.222 -0.63 0 C-N-CA 120.073 -1.061 . . . . 0.0 113.356 -178.445 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.407 ' HB2' ' CA ' ' A' ' 19' ' ' GLY . 32.7 Cg_exo -60.55 -50.19 7.35 Favored 'Trans proline' 0 C--N 1.349 0.604 0 C-N-CA 121.836 1.69 . . . . 0.0 111.19 -179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.691 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.06 30.29 5.18 Favored Glycine 0 N--CA 1.447 -0.586 0 CA-C-N 115.652 -0.704 . . . . 0.0 112.438 178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.499 ' HG3' ' N ' ' A' ' 36' ' ' GLY . 0.0 OUTLIER -65.69 -38.59 89.66 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 117.067 0.434 . . . . 0.0 110.981 -179.552 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . 0.499 ' N ' ' HG3' ' A' ' 35' ' ' GLU . . . -110.69 132.96 11.27 Favored Glycine 0 N--CA 1.449 -0.499 0 N-CA-C 111.491 -0.644 . . . . 0.0 111.491 179.591 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.453 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.9 Cg_endo -89.31 -143.17 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 122.505 2.137 . . . . 0.0 113.785 -178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.682 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -67.42 106.92 2.26 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.049 -0.978 . . . . 0.0 112.022 -179.267 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -147.59 -33.73 0.26 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.87 0.367 . . . . 0.0 111.406 179.691 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.484 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 97.2 m-20 -79.2 163.49 59.47 Favored Pre-proline 0 C--N 1.324 -0.512 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.373 -179.1 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.484 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 29.6 Cg_endo -77.83 48.7 2.71 Favored 'Trans proline' 0 C--N 1.347 0.45 0 C-N-CA 123.378 2.718 . . . . 0.0 111.549 178.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.695 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.1 OUTLIER -177.27 -29.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 114.274 -1.33 . . . . 0.0 107.998 179.458 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.589 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 2.3 m170 -62.29 -58.21 8.55 Favored 'General case' 0 CA--C 1.518 -0.256 0 CA-C-N 114.951 -1.022 . . . . 0.0 109.85 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.682 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.97 -28.18 66.07 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 115.356 -0.838 . . . . 0.0 110.349 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.736 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.08 -55.03 11.98 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.77 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.617 ' HE2' HD11 ' A' ' 13' ' ' LEU . 2.7 tpp -67.4 -36.7 81.82 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 120.633 -0.427 . . . . 0.0 111.807 -179.014 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.476 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 3.8 ttp180 -61.92 -37.57 85.16 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.891 -179.16 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.59 -41.6 23.72 Favored 'General case' 0 C--N 1.327 -0.376 0 C-N-CA 120.741 -0.384 . . . . 0.0 110.593 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.793 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.26 -53.74 54.83 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 109.171 -0.677 . . . . 0.0 109.171 178.705 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.43 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.84 -48.51 44.48 Favored Glycine 0 C--O 1.215 -1.08 0 CA-C-N 115.204 -0.907 . . . . 0.0 112.25 178.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.0 t0 -57.13 -49.6 75.4 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 121.003 0.43 . . . . 0.0 111.553 179.363 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 2.4 tt0 -61.87 -44.08 97.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.911 -179.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.815 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -73.06 -33.42 65.65 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.986 179.653 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -63.47 -26.65 68.82 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.652 0.739 . . . . 0.0 109.267 178.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 25.2 m -88.61 -25.61 22.35 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-N 115.257 -0.883 . . . . 0.0 111.556 179.131 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.0 mtt180 -99.83 -55.25 2.7 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-O 120.923 0.392 . . . . 0.0 111.952 -179.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -85.57 73.43 10.47 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 122.92 0.488 . . . . 0.0 110.567 179.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.416 HH11 ' HD3' ' A' ' 58' ' ' ARG . 3.1 mpt_? -73.82 -18.49 60.94 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.01 -0.541 . . . . 0.0 112.011 -179.035 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . 0.448 HH11 ' HD2' ' A' ' 59' ' ' ARG . 0.0 OUTLIER -79.35 58.55 2.62 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.044 0.45 . . . . 0.0 111.259 -179.677 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -121.07 -48.95 2.21 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.108 -179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.056 ' HA ' HD22 ' A' ' 64' ' ' LEU . 86.0 m-85 -64.17 -28.28 69.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.661 -0.699 . . . . 0.0 112.197 -178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.37 -34.29 76.4 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.702 0.287 . . . . 0.0 111.608 -179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.482 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.5 m-20 -74.54 -18.47 60.59 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.964 0.411 . . . . 0.0 110.853 -179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.056 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -73.01 -39.05 66.34 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.496 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.524 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -75.16 -48.02 25.65 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.092 -0.958 . . . . 0.0 110.222 179.44 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.612 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.28 -43.64 61.64 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.902 179.384 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.655 HE22 HD11 ' A' ' 106' ' ' LEU . 24.8 mt-30 -69.54 -58.12 4.35 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.774 -0.648 . . . . 0.0 112.702 179.871 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.439 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.7 OUTLIER -82.02 16.54 1.87 Allowed 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 113.472 0.916 . . . . 0.0 113.472 -176.778 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.524 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 1.6 t-80 -78.17 -33.78 50.0 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.942 0.401 . . . . 0.0 110.129 179.363 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.669 HG13 ' H ' ' A' ' 71' ' ' THR . 2.2 p -92.26 -67.9 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.342 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.669 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -163.43 154.95 14.68 Favored Pre-proline 0 C--O 1.234 0.284 0 N-CA-C 110.111 -0.329 . . . . 0.0 110.111 179.881 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 98.3 Cg_endo -89.36 -153.56 0.04 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.935 2.423 . . . . 0.0 112.108 179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 81.25 -78.73 1.89 Allowed Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.861 -0.685 . . . . 0.0 113.41 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -74.94 47.18 0.33 Allowed 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 121.357 0.599 . . . . 0.0 112.209 -179.015 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -93.29 -18.21 22.71 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.262 179.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 3.8 pt20 -61.86 -38.35 87.91 Favored 'General case' 0 CA--C 1.513 -0.46 0 CA-C-N 115.901 -0.59 . . . . 0.0 111.6 -179.153 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.474 ' H ' ' HG2' ' A' ' 77' ' ' GLN . 0.4 OUTLIER -66.7 -40.44 88.49 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.533 179.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.47 ' HB3' HD23 ' A' ' 180' ' ' LEU . 17.5 mtt180 -67.22 -45.8 75.73 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.969 0.414 . . . . 0.0 110.0 179.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -60.17 -49.76 76.34 Favored 'General case' 0 N--CA 1.453 -0.306 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.853 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.1 p -57.6 -34.56 69.38 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 111.955 0.354 . . . . 0.0 111.955 -179.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -60.55 -57.74 11.44 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-O 120.995 0.426 . . . . 0.0 110.485 179.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.54 HG21 ' HG ' ' A' ' 180' ' ' LEU . 31.3 t -58.65 -38.44 71.43 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.386 -0.825 . . . . 0.0 110.877 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 16.9 m -65.73 -46.08 80.24 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.982 -179.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.574 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.48 -36.82 81.85 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.789 -179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.449 ' OE1' ' HA ' ' A' ' 177' ' ' ALA . 24.8 mt-10 -72.98 -23.57 60.67 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.928 0.395 . . . . 0.0 110.582 179.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.462 HD12 ' HA ' ' A' ' 86' ' ' LEU . 1.2 tp -81.74 -37.69 26.86 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.483 0.659 . . . . 0.0 109.818 179.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -83.93 -8.23 59.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.574 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -46.3 -42.01 14.0 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.962 -0.563 . . . . 0.0 112.095 -179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -175.19 48.38 0.13 Allowed Glycine 0 N--CA 1.444 -0.771 0 C-N-CA 119.723 -1.227 . . . . 0.0 113.13 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.451 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 174.12 53.85 0.05 OUTLIER Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 119.442 -1.361 . . . . 0.0 114.747 179.152 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.556 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 12.2 Cg_endo -80.09 41.36 1.11 Allowed 'Trans proline' 0 C--N 1.349 0.603 0 C-N-CA 122.12 1.88 . . . . 0.0 111.441 177.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.776 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 0.7 OUTLIER -69.34 163.95 23.97 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.673 -0.694 . . . . 0.0 111.618 -178.822 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.584 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.5 m95 -54.2 -29.05 44.67 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.61 -179.436 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -63.22 -37.74 95.37 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 178.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.417 ' HG2' ' HG ' ' A' ' 86' ' ' LEU . 0.8 OUTLIER -87.68 -24.89 23.75 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.514 -0.343 . . . . 0.0 110.703 178.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -54.96 -31.52 60.69 Favored 'General case' 0 C--O 1.235 0.296 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.499 179.991 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.815 HG11 ' HB2' ' A' ' 53' ' ' PHE . 10.7 t -62.89 -52.95 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.472 178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.18 72.27 Favored 'General case' 0 C--O 1.222 -0.355 0 CA-C-N 114.992 -1.004 . . . . 0.0 111.331 179.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.2 m-85 -56.55 -54.6 43.99 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 121.037 0.446 . . . . 0.0 110.231 179.532 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.472 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 15.3 m-85 -74.94 -39.48 61.34 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.002 -179.868 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.7 t -61.39 -36.76 75.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 115.978 -0.555 . . . . 0.0 111.254 -179.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.509 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.3 OUTLIER -53.18 -59.77 4.13 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.821 0.343 . . . . 0.0 111.562 -179.828 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -69.57 -38.67 78.89 Favored Glycine 0 N--CA 1.447 -0.621 0 C-N-CA 120.467 -0.873 . . . . 0.0 113.28 -179.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -59.91 -44.8 94.06 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 117.192 0.496 . . . . 0.0 110.804 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.33 -41.24 73.48 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 109.768 -0.456 . . . . 0.0 109.768 178.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.747 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.42 -47.37 84.17 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.604 -0.726 . . . . 0.0 110.403 179.296 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.674 ' HB3' HD21 ' A' ' 22' ' ' LEU . 60.6 m -65.18 -45.39 85.06 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.206 179.863 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.1 -40.05 70.03 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.772 0.32 . . . . 0.0 111.601 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.6 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.4 OUTLIER -85.05 -8.77 58.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.683 -179.952 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 67.3 m -89.92 -29.03 18.79 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.791 0.329 . . . . 0.0 110.16 179.145 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.573 HG23 ' O ' ' A' ' 107' ' ' CYS . 51.9 t -68.65 -32.42 55.0 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.023 179.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.6 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 14.5 p30 -85.32 0.96 50.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.859 0.362 . . . . 0.0 111.151 -179.953 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -125.72 -170.38 2.17 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.395 179.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -87.21 53.24 2.75 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.029 0.443 . . . . 0.0 110.633 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.439 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -136.16 46.44 2.29 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.408 -179.402 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.73 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 15.5 mp0 -64.17 -56.19 25.8 Favored Pre-proline 0 CA--C 1.538 0.506 0 CA-C-N 115.807 -0.633 . . . . 0.0 112.424 -179.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.73 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.1 Cg_exo -64.31 -26.52 63.83 Favored 'Trans proline' 0 C--N 1.354 0.82 0 C-N-CA 122.051 1.834 . . . . 0.0 112.614 -179.43 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 12.4 tp -66.4 -29.11 69.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.3 -179.769 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 53.5 t -57.24 -52.54 55.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 111.284 179.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.42 -32.27 83.59 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.296 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.486 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 19.1 mm100 -65.95 -52.33 50.71 Favored 'General case' 0 C--O 1.219 -0.525 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 178.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.492 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 48.6 t -58.28 -35.58 54.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-O 121.009 0.433 . . . . 0.0 109.91 178.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -62.19 -47.02 86.32 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.26 178.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.688 ' HA ' HG12 ' A' ' 127' ' ' VAL . 16.0 pt-20 -72.69 -39.63 66.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.934 179.595 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 38.9 m0 -55.75 -37.81 68.98 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 178.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 7.3 ttm -74.11 -53.67 9.42 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.187 -0.915 . . . . 0.0 111.638 -179.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.6 p -62.81 -34.07 63.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -69.62 -46.3 66.56 Favored 'General case' 0 CA--C 1.519 -0.228 0 C-N-CA 120.69 -0.404 . . . . 0.0 110.476 179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.574 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 10.0 t80 -61.51 -35.1 76.75 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.582 0.706 . . . . 0.0 110.123 178.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.006 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.93 -56.6 5.39 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.201 -0.909 . . . . 0.0 112.132 -179.269 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.84 -31.76 72.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 -178.626 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 11.8 m -82.9 -36.86 24.96 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 113.365 0.876 . . . . 0.0 113.365 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.402 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -125.86 -42.5 1.9 Allowed 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 114.014 1.116 . . . . 0.0 114.014 -177.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.006 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.4 mm? -60.85 -46.31 91.08 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.554 -0.458 . . . . 0.0 111.371 -178.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.97 -34.21 54.85 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.422 -0.353 . . . . 0.0 111.444 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.2 t70 -65.08 -54.95 22.14 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.776 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.7 t90 -56.66 -48.3 77.91 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.527 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.5 mt -57.36 -47.26 84.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.489 -0.778 . . . . 0.0 112.569 -178.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 41.7 m-70 -68.27 -30.11 69.06 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 111.98 0.363 . . . . 0.0 111.98 -178.839 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -89.09 -9.02 52.67 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 112.167 0.432 . . . . 0.0 112.167 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -91.52 -57.07 2.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 121.04 0.447 . . . . 0.0 111.609 -179.632 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -172.97 -13.3 0.02 OUTLIER Glycine 0 CA--C 1.507 -0.416 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.6 168.4 39.78 Favored Glycine 0 N--CA 1.443 -0.836 0 C-N-CA 120.776 -0.726 . . . . 0.0 113.117 179.482 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.468 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 96.9 m95 -61.75 -29.47 70.15 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 179.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.38 -35.43 80.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.14 178.858 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -63.6 -47.49 81.21 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 121.246 0.546 . . . . 0.0 109.55 179.419 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.525 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 15.7 t80 -63.27 -38.25 90.43 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.078 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.736 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 7.5 m -65.98 -27.24 68.0 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.741 0.305 . . . . 0.0 111.282 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -82.73 -34.92 27.08 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 178.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.655 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -66.15 -39.95 90.19 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.107 -0.952 . . . . 0.0 111.615 179.807 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.405 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.5 m-85 -116.47 20.39 14.17 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 112.286 0.476 . . . . 0.0 112.286 -178.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . . . . . . . . . . . -107.13 -140.33 9.6 Favored Glycine 0 N--CA 1.447 -0.632 0 C-N-CA 120.051 -1.071 . . . . 0.0 112.444 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -84.21 -34.67 23.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.031 0.443 . . . . 0.0 110.336 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.511 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.16 42.23 2.98 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.834 -0.621 . . . . 0.0 112.022 179.359 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.23 68.19 10.42 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.985 0.422 . . . . 0.0 110.554 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.575 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -63.89 173.23 1.9 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.745 -0.661 . . . . 0.0 111.272 -179.573 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.418 ' H ' ' HG2' ' A' ' 157' ' ' GLU . 0.4 OUTLIER -49.84 -39.3 38.43 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.573 -179.575 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.575 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 1.6 mm-40 -63.56 -52.3 61.65 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.871 179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.655 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -61.38 -38.78 88.27 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.517 -179.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 54.2 mtm-85 -59.65 -57.1 14.39 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.463 -179.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 2.1 ptt180 -67.8 -29.24 68.36 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.684 0.278 . . . . 0.0 111.581 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.461 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 4.3 tp -69.02 -46.68 67.33 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 111.99 0.367 . . . . 0.0 111.99 -179.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.47 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.8 ptt180 -68.87 -37.2 78.9 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.114 -0.634 . . . . 0.0 111.357 -179.261 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.575 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 3.9 mt-10 -70.67 -43.2 69.58 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 120.543 -0.463 . . . . 0.0 110.141 179.074 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.7 -14.17 72.37 Favored Glycine 0 C--N 1.334 0.422 0 C-N-CA 120.454 -0.879 . . . . 0.0 111.3 178.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.608 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 15.4 t-20 -73.25 -65.46 0.81 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.295 -0.452 . . . . 0.0 111.017 179.624 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.61 ' HE3' ' HD3' ' A' ' 171' ' ' ARG . 48.0 p-90 -61.54 -24.7 66.81 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-N 116.398 -0.365 . . . . 0.0 111.576 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.35 -64.11 0.91 Allowed 'General case' 0 C--N 1.331 -0.211 0 O-C-N 123.116 0.26 . . . . 0.0 110.734 179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -87.81 -21.46 25.06 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 112.94 0.718 . . . . 0.0 112.94 -179.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.608 ' HB ' ' O ' ' A' ' 166' ' ' ASN . 2.1 t -81.01 -36.32 15.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 N-CA-C 112.39 0.515 . . . . 0.0 112.39 -177.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.61 ' HD3' ' HE3' ' A' ' 167' ' ' TRP . 0.9 OUTLIER -82.87 -13.35 56.3 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.075 -0.65 . . . . 0.0 110.516 179.88 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.907 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.1 p -88.49 -31.62 18.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.76 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.749 HG13 ' HG ' ' A' ' 174' ' ' LEU . 5.7 p -67.07 -24.51 32.32 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-O 121.476 0.655 . . . . 0.0 110.136 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.749 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.81 42.91 2.91 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.231 178.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.907 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.6 OUTLIER -69.28 -43.23 74.27 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.912 -179.485 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -77.62 27.19 1.89 Allowed Glycine 0 CA--C 1.519 0.343 0 N-CA-C 114.642 0.617 . . . . 0.0 114.642 -178.201 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . 0.524 ' O ' HG13 ' A' ' 82' ' ' VAL . . . -89.69 2.07 55.26 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 117.225 0.513 . . . . 0.0 111.046 179.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . 0.443 HG12 ' OD2' ' A' ' 63' ' ' ASP . 0.0 OUTLIER -80.02 68.21 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.253 0.549 . . . . 0.0 110.925 -179.705 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -92.03 9.65 32.36 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.785 -179.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.54 ' HG ' HG21 ' A' ' 82' ' ' VAL . 12.4 mt -95.84 -43.6 7.78 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.914 0.388 . . . . 0.0 110.509 179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.437 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.09 94.62 0.46 Allowed Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.624 -0.717 . . . . 0.0 112.733 -179.457 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.612 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -86.68 149.2 25.06 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 179.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 4.7 mt . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.083 -0.961 . . . . 0.0 110.055 179.853 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.513 0 N-CA-C 111.973 -0.451 . . . . 0.0 111.973 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.09 -36.52 88.81 Favored 'Trans proline' 0 C--N 1.347 0.453 0 C-N-CA 123.155 2.57 . . . . 0.0 113.07 -179.49 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.454 ' HA ' HD13 ' A' ' -2' ' ' LEU . 0.4 OUTLIER 65.36 77.15 0.31 Allowed 'General case' 0 N--CA 1.467 0.396 0 O-C-N 123.475 0.484 . . . . 0.0 111.489 179.833 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -122.46 36.57 3.11 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.79 -0.719 . . . . 0.0 112.423 179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.34 116.21 16.82 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.972 0.415 . . . . 0.0 111.292 -179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.3 mmt -90.24 167.92 12.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.741 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.47 150.85 40.96 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.958 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.528 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.6 p -114.27 130.49 23.92 Favored Pre-proline 0 N--CA 1.449 -0.51 0 CA-C-O 121.114 0.483 . . . . 0.0 110.851 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.528 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 7.8 Cg_exo -73.47 158.01 48.47 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.207 2.605 . . . . 0.0 112.267 -179.257 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -112.38 129.14 56.41 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.729 179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -89.16 110.46 21.2 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.383 -0.372 . . . . 0.0 110.187 179.602 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.491 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -79.07 132.74 62.56 Favored Pre-proline 0 C--N 1.324 -0.511 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.409 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 7.9 Cg_exo -73.56 49.32 1.76 Allowed 'Trans proline' 0 CA--C 1.53 0.321 0 C-N-CA 123.662 2.908 . . . . 0.0 112.453 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.11 -164.48 1.17 Allowed 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.617 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -55.5 -37.93 68.52 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.702 -0.681 . . . . 0.0 111.204 179.818 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.483 ' HG3' ' H ' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -62.1 -35.4 78.56 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.924 179.564 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.93 -36.13 49.68 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.092 0.472 . . . . 0.0 109.886 179.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.631 ' HB2' HD13 ' A' ' 42' ' ' LEU . 2.4 tp -70.44 -43.28 70.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.844 -0.616 . . . . 0.0 111.13 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.657 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.7 p -65.87 -35.35 74.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.281 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . 0.408 ' O ' ' HA3' ' A' ' 19' ' ' GLY . . . -72.23 -22.59 61.22 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.867 179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -77.7 -64.24 1.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.517 -0.31 . . . . 0.0 111.306 -179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.569 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.8 t80 -54.95 -52.71 62.16 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.828 -0.624 . . . . 0.0 111.829 -178.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.471 ' O ' HD13 ' A' ' 22' ' ' LEU . 46.5 t -72.29 -40.0 64.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 CA-C-O 120.776 0.322 . . . . 0.0 110.639 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.517 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -61.32 -54.3 37.39 Favored Glycine 0 N--CA 1.449 -0.449 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.847 179.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.768 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 48.9 t80 -62.8 -39.69 95.03 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.572 0.186 . . . . 0.0 111.271 -179.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 17' ' ' PHE . 0.0 OUTLIER -63.46 -42.99 98.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.891 0.377 . . . . 0.0 110.645 -179.978 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 6.9 mp -70.42 -44.79 67.19 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.902 -0.59 . . . . 0.0 109.618 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.825 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.3 OUTLIER -62.47 -20.69 64.81 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.058 179.865 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.641 ' HB3' ' HD3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -82.93 -35.38 26.11 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.47 -179.619 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.641 ' HD3' ' HB3' ' A' ' 24' ' ' GLN . 0.0 OUTLIER -151.08 76.25 1.22 Allowed 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.96 0.409 . . . . 0.0 112.025 -179.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 151.67 -70.43 0.3 Allowed Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.802 -0.713 . . . . 0.0 112.123 179.311 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.51 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 0.7 OUTLIER -90.26 56.43 3.39 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-O 121.389 0.614 . . . . 0.0 109.537 179.007 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.7 t -78.21 -34.3 18.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.486 -0.779 . . . . 0.0 110.757 -179.195 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -70.44 -41.65 72.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.386 0.612 . . . . 0.0 109.605 179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.45 56.71 4.9 Favored Glycine 0 N--CA 1.448 -0.532 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.913 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.825 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -64.83 120.99 13.55 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 179.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.473 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 172.31 -58.36 0.16 Allowed Glycine 0 C--O 1.226 -0.35 0 C-N-CA 120.006 -1.093 . . . . 0.0 113.173 -179.208 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.517 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.4 Cg_exo -60.35 -48.45 11.6 Favored 'Trans proline' 0 C--N 1.347 0.465 0 C-N-CA 121.785 1.657 . . . . 0.0 111.014 -179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.768 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.91 40.04 2.71 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.898 178.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.473 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 10.1 pt-20 -93.76 -8.09 41.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.949 0.404 . . . . 0.0 110.457 -179.612 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -108.77 164.49 12.57 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 120.73 -0.748 . . . . 0.0 112.724 -179.24 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 90.5 Cg_endo -99.31 -164.75 0.07 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.005 0 C-N-CA 123.606 2.871 . . . . 0.0 113.191 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.685 ' HA ' ' HB3' ' A' ' 43' ' ' HIS . . . -89.01 73.11 8.32 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.931 179.054 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -121.11 34.01 5.36 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.099 0.476 . . . . 0.0 111.589 -178.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.518 ' HB2' ' CG ' ' A' ' 43' ' ' HIS . 5.4 m-20 -130.11 161.1 62.08 Favored Pre-proline 0 C--N 1.321 -0.661 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 179.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.408 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 6.8 Cg_exo -70.76 28.77 0.21 Allowed 'Trans proline' 0 CA--C 1.529 0.259 0 C-N-CA 123.912 3.075 . . . . 0.0 113.055 179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.631 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -166.78 -23.51 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.979 179.765 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.685 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 5.0 m170 -55.52 -64.78 0.74 Allowed 'General case' 0 N--CA 1.466 0.332 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.465 -179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.468 ' HB3' ' HB1' ' A' ' 38' ' ' ALA . 0.8 OUTLIER -58.4 -23.9 58.53 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.536 -179.627 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.73 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.37 -46.5 40.09 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.113 179.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 15.2 ttm -72.25 -39.78 68.18 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.819 -179.187 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 14.6 mtt-85 -60.81 -36.14 78.3 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.569 -179.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.44 -31.34 42.53 Favored 'General case' 0 CA--C 1.515 -0.388 0 CA-C-O 121.183 0.516 . . . . 0.0 109.98 179.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.869 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -65.19 -56.7 11.33 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 178.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.569 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.62 -48.47 42.95 Favored Glycine 0 C--O 1.218 -0.858 0 CA-C-N 114.83 -1.077 . . . . 0.0 112.747 179.593 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.2 t0 -56.61 -46.45 80.91 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 120.781 0.324 . . . . 0.0 111.479 179.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -61.17 -46.23 91.36 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.908 0.385 . . . . 0.0 110.976 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.838 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.61 -31.78 65.43 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.871 179.965 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -64.86 -24.9 67.68 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.651 0.738 . . . . 0.0 109.211 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 20.5 m -89.38 -36.54 15.43 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 115.162 -0.927 . . . . 0.0 110.913 178.697 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.8 mtt180 -84.44 -64.43 1.16 Allowed 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 121.253 0.549 . . . . 0.0 111.151 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -81.93 72.01 8.98 Favored 'General case' 0 C--N 1.325 -0.475 0 C-N-CA 123.843 0.857 . . . . 0.0 110.921 179.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 24.3 mtm180 -82.8 -0.03 45.99 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 111.964 0.357 . . . . 0.0 111.964 -179.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -94.04 23.82 4.7 Favored 'General case' 0 C--N 1.325 -0.482 0 O-C-N 122.245 -0.284 . . . . 0.0 111.361 -179.642 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 8.8 t -102.53 -1.24 30.83 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.933 0.397 . . . . 0.0 111.369 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.758 ' HA ' HD22 ' A' ' 64' ' ' LEU . 10.4 m-85 -92.6 -19.77 21.56 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 120.97 0.414 . . . . 0.0 111.374 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -39.63 80.69 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.755 -179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.499 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 3.2 m-20 -62.76 -22.86 66.88 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.036 -0.529 . . . . 0.0 112.102 -178.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.758 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -68.69 -39.62 80.43 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.052 -0.721 . . . . 0.0 109.052 179.064 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.477 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -79.56 -44.72 20.57 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.141 179.163 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.554 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.3 -42.66 61.32 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.386 179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.634 HE22 HD11 ' A' ' 106' ' ' LEU . 27.2 mt-30 -73.16 -53.94 9.73 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.519 0.563 . . . . 0.0 112.519 -179.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.577 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -83.26 14.74 3.32 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.787 0.662 . . . . 0.0 112.787 -177.32 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.477 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 82.6 t60 -77.98 -32.64 51.4 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 121.266 0.555 . . . . 0.0 109.631 179.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.76 -73.24 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.535 -0.757 . . . . 0.0 111.195 179.837 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.35 153.74 16.91 Favored Pre-proline 0 C--O 1.237 0.404 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.512 -179.382 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -86.64 -167.27 0.36 Allowed 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 123.199 2.599 . . . . 0.0 111.985 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.406 ' C ' ' H ' ' A' ' 75' ' ' ALA . . . 85.78 -63.41 4.26 Favored Glycine 0 CA--C 1.517 0.216 0 C-N-CA 120.869 -0.681 . . . . 0.0 112.998 179.261 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -75.99 24.96 0.12 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.088 0.471 . . . . 0.0 111.85 -179.63 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.406 ' H ' ' C ' ' A' ' 73' ' ' GLY . . . -80.23 -23.32 40.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.299 -0.409 . . . . 0.0 111.622 -179.815 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.599 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 1.8 pt20 -62.01 -43.42 98.89 Favored 'General case' 0 CA--C 1.517 -0.32 0 C-N-CA 120.888 -0.325 . . . . 0.0 111.618 -179.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 19.5 mp0 -62.15 -42.43 99.25 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 179.398 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 6.9 mtt180 -63.23 -44.98 93.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.88 179.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -62.84 -50.78 69.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.496 179.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 7.2 p -56.1 -33.68 65.31 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 121.225 -0.19 . . . . 0.0 111.419 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.442 HE21 ' HB3' ' A' ' 81' ' ' GLN . 3.3 mm100 -60.27 -66.58 0.5 Allowed 'General case' 0 CA--C 1.515 -0.393 0 CA-C-O 121.341 0.591 . . . . 0.0 110.585 179.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.542 HG11 ' HG ' ' A' ' 180' ' ' LEU . 12.0 m -56.52 -32.73 37.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.681 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 51.1 m -65.85 -43.82 87.28 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.353 179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.57 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.5 OUTLIER -70.8 -37.02 73.24 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.121 0.486 . . . . 0.0 109.694 179.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -67.6 -29.05 68.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.884 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.548 HD23 ' HD3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -80.84 -31.79 35.36 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.309 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.434 ' CE1' ' HG3' ' A' ' 91' ' ' PRO . 37.3 t80 -93.27 1.89 56.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.539 179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -55.62 -24.99 36.38 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.824 -0.625 . . . . 0.0 112.256 -179.117 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 168.94 60.04 0.03 OUTLIER Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.098 -1.048 . . . . 0.0 113.344 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.469 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.25 59.25 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.442 0 C-N-CA 119.607 -1.282 . . . . 0.0 114.648 178.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.6 Cg_endo -82.78 39.06 0.79 Allowed 'Trans proline' 0 N--CA 1.461 -0.413 0 C-N-CA 122.275 1.983 . . . . 0.0 111.642 178.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.833 ' HB2' HG11 ' A' ' 170' ' ' VAL . 3.3 t-20 -66.86 164.36 17.54 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.728 -0.669 . . . . 0.0 111.606 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.603 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 24.9 m95 -54.49 -27.15 35.84 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.235 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.499 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.34 -38.62 95.2 Favored Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 178.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.649 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.7 mmp_? -87.53 -26.61 23.07 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.466 -0.367 . . . . 0.0 110.974 179.123 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.816 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.6 OUTLIER -54.61 -31.57 57.38 Favored 'General case' 0 C--O 1.236 0.382 0 CA-C-O 121.421 0.629 . . . . 0.0 109.969 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.869 HG22 ' HB1' ' A' ' 49' ' ' ALA . 22.0 t -62.09 -55.87 21.33 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.091 -0.959 . . . . 0.0 109.539 178.355 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.486 ' HA ' ' HB ' ' A' ' 101' ' ' VAL . . . -63.82 -29.22 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.09 -0.959 . . . . 0.0 111.47 179.852 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.816 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -55.79 -54.65 41.9 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 121.095 0.474 . . . . 0.0 110.191 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.657 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 5.5 m-85 -77.83 -35.54 51.12 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.944 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 98' ' ' ALA . 2.3 t -60.73 -39.86 83.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.051 -179.885 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.532 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 1.4 m-85 -55.11 -51.11 67.43 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-O 120.786 0.327 . . . . 0.0 111.336 -179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.23 -38.77 38.53 Favored Glycine 0 N--CA 1.447 -0.596 0 C-N-CA 120.375 -0.917 . . . . 0.0 113.138 -179.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.83 -43.33 99.07 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 117.131 0.465 . . . . 0.0 110.927 -179.726 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.678 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -37.91 74.68 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 109.759 -0.46 . . . . 0.0 109.759 179.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.634 HD11 HE22 ' A' ' 67' ' ' GLN . 0.2 OUTLIER -61.29 -44.48 97.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.493 -0.776 . . . . 0.0 110.156 179.151 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 94.8 m -63.92 -45.79 87.68 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 114.945 -1.025 . . . . 0.0 111.284 179.957 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -52.06 -47.96 64.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.882 0.372 . . . . 0.0 111.726 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.622 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.2 OUTLIER -77.34 -12.25 59.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.806 -179.681 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 74.3 m -88.53 -24.96 22.78 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.941 0.401 . . . . 0.0 110.466 179.471 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.565 HG23 ' O ' ' A' ' 107' ' ' CYS . 57.4 t -75.64 -35.77 32.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.797 179.654 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.622 HD21 ' HA ' ' A' ' 109' ' ' GLU . 22.8 p30 -81.44 0.56 37.1 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.956 0.408 . . . . 0.0 111.174 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -127.48 -167.51 1.75 Allowed 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.029 179.475 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 -91.27 62.66 4.77 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.224 0.535 . . . . 0.0 110.471 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.577 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -141.66 37.75 1.65 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.946 -179.645 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.613 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.3 mp0 -55.84 -55.86 36.47 Favored Pre-proline 0 CA--C 1.536 0.409 0 CA-C-N 115.832 -0.622 . . . . 0.0 112.307 -179.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 23.7 Cg_exo -65.02 -18.55 62.37 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 122.082 1.855 . . . . 0.0 112.341 -179.72 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.575 ' O ' HG23 ' A' ' 122' ' ' VAL . 2.2 mm? -74.77 -35.22 62.55 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.698 179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.411 HG13 ' HB3' ' A' ' 107' ' ' CYS . 90.3 t -54.91 -57.72 6.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.491 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.07 -31.51 79.01 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.423 -0.894 . . . . 0.0 111.965 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.506 ' HB3' ' CE2' ' A' ' 125' ' ' TRP . 5.5 mm-40 -66.35 -49.78 65.75 Favored 'General case' 0 C--O 1.218 -0.601 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.575 HG23 ' O ' ' A' ' 118' ' ' LEU . 59.8 t -57.35 -36.12 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 109.7 -0.481 . . . . 0.0 109.7 178.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 17.9 tt0 -62.24 -45.61 92.54 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.631 178.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.775 ' HA ' HG12 ' A' ' 127' ' ' VAL . 13.4 pt-20 -76.2 -36.86 58.42 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.114 179.675 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.599 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 39.4 m0 -56.69 -38.62 72.51 Favored 'General case' 0 N--CA 1.467 0.401 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 178.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 15.6 ttm -72.85 -54.94 7.46 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 114.472 -1.24 . . . . 0.0 111.685 -179.048 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.775 HG12 ' HA ' ' A' ' 124' ' ' GLU . 5.5 p -60.97 -32.49 52.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 111.77 0.285 . . . . 0.0 111.77 -178.968 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -67.9 -50.41 56.38 Favored 'General case' 0 C--O 1.231 0.124 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.306 179.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.57 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 13.3 t80 -58.74 -35.21 72.36 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.642 0.734 . . . . 0.0 110.284 179.014 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.038 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -73.93 -48.5 30.22 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.956 -179.19 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -58.04 -42.22 84.94 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 112.44 0.533 . . . . 0.0 112.44 -178.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 1.8 m -80.78 -40.57 24.87 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -177.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -117.5 -42.1 2.9 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 -176.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.038 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -63.2 -46.71 85.77 Favored 'General case' 0 C--N 1.323 -0.546 0 C-N-CA 120.284 -0.566 . . . . 0.0 111.418 -178.349 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.39 -33.85 55.39 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.613 179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -67.66 -53.06 30.92 Favored 'General case' 0 CA--C 1.518 -0.286 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.571 179.425 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.806 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 55.6 t90 -55.3 -47.51 75.46 Favored 'General case' 0 N--CA 1.456 -0.16 0 CA-C-O 121.263 0.554 . . . . 0.0 109.567 178.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.6 HG13 ' HE3' ' A' ' 137' ' ' TRP . 4.3 mt -57.85 -49.17 81.91 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-N 115.172 -0.922 . . . . 0.0 111.402 -179.219 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 21.8 m170 -60.62 -39.69 89.15 Favored 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 112.089 0.404 . . . . 0.0 112.089 -179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.6 m -78.0 -26.89 48.85 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 111.893 0.331 . . . . 0.0 111.893 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -75.4 -56.04 5.1 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 112.527 0.565 . . . . 0.0 112.527 -179.359 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -179.28 -15.75 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.655 0 N-CA-C 111.252 -0.739 . . . . 0.0 111.252 -178.859 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 92.32 170.85 41.1 Favored Glycine 0 N--CA 1.444 -0.828 0 C-N-CA 120.653 -0.784 . . . . 0.0 113.183 179.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . . . . . . . . . 98.2 m95 -61.82 -26.09 67.9 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 109.706 -0.479 . . . . 0.0 109.706 179.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -65.24 -33.91 77.11 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-N 115.426 -0.806 . . . . 0.0 110.449 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.603 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -66.74 -38.71 87.18 Favored 'General case' 0 C--N 1.333 -0.126 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 178.79 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.505 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 6.5 t80 -65.79 -38.88 90.21 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.964 -1.016 . . . . 0.0 110.659 178.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.73 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.0 OUTLIER -67.46 -27.69 67.24 Favored 'General case' 0 C--O 1.224 -0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.8 179.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.96 -18.06 31.64 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 121.094 0.474 . . . . 0.0 110.349 179.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.574 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -75.78 -49.42 18.16 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.673 179.947 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -137.45 31.51 2.58 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 112.425 0.528 . . . . 0.0 112.425 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.471 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -93.3 -113.85 2.29 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.133 -1.032 . . . . 0.0 111.359 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -84.43 -62.94 1.43 Allowed 'General case' 0 C--N 1.319 -0.738 0 CA-C-O 121.14 0.495 . . . . 0.0 109.691 179.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.7 64.11 4.34 Favored Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.739 -0.664 . . . . 0.0 112.348 179.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -80.74 74.99 7.67 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.236 0.541 . . . . 0.0 110.182 179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.679 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.54 153.81 22.53 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.342 -0.844 . . . . 0.0 111.153 -179.267 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.661 ' HA ' ' HG2' ' A' ' 160' ' ' ARG . 0.0 OUTLIER -57.99 -27.36 63.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.753 -179.438 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.679 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.2 mm-40 -73.83 -32.43 63.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.958 179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.502 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -78.33 -41.56 33.23 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.047 0.451 . . . . 0.0 110.683 -179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.661 ' HG2' ' HA ' ' A' ' 157' ' ' GLU . 0.0 OUTLIER -66.61 -37.89 85.83 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.579 -179.612 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.594 ' HD2' ' OE1' ' A' ' 158' ' ' GLU . 9.8 ptp85 -72.65 -29.11 63.16 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 120.342 -0.543 . . . . 0.0 110.088 179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.2 -38.3 81.83 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.716 178.715 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.665 HH22 ' HA ' ' A' ' 49' ' ' ALA . 8.3 ttp180 -65.89 -41.9 90.96 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.824 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.585 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -61.62 -48.25 81.76 Favored 'General case' 0 C--O 1.233 0.198 0 O-C-N 123.346 0.404 . . . . 0.0 110.295 179.629 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -67.13 -28.52 73.77 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.507 -0.854 . . . . 0.0 111.408 178.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.665 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.06 -58.66 4.99 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.565 -0.318 . . . . 0.0 111.253 -179.846 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.657 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.2 p-90 -62.08 -27.42 68.9 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 120.805 -0.358 . . . . 0.0 111.416 -178.918 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -57.77 -39.17 76.81 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.038 0.446 . . . . 0.0 110.344 178.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.21 -28.73 20.98 Favored 'General case' 0 C--N 1.324 -0.533 0 N-CA-C 112.969 0.729 . . . . 0.0 112.969 -179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.833 HG11 ' HB2' ' A' ' 92' ' ' ASN . 8.1 m -95.3 -36.28 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 N-CA-C 114.923 1.453 . . . . 0.0 114.923 -176.478 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.604 ' HG2' ' HE3' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -81.34 -15.71 54.54 Favored 'General case' 0 C--N 1.318 -0.792 0 O-C-N 121.46 -0.775 . . . . 0.0 111.138 -178.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . . . . . . . . . 1.5 m -96.08 -17.04 21.2 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.156 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 1.012 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -81.2 -26.5 10.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.529 0.68 . . . . 0.0 109.521 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 1.012 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.3 OUTLIER -120.88 39.54 3.77 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.692 179.286 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.08 -30.49 71.03 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.265 -179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -78.8 38.15 1.93 Allowed Glycine 0 CA--C 1.52 0.399 0 CA-C-N 116.102 -0.499 . . . . 0.0 113.541 -179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -99.42 6.54 45.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.024 0.44 . . . . 0.0 110.139 179.185 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 1.4 t -85.56 60.02 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.365 179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.99 -11.14 60.0 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.277 -179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.542 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.1 OUTLIER -96.39 -9.38 30.09 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.848 179.953 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -71.87 89.7 0.48 Allowed Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 121.045 -0.598 . . . . 0.0 112.651 -179.487 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.554 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -108.87 171.46 7.42 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.64 0.257 . . . . 0.0 110.4 179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.245 0.828 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 179.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.55 -0.62 . . . . 0.0 111.55 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_exo -61.84 -39.79 49.4 Favored 'Trans proline' 0 C--N 1.343 0.283 0 C-N-CA 122.726 2.284 . . . . 0.0 111.643 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.06 176.78 5.63 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.479 179.256 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 141.4 -25.74 2.46 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.411 -0.9 . . . . 0.0 112.581 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 58.9 m -157.27 151.58 25.0 Favored 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -152.22 160.65 43.33 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.701 -0.481 . . . . 0.0 109.701 179.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -125.73 118.15 24.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.874 0.368 . . . . 0.0 110.646 -179.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.418 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 3.2 p -99.78 118.41 61.88 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.359 -179.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.8 Cg_exo -77.5 139.09 17.98 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.316 2.677 . . . . 0.0 112.02 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -142.22 133.36 26.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.666 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 10.5 m -77.17 157.87 30.7 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.152 -179.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.505 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -84.67 128.37 61.38 Favored Pre-proline 0 C--N 1.327 -0.388 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.158 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.505 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 11.4 Cg_exo -71.52 99.87 0.98 Allowed 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 123.103 2.536 . . . . 0.0 111.704 179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.63 -163.32 0.79 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.938 -0.574 . . . . 0.0 111.652 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -55.53 -38.59 69.46 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.959 -179.565 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 28.3 ttp180 -63.12 -35.47 80.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.716 0.294 . . . . 0.0 110.729 179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -75.73 -34.99 60.36 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.208 0.528 . . . . 0.0 109.756 178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.642 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.0 OUTLIER -71.91 -42.73 66.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.81 -0.632 . . . . 0.0 111.056 179.896 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.579 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.4 p -65.11 -36.0 76.75 Favored 'Isoleucine or valine' 0 C--O 1.232 0.172 0 CA-C-O 121.131 0.491 . . . . 0.0 109.703 179.258 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.25 -21.91 60.51 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.375 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -75.9 -63.95 1.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.903 179.838 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.505 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 3.4 t80 -54.45 -54.04 46.2 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.51 -179.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.423 ' O ' HD13 ' A' ' 22' ' ' LEU . 58.0 t -67.75 -39.55 82.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 N-CA-C 110.169 -0.308 . . . . 0.0 110.169 179.814 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.748 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -59.47 -54.71 35.5 Favored Glycine 0 C--O 1.224 -0.528 0 C-N-CA 120.849 -0.691 . . . . 0.0 112.246 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.677 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 34.5 t80 -61.86 -43.21 99.31 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 122.563 0.345 . . . . 0.0 110.994 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.422 ' HD3' ' HA ' ' A' ' 21' ' ' LYS . 12.7 mmtt -61.13 -40.27 93.16 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.341 -179.69 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.689 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.1 mp -79.16 -46.65 17.53 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.078 -179.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.426 ' HA ' ' O ' ' A' ' 27' ' ' TYR . 39.6 ttp85 -63.75 -17.25 62.85 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.85 -0.614 . . . . 0.0 111.397 -179.537 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.492 ' HB3' ' O ' ' A' ' 20' ' ' TYR . 0.3 OUTLIER -85.02 -24.05 28.37 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.809 -0.357 . . . . 0.0 110.971 179.276 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 1.9 pttt -160.1 76.14 0.62 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.1 0.476 . . . . 0.0 111.738 179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 147.81 -68.78 0.37 Allowed Glycine 0 CA--C 1.508 -0.358 0 C-N-CA 120.577 -0.82 . . . . 0.0 112.271 179.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.59 ' HB2' ' HB3' ' A' ' 22' ' ' LEU . 2.0 t80 -84.85 52.08 2.32 Favored 'General case' 0 C--N 1.315 -0.933 0 C-N-CA 123.008 0.523 . . . . 0.0 109.785 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 4.6 t -78.63 -40.05 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.59 -179.211 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.74 -40.42 96.69 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.409 0.623 . . . . 0.0 109.626 178.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -88.25 52.06 4.04 Favored Glycine 0 N--CA 1.447 -0.616 0 CA-C-N 115.274 -0.876 . . . . 0.0 112.043 179.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . . . . . . . . . . . -65.69 124.49 22.53 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.54 ' CA ' ' HG3' ' A' ' 35' ' ' GLU . . . 176.92 -54.23 0.1 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 119.603 -1.284 . . . . 0.0 113.637 -179.106 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.748 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 13.0 Cg_exo -72.26 -49.88 0.27 Allowed 'Trans proline' 0 C--N 1.345 0.375 0 C-N-CA 122.406 2.071 . . . . 0.0 112.284 -179.112 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.677 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -86.04 28.12 5.22 Favored Glycine 0 N--CA 1.45 -0.422 0 CA-C-N 115.819 -0.628 . . . . 0.0 113.774 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HG3' ' CA ' ' A' ' 32' ' ' GLY . 3.1 mt-10 -88.04 -26.22 22.68 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.387 0.613 . . . . 0.0 110.241 179.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -84.3 147.86 23.7 Favored Glycine 0 N--CA 1.446 -0.646 0 CA-C-N 115.274 -0.875 . . . . 0.0 112.301 179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 81.2 Cg_endo -94.79 -155.13 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 123.062 2.508 . . . . 0.0 112.833 -179.425 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.628 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -88.82 85.94 6.86 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.524 179.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -130.29 21.93 5.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.46 0.648 . . . . 0.0 110.333 -179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.425 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 1.5 m-20 -125.58 159.35 61.1 Favored Pre-proline 0 N--CA 1.446 -0.635 0 CA-C-N 115.283 -0.871 . . . . 0.0 110.29 -179.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.425 ' C ' ' HG ' ' A' ' 42' ' ' LEU . 61.2 Cg_endo -81.32 47.2 2.47 Favored 'Trans proline' 0 N--CA 1.458 -0.603 0 C-N-CA 123.291 2.661 . . . . 0.0 111.576 179.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER -177.94 -30.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.018 -0.992 . . . . 0.0 109.515 179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.429 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -57.25 -62.11 2.0 Allowed 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.735 179.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.628 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 44.4 tt0 -55.8 -30.84 62.0 Favored 'General case' 0 CA--C 1.521 -0.152 0 CA-C-N 115.488 -0.778 . . . . 0.0 110.852 179.851 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.56 -51.49 28.13 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.46 -0.791 . . . . 0.0 111.999 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . . . . . . . . . 19.1 ttm -67.9 -41.83 82.11 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 111.782 0.289 . . . . 0.0 111.782 -178.731 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 6.5 mtp180 -61.77 -35.18 77.4 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.89 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.46 -41.31 27.84 Favored 'General case' 0 CA--C 1.515 -0.383 0 C-N-CA 120.899 -0.32 . . . . 0.0 110.614 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.791 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.49 -54.25 48.74 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 179.145 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.505 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -52.72 -47.24 58.76 Favored Glycine 0 C--O 1.219 -0.784 0 CA-C-N 115.213 -0.903 . . . . 0.0 112.441 179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -59.43 -46.83 87.63 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.412 ' OE2' ' HD2' ' A' ' 56' ' ' ARG . 0.0 OUTLIER -62.95 -45.2 93.6 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.841 0.353 . . . . 0.0 110.743 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.858 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.2 OUTLIER -72.57 -33.0 66.46 Favored 'General case' 0 C--O 1.218 -0.593 0 C-N-CA 120.988 -0.285 . . . . 0.0 111.143 179.998 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -64.87 -26.7 68.44 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.441 0.639 . . . . 0.0 109.706 179.343 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.4 m -87.43 -29.21 21.62 Favored 'General case' 0 CA--C 1.537 0.471 0 CA-C-N 115.55 -0.75 . . . . 0.0 111.479 179.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.412 ' HD2' ' OE2' ' A' ' 52' ' ' GLU . 6.5 mtp180 -91.68 -46.34 7.97 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-O 120.864 0.364 . . . . 0.0 111.69 -179.307 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -85.16 86.68 7.36 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 123.19 0.596 . . . . 0.0 110.207 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.4 mtp180 -68.52 -23.45 64.54 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.535 -179.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 1.1 ttm180 -86.06 65.97 9.35 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.993 0.425 . . . . 0.0 110.005 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -120.72 -38.12 2.9 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.507 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.563 ' HA ' HD22 ' A' ' 64' ' ' LEU . 42.1 m-85 -91.15 -3.4 57.08 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.445 -178.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -71.51 -47.47 55.11 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.313 -179.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.449 ' OD2' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -59.84 -32.11 70.36 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.926 -0.579 . . . . 0.0 111.469 -179.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.838 ' HG ' ' HA ' ' A' ' 106' ' ' LEU . 4.8 mp -56.84 -44.89 82.54 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.589 179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.658 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -80.46 -42.2 23.04 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 114.948 -1.023 . . . . 0.0 110.523 179.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.512 ' HB1' ' HB3' ' A' ' 182' ' ' ALA . . . -50.6 -41.82 55.13 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.258 179.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.683 ' HG2' ' HD3' ' A' ' 78' ' ' ARG . 27.8 mt-30 -79.31 -53.47 6.91 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.518 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -82.37 13.1 3.79 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 113.927 1.084 . . . . 0.0 113.927 -176.708 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.658 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.6 -25.87 41.38 Favored 'General case' 0 C--N 1.325 -0.47 0 C-N-CA 120.492 -0.483 . . . . 0.0 110.458 179.449 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -71.92 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.037 179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -160.04 151.66 16.52 Favored Pre-proline 0 C--O 1.237 0.417 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.387 -179.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -80.79 -177.52 3.8 Favored 'Trans proline' 0 N--CA 1.459 -0.558 0 C-N-CA 123.065 2.51 . . . . 0.0 111.599 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.721 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 89.27 -71.5 2.32 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.484 -0.865 . . . . 0.0 112.972 179.441 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.61 45.13 0.18 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.226 0.536 . . . . 0.0 112.026 -179.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -99.17 -21.1 16.29 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.744 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.682 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.5 pt20 -63.77 -40.25 96.24 Favored 'General case' 0 CA--C 1.515 -0.394 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.795 -179.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.447 ' O ' ' HG2' ' A' ' 81' ' ' GLN . 18.2 mp0 -63.79 -44.4 93.44 Favored 'General case' 0 C--N 1.327 -0.41 0 O-C-N 123.176 0.297 . . . . 0.0 111.104 179.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.683 ' HD3' ' HG2' ' A' ' 67' ' ' GLN . 42.8 mtt180 -65.52 -38.21 89.0 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.04 0.448 . . . . 0.0 110.033 179.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.43 ' O ' HG22 ' A' ' 82' ' ' VAL . 5.0 t80 -66.17 -51.25 59.55 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.421 179.276 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.5 p -56.66 -35.39 68.34 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 121.108 -0.237 . . . . 0.0 111.447 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . 0.447 ' HG2' ' O ' ' A' ' 77' ' ' GLN . 38.4 mm-40 -59.88 -54.66 43.56 Favored 'General case' 0 CA--C 1.52 -0.202 0 CA-C-O 120.942 0.401 . . . . 0.0 110.822 179.448 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.832 HG11 HD22 ' A' ' 180' ' ' LEU . 9.9 m -66.89 -32.15 56.7 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.413 0 CA-C-N 115.96 -0.563 . . . . 0.0 111.097 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 29.9 m -66.2 -46.8 76.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.755 179.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.575 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 1.0 OUTLIER -67.2 -35.62 79.99 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.907 0.384 . . . . 0.0 110.323 179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -70.49 -27.03 63.89 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.259 179.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -80.39 -28.15 37.98 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.694 179.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 83.1 t80 -95.24 -6.4 41.57 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.603 -179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -43.07 -50.18 6.09 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-N 115.737 -0.665 . . . . 0.0 112.429 -179.208 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -164.56 66.35 0.22 Allowed Glycine 0 N--CA 1.444 -0.774 0 C-N-CA 119.84 -1.171 . . . . 0.0 113.4 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.471 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 150.48 62.05 0.01 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 119.665 -1.255 . . . . 0.0 114.677 178.616 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.526 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 13.5 Cg_endo -81.74 41.66 1.18 Allowed 'Trans proline' 0 N--CA 1.459 -0.504 0 C-N-CA 122.49 2.127 . . . . 0.0 111.582 177.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.792 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.2 t-20 -66.71 164.3 17.28 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.474 -179.026 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.453 ' O ' HG23 ' A' ' 97' ' ' VAL . 20.4 m95 -53.88 -29.15 40.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.169 -179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.665 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -64.84 -36.05 92.64 Favored Glycine 0 N--CA 1.448 -0.508 0 N-CA-C 111.176 -0.769 . . . . 0.0 111.176 178.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.721 HH11 ' HB2' ' A' ' 174' ' ' LEU . 2.3 mmp_? -87.23 -27.18 23.12 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.56 -0.32 . . . . 0.0 110.447 178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.927 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.3 OUTLIER -55.93 -30.55 61.83 Favored 'General case' 0 C--O 1.236 0.362 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.941 179.388 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.858 HG11 ' HB2' ' A' ' 53' ' ' PHE . 18.0 t -63.84 -55.04 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 CA-C-N 115.181 -0.918 . . . . 0.0 109.525 178.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.22 -29.74 70.6 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.444 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.927 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 7.8 m-85 -57.01 -59.87 4.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 CA-C-O 121.094 0.474 . . . . 0.0 110.354 179.517 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.579 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.1 m-85 -72.88 -37.91 67.15 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.684 -0.689 . . . . 0.0 111.348 -179.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.16 -38.76 78.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.303 -179.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.489 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -59.27 -46.17 89.24 Favored 'General case' 0 C--O 1.231 0.119 0 C-N-CA 121.04 -0.264 . . . . 0.0 111.379 -179.809 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -78.97 -40.32 17.3 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.183 -1.008 . . . . 0.0 113.064 -179.788 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -60.37 -43.92 96.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 117.038 0.419 . . . . 0.0 110.862 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . . . . . . . . . . . -68.06 -42.37 80.58 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 178.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.838 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.3 OUTLIER -57.99 -45.45 86.77 Favored 'General case' 0 CA--C 1.52 -0.184 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.645 179.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.689 ' HB3' HD21 ' A' ' 22' ' ' LEU . 88.6 m -59.55 -41.73 90.75 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.285 -0.871 . . . . 0.0 111.151 179.779 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -59.33 -36.74 76.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.968 0.413 . . . . 0.0 110.825 179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.585 ' HA ' ' ND2' ' A' ' 112' ' ' ASN . 0.0 OUTLIER -78.27 -24.25 46.88 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.767 -179.962 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.63 -24.62 41.77 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 120.541 -0.464 . . . . 0.0 110.953 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.611 HG23 ' O ' ' A' ' 107' ' ' CYS . 50.6 t -72.07 -37.57 60.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.976 179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.585 ' ND2' ' HA ' ' A' ' 109' ' ' GLU . 11.7 p30 -85.78 -0.06 54.25 Favored 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 120.853 -0.339 . . . . 0.0 111.335 -179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 14.3 mtmt -123.66 -173.53 2.76 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.903 0.382 . . . . 0.0 110.935 179.669 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -84.8 53.31 2.67 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.81 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.518 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -138.23 48.0 1.98 Allowed 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.959 0.409 . . . . 0.0 110.484 -179.382 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.484 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -60.24 -54.99 49.78 Favored Pre-proline 0 CA--C 1.539 0.523 0 CA-C-N 115.821 -0.627 . . . . 0.0 112.52 -179.513 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.484 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 16.9 Cg_exo -68.71 -12.81 35.6 Favored 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 122.147 1.898 . . . . 0.0 112.96 -179.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.721 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.5 mp -78.77 -27.97 44.66 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.183 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -58.56 -57.44 10.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.806 0.336 . . . . 0.0 111.365 -179.871 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.21 -29.65 71.78 Favored Glycine 0 C--N 1.331 0.28 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.265 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.441 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.4 mm-40 -67.68 -52.67 35.13 Favored 'General case' 0 C--O 1.218 -0.557 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 178.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 118' ' ' LEU . 63.8 t -56.34 -34.57 40.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 121.283 0.563 . . . . 0.0 109.813 178.614 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -62.62 -47.89 81.76 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.21 -0.904 . . . . 0.0 110.342 178.579 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.667 ' HA ' HG12 ' A' ' 127' ' ' VAL . 21.3 pt-20 -74.48 -37.49 63.17 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.84 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.682 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.5 m0 -54.68 -36.75 64.96 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 108.42 -0.956 . . . . 0.0 108.42 178.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.562 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 1.6 mtm -73.95 -57.57 3.88 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 114.669 -1.15 . . . . 0.0 111.518 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.667 HG12 ' HA ' ' A' ' 124' ' ' GLU . 1.5 p -60.36 -32.25 50.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 112.442 0.534 . . . . 0.0 112.442 -178.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -71.25 -47.35 57.62 Favored 'General case' 0 CA--C 1.518 -0.277 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.038 179.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.575 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 24.7 t80 -59.72 -37.21 78.27 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.708 0.765 . . . . 0.0 110.161 179.052 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.004 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -71.89 -52.74 15.82 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.897 -1.047 . . . . 0.0 111.85 -179.08 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -58.73 -35.2 72.31 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.789 0.328 . . . . 0.0 111.784 -179.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 6.5 m -79.54 -43.25 23.42 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 113.728 1.01 . . . . 0.0 113.728 -178.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.42 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.4 OUTLIER -123.64 -38.13 2.56 Favored 'General case' 0 N--CA 1.468 0.441 0 N-CA-C 114.62 1.341 . . . . 0.0 114.62 -177.31 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.004 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.1 mm? -64.04 -49.1 73.7 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 118.358 0.526 . . . . 0.0 111.571 -178.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -53.28 -33.32 52.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 CA-C-N 116.561 -0.291 . . . . 0.0 111.111 179.518 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.3 t70 -63.31 -56.26 17.95 Favored 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.792 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 54.6 t90 -56.59 -46.59 80.73 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.126 0.488 . . . . 0.0 109.863 178.306 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG13 ' HE3' ' A' ' 137' ' ' TRP . 15.1 mt -58.88 -47.02 90.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.672 -0.694 . . . . 0.0 112.251 -179.007 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 45.5 m-70 -68.06 -31.66 71.46 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.913 -0.315 . . . . 0.0 111.64 -179.124 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 19.2 m -90.14 -4.83 57.06 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 112.382 0.512 . . . . 0.0 112.382 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.52 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -98.68 -51.67 3.84 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.5 0.555 . . . . 0.0 112.5 -178.857 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.62 -10.66 0.02 OUTLIER Glycine 0 CA--C 1.505 -0.58 0 C-N-CA 120.565 -0.826 . . . . 0.0 111.475 -179.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 86.84 166.55 42.66 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.684 -0.769 . . . . 0.0 113.101 179.397 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.444 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.5 m95 -60.93 -27.79 68.48 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.591 -0.522 . . . . 0.0 109.591 179.233 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -63.99 -37.18 86.48 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 115.267 -0.879 . . . . 0.0 110.814 178.85 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -62.76 -41.83 99.4 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 108.66 -0.866 . . . . 0.0 108.66 178.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . . . . . . . . . 14.4 t80 -65.58 -34.68 78.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.78 -1.1 . . . . 0.0 110.517 178.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -67.04 -28.15 67.98 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.738 0.304 . . . . 0.0 111.07 179.436 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.53 -27.41 25.6 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.376 0.608 . . . . 0.0 109.811 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.662 HD22 ' HB3' ' A' ' 163' ' ' ARG . 2.2 mt -74.24 -38.68 63.43 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.432 -0.804 . . . . 0.0 111.353 -179.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.565 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 6.2 m-85 -122.29 26.67 8.33 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.552 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.454 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -117.9 -141.3 6.75 Favored Glycine 0 N--CA 1.443 -0.847 0 C-N-CA 119.855 -1.164 . . . . 0.0 112.914 -179.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -77.8 -41.79 36.05 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.512 -0.344 . . . . 0.0 111.299 -179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.48 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -83.49 41.55 2.94 Favored Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.941 -0.647 . . . . 0.0 112.479 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -85.24 72.85 10.68 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 121.051 0.453 . . . . 0.0 110.268 179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.568 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -66.83 170.09 7.08 Favored 'General case' 0 N--CA 1.45 -0.443 0 CA-C-N 115.49 -0.777 . . . . 0.0 111.006 -179.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . 0.71 ' HA ' ' HD2' ' A' ' 160' ' ' ARG . 5.6 mm-40 -52.97 -37.93 61.66 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.746 -179.523 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.568 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 3.9 mp0 -63.64 -47.63 80.54 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.558 -0.292 . . . . 0.0 110.437 179.739 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.44 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -65.34 -37.05 85.9 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.922 179.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.71 ' HD2' ' HA ' ' A' ' 157' ' ' GLU . 77.5 mtt180 -58.18 -58.53 8.07 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.763 179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 157' ' ' GLU . 3.6 ptt180 -67.4 -28.77 68.2 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.464 ' HB2' ' O ' ' A' ' 158' ' ' GLU . 0.8 OUTLIER -67.22 -49.77 63.25 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.489 -179.399 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.662 ' HB3' HD22 ' A' ' 150' ' ' LEU . 0.9 OUTLIER -64.79 -37.98 89.42 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.699 -0.401 . . . . 0.0 111.142 -179.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.576 ' HA ' ' NE1' ' A' ' 167' ' ' TRP . 5.5 mt-10 -69.08 -47.01 66.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.632 0.253 . . . . 0.0 110.442 179.247 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.84 -24.51 72.92 Favored Glycine 0 N--CA 1.45 -0.395 0 C-N-CA 120.246 -0.978 . . . . 0.0 111.169 178.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.691 ' O ' HG22 ' A' ' 170' ' ' VAL . 2.0 m-20 -66.04 -60.86 2.41 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.404 -0.398 . . . . 0.0 110.977 179.748 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.697 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 14.3 p-90 -61.72 -26.32 67.98 Favored 'General case' 0 CA--C 1.52 -0.201 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.742 -179.009 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -60.48 -40.94 93.1 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.241 0.543 . . . . 0.0 110.228 179.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 1.1 m -86.87 -24.44 24.9 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.696 -0.684 . . . . 0.0 112.834 -179.729 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.776 HG11 ' HB2' ' A' ' 92' ' ' ASN . 5.3 m -97.07 -38.93 8.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.499 0 N-CA-C 114.333 1.235 . . . . 0.0 114.333 -177.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -73.83 -26.18 60.46 Favored 'General case' 0 C--N 1.321 -0.659 0 O-C-N 121.625 -0.672 . . . . 0.0 111.396 -178.428 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.747 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -86.28 -25.71 25.35 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.43 179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.765 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -73.7 -22.08 18.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.367 0.604 . . . . 0.0 109.763 178.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.765 ' HG ' HG13 ' A' ' 173' ' ' VAL . 2.9 mt -120.33 40.42 3.48 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.178 178.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.747 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -62.77 -22.27 66.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.259 -0.882 . . . . 0.0 111.806 -179.885 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -83.36 9.46 61.33 Favored Glycine 0 CA--C 1.52 0.401 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.714 -179.08 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -75.28 -2.59 28.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.875 0.338 . . . . 0.0 111.744 179.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.3 t -85.11 69.8 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.242 0.544 . . . . 0.0 110.395 179.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.469 ' HB3' HG12 ' A' ' 82' ' ' VAL . . . -81.1 -9.41 59.82 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.055 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.832 HD22 HG11 ' A' ' 82' ' ' VAL . 0.0 OUTLIER -92.98 36.03 1.04 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.0 0.429 . . . . 0.0 111.319 -179.299 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -84.37 76.23 2.26 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.541 -0.837 . . . . 0.0 112.168 179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.512 ' HB3' ' HB1' ' A' ' 66' ' ' ALA . . . -117.48 150.83 38.28 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.794 0.297 . . . . 0.0 110.555 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 1.1 mt . . . . . 0 C--O 1.25 1.098 0 CA-C-O 118.194 -0.908 . . . . 0.0 110.031 -179.971 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.7 0 N-CA-C 111.986 -0.446 . . . . 0.0 111.986 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -63.89 136.15 51.59 Favored 'Trans proline' 0 C--O 1.235 0.331 0 C-N-CA 122.83 2.353 . . . . 0.0 112.263 -179.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 5.9 mt -110.33 160.24 16.73 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.457 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -175.97 118.73 0.67 Allowed Glycine 0 N--CA 1.448 -0.547 0 N-CA-C 111.444 -0.663 . . . . 0.0 111.444 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . 0.534 ' O ' ' HB2' ' A' ' 1' ' ' MET . 0.9 OUTLIER -98.25 85.21 3.39 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 120.488 0.185 . . . . 0.0 110.763 -179.54 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.534 ' HB2' ' O ' ' A' ' 0' ' ' SER . 25.8 mtm 76.65 123.92 0.04 OUTLIER 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.108 0.88 . . . . 0.0 111.491 -179.761 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -144.26 132.24 21.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.964 179.544 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.454 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.0 p -99.54 138.77 20.52 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-O 120.941 0.401 . . . . 0.0 110.907 -179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.454 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 4.0 Cg_endo -85.59 25.46 0.69 Allowed 'Trans proline' 0 N--CA 1.457 -0.653 0 C-N-CA 123.178 2.585 . . . . 0.0 112.219 -179.807 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -111.35 -10.75 14.21 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.948 -179.777 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.65 127.68 46.96 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.562 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.493 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -134.41 132.97 21.18 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.559 179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.493 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 4.8 Cg_exo -74.38 80.9 2.15 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 123.144 2.563 . . . . 0.0 111.739 -179.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -74.33 -173.95 1.85 Allowed 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.704 -179.691 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -56.57 -33.83 66.54 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 112.241 0.46 . . . . 0.0 112.241 -179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 4.7 ptm180 -66.36 -33.37 75.56 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.789 0.328 . . . . 0.0 110.393 179.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.83 -47.47 18.79 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.454 HD11 ' SD ' ' A' ' 46' ' ' MET . 1.2 tp -59.4 -41.26 89.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.682 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.679 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -65.64 -42.55 93.03 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 C-N-CA 120.838 -0.345 . . . . 0.0 110.284 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.07 -29.73 67.91 Favored 'General case' 0 N--CA 1.456 -0.171 0 CA-C-O 120.987 0.422 . . . . 0.0 110.379 178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -71.38 -57.28 4.59 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.446 -0.797 . . . . 0.0 111.101 -179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.0 t80 -57.63 -52.32 65.91 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.273 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.509 ' O ' HD13 ' A' ' 22' ' ' LEU . 60.6 t -63.49 -42.68 97.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 N-CA-C 109.722 -0.473 . . . . 0.0 109.722 179.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.697 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -60.2 -46.12 94.81 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.806 -0.711 . . . . 0.0 112.013 178.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.782 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 63.5 t80 -64.38 -42.43 96.16 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.979 0.419 . . . . 0.0 110.552 179.814 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.496 ' HA ' ' HD3' ' A' ' 21' ' ' LYS . 0.0 OUTLIER -65.27 -41.34 94.34 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.542 179.893 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.604 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.1 mp -71.7 -43.49 65.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.957 -0.565 . . . . 0.0 109.773 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.685 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 0.1 OUTLIER -62.99 -20.04 64.91 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.113 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -78.93 -42.42 27.04 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.693 -0.685 . . . . 0.0 110.927 179.659 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 7.1 pttt -153.95 79.93 1.13 Allowed 'General case' 0 C--O 1.233 0.194 0 CA-C-O 120.964 0.411 . . . . 0.0 111.808 -179.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 155.25 -65.79 0.32 Allowed Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 120.488 -0.863 . . . . 0.0 112.88 179.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.421 ' HD1' ' HA ' ' A' ' 27' ' ' TYR . 0.5 OUTLIER -99.35 60.3 1.16 Allowed 'General case' 0 C--N 1.316 -0.856 0 CA-C-O 121.296 0.57 . . . . 0.0 110.18 179.879 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 1.9 p -79.6 -24.9 12.28 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.655 -0.702 . . . . 0.0 110.633 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.87 -40.97 60.66 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.608 179.056 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -87.43 59.83 4.36 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.214 -0.903 . . . . 0.0 111.357 178.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.685 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -69.96 116.01 9.84 Favored 'General case' 0 C--N 1.318 -0.796 0 CA-C-N 115.366 -0.417 . . . . 0.0 110.474 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.495 ' H ' ' HD2' ' A' ' 23' ' ' ARG . . . 173.71 -57.7 0.14 Allowed Glycine 0 C--O 1.226 -0.405 0 C-N-CA 119.759 -1.21 . . . . 0.0 113.501 -179.357 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.697 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 52.0 Cg_exo -57.46 -46.04 30.25 Favored 'Trans proline' 0 C--N 1.348 0.516 0 C-N-CA 122.337 2.024 . . . . 0.0 111.698 -179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.782 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -95.79 31.13 7.52 Favored Glycine 0 N--CA 1.446 -0.683 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.574 179.298 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -80.97 -23.75 38.54 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.04 0.448 . . . . 0.0 109.879 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -90.44 135.67 13.01 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.994 -0.622 . . . . 0.0 112.534 179.657 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.425 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 86.3 Cg_endo -89.31 -138.64 0.02 OUTLIER 'Trans proline' 0 N--CA 1.458 -0.601 0 C-N-CA 122.965 2.443 . . . . 0.0 113.121 -179.342 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.555 ' HB1' ' HB2' ' A' ' 44' ' ' GLN . . . -96.75 94.33 7.22 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.736 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -139.0 21.67 2.63 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.943 0.402 . . . . 0.0 110.846 -179.377 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.519 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 6.2 m-20 -132.83 159.73 71.42 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.761 -179.25 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.497 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.4 Cg_endo -79.96 51.87 4.07 Favored 'Trans proline' 0 N--CA 1.459 -0.511 0 C-N-CA 123.389 2.726 . . . . 0.0 111.685 178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.421 ' HB3' ' HB3' ' A' ' 144' ' ' TRP . 0.2 OUTLIER 179.16 -33.44 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 114.906 -1.043 . . . . 0.0 109.058 179.556 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -58.95 -59.82 4.85 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.094 -0.957 . . . . 0.0 110.907 179.943 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.555 ' HB2' ' HB1' ' A' ' 38' ' ' ALA . 29.9 tt0 -58.21 -29.1 65.43 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.644 -0.707 . . . . 0.0 110.693 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.932 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -70.83 -51.44 26.67 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.686 -0.688 . . . . 0.0 111.308 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.454 ' SD ' HD11 ' A' ' 13' ' ' LEU . 4.0 ttm -64.98 -36.58 84.87 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.392 -0.367 . . . . 0.0 111.524 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -61.71 -38.26 87.2 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.688 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.77 -40.9 31.94 Favored 'General case' 0 CA--C 1.512 -0.49 0 CA-C-O 120.76 0.314 . . . . 0.0 110.322 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.74 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.05 -57.39 13.3 Favored 'General case' 0 N--CA 1.45 -0.428 0 CA-C-N 115.855 -0.612 . . . . 0.0 109.369 178.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.64 -47.21 37.82 Favored Glycine 0 C--O 1.218 -0.885 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.598 178.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -60.05 -48.94 79.64 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 117.016 0.408 . . . . 0.0 111.22 179.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.39 -43.25 92.97 Favored 'General case' 0 C--O 1.235 0.328 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.187 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.778 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -72.46 -38.6 68.2 Favored 'General case' 0 C--O 1.219 -0.503 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.624 179.494 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -59.88 -22.59 62.53 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.739 0.781 . . . . 0.0 109.725 179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 23.1 m -94.91 -37.23 11.28 Favored 'General case' 0 CA--C 1.543 0.675 0 CA-C-N 115.22 -0.9 . . . . 0.0 111.672 178.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 7.4 mtt180 -84.96 -26.36 27.21 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.903 0.705 . . . . 0.0 112.903 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.453 ' HB3' HG23 ' A' ' 60' ' ' THR . 0.0 OUTLIER -86.83 98.78 11.38 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.161 0.505 . . . . 0.0 110.717 -179.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.5 mtt180 -64.18 -34.09 77.28 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.227 -0.897 . . . . 0.0 111.662 -179.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.19 93.61 4.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.125 0.488 . . . . 0.0 110.289 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . 0.453 HG23 ' HB3' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -120.1 -59.16 1.81 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.615 -0.72 . . . . 0.0 111.477 -178.81 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 1.019 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.7 m-85 -87.79 -10.51 50.73 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 112.472 0.545 . . . . 0.0 112.472 -178.632 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -66.63 -41.4 88.36 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 120.948 0.404 . . . . 0.0 111.518 -179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.459 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.9 m-20 -73.61 -15.2 61.27 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.076 0.465 . . . . 0.0 110.663 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 1.019 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.1 OUTLIER -75.99 -40.04 54.6 Favored 'General case' 0 C--N 1.32 -0.691 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 178.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.579 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -73.7 -45.54 51.62 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 114.985 -1.007 . . . . 0.0 109.747 179.041 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' CB ' ' HA2' ' A' ' 181' ' ' GLY . . . -51.89 -43.84 63.5 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.691 179.085 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.579 HE22 HD11 ' A' ' 106' ' ' LEU . 27.6 mt-30 -68.79 -56.43 8.06 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 113.304 0.853 . . . . 0.0 113.304 -179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.554 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.5 OUTLIER -88.25 16.66 5.96 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 114.039 1.125 . . . . 0.0 114.039 -175.853 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.579 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 0.3 OUTLIER -79.63 -24.82 41.64 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.025 179.685 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.68 -64.74 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.578 -179.704 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.419 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 1.1 t -170.02 150.88 3.82 Favored Pre-proline 0 C--O 1.238 0.47 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 -179.335 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 1.9 Cg_endo -81.83 -165.19 0.32 Allowed 'Trans proline' 0 N--CA 1.46 -0.452 0 C-N-CA 123.03 2.487 . . . . 0.0 112.083 -179.507 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 84.24 -70.73 3.1 Favored Glycine 0 CA--C 1.517 0.19 0 C-N-CA 120.674 -0.774 . . . . 0.0 113.018 179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -73.92 39.81 0.11 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-O 121.059 0.457 . . . . 0.0 112.031 -179.607 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -94.59 -23.24 17.72 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.498 -0.319 . . . . 0.0 111.087 179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.672 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 4.3 pt20 -62.81 -39.2 93.56 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 111.818 0.303 . . . . 0.0 111.818 -179.339 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 24.9 mp0 -63.07 -44.63 95.23 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.747 0.308 . . . . 0.0 110.304 179.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 4.5 mtt180 -63.34 -43.39 97.84 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.196 -0.456 . . . . 0.0 109.984 179.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -62.77 -50.94 69.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.362 179.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.8 p -56.77 -33.1 66.27 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 111.581 0.215 . . . . 0.0 111.581 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 18.9 mm-40 -62.1 -64.23 1.0 Allowed 'General case' 0 CA--C 1.517 -0.301 0 CA-C-O 120.982 0.42 . . . . 0.0 110.489 179.395 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.687 HG11 ' HG ' ' A' ' 180' ' ' LEU . 13.6 m -58.61 -32.66 46.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.702 -179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.3 m -66.02 -43.15 88.48 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.677 0.275 . . . . 0.0 110.31 179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.579 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -69.45 -36.36 76.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.244 179.446 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.415 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 3.2 mm-40 -70.33 -29.68 66.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.067 179.013 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -76.47 -34.99 58.67 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.296 179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -88.42 -5.51 58.23 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.655 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.415 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.5 OUTLIER -45.62 -46.61 14.56 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.004 -0.544 . . . . 0.0 112.118 -179.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -174.23 62.64 0.12 Allowed Glycine 0 N--CA 1.443 -0.862 0 C-N-CA 120.067 -1.063 . . . . 0.0 112.758 -179.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.591 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 163.46 53.6 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 119.711 -1.233 . . . . 0.0 114.6 179.252 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.639 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 16.9 Cg_endo -79.9 39.37 0.83 Allowed 'Trans proline' 0 C--N 1.351 0.694 0 C-N-CA 122.183 1.922 . . . . 0.0 111.555 178.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.799 ' HB2' HG11 ' A' ' 170' ' ' VAL . 2.4 t-20 -67.04 162.9 21.12 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.401 -179.168 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.486 ' CE3' ' HB2' ' A' ' 147' ' ' PHE . 23.1 m95 -55.98 -27.48 52.96 Favored 'General case' 0 N--CA 1.463 0.197 0 O-C-N 123.299 0.375 . . . . 0.0 111.177 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -66.62 -37.31 92.41 Favored Glycine 0 C--N 1.334 0.462 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 178.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.415 HH11 ' HD3' ' A' ' 95' ' ' ARG . 1.3 tpt180 -86.29 -26.63 24.85 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.197 -0.501 . . . . 0.0 110.291 178.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.78 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.99 -30.17 61.4 Favored 'General case' 0 C--O 1.237 0.408 0 CA-C-N 115.716 -0.675 . . . . 0.0 110.309 179.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.778 HG11 ' HB2' ' A' ' 53' ' ' PHE . 7.4 t -62.89 -52.81 54.79 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-N 115.315 -0.857 . . . . 0.0 109.38 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.14 -28.64 69.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.031 -0.986 . . . . 0.0 111.398 179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.78 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.1 m-85 -57.75 -57.01 14.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.028 0.442 . . . . 0.0 110.215 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.679 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 10.9 m-85 -74.97 -39.9 61.04 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.905 -0.588 . . . . 0.0 110.941 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.9 -38.85 75.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.441 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.571 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -57.15 -51.1 70.65 Favored 'General case' 0 CA--C 1.522 -0.125 0 CA-C-O 120.639 0.257 . . . . 0.0 111.211 -179.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -75.21 -38.15 40.41 Favored Glycine 0 N--CA 1.447 -0.591 0 C-N-CA 120.383 -0.913 . . . . 0.0 113.266 -179.723 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -45.11 94.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 117.174 0.487 . . . . 0.0 110.778 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.43 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.57 -38.91 81.13 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 109.389 -0.596 . . . . 0.0 109.389 178.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.769 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.09 -43.31 91.81 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 115.437 -0.801 . . . . 0.0 110.128 179.016 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.604 ' HB3' HD21 ' A' ' 22' ' ' LEU . 90.0 m -65.51 -42.92 91.52 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.092 -0.958 . . . . 0.0 111.386 179.871 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -55.75 -44.74 77.9 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.921 0.391 . . . . 0.0 111.301 -179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.506 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.3 OUTLIER -80.7 -9.54 59.79 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.81 179.988 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . . . . . . . . . 60.2 m -91.16 -23.28 20.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 120.926 0.393 . . . . 0.0 110.258 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 107' ' ' CYS . 71.9 t -74.44 -34.35 35.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.641 179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.506 HD21 ' HA ' ' A' ' 109' ' ' GLU . 24.1 p30 -85.3 0.81 50.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.841 0.353 . . . . 0.0 111.302 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -124.85 -174.81 3.12 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.55 179.676 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 7.2 mt-10 -82.99 62.31 6.47 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.053 0.454 . . . . 0.0 110.522 179.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.554 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.29 45.55 2.47 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.479 -179.343 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.672 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 25.6 mt-10 -52.12 -59.38 8.51 Favored Pre-proline 0 CA--C 1.539 0.547 0 CA-C-N 115.74 -0.664 . . . . 0.0 112.609 -179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.672 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 7.4 Cg_exo -74.26 -22.09 16.95 Favored 'Trans proline' 0 C--N 1.355 0.909 0 C-N-CA 122.134 1.889 . . . . 0.0 112.627 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.522 ' HB2' ' HB3' ' A' ' 115' ' ' MET . 3.0 mm? -64.57 -37.47 87.68 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.302 -179.287 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 115' ' ' MET . 90.4 t -57.22 -54.55 29.06 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.773 0.32 . . . . 0.0 110.913 179.776 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.56 -32.37 83.98 Favored Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.574 -0.822 . . . . 0.0 111.95 179.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.574 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.6 mt-30 -65.59 -52.22 53.74 Favored 'General case' 0 C--O 1.216 -0.67 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 118' ' ' LEU . 82.8 t -56.16 -35.14 41.1 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 178.809 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 7.6 tt0 -63.29 -47.34 82.72 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.365 178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.76 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.2 pt-20 -72.58 -38.19 67.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.998 179.744 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.672 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.9 m0 -58.1 -40.58 81.52 Favored 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.489 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 6.2 ttm -73.22 -51.28 18.31 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.663 -1.153 . . . . 0.0 111.747 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.76 HG12 ' HA ' ' A' ' 124' ' ' GLU . 3.9 p -63.23 -34.61 67.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -178.655 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.7 mt-10 -73.35 -39.5 65.14 Favored 'General case' 0 CA--C 1.522 -0.126 0 C-N-CA 120.502 -0.479 . . . . 0.0 110.677 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.579 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 12.6 t80 -66.6 -34.53 78.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-O 121.647 0.736 . . . . 0.0 110.129 178.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.972 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -77.46 -53.0 8.16 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.234 -0.894 . . . . 0.0 112.828 -178.718 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.44 -31.6 71.55 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 -177.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 5.6 m -85.46 -37.92 19.2 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 113.352 0.871 . . . . 0.0 113.352 -178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 7.8 mtt180 -119.75 -43.66 2.56 Favored 'General case' 0 N--CA 1.463 0.194 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -178.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.972 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 0.8 OUTLIER -61.49 -46.57 89.46 Favored 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 120.602 -0.439 . . . . 0.0 111.377 -178.469 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.09 62.59 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.059 179.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 4.7 t0 -63.47 -50.3 70.24 Favored 'General case' 0 CA--C 1.518 -0.279 0 N-CA-C 109.998 -0.371 . . . . 0.0 109.998 179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.693 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 51.9 t90 -59.28 -46.82 87.5 Favored 'General case' 0 N--CA 1.452 -0.371 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 177.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.498 HG13 ' HE3' ' A' ' 137' ' ' TRP . 7.6 mt -57.34 -48.44 82.56 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.995 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 53.7 m-70 -65.04 -32.06 73.59 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.581 0.229 . . . . 0.0 111.377 -179.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 5.2 m -82.43 -17.48 45.22 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 112.125 0.417 . . . . 0.0 112.125 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 2.0 t -85.45 -54.74 4.39 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.845 0.355 . . . . 0.0 111.497 -179.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 143' ' ' GLY . . . -177.37 -19.31 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.617 0 N-CA-C 110.628 -0.989 . . . . 0.0 110.628 -179.355 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.4 ' H ' ' H ' ' A' ' 142' ' ' GLY . . . 100.41 170.93 29.35 Favored Glycine 0 N--CA 1.441 -1.007 0 C-N-CA 120.845 -0.693 . . . . 0.0 112.394 179.574 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.425 ' HZ3' ' CE ' ' A' ' 46' ' ' MET . 96.1 m95 -59.41 -30.23 68.31 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 179.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.08 -37.31 84.54 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.815 178.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -62.27 -41.55 98.57 Favored 'General case' 0 N--CA 1.463 0.182 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.486 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.5 t80 -64.88 -38.23 90.26 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.485 178.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.932 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -63.1 -28.12 69.86 Favored 'General case' 0 C--O 1.224 -0.252 0 CA-C-O 120.714 0.292 . . . . 0.0 111.501 179.689 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.19 -26.75 26.57 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.504 0.668 . . . . 0.0 109.71 178.853 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.522 HD22 ' HB3' ' A' ' 163' ' ' ARG . 0.4 OUTLIER -75.46 -39.88 58.17 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.384 -0.825 . . . . 0.0 111.336 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -123.45 28.11 7.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.972 -178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.469 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -119.2 -141.44 6.51 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.738 -1.22 . . . . 0.0 113.239 -179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.52 -40.0 44.2 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.862 0.363 . . . . 0.0 111.42 -179.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.44 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.92 46.13 3.58 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.966 -0.635 . . . . 0.0 112.157 179.782 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.57 72.32 10.67 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.227 0.537 . . . . 0.0 110.631 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.67 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.4 OUTLIER -65.28 168.54 6.83 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.185 -179.679 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -54.84 -34.77 63.24 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.833 -0.621 . . . . 0.0 112.015 -179.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.67 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.1 mm-40 -73.17 -32.72 65.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.718 0.294 . . . . 0.0 111.187 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.477 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -74.6 -42.83 57.96 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 120.911 0.386 . . . . 0.0 111.386 -179.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 20.9 ptt180 -66.68 -39.54 88.17 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.219 -179.455 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 18.8 ptt180 -72.01 -28.53 63.45 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.896 0.379 . . . . 0.0 110.581 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 2.1 mt -74.68 -47.07 33.8 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.403 -179.934 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.522 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.1 ptt180 -64.27 -37.57 87.96 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.737 -0.385 . . . . 0.0 111.7 -179.299 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.466 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 2.4 tt0 -68.24 -45.81 72.21 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-O 120.93 0.395 . . . . 0.0 110.109 179.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.91 -25.82 75.05 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.272 -0.966 . . . . 0.0 111.552 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.615 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.9 m-20 -66.1 -58.86 4.51 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.656 0.265 . . . . 0.0 111.102 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.684 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 17.3 p-90 -61.71 -27.52 68.76 Favored 'General case' 0 C--O 1.224 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.067 -179.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.1 -43.9 74.42 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.032 0.444 . . . . 0.0 110.754 179.14 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' VAL . 0.7 OUTLIER -86.84 -33.61 19.76 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 112.789 0.663 . . . . 0.0 112.789 179.992 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.799 HG11 ' HB2' ' A' ' 92' ' ' ASN . 17.0 m -85.05 -26.14 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.871 1.063 . . . . 0.0 113.871 -177.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 10.6 ttp180 -79.07 -30.46 43.97 Favored 'General case' 0 C--N 1.317 -0.836 0 O-C-N 121.753 -0.592 . . . . 0.0 110.074 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.821 ' HA ' HG23 ' A' ' 175' ' ' THR . 1.5 m -89.21 -27.98 20.27 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.448 -179.791 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.777 HG13 ' HG ' ' A' ' 174' ' ' LEU . 4.2 p -66.34 -27.38 40.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.161 0.505 . . . . 0.0 110.729 179.576 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.777 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -120.24 44.35 2.46 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.21 0.529 . . . . 0.0 110.242 178.614 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.821 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.2 OUTLIER -65.42 -29.05 69.7 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.901 -179.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.97 9.93 43.18 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 114.397 0.519 . . . . 0.0 114.397 -178.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -76.33 11.12 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 117.134 0.467 . . . . 0.0 111.719 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.6 t -85.94 70.6 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.242 0.544 . . . . 0.0 110.372 179.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -104.19 13.55 32.09 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.863 -0.608 . . . . 0.0 111.087 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.687 ' HG ' HG11 ' A' ' 82' ' ' VAL . 18.4 mt -99.52 -51.55 3.74 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.004 0.43 . . . . 0.0 110.154 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.585 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -72.07 96.68 0.71 Allowed Glycine 0 N--CA 1.446 -0.692 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.794 179.642 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.493 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -92.57 152.43 19.61 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.912 0.386 . . . . 0.0 111.088 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.243 0.754 0 CA-C-N 115.768 -0.651 . . . . 0.0 109.4 179.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.715 0 N-CA-C 111.655 -0.578 . . . . 0.0 111.655 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.19 134.24 58.06 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 122.876 2.384 . . . . 0.0 111.634 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.464 ' HA ' HD13 ' A' ' -2' ' ' LEU . 0.6 OUTLIER 72.51 -55.36 0.67 Allowed 'General case' 0 N--CA 1.468 0.427 0 O-C-N 123.978 0.799 . . . . 0.0 111.38 -179.32 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -176.35 -131.99 1.56 Allowed Glycine 0 N--CA 1.446 -0.634 0 C-N-CA 121.081 -0.581 . . . . 0.0 112.134 179.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 33.9 m -124.31 173.85 8.11 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -131.68 125.1 31.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.018 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -100.24 144.86 28.76 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.615 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.476 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.2 p -105.5 139.5 20.24 Favored Pre-proline 0 C--N 1.323 -0.579 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.636 -179.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.476 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 3.6 Cg_exo -77.26 1.92 8.22 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.968 2.445 . . . . 0.0 112.355 -179.427 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -158.04 133.98 9.22 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.72 -0.673 . . . . 0.0 110.184 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.4 m -148.35 172.12 14.91 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 179.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.436 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -124.47 138.08 30.41 Favored Pre-proline 0 C--N 1.324 -0.513 0 CA-C-O 120.616 0.246 . . . . 0.0 111.029 -179.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.436 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 5.1 Cg_exo -77.58 70.4 6.9 Favored 'Trans proline' 0 N--CA 1.462 -0.324 0 C-N-CA 123.201 2.6 . . . . 0.0 111.571 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -77.48 -168.35 1.14 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.26 -179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -52.65 -38.27 60.05 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.29 -0.868 . . . . 0.0 111.909 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -62.35 -38.85 91.09 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.83 0.347 . . . . 0.0 110.664 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -74.93 -35.09 62.18 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.133 0.492 . . . . 0.0 109.977 179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.496 ' HB2' HD13 ' A' ' 42' ' ' LEU . 1.5 tp -72.32 -42.07 65.83 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.138 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.713 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 7.9 p -65.87 -36.0 76.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 179.481 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -72.8 -23.66 60.82 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.253 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.34 -65.74 0.85 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.02 179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.433 ' HZ ' ' HA3' ' A' ' 50' ' ' GLY . 4.1 t80 -53.41 -51.57 62.16 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.933 -179.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.515 ' O ' HD13 ' A' ' 22' ' ' LEU . 97.4 t -69.5 -43.67 80.47 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.37 -180.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.42 -50.86 62.65 Favored Glycine 0 N--CA 1.449 -0.45 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.23 179.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.739 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 4.6 t80 -58.23 -49.66 76.3 Favored 'General case' 0 C--N 1.322 -0.629 0 C-N-CA 122.976 0.51 . . . . 0.0 111.33 -179.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -62.41 -35.98 80.93 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.546 -179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.722 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.0 mp -76.33 -48.36 20.3 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.532 ' HD2' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -63.92 -18.4 64.18 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.111 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.489 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 0.0 OUTLIER -84.63 -14.25 49.2 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.5 179.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 31.7 tttp -146.26 -52.7 0.24 Allowed 'General case' 0 CA--C 1.531 0.249 0 N-CA-C 114.083 1.142 . . . . 0.0 114.083 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . -89.97 -68.77 1.22 Allowed Glycine 0 C--O 1.229 -0.167 0 C-N-CA 120.626 -0.797 . . . . 0.0 113.741 -178.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.527 ' O ' ' HA ' ' A' ' 23' ' ' ARG . 1.1 t80 -82.61 53.15 2.26 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.265 0.555 . . . . 0.0 110.529 -179.605 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.8 p -78.94 -30.54 14.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-N 115.47 -0.786 . . . . 0.0 110.632 -179.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -68.76 -42.51 77.37 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.213 -0.662 . . . . 0.0 109.213 178.809 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.35 59.24 4.86 Favored Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.258 -0.883 . . . . 0.0 111.834 178.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.532 ' HA ' ' HD2' ' A' ' 23' ' ' ARG . . . -63.21 117.9 7.2 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.538 -0.331 . . . . 0.0 110.632 -179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' A' ' 35' ' ' GLU . . . 175.57 -49.38 0.12 Allowed Glycine 0 CA--C 1.521 0.435 0 C-N-CA 120.267 -0.968 . . . . 0.0 113.725 -179.027 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.52 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 21.1 Cg_exo -67.15 -50.0 1.17 Allowed 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 121.894 1.729 . . . . 0.0 111.548 -179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.739 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -93.14 34.0 4.8 Favored Glycine 0 N--CA 1.447 -0.599 0 CA-C-N 115.663 -0.698 . . . . 0.0 112.84 179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.427 ' OE1' ' HA2' ' A' ' 32' ' ' GLY . 14.6 pt-20 -88.76 -13.48 39.4 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.134 0.492 . . . . 0.0 110.44 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -89.98 144.27 17.54 Favored Glycine 0 N--CA 1.447 -0.604 0 CA-C-N 115.749 -0.659 . . . . 0.0 111.847 179.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -92.87 -175.93 0.58 Allowed 'Trans proline' 0 N--CA 1.452 -0.948 0 C-N-CA 122.832 2.355 . . . . 0.0 113.137 -179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.765 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -82.49 80.95 8.5 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.065 179.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -123.39 -11.55 7.88 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.96 0.41 . . . . 0.0 111.949 -178.388 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.442 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.1 m-20 -86.45 160.35 51.17 Favored Pre-proline 0 C--N 1.32 -0.709 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.903 -178.851 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.454 ' HA ' HG21 ' A' ' 148' ' ' THR . 30.2 Cg_endo -77.96 50.12 3.18 Favored 'Trans proline' 0 N--CA 1.461 -0.398 0 C-N-CA 123.263 2.642 . . . . 0.0 111.423 179.045 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.496 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.53 -31.06 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.407 -1.269 . . . . 0.0 108.783 179.665 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.696 ' HB3' ' HA ' ' A' ' 38' ' ' ALA . 1.6 m170 -58.67 -61.28 2.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.309 -0.859 . . . . 0.0 110.635 179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.765 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -58.94 -25.01 63.1 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 115.645 -0.707 . . . . 0.0 111.027 -179.978 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.939 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -74.99 -50.23 17.28 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.923 -0.58 . . . . 0.0 111.61 -179.813 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.49 ' HE1' HD21 ' A' ' 13' ' ' LEU . 6.3 ttm -67.15 -41.93 85.21 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -61.19 -33.23 73.12 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.196 -0.457 . . . . 0.0 112.059 -179.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -80.63 -40.05 26.34 Favored 'General case' 0 CA--C 1.514 -0.416 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.284 179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.693 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.81 -54.93 40.53 Favored 'General case' 0 CA--C 1.515 -0.395 0 N-CA-C 108.813 -0.81 . . . . 0.0 108.813 178.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . 0.433 ' HA3' ' HZ ' ' A' ' 17' ' ' PHE . . . -50.46 -46.21 45.62 Favored Glycine 0 C--O 1.215 -1.072 0 CA-C-N 115.272 -0.876 . . . . 0.0 112.112 178.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.9 t0 -56.44 -56.16 24.66 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-O 121.122 0.486 . . . . 0.0 111.423 179.079 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -58.84 -44.4 90.94 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.197 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.748 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.4 OUTLIER -72.45 -34.84 68.06 Favored 'General case' 0 C--O 1.216 -0.702 0 CA-C-N 116.5 -0.318 . . . . 0.0 111.611 -179.858 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -62.9 -28.06 69.79 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.755 0.788 . . . . 0.0 109.556 179.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 14.2 m -83.47 -31.12 26.71 Favored 'General case' 0 CA--C 1.543 0.68 0 CA-C-N 115.025 -0.989 . . . . 0.0 111.455 179.403 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 16.6 mtt180 -92.3 -45.23 8.31 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 112.292 0.478 . . . . 0.0 112.292 -179.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -85.36 87.38 7.38 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 123.149 0.579 . . . . 0.0 111.077 -179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -81.19 -15.47 55.63 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.698 -179.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? -90.38 61.47 5.02 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.116 0.484 . . . . 0.0 110.988 -179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.55 -55.82 1.91 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.616 -0.72 . . . . 0.0 111.277 -179.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.968 ' HA ' HD22 ' A' ' 64' ' ' LEU . 58.5 m-85 -66.16 -18.89 65.63 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.536 -0.756 . . . . 0.0 112.403 -178.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.75 -44.12 86.87 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.007 0.432 . . . . 0.0 111.039 -179.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.698 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.2 m-20 -68.09 -26.89 66.05 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.609 -0.723 . . . . 0.0 110.734 -179.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.968 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.9 OUTLIER -63.5 -41.43 98.54 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.593 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.541 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.96 -45.29 28.09 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 114.904 -1.043 . . . . 0.0 110.337 179.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.585 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.94 -43.08 63.31 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.298 179.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.653 HE22 HD11 ' A' ' 106' ' ' LEU . 23.8 mt-30 -69.75 -54.36 14.08 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.931 -0.577 . . . . 0.0 112.474 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -87.44 18.99 3.5 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 -177.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.541 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 2.1 t-160 -78.46 -38.66 40.6 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 120.818 0.342 . . . . 0.0 110.516 179.835 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.587 HG13 ' H ' ' A' ' 71' ' ' THR . 2.9 p -92.01 -63.36 1.44 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.918 -0.583 . . . . 0.0 112.155 -179.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.587 ' H ' HG13 ' A' ' 70' ' ' VAL . 0.0 OUTLIER -162.6 149.19 10.66 Favored Pre-proline 0 C--O 1.236 0.356 0 O-C-N 122.371 -0.206 . . . . 0.0 110.742 -179.842 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -85.32 -163.19 0.18 Allowed 'Trans proline' 0 N--CA 1.461 -0.416 0 C-N-CA 122.896 2.397 . . . . 0.0 112.203 179.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.644 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 84.52 -72.77 2.75 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.897 179.368 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.45 47.39 0.3 Allowed 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.253 0.549 . . . . 0.0 111.719 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.408 ' HB3' ' HH2' ' A' ' 125' ' ' TRP . . . -94.66 -21.98 18.44 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.594 179.716 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.658 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 6.1 pt20 -62.11 -38.03 87.38 Favored 'General case' 0 CA--C 1.513 -0.471 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.878 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -65.91 -39.06 90.24 Favored 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.701 179.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 5.9 mtt180 -68.5 -43.78 76.13 Favored 'General case' 0 C--N 1.325 -0.485 0 N-CA-C 109.906 -0.405 . . . . 0.0 109.906 179.225 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 4.6 t80 -63.39 -50.2 70.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.576 -0.738 . . . . 0.0 110.756 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.3 p -57.69 -34.12 69.09 Favored 'General case' 0 N--CA 1.463 0.215 0 N-CA-C 111.956 0.354 . . . . 0.0 111.956 -179.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 16.0 mm-40 -63.93 -61.09 2.51 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 120.768 0.318 . . . . 0.0 110.802 179.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.908 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.2 m -58.57 -31.73 44.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 115.834 -0.621 . . . . 0.0 111.316 -179.824 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.8 -43.95 82.52 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.999 -0.371 . . . . 0.0 109.999 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.465 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -68.93 -31.48 70.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.137 0.494 . . . . 0.0 109.738 178.887 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.43 ' HA ' ' NE2' ' A' ' 88' ' ' GLN . 74.5 mt-10 -73.09 -31.24 64.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.778 -0.647 . . . . 0.0 110.338 179.127 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.519 HD23 ' HG3' ' A' ' 95' ' ' ARG . 0.2 OUTLIER -79.35 -36.26 39.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.611 179.731 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -86.67 -8.02 57.8 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.608 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.43 ' NE2' ' HA ' ' A' ' 85' ' ' GLU . 0.0 OUTLIER -42.54 -48.77 5.39 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.686 -0.688 . . . . 0.0 112.622 -179.173 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . -169.39 58.25 0.2 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 119.861 -1.161 . . . . 0.0 113.225 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.492 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 161.43 57.14 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 119.705 -1.235 . . . . 0.0 114.726 179.183 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.643 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.1 Cg_endo -79.43 44.94 1.81 Allowed 'Trans proline' 0 C--N 1.35 0.609 0 C-N-CA 122.085 1.856 . . . . 0.0 111.4 178.006 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.898 ' HB2' HG21 ' A' ' 170' ' ' VAL . 0.6 OUTLIER -69.29 164.98 21.6 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.594 -0.73 . . . . 0.0 111.673 -178.84 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.469 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 20.0 m95 -56.22 -29.64 61.27 Favored 'General case' 0 N--CA 1.465 0.296 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.222 -179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -64.35 -37.3 94.31 Favored Glycine 0 N--CA 1.447 -0.616 0 N-CA-C 110.831 -0.908 . . . . 0.0 110.831 178.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.519 ' HG3' HD23 ' A' ' 86' ' ' LEU . 0.0 OUTLIER -86.13 -26.53 25.15 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.257 -0.471 . . . . 0.0 110.63 179.058 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.685 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -55.37 -30.7 60.86 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.923 -0.581 . . . . 0.0 110.435 179.716 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.748 HG11 ' HB2' ' A' ' 53' ' ' PHE . 6.2 t -64.17 -54.57 29.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.515 -0.766 . . . . 0.0 109.504 178.477 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -63.5 -28.24 69.82 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.313 -0.858 . . . . 0.0 111.237 179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.685 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.4 m-85 -57.54 -56.87 16.29 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.116 0.484 . . . . 0.0 109.98 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.713 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 7.4 m-85 -75.85 -36.96 59.42 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.711 -0.677 . . . . 0.0 111.34 -179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.4 t -60.75 -36.2 69.41 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.126 -179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.5 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.4 OUTLIER -56.75 -53.97 51.7 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-O 120.59 0.233 . . . . 0.0 111.363 -179.962 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . 0.404 ' HA3' ' SD ' ' A' ' 126' ' ' MET . . . -75.11 -36.89 44.56 Favored Glycine 0 N--CA 1.448 -0.503 0 C-N-CA 120.351 -0.928 . . . . 0.0 113.362 -179.565 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -62.14 -42.93 99.73 Favored 'General case' 0 N--CA 1.464 0.275 0 CA-C-N 117.254 0.527 . . . . 0.0 110.701 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.462 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -70.36 -40.91 73.75 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 178.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.8 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -56.71 -51.19 69.77 Favored 'General case' 0 CA--C 1.52 -0.175 0 CA-C-N 115.381 -0.827 . . . . 0.0 110.062 179.037 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.722 ' HB3' HD21 ' A' ' 22' ' ' LEU . 93.7 m -57.02 -47.06 81.8 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.742 -1.117 . . . . 0.0 111.619 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.24 -37.74 64.97 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 111.895 0.332 . . . . 0.0 111.895 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.643 ' HA ' HD21 ' A' ' 112' ' ' ASN . 1.9 mt-10 -83.98 -25.37 30.06 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -179.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.421 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 1.4 p -79.07 -24.01 43.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.919 179.823 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.577 HG23 ' O ' ' A' ' 107' ' ' CYS . 89.5 t -71.16 -35.19 57.5 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.132 0 CA-C-O 120.788 0.327 . . . . 0.0 110.966 179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.643 HD21 ' HA ' ' A' ' 109' ' ' GLU . 15.6 p30 -84.41 1.09 46.94 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.943 0.401 . . . . 0.0 110.765 179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 5.3 mtmt -119.67 -168.29 1.57 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.736 -0.665 . . . . 0.0 109.668 178.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 25.8 mt-10 -94.86 58.43 2.24 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.086 0.47 . . . . 0.0 110.562 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.434 ' HB3' ' HB2' ' A' ' 118' ' ' LEU . 0.0 OUTLIER -137.91 47.01 2.05 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.392 -179.582 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.589 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 6.9 mt-10 -57.33 -55.62 42.46 Favored Pre-proline 0 CA--C 1.538 0.503 0 CA-C-N 115.748 -0.66 . . . . 0.0 112.7 -179.337 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.589 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 24.8 Cg_exo -63.17 -31.6 74.85 Favored 'Trans proline' 0 C--N 1.354 0.868 0 C-N-CA 121.958 1.772 . . . . 0.0 112.584 -179.489 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.644 HD21 ' H ' ' A' ' 73' ' ' GLY . 1.6 mp -60.16 -34.33 73.41 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.79 -179.609 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 92.6 t -57.2 -52.27 58.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.85 0.357 . . . . 0.0 111.368 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.26 -33.04 85.71 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.208 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.654 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.2 mm100 -67.0 -47.0 72.81 Favored 'General case' 0 C--O 1.217 -0.624 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 179.224 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 118' ' ' LEU . 91.9 t -59.82 -35.55 60.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.231 -0.655 . . . . 0.0 109.231 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 9.2 tt0 -62.27 -46.35 89.19 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.412 178.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.654 ' HG2' ' HA ' ' A' ' 121' ' ' GLN . 19.3 pt-20 -71.5 -40.47 70.16 Favored 'General case' 0 C--O 1.225 -0.199 0 CA-C-N 116.611 -0.268 . . . . 0.0 110.824 179.467 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.658 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.4 m0 -57.3 -40.42 77.8 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.419 0.628 . . . . 0.0 109.371 179.008 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.404 ' SD ' ' HA3' ' A' ' 103' ' ' GLY . 2.6 ttp -71.07 -53.62 14.01 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.177 -0.92 . . . . 0.0 111.641 -179.268 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.679 ' O ' ' HG2' ' A' ' 131' ' ' GLU . 5.6 p -62.46 -38.81 82.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.006 0.373 . . . . 0.0 112.006 -178.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -63.54 -46.49 85.72 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.893 0.378 . . . . 0.0 110.622 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.465 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 14.6 t80 -62.47 -33.42 74.81 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.479 0.657 . . . . 0.0 110.597 179.293 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.989 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.93 -58.76 3.09 Favored 'General case' 0 C--N 1.318 -0.798 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -178.174 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . 0.679 ' HG2' ' O ' ' A' ' 127' ' ' VAL . 6.2 pt-20 -64.95 -20.75 66.64 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 112.367 0.506 . . . . 0.0 112.367 -177.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 10.7 m -89.32 -32.05 17.53 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 112.633 0.605 . . . . 0.0 112.633 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.95 -42.91 0.99 Allowed 'General case' 0 N--CA 1.467 0.4 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -178.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.989 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.77 -47.38 85.93 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.836 -0.346 . . . . 0.0 111.268 -178.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . 0.401 ' O ' ' HD2' ' A' ' 139' ' ' HIS . . . -51.93 -39.97 60.02 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 116.123 -0.489 . . . . 0.0 111.544 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -61.01 -47.12 87.9 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 120.861 -0.336 . . . . 0.0 110.744 179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.781 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 56.5 t90 -60.47 -50.18 74.61 Favored 'General case' 0 N--CA 1.45 -0.453 0 N-CA-C 109.313 -0.625 . . . . 0.0 109.313 178.18 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.624 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.8 mt -57.11 -47.47 83.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.266 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . 0.401 ' HD2' ' O ' ' A' ' 135' ' ' ALA . 43.3 m-70 -62.97 -34.25 77.11 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 111.814 0.301 . . . . 0.0 111.814 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.4 m -90.9 -9.85 44.72 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 112.8 0.667 . . . . 0.0 112.8 -179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . 0.433 ' HB2' ' O ' ' A' ' 137' ' ' TRP . 0.1 OUTLIER -91.35 -45.09 8.78 Favored 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -178.493 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 177.62 -15.09 0.03 OUTLIER Glycine 0 CA--C 1.504 -0.608 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.55 165.78 39.77 Favored Glycine 0 N--CA 1.441 -0.974 0 C-N-CA 120.736 -0.745 . . . . 0.0 112.397 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.471 ' CZ2' HD13 ' A' ' 138' ' ' ILE . 95.4 m95 -60.53 -29.62 69.23 Favored 'General case' 0 C--N 1.322 -0.603 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 179.355 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.74 -36.93 82.42 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 115.33 -0.85 . . . . 0.0 111.005 178.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -62.02 -41.85 98.54 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 179.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.43 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 17.9 t80 -67.93 -33.41 74.63 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.627 178.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.939 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.2 OUTLIER -66.6 -26.54 67.15 Favored 'General case' 0 C--O 1.223 -0.327 0 CA-C-O 120.714 0.292 . . . . 0.0 111.055 179.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -84.89 -36.89 21.21 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.345 -0.613 . . . . 0.0 109.345 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.656 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.4 OUTLIER -63.56 -41.15 98.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.237 -0.892 . . . . 0.0 112.004 -179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.417 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 2.4 m-85 -122.83 26.77 8.04 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.83 -178.524 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.445 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -127.46 -138.55 4.72 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 119.493 -1.336 . . . . 0.0 114.043 -179.089 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -61.37 -62.46 1.81 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.759 -0.721 . . . . 0.0 112.347 -178.372 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.5 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -79.42 54.0 4.28 Favored Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 121.085 -0.579 . . . . 0.0 113.341 -179.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -84.34 69.12 10.44 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.103 0.478 . . . . 0.0 110.118 179.389 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.556 ' CD1' ' HB2' ' A' ' 158' ' ' GLU . 0.5 OUTLIER -67.22 167.01 13.0 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.688 -0.687 . . . . 0.0 111.297 -179.306 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 38.5 mm-40 -51.6 -35.83 43.22 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.503 -0.771 . . . . 0.0 112.371 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.556 ' HB2' ' CD1' ' A' ' 156' ' ' LEU . 4.2 mm-40 -65.48 -48.07 73.91 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.926 0.393 . . . . 0.0 110.308 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.656 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -62.8 -34.54 77.48 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.731 179.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 5.6 mtm180 -59.55 -57.2 14.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.961 179.834 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.0 ptt180 -70.4 -27.66 64.46 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.165 -179.747 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 35.3 tp -66.69 -47.29 72.89 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.52 -0.309 . . . . 0.0 111.287 -179.562 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.534 ' HB3' HD22 ' A' ' 150' ' ' LEU . 1.0 OUTLIER -69.88 -33.15 71.83 Favored 'General case' 0 C--N 1.33 -0.248 0 C-N-CA 120.452 -0.499 . . . . 0.0 111.297 -179.468 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.436 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 0.0 OUTLIER -71.29 -43.7 66.62 Favored 'General case' 0 C--N 1.331 -0.205 0 C-N-CA 120.607 -0.437 . . . . 0.0 110.103 179.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -70.11 -26.37 74.37 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.172 -1.013 . . . . 0.0 110.722 178.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.548 ' O ' ' HB ' ' A' ' 170' ' ' VAL . 7.2 t-20 -59.9 -61.03 2.91 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.831 -0.684 . . . . 0.0 111.265 179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.763 ' HA ' HG12 ' A' ' 170' ' ' VAL . 32.4 p-90 -69.48 -22.82 63.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.475 -179.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -50.84 -58.72 5.26 Favored 'General case' 0 C--N 1.329 -0.289 0 O-C-N 122.994 0.184 . . . . 0.0 110.745 179.578 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 4.6 m -88.93 -24.04 22.55 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.898 HG21 ' HB2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -81.62 -28.92 10.22 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 N-CA-C 112.826 0.676 . . . . 0.0 112.826 -177.398 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.418 ' HA ' HH11 ' A' ' 95' ' ' ARG . 1.3 ttt180 -82.16 -22.34 36.13 Favored 'General case' 0 C--N 1.319 -0.741 0 O-C-N 121.847 -0.533 . . . . 0.0 109.614 179.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.444 ' HA ' ' HB ' ' A' ' 175' ' ' THR . 0.6 OUTLIER -83.61 -43.01 16.1 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.596 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.97 HG13 ' HG ' ' A' ' 174' ' ' LEU . 14.4 p -57.89 -37.0 58.11 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.184 0 CA-C-O 121.12 0.486 . . . . 0.0 110.861 -179.536 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.97 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.2 OUTLIER -110.61 36.26 3.17 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.208 0.527 . . . . 0.0 110.16 178.969 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.444 ' HB ' ' HA ' ' A' ' 172' ' ' THR . 1.9 t -77.66 -9.71 59.12 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.057 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -91.34 7.27 80.55 Favored Glycine 0 C--O 1.228 -0.231 0 C-N-CA 120.812 -0.709 . . . . 0.0 112.732 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.97 25.72 0.36 Allowed 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 112.002 0.371 . . . . 0.0 112.002 -179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -87.26 51.01 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.913 0.387 . . . . 0.0 110.514 179.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -84.34 -1.81 56.04 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.624 -179.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.908 ' HG ' HG11 ' A' ' 82' ' ' VAL . 15.8 mt -86.67 -30.71 21.52 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.816 0.341 . . . . 0.0 110.29 179.654 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -77.75 91.05 1.07 Allowed Glycine 0 N--CA 1.448 -0.528 0 CA-C-N 115.851 -0.613 . . . . 0.0 111.685 179.586 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.585 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -79.93 136.4 36.64 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.071 0.463 . . . . 0.0 111.632 -179.237 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.177 -0.916 . . . . 0.0 109.915 179.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . 0.416 ' HA2' ' HD3' ' A' ' -3' ' ' PRO . . . . . . . . 0 N--CA 1.481 1.644 0 N-CA-C 112.217 -0.353 . . . . 0.0 112.217 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' -2' ' ' LEU . 13.8 Cg_exo -69.0 128.34 16.57 Favored 'Trans proline' 0 C--O 1.234 0.284 0 C-N-CA 122.807 2.338 . . . . 0.0 111.705 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' A' ' -3' ' ' PRO . 0.4 OUTLIER 73.54 -55.17 0.68 Allowed 'General case' 0 N--CA 1.47 0.537 0 O-C-N 123.85 0.719 . . . . 0.0 111.128 -179.377 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -158.94 -168.48 21.07 Favored Glycine 0 N--CA 1.444 -0.83 0 N-CA-C 111.733 -0.547 . . . . 0.0 111.733 179.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 50.6 m -151.48 143.71 24.04 Favored 'General case' 0 C--N 1.322 -0.594 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 179.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.39 150.88 22.33 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.815 0.34 . . . . 0.0 110.993 -179.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -112.33 136.92 51.19 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.553 179.738 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.434 ' HA ' ' HD3' ' A' ' 4' ' ' PRO . 2.8 p -99.36 131.1 25.63 Favored Pre-proline 0 C--N 1.321 -0.637 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.959 -179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.434 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 16.9 Cg_exo -67.54 98.04 0.47 Allowed 'Trans proline' 0 C--N 1.344 0.317 0 C-N-CA 122.948 2.432 . . . . 0.0 112.341 -179.599 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -88.65 42.53 1.08 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.017 0.437 . . . . 0.0 111.246 -179.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 45.6 m -158.13 124.3 4.69 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 116.308 -0.405 . . . . 0.0 109.98 179.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.455 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -150.56 149.13 25.4 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.339 -179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.455 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 11.9 Cg_exo -70.74 108.0 2.17 Favored 'Trans proline' 0 C--O 1.233 0.261 0 C-N-CA 123.051 2.501 . . . . 0.0 112.112 179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -80.31 -176.58 5.71 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 179.49 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -57.77 -32.19 67.25 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.297 179.517 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . 0.444 HH11 ' HD3' ' A' ' 11' ' ' ARG . 0.0 OUTLIER -68.23 -32.66 73.01 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.658 -0.246 . . . . 0.0 110.396 179.275 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -77.26 -43.59 32.85 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 178.074 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 42' ' ' LEU . 1.4 tp -62.01 -43.55 98.59 Favored 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.339 179.49 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.522 HG11 ' HB ' ' A' ' 127' ' ' VAL . 4.4 p -66.14 -37.65 80.23 Favored 'Isoleucine or valine' 0 C--O 1.234 0.289 0 CA-C-O 120.778 0.323 . . . . 0.0 110.512 179.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -70.27 -32.9 70.93 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.959 0.409 . . . . 0.0 110.422 179.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 70.2 m-20 -70.28 -52.55 22.07 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 115.71 -0.677 . . . . 0.0 111.045 -179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.421 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 4.7 t80 -58.1 -52.99 63.24 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.0 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.409 ' O ' HD13 ' A' ' 22' ' ' LEU . 72.1 t -64.15 -40.52 89.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 N-CA-C 109.688 -0.486 . . . . 0.0 109.688 179.345 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.604 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.75 -51.81 56.8 Favored Glycine 0 C--O 1.221 -0.667 0 C-N-CA 120.985 -0.626 . . . . 0.0 111.745 178.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.732 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 20.9 t80 -61.98 -38.84 90.09 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 122.638 0.375 . . . . 0.0 110.926 179.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.516 ' O ' ' HG2' ' A' ' 24' ' ' GLN . 7.4 mmtt -66.35 -43.56 85.72 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.91 -0.587 . . . . 0.0 111.06 -179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.719 HD21 ' HB3' ' A' ' 107' ' ' CYS . 8.6 mp -75.94 -46.35 30.31 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.533 -179.72 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.596 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 3.2 ttp180 -62.22 -21.19 64.95 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.956 -0.565 . . . . 0.0 111.514 -179.348 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.516 ' HG2' ' O ' ' A' ' 21' ' ' LYS . 0.6 OUTLIER -85.74 -24.03 27.07 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 120.755 -0.378 . . . . 0.0 111.326 179.335 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 2.1 pttt -158.36 75.34 0.73 Allowed 'General case' 0 N--CA 1.464 0.272 0 CA-C-O 121.087 0.47 . . . . 0.0 111.456 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 150.34 -74.62 0.26 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.697 -0.763 . . . . 0.0 112.645 179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.508 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 2.0 t80 -85.74 58.14 4.87 Favored 'General case' 0 C--N 1.319 -0.74 0 CA-C-O 120.957 0.408 . . . . 0.0 110.473 179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 2.8 t -78.39 -33.87 17.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.295 0.569 . . . . 0.0 110.182 -179.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 72.3 m -72.72 -14.15 61.5 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.603 -0.726 . . . . 0.0 110.182 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.508 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -109.8 40.27 2.61 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.477 -0.783 . . . . 0.0 111.662 179.454 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.596 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -60.27 130.48 46.87 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 109.785 -0.45 . . . . 0.0 109.785 179.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.93 -48.43 0.19 Allowed Glycine 0 CA--C 1.52 0.398 0 C-N-CA 119.836 -1.173 . . . . 0.0 113.819 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.604 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 3.2 Cg_exo -84.11 -48.77 0.04 OUTLIER 'Trans proline' 0 N--CA 1.459 -0.559 0 C-N-CA 122.291 1.994 . . . . 0.0 111.973 -179.215 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.732 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -78.38 22.57 3.13 Favored Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.403 -0.817 . . . . 0.0 114.989 -178.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.501 ' OE2' ' HD2' ' A' ' 23' ' ' ARG . 0.3 OUTLIER -79.84 -26.75 40.3 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 117.72 0.76 . . . . 0.0 109.46 178.866 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -86.43 132.44 11.14 Favored Glycine 0 N--CA 1.451 -0.342 0 CA-C-N 115.529 -0.76 . . . . 0.0 112.356 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.416 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 90.2 Cg_endo -89.05 -148.53 0.03 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.639 0 C-N-CA 122.985 2.457 . . . . 0.0 113.275 -179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.89 ' HB1' ' HA ' ' A' ' 44' ' ' GLN . . . -86.33 97.79 10.61 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.66 -0.7 . . . . 0.0 111.356 -179.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -133.7 -34.78 1.01 Allowed 'General case' 0 CA--C 1.531 0.239 0 N-CA-C 112.995 0.739 . . . . 0.0 112.995 -179.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.485 ' HB3' ' HD2' ' A' ' 41' ' ' PRO . 2.7 m-20 -78.97 160.43 71.4 Favored Pre-proline 0 C--N 1.323 -0.553 0 CA-C-O 120.686 0.279 . . . . 0.0 111.617 -178.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.585 ' HA ' HG21 ' A' ' 148' ' ' THR . 25.6 Cg_endo -74.43 51.75 2.65 Favored 'Trans proline' 0 C--N 1.347 0.449 0 C-N-CA 123.525 2.816 . . . . 0.0 112.44 -179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.564 HD13 HD13 ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.59 -34.12 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 114.306 -1.315 . . . . 0.0 107.881 178.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.421 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.0 OUTLIER -59.64 -58.0 10.48 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 114.461 -1.245 . . . . 0.0 110.089 179.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.89 ' HA ' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -59.72 -28.0 66.96 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.693 179.388 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.682 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -69.88 -49.66 50.04 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.666 -0.697 . . . . 0.0 111.3 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.484 ' SD ' HD11 ' A' ' 13' ' ' LEU . 0.5 OUTLIER -63.55 -31.02 72.06 Favored 'General case' 0 C--O 1.234 0.276 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.976 -179.369 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . 0.492 ' HD3' ' HB2' ' A' ' 38' ' ' ALA . 15.2 ttp180 -62.6 -42.37 99.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.65 -0.25 . . . . 0.0 111.413 -179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -77.3 -23.62 51.03 Favored 'General case' 0 CA--C 1.517 -0.303 0 CA-C-O 121.54 0.686 . . . . 0.0 110.295 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.844 ' HB2' ' HZ ' ' A' ' 147' ' ' PHE . . . -70.32 -64.88 0.81 Allowed 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 115.351 -0.84 . . . . 0.0 109.301 178.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -49.31 -46.18 35.51 Favored Glycine 0 C--O 1.216 -1.013 0 O-C-N 124.107 0.879 . . . . 0.0 112.397 179.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 47.5 t0 -51.64 -51.87 52.28 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-O 121.382 0.61 . . . . 0.0 111.425 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -61.45 -45.69 93.19 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.598 -0.728 . . . . 0.0 112.047 -179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.473 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.8 OUTLIER -75.53 -33.74 60.73 Favored 'General case' 0 C--N 1.325 -0.478 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.922 -178.83 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -63.46 -26.85 68.91 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.022 -0.733 . . . . 0.0 109.022 179.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 87.2 m -88.58 -41.84 12.42 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 115.186 -0.916 . . . . 0.0 111.485 178.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -87.27 -64.43 1.15 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 121.123 0.487 . . . . 0.0 112.205 -179.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -80.41 61.26 4.11 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.121 0.486 . . . . 0.0 111.338 -179.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -85.24 0.38 52.06 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 111.96 0.356 . . . . 0.0 111.96 -179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.7 ptt180 -89.11 18.21 5.19 Favored 'General case' 0 C--N 1.326 -0.443 0 N-CA-C 111.747 0.277 . . . . 0.0 111.747 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 2.8 t -104.38 -0.07 28.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.269 0.557 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.754 ' HA ' HD22 ' A' ' 64' ' ' LEU . 80.3 m-85 -84.89 -23.25 29.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.112 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.76 -35.61 81.64 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.763 179.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 1.013 ' HB3' ' HB3' ' A' ' 180' ' ' LEU . 1.4 m-20 -62.0 -33.49 74.43 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.299 -179.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.754 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.0 OUTLIER -58.84 -41.76 87.67 Favored 'General case' 0 C--N 1.319 -0.747 0 CA-C-O 121.529 0.681 . . . . 0.0 109.325 179.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.513 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -80.39 -40.56 26.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.131 -0.94 . . . . 0.0 110.579 179.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.628 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -51.21 -46.13 62.1 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.522 179.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.569 HE22 HD11 ' A' ' 106' ' ' LEU . 35.2 mt-30 -76.52 -49.16 17.18 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 112.896 0.702 . . . . 0.0 112.896 -179.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.448 ' HG ' ' SD ' ' A' ' 115' ' ' MET . 0.4 OUTLIER -80.28 6.35 12.21 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 113.793 1.034 . . . . 0.0 113.793 -176.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.513 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 19.1 t60 -82.64 -31.99 28.48 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 120.872 0.368 . . . . 0.0 110.66 179.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . 0.596 HG22 HG22 ' A' ' 71' ' ' THR . 2.3 p -91.76 -54.77 6.93 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -179.123 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.596 HG22 HG22 ' A' ' 70' ' ' VAL . 5.0 t -171.97 144.51 1.5 Allowed Pre-proline 0 C--O 1.237 0.437 0 CA-C-O 120.91 0.386 . . . . 0.0 111.007 -179.3 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.479 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 3.6 Cg_endo -84.36 -171.81 1.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.81 0 C-N-CA 123.258 2.639 . . . . 0.0 111.258 178.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 82.27 -67.4 3.7 Favored Glycine 0 N--CA 1.453 -0.188 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.74 179.477 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.37 48.59 0.34 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.385 0.612 . . . . 0.0 111.674 -179.881 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.729 ' HA ' ' HD2' ' A' ' 78' ' ' ARG . . . -104.39 -17.16 14.89 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.46 179.512 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.664 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.4 pt20 -64.27 -35.69 81.66 Favored 'General case' 0 CA--C 1.512 -0.497 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.251 -179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 26.0 mp0 -67.58 -39.63 84.84 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 120.891 0.377 . . . . 0.0 110.428 179.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . 0.729 ' HD2' ' HA ' ' A' ' 75' ' ' ALA . 23.1 mtt180 -68.59 -45.87 70.85 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.152 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -61.34 -47.84 84.06 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-N 115.615 -0.72 . . . . 0.0 110.906 179.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 2.2 p -58.28 -33.75 69.77 Favored 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 120.785 -0.366 . . . . 0.0 111.345 179.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -60.09 -64.07 1.08 Allowed 'General case' 0 CA--C 1.516 -0.342 0 CA-C-O 120.931 0.396 . . . . 0.0 110.862 179.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.504 ' O ' ' HB2' ' A' ' 86' ' ' LEU . 9.1 p -57.87 -34.58 48.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.278 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 38.7 m -68.21 -45.63 72.81 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.742 0.306 . . . . 0.0 110.809 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.667 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.6 OUTLIER -71.36 -38.02 71.6 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.851 0.358 . . . . 0.0 110.519 -179.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.19 -19.38 63.18 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.269 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.504 ' HB2' ' O ' ' A' ' 82' ' ' VAL . 0.7 OUTLIER -85.28 -39.47 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.122 0.487 . . . . 0.0 109.833 178.66 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . 0.416 ' HB2' ' HE1' ' A' ' 129' ' ' TYR . 32.9 t80 -79.24 -7.67 58.44 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.243 179.451 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -48.59 -35.97 14.65 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.431 179.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 174.51 62.46 0.05 OUTLIER Glycine 0 N--CA 1.445 -0.745 0 C-N-CA 120.188 -1.006 . . . . 0.0 112.834 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.62 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 164.05 51.35 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 119.541 -1.314 . . . . 0.0 115.04 178.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.62 ' HD3' ' H ' ' A' ' 90' ' ' GLY . 18.3 Cg_endo -81.37 37.01 0.65 Allowed 'Trans proline' 0 C--N 1.351 0.699 0 CA-C-N 119.762 1.781 . . . . 0.0 111.542 177.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.2 t-20 -68.04 164.87 19.17 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.903 -178.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.588 ' CZ2' ' HG2' ' A' ' 146' ' ' GLU . 26.0 m95 -53.97 -28.2 36.12 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.458 -179.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.402 ' HA3' ' HB3' ' A' ' 167' ' ' TRP . . . -65.16 -41.14 97.11 Favored Glycine 0 N--CA 1.449 -0.489 0 C-N-CA 120.538 -0.839 . . . . 0.0 111.117 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.422 HH11 ' HD3' ' A' ' 95' ' ' ARG . 0.3 OUTLIER -86.09 -23.67 26.58 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.646 -0.277 . . . . 0.0 110.654 178.98 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.862 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.7 OUTLIER -56.21 -31.59 63.63 Favored 'General case' 0 C--O 1.236 0.388 0 CA-C-O 121.479 0.657 . . . . 0.0 109.852 179.486 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.766 HG22 ' HB1' ' A' ' 49' ' ' ALA . 38.7 t -61.26 -54.15 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 CA-C-N 114.886 -1.052 . . . . 0.0 109.391 178.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.94 -28.33 69.45 Favored 'General case' 0 C--O 1.221 -0.429 0 CA-C-N 115.009 -0.996 . . . . 0.0 111.351 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.862 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 5.7 m-85 -56.17 -57.27 12.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.782 0.325 . . . . 0.0 110.509 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.474 ' HA ' ' SD ' ' A' ' 126' ' ' MET . 40.9 m-85 -74.56 -38.74 62.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.719 179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 3.0 t -60.4 -40.16 83.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.793 -179.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.589 ' HE2' HD22 ' A' ' 180' ' ' LEU . 0.6 OUTLIER -54.79 -52.68 61.88 Favored 'General case' 0 N--CA 1.462 0.173 0 CA-C-O 120.778 0.323 . . . . 0.0 111.41 -179.638 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.21 -38.11 47.32 Favored Glycine 0 N--CA 1.447 -0.582 0 C-N-CA 120.307 -0.949 . . . . 0.0 113.078 -179.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.79 -45.11 95.29 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 117.12 0.46 . . . . 0.0 110.756 -179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.578 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -67.54 -39.12 85.0 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.719 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -59.97 -42.41 94.08 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 115.456 -0.793 . . . . 0.0 110.456 179.282 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.719 ' HB3' HD21 ' A' ' 22' ' ' LEU . 95.0 m -69.19 -39.37 78.71 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.146 -0.934 . . . . 0.0 111.455 -179.86 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -58.77 -38.75 79.17 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 120.788 0.328 . . . . 0.0 111.395 -179.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.558 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.7 OUTLIER -84.67 -15.0 46.86 Favored 'General case' 0 C--N 1.326 -0.416 0 C-N-CA 120.318 -0.553 . . . . 0.0 112.479 -179.332 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.465 ' OG ' ' HA ' ' A' ' 107' ' ' CYS . 0.0 OUTLIER -82.81 -24.64 33.27 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.113 -0.635 . . . . 0.0 110.354 179.01 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.524 HG23 ' O ' ' A' ' 107' ' ' CYS . 91.4 t -69.23 -33.22 57.02 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.318 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.558 HD21 ' HA ' ' A' ' 109' ' ' GLU . 21.6 p30 -84.99 1.06 49.24 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.913 0.387 . . . . 0.0 111.162 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . . . . . . . . . 21.8 mtmm -126.94 -173.26 2.84 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.435 179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 19.5 mt-10 -84.61 56.37 3.82 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.875 0.369 . . . . 0.0 110.703 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.448 ' SD ' ' HG ' ' A' ' 68' ' ' LEU . 0.0 OUTLIER -135.06 43.31 2.7 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.826 0.346 . . . . 0.0 110.98 -179.104 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.505 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 1.8 mt-10 -57.33 -53.55 64.22 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.396 -179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.505 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 17.3 Cg_exo -67.7 -27.52 38.12 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.072 1.848 . . . . 0.0 112.636 -179.441 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.485 ' O ' HG23 ' A' ' 122' ' ' VAL . 1.3 tp -62.78 -35.66 80.56 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.615 -179.394 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 89.1 t -55.74 -51.28 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.799 0.333 . . . . 0.0 111.56 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -63.34 -33.52 87.46 Favored Glycine 0 C--N 1.33 0.209 0 C-N-CA 120.724 -0.751 . . . . 0.0 112.366 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.53 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 2.4 mm100 -67.18 -50.35 61.33 Favored 'General case' 0 C--O 1.219 -0.537 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 179.402 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.485 HG23 ' O ' ' A' ' 118' ' ' LEU . 45.1 t -58.68 -33.71 49.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 178.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 14.5 tt0 -63.04 -46.58 86.84 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.263 178.517 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.799 ' HA ' HG12 ' A' ' 127' ' ' VAL . 15.4 pt-20 -74.03 -39.31 63.64 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.431 -0.349 . . . . 0.0 111.085 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.664 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 37.2 m0 -56.41 -37.88 70.76 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 108.98 -0.748 . . . . 0.0 108.98 178.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . 0.474 ' SD ' ' HA ' ' A' ' 100' ' ' PHE . 8.9 ttm -73.61 -55.43 6.31 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 114.9 -1.045 . . . . 0.0 111.506 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.799 HG12 ' HA ' ' A' ' 124' ' ' GLU . 9.8 p -60.32 -36.19 67.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 N-CA-C 112.257 0.466 . . . . 0.0 112.257 -178.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -67.54 -48.76 66.03 Favored 'General case' 0 CA--C 1.52 -0.174 0 C-N-CA 120.819 -0.352 . . . . 0.0 110.823 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.667 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 8.7 t80 -59.01 -34.72 72.19 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 121.63 0.729 . . . . 0.0 110.148 179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.995 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -73.07 -56.93 4.44 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.933 -1.031 . . . . 0.0 112.573 -179.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.23 -36.28 79.52 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 112.16 0.43 . . . . 0.0 112.16 -178.377 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.1 m -77.43 -38.52 49.37 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 113.337 0.866 . . . . 0.0 113.337 -178.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.84 -42.61 2.04 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 114.522 1.304 . . . . 0.0 114.522 -177.607 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.995 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.3 mm? -60.82 -44.5 96.81 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 118.321 0.509 . . . . 0.0 111.676 -178.452 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -54.08 -34.94 61.44 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.528 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.12 -49.52 67.21 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 120.874 -0.33 . . . . 0.0 110.52 179.515 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 60.0 t90 -57.96 -48.08 81.03 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 178.225 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.566 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -56.65 -49.55 77.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.944 -179.714 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 17.1 m170 -56.65 -39.51 73.83 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.81 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 55.1 m -86.79 -11.27 51.5 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.2 -22.02 16.4 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 113.15 0.796 . . . . 0.0 113.15 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 151.35 -24.99 0.97 Allowed Glycine 0 CA--C 1.505 -0.548 0 C-N-CA 120.193 -1.004 . . . . 0.0 111.499 -179.722 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.566 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 95.86 169.55 35.26 Favored Glycine 0 N--CA 1.441 -1.023 0 C-N-CA 120.667 -0.778 . . . . 0.0 113.011 179.197 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.557 ' HB3' ' HB3' ' A' ' 42' ' ' LEU . 96.2 m95 -60.06 -29.4 68.52 Favored 'General case' 0 C--N 1.325 -0.469 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -61.75 -35.87 79.38 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-N 115.442 -0.799 . . . . 0.0 110.571 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.588 ' HG2' ' CZ2' ' A' ' 93' ' ' TRP . 0.0 OUTLIER -64.46 -42.0 96.2 Favored 'General case' 0 N--CA 1.462 0.151 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 178.983 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.844 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -61.95 -39.47 92.2 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.318 178.898 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.682 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.1 OUTLIER -66.07 -27.16 67.87 Favored 'General case' 0 C--O 1.221 -0.406 0 CA-C-O 121.069 0.461 . . . . 0.0 110.75 178.933 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.22 -15.31 41.24 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.125 0.488 . . . . 0.0 109.856 178.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.677 ' HA ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -79.03 -48.87 13.63 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.611 -0.722 . . . . 0.0 110.22 179.497 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.58 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.5 m-85 -138.99 30.75 2.22 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 112.645 0.609 . . . . 0.0 112.645 -178.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.423 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -95.09 -132.17 6.75 Favored Glycine 0 N--CA 1.448 -0.536 0 C-N-CA 119.903 -1.141 . . . . 0.0 112.189 179.501 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -68.48 -31.42 70.68 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 120.983 0.42 . . . . 0.0 110.594 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.434 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -115.5 65.85 0.3 Allowed Glycine 0 N--CA 1.449 -0.475 0 CA-C-N 115.842 -0.617 . . . . 0.0 111.763 179.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.77 76.33 10.01 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.207 0.527 . . . . 0.0 110.481 -179.909 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.495 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -60.7 153.59 23.68 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.271 -0.877 . . . . 0.0 111.324 -179.588 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -55.66 -28.03 53.22 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.634 -0.712 . . . . 0.0 112.308 -179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.495 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.0 OUTLIER -74.75 -42.14 58.78 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.991 0.424 . . . . 0.0 110.801 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.677 ' HB1' ' HA ' ' A' ' 150' ' ' LEU . . . -68.79 -34.66 75.91 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.242 0.544 . . . . 0.0 110.541 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.58 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 8.3 mtm-85 -63.97 -50.45 68.55 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.613 -0.722 . . . . 0.0 111.074 179.83 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 12.5 ptt180 -68.9 -30.11 68.53 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 120.886 -0.326 . . . . 0.0 110.569 179.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.476 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -64.77 -37.38 87.42 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.254 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . . . . . . . . . 15.1 ttp180 -69.48 -42.21 75.13 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.517 -0.311 . . . . 0.0 110.555 179.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.639 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 3.4 tt0 -65.46 -44.62 86.64 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.403 179.689 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.87 -22.45 75.63 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.47 -0.871 . . . . 0.0 111.632 178.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.488 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.6 t-20 -74.66 -52.96 10.24 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.803 0.335 . . . . 0.0 111.0 -179.826 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.845 ' HA ' HG22 ' A' ' 170' ' ' VAL . 14.7 p-90 -66.97 -23.8 65.98 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 120.795 -0.362 . . . . 0.0 111.274 -179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -55.85 -44.07 77.66 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.15 0.5 . . . . 0.0 110.382 179.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -87.34 -32.59 19.55 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.926 -0.579 . . . . 0.0 112.516 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.845 HG22 ' HA ' ' A' ' 167' ' ' TRP . 34.3 m -86.12 -25.57 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.675 0 N-CA-C 113.929 1.085 . . . . 0.0 113.929 -177.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.417 ' HA ' ' NH1' ' A' ' 95' ' ' ARG . 8.4 ttp180 -80.84 -25.38 37.76 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 121.588 -0.695 . . . . 0.0 109.938 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.826 ' HA ' HG23 ' A' ' 175' ' ' THR . 2.2 m -90.09 -28.6 18.9 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.763 179.673 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.94 HG13 ' HG ' ' A' ' 174' ' ' LEU . 8.8 p -65.32 -29.05 46.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 CA-C-O 121.366 0.603 . . . . 0.0 110.388 179.372 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.94 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -120.07 46.15 2.02 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.185 178.741 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.826 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -64.99 -42.33 94.62 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.521 -179.815 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -75.94 25.18 1.53 Allowed Glycine 0 CA--C 1.522 0.477 0 N-CA-C 114.499 0.56 . . . . 0.0 114.499 -178.629 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -88.96 -2.21 58.48 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 117.323 0.561 . . . . 0.0 110.457 179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.5 t -78.36 66.48 0.33 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.805 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -99.03 12.03 37.24 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.433 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 1.013 ' HB3' ' HB3' ' A' ' 63' ' ' ASP . 5.6 mp -91.41 -47.06 7.66 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.723 -0.672 . . . . 0.0 110.656 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . 0.401 ' HA2' ' CB ' ' A' ' 66' ' ' ALA . . . -70.02 92.77 0.39 Allowed Glycine 0 N--CA 1.45 -0.411 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 179.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.628 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -89.6 100.48 13.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.926 0.393 . . . . 0.0 111.928 -178.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.189 -0.91 . . . . 0.0 109.53 179.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.701 0 N-CA-C 111.56 -0.616 . . . . 0.0 111.56 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_exo -67.75 133.77 30.55 Favored 'Trans proline' 0 N--CA 1.463 -0.318 0 C-N-CA 122.842 2.361 . . . . 0.0 111.478 179.525 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 2.5 mp -78.7 -83.71 0.09 Allowed 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 120.997 0.427 . . . . 0.0 110.217 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . -147.14 140.07 8.34 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.703 -0.76 . . . . 0.0 111.966 179.554 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.41 -47.3 14.6 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.651 0.262 . . . . 0.0 110.541 -179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 73.83 152.72 0.13 Allowed 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.787 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.31 160.49 32.54 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.646 -0.706 . . . . 0.0 109.892 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.559 HG21 ' HB2' ' A' ' 7' ' ' ALA . 0.1 OUTLIER -102.48 141.38 22.41 Favored Pre-proline 0 C--N 1.325 -0.468 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 179.748 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . 0.491 ' HD3' ' HA ' ' A' ' 3' ' ' THR . 5.9 Cg_exo -78.9 -7.62 15.48 Favored 'Trans proline' 0 C--O 1.233 0.263 0 C-N-CA 123.022 2.481 . . . . 0.0 112.967 -178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -170.59 -47.28 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.702 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 21.6 m -153.92 148.32 26.06 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.644 -179.867 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.559 ' HB2' HG21 ' A' ' 3' ' ' THR . . . -88.37 137.61 30.7 Favored Pre-proline 0 C--N 1.324 -0.526 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.259 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.446 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 3.6 Cg_exo -75.13 34.93 0.41 Allowed 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 123.589 2.86 . . . . 0.0 112.303 179.988 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . 0.404 ' HB3' ' H ' ' A' ' 10' ' ' THR . 1.5 m-20 -84.75 -159.08 0.39 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.744 -0.662 . . . . 0.0 110.483 -179.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.404 ' H ' ' HB3' ' A' ' 9' ' ' ASP . 0.0 OUTLIER -56.47 -35.04 67.48 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.131 -0.486 . . . . 0.0 112.15 -179.549 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 3.1 ptm180 -63.58 -39.59 94.78 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.689 0.28 . . . . 0.0 111.006 179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -76.91 -32.95 57.76 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.814 0.34 . . . . 0.0 110.299 179.377 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.749 ' HB2' HD13 ' A' ' 42' ' ' LEU . 7.4 tp -74.74 -42.22 58.66 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.427 -179.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 5.5 p -66.37 -37.93 80.71 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 CA-C-O 120.834 0.349 . . . . 0.0 110.23 179.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -73.95 -25.72 60.11 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.75 0.31 . . . . 0.0 110.588 179.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -75.5 -60.25 2.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.082 -179.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . 0.479 ' CD2' ' HB3' ' A' ' 100' ' ' PHE . 6.7 t80 -56.63 -50.11 73.01 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 111.768 0.284 . . . . 0.0 111.768 -179.232 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.49 ' O ' HD13 ' A' ' 22' ' ' LEU . 74.4 t -66.83 -42.18 88.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.51 -0.313 . . . . 0.0 110.19 179.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 23' ' ' ARG . . . -61.47 -52.75 49.23 Favored Glycine 0 C--O 1.225 -0.465 0 C-N-CA 120.628 -0.796 . . . . 0.0 111.888 178.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.802 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 23.6 t80 -57.19 -46.55 82.75 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 123.073 0.549 . . . . 0.0 111.468 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 1.8 tmtm? -63.52 -45.46 90.52 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.749 0.309 . . . . 0.0 111.059 -179.621 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.666 HD21 ' HB3' ' A' ' 107' ' ' CYS . 7.7 mp -66.85 -47.24 72.54 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.16 -179.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.458 ' HB2' ' O ' ' A' ' 19' ' ' GLY . 23.7 ttp85 -60.77 -25.81 66.79 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.663 -0.699 . . . . 0.0 111.3 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -85.94 -21.79 27.73 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.952 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.3 tttt -157.43 72.19 0.67 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.759 0.314 . . . . 0.0 111.654 -179.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.68 -75.99 0.25 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.63 -0.795 . . . . 0.0 112.607 179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.479 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.2 t80 -84.37 56.13 3.66 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-O 121.217 0.532 . . . . 0.0 110.678 179.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 11.3 p -79.05 -28.54 13.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.087 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 62.2 m -76.36 -15.16 60.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.478 0.656 . . . . 0.0 109.962 178.679 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.479 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -111.85 53.9 0.57 Allowed Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.246 -0.888 . . . . 0.0 110.963 178.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.457 ' HB1' ' OE2' ' A' ' 35' ' ' GLU . . . -63.49 144.59 56.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.204 -0.498 . . . . 0.0 110.408 -179.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.421 ' CA ' ' HG2' ' A' ' 35' ' ' GLU . . . 142.77 -57.25 0.56 Allowed Glycine 0 CA--C 1.52 0.379 0 C-N-CA 119.501 -1.333 . . . . 0.0 113.979 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.421 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 31.5 Cg_exo -61.7 -45.36 17.61 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.579 2.186 . . . . 0.0 112.403 -179.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.802 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -103.43 39.44 2.79 Favored Glycine 0 N--CA 1.446 -0.645 0 C-N-CA 120.727 -0.749 . . . . 0.0 113.743 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' OE2' ' HB1' ' A' ' 31' ' ' ALA . 74.4 mm-40 -79.31 -59.92 2.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 117.349 0.574 . . . . 0.0 109.95 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -70.05 128.96 20.38 Favored Glycine 0 N--CA 1.45 -0.371 0 CA-C-N 115.001 -0.999 . . . . 0.0 111.927 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . 0.438 ' HB2' ' H ' ' A' ' 38' ' ' ALA . 91.3 Cg_endo -88.28 -132.08 0.01 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 122.835 2.357 . . . . 0.0 113.476 -178.907 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.504 ' HB1' ' HG2' ' A' ' 44' ' ' GLN . . . -73.79 92.4 2.02 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.493 -179.404 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.93 39.9 1.04 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.783 -179.904 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -156.41 164.9 19.93 Favored Pre-proline 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.654 179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.477 ' HA ' HG21 ' A' ' 148' ' ' THR . 57.9 Cg_endo -82.39 49.63 3.17 Favored 'Trans proline' 0 N--CA 1.46 -0.481 0 C-N-CA 123.135 2.557 . . . . 0.0 112.275 179.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.749 HD13 ' HB2' ' A' ' 13' ' ' LEU . 0.2 OUTLIER 179.8 -27.84 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.485 179.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.514 ' HD2' HD12 ' A' ' 42' ' ' LEU . 4.4 m170 -62.55 -56.03 21.83 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.715 -0.675 . . . . 0.0 110.929 -179.784 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' HG2' ' HB1' ' A' ' 38' ' ' ALA . 0.0 OUTLIER -63.98 -23.81 67.48 Favored 'General case' 0 CA--C 1.516 -0.328 0 CA-C-O 121.259 0.552 . . . . 0.0 110.044 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.486 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -67.63 -54.1 22.46 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.796 179.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.465 ' HE3' HD21 ' A' ' 13' ' ' LEU . 3.8 tpp -70.13 -30.07 67.16 Favored 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.724 -0.391 . . . . 0.0 111.338 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.04 -39.87 95.04 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.555 -0.293 . . . . 0.0 111.572 -179.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -78.22 -28.52 47.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 121.644 0.735 . . . . 0.0 109.685 179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.935 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -68.5 -61.08 1.99 Allowed 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.168 -0.924 . . . . 0.0 109.643 178.898 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.12 -45.9 42.72 Favored Glycine 0 C--O 1.215 -1.081 0 O-C-N 124.108 0.88 . . . . 0.0 112.292 179.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -52.28 -52.75 51.01 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 122.588 0.355 . . . . 0.0 111.884 179.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -63.48 -44.0 95.64 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.644 -0.253 . . . . 0.0 111.404 -179.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.678 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.7 OUTLIER -72.56 -35.0 67.87 Favored 'General case' 0 C--O 1.221 -0.434 0 N-CA-C 111.841 0.312 . . . . 0.0 111.841 -179.366 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -65.25 -27.15 68.45 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.323 0.583 . . . . 0.0 109.518 179.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 11.6 m -88.01 -39.24 14.83 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 115.6 -0.727 . . . . 0.0 111.729 179.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 2.7 mtt180 -90.37 -57.23 2.91 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 112.178 0.436 . . . . 0.0 112.178 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 1.4 t80 -81.4 69.21 7.98 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.259 0.552 . . . . 0.0 110.22 179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . 0.409 HH11 ' HD2' ' A' ' 58' ' ' ARG . 17.7 mtt180 -72.89 0.59 10.69 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.716 -0.675 . . . . 0.0 112.592 -178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 2.1 ttm180 -96.88 51.69 1.14 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.199 0.523 . . . . 0.0 110.198 179.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -120.0 0.15 10.71 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.613 -0.721 . . . . 0.0 111.412 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.895 ' HA ' HD22 ' A' ' 64' ' ' LEU . 36.6 m-85 -110.51 -25.91 9.77 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.752 0.311 . . . . 0.0 111.592 -178.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.82 -41.11 97.94 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.74 -179.295 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -68.99 -18.95 64.12 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.748 -179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.895 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.5 OUTLIER -66.87 -45.41 78.18 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 178.359 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.674 ' O ' ' HB3' ' A' ' 69' ' ' HIS . . . -75.67 -47.24 27.11 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 114.271 -1.331 . . . . 0.0 110.182 179.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.589 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -47.77 -41.63 23.73 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.18 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.571 ' HG3' ' HB3' ' A' ' 180' ' ' LEU . 27.9 mt-30 -71.83 -65.65 0.74 Allowed 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.552 ' HB3' ' HE1' ' A' ' 115' ' ' MET . 0.7 OUTLIER -78.49 14.48 1.25 Allowed 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 -176.339 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.674 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 1.6 p-80 -79.15 -20.56 48.23 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.533 179.464 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -91.87 -72.69 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.825 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . 0.427 ' HA ' ' HD3' ' A' ' 72' ' ' PRO . 0.2 OUTLIER -157.15 135.64 7.63 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.642 -178.983 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . 0.427 ' HD3' ' HA ' ' A' ' 71' ' ' THR . 21.2 Cg_exo -66.44 170.14 12.8 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 123.115 2.543 . . . . 0.0 112.378 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . 0.715 ' H ' HD21 ' A' ' 118' ' ' LEU . . . 92.18 -58.49 2.76 Favored Glycine 0 C--N 1.33 0.238 0 C-N-CA 120.631 -0.795 . . . . 0.0 112.67 179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -77.55 50.54 0.82 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.43 0.634 . . . . 0.0 110.848 179.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . . . . . . . . . . . -110.67 -25.08 10.14 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.521 -0.763 . . . . 0.0 110.739 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.626 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 0.0 OUTLIER -63.03 -42.1 99.68 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.848 -179.02 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.5 mp0 -62.95 -44.71 95.33 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.383 179.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 79.5 mtt-85 -61.7 -42.68 99.26 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.246 179.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.0 t80 -62.47 -51.0 69.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.469 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 1.7 p -59.07 -32.2 69.57 Favored 'General case' 0 CA--C 1.533 0.302 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.725 -179.823 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 6.9 mm-40 -61.07 -60.52 3.64 Favored 'General case' 0 CA--C 1.517 -0.311 0 CA-C-O 120.917 0.389 . . . . 0.0 110.72 179.522 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.546 HG11 ' HG ' ' A' ' 180' ' ' LEU . 16.7 m -60.29 -32.53 51.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-N 115.591 -0.731 . . . . 0.0 111.226 -179.667 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 37.6 m -65.61 -42.42 91.6 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.455 ' HA ' ' OH ' ' A' ' 129' ' ' TYR . 0.3 OUTLIER -67.16 -40.44 86.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.85 178.938 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 87.4 mt-10 -67.13 -31.79 72.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.486 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.01 -36.59 59.09 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.45 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 36.0 t80 -85.83 -5.81 59.19 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.255 -0.429 . . . . 0.0 111.149 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -50.55 -34.46 25.61 Favored 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.241 -0.436 . . . . 0.0 112.018 -179.397 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 178.83 62.54 0.07 OUTLIER Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 119.95 -1.119 . . . . 0.0 113.352 179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.53 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 159.88 56.64 0.01 OUTLIER Glycine 0 CA--C 1.522 0.503 0 C-N-CA 119.544 -1.313 . . . . 0.0 115.014 178.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.547 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 11.8 Cg_endo -82.13 29.37 0.54 Allowed 'Trans proline' 0 C--N 1.346 0.447 0 C-N-CA 122.396 2.064 . . . . 0.0 111.194 177.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.857 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 3.9 m120 -61.63 162.06 8.96 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.193 -0.912 . . . . 0.0 111.889 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 27.7 m95 -52.68 -25.77 11.91 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.864 -179.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -67.64 -40.98 90.31 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.573 -0.822 . . . . 0.0 111.522 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.674 HH11 ' HB2' ' A' ' 174' ' ' LEU . 3.0 mmp_? -87.09 -22.43 25.4 Favored 'General case' 0 C--N 1.325 -0.463 0 O-C-N 122.926 -0.161 . . . . 0.0 110.758 179.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.84 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.1 OUTLIER -54.71 -31.08 57.61 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 123.728 0.643 . . . . 0.0 110.229 179.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.935 HG22 ' HB1' ' A' ' 49' ' ' ALA . 17.6 t -59.77 -56.99 13.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.105 -0.952 . . . . 0.0 109.95 178.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -62.4 -27.32 69.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.582 -179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.84 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 9.0 m-85 -58.49 -55.12 39.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.085 0.469 . . . . 0.0 110.123 179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.479 ' HB3' ' CD2' ' A' ' 17' ' ' PHE . 12.8 m-85 -76.16 -37.86 57.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.807 -0.633 . . . . 0.0 111.134 -179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 5.7 t -62.73 -37.88 80.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.801 -179.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.412 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.6 OUTLIER -54.5 -53.86 48.67 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 111.873 0.323 . . . . 0.0 111.873 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -74.13 -35.66 52.88 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.229 -0.986 . . . . 0.0 113.444 -179.195 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -63.13 -42.61 99.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 117.136 0.468 . . . . 0.0 110.513 179.889 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.408 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -69.43 -40.17 77.4 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.604 -0.517 . . . . 0.0 109.604 178.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.823 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -59.65 -42.11 92.05 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.704 179.436 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.666 ' HB3' HD21 ' A' ' 22' ' ' LEU . 96.9 m -69.06 -41.16 77.97 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-N 115.163 -0.926 . . . . 0.0 111.024 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -53.86 -48.46 69.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.983 -179.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.45 ' O ' ' HB2' ' A' ' 112' ' ' ASN . 1.0 OUTLIER -74.13 -20.22 60.31 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.838 -0.345 . . . . 0.0 111.874 -179.619 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.579 ' HB3' HG22 ' A' ' 119' ' ' VAL . 0.3 OUTLIER -78.78 -35.94 43.68 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 120.504 -0.478 . . . . 0.0 110.482 179.606 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.616 HG23 ' O ' ' A' ' 107' ' ' CYS . 24.6 t -67.81 -16.3 20.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.613 -0.267 . . . . 0.0 110.829 179.433 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.45 ' HB2' ' O ' ' A' ' 109' ' ' GLU . 12.3 m-20 -45.73 -70.25 0.11 Allowed 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.487 179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.526 ' O ' ' HG3' ' A' ' 114' ' ' GLU . 0.0 OUTLIER -175.55 37.45 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.886 179.375 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . 0.526 ' HG3' ' O ' ' A' ' 113' ' ' LYS . 17.2 mt-10 -159.68 122.1 3.43 Favored 'General case' 0 C--N 1.333 -0.137 0 CA-C-N 116.741 -0.209 . . . . 0.0 110.878 179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.552 ' HE1' ' HB3' ' A' ' 68' ' ' LEU . 4.0 mtm 70.31 114.84 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.607 0 O-C-N 123.777 0.673 . . . . 0.0 112.106 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.701 ' HB2' ' HD3' ' A' ' 117' ' ' PRO . 0.6 OUTLIER -102.05 -55.34 0.13 Allowed Pre-proline 0 CA--C 1.541 0.625 0 CA-C-N 116.15 -0.477 . . . . 0.0 112.146 179.753 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.701 ' HD3' ' HB2' ' A' ' 116' ' ' GLU . 36.2 Cg_exo -59.85 -27.79 85.73 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 122.487 2.125 . . . . 0.0 113.967 -178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.715 HD21 ' H ' ' A' ' 73' ' ' GLY . 0.8 OUTLIER -62.3 -31.57 72.19 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 112.297 0.48 . . . . 0.0 112.297 -178.915 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.579 HG22 ' HB3' ' A' ' 110' ' ' SER . 94.6 t -60.36 -55.95 20.91 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.388 0 CA-C-O 120.623 0.249 . . . . 0.0 111.371 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -62.51 -28.88 72.0 Favored Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.51 -0.852 . . . . 0.0 112.016 179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.519 ' HA ' ' HG2' ' A' ' 124' ' ' GLU . 1.9 mt-30 -68.52 -49.21 61.32 Favored 'General case' 0 C--O 1.219 -0.552 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.01 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.513 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 99.6 t -56.64 -36.25 47.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 178.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -61.64 -47.05 87.16 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.859 178.563 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.632 ' HA ' HG12 ' A' ' 127' ' ' VAL . 20.8 pt-20 -73.93 -36.72 64.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.16 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.626 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 40.1 m0 -57.12 -38.34 73.29 Favored 'General case' 0 N--CA 1.466 0.345 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 178.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 8.9 ttm -73.61 -54.28 8.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 114.633 -1.167 . . . . 0.0 111.63 -179.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' A' ' 124' ' ' GLU . 2.2 p -61.22 -30.42 47.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 C-N-CA 120.936 -0.306 . . . . 0.0 111.772 -179.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.5 tt0 -69.32 -50.0 50.58 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 120.793 -0.363 . . . . 0.0 110.263 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . 0.455 ' OH ' ' HA ' ' A' ' 84' ' ' ASP . 11.8 t80 -61.76 -34.4 75.78 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.473 0.654 . . . . 0.0 110.599 179.311 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 0.869 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.1 OUTLIER -72.12 -56.01 6.32 Favored 'General case' 0 C--N 1.318 -0.781 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.133 -178.854 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -60.99 -34.3 74.57 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 112.153 0.427 . . . . 0.0 112.153 -178.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 9.5 m -79.04 -40.92 30.09 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 113.332 0.864 . . . . 0.0 113.332 -178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.5 mtt180 -121.61 -42.73 2.41 Favored 'General case' 0 N--CA 1.465 0.303 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 -177.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.869 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.7 mm? -59.6 -46.0 90.25 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 118.227 0.467 . . . . 0.0 111.166 -178.496 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -51.18 -39.5 56.57 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 116.317 -0.402 . . . . 0.0 111.376 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -60.5 -55.78 29.36 Favored 'General case' 0 CA--C 1.518 -0.258 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.449 179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.857 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 62.2 t90 -55.79 -46.34 77.99 Favored 'General case' 0 N--CA 1.452 -0.341 0 CA-C-O 121.117 0.484 . . . . 0.0 109.772 178.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.406 HG23 ' HA2' ' A' ' 143' ' ' GLY . 0.6 OUTLIER -58.24 -48.19 85.45 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.609 -0.723 . . . . 0.0 111.721 -179.428 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 73.3 m-70 -66.07 -32.22 73.56 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 121.193 -0.203 . . . . 0.0 111.372 -179.592 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 2.4 m -84.0 -11.85 56.16 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.416 0.524 . . . . 0.0 112.416 -179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -95.77 -49.61 5.27 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 112.321 0.489 . . . . 0.0 112.321 -179.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . 176.3 -18.08 0.04 OUTLIER Glycine 0 CA--C 1.504 -0.633 0 N-CA-C 111.062 -0.815 . . . . 0.0 111.062 -179.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.406 ' HA2' HG23 ' A' ' 138' ' ' ILE . . . 96.15 170.6 35.06 Favored Glycine 0 N--CA 1.444 -0.814 0 C-N-CA 120.869 -0.681 . . . . 0.0 113.017 179.247 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.48 ' CZ3' HD11 ' A' ' 96' ' ' LEU . 92.9 m95 -60.48 -30.62 69.8 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -62.03 -34.52 76.38 Favored 'General case' 0 N--CA 1.455 -0.194 0 CA-C-N 115.307 -0.86 . . . . 0.0 110.792 178.575 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.442 ' HG3' HD12 ' A' ' 150' ' ' LEU . 0.0 OUTLIER -65.38 -42.19 92.95 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.064 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.754 ' HZ ' ' HB2' ' A' ' 49' ' ' ALA . 5.9 t80 -66.05 -33.85 76.75 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.454 -0.794 . . . . 0.0 110.391 178.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.548 ' O ' ' HA3' ' A' ' 152' ' ' GLY . 0.3 OUTLIER -71.07 -24.49 62.34 Favored 'General case' 0 C--O 1.224 -0.266 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.468 178.754 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -86.35 -31.68 21.4 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 178.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.442 HD12 ' HG3' ' A' ' 146' ' ' GLU . 0.1 OUTLIER -60.39 -51.38 69.73 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.581 -179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.647 ' CE1' ' HA ' ' A' ' 160' ' ' ARG . 1.9 m-85 -132.55 33.85 3.75 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.47 -0.492 . . . . 0.0 112.04 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -103.54 -127.79 6.16 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.173 -1.013 . . . . 0.0 112.431 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -66.42 -37.61 85.59 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.967 0.413 . . . . 0.0 111.078 -179.558 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . . . . . . . . . . . -108.32 61.81 0.3 Allowed Glycine 0 N--CA 1.449 -0.458 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.465 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -82.56 72.85 9.63 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.136 0.493 . . . . 0.0 110.637 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.706 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -66.2 164.16 16.3 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.837 -179.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 46.3 mp0 -59.72 -32.84 70.91 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.574 -179.556 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.706 ' HB2' HD12 ' A' ' 156' ' ' LEU . 1.5 mt-10 -71.47 -35.78 70.96 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.661 -179.73 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.75 -36.26 62.6 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.355 0.598 . . . . 0.0 109.73 179.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . 0.647 ' HA ' ' CE1' ' A' ' 151' ' ' TYR . 4.0 mtp180 -61.75 -51.64 67.5 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.294 179.137 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 158' ' ' GLU . 1.3 ptm180 -67.64 -28.39 67.68 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.652 179.6 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . 0.502 ' O ' ' HB2' ' A' ' 166' ' ' ASN . 0.1 OUTLIER -66.85 -45.3 78.62 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.129 -179.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.529 ' NH2' ' HA ' ' A' ' 49' ' ' ALA . 13.0 ttp180 -67.26 -38.04 84.48 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.709 -0.397 . . . . 0.0 110.911 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.418 ' HA ' ' CD1' ' A' ' 167' ' ' TRP . 0.1 OUTLIER -67.66 -47.12 70.42 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.214 179.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -68.75 -21.79 75.11 Favored Glycine 0 N--CA 1.449 -0.464 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.503 178.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.6 ' O ' HG22 ' A' ' 170' ' ' VAL . 0.5 OUTLIER -68.96 -54.04 17.52 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.645 -0.277 . . . . 0.0 110.827 179.967 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.649 ' HA ' ' CG2' ' A' ' 170' ' ' VAL . 15.0 p-90 -67.76 -25.08 65.44 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 116.598 -0.274 . . . . 0.0 110.985 -179.663 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.97 -44.14 74.12 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.975 0.417 . . . . 0.0 110.262 179.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -87.59 -28.75 21.73 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 112.929 0.715 . . . . 0.0 112.929 -179.628 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.649 ' CG2' ' HA ' ' A' ' 167' ' ' TRP . 27.8 m -93.04 -31.33 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 N-CA-C 114.313 1.227 . . . . 0.0 114.313 -177.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -72.17 -41.0 67.54 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.544 -0.722 . . . . 0.0 110.29 -179.704 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.738 ' HA ' HG23 ' A' ' 175' ' ' THR . 3.7 m -74.66 -28.47 60.87 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.836 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.809 HG13 ' HG ' ' A' ' 174' ' ' LEU . 2.6 p -70.44 -26.09 28.21 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.569 179.36 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.809 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.8 OUTLIER -120.72 39.73 3.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.125 0.488 . . . . 0.0 110.726 179.128 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.738 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.4 OUTLIER -68.5 -16.2 63.8 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.037 -0.529 . . . . 0.0 111.576 -179.765 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -87.96 14.08 59.65 Favored Glycine 0 C--O 1.225 -0.444 0 C-N-CA 121.003 -0.618 . . . . 0.0 113.184 -179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -79.34 8.2 6.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.942 0.371 . . . . 0.0 111.806 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 2.1 t -87.18 58.4 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-O 120.925 0.393 . . . . 0.0 110.475 179.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . . . . . . . . . . . -78.34 -5.09 51.17 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 112.058 0.392 . . . . 0.0 112.058 -179.084 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.571 ' HB3' ' HG3' ' A' ' 67' ' ' GLN . 0.2 OUTLIER -100.7 -7.84 23.42 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.3 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -68.03 89.48 0.2 Allowed Glycine 0 CA--C 1.519 0.327 0 C-N-CA 121.156 -0.545 . . . . 0.0 113.141 -179.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.589 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -127.98 -172.44 2.69 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.592 0.234 . . . . 0.0 110.409 179.731 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.171 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.321 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -4' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.72 0 N-CA-C 111.897 -0.481 . . . . 0.0 111.897 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' -3' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_exo -64.89 133.1 34.71 Favored 'Trans proline' 0 C--N 1.344 0.331 0 C-N-CA 122.969 2.446 . . . . 0.0 112.348 -179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' -2' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -98.67 -3.44 35.98 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.746 -179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' -1' ' ' GLY . . . . . . . . . . . . . . . 109.04 -78.42 0.24 Allowed Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.864 -0.684 . . . . 0.0 112.195 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 0' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -73.42 -56.98 4.34 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.726 0.298 . . . . 0.0 110.697 179.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.0 mpp? 70.86 -56.41 0.62 Allowed 'General case' 0 N--CA 1.47 0.566 0 CA-C-N 115.413 -0.812 . . . . 0.0 112.234 179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -99.7 138.66 36.48 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.68 0.276 . . . . 0.0 110.906 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 p -99.74 140.87 21.89 Favored Pre-proline 0 C--N 1.324 -0.542 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.762 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' PRO . . . . . . . . . . . . . 14.8 Cg_exo -68.63 160.46 49.34 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 122.747 2.298 . . . . 0.0 111.765 179.626 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -126.57 141.5 51.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.409 -0.359 . . . . 0.0 110.521 179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 4.5 m 62.68 96.94 0.04 OUTLIER 'General case' 0 N--CA 1.464 0.253 0 O-C-N 123.891 0.744 . . . . 0.0 111.703 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ALA . . . . . 0.48 ' HA ' ' HD3' ' A' ' 8' ' ' PRO . . . -99.11 138.26 20.56 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.859 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . 0.48 ' HD3' ' HA ' ' A' ' 7' ' ' ALA . 15.3 Cg_exo -68.88 101.95 0.84 Allowed 'Trans proline' 0 C--N 1.342 0.235 0 C-N-CA 122.984 2.456 . . . . 0.0 111.872 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -86.63 -161.4 0.66 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.458 -179.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -55.32 -43.33 74.81 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.385 -179.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ARG . . . . . . . . . . . . . 30.7 ttp180 -58.65 -39.33 80.29 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.631 0.253 . . . . 0.0 110.726 -179.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -71.56 -47.91 51.96 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 178.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.413 HD11 ' SD ' ' A' ' 46' ' ' MET . 4.2 tp -58.78 -45.09 90.63 Favored 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 115.907 -0.588 . . . . 0.0 112.377 -179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.67 ' HA ' ' HE2' ' A' ' 100' ' ' PHE . 9.9 p -65.9 -39.29 84.25 Favored 'Isoleucine or valine' 0 C--O 1.232 0.174 0 CA-C-O 120.717 0.294 . . . . 0.0 111.14 -179.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' ALA . . . . . . . . . . . . . . . -69.72 -36.87 76.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.783 0.325 . . . . 0.0 111.242 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 97.1 m-20 -72.87 -48.85 33.91 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.908 -178.683 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PHE . . . . . . . . . . . . . 5.8 t80 -59.31 -51.06 71.58 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-O 120.812 0.339 . . . . 0.0 110.844 179.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.402 ' O ' HD13 ' A' ' 22' ' ' LEU . 53.5 t -65.24 -40.99 90.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 N-CA-C 109.585 -0.524 . . . . 0.0 109.585 179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . 0.413 ' HA3' ' HB2' ' A' ' 33' ' ' PRO . . . -58.96 -48.02 87.83 Favored Glycine 0 C--O 1.222 -0.653 0 C-N-CA 121.005 -0.617 . . . . 0.0 111.94 178.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' TYR . . . . . 0.721 ' HA ' ' HA3' ' A' ' 34' ' ' GLY . 14.2 t80 -58.12 -47.75 82.34 Favored 'General case' 0 C--N 1.326 -0.446 0 C-N-CA 122.821 0.448 . . . . 0.0 111.074 179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -64.61 -45.68 85.86 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.175 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' LEU . . . . . 0.641 HD11 ' HB2' ' A' ' 107' ' ' CYS . 8.1 mp -67.15 -46.93 72.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.416 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.491 ' HG3' ' HA ' ' A' ' 31' ' ' ALA . 35.4 ttp85 -62.96 -20.34 65.15 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.841 179.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.412 ' HB2' ' O ' ' A' ' 20' ' ' TYR . 1.7 tt0 -82.19 -36.41 27.32 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.926 179.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -150.44 77.89 1.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 111.935 0.346 . . . . 0.0 111.935 -178.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLY . . . . . . . . . . . . . . . 149.49 -68.3 0.35 Allowed Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.399 -0.905 . . . . 0.0 113.09 179.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' TYR . . . . . 0.414 ' CZ ' ' HA3' ' A' ' 30' ' ' GLY . 1.1 t80 -92.57 59.67 3.38 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-O 121.246 0.546 . . . . 0.0 110.701 -179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -79.16 -26.95 13.16 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.804 -0.635 . . . . 0.0 109.92 179.668 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -69.42 -36.86 77.09 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.791 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.414 ' HA3' ' CZ ' ' A' ' 27' ' ' TYR . . . -96.46 50.6 1.61 Allowed Glycine 0 N--CA 1.448 -0.565 0 CA-C-N 115.303 -0.862 . . . . 0.0 111.955 179.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ALA . . . . . 0.491 ' HA ' ' HG3' ' A' ' 23' ' ' ARG . . . -67.75 131.28 45.27 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 110.06 -0.348 . . . . 0.0 110.06 179.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 163.01 -53.75 0.3 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 119.755 -1.212 . . . . 0.0 113.612 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PRO . . . . . 0.413 ' HB2' ' HA3' ' A' ' 19' ' ' GLY . 18.0 Cg_exo -68.56 -49.22 0.86 Allowed 'Trans proline' 0 C--N 1.348 0.53 0 C-N-CA 122.217 1.945 . . . . 0.0 111.643 -179.29 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.721 ' HA3' ' HA ' ' A' ' 20' ' ' TYR . . . -88.5 31.88 4.69 Favored Glycine 0 N--CA 1.444 -0.79 0 CA-C-N 115.56 -0.746 . . . . 0.0 113.517 -179.691 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 25.2 mm-40 -74.83 -59.44 2.73 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.437 0.637 . . . . 0.0 109.314 179.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -87.19 124.88 7.23 Favored Glycine 0 N--CA 1.448 -0.52 0 CA-C-N 115.115 -0.948 . . . . 0.0 112.422 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -85.82 -112.0 0.0 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 122.998 2.465 . . . . 0.0 112.955 -179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -70.44 97.15 1.24 Allowed 'General case' 0 C--N 1.315 -0.921 0 CA-C-N 115.568 -0.742 . . . . 0.0 112.141 -179.297 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -146.7 20.12 1.31 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.067 179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASP . . . . . 0.594 ' HB2' ' HB2' ' A' ' 43' ' ' HIS . 30.8 m-20 -146.26 162.35 35.18 Favored Pre-proline 0 C--O 1.237 0.421 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.463 -179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.513 ' HD2' ' HB3' ' A' ' 40' ' ' ASP . 58.3 Cg_endo -79.22 52.33 4.24 Favored 'Trans proline' 0 C--N 1.344 0.333 0 C-N-CA 123.366 2.711 . . . . 0.0 111.468 178.468 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 179.29 -33.69 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 114.558 -1.201 . . . . 0.0 108.03 179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' HIS . . . . . 0.594 ' HB2' ' HB2' ' A' ' 40' ' ' ASP . 0.3 OUTLIER -62.66 -50.4 71.36 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 114.67 -1.15 . . . . 0.0 110.575 179.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 30.9 tt0 -64.06 -25.23 68.01 Favored 'General case' 0 CA--C 1.517 -0.291 0 CA-C-N 115.649 -0.705 . . . . 0.0 110.287 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ALA . . . . . 0.973 ' HB2' ' HA ' ' A' ' 148' ' ' THR . . . -75.94 -54.22 7.21 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.242 -0.89 . . . . 0.0 111.465 -179.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' MET . . . . . 0.46 ' HE3' ' HZ3' ' A' ' 144' ' ' TRP . 3.3 ttm -61.97 -38.29 88.0 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.976 -178.793 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ARG . . . . . . . . . . . . . 1.4 tmt_? -61.32 -37.91 84.98 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.128 -0.487 . . . . 0.0 112.075 -179.255 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ALA . . . . . . . . . . . . . . . -79.4 -38.51 34.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.519 -179.494 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.783 ' HB1' HG22 ' A' ' 97' ' ' VAL . . . -59.56 -55.88 28.96 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.744 -0.662 . . . . 0.0 109.308 178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLY . . . . . . . . . . . . . . . -50.67 -49.45 40.37 Favored Glycine 0 C--O 1.217 -0.963 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.206 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 17.9 t70 -54.74 -53.15 58.8 Favored 'General case' 0 C--O 1.236 0.386 0 CA-C-O 120.906 0.384 . . . . 0.0 111.929 179.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -63.1 -46.6 86.6 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.355 -179.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.845 ' HB2' HG11 ' A' ' 97' ' ' VAL . 0.1 OUTLIER -69.77 -36.72 75.98 Favored 'General case' 0 C--O 1.217 -0.612 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.778 -179.538 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 14.5 tt0 -61.04 -32.86 72.47 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.503 0.668 . . . . 0.0 109.742 179.599 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' THR . . . . . . . . . . . . . 33.2 m -79.34 -28.92 42.09 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.356 -0.838 . . . . 0.0 111.351 179.563 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.3 mtt180 -92.44 -31.89 15.11 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -179.239 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -86.44 93.39 9.12 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.152 0.501 . . . . 0.0 111.191 -179.286 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ARG . . . . . . . . . . . . . 2.6 mpt_? -71.64 -25.42 62.14 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.875 179.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ARG . . . . . . . . . . . . . 3.9 mtt85 -94.27 77.31 3.97 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.122 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -120.85 -62.51 1.44 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.141 -0.482 . . . . 0.0 112.097 -178.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PHE . . . . . 0.947 ' HA ' HD22 ' A' ' 64' ' ' LEU . 23.0 m-85 -76.79 -10.81 59.64 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 -178.49 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.69 -47.61 80.48 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 112.288 0.477 . . . . 0.0 112.288 -179.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' HB3' ' HB2' ' A' ' 180' ' ' LEU . 1.1 m-20 -68.41 -21.23 64.69 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-O 120.975 0.417 . . . . 0.0 111.201 -179.417 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.947 HD22 ' HA ' ' A' ' 61' ' ' PHE . 0.8 OUTLIER -68.86 -42.01 77.66 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 108.92 -0.771 . . . . 0.0 108.92 178.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.523 ' O ' ' HB2' ' A' ' 69' ' ' HIS . . . -76.77 -43.38 37.21 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.159 -0.928 . . . . 0.0 110.567 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . 0.588 ' HB1' ' H ' ' A' ' 182' ' ' ALA . . . -53.48 -43.22 67.99 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.896 -0.593 . . . . 0.0 111.194 179.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.72 HE22 HD11 ' A' ' 106' ' ' LEU . 26.6 mt-30 -71.33 -58.05 3.89 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 112.993 0.738 . . . . 0.0 112.993 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.02 3.8 6.38 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 113.206 0.817 . . . . 0.0 113.206 -176.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' HIS . . . . . 0.523 ' HB2' ' O ' ' A' ' 65' ' ' ALA . 65.5 t60 -78.81 -26.89 44.31 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.986 0.422 . . . . 0.0 109.873 179.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -91.07 -71.65 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.277 -179.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -161.13 147.58 11.47 Favored Pre-proline 0 C--O 1.236 0.391 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.918 -179.124 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -89.54 -169.81 0.4 Allowed 'Trans proline' 0 N--CA 1.458 -0.615 0 C-N-CA 123.138 2.559 . . . . 0.0 111.917 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . 79.76 -70.24 2.91 Favored Glycine 0 CA--C 1.518 0.25 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.343 179.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -74.41 37.15 0.11 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.971 0.415 . . . . 0.0 111.905 -179.585 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ALA . . . . . 0.427 ' HB3' HD11 ' A' ' 118' ' ' LEU . . . -85.84 -16.42 38.72 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.36 -0.382 . . . . 0.0 110.368 179.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' GLN . . . . . 0.62 ' HB3' ' CZ2' ' A' ' 125' ' ' TRP . 2.0 pt20 -60.95 -42.0 97.39 Favored 'General case' 0 CA--C 1.512 -0.481 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.588 -179.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 42.9 mt-30 -63.3 -39.57 94.92 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.855 0.36 . . . . 0.0 110.499 179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ARG . . . . . . . . . . . . . 7.2 mtt180 -67.58 -43.58 80.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.021 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 6.8 t80 -63.06 -48.9 76.7 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.434 179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' THR . . . . . . . . . . . . . 3.0 p -57.73 -31.88 66.87 Favored 'General case' 0 CA--C 1.529 0.164 0 C-N-CA 121.008 -0.277 . . . . 0.0 111.394 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLN . . . . . . . . . . . . . 17.9 mm100 -62.43 -63.27 1.28 Allowed 'General case' 0 CA--C 1.513 -0.451 0 CA-C-O 120.891 0.376 . . . . 0.0 110.636 179.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.636 HG11 ' HG ' ' A' ' 180' ' ' LEU . 20.9 m -58.78 -32.12 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 CA-C-N 115.558 -0.747 . . . . 0.0 111.512 -179.651 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 47.6 m -65.91 -43.48 88.01 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.437 ' O ' ' HG2' ' A' ' 88' ' ' GLN . 0.2 OUTLIER -69.26 -40.6 77.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.638 178.708 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 7.6 mt-10 -64.14 -28.3 69.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.646 -0.707 . . . . 0.0 110.412 179.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.689 ' HG ' HH11 ' A' ' 95' ' ' ARG . 0.0 OUTLIER -83.62 -28.5 28.41 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.269 0.557 . . . . 0.0 110.088 179.075 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PHE . . . . . . . . . . . . . 9.4 t80 -91.08 0.5 57.52 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.07 -179.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLN . . . . . 0.437 ' HG2' ' O ' ' A' ' 84' ' ' ASP . 9.1 mm100 -49.0 -33.27 10.72 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 116.212 -0.449 . . . . 0.0 112.003 -179.621 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 165.67 55.29 0.02 OUTLIER Glycine 0 N--CA 1.445 -0.735 0 C-N-CA 120.251 -0.976 . . . . 0.0 112.962 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.443 ' H ' ' HD3' ' A' ' 91' ' ' PRO . . . 172.61 54.95 0.05 OUTLIER Glycine 0 CA--C 1.523 0.591 0 C-N-CA 119.953 -1.118 . . . . 0.0 114.324 179.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' PRO . . . . . 0.661 ' HG2' ' CD1' ' A' ' 137' ' ' TRP . 18.0 Cg_endo -80.87 43.06 1.46 Allowed 'Trans proline' 0 C--N 1.35 0.657 0 C-N-CA 122.169 1.913 . . . . 0.0 111.977 178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.804 ' HA ' ' CZ2' ' A' ' 137' ' ' TRP . 1.3 t-20 -67.71 161.74 25.29 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.759 -0.655 . . . . 0.0 111.896 -178.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' TRP . . . . . 0.595 ' HA ' ' HB2' ' A' ' 96' ' ' LEU . 16.3 m95 -55.33 -26.98 44.06 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.708 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . -62.78 -43.76 98.47 Favored Glycine 0 N--CA 1.447 -0.602 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.689 HH11 ' HG ' ' A' ' 86' ' ' LEU . 5.2 mmt180 -86.31 -18.77 31.1 Favored 'General case' 0 C--N 1.327 -0.383 0 O-C-N 122.819 -0.224 . . . . 0.0 110.716 179.025 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.752 ' HA ' ' HD2' ' A' ' 99' ' ' PHE . 0.2 OUTLIER -56.86 -31.66 65.03 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-O 121.329 0.585 . . . . 0.0 110.218 179.574 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.845 HG11 ' HB2' ' A' ' 53' ' ' PHE . 5.9 t -61.3 -53.73 44.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.16 -0.927 . . . . 0.0 109.521 178.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -64.64 -26.85 68.57 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.03 -0.986 . . . . 0.0 111.395 179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.752 ' HD2' ' HA ' ' A' ' 96' ' ' LEU . 4.1 m-85 -57.42 -57.53 12.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.042 0.449 . . . . 0.0 110.068 179.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.67 ' HE2' ' HA ' ' A' ' 14' ' ' VAL . 8.6 m-85 -74.79 -40.07 61.36 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.724 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 2.5 t -58.02 -38.91 69.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.59 -179.611 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.495 ' O ' ' HB2' ' A' ' 106' ' ' LEU . 0.5 OUTLIER -56.71 -49.49 75.01 Favored 'General case' 0 C--N 1.334 -0.084 0 CA-C-O 120.729 0.3 . . . . 0.0 111.317 -179.857 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -77.36 -37.91 30.37 Favored Glycine 0 N--CA 1.447 -0.611 0 C-N-CA 120.238 -0.982 . . . . 0.0 113.003 -179.827 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -61.66 -44.04 97.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 117.025 0.413 . . . . 0.0 110.688 -179.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.53 ' HB1' HD21 ' A' ' 64' ' ' LEU . . . -68.56 -40.07 80.77 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 178.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.772 ' HA ' ' HG ' ' A' ' 64' ' ' LEU . 0.2 OUTLIER -58.79 -43.66 90.54 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.281 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' CYS . . . . . 0.641 ' HB2' HD11 ' A' ' 22' ' ' LEU . 88.5 m -63.57 -44.37 94.29 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 114.987 -1.006 . . . . 0.0 111.071 179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . -54.36 -45.03 72.68 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.684 0.278 . . . . 0.0 111.569 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . 0.64 ' HA ' HD21 ' A' ' 112' ' ' ASN . 0.4 OUTLIER -75.09 -23.06 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.658 -179.838 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' SER . . . . . 0.407 ' HB2' HG22 ' A' ' 119' ' ' VAL . 49.1 m -79.56 -22.24 44.08 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 116.581 -0.281 . . . . 0.0 111.116 -179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' VAL . . . . . 0.561 HG23 ' O ' ' A' ' 107' ' ' CYS . 96.3 t -75.97 -35.44 29.47 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 120.937 0.399 . . . . 0.0 110.967 179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' ASN . . . . . 0.64 HD21 ' HA ' ' A' ' 109' ' ' GLU . 14.7 p30 -85.04 1.13 49.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.481 -0.327 . . . . 0.0 111.218 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LYS . . . . . 0.401 ' HB3' ' SD ' ' A' ' 115' ' ' MET . 8.9 mtmt -123.6 -174.6 3.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.973 179.202 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -84.5 48.74 1.56 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.154 0.502 . . . . 0.0 110.893 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' MET . . . . . 0.401 ' SD ' ' HB3' ' A' ' 113' ' ' LYS . 0.0 OUTLIER -129.94 37.84 3.88 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.519 -179.679 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.536 ' H ' ' HG3' ' A' ' 116' ' ' GLU . 0.0 OUTLIER -54.68 -53.73 57.09 Favored Pre-proline 0 CA--C 1.539 0.553 0 CA-C-N 116.075 -0.511 . . . . 0.0 112.058 -179.794 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . 0.509 ' O ' ' HG2' ' A' ' 121' ' ' GLN . 23.4 Cg_exo -65.15 -32.12 53.0 Favored 'Trans proline' 0 C--N 1.353 0.794 0 C-N-CA 122.005 1.804 . . . . 0.0 112.299 -179.915 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' LEU . . . . . 0.493 HD22 ' HA ' ' A' ' 118' ' ' LEU . 0.1 OUTLIER -59.61 -31.06 69.13 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.609 -179.809 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.407 HG22 ' HB2' ' A' ' 110' ' ' SER . 87.2 t -58.17 -51.2 73.92 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 120.903 0.382 . . . . 0.0 111.256 179.658 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -64.06 -31.58 81.31 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.687 -0.768 . . . . 0.0 112.089 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' GLN . . . . . 0.509 ' HG2' ' O ' ' A' ' 117' ' ' PRO . 14.3 mm100 -66.27 -51.81 53.77 Favored 'General case' 0 N--CA 1.449 -0.488 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' VAL . . . . . 0.434 HG22 ' CZ3' ' A' ' 125' ' ' TRP . 61.2 t -58.15 -33.71 47.56 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 CA-C-O 121.015 0.436 . . . . 0.0 109.835 178.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLN . . . . . . . . . . . . . 20.0 tt0 -63.16 -47.57 82.11 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.325 178.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLU . . . . . 0.66 ' HA ' HG12 ' A' ' 127' ' ' VAL . 18.4 pt-20 -72.4 -39.44 67.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 120.95 -0.3 . . . . 0.0 111.141 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' TRP . . . . . 0.62 ' CZ2' ' HB3' ' A' ' 76' ' ' GLN . 34.7 m0 -57.61 -38.61 75.23 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-O 121.488 0.661 . . . . 0.0 109.312 178.824 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' MET . . . . . . . . . . . . . 12.0 ttm -73.77 -52.83 11.87 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.027 -0.988 . . . . 0.0 111.795 -178.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' VAL . . . . . 0.66 HG12 ' HA ' ' A' ' 124' ' ' GLU . 4.5 p -62.15 -33.32 58.04 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 112.021 0.378 . . . . 0.0 112.021 -178.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -68.55 -52.07 35.97 Favored 'General case' 0 CA--C 1.521 -0.145 0 C-N-CA 120.748 -0.381 . . . . 0.0 110.605 179.542 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' TYR . . . . . . . . . . . . . 5.7 t80 -57.49 -33.32 67.89 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-O 121.467 0.651 . . . . 0.0 110.568 179.226 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' LEU . . . . . 1.045 ' HA ' ' HB2' ' A' ' 134' ' ' LEU . 0.0 OUTLIER -75.07 -55.81 5.36 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.384 -0.826 . . . . 0.0 112.748 -179.18 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -62.68 -32.02 73.02 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 112.338 0.495 . . . . 0.0 112.338 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' THR . . . . . . . . . . . . . 4.7 m -82.61 -34.7 27.53 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 -179.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . 0.442 HH11 ' HD2' ' A' ' 133' ' ' ARG . 0.0 OUTLIER -126.97 -44.91 1.6 Allowed 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 -177.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 1.045 ' HB2' ' HA ' ' A' ' 130' ' ' LEU . 1.0 OUTLIER -59.05 -46.54 87.98 Favored 'General case' 0 N--CA 1.467 0.401 0 C-N-CA 120.66 -0.416 . . . . 0.0 111.429 -178.394 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ALA . . . . . . . . . . . . . . . -52.64 -38.85 61.04 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.259 179.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -60.03 -52.59 64.73 Favored 'General case' 0 CA--C 1.518 -0.274 0 C-N-CA 120.917 -0.313 . . . . 0.0 110.418 179.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TRP . . . . . 0.804 ' CZ2' ' HA ' ' A' ' 92' ' ' ASN . 52.8 t90 -56.62 -48.69 76.92 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 178.281 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ILE . . . . . 0.507 HG13 ' HE3' ' A' ' 137' ' ' TRP . 6.7 mt -57.09 -47.77 83.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.487 -0.778 . . . . 0.0 112.016 -179.194 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' HIS . . . . . . . . . . . . . 71.8 m-70 -66.39 -29.17 69.28 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 111.508 0.188 . . . . 0.0 111.508 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.0 m -88.04 -16.13 34.46 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 112.315 0.487 . . . . 0.0 112.315 -179.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.56 -54.39 4.43 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -178.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' GLY . . . . . . . . . . . . . . . -176.78 -9.74 0.02 OUTLIER Glycine 0 CA--C 1.506 -0.51 0 C-N-CA 120.802 -0.713 . . . . 0.0 111.545 -179.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 91.03 166.88 40.98 Favored Glycine 0 N--CA 1.443 -0.878 0 C-N-CA 120.79 -0.719 . . . . 0.0 113.009 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TRP . . . . . 0.46 ' HZ3' ' HE3' ' A' ' 46' ' ' MET . 91.6 m95 -60.67 -29.15 69.12 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 179.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ALA . . . . . . . . . . . . . . . -64.14 -35.22 80.06 Favored 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.89 178.607 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -62.78 -42.77 99.84 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 178.935 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' PHE . . . . . 0.473 ' HB2' ' CE3' ' A' ' 93' ' ' TRP . 14.3 t80 -66.1 -33.17 75.17 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.032 -0.985 . . . . 0.0 110.137 178.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . 0.973 ' HA ' ' HB2' ' A' ' 45' ' ' ALA . 0.9 OUTLIER -66.39 -27.7 68.06 Favored 'General case' 0 C--O 1.222 -0.375 0 CA-C-O 120.738 0.304 . . . . 0.0 111.02 179.294 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -85.22 -37.0 20.61 Favored 'General case' 0 C--N 1.32 -0.679 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 178.661 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LEU . . . . . 0.62 HD22 ' HB3' ' A' ' 163' ' ' ARG . 5.0 mt -63.61 -42.95 98.18 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.536 179.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' TYR . . . . . 0.401 ' CE1' ' HA ' ' A' ' 49' ' ' ALA . 1.4 m-85 -123.39 31.29 5.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.814 -178.649 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 148' ' ' THR . . . -122.94 -138.37 5.26 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 119.752 -1.214 . . . . 0.0 113.107 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.08 -42.77 36.91 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.371 -0.415 . . . . 0.0 111.785 -178.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' GLY . . . . . 0.432 ' O ' HD23 ' A' ' 156' ' ' LEU . . . -85.52 53.43 4.73 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.44 -179.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' ALA . . . . . . . . . . . . . . . -83.5 71.76 10.3 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.263 0.554 . . . . 0.0 110.403 179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' LEU . . . . . 0.681 HD12 ' HB2' ' A' ' 158' ' ' GLU . 0.2 OUTLIER -63.02 157.68 21.38 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.653 -0.703 . . . . 0.0 110.39 -179.918 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' GLU . . . . . . . . . . . . . 21.5 mp0 -53.07 -33.68 53.09 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.198 -0.456 . . . . 0.0 112.209 -179.176 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLU . . . . . 0.681 ' HB2' HD12 ' A' ' 156' ' ' LEU . 6.2 mt-10 -72.8 -39.41 66.7 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.821 0.343 . . . . 0.0 110.919 -179.848 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.17 -37.36 72.18 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.993 0.425 . . . . 0.0 110.83 179.377 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' ARG . . . . . . . . . . . . . 9.3 mtm180 -60.66 -51.46 69.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.059 -0.518 . . . . 0.0 111.037 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' ARG . . . . . . . . . . . . . 4.5 ptm180 -69.16 -26.12 64.7 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.019 179.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' LEU . . . . . . . . . . . . . 1.4 mt -72.68 -46.02 55.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.37 -179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ARG . . . . . 0.62 ' HB3' HD22 ' A' ' 150' ' ' LEU . 3.8 ptt180 -65.1 -38.62 91.29 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.789 -0.365 . . . . 0.0 111.288 -179.269 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLU . . . . . 0.587 ' HG2' ' HE1' ' A' ' 167' ' ' TRP . 1.6 mt-10 -71.02 -43.54 67.72 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 120.803 0.335 . . . . 0.0 110.204 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' GLY . . . . . . . . . . . . . . . -66.81 -28.46 73.79 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.296 -0.954 . . . . 0.0 111.647 179.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' ASN . . . . . 0.56 ' O ' HG22 ' A' ' 170' ' ' VAL . 1.3 t-20 -67.1 -57.76 6.18 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 120.609 0.242 . . . . 0.0 111.465 -179.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' TRP . . . . . 0.791 ' HA ' HG22 ' A' ' 170' ' ' VAL . 15.7 p-90 -62.12 -25.34 67.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.491 -178.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' ALA . . . . . . . . . . . . . . . -54.07 -51.4 64.23 Favored 'General case' 0 C--N 1.326 -0.444 0 C-N-CA 121.043 -0.263 . . . . 0.0 111.051 179.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.02 -29.19 22.14 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 112.856 0.687 . . . . 0.0 112.856 -179.584 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' VAL . . . . . 0.791 HG22 ' HA ' ' A' ' 167' ' ' TRP . 26.8 m -79.4 -23.9 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 119.665 -0.814 . . . . 0.0 112.265 -178.511 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' ARG . . . . . 0.595 ' HA ' ' HE ' ' A' ' 95' ' ' ARG . 3.7 ttp180 -83.09 -14.43 53.72 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' THR . . . . . 0.661 ' HA ' HG23 ' A' ' 175' ' ' THR . 0.7 OUTLIER -98.52 -33.21 11.09 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.471 179.686 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' VAL . . . . . 0.964 HG13 ' HG ' ' A' ' 174' ' ' LEU . 11.7 p -63.19 -33.14 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.215 0.531 . . . . 0.0 110.57 -179.76 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.964 ' HG ' HG13 ' A' ' 173' ' ' VAL . 0.1 OUTLIER -112.34 39.4 2.46 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.77 178.882 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' THR . . . . . 0.661 HG23 ' HA ' ' A' ' 172' ' ' THR . 0.1 OUTLIER -54.37 -42.86 70.83 Favored 'General case' 0 CA--C 1.534 0.339 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.372 179.77 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . . . . . . . . . . . -79.72 59.55 4.43 Favored Glycine 0 CA--C 1.519 0.282 0 CA-C-N 116.143 -0.481 . . . . 0.0 113.131 -179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ALA . . . . . . . . . . . . . . . -120.14 6.69 10.76 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.413 0.625 . . . . 0.0 109.62 179.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -86.65 61.61 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.455 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' ALA . . . . . 0.404 ' H ' HG12 ' A' ' 82' ' ' VAL . . . -82.41 -8.11 59.63 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.568 -178.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' LEU . . . . . 0.636 ' HG ' HG11 ' A' ' 82' ' ' VAL . 0.8 OUTLIER -94.43 -33.76 13.0 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.617 -0.265 . . . . 0.0 110.802 179.987 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . -66.14 96.62 0.28 Allowed Glycine 0 N--CA 1.449 -0.456 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.627 -179.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.588 ' H ' ' HB1' ' A' ' 66' ' ' ALA . . . -110.81 43.25 1.46 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 120.835 0.35 . . . . 0.0 110.588 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.007 0 CA-C-O 117.994 -1.003 . . . . 0.0 109.755 179.98 . . . . . . . . 1 1 . 1 stop_ save_